Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

5.4.99.7: Lanosterol synthase

This is an abbreviated version!
For detailed information about Lanosterol synthase, go to the full flat file.

Word Map on EC 5.4.99.7

Reaction

(3S)-2,3-epoxy-2,3-dihydrosqualene
=
lanosterol

Synonyms

2,3 oxidosqualene:lanosterol cyclase, 2,3-Epoxysqualene lanosterol-cyclase, 2,3-epoxysqualene--lanosterol cyclase, 2,3-Epoxysqualene-lanosterol cyclase, 2,3-Oxidosqualene cyclase, 2,3-oxidosqualene cyclase-lanosterol synthase, 2,3-Oxidosqualene sterol cyclase, 2,3-Oxidosqualene-lanosterol cyclase, 2,3-oxidosqualene:lanosterol cyclase, AtLAS, Cyclase, 2,3-oxidosqualene-lanosterol, ERG7, Erg7p, hOSC, Lanosterol 2,3-oxidosqualene cyclase, lanosterol synthase, LAS, LAS1, Lss, OSC, OSLC, Oxidosqualene cyclase, oxidosqualene cyclase/lanosterol synthase, Oxidosqualene--lanosterol cyclase, Oxidosqualene-lanosterol cyclase, oxidosqualene:lanosterol cyclase, SceOSC, Squalene 2,3-epoxide:lanosterol cyclase, Squalene 2,3-oxide-lanosterol cyclase, Squalene epoxidase-cyclase, Squalene-2,3-oxide-lanosterol cyclase, tuber-specific StLAS-like

ECTree

     5 Isomerases
         5.4 Intramolecular transferases
             5.4.99 Transferring other groups
                5.4.99.7 Lanosterol synthase

Disease

topprint

Disease on EC 5.4.99.7 - Lanosterol synthase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abnormalities, Multiple
A Rare Presentation of Os Odontoideum with Multiple Vertebral Fusion in Type III Klippel-Feil Syndrome (KFS) - A Case Report.
Abortion, Spontaneous
Single-cell Immune Landscape of Human Recurrent Miscarriage.
Abscess
Infiltrating aggressive epitheliosis of the temporal bone: a newly described disease entity.
Multiple Abscesses With Osteomyelitis and Destruction of Both the Atlas and the Axis in a 4-week-old Infant.
[Atlas of the clinico-pathological study of neurological diseases. 1. Otogenic cerebellar abscess]
Achondroplasia
Foramen magnum stenosis from overgrowth of the opisthion in a child with achondroplasia.
Acquired Immunodeficiency Syndrome
Color atlas: aids and the skin
Complications of hip prostheses: an atlas of new preventive technical aids.
Data harmonization process for creating the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Atlas.
Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Côte d'Ivoire, Mali and Senegal.
Factors Associated With Self-Reported Hearing Aid Management Skills and Knowledge.
FETAX interlaboratory validation study: phase III--Part 1 testing.
Open Access Publishing of Textbooks and Guidelines for Otolaryngologists in Developing Countries.
Symmetric diffeomorphic registration of fibre orientation distributions.
Teaching aids atlas of spine imaging
Using micro-computed tomography to reveal the anatomy of adult Diaphorina citri Kuwayama (Insecta: Hemiptera, Liviidae) and how it pierces and feeds within a citrus leaf.
Validation of a digitally displayed photographic food portion-size estimation aid among women in urban and rural Malawi.
Whole mouse brain reconstruction and registration to a reference atlas with standard histochemical processing of coronal sections.
Acromegaly
Craniofacial and pharyngeal airway morphology in patients with acromegaly.
Unilateral atlantal mass hypertrophy in acromegaly. Case report.
Acute Coronary Syndrome
Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial.
Comparison of the efficacy and safety of two rivaroxaban doses in acute coronary syndrome (from ATLAS ACS 2-TIMI 51).
D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy).
Mortality in the TRACER and ATLAS ACS 2 Trials: Two More Reasons to Audit Vital Records in PLATO.
Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial).
Rivaroxaban for stroke prevention in atrial fibrillation and secondary prevention in patients with a recent acute coronary syndrome.
Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed?
Rivaroxaban: An Evaluation of its Cardiovascular Benefit-Risk Profile Across Indications Based on Numbers Needed to Treat or Harm, and on Clinically Meaningful Endpoint Comparisons.
Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial.
The "Dual-Pathway" Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2-TIMI 51 Trial.
The ATLAS ACS 2-TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects With Acute Coronary Syndrome ACS 2-Thrombolysis In Myocardial Infarction 51).
The treatment of missing data in a large cardiovascular clinical outcomes study.
[Practical Aspects of the Use of Oral Anticoagulant Rivaroxaban for the Prevention of Adverse Outcomes After Acute Coronary Syndrome].
[Rivarobaxan for patients with recent acute coronary syndrome : ATLAS ACS 2-TIMI 51].
Acute Kidney Injury
Global Kidney Health Atlas (GKHA): design and methods.
Adenocarcinoma
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.
A Four-Gene-Based Risk Score With High Prognostic Value in Gastric Cancer.
A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine.
A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer.
A novel microRNA signature predicts survival in stomach adenocarcinoma.
A panel of collagen genes are associated with prognosis of patients with gastric cancer and regulated by microRNA-29c-3p: an integrated bioinformatics analysis and experimental validation.
Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer.
Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated ?-Catenin Activation Compared with Squamous Cell Carcinoma.
Agonistic CD40 Antibodies in Cancer Treatment.
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma.
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.
AMP?activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
An Integrated Pan-Cancer Analysis and Structure-Based Virtual Screening of GPR15.
Analysis of cyclin E co-expression genes reveals nuclear transcription factor Y subunit alpha is an oncogene in gastric cancer.
Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
Association between the CYP11 family and six cancer types.
Autophagy-related genes are potential diagnostic and prognostic biomarkers in prostate cancer.
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal cancer.
Bioinformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer.
Biomarker Identification through Multiomics Data Analysis of Prostate Cancer Prognostication Using a Deep Learning Model and Similarity Network Fusion.
C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis.
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Case Report: Novel RPGRIP1L Gene Mutations Identified by Whole Exome Sequencing in a Patient With Multiple Primary Tumors.
CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer.
Chromosomal breaks at FRA18C: association with reduced DOK6 expression, altered oncogenic signaling and increased gastric cancer survival.
Cilia gene expression patterns in cancer.
Clinical Importance of Epstein?Barr Virus-Associated Gastric Cancer.
Clinicopathological, immune and molecular correlates of PD-L2 methylation in gastric adenocarcinomas.
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.
Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach.
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma.
Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis.
Comprehensive Analysis Identifying Wnt Ligands Gene Family for Biochemical Recurrence in Prostate Adenocarcinoma and Construction of a Nomogram.
Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA.
Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in Pancreatic Cancer.
Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification.
Comprehensive analysis of prognostic alternative splicing signature in cervical cancer.
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma.
Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.
Comprehensive molecular characterization of gastric adenocarcinoma.
Computational analysis of fused co-expression networks for the identification of candidate cancer gene biomarkers.
Computational assessment of stomach tumor volume from multi-slice computerized tomography images in presence of type 2 cancer.
Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.
Construction of a Competitive Endogenous RNA Network and Identification of Potential Regulatory Axis in Gastric Cancer.
Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.
Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients.
CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies.
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Curation of the Pancreatic Ductal Adenocarcinoma Subset of the Cancer Genome Atlas Is Essential for Accurate Conclusions about Survival-Related Molecular Mechanisms.
Data mining analysis of the prognostic impact of N6-methyladenosine regulators in patients with endometrial adenocarcinoma.
Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas.
DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma.
Decreased Tumoral Expression of Colon-Specific Water Channel Aquaporin 8 Is Associated With Reduced Overall Survival in Colon Adenocarcinoma.
Deep Learning for Automatic Subclassification of Gastric Carcinoma Using Whole-Slide Histopathology Images.
Deep-Hipo: Multi-scale receptive field deep learning for histopathological image analysis.
Development and validation of an autophagy-related prognostic signature in esophageal cancer.
Development and validation of the trans-omics model for pancreatic adenocarcinoma.
Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas.
Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Diagnostic and therapeutic potencies of miR-18a-5p in mixed-type gastric adenocarcinoma.
Differential microRNA expression profiles associated with microsatellite status reveal possible epigenetic regulation of microsatellite instability in gastric adenocarcinoma.
Dishevelled segment polarity protein 3 (DVL3): a novel and easily applicable recurrence predictor in localised prostate adenocarcinoma.
DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors.
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer.
Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
Dynamic Control of Mitochondrial Ca2+ Levels as a Survival Strategy of Cancer Cells.
Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
eEF2K as a novel metastatic and prognostic biomarker in gastric cancer patients.
Emerging Multimodality Approaches to Treat Localized Esophageal Cancer.
EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells.
Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer.
Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.
Evaluation of somatic copy number estimation tools for whole-exome sequencing data.
Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of POLD1 and MLH1.
Exploiting DNA repair defects in colorectal cancer.
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma.
Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Expression profiling of gastric adenocarcinoma using cDNA array.
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
FXR silencing in human colon cancer by DNA methylation and KRAS signaling.
Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells.
Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Gene Expression Changes and Associated Pathways Involved in the Progression of Prostate Cancer Advanced Stages.
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.
Genetics: New molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas.
Genetics: new molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas.
Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Genome-wide methylation and expression profiling identify a novel epigenetic signature in gastrointestinal pan-adenocarcinomas.
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer.
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
Glycolysis-Based Genes Associated with the Clinical Outcome of Pancreatic Ductal Adenocarcinoma Identified by The Cancer Genome Atlas Data Analysis.
Heterogeneity of MSI-H gastric cancer identifies a subtype with worse survival.
High KCNQ1OT1 expression might independently predict shorter survival of colon adenocarcinoma.
High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
High-throughput Single-cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma.
Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs.
Hypoxia-related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD-L1 squamous and adenocarcinoma NSCLC.
Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Identification of a 6-gene signature predicting prognosis for colorectal cancer.
Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
Identification of DNA methylation signature to predict prognosis in gastric adenocarcinoma.
Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer.
Identification of key genes controlling cancer stem cell characteristics in gastric cancer.
Identification of key genes in prostate cancer gene expression profile by bioinformatics.
Identification of key long non-coding RNAs in gastric adenocarcinoma.
Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database.
Identification of low abundance microbiome in clinical samples using whole genome sequencing.
Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model.
Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
Identification of potential autophagy-associated lncRNA in prostate cancer.
Identification of potential biomarkers and their clinical significance in gastric cancer using bioinformatics analysis methods.
Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Identification of prognostic tumor-infiltrating immune cells in endometrial adenocarcinoma.
Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.
Identification of the hub genes and prognostic indicators of gastric cancer and correlation of indicators with tumor-infiltrating immune cell levels.
Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Identification of two novel biomarkers of rectal carcinoma progression and prognosis via co-expression network analysis.
Identifying miRNA-mRNA Integration Set Associated With Survival Time.
Images from the Haematologica Atlas of Hematologic Cytology: bone marrow metastases from gastric adenocarcinoma.
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy.
Immune signature profiling identified prognostic factors for gastric cancer.
Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer.
Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Integrated genomic analyses of ovarian carcinoma.
Integrative bioinformatics analysis of prognostic alternative splicing signatures in gastric cancer.
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
Integrative molecular characterization of Chinese prostate cancer specimens.
Integrin ?5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker.
KIT performed as a driver gene candidate affecting the survival status of patients with stomach adenocarcinoma.
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription.
Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness.
LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1.
LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model.
Loss of PTPN4 activates STAT3 to promote the tumor growth in rectal cancer.
LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer.
MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
Metastasis regulation by PPARD expression in cancer cells.
Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.
Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.
miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1.
MiR-374b-5p inhibits KDM5B-induced epithelial-mesenchymal transition in pancreatic cancer.
Modeling Gene-Wise Dependencies Improves the Identification of Drug Response Biomarkers in Cancer Studies.
Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.
Multiomics integrative analysis for gene signatures and prognostic values of m6A regulators in pancreatic adenocarcinoma: a retrospective study in The Cancer Genome Atlas project.
Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.
Mutations of p53 associated with pancreatic cancer and therapeutic implications.
Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer.
Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
OSeac: An Online Survival Analysis Tool for Esophageal Adenocarcinoma.
Pan-cancer analysis of TCGA data reveals notable signaling pathways.
Pathologic evolution-related Gene Analysis based on both single-cell and bulk transcriptomics in Colorectal Cancer.
PICOT binding to chromatin-associated EED negatively regulates cyclin D2 expression by increasing H3K27me3 at the CCND2 gene promoter.
Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.
Potential prognostic impact of EBV RNA-seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort.
Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Prognostic Implication of the m6A RNA Methylation Regulators in Rectal Cancer.
Prognostic targets recognition of rectal adenocarcinoma based on transcriptomics.
Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.
Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.
Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype.
Quality control of single amino acid variations detected by tandem mass spectrometry.
Recent advancements in esophageal cancer treatment in Japan.
Reconstruction and analysis of circRNA?miRNA?mRNA network in the pathology of cervical cancer.
Reduced expression of the DNA glycosylase gene MUTYH is associated with an increased number of somatic mutations via a reduction in the DNA repair capacity in prostate adenocarcinoma.
Research on circadian clock genes in non-small-cell lung carcinoma.
Robust semiparametric gene-environment interaction analysis using sparse boosting.
S100P acts as a target of miR-495 in pancreatic cancer through bioinformatics analysis and experimental verification.
Screening and Identification of Prognostic Tumor-Infiltrating Immune Cells and Genes of Endometrioid Endometrial Adenocarcinoma: Based on The Cancer Genome Atlas Database and Bioinformatics.
Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial?mesenchymal transition.
Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4.
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlas.
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer.
SSRP1 influences colorectal cancer cell growth and apoptosis via the AKT pathway.
Survival-associated alternative splicing signatures in esophageal carcinoma.
Systematic mutation analysis in rare colorectal cancer presenting ovarian metastases.
Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3? pathway in non-small cell lung cancer.
The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study.
The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 in and Promotes Tumorigenesis in Mice.
The Identification of Critical m6A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma.
The integrative knowledge base for miRNA-mRNA expression in colorectal cancer.
The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma.
The somatic mutation landscape of premalignant colorectal adenoma.
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.
Transcriptome analysis reveals the effect of oral contraceptive use on cervical cancer.
Transcriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma.
Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset.
TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-? signaling.
Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance.
Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes.
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer.
Two critical positions in zinc finger domains are heavily mutated in three human cancer types.
Upregulated GAPLINC predicts a poor prognosis in bladder cancer patients and promotes tumor proliferation and invasion.
Upregulated long-non-coding RNA DLEU2 exon 9 expression was an independent indicator of unfavorable overall survival in patients with esophageal adenocarcinoma.
Upregulation of exosomal microRNA?21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity.
Upregulation of ZBTB7A exhibits a tumor suppressive role in gastric cancer cells.
UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy.
Verification of expressions of lncRNA FOXCUT in gastric adenocarcinoma patients and its effects on cell biological function based on TCGA database.
Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.
Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers.
Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
[Precision medicine in rearranged ALK NSCLC: a case report.]
Adenocarcinoma of Lung
A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.
A Methodology for Texture Feature-based Quality Assessment in Nucleus Segmentation of Histopathology Image.
A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
A novel autophagy-related lncRNA survival model for lung adenocarcinoma.
A prognostic model for lung adenocarcinoma patient survival with a focus on four miRNAs.
A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database.
Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis.
An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors.
An individualized gene expression signature for prediction of lung adenocarcinoma metastases.
An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1-Positive Lung Adenocarcinomas.
Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma.
Assisted differential network analysis for gene expression data.
Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET.
Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma.
Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma.
AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Autocrine TGF? Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment.
Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Bioinformatics and functional analyses of key genes in smoking-associated lung adenocarcinoma.
C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomas.
Cancer-associated fibroblasts are associated with poor prognosis in solid type of lung adenocarcinoma in a machine learning analysis.
Cancer-Associated Point Mutations in the DLC1 Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased Function.
Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma.
Cascaded Wx: A Novel Prognosis-Related Feature Selection Framework in Human Lung Adenocarcinoma Transcriptomes.
CCAAT/Enhancer Binding Protein ? Is Dispensable for Development of Lung Adenocarcinoma.
CERNA SEARCH METHOD IDENTIFIED A MET-ACTIVATED SUBGROUP AMONG EGFR DNA AMPLIFIED LUNG ADENOCARCINOMA PATIENTS.
Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma.
Cilia gene expression patterns in cancer.
circCCND1 Regulates Oxidative Stress and FGF9 to Enhance Chemoresistance of Non-Small Cell Lung Cancer via Sponging miR-187-3p.
Classification of lung adenocarcinoma transcriptome subtypes from pathological images using deep convolutional networks.
Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.
Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases.
Clinicopathological significance of microRNA-21 in extracellular vesicles of pleural lavage fluid of lung adenocarcinoma and its functions inducing the mesothelial to mesenchymal transition.
Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosis.
Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis.
Combinatory inhibition of TRIM65 and MDM2 in lung cancer cells.
Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Comprehensive Analysis of Competing Endogenous RNA (ceRNA) Network Based on RNAs Differentially Expressed in Lung Adenocarcinoma Using The Cancer Genome Atlas (TCGA) Database.
Comprehensive analysis of competitive endogenous RNA associated with immune infiltration in lung adenocarcinoma.
Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma.
Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.
Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma.
Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma.
Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways.
Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas.
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Development of a miRNA-seq based prognostic signature in lung adenocarcinoma.
Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.
Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas.
Differential expression and significance of PD-L1, IDO-1 and B7-H4 in human lung cancer.
Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.
Dissecting the multi-omics atlas of the exosomes released by human lung adenocarcinoma stem-like cells.
DNA methylation biomarkers for the occurrence of lung adenocarcinoma from TCGA data mining.
DNA methylation signature of smoking in lung cancer is enriched for exposure signatures in newborn and adult blood.
Elevated integrin ?6 expression is involved in the occurrence and development of lung adenocarcinoma, and predicts a poor prognosis: a study based on immunohistochemical analysis and bioinformatics.
Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma.
Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients.
Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms.
Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma.
Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer.
Examination of Independent Prognostic Power of Gene Expressions and Histopathological Imaging Features in Cancer.
Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis.
Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma.
Exploring the Effect of Differentially Expressed Long Non-coding RNAs Driven by Copy Number Variation on Competing Endogenous RNA Network by Mining Lung Adenocarcinoma Data.
Exploring the survival prognosis of lung adenocarcinoma based on the cancer genome atlas database using artificial neural network.
Expression and clinical significance of AURKB gene in lung adenocarcinoma: Analysis based on the data-mining of bioinformatic database.
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
Expression of p42.3 in non-small cell lung cancer.
Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.
Expression of UBE2C in lung adenocarcinoma based on database analysis and its clinical significance.
Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
Expression profiling of ubiquitin-related genes in LKB1 mutant lung adenocarcinoma.
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.
Factor analysis for survival time prediction with informative censoring and diverse covariates.
FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).
FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan.
FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma.
Gastric-type gene expression and phenotype in non-terminal respiratory unit type adenocarcinoma of the lung with invasive mucinous adenocarcinoma morphology.
Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma.
Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database.
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk.
Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis.
Genomic alterations in lung adenocarcinoma.
Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors.
Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses.
Germline mutations in DNA repair genes in lung adenocarcinoma.
Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma.
High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets.
High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
Histopathological Imaging?Environment Interactions in Cancer Modeling.
HLA class I binding of mutant EGFR peptides in NSCLC is associated with improved survival.
HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1.
HSD17B4, ACAA1, and PXMP4 in Peroxisome Pathway Are Down-Regulated and Have Clinical Significance in Non-small Cell Lung Cancer.
HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Hypermethylation of the PTTG1IP promoter leads to low expression in early-stage non-small cell lung cancer.
Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma.
Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma.
Identification immunophenotyping of lung adenocarcinomas based on the tumor microenvironment.
Identification of a Hypoxia-Associated Signature for Lung Adenocarcinoma.
Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles.
Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.
Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases.
Identification of Novel microRNA Prognostic Markers Using Cascaded Wx, a Neural Network-Based Framework, in Lung Adenocarcinoma Patients.
Identification of Prognostic Genes and Pathways in Lung Adenocarcinoma Using a Bayesian Approach.
Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.
Identification SYT13 as a novel biomarker in lung adenocarcinoma.
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma.
Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer.
Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients.
Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma.
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
Increased CX3CL1 mRNA expression level is a positive prognostic factor in patients with lung adenocarcinoma.
Increased Expression of KNSTRN in Lung Adenocarcinoma Predicts Poor Prognosis: A Bioinformatics Analysis Based on TCGA Data.
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Increased VEGF-A in solid type of lung adenocarcinoma reduces the patients' survival.
Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
Integrated TCGA analysis implicates lncRNA CTB-193M12.5 as a prognostic factor in lung adenocarcinoma.
Integrating germline and somatic genetics to identify genes associated with lung cancer.
Integrating multidimensional omics data for cancer outcome.
Integration and comparison of different genomic data for outcome prediction in cancer.
Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis.
KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
KRT6A Promotes EMT and Cancer Stem Cell Transformation in Lung Adenocarcinoma.
Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma.
Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma.
Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma.
LncRNA PPP1R14B-AS1 Promotes Tumor Cell Proliferation and Migration via the Enhancement of Mitochondrial Respiration.
Long noncoding RNA POU6F2-AS1 regulates lung cancer aggressiveness through sponging miR-34c-5p to modulate KCNJ4 expression.
Loss of FGL1 induces epithelial?mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma.
Low-Level Expression of MTUS1 Is Associated with Poor Survival in Patients with Lung Adenocarcinoma.
LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection.
m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma.
Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes.
MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
Mechanism of Fuzheng Kang'ai Formula () Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer.
Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.
MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer.
MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.
Microarray expression profile of microRNAs in lung adenocarcinoma patients with the Cancer Genome Atlas and its clinical validation.
MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma.
MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
MiR-195 restrains lung adenocarcinoma by regulating CD4+ T cell activation via the CCDC88C/Wnt signaling pathway: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatic analysis.
miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data.
MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas.
MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.
miR?888 regulates cancer progression by targeting multiple targets in lung adenocarcinoma.
MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
Modeling Gene-Wise Dependencies Improves the Identification of Drug Response Biomarkers in Cancer Studies.
Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation.
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing.
Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma.
Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma.
Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets.
Multiscale Embedded Gene Co-expression Network Analysis.
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
Network-adjusted Kendall's Tau Measure for Feature Screening with Application to High-dimensional Survival Genomic Data.
New insights into the molecular profile of lung adenocarcinoma and implications for therapy.
Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis.
Overexpression of eIF3D in Lung Adenocarcinoma Is a New Independent Prognostic Marker of Poor Survival.
Overexpression of HOTTIP promotes proliferation and drug resistance of lung adenocarcinoma by regulating AKT signaling pathway.
Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma.
P38 pathway as a key downstream signal of connective tissue growth factor to regulate metastatic potential in non-small-cell lung cancer.
p52 expression enhances lung cancer progression.
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Pan-cancer analysis of TCGA data reveals notable signaling pathways.
Patterns of Transposable Element Expression and Insertion in Cancer.
PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer.
PDL1 Regulation by p53 via miR-34.
Phosphoinositide specific phospholipase C?1 inhibition-driven autophagy caused cell death in human lung adenocarcinoma A549 cells in vivo and in vitro.
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features.
Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein.
Prognostic Implication of the Expression Level of PECAM-1 in Non-small Cell Lung Cancer.
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data.
Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients.
Pseudogene CHIAP2 inhibits proliferation and invasion of lung adenocarcinoma cells by means of the WNT pathway.
Reference genome and annotation updates lead to contradictory prognostic predictions in gene expression signatures: a case study of resected stage I lung adenocarcinoma.
Robust genomic copy number predictor of pan cancer metastasis.
Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.
Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis.
Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.
Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.
SIFORM: shared informative factor models for integration of multi-platform bioinformatic data.
Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine.
Silencing of ARL14 Gene Induces Lung Adenocarcinoma Cells to a Dormant State.
Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1.
Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules.
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlas.
Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants.
SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
Spindle pole body component 25 homolog expressed by ECM stiffening is required for lung cancer cell proliferation.
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma.
SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2.
TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1.
Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.
TGF?2-mediated epithelial-mesenchymal transition and NF-?B pathway activation contribute to osimertinib resistance.
The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction.
The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
The mitochondrial fission factor FIS1 promotes stemness of human lung cancer stem cells via mitophagy.
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer.
The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma.
The pseudogene-derived long noncoding RNA SFTA1P is down-regulated and suppresses cell migration and invasion in lung adenocarcinoma.
The Role of Nrf2 Activity in Cancer Development and Progression.
The signature lncRNAs associated with the lung adenocarcinoma patients prognosis.
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers.
The up-regulation of Myb may help mediate EGCG inhibition effect on mouse lung adenocarcinoma.
The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
Threonine Tyrosine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy.
Thrombospondin 2 promotes tumor metastasis by inducing matrix metalloproteinase-13 production in lung cancer cells.
TIMP-1-Mediated Chemoresistance via Induction of IL-6 in NSCLC.
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer.
TRIM28 is a distinct prognostic biomarker that worsens the tumor immune microenvironment in lung adenocarcinoma.
TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.
Uncovering Prognosis-Related Genes and Pathways by Multi-Omics Analysis in Lung Cancer.
Upregulation of glucosamine-phosphate N-acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma.
Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
USP4 expression independently predicts favorable survival in lung adenocarcinoma.
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research.
Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma.
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas.
ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma.
[Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect ?on Immune Microenvironment].
[FOXC1 Knockdown Reverses Gefitinib Resistance in Non-small Cell Lung Cancer].
[Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
[Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
Adenocarcinoma, Mucinous
Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma.
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
Adenoma
Consensus molecular subtype classification of colorectal adenomas.
Identification of key genes controlling cancer stem cell characteristics in gastric cancer.
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis.
The somatic mutation landscape of premalignant colorectal adenoma.
Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.
Adenoma, Oxyphilic
Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma.
DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma.
FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
Adenomatous Polyposis Coli
Application of open-access databases to determine functional connectivity between resveratrol-binding protein QR2 and colorectal carcinoma.
Circular RNA hsa_circ_0005114-miR-142-3p/miR-590-5p-adenomatous polyposis coli protein axis as a potential target for treatment of glioma.
Adenoviridae Infections
AJKD Atlas of Renal Pathology: Adenovirus Infection.
Adrenal Cortex Neoplasms
Molecular genomic profiling of adrenocortical cancers in clinical practice.
Adrenocortical Carcinoma
Adrenocortical cancer cell line mutational profile reveals aggressive genetic background.
Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment.
New and Emerging Biomarkers in Endocrine Pathology.
Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma.
African Swine Fever
A proteomic atlas of the African swine fever virus particle.
Albuminuria
Evaluation of the Urine Protein/Creatinine Ratio Measured with the Dipsticks Clinitek Atlas PRO 12.
Alopecia
Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome.
Congenital cataract with LSS gene mutations: a new case report.
Optical Coherence Tomography in the Evaluation of the Scalp and Hair: Common Features and Clinical Utility.
Alzheimer Disease
A Comparative Atlas-Based Recognition of Mild Cognitive Impairment With Voxel-Based Morphometry.
A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI.
A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research.
A probabilistic atlas of locus coeruleus pathways to transentorhinal cortex for connectome imaging in Alzheimer's disease.
A probabilistic atlas of the human thalamic nuclei combining ex vivo MRI and histology.
A single-cell atlas of entorhinal cortex from individuals with Alzheimer's disease reveals cell-type-specific gene expression regulation.
Accurate segmentation of brain images into 34 structures combining a non-stationary adaptive statistical atlas and a multi-atlas with applications to Alzheimer's disease.
Accurate Whole-Brain Segmentation for Alzheimer's Disease Combining an Adaptive Statistical Atlas and Multi-atlas.
AD Course Map charts Alzheimer's disease progression.
An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations.
An MRI-Based Atlas for Correlation of Imaging and Pathologic Findings in Alzheimer's Disease.
Atlas based sparse logistic regression for Alzheimer's Disease classification.
Atlas stumbled: kinesin light chain-1 variant E triggers a vicious cycle of axonal transport disruption and amyloid-? generation in Alzheimer's disease.
Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?
Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease.
Characterizing the human hippocampus in aging and Alzheimer's disease using a computational atlas derived from ex vivo MRI and histology.
Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
Comparative Evaluation of Diffusion Kurtosis Imaging and Diffusion Tensor Imaging in Detecting Cerebral Microstructural Changes in Alzheimer Disease.
Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography.
Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas.
Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders.
High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlas.
Incorporating parameter uncertainty in Bayesian segmentation models: application to hippocampal subfield volumetry.
Mathematical/computational challenges in creating deformable and probabilistic atlases of the human brain.
Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models.
Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size.
Patch-based Mapping of Transentorhinal Cortex with a Distributed Atlas.
Proteomic Atlas of the Human Brain in Alzheimer's Disease.
Sex Moderates Amyloid and Apolipoprotein ?4 Effects on Default Mode Network Connectivity at Rest.
Single-cell atlas maps cell-specific gene changes in Alzheimer disease.
Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images.
Sulcal variability in the Alzheimer's brain: correlations with cognition.
Two-dimensional Enrichment Analysis for Mining High-level Imaging Genetic Associations.
Two-dimensional enrichment analysis for mining high-level imaging genetic associations.
Use of brain MRI atlases to determine boundaries of age-related pathology: the importance of statistical method.
Zebrafish brain RNA sequencing reveals that cell adhesion molecules are critical in brain aging.
Amyloidosis
AJKD Atlas of Renal Pathology: Hereditary and Other Non-AL Amyloidoses.
Amyotrophic Lateral Sclerosis
Identification of 17 Highly Expressed Genes within Mouse Lumbar Spinal Cord Anterior Horn Region from an In-Situ Hybridization Atlas of 3430 Genes: Implications for Motor Neuron Disease.
MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma.
Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: Revisited.
Anemia, Diamond-Blackfan
Sperm RNA elements as markers of health.
Aneurysm
A clinical comparison of Atlas and LVIS Jr stent-assisted aneurysm coiling.
Aneurysm of the vertebral artery near the atlas arch.
Cerebrovascular disorders associated with von Recklinghausen's neurofibromatosis: a case report.
Clinical Safety and Effectiveness of Stent-Assisted Coil Embolization with Neuroform Atlas Stent in Intracranial Aneurysm.
Commentary: Neuroform Atlas Stent for Treatment of Middle Cerebral Artery Aneurysms: 1-Year Outcomes From Neuroform Atlas Stent Pivotal Trial.
Comparison of Clinical Outcomes After Stent-Assisted Coiling with 3 Types of Self-Expanding Laser-Cut Stents in Patients with Wide-Necked Intracranial Aneurysms.
Direct suction decompression and fenestrated clip reconstruction of complex paraclinoid carotid artery aneurysm: operative video and nuances of skull base technique.
Double stent assisted coiling of intracranial bifurcation aneurysms in Y and X configurations with the Neuroform ATLAS stent: immediate and mid term angiographic and clinical follow-up.
Early Multicenter Experience With the Neuroform Atlas Stent: Feasibility, Safety, and Efficacy.
Early post-Humanitarian Device Exemption experience with the Neuroform Atlas stent.
Experiences with intraluminal occlusion with the Fogarty catheter in the treatment of carotid-cavernous sinus fistulas and other lesions at the base of the skull.
Extracranial aneurysms of the posterior inferior cerebellar artery.
Initial multicentre experience using the neuroform atlas stent for the treatment of un-ruptured saccular cerebral aneurysms.
Low-Profile Laser-Cut Stents for Endovascular Treatment of Intracranial Aneurysms : Incidence, Clinical Presentation and Risk Factors of Thromboembolic Events.
Low-profile visualized intraluminal support Blue stenting within a Neuroform Atlas stent for a large wide-necked aneurysm: A case report and a bench-top experiment.
Low-Profile Visualized Intraluminal Support Jr Braided Stent Versus Atlas Self-Expandable Stent for Treatment of Intracranial Aneurysms: A Single Center Experience.
Modified "Extended" Suboccipital Subtonsillar Clipping of a Ruptured Proximal Pica Aneurysm: Technical Note with Relevant Anatomical Demonstration.
Multi-centric European post-market follow-up study of the Neuroform Atlas Stent System: primary results.
Neuroform Atlas stent deployment through the Barrel vascular reconstruction device for the treatment of a wide-necked acutely ruptured basilar aneurysm.
Neuroform Atlas Stent for Treatment of Middle Cerebral Artery Aneurysms: 1-Year Outcomes From Neuroform Atlas Stent Pivotal Trial.
Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort.
NeuroForm Atlas Stent-Assisted Coiling: Preliminary Results.
Outcomes of Stent-Assisted Coiling Using the Neuroform Atlas Stent in Unruptured Wide-Necked Intracranial Aneurysms.
Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms: One-Year Outcomes.
Pivotal trial of the Neuroform Atlas stent for treatment of posterior circulation aneurysms: one-year outcomes.
Preliminary experience of stent-assisted coiling of wide-necked intracranial aneurysms with a single microcatheter.
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.
Safety and Efficacy of Stent-Assisted Coiling of Unruptured Intracranial Aneurysms Using Low-Profile Stents in Small Parent Arteries.
Safety and efficacy of the Neuroform Atlas for stent-assisted coiling of intracranial aneurysms: A multicenter experience.
Safety and Efficacy of the Neuroform Atlas Stent for Treatment of Intracranial Aneurysms : A Systematic Review and Meta-Analysis.
Stent-Assisted Coiling of a Sidewall Aneurysm of the Distal Middle Cerebral Artery: 2-Dimensional Operative Video.
Stent-assisted coiling of cerebral aneurysms: Head to head comparison between the Neuroform Atlas and EZ stents.
The Geometry of Y-Stent Configurations Used for Wide-Necked Aneurysm Treatment: Analyzing Double-Barrel Stents In Vitro Using Flat-Panel Computed Tomography.
The Neuroform Atlas stent to assist coil embolization of intracranial aneurysms: a multicentre experience.
Two-center experience with Neuroform Atlas stent-assisted coil occlusion of broad-based intracranial aneurysms.
Usefulness of pointwise encoding time reduction with radial acquisition sequence in subtraction-based magnetic resonance angiography for follow-up of the Neuroform Atlas stent-assisted coil embolization for cerebral aneurysms.
Vertebro-PICA aneurysms: midline suboccipital approach and laminectomy of the atlas.
Y-Stent-Assisted Coiling With Low-Profile Neuroform Atlas Stents for Endovascular Treatment of Wide-Necked Complex Intracranial Bifurcation Aneurysms.
[Atlas of nervous system diseases. 10. Giant aneurysm of the cranial base]
[Stereotaxic clipping of cerebral arteriovenous aneurysms]
[Surgery of vertebral aneurysms at the origin of PICA (author's transl)]
[Treatment by a direct surgical approach of a false arterio-venous traumatic aneurysm between the vertebral artery and the internal jugular vein at the level of the atlas (author's transl)]
Aneurysm, False
Spontaneous parapharyngeal haematoma caused by a leaking vertebral artery pseudoaneurysm.
Angiomyolipoma
A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis.
Ankylosis
Cervical spine involvement in longstanding ankylosing spondylitis.
Relationship between the morphology of the atlanto-occipital joint and the radiographic results in patients with atlanto-axial subluxation due to rheumatoid arthritis.
[Ankylosis of the atlas and epistropheus; report on one case.]
Anomia
Probabilistic map of critical functional regions of the human cerebral cortex: Broca's area revisited.
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Histopathological atlas of renal diseases: ANCA-associated vasculitis (first part).
Histopathological atlas of renal diseases: ANCA-associated vasculitis (Second part).
Anus Neoplasms
Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer.
Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancer.
Aortic Coarctation
[Carotid-vertebrobasilar anastomosis]
Aortic Valve Disease
Cell-Type Transcriptome Atlas of Human Aortic Valves Reveal Cell Heterogeneity and Endothelial to Mesenchymal Transition Involved in Calcific Aortic Valve Disease.
Spatiotemporal Multi-Omics-Derived Atlas of Calcific Aortic Valve Disease.
Aortic Valve Stenosis
Metabolomic Signature of Human Aortic Valve Stenosis.
Aphasia, Primary Progressive
Automatic analysis of cerebral atrophy.
Apnea
The AR-8800--a new impedance pneumograph (plethysmograph) respiratory monitor.
Arachnoiditis
[The neurologic manifestations of malformations of the occipito-atloid joint; a case of occipitalization of the atlas accompanied by cystic arachnoiditis, and treated surgically.]
Arnold-Chiari Malformation
Congenital reducible atlantoaxial dislocation: classification and surgical considerations.
Craniovertebral anomalies: a study of 82 cases.
Successful treatment of adult Arnold-Chiari malformation associated with basilar impression and syringomyelia by the transoral anterior approach.
[A case of hypoplasia and unilateral assimilation of the atlas with platybasia, basilar impression and Arnold-Chiari deformity.]
Arrhythmias, Cardiac
Evaluation of predictive scores for late and very late recurrence after cryoballoon-based ablation of atrial fibrillation.
Arteriovenous Fistula
Gunshot wound with fracture of the atlas and arteriovenous fistula of the vertebral artery. Case report.
[Treatment by a direct surgical approach of a false arterio-venous traumatic aneurysm between the vertebral artery and the internal jugular vein at the level of the atlas (author's transl)]
Arthralgia
[Imaging in rheumatology]
Arthritis
An introduction to the Atlas of Standard Radiographs of Arthritis.
Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part I: Active lesions.
Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part II: Structural damage lesions.
Cross-tissue organization of the fibroblast lineage.
Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis.
MR atlas for articular cartilage morphology: potential to detect shape differences.
Radiographically defined osteoarthritis of the hand and knee in young and middle-aged African American and Caucasian women.
Radiological cervical arthritis in populations.
Temporomandibular joint atlas for detection and grading of juvenile idiopathic arthritis involvement by magnetic resonance imaging.
The Atlas of Standard Radiographs of Arthritis.
The epidemiology of osteoarthritis: Manchester and beyond.
The experience of pain and emergent osteoarthritis of the knee.
[DISLOCATION OF THE ATLAS IN RHEUMATIC POLYARTHRITIS.]
[Two rare cases of development of metastatic arthritis in atlas epistropheus with torticollis (Grisel's disease), and its treatment.]
Arthritis, Experimental
An Accord of Nuclear Receptor Expression in CD4+ T Cells in Rheumatoid Arthritis.
Arthritis, Infectious
Osteomyelitis of the atlanto-occipital region as a sequela to a pharyngeal stick injury.
Arthritis, Juvenile
Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis.
Temporomandibular joint atlas for detection and grading of juvenile idiopathic arthritis involvement by magnetic resonance imaging.
Arthritis, Rheumatoid
3- to 11-year followup of occipitocervical fusion for rheumatoid arthritis.
An introduction to the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas.
Atlanto-axial arthrodesis by the wedge compression method.
Atlantoaxial joint distraction for treatment of basilar invagination secondary to rheumatoid arthritis.
Backward tilting of the posterior atlantal arch in rheumatoid arthritis.
Biomechanical rationale for the pathology of rheumatoid arthritis in the craniovertebral junction.
CERVICAL SPINE LESIONS IN RHEUMATOID ARTHRITIS PATIENTS.
Examination of intra and interrater reliability with a new ultrasonographic reference atlas for scoring of synovitis in patients with rheumatoid arthritis.
Functional genomics atlas of synovial fibroblasts defining rheumatoid arthritis heritability.
Lateral subluxation of the atlas in rheumatoid arthritis.
Lateral subluxation of the atlas in rheumatoid arthritis: a case report and post-mortem study.
Magnetic resonance imaging in rheumatoid arthritis advances and research priorities.
Nonreducible rotational head tilt and atlantoaxial lateral mass collapse. Clinical and roentgenographic features in patients with juvenile rheumatoid arthritis and ankylosing spondylitis.
Occipital-cervical instability.
Posterior atlanto-axial subluxation in rheumatoid arthritis.
Regeneration of the skeleton by recombinant human bone morphogenetic proteins.
Spontaneous dislocation of the atlas as a complication in rheumatoid arthritis.
Spontaneous fracture of atlas of cervical spine affected by rheumatoid arthritis.
Surgical treatment of craniovertebral junction instability : clinical outcomes and effectiveness in personal experience.
The development of the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas.
The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas: the metacarpophalangeal joints.
The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas: the wrist joint.
The relationship between the degree of displacement of the atlas to axis and the clinical data in atlanto-axial subluxation due to rheumatoid arthritis.
Three-dimensional motion of the upper cervical spine in rheumatoid arthritis.
Vertical settling in rheumatoid arthritis. Diagnostic value of the Ranawat and Redlund-Johnell methods.
[Distortion of the atlas in the course of rheumatoid arthritis]
[Harms technique of C1-C2 fixation with polyaxial screws and rods]
[Spontaneous atlas dislocation in a child with trisomy 21 and rheumatoid arthritis]
[Subluxation of the atlas in rheumatoid arthritis (author's transl)]
[Surgical treatment of spontaneous dislocation of the atlas and axis in rheumatoid arthritis]
[Ventral decompression techniques in patients with traumatic and non-traumatic atlanto-axial dislocations].
Asbestosis
[Computed tomographic atlas of benign asbestos related pathology]
Asthma
Long noncoding RNA atlas of the inflammation caused by asthma in mice.
Protein profiles of CCL5, HPGDS, and NPSR1 in plasma reveal association with childhood asthma.
Astigmatism
Clinical outcomes of laser in situ keratomileusis using combined topography and refractive wavefront treatments for myopic astigmatism.
Comparison of corneal powers obtained from 4 different devices.
Comparison of Whole Eye versus First-Surface Astigmatism in Down Syndrome.
Keratometry versus total corneal refractive power: Analysis of measurement repeatability with 5 different devices in normal eyes with low astigmatism.
Prediction of refractive outcomes with toric intraocular lens implantation.
Repeatability and comparability of corneal power and corneal astigmatism obtained from a point-source color light-emitting diode topographer, a Placido-based corneal topographer, and a low-coherence reflectometer.
Astrocytoma
Analysis of Cellular Feature Differences of Astrocytomas with Distinct Mutational Profiles Using Digitized Histopathology Images.
Atlas of tissue culture; astrocytoma and glioblastoma.
Chromatin-regulating genes are associated with postoperative prognosis and isocitrate dehydrogenase mutation in astrocytoma.
Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas.
In silico analysis identifies a putative cell-of-origin for BRAF fusion-positive cerebellar pilocytic astrocytoma.
Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma.
miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database.
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
Total copy number variation as a prognostic factor in adult astrocytoma subtypes.
[Preliminary analysis on the gene expression profiles of different types of gliomas with cDNA array]
Ataxia
Incomplete ossification of the atlas in dogs with cervical signs.
Atherosclerosis
Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing.
Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry.
First Giant Steps Toward a Cell Atlas of Atherosclerosis.
Insight Mechanism of the Selective Lanosterol Synthase Inhibitor: Molecular Modeling, Docking and Density Functional Theory Approaches.
Left ventricular shape variation in asymptomatic populations: the Multi-Ethnic Study of Atherosclerosis.
Metabolic Phenotyping of Atherosclerotic Plaques Reveals Latent Associations between Free Cholesterol and Ceramide Metabolism in Atherogenesis.
The vertebral artery: a review of anatomical, histopathological and functional factors influencing blood flow to the hindbrain.
[Angiographic examination of the vertebral artery at the atlantoxial joint during head rotation]
Atrial Fibrillation
Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure - ATLAS score.
Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure: ATLAS score-Author's reply.
Poincaré Plot Image and Rhythm-Specific Atlas for Atrial Bigeminy and Atrial Fibrillation Detection.
Surgical Closure of the Left Atrial Appendage: The Past, The Present, The Future.
Atypical Squamous Cells of the Cervix
Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears.
Autoimmune Diseases
A Single-Cell Transcriptomic Atlas of Thymus Organogenesis Resolves Cell Types and Developmental Maturation.
An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19.
Axial Spondyloarthritis
A Benchmarking Study Evaluating Axial Spondyloarthritis Burden in Spain and Other European Countries. Results from the Spanish Atlas and the European Map of Axial Spondyloarthritis (EMAS) Studies.
Atlas of Axial Spondyloarthritis in Spain 2017: Study Design and Population.
Similarities and differences between non-radiographic and radiographic axial spondyloarthritis: The patient perspective from the Spanish atlas.
The Impact of Axial Spondyloarthritis on Mental Health: Results from the Atlas.
Bacteremia
Telavancin in the Treatment of Concurrent Staphylococcus aureus Bacteremia: A Retrospective Analysis of ATLAS and ATTAIN Studies.
Bacterial Infections
Defining Host Responses during Systemic Bacterial Infection through Construction of a Murine Organ Proteome Atlas.
Bacteriuria
Comparison of three automated urinalysis systems--Bayer Clinitek Atlas, Roche Urisys 2400 and Arkray Aution Max for testing urine chemistry and detection of bacteriuria.
Barrett Esophagus
Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer.
Basal Ganglia Diseases
An MRI atlas of the mouse basal ganglia.
Bile Duct Neoplasms
A six-microRNA set as prognostic indicators for bile duct cancer.
Biliary Atresia
Mass spectrometry-based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin.
Blindness
Eye clinic attendance at the olympic and paralympic games Rio 2016 and its correlation to the WHO indicators on eye health.
Progress Towards Elimination of Trachoma as a Public Health Problem in Eritrea: Results of a Systematic Review and Nine Population-based Prevalence Surveys Conducted in 2014.
Bone Cysts
Aneurysmal bone cyst of the atlas: operative removal through an anterolateral approach. A case report.
Aneurysmal bone cyst of the atlas: successful treatment through selective arterial embolization: case report.
Characterisation of first metatarsophalangeal joint osteoarthritis using magnetic resonance imaging.
Denosumab: a potential treatment option for aneurysmal bone cyst of the atlas.
Homeodomain-containing gene 10 inhibits cell apoptosis and promotes cell invasion and migration in osteosarcoma cell lines.
Reconstruction of C-1 lateral mass with titanium mesh cage after resection of an aneurysmal bone cyst of the atlas.
[Atlas fracture due to aneurysmal bone cyst after minor trauma.]
Bone Cysts, Aneurysmal
Craniovertebral junction neoplasms in the pediatric population.
Surgical approaches: postoperative care and complications "posterolateral-far lateral transcondylar approach to the ventral foramen magnum and upper cervical spinal canal".
Bone Diseases
A Colour Atlas of Bone Disease.
Atlas of computerized blood flow analysis in bone disease.
Bone Diseases, Developmental
Bone Dysplasia: a must-have Atlas for the clinician.
Bone Dysplasias. An Atlas of Genetic Disorders of Skeletal Development (Fourth Edition).
Bone Dysplasias: An Atlas of Genetic Disorders of Skeletal Development, Second Edition.
Bone Resorption
Odontoid compression of the brain stem in a patient with rheumatoid arthritis. Case report.
Brain Abscess
William Macewen and the treatment of brain abscesses: revisited after one hundred years.
Brain Concussion
Specific cord damage at the atlas level as a pathogenic mechanism in cerebral concussion.
Brain Diseases
A high-resolution in vivo atlas of the human brain's serotonin system.
A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System.
Age-Related Prevalence of Periodontoid Calcification and Its Associations with Acute Cervical Pain.
Atlas of brain proton magnetic resonance spectra. Part II: Inherited metabolic encephalopathies.
Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment.
Atlasing the frontal lobe connections and their variability due to age and education: a spherical deconvolution tractography study.
Developing Neuroimaging Biomarker for Brain Diseases with a Machine Learning Framework and the Brainnetome Atlas.
In silico prioritization based on coexpression can aid epileptic encephalopathy gene discovery.
Longitudinal atlas for normative human brain development and aging over the lifespan using quantitative susceptibility mapping.
Brain Diseases, Metabolic
Atlas of brain proton magnetic resonance spectra. Part II: Inherited metabolic encephalopathies.
Brain Infarction
Statistical atlas of acute stroke from magnetic resonance diffusion-weighted-images of the brain.
Brain Injuries
High Resolution Computed Tomography Atlas of the Porcine Temporal Bone and Skull Base: Anatomical Correlates for Traumatic Brain Injury Research.
Single-cell atlas reveals meningeal leukocyte heterogeneity in the developing mouse brain.
[NEUROLOGICAL ATLAS. 2. PATHOLOGY OF BRAIN INJURIES.]
Brain Injuries, Traumatic
High Resolution Computed Tomography Atlas of the Porcine Temporal Bone and Skull Base: Anatomical Correlates for Traumatic Brain Injury Research.
Low-Rank Atlas Image Analyses in the Presence of Pathologies.
Performance Evaluation of a Pre-computed Brain Response Atlas in Dummy Head Impacts.
SPECT brain perfusion abnormalities in mild or moderate traumatic brain injury.
Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury.
Brain Ischemia
Detection of an unkown peak at 1.2 ppm in proton magnetic resonance spectra of cats with cerebral ischemic necrosis.
Brain Neoplasms
90-gene signature assay for tissue origin diagnosis of brain metastases.
A Deep Network for Joint Registration and Reconstruction of Images with Pathologies.
A novel small-molecule activator of Sirtuin-1 induces autophagic cell death/mitophagy as a potential therapeutic strategy in glioblastoma.
A pediatric brain tumor atlas of genes deregulated by somatic genomic rearrangement.
A robust topology-based algorithm for gene expression profiling.
An anatomically curated fiber clustering white matter atlas for consistent white matter tract parcellation across the lifespan.
An independently validated survival nomogram for lower grade glioma.
Anatomic Gene Expression Atlas Fuels Glioblastoma Discovery.
annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
ATLAS OF THE HISTOLOGY OF BRAIN TUMORS.
Atlas to patient registration with brain tumor based on a mesh-free method.
Automated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: From atlas to dose-volume histograms.
Automated network analysis identifies core pathways in glioblastoma.
Automatic brain tumor segmentation by subject specific modification of atlas priors.
Characterization and Correction of Geometric Distortions in 814 Diffusion Weighted Images.
Commentary: Planning Brain Tumor Resection Using a Probabilistic Atlas of Cortical and Subcortical Structures Critical for Functional Processing: A Proof of Concept.
Concurrent tumor segmentation and registration with uncertainty-based sparse non-uniform graphs.
DeepSurvNet: deep survival convolutional network for brain cancer survival rate classification based on histopathological images.
Deformable registration of brain tumor images via a statistical model of tumor-induced deformation.
Delineation atlas of the Circle of Willis and the large intracranial arteries for evaluation of doses to neurovascular structures in pediatric brain tumor patients treated with radiation therapy.
Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.
Faceted Visualization of Three Dimensional Neuroanatomy By Combining Ontology with Faceted Search.
Histopathological Image Classification Using Discriminative Feature-Oriented Dictionary Learning.
Imaging-AMARETTO: An Imaging Genomics Software Tool to Interrogate Multiomics Networks for Relevance to Radiography and Histopathology Imaging Biomarkers of Clinical Outcomes.
Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data.
Mapping of long-term cognitive and motor deficits in pediatric cerebellar brain tumor survivors into a cerebellar white matter atlas.
Multigene sets for clinical application in glioma.
NUT midline carcinomas and their differentials by a single molecular profiling method: a new promising diagnostic strategy illustrated by a case report.
ORBIT: a multiresolution framework for deformable registration of brain tumor images.
Planning Brain Tumor Resection Using a Probabilistic Atlas of Cortical and Subcortical Structures Critical for Functional Processing: A Proof of Concept.
Presence of viral DNA in whole-genome sequencing of brain tumor tissues from the cancer genome atlas.
Profilin 3 genetic architecture in glioma formalin fixed paraffin embedded (FFPE) archive.
Prognostic implications of immune-related eight-gene signature in pediatric brain tumors.
Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma.
The human secretome atlas initiative: Implications in health and disease conditions.
The use of global profiling in biomarker development for gliomas.
Two Unique Glioma Subtypes Revealed.
Ultrastructure of Brain Tumors & Biopsies:— A Diagnostic Atlas.
Unsupervised Resolution of Histomorphologic Heterogeneity in Renal Cell Carcinoma Using a Brain Tumor-Educated Neural Network.
X-CAL: Explicit Calibration for Survival Analysis.
[Histological atlas of brain tumors (12): Metastatic brain tumors]
Brain Stem Infarctions
A new method to investigate brain stem structural-functional correlations using digital post-processing MRI--reliability in ischemic internuclear ophthalmoplegia.
Breast Diseases
Atlas of the Ultrastructure of Human Breast Diseases.
Chinese association of ultrasound in medicine and engineering, superficial organs and peripheral vessels committee expert consensus on clinical frequently asked questions in breast ultrasonography, June 2018.
Breast Neoplasms
4-Hydroxytamoxifen enhances sensitivity of estrogen receptor ?-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion.
6-lncRNA Assessment Model for Monitoring and Prognosis of HER2-Positive Breast Cancer: Based on Transcriptome Data.
A 23 gene-based molecular prognostic score precisely predicts overall survival of breast cancer patients.
A bioinformatics approach to identify novel long, non-coding RNAs in breast cancer cell lines from an existing RNA-sequencing dataset.
A Cell-Line-Specific Atlas of PARP-Mediated Protein Asp/Glu-ADP-Ribosylation in Breast Cancer.
A comprehensive analysis of breast cancer microbiota and host gene expression.
A Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer(1,2.)
A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies.
A comprehensive function analysis of LMO2 in different breast cancer subtypes.
A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.
A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer.
A four-gene signature for prognosis in breast cancer patients with hypermethylated IL15RA.
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
A joint analysis of metabolomics and genetics of breast cancer.
A Joint Graphical Model for Inferring Gene Networks Across Multiple Subpopulations and Data Types.
A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase C?II.
A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.
A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers.
A luminal breast cancer genome atlas: progress and barriers.
A Multi-Source Data Fusion Framework for Revealing the Regulatory Mechanism of Breast Cancer Immune Evasion.
A murine preclinical syngeneic transplantation model for breast cancer precision medicine.
A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.
A novel autophagy-related lncRNA prognostic risk model for breast cancer.
A novel immune-related prognostic index for predicting breast cancer overall survival.
A Novel lncRNA HOXC-AS3 Acts as a miR-3922-5p Sponge to Promote Breast Cancer Metastasis.
A Novel Prognostic Signature of mRNA-lncRNA in Breast Cancer.
A pathways-based prediction model for classifying breast cancer subtypes.
A pilot study on the prevalence of DNA palindromes in breast cancer genomes.
A potential peptide therapeutic derived from the juxtamembrane domain of the epidermal growth factor receptor.
A powerful nonparametric method for detecting differentially co-expressed genes: distance correlation screening and edge-count test.
A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
A Random Walk Based Cluster Ensemble Approach for Data Integration and Cancer Subtyping.
A regularized multivariate regression approach for eQTL analysis.
A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
A single-cell and spatially resolved atlas of human breast cancers.
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer.
A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.
A Translational Pipeline for Overall Survival Prediction of Breast Cancer Patients by Decision-Level Integration of Multi-Omics Data.
ABC-GWAS: Functional Annotation of Estrogen Receptor-Positive Breast Cancer Genetic Variants.
Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer.
Acetyl-11-keto-?-boswellic Acid Inhibits Precancerous Breast Lesion MCF-10AT Cells via Regulation of LINC00707/miR-206 that Reduces Estrogen Receptor-?.
Actionable gene alterations in an Asian population with triple-negative breast cancer.
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes.
Adjuvant endocrine treatment for estrogen receptor (ER)-positive/HER2-negative breast cancer.
Age-associated genes in human mammary gland drive human breast cancer progression.
AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.
Alcohol consumption and breast tumor gene expression.
Aldehyde Dehydrogenase 1-related Genes in Triple-negative Breast Cancer Investigated Using Network Analysis.
Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer.
Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer.
Altered gene expression in glycolysis-cholesterol synthesis axis correlates with outcome of triple-negative breast cancer.
Alzheimer's Disease Susceptibility Genes in Malignant Breast Tumors.
Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer.
An atlas of histone deacetylase expression in breast cancer: fluorescence methodology for comparative semi-quantitative analysis.
An immune-related risk gene signature predicts the prognosis of breast cancer.
An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier.
An indexed atlas for content-based retrieval and analysis of mammograms.
An Information Theoretical Multilayer Network Approach to Breast Cancer Transcriptional Regulation.
An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.
An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer.
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer.
An mRNA characterization model predicting survival in patients with invasive breast cancer based on The Cancer Genome Atlas database.
Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes.
Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry.
Angiopoietin pathway gene expression associated with poor breast cancer survival.
ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control.
Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling.
ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast Cancer.
APOBEC3B expression and its prognostic potential in breast cancer.
APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status.
APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
Arm Selection Preference of MicroRNA-193a Varies in Breast Cancer.
Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles.
Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling.
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.
Association between histone lysine methyltransferase KMT2C mutation and clinicopathological factors in breast cancer.
Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple negative breast cancer.
Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
Associations of two-pore domain potassium channels and triple negative breast cancer subtype in The Cancer Genome Atlas: systematic evaluation of gene expression and methylation.
Atezolizumab potentiates Tcell-mediated cytotoxicity and coordinates with FAK to suppress cell invasion and motility in PD-L1+ triple negative breast cancer cells.
Atlas based segmentation in prone breast cancer radiation therapy.
Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling.
Atlas of sentinel lymph nodes in early breast cancer using single-photon emission computed tomography: implication for lymphatic contouring.
Atlas Sampling for Prone Breast Automatic Segmentation of Organs at Risk: The Importance of Patients' Body Mass Index and Breast Cup Size for an Optimized Contouring of the Heart and the Coronary Vessels.
Atlas-based auto-segmentation for delineating the heart and cardiac substructures in breast cancer radiation therapy.
Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Automated deconvolution of structured mixtures from heterogeneous tumor genomic data.
Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of GCM2, ITPRIPL1 and CCDC181 for Detection of Early Breast Cancer and Surgical Treatment Response.
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
B-CAN: a resource sharing platform to improve the operation, visualization and integrated analysis of TCGA breast cancer data.
Bayesian Network Marker Selection via the Thresholded Graph Laplacian Gaussian Prior.
BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer.
BCL2 Regulation According to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.
Bcl9 Depletion Modulates Endothelial Cell in Tumor Immune Microenvironment in Colorectal Cancer Tumor.
Benzodiazepines use and breast cancer risk: A population-based study and gene expression profiling evidence.
Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity.
Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells.
Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment.
Bioinformatics Analysis Identifies IL6ST as a Potential Tumor Suppressor Gene for Triple-Negative Breast Cancer.
Bioinformatics analysis of prognosis-related long non-coding RNAs in invasive breast carcinoma.
Biomarker discovery using a comparative omics approach in a mouse model developing heterogeneous mammary cancer subtypes.
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.
Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.
Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7.
BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
BrcaSeg: A Deep Learning Approach for Tissue Quantification and Genomic Correlations of Histopathological Images.
BreakTrans: uncovering the genomic architecture of gene fusions.
Breast cancer classification: linking molecular mechanisms to disease prognosis.
Breast Cancer Type Classification Using Machine Learning.
Breast MRI radiomics: comparison of computer- and human-extracted imaging phenotypes.
Bromodomain-containing Protein 4 Is a Favourable Prognostic Factor in Breast Cancer Patients.
BSSV: Bayesian based somatic structural variation identification with whole genome DNA-seq data.
Building radiation-resistant model in triple-negative breast cancer to screen radioresistance-related molecular markers.
c-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc/miR-29b-3p/CDK6 axis.
C16?ceramide and sphingosine 1?phosphate/S1PR2 have opposite effects on cell growth through mTOR signaling pathway regulation.
CaDrA: A Computational Framework for Performing Candidate Driver Analyses Using Genomic Features.
Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.
CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer.
Cd11b(+) myeloid cells support hepatic metastasis through down-regulation of angiopoietin-like 7 in cancer cells.
CD44 splice isoform switching determines breast cancer stem cell state.
CEACAM Gene Family Mutations Associated With Inherited Breast Cancer Risk - A Comparative Oncology Approach to Discovery.
CeNETs analysis reveals the prognostic value of a signature integration from five lncRNAs in breast cancer.
ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone.
Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.
Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071.
Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer.
circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer.
Circular RNAs and their associations with breast cancer subtypes.
Classical pathology and mutational load of breast cancer - integration of two worlds.
Classification of breast cancer patients using somatic mutation profiles and machine learning approaches.
Classification of Genes Based on Age-Related Differential Expression in Breast Cancer.
CLDN10 single nucleotide polymorphism rs1325774 alters the risk of breast cancer in south chinese women.
Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer.
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).
Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer.
Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer.
Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer.
Comments on: Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery (Clough KB, Kaufman GJ, et al. ASO DOI 10.1245/s10434-009-0792-y).
Common polymorphic inversions at 17q21.31 and 8p23.1 associate with cancer prognosis.
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer.
Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Complicated prognostic values of CCL28 in breast cancer by subtype.
Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data.
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.
Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer.
Comprehensive analysis of the GATA transcription factor gene family in breast carcinoma using gene microarrays, online databases and integrated bioinformatics.
Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development.
Comprehensive expression-based isoform biomarkers predictive of drug responses based on isoform co-expression networks and clinical data.
Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer.
Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer.
Computational Detection of Breast Cancer Invasiveness with DNA Methylation Biomarkers.
Computational identification of micro-structural variations and their proteogenomic consequences in cancer.
Computational Identification of Sex-Biased Biomarker MicroRNAs and Genes Associated with Immune Infiltration in Breast Cancer.
Condition-adaptive fused graphical lasso (CFGL): An adaptive procedure for inferring condition-specific gene co-expression network.
CONFIGURE: A pipeline for identifying context specific regulatory modules from gene expression data and its application to breast cancer.
Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
Construction and Analysis of a Long Non-Coding RNA-Associated Competing Endogenous RNA Network Identified Potential Prognostic Biomarkers in Luminal Breast Cancer.
Construction and validation of an immunity-related prognostic signature for breast cancer.
Contouring Guidelines for the Axillary Lymph Nodes for the Delivery of Radiation Therapy in Breast Cancer: Evaluation of the RTOG Breast Cancer Atlas.
Copy Number Profiling of MammaPrint™ Genes Reveals Association with the Prognosis of Breast Cancer Patients.
Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients.
Correlation between gene expression and mutator phenotype predicts homologous recombination deficiency and outcome in ovarian cancer.
CpG methylation signature predicts prognosis in breast cancer.
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
CREDO: Highly confident disease-relevant A-to-I RNA-editing discovery in breast cancer.
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.
Crumbs protein homolog 3 (CRB3) expression is associated with oestrogen and progesterone receptor positivity in breast cancer.
CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors.
CXCR3 Expression and Genome-Wide 3' Splice Site Selection in the TCGA Breast Cancer Cohort.
Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer.
Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer.
D-CCA: A Decomposition-based Canonical Correlation Analysis for High-Dimensional Datasets.
Data mining of micrornas in breast carcinogenesis which may be a potential target for cancer prevention.
DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma.
De novo pathway-based biomarker identification.
De novo, systemic, deleterious amino acid substitutions are common in large cytoskeleton-related protein coding regions.
Deciphering the Correlation between Breast Tumor Samples and Cell Lines by Integrating Copy Number Changes and Gene Expression Profiles.
Deciphering the Oncogenic Role of VPS28 Modulated by miR-491-5p in Breast Cancer Cells Using In Silico and Functional Analysis.
Deconvolution and phylogeny inference of structural variations in tumor genomic samples.
Deconvolution of DNA methylation identifies differentially methylated gene regions on 1p36 across breast cancer subtypes.
Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis.
Deep learning predicts chromosomal instability from histopathology images.
Deep-Learning-Based Characterization of Tumor-Infiltrating Lymphocytes in Breast Cancers From Histopathology Images and Multiomics Data.
Defining the Na(+)/H(+) exchanger NHE1 interactome in triple-negative breast cancer cells.
Delineation of Supraclavicular Target Volumes in Breast Cancer Radiation Therapy.
Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group.
Detection of miRNA regulatory effect on triple negative breast cancer transcriptome.
Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer.
Determining breast cancer histological grade from RNA-sequencing data.
Developing a radiosensitivity gene signature for Caucasian patients with breast cancer.
Developing ZNF Gene Signatures Predicting Radiosensitivity of Patients with Breast Cancer.
Development and Validation of a Heart Atlas To Study Cardiac Exposure to Radiation Following Treatment for Breast Cancer.
Development of an Immune-Related Prognostic Signature in Breast Cancer.
Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.
Differences in gene-expression profiles in breast cancer between African and European-ancestry women.
Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas.
Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes.
Differentially expressed genes and key molecules of BRCA1/2-mutant breast cancer: evidence from bioinformatics analyses.
Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
DIGITAL BREAST TOMOSYNTHESIS AND FULL-FIELD DIGITAL MAMMOGRAPHY IN BREAST CANCER DETECTION ASSOCIATED WITH FOUR ASYMMETRY TYPES.
Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes.
Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo.
Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer.
Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian versus Western Populations.
Dissecting tRNA-derived fragment complexities using personalized transcriptomes reveals novel fragment classes and unexpected dependencies.
Distinct pattern of one-carbon metabolism, a nutrient-sensitive pathway, in invasive breast cancer: A metabolomic study.
Distribution and prognostic value of tumor?infiltrating T cells in breast cancer.
DNA methylation and hormone receptor status in breast cancer.
DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients.
DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.
DNA Methylation Targets Influenced by Bisphenol A and/or Genistein Are Associated with Survival Outcomes in Breast Cancer Patients.
DNA Repair Gene Expression Adjusted by the PCNA Metagene Predicts Survival in Multiple Cancers.
DNASE1L2, as a Carcinogenic Marker, Affects the Phenotype of Breast Cancer Cells Via Regulating Epithelial-Mesenchymal Transition Process.
DNMT3B7 expression promotes tumor progression to a more aggressive phenotype in breast cancer cells.
Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study.
Downregulated expression of ARHGAP10 correlates with advanced stage and high Ki-67 index in breast cancer.
Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/?-catenin signaling in breast cancer.
Downregulation of long non-coding RNA MR4435-2HG suppresses breast cancer progression via the Wnt/?-catenin signaling pathway.
Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes.
DSN1 is a prognostic biomarker and correlated with clinical characterize in breast cancer.
Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
Dysregulated lncRNA-miRNA-mRNA Network Reveals Patient Survival-Associated Modules and RNA Binding Proteins in Invasive Breast Carcinoma.
Ectodermal-neural cortex 1 as a novel biomarker predicts poor prognosis and induces metastasis in breast cancer by promoting Wnt/?-catenin pathway.
eEF2K--a new target in breast cancers with combined inactivation of p53 and PTEN.
Effect of estrogen receptor ? binding on functional DNA methylation in breast cancer.
Effects of AKT1 E17K mutation hotspots on the biological behavior of breast cancer cells.
Effects of CORO2A on Cell Migration and Proliferation and Its Potential Regulatory Network in Breast Cancer.
Eight immune-related genes predict survival outcomes and immune characteristics in breast cancer.
Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosis.
Elevated expression of protein arginine methyltransferase 5 predicts the poor prognosis of breast cancer.
Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
Enhanced expression of histone chaperone APLF associate with breast cancer.
Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.
Epigenetically regulated Fibronectin leucine rich transmembrane protein 2 (FLRT2) shows tumor suppressor activity in breast cancer cells.
Epigenetics in breast cancer: what's new?
Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types.
Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
ER? is a negative regulator of PD-L1 gene transcription in breast cancer.
ER?-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.
ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-?B/Cyclin D1 pathway.
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
Estrogen receptor ? is involved in the regulation of ITGA8 methylation in estrogen receptor-positive breast cancer.
Estrogen receptor alpha (ER?/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.
Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.
Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway.
ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes.
Evaluation of a delineation software for cardiac atlas-based autosegmentation: An example of the use of artificial intelligence in modern radiotherapy.
Evaluation of a software for automatic delineation of the mammary gland and organs at risk in patients treated for breast cancer in lateral position.
Evaluation of CpG-SNPs in miRNA promoters and risk of breast cancer.
Evaluation of integrative clustering methods for the analysis of multi-omics data.
Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database.
Expression and Circulating Levels of Perlecan in Breast Cancer - Implications for Oestrogen Dependent Stromal Remodeling.
Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Expression and Prognostic Characteristics of m6 A RNA Methylation Regulators in Breast Cancer.
Expression and prognostic value of transcription-associated cyclin-dependent kinases in human breast cancer.
Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas.
Expression of the BAD pathway is a marker of triple-negative status and poor outcome.
Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancer.
Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.
Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.
Expression profile of Toll?like receptors in human breast cancer.
Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein.
Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.
Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer.
FDG / PET-CT based lymph node atlas in breast cancer patients.
Feasibility of multi-atlas cardiac segmentation from thoracic planning CT in a probabilistic framework.
Feature Selection for Breast Cancer Classification by Integrating Somatic Mutation and Gene Expression.
FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ER? and PRB?4 isoform to MYC regulatory sequences.
FGMD: A novel approach for functional gene module detection in cancer.
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.
Frailness and resilience of gene networks predicted by detection of co-occurring mutations via a stochastic perturbative approach.
From TCGA to treatment.
FSIP1 is correlated with estrogen receptor status and poor prognosis.
GABC: A comprehensive resource and Genome Atlas for Breast Cancer.
Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method.
Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor.
Gene expression profiling in women with breast cancer in a Saudi population.
Gene-based comparative analysis of tools for estimating copy number alterations using whole-exome sequencing data.
Generation and application of a probabilistic breast cancer atlas.
Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer.
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.
Genome-Wide Analysis of Methylation-Driven Genes and Identification of an Eight-Gene Panel for Prognosis Prediction in Breast Cancer.
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer.
Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective.
Geometric and dosimetric evaluation of atlas based auto-segmentation of cardiac structures in breast cancer patients.
Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest.
Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer.
Germline cytoskeletal and extra-cellular matrix-related single nucleotide variations associated with distinct cancer survival rates.
Germline Genetic Association between Stromal Interaction Molecule 1 (STIM1) and Clinical Outcomes in Breast Cancer Patients.
Gestational high-fat diet and bisphenol A exposure heightens mammary cancer risk.
Global Alternative Splicing Defects in Human Breast Cancer Cells.
Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
HARVESTMAN: a framework for hierarchical feature learning and selection from whole genome sequencing data.
Heat shock proteins create a signature to predict the clinical outcome in breast cancer.
Heterogeneity of genomic profile in patients with HER2-positive breast cancer.
HIF3A DNA methylation, obesity and weight gain, and breast cancer risk among Mexican American women.
High BMI1 Expression with Low CD8+ and CD4+ T Cell Activity Could Promote Breast Cancer Cell Survival: A Machine Learning Approach.
High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor?positive breast cancer.
High expression of DLG3 is associated with decreased survival from breast cancer.
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers.
High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer.
High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.
High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients.
High KDM1A Expression Associated with Decreased CD8+T Cells Reduces the Breast Cancer Survival Rate in Patients with Breast Cancer.
High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer.
High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities.
High-dimensional genomic data bias correction and data integration using MANCIE.
Highly connected, non-redundant microRNA functional control in breast cancer molecular subtypes.
Highly robust model of transcription regulator activity predicts breast cancer overall survival.
Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer.
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer.
Homeobox B4 inhibits breast cancer cell migration by directly binding to StAR-related lipid transfer domain protein 13.
Hormone Receptor-Status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape.
HOX Transcript Antisense RNA HOTAIR Abrogates Vasculogenic Mimicry by Targeting the AngiomiR-204/FAK Axis in Triple Negative Breast Cancer Cells.
Humanin Promotes Tumor Progression in Experimental Triple Negative Breast Cancer.
Humanized yeast genetic interaction mapping predicts synthetic lethal interactions of FBXW7 in breast cancer.
Hybrid Stem Cell States: Insights Into the Relationship Between Mammary Development and Breast Cancer Using Single-Cell Transcriptomics.
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Hypothyroidism induces oxidative stress and DNA damage in breast.
Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer.
Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.
Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
Identification and Validation of Circulating MicroRNA Signatures for Breast Cancer Early Detection Based on Large Scale Tissue-Derived Data.
Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy.
Identification of a 15-pseudogene based prognostic signature for predicting survival and antitumor immune response in breast cancer.
Identification of a four-long non-coding RNA signature in predicting breast cancer survival.
Identification of a Rat Mammary Tumor Risk Locus That Is Syntenic with the Commonly Amplified 8q12.1 and 8q22.1 Regions in Human Breast Cancer Patients.
Identification of an immune-related long noncoding RNA signature that predicts prognosis in breast cancer patients.
Identification of Biomarkers for Breast Cancer Using Databases.
Identification of breast cancer associated variants that modulate transcription factor binding.
Identification of breast cancer prognostic modules via differential module selection based on weighted gene Co-expression network analysis.
Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Identification of CTLA-4 associated with tumor microenvironment and competing interactions in triple negative breast cancer by co-expression network analysis.
Identification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine.
Identification of Drivers of Aneuploidy in Breast Tumors.
Identification of epigenetic modulators in human breast cancer by integrated analysis of DNA methylation and RNA-Seq data.
Identification of FOXM1 as a specific marker for triple?negative breast cancer.
Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast Cancer.
Identification of genes associated with survival of breast cancer patients.
Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.
Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis.
Identification of Key lncRNA-mRNA Pairs and Functional lncRNAs in Breast Cancer by Integrative Analysis of TCGA Data.
Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.
Identification of MicroRNAs as Diagnostic Biomarkers for Breast Cancer Based on the Cancer Genome Atlas.
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Identification of Novel Biomarkers Associated With the Prognosis and Potential Pathogenesis of Breast Cancer via Integrated Bioinformatics Analysis.
Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer.
Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
Identification of potential prognostic biomarkers for breast cancer using WGCNA and PPI integrated techniques.
Identification of Prognostic Candidate Genes in Breast Cancer by Integrated Bioinformatic Analysis.
Identification of putative actionable alterations in clinically relevant genes in breast cancer.
Identification of the copy number variant biomarkers for breast cancer subtypes.
Identification of unanimous immune subtypes for different hormone receptor phenotypes of human breast cancer with potential prognostic significance.
Identifying a miRNA signature for predicting the stage of breast cancer.
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Identifying causal networks linking cancer processes and anti-tumor immunity using Bayesian network inference and metagene constructs.
Identifying Functional Modules in Co-Regulatory Networks Through Overlapping Spectral Clustering.
Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas.
IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.
Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
Immunoglobulin superfamily genes are novel prognostic biomarkers for breast cancer.
Immunoglobulin superfamily member 10 is a novel prognostic biomarker for breast cancer.
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers.
Impact of miRNA sequence on miRNA expression and correlation between miRNA expression and cell cycle regulation in breast cancer cells.
Impacts of RETN genetic polymorphism on breast cancer development.
Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery.
In silico study of cancer stage-specific DNA methylation pattern in White breast cancer patients based on TCGA dataset.
Increased expression of TMED2 is an unfavorable prognostic factor in patients with breast cancer.
Increased Proportion of Variance Explained and Prediction Accuracy of Survival of Breast Cancer Patients with Use of Whole-Genome Multiomic Profiles.
Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular Breast Cancer and Normal PAM50 Subtype.
Induction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study.
Inferring perturbation profiles of cancer samples.
Information theoretic sub-network mining characterizes breast cancer subtypes in terms of cancer core mechanisms.
Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78.
Inhibition of insulin-like growth factor 1 signaling synergistically enhances the tumor suppressive role of triptolide in triple-negative breast cancer cells.
Insights from Global Analyses of Long Noncoding RNAs in Breast Cancer.
Institut Curie guidelines on breast target volume delineation for patients treated in lateral position.
INTEGRATE: gene fusion discovery using whole genome and transcriptome data.
Integrated Analysis of ceRNA Network Reveals Prognostic and Metastasis Associated Biomarkers in Breast Cancer.
Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
Integrated bioinformatics analysis to identify 15 hub genes in breast cancer.
Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer.
Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer.
Integrating multi-omics for uncovering the architecture of cross-talking pathways in breast cancer.
Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Integrating spatial gene expression and breast tumour morphology via deep learning.
Integration and comparison of different genomic data for outcome prediction in cancer.
Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
Integration of Multi-omics Data for Gene Regulatory Network Inference and Application to Breast Cancer.
Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power.
Integration of transcriptomic data in a genome-scale metabolic model to investigate the link between obesity and breast cancer.
Integrative analysis of common genes and driver mutations implicated in hormone stimulation for four cancers in women.
Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
Integrative clustering of high-dimensional data with joint and individual clusters.
Integrative gene set analysis of multi-platform data with sample heterogeneity.
Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer.
Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
Integrative transcriptome data mining for identification of core lncRNAs in breast cancer.
Integrative, multi-omics, analysis of blood samples improves model predictions: applications to cancer.
Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer.
Intersectin 1 (ITSN1) identified by comprehensive bioinformatic analysis and experimental validation as a key candidate biological target in breast cancer.
Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer.
Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer.
Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation.
Invalidation of mitophagy by FBP1-mediated repression promotes apoptosis in breast cancer.
Investigating a multigene prognostic assay based on significant pathways for Luminal A breast cancer through gene expression profile analysis.
IODNE: An integrated optimization method for identifying the deregulated subnetwork for precision medicine in cancer.
isma: an R package for the integrative analysis of mutations detected by multiple pipelines.
JAK2 expression is correlated with the molecular and clinical features of breast cancer as a favorable prognostic factor.
Joint reconstruction of multiple gene networks by simultaneously capturing inter-tumor and intra-tumor heterogeneity.
Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.
Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer.
Kinase-substrate Edge Biomarkers Provide a More Accurate Prognostic Prediction in ER-negative Breast Cancer.
KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer.
Knockdown of RAC1 and VASP gene expression inhibits breast cancer cell migration.
KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
Lactate Dehydrogenase-A (LDH-A) Preserves Cancer Stemness and Recruitment of Tumor-Associated Macrophages to Promote Breast Cancer Progression.
Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer.
LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells.
LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.
LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Linking signaling pathways to transcriptional programs in breast cancer.
Lipocalin-1 Expression as a Prognosticator Marker of Survival in Breast Cancer Patients.
LMSM: A modular approach for identifying lncRNA related miRNA sponge modules in breast cancer.
lncRNA FOXD3-AS1 is associated with clinical progression and regulates cell migration and invasion in breast cancer.
LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci.
LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer.
LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.
LOC550643, a Long Non-coding RNA, Acts as Novel Oncogene in Regulating Breast Cancer Growth and Metastasis.
Long intergenic non-coding RNA expression signature in human breast cancer.
Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGF? and focal adhesion kinase (FAK) signaling.
Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer.
Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p.
Long Non-Coding RNA TUG1 Expression Is Associated with Different Subtypes in Human Breast Cancer.
Long non?coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4.
Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Low CYP24A1 mRNA expression and its role in prognosis of breast cancer.
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome.
m6A RNA Methylation Regulator YTHDF1 Correlated With Immune Microenvironment Predicts Clinical Outcomes and Therapeutic Efficacy in Breast Cancer.
MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2.
Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis.
Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.
Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma.
MARCH8 Suppresses Tumor Metastasis and Mediates Degradation of STAT3 and CD44 in Breast Cancer Cells.
MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.
Mesothelin expression is associated with poor outcomes in breast cancer.
Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer.
MGSEA - a multivariate Gene set enrichment analysis.
microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity.
microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival.
MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability.
microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1.
MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.
MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer.
MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Microsatellite genotyping reveals a signature in breast cancer exomes.
Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma.
Mining the prognostic significance of the GINS2 gene in human breast cancer using bioinformatics analysis.
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer.
miR-195/miR-497 Regulate CD274 Expression of Immune Regulatory Ligands in Triple-Negative Breast Cancer.
miR-301b and NR3C2 co-regulate cells malignant properties and have the potential to be independent prognostic factors in breast cancer.
MiR-301b-3p Promotes the Occurrence and Development of Breast Cancer Cells via Targeting HOXA5.
miR-410-3p suppresses breast cancer progression by targeting Snail.
miRGTF-net: Integrative miRNA-gene-TF network analysis reveals key drivers of breast cancer recurrence.
Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic Approach.
MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients.
Model based on GA and DNN for prediction of mRNA-Smad7 expression regulated by miRNAs in breast cancer.
MODEL FREE ESTIMATION OF GRAPHICAL MODEL USING GENE EXPRESSION DATA.
Molecular and Clinical Characterization of CCT2 Expression and Prognosis via Large-Scale Transcriptome Profile of Breast Cancer.
Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers.
Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer.
Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors.
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.
Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
Monocarboxylate transporters in breast cancer and adipose tissue are novel biomarkers and potential therapeutic targets.
MTBP Is Overexpressed in Triple-Negative Breast Cancer and Contributes to Its Growth and Survival.
MUC1-C integrates activation of the IFN-? pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Multi-Objective Optimization Algorithm to Discover Condition-Specific Modules in Multiple Networks.
Multi-omics Data Integration by Generative Adversarial Network.
Multi-Stability and Consequent Phenotypic Plasticity in AMPK-Akt Double Negative Feedback Loop in Cancer Cells.
Multiple breast cancer risk variants are associated with differential transcript isoform expression in tumors.
Multiple network algorithm for epigenetic modules via the integration of genome-wide DNA methylation and gene expression data.
Multiscale Embedded Gene Co-expression Network Analysis.
Municipal distribution of breast cancer mortality among women in Spain.
MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures.
Mutational landscape differences between young-onset and older-onset breast cancer patients.
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.
Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.
Needles in a haystack: finding recurrent genomic changes in breast cancer.
Network-Based Approach to Identify the Antiproliferative Mechanisms of Bruceine D in Breast Cancer From the Cancer Genome Atlas.
Network-Based Isoform Quantification with RNA-Seq Data for Cancer Transcriptome Analysis.
Non-coding single nucleotide variants affecting estrogen receptor binding and activity.
Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.
Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.
NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells.
Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.
Octogenarians' Breast Cancer Is Associated with an Unfavorable Tumor Immune Microenvironment and Worse Disease-Free Survival.
Omission of adjuvant radiation therapy in elderly patients with low risk breast cancer undergoing breast-conserving surgery - two center experience.
Oncogenic Role and Prognostic Value of MicroRNA-937-3p in Patients with Breast Cancer.
Oncoplastic surgery for breast cancer based on tumour location and a quadrant-per-quadrant atlas.
Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts.
Overexpressed somatic alleles are enriched in functional elements in Breast Cancer.
Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/?-catenin/EMT signalling axis.
Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients.
Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway.
Overlapping clustering of gene expression data using penalized weighted normalized cut.
p120 catenin is a key effector of a Ras-PKC? oncogenic signaling axis.
Pan-cancer analysis of TCGA data reveals notable signaling pathways.
Pannexin1 Is Associated with Enhanced Epithelial-To-Mesenchymal Transition in Human Patient Breast Cancer Tissues and in Breast Cancer Cell Lines.
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer.
PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer.
PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.
Phenethyl Isothiocyanate Suppresses Stemness in the Chemo- and Radio-Resistant Triple-Negative Breast Cancer Cell Line MDA-MB-231/IR Via Downregulation of Metadherin.
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.
Pokemon Inhibits Transforming Growth Factor ?-Smad4-Related Cell Proliferation Arrest in Breast Cancer through Specificity Protein 1.
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.
Population-dependent Intron Retention and DNA Methylation in Breast Cancer.
Potential functional variants of KIAA genes are associated with breast cancer risk in a case control study.
Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis.
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data.
Prevalence and clinical relevance of tumor-associated tissue eosinophilia (TATE) in breast cancer.
Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data.
Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs.
Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity.
Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers.
Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process.
Prognostic Role of KRAS mRNA Expression in Breast Cancer.
Prognostic significance of heat shock protein 90AA1 (HSP90?) in invasive breast cancer.
Prognostic stromal gene signatures in breast cancer.
Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Proper Use of Allele-Specific Expression Improves Statistical Power for cis-eQTL Mapping with RNA-Seq Data.
Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
Proteins with Evolutionarily Hypervariable Domains are Associated with Immune Response and Better Survival of Basal-like Breast Cancer Patients.
PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1.
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation.
PTEN and NEDD4 in Human Breast Carcinoma.
Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression.
R.JIVE for exploration of multi-source molecular data.
Radiogenomic Analysis of Breast Cancer: Luminal B Molecular Subtype Is Associated with Enhancement Dynamics at MR Imaging.
Radiotherapy dose distribution prediction for breast cancer using deformable image registration.
RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-?B activation and EGFR signaling.
RDGN-based predictive model for the prognosis of breast cancer.
Regulation of mRNA expression in breast cancer - a cis-tematic trans-action.
Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancer.
Regulatory network reconstruction of five essential microRNAs for survival analysis in breast cancer by integrating miRNA and mRNA expression datasets.
RelA-Induced Interferon Response Negatively Regulates Proliferation.
Relationships Between Human-Extracted MRI Tumor Phenotypes of Breast Cancer and Clinical Prognostic Indicators Including Receptor Status and Molecular Subtype.
Reply to Comments on: Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery.
Rlip Depletion Suppresses Growth of Breast Cancer.
RNA m6A Methylation Regulators Subclassify Luminal Subtype in Breast Cancer.
RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens.
RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer.
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
Robust genomic copy number predictor of pan cancer metastasis.
Role of exchange protein directly activated by cAMP (EPAC1) in breast cancer cell migration and apoptosis.
Role of Krüppel-like Factor 4-p21CIP1 Axis in Breast Cancer Stem-like Cell Inhibition by Benzyl Isothiocyanate.
S-score: a scoring system for the identification and prioritization of predicted cancer genes.
Screening of Prognostic Factors in Early-Onset Breast Cancer.
SEC61G promotes breast cancer development and metastasis via modulating glycolysis and is transcriptionally regulated by E2F1.
Selective expression of long non-coding RNAs in a breast cancer cell progression model.
Sensitivity to differential NRF1 gene signatures contributes to breast cancer disparities.
SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis.
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway.
shRNA knockdown of DNA helicase ERCC6L expression inhibits human breast cancer growth.
Simplified rules for everyday delineation of lymph node areas for breast cancer radiotherapy.
Single-Cell RNA Sequencing of a Postmenopausal Normal Breast Tissue Identifies Multiple Cell Types That Contribute to Breast Cancer.
SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
Somatic Mutations in LRRK2 Identify a Subset of Invasive Mammary Carcinomas Associated with High Mutation Burden.
SPTBN1 inhibits growth and epithelial-mesenchymal transition in breast cancer by downregulating miR-21.
SRY-related high-mobility-group box 6 suppresses cell proliferation and is downregulated in breast cancer.
Statin use, HMGCR expression, and breast cancer survival - The Malmö Diet and Cancer Study.
Statistical analysis of array expression data as applied to the problem of tamoxifen resistance.
Stromal-associated cytokines bias the interplay between gene expression and DNA methylation in human breast cancers.
Structural learning and integrative decomposition of multi-view data.
Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.
Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers.
Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer.
Systematic Identification and Assessment of Therapeutic Targets for Breast Cancer Based on Genome-Wide RNA Interference Transcriptomes.
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy.
Testing equality of means in partially paired data with incompleteness in single response.
TGF? isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications.
Th2 cell infiltrations predict neoadjuvant chemotherapy response of estrogen receptor-positive breast cancer.
The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance.
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer.
The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network.
The Association of Serum IL-33 and sST2 with Breast Cancer.
The Atlas trial: Tamoxifen for a longer duration for early breast cancer.
The BIRC Family Genes Expression in Patients with Triple Negative Breast Cancer.
The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool.
The Cancer Genome Atlas: clinical applications for breast cancer.
The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas.
The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer.
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC).
The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathway.
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
The GALNT6?LGALS3BP axis promotes breast cancer cell growth.
The genomic map of breast cancer: which roads lead to better targeted therapies?
The human intermediate prolactin receptor is a mammary proto-oncogene.
The IL1?-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
The immune-related gene CD52 is a favorable biomarker for breast cancer prognosis.
The impact of HER2 overexpression on the miRNA and circRNA transcriptomes in two breast cell lines and their vesicles.
The Landscape of Chromosome Instability in Breast Cancers and Associations with the Tumor Mutation Burden: An Analysis of Data from TCGA.
The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial.
The LZIP: A Bayesian latent factor model for correlated zero-inflated counts.
The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients.
The m6A-related gene signature for predicting the prognosis of breast cancer.
The magnitude of cancer breast in India: a summary.
The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA Export.
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer.
The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
The molecular basis of breast cancer pathological phenotypes.
The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis.
The MS-lincRNA landscape reveals a novel lincRNA BCLIN25 that contributes to tumorigenesis by upregulating ERBB2 expression via epigenetic modification and RNA-RNA interactions in breast cancer.
The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
The Relationship Between Mismatch Repair Deficiency and PD-L1 Expression in Breast Carcinoma.
The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer.
The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy.
The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer.
The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer.
TIGIT-related transcriptome profile and its association with tumor immune microenvironment in breast cancer.
Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-?B/STAT3 signalling pathway in breast cancer cells.
Time-Varying Differential Network Analysis for Revealing Network Rewiring over Cancer Progression.
Tools for consensus analysis of experts' contours for radiotherapy structure definitions.
Topological integration of RPPA proteomic data with multi-omics data for survival prediction in breast cancer via pathway activity inference.
Towards clinically more relevant dissection of patient heterogeneity via survival-based Bayesian clustering.
TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases.
TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis.
Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CA (H1047R) in HER2/ER-positive breast cancer.
Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome.
Translating ceRNA Susceptibilities into Correlation Functions.
Translational database selection and multiplexed sequence capture for up front filtering of reliable breast cancer biomarker candidates.
Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.
TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets.
TSDLPP: A Novel Two-stage Deep Learning Framework for Prognosis Prediction Based on Whole Slide Histopathological Images.
Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast Cancer.
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
Tumor Suppressor Effect of RBMS3 in Breast Cancer.
Tuning Parameter Selection in Cox Proportional Hazards Model with a Diverging Number of Parameters.
Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2.
UBASH3B promotes tamoxifen resistance and could be negatively regulated by ESR1.
Ubiquitin-like modifier-activating enzyme 7 as a marker for the diagnosis and prognosis of breast cancer.
Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma.
Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity.
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis.
Unsupervised multiple kernel learning for heterogeneous data integration.
Up-regulation of L Antigen Family Member 3 Associates With Aggressive Progression of Breast Cancer.
Upregulation of Long Non-Coding RNA DRAIC Correlates with Adverse Features of Breast Cancer.
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.
Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer.
Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study.
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer.
WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-?B activation.
Where cancer genomics should go next: a clinician's perspective.
XPF -673C>T variation is associated with the susceptibility to breast cancer.
XRCC1 promotes replication restart, nascent fork degradation and mutagenic DNA repair in BRCA2-deficient cells.
ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
[Adjuvant tamoxifen duration: more large-scale randomized evidence is needed]
[Breast cancer mortality in women in the Schleswig-Holstein district 1981 to 1995]
[Breast cancer: atlas]
[Evaluation of an automatic delineation system for organs at risk and target lymph nodes volumes for patients treated for breast cancer].
[For how long should breast cancer patients take Tamoxifen? The International Program ATLAS will answer this question]
[Local recurrences after conservative surgery in breast carcinoma]
Bronchitis
Atlas of Bronchitis.
Bursitis
An equine cadaver study investigating the relationship between cervical flexion, nuchal ligament elongation and pressure at the first and second cervical vertebra.
CADASIL
Cortical Superficial Siderosis in Different Types of Cerebral Small Vessel Disease.
Calcinosis
Breast microcalcifications: the lesions in anatomical pathology.
Carcinogenesis
A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis.
ALK gene alterations in cancer: biological aspects and therapeutic implications.
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.
Assessing the functional bias of commercial microarrays using the onto-compare database.
Author Correction: Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis.
Benzodiazepines use and breast cancer risk: A population-based study and gene expression profiling evidence.
circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer.
Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining.
Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis.
Differences in key genes in human alveolar macrophages between phenotypically normal smokers and nonsmokers: diagnostic and prognostic value in lung cancer.
EGFRvIII-specific CAR-T cells produced by piggyBac transposon exhibit efficient growth suppression against hepatocellular carcinoma.
Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.
Elevated KLF7 levels may serve as a prognostic signature and might contribute to progression of squamous carcinoma.
Emerging targets for glioblastoma stem cell therapy.
Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types.
Epigenetic silencing of the synthesis of immunosuppressive Siglec ligand glycans by NF-?B/EZH2/YY1 axis in early-stage colon cancers.
Feature Selection for Breast Cancer Classification by Integrating Somatic Mutation and Gene Expression.
Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA.
Glioblastoma: molecular pathways, stem cells and therapeutic targets.
Histone Methyltransferases Useful in Gastric Cancer Research.
HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma.
Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis.
Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.
Identification of MicroRNA-Related Tumorigenesis Variants and Genes in the Cancer Genome Atlas (TCGA) Data.
Identification of oncogenic long noncoding RNAs CASC9 and LINC00152 in oral carcinoma through genome-wide comprehensive analysis.
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.
Integrating genomics in head and neck cancer treatment: Promises and pitfalls.
Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer.
Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma.
LncRNA CASC9 interacts with CPSF3 to regulate TGF-? signaling in colorectal cancer.
Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database.
Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis.
Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma.
MicroRNA-3690 promotes cell proliferation and cell cycle progression by altering DKK3 expression in human thyroid cancer.
MicroRNA?mRNA integrated analysis based on a case of well?differentiated thyroid cancer with both metastasis and metastatic recurrence.
miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10.
Modeling Gene-Wise Dependencies Improves the Identification of Drug Response Biomarkers in Cancer Studies.
Molecular profiling of transcription factors pinpoints MYC-estrogen related receptor ?-regulatory factor X5 panel for characterizing the immune microenvironment and predicting the efficacy of immune checkpoint inhibitors in renal cell carcinoma.
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.
Multiscale Modeling of Inflammation-Induced Tumorigenesis Reveals Competing Oncogenic and Oncoprotective Roles for Inflammation.
Myeloid translocation genes differentially regulate colorectal cancer programs.
Natural Product Regulates Autophagy in Cancer.
Oncogenic long noncoding RNA landscape in breast cancer.
Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway.
Pan-Cancer Analysis of Head-to-Head Gene Pairs in Terms of Transcriptional Activity, Co-expression and Regulation.
Pan-cancer analysis on microRNA-associated gene activation.
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Potential role for targeted therapy in muscle-invasive bladder cancer: lessons from the cancer genome atlas and beyond.
Potential therapeutic targets of TP53 gene in the context of its classically canonical functions and its latest non-canonical functions in human cancer.
Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data.
Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma.
Profiling of differentially expressed genes in LRRC4 overexpressed glioblastoma cells by cDNA array.
Prostasin regulates PD-L1 expression in human lung cancer cells.
Proteome atlas of human chromosome 8 and its multiple 8p deficiencies in tumorigenesis of the stomach, colon, and liver.
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
Recent therapeutic advances in the treatment of colorectal cancer.
Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives.
Role of chromosome 1q copy number variation in hepatocellular carcinoma.
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
Significance of TP53 Mutation in Cellular Process and Disease Progression in Lung Adenocarcinoma.
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
The Molecular Effects of a High Fat Diet on Endometrial Tumour Biology.
The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.
The X-linked tumor suppressor TSPX downregulates cancer-drivers/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner.
Ultraviolet-A radiation induces changes in cyclin G gene expression in mouse melanoma B16-F1 cells.
Carcinoid Tumor
[Scintigraphy atlas of somatostatin receptors in neuroendocrine tumors of the pancreas and carcinoid tumors]
Carcinoma
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database.
?Np63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival.
A 10?microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.
A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis.
A Bayesian integrative approach for multi-platform genomic data: A kidney cancer case study.
A BRCA1/2 mutational signature and survival in ovarian high grade serous carcinoma.
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.
A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma.
A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.
A Galaxy Implementation of Next-Generation Clustered Heatmaps for Interactive Exploration of Molecular Profiling Data.
A graph-embedded deep feedforward network for disease outcome classification and feature selection using gene expression data.
A hidden Markov modeling approach for identifying tumor subclones in next-generation sequencing studies.
A micro-peptide encoded by HOXB-AS3 promotes the proliferation and viability of oral squamous cell carcinoma cell lines by directly binding with IGF2BP2 to stabilize c-Myc.
A New ?0-Regularized Log-Linear Poisson Graphical Model with Applications to RNA Sequencing Data.
A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.
A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome.
A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma.
A panel of Transcription factors identified by data mining can predict the prognosis of head and neck squamous cell carcinoma.
A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer.
A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma.
A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
A seven long-noncoding RNA signature predicts prognosis of lung squamous cell carcinoma.
A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma.
A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma.
A tale of two cancers: Complete genetic analysis of chromophobe renal cell carcinoma contrasts with clear cell renal cell carcinoma.
A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications.
Aberrations of Chromosomes 1 and 16 in Breast Cancer: A Framework for Cooperation of Transcriptionally Dysregulated Genes.
Accounting for differential variability in detecting differentially methylated regions.
ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy.
ADH7, miR-3065 and LINC01133 are associated with cervical cancer progression in different age groups.
Adjuvant therapy for high-risk renal cell carcinoma after nephrectomy how many trials are positive? Only one or more than one.
Advanced urothelial cancer: a radiology update.
Adverse Drug Event-based Stratification of Tumor Mutations: A Case Study of Breast Cancer Patients Receiving Aromatase Inhibitors.
Agonistic CD40 Antibodies in Cancer Treatment.
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma.
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.
Amplification of the bromodomain-containing protein 4 gene in ovarian high-grade serous carcinoma is associated with worse prognosis and survival.
Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma.
An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients.
An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma.
An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases.
An Immune Atlas of Clear Cell Renal Cell Carcinoma.
An improved clear cell renal cell carcinoma stage prediction model based on gene sets.
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.
An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription.
Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies
Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.
Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma.
Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer.
APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
APPL1 promotes the migration of gastric cancer cells by regulating Akt2 phosphorylation.
Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.
Assessment for prognostic value of differentially expressed genes in immune microenvironment of clear cell renal cell carcinoma.
Assessment of Renal Cell Carcinoma by Texture Analysis in Clinical Practice: A Six-Site, Six-Platform Analysis of Reliability.
Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET.
Association between the CYP11 family and six cancer types.
Association of LINC00673 Genetic Variants with Progression of Oral Cancer.
Associations between proteasomal activator PA28? and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
Atlas of Bladder Carcinoma.
Atlas of Clear Cell Carcinoma of the Ovary. A Pathological Guide.
Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
ATLAS OF TRANSBRONCHIAL BIOPSY: Early Diagnosis of Peripheral Pulmonary Carcinomas.
ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups.
Atlas-based delineation of lymph node levels in head and neck computed tomography images.
Automatic upstaging of tongue squamous cell carcinoma with lateral extrinsic muscle involvement is not justified.
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial.
BAP1 is Overexpressed in Black Compared with White patients with Mx-M1 Clear Cell Renal Cell Carcinoma: A report from the Cancer Genome Atlas.
Bayesian inference of hub nodes across multiple networks.
Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.
Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
Bioinformatic Exploration for Prognostic Significance of Sphingolipid Metabolism-Related Genes in Invasive Ductal Carcinoma Using the Cancer Genome Atlas Cohort.
Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
Bioinformatics analysis suggests that COL4A1 may play an important role in gastric carcinoma recurrence.
Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma.
Bladder Cancer and Genetic Mutations.
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas.
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
CanDrA: cancer-specific driver missense mutation annotation with optimized features.
Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining.
CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target.
Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
Cilia gene expression patterns in cancer.
CLASSIFICATION OF TUMOR HISTOPATHOLOGY VIA SPARSE FEATURE LEARNING.
Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.
Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
Clinical applications of The Cancer Genome Atlas project (TCGA) for squamous cell lung carcinoma.
Clinical signi?cance and prognostic value of SOX7 expression in liver and pancreatic carcinoma.
Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma.
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Combining DNA methylation and RNA sequencing data of cancer for supervised knowledge extraction.
Comparing gene expression data from formalin-fixed, paraffin embedded tissues and qPCR with that from snap-frozen tissue and microarrays for modeling outcomes of patients with ovarian carcinoma.
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA.
Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma.
Comprehensive analysis of prognostic alternative splicing signature in cervical cancer.
Comprehensive Analysis of the ATP-binding Cassette Subfamily B Across Renal Cancers Identifies ABCB8 Overexpression in Phenotypically Aggressive Clear Cell Renal Cell Carcinoma.
Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.
Comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network for bladder cancer.
Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma.
Comprehensive characterization of tumor mutation burden in clear cell renal cell carcinoma based on the three independent cohorts.
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Comprehensive genomic characterization of squamous cell lung cancers.
Comprehensive molecular characterization of urothelial bladder carcinoma.
Comprehensive Transcriptomic Analysis Identifies ST8SIA1 as a Survival-Related Sialyltransferase Gene in Breast Cancer.
Computational analysis of fused co-expression networks for the identification of candidate cancer gene biomarkers.
Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma.
Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.
CORO6 Promotes Cell Growth and Invasion of Clear Cell Renal Cell Carcinoma via Activation of WNT Signaling.
Correlation between RNA-Seq and microarrays results using TCGA data.
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Cytoplasmic Pattern p53 Immunoexpression in Pelvic and Endometrial Carcinomas With TP53 Mutation Involving Nuclear Localization Domains: An Uncommon But Potential Diagnostic Pitfall With Clinical Implications.
da Vinci robotic partial nephrectomy for renal cell carcinoma: an atlas of the four-arm technique.
Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma.
Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma.
Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.
Deep-Hipo: Multi-scale receptive field deep learning for histopathological image analysis.
Delta-like ligand-Notch1 signalling is selectively modulated by HPV16 E6 to promote squamous cell proliferation and correlates with cervical cancer prognosis.
Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways.
Development and validation of an autophagy-related prognostic signature in esophageal cancer.
Development of a novel six-long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma.
Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.
Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Diagnostic model of combined ceRNA and DNA methylation related genes in esophageal carcinoma.
Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular Subtyping.
Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.
Differential expression analysis of clear cell renal cell carcinomas in THE CANCER GENOME ATLAS distinguishes an aggressive subset enriched with chromosome 7 and 12 gains.
Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.
Differential Interactome Proposes Subtype-Specific Biomarkers and Potential Therapeutics in Renal Cell Carcinomas.
Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma.
Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.
Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response.
Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.
Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.
DNA methylation of metallothionein genes is associated with the clinical features of renal cell carcinoma.
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.
DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins.
Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.
Dysregulation of the miRNA biogenesis components DICER1, DROSHA, DGCR8 and AGO2 in clear cell renal cell carcinoma in both a Korean cohort and the cancer genome atlas kidney clear cell carcinoma cohort.
EARN: an ensemble machine learning algorithm to predict driver genes in metastatic breast cancer.
Effect of FAM196B in human lung adenocarcinoma.
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).
Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.
Emerging Multimodality Approaches to Treat Localized Esophageal Cancer.
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.
Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types.
Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response.
ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.
ESR1-stabilizing lncRNA TMPO-AS1 promotes hormone-refractory breast cancer progression.
Estrogen receptor alpha (ER?/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Evaluation of somatic copy number estimation tools for whole-exome sequencing data.
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
Expression and clinical value of CD105 in renal cell carcinoma based on data mining in The Cancer Genome Atlas.
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Expression of lactate/H? symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence.
Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study.
Expression of p42.3 in non-small cell lung cancer.
Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.
Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Factor analysis for survival time prediction with informative censoring and diverse covariates.
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).
Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.
Fifteen-gene expression based model predicts the survival of clear cell renal cell carcinoma.
Five extracellular matrix-associated genes upregulated in oral tongue squamous cell carcinoma: An integrated bioinformatics analysis.
For robust big data analyses: a collection of 150 important pro-metastatic genes.
FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma.
Frequent KRAS Mutations in Oncocytic Papillary Renal Neoplasm with Inverted Nuclei.
G3BP1 may serve as a potential biomarker of proliferation, apoptosis, and prognosis in oral squamous cell carcinoma.
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature.
Gene expression patterns associated with tumor-infiltrating CD4+ and CD8+ T cells in invasive breast carcinomas.
Gene expression profile in oral squamous cell carcinoma: a pilot study.
Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway.
Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer.
Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Genetic alteration in notch pathway is associated with better prognosis in renal cell carcinoma.
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma.
Genetics: A molecular atlas of clear cell renal cell carcinoma.
Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-?.
Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes.
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.
Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
Genomics and clinical correlates of renal cell carcinoma.
GeTallele: A Method for Analysis of DNA and RNA Allele Frequency Distributions.
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
HAO2 inhibits malignancy of clear cell renal cell carcinoma by promoting lipid catabolic process.
HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas.
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients.
High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
High-affinity peptide ligand LXY30 for targeting ?3?1 integrin in non-small cell lung cancer.
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.
Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.
Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.
Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs.
HMGA2 and high-grade serous ovarian carcinoma.
Hormone Receptor-Status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape.
hsegHMM: hidden Markov model-based allele-specific copy number alteration analysis accounting for hypersegmentation.
Hypermethylation of the PTTG1IP promoter leads to low expression in early-stage non-small cell lung cancer.
Hypoxic stress suppresses lung tumor-secreted exosomal miR101 to activate macrophages and induce inflammation.
Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma.
Identification of 9-Core Immune-Related Genes in Bladder Urothelial Carcinoma Prognosis.
Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
Identification of a Four Hypoxia-Associated Long Non-Coding RNA Signature and Establishment of a Nomogram Predicting Prognosis of Clear Cell Renal Cell Carcinoma.
Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Identification of a Human Papillomavirus-Associated Oncogenic miRNA Panel in Human Oropharyngeal Squamous Cell Carcinoma Validated by Bioinformatics Analysis of The Cancer Genome Atlas.
Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
Identification of a six-gene signature associated with tumor mutation burden for predicting prognosis in patients with invasive breast carcinoma.
Identification of a universal 6-lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma.
Identification of an 11-Autophagy-Related-Gene Signature as Promising Prognostic Biomarker for Bladder Cancer Patients.
Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
Identification of an lncRNA?miRNA?mRNA interaction mechanism in breast cancer based on bioinformatic analysis.
Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis.
Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas.
Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.
Identification of Genetic and Epigenetic Variants Associated with Breast Cancer Prognosis by Integrative Bioinformatics Analysis.
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.
Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis.
Identification of key classification features of early cervical squamous cell carcinoma.
Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma.
Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.
Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules.
Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas.
Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
Identification of PGRMC1 as a Candidate Oncogene for Head and Neck Cancers and Its Involvement in Metabolic Activities.
Identification of Prognosis Associated microRNAs in HNSCC Subtypes Based on TCGA Dataset.
Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.
Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods.
Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.
Identification of topological features in renal tumor microenvironment associated with patient survival.
Identification SYT13 as a novel biomarker in lung adenocarcinoma.
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival.
Identifying molecular genetic features and oncogenic pathways of clear cell renal cell carcinoma through the anatomical (PADUA) scoring system.
Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer.
Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features.
Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment.
Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients.
Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development.
Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
Improving target volume delineation in intact cervical carcinoma: Literature review and step-by-step pictorial atlas to aid contouring.
In silico analysis of differential gene expressions in biliary stricture and hepatic carcinoma.
In silico analysis reveals a shared immune signature in CASP8-mutated carcinomas with varying correlations to prognosis.
Incorporating genetic networks into case-control association studies with high-dimensional DNA methylation data.
Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
Increased Expression of TICRR Predicts Poor Clinical Outcomes: A Potential Therapeutic Target for Papillary Renal Cell Carcinoma.
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Independent prognostic miRNAs for bladder urothelial carcinoma.
Inferring gene expression networks with hubs using a degree weighted Lasso approach.
Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.
Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.
Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Integrated analysis of the prognostic values of RNA-binding proteins in head and neck squamous cell carcinoma.
Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.
Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders.
Integrating omics data and protein interaction networks to prioritize driver genes in cancer.
Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma.
Integrative analysis of genetic and epigenetic profiling of lung squamous cell carcinoma (LSCC) patients to identify smoking level relevant biomarkers.
Integrative Analysis of Multi-Genomic Data for Kidney Renal Cell Carcinoma.
Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.
Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.
Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma.
Integrative omics analysis reveals effective stratification and potential prognosis markers of pan-gastrointestinal cancers.
Integrin ?1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells.
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
Interferon-?-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation.
Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma.
IPI59: An Actionable Biomarker to Improve Treatment Response in Serous Ovarian Carcinoma Patients.
Kidney cancer: Creating a molecular atlas of clear cell renal cell carcinoma genetics.
LAMC1 upregulation via TGF? induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-?B-CXCL1-STAT3.
Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder Affects Cell Functions.
LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis.
LncNetP, a systematical lncRNA prioritization approach based on ceRNA and disease phenotype association assumptions.
LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
LncRNA PCAT6: A potential biomarker for diagnosis and prognosis of bladder cancer.
Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer.
Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma.
Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1.
Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
Long non-coding RNAs as prognostic biomarkers in papillary renal cell carcinoma.
Long non-coding RNAs as prognostic markers in human breast cancer.
Long non?coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4.
Long noncoding RNA PVT1 inhibits renal cancer cell apoptosis by up-regulating Mcl-1.
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma.
Low microRNA150 expression is associated with activated carcinogenic pathways and a poor prognosis in patients with breast cancer.
LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype.
LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer.
LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining.
Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.
Matrisome-Associated Gene Expression Patterns Correlating with TIMP2 in Cancer.
Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
MCTS1 Directly Binds to TWF1 and Synergistically Modulate Cyclin D1 and C-Myc Translation in Luminal A/B Breast Cancer Cells.
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.
Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.
Methylation Signature Genes Identification of the Lung Squamous Cell Carcinoma Occurrence and Recognition Research.
Mex3a expression and survival analysis of bladder urothelial carcinoma.
MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma.
Mining TCGA database for screening and identification of hub genes in kidney renal clear cell carcinoma microenvironment.
Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.
miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1.
miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
miRNA-target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer.
MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension.
MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma.
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.
Molecular Genetics of Endometrial Carcinoma.
Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.
MUC1-C integrates activation of the IFN-? pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer.
Multimodal 3D DenseNet for IDH Genotype Prediction in Gliomas.
Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
Mutation or loss of p53 differentially modifies TGF? action in ovarian cancer.
Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma.
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
MYCT1 Inhibits the Adhesion and Migration of Laryngeal Cancer Cells Potentially Through Repressing Collagen VI.
NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
NEIL1 p.Gln282Stop variant is predominantly localized in the cytoplasm and exhibits reduced activity in suppressing mutations.
New and Emerging Biomarkers in Endocrine Pathology.
NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer.
NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype.
Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes.
Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling.
Non-coding RNAs profiling in head and neck cancers.
Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma.
Otoferlin is a prognostic biomarker in patients with clear cell renal cell carcinoma: A systematic expression analysis.
Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8.
Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma.
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patients.
Pan-cancer analysis of TCGA data reveals notable signaling pathways.
Para-aortic lymph node metastasis in lower Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy: a CT-based atlas and its clinical implications for Adjuvant Radiotherapy.
Parallel evolution of tumour subclones mimics diversity between tumours.
Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis.
Patterns of Transposable Element Expression and Insertion in Cancer.
PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer.
PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells: Differences Across Histologic and TCGA-based Molecular Subgroups.
PDGFR? Is a Novel Marker of Stromal Activation in Oral Squamous Cell Carcinomas.
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma.
PHENOTYPIC CHARACTERIZATION OF BREAST INVASIVE CARCINOMA VIA TRANSFERABLE TISSUE MORPHOMETRIC PATTERNS LEARNED FROM GLIOBLASTOMA MULTIFORME.
Phospho?STAT1 expression as a potential biomarker for anti?PD?1/anti?PD?L1 immunotherapy for breast cancer.
PI3KCA Mutations in Uterine Cervix Carcinoma.
PINCAGE: Probabilistic integration of cancer genomics data for perturbed gene identification and sample classification.
PON1 hypermethylation is associated with progression of renal cell carcinoma.
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features.
Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs.
Predictive modeling using a somatic mutational profile in ovarian high grade serous carcinoma.
Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma.
Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Profile of sphingolipid-related genes and its association with prognosis highlights sphingolipid metabolism in oral cancer.
Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array.
Prognostic alternative splicing signature in cervical squamous cell carcinoma.
Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Prognostic and immunomodulatory effects of PIM1 in colorectal carcinoma.
Prognostic gene signature identification using causal structure learning: applications in kidney cancer.
Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC).
Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
Prognostic significance of autophagy-related genes within esophageal carcinoma.
Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Prognostic value of long noncoding RNA urothelial carcinoma-associated 1 in esophageal carcinoma: A protocol for meta-analysis, TCGA data and bioinformatics analysis.
Prognostic Value of RNASEH2A-, CDK1-, and CD151-Related Pathway Gene Profiling for Kidney Cancers.
Protein tyrosine phosphatase, receptor type B is a potential biomarker and facilitates cervical cancer metastasis via epithelial-mesenchymal transition.
Proteomic analysis of colon and rectal carcinoma using standard and customized databases.
Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination.
PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC.
QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma.
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
Rapidly and Slowly Growing Lineages in Chromosomal Instability-Type Gland-Forming Gastric Carcinomas as Revealed by Multisampling Analysis of DNA Copy-Number Profile.
Re: Axitinib versus Placebo as an Adjuvant Treatment of Renal Cell Carcinoma: Results from the Phase III, Randomized ATLAS Trial.
Recent advances in genitourinary tumors: A review focused on biology and systemic treatment.
Reciprocal loop of hypoxia-inducible factor-1? (HIF-1?) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.
Reconstruction and analysis of circRNA?miRNA?mRNA network in the pathology of cervical cancer.
Regulation of breast tumorigenesis through acid sensors.
Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
Replisome genes regulation by antitumor miR-101-5p in clear cell renal cell carcinoma.
Research on circadian clock genes in non-small-cell lung carcinoma.
Revealing Biological Pathways Implicated in Lung Cancer from TCGA Gene Expression Data Using Gene Set Enrichment Analysis.
RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma.
RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes.
Robust identification of target genes and outliers in triple-negative breast cancer data.
Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.
Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma.
Screening and Identification of an Immune-Associated lncRNA Prognostic Signature in Ovarian Carcinoma: Evidence from Bioinformatic Analysis.
SEMA6D Expression and Patient Survival in Breast Invasive Carcinoma.
Semiparametric integrative interaction analysis for non-small-cell lung cancer.
Short-term RANKL exposure initiates a neoplastic transcriptional program in the basal epithelium of the murine salivary gland.
SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples.
Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine.
SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.
SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlas.
Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project.
Somatic mutations favorable to patient survival are predominant in ovarian carcinomas.
Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants.
SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer.
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/?-catenin pathway in cervical carcinoma cells.
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma.
Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis.
Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target.
SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Surgical atlas. Cone/wedge resection of renal cell carcinoma.
Surgical atlas. Surgical management of penile carcinoma: the inguinal nodes.
Survival analysis for long noncoding RNAs identifies TP53TG1 as an antioncogenic target for the breast cancer.
Survival-associated alternative splicing signatures in esophageal carcinoma.
Synthesis of diagnostic quality cancer pathology images by generative adversarial networks.
Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma.
Systematic profiling identifies PDLIM2 as a novel prognostic predictor for oesophageal squamous cell carcinoma (ESCC).
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1.
TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1.
TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma.
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
The Case for a Pre-Cancer Genome Atlas (PCGA).
The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3? pathway in non-small cell lung cancer.
The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
The construction and analysis of competitive endogenous RNA (ceRNA) networks in metastatic renal cell carcinoma: a study based on The Cancer Genome Atlas.
The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas.
The Early Diagnostic and Prognostic Value of BIRC5 in Clear-Cell Renal Cell Carcinoma Based on the Cancer Genome Atlas Data.
The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future.
The evolving genomic landscape in urothelial cancer.
The evolving genomic landscape of urothelial carcinoma.
The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples.
The Impact of Normalization Approaches to Automatically Detect Radiogenomic Phenotypes Characterizing Breast Cancer Receptors Status.
The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis.
The long non-coding RNA LINC00460 predicts the prognosis and promotes the proliferation and migration of cells in bladder urothelial carcinoma.
The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma.
The management of localized esophageal squamous cell carcinoma: Western approach.
The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
The Molecular Biologic Basis of Esophageal and Gastric Cancers.
The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.
The Molecular Taxonomy of Primary Prostate Cancer.
The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2.
The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma.
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer.
The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
The prognostic values of matrix metalloproteinases in ovarian cancer.
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers.
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas.
Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial-Mesenchymal Transition.
Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort.
Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Transcriptome analysis reveals the effect of oral contraceptive use on cervical cancer.
Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer.
Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients' survival.
TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
TRIM65 negatively regulates p53 through ubiquitination.
Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance.
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy.
Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
Tumors masquerading as type 2 papillary renal cell carcinoma: pathologists' ever-expanding differential diagnosis for a heterogeneous group of entities.
Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.
Unsupervised Resolution of Histomorphologic Heterogeneity in Renal Cell Carcinoma Using a Brain Tumor-Educated Neural Network.
Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Upregulated long-non-coding RNA DLEU2 exon 9 expression was an independent indicator of unfavorable overall survival in patients with esophageal adenocarcinoma.
Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma.
UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells.
Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.
WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-?B activation.
Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the Cancer Genome Atlas database.
Where cancer genomics should go next: a clinician's perspective.
Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas.
Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma.
Whole-transcriptome sequencing identified gene expression signatures associated with aggressive clear cell renal cell carcinoma.
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma.
[Data mining of esophageal squamous cell carcinoma from The Cancer Genome Atlas database].
[Expression and Clinical Significance of Late Endosomal/Lysosomal Adaptor,Mitogen-activated Protein Kinase and Mammalian Target of Rapamycin Activator 3 in Bladder Carcinoma].
[Implications of TCGA Network Data on 2nd Generation Immunotherapy Concepts Based on PD-L1 and PD-1 Target Structures].
[In situ carcinoma; considerations on Hinselmann's 32 theories and Mestwerdt's Atlas of colposcopy.]
[In situ carcinoma; considerations on Hinselmann's 32 theories and on Mestwerdt's Atlas of colposcopy.]
[Study on the Difference of Gene Expression between Central and Peripheral Lung Squamous Cell Carcinoma Based on TCGA Database].
Carcinoma, Acinar Cell
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
Carcinoma, Ductal
Bioinformatic Exploration for Prognostic Significance of Sphingolipid Metabolism-Related Genes in Invasive Ductal Carcinoma Using the Cancer Genome Atlas Cohort.
Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.
DNASE1L2, as a Carcinogenic Marker, Affects the Phenotype of Breast Cancer Cells Via Regulating Epithelial-Mesenchymal Transition Process.
Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.
Similarities and Differences in Gene Expression Networks Between the Breast Cancer Cell Line Michigan Cancer Foundation-7 and Invasive Human Breast Cancer Tissues.
SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma.
Carcinoma, Endometrioid
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.
DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Glucose-regulated protein 94 deficiency induces squamous cell metaplasia and suppresses PTEN-null driven endometrial epithelial tumor development.
The genetic landscape of endometrial clear cell carcinomas.
Carcinoma, Hepatocellular
A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
A human liver cell atlas reveals heterogeneity and epithelial progenitors.
A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma.
A micro-RNA expression signature for human NAFLD progression.
A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
A Primer on a Hepatocellular Carcinoma Bioresource Bank Using the Cancer Genome Atlas Guidelines: Practical Issues and Pitfalls.
A prognostic model composed of four long noncoding RNAs predicts the overall survival of Asian patients with hepatocellular carcinoma.
A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma.
A qRT-PCR and Gene Functional Enrichment Study Focused on Downregulation of miR-141-3p in Hepatocellular Carcinoma and Its Clinicopathological Significance.
A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
An ancestry informative marker panel design for individual ancestry estimation of Hispanic population using whole exome sequencing data.
Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival.
Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma.
Analysis of the cancer genome atlas data to determine the correlation between PROX1 and TERT in hepatocellular carcinoma.
Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.
Association between the CYP11 family and six cancer types.
AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Bioinformatic analysis of the prognostic value of the lncRNAs encoding snoRNAs in hepatocellular carcinoma.
Bioinformatics analysis of the interactions among lncRNA, miRNA and mRNA expression, genetic mutations and epigenetic modifications in hepatocellular carcinoma.
CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
Characterization of Hepatocellular Carcinoma Cell Lines Using a Fractionation-Then-Sequencing Approach Reveals Nuclear-Enriched HCC-Associated lncRNAs.
Cinobufagin Triggers Defects in Spindle Formation and Cap-Dependent Translation in Liver Cancer Cells by Inhibiting the AURKA-mTOR-eIF4E Axis.
Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma.
Clinical significance of APOB inactivation in hepatocellular carcinoma.
Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.
Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.
Computational analysis of fused co-expression networks for the identification of candidate cancer gene biomarkers.
Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NF?B pathway in hepatocellular carcinoma.
Data mining of the expression and regulatory role of BCAT1 in hepatocellular carcinoma.
Decreased expression of ARID1A invasively downregulates the expression of ribosomal proteins in hepatocellular carcinoma.
Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma.
Development and External Validation of a Novel Immune Checkpoint-Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma.
Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma.
Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas.
Disturbed mitochondrial acetylation in accordance with the availability of acetyl groups in hepatocellular carcinoma.
DNA methylation changes involved in the tumor increase in F2 males born to gestationally arsenite-exposed F1 male mice.
DPM1 expression as a potential prognostic tumor marker in hepatocellular carcinoma.
Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2.
EGFRvIII-specific CAR-T cells produced by piggyBac transposon exhibit efficient growth suppression against hepatocellular carcinoma.
Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.
EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database.
Examination of Independent Prognostic Power of Gene Expressions and Histopathological Imaging Features in Cancer.
Exploring the Role of Endoplasmic Reticulum Stress in Hepatocellular Carcinoma through mining of the Human Protein Atlas.
Expression and gene regulation network of RBM8A in hepatocellular carcinoma based on data mining.
Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.
Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.
Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma.
Expression of yhwaz and gene regulation network in hepatocellular carcinoma.
Extracellular matrix transcriptome dynamics in hepatocellular carcinoma.
For robust big data analyses: a collection of 150 important pro-metastatic genes.
Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma.
Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
Gene expression profiles of hepatoma cell line BEL-7402.
Gene expression profiles of hepatoma cell line HLE.
Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters.
Genetic Alterations and Transcriptional Expression of m6A RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma.
Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
Genomic Identification of RNA Editing Through Integrating Omics Datasets and the Clinical Relevance in Hepatocellular Carcinoma.
Gestational arsenite exposure augments hepatic tumors of C3H mice by promoting senescence in F1 and F2 offspring via different pathways.
Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma.
HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas.
High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma.
High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma.
High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma.
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy.
High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
Higher variety and quantity of microRNA-139-5p isoforms confer suppressive role in hepatocellular carcinoma.
Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression.
Hypermethylation of the PZP gene is associated with hepatocellular carcinoma cell proliferation, invasion and migration.
Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
Identification of a Novel Epithelial-to-Mesenchymal-related Gene Signature in Predicting Survival of Patients with Hepatocellular Carcinoma.
Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis.
Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma.
Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses.
Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile.
Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
Identification of LINC01615 as potential metastasis-related long noncoding RNA in hepatocellular carcinoma.
Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.
Identification of Methylation-Regulated Differentially Expressed Genes and Related Pathways in Hepatocellular Carcinoma: A Study Based on TCGA Database and Bioinformatics Analysis.
Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
Identification of modules and novel prognostic biomarkers in liver cancer through integrated bioinformatics analysis.
Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma.
Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma.
Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma.
Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma.
Integrated analysis of hypoxia-induced miR-210 signature as a potential prognostic biomarker of hepatocellular carcinoma: a study based on The Cancer Genome Atlas.
Integration of miRNA-regulatory networks in hepatic stellate cells identifies TIMP3 as a key factor in chronic liver disease.
Integrin gene expression profiles of human hepatocellular carcinoma.
Iron metabolism gene expression and prognostic features of hepatocellular carcinoma.
Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness.
Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis.
LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas.
LncRNA ROR1?AS1 high expression and its prognostic significance in liver cancer.
Long Noncoding RNA LINC01134 Promotes Hepatocellular Carcinoma Metastasis via Activating AKT1S1 and NF-?B Signaling.
Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma.
MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Mir-1287 suppresses the proliferation, invasion, and migration in hepatocellular carcinoma by targeting PIK3R3.
miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.
miR-3677-5p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with prognosis.
miRNA-mRNA Regulatory Network and Factors Associated with Prediction of Prognosis in Hepatocellular Carcinoma.
Mitochondrial Respiratory Defect Enhances Hepatoma Cell Invasiveness via STAT3/NFE2L1/STX12 Axis.
Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.
Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma.
Molecular characterization of long-term survivors of hepatocellular carcinoma.
MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma.
NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals.
OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma.
Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-?B signaling in hepatocellular carcinoma.
Paradoxical effects of cellular senescence-inhibited gene involved in hepatocellular carcinoma migration and proliferation by ERK pathway and mesenchymal-like markers.
PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.
Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.
Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Prognostic and immunological potential of PPM1G in hepatocellular carcinoma.
Prognostic implications of aberrantly expressed methylation?driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma.
Prognostic value of carbonic anhydrase XII (CA XII) overexpression in hepatocellular carcinoma.
Prognostic Value of Phosphotyrosine Phosphatases in Hepatocellular Carcinoma.
Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice.
Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase: search for the enzyme's repressor derived from mevalonate.
Regulation of UDP-Glucuronosyltransferases UGT2B4 and UGT2B7 by MicroRNAs in Liver Cancer Cells.
Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways.
Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
Signatures of gene expression, DNA methylation and microRNAs of hepatocellular carcinoma with vascular invasion.
Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
STAT3-induced upregulation of lncRNA CASC11 promotes the cell migration, invasion and epithelial-mesenchymal transition in hepatocellular carcinoma by epigenetically silencing PTEN and activating PI3K/AKT signaling pathway.
Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
Systemic Expression Analysis Reveals Prognostic Significance of WIPI3 in Hepatocellular Carcinoma.
T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma.
Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.
TGF?1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.
The Cancer Genome Atlas (TCGA) based m6A methylation-related genes predict prognosis in hepatocellular carcinoma.
The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma.
TMEM206 is a potential prognostic marker of hepatocellular carcinoma.
TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma.
Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.
Transcriptomic analysis links hepatocellular carcinoma (HCC) in HZE ion irradiated mice to a human HCC subtype with favorable outcomes.
Transcriptomic and Proteomic Analysis of Steatohepatitic Hepatocellular Carcinoma Reveals Novel Distinct Biologic Features.
Transforming Growth Factor Beta Promotes Liver Tumorigenesis in Mice via Upregulation of Snail.
Tribbles pseudokinase 3 (TRIB3) contributes to the progression of hepatocellular carcinoma by activating the mitogen-activated protein kinase pathway.
Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma.
UCK2 upregulation might serve as an indicator of unfavorable prognosis of hepatocellular carcinoma.
Uncovering the potential differentially expressed miRNAs as diagnostic biomarkers for hepatocellular carcinoma based on machine learning in The Cancer Genome Atlas database.
Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein.
ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells.
[Exploring of a prognostic long non-coding RNA signature of hepatocellular carcinoma by using public database].
[Integrated analysis of DNA methylation and gene expression profiles of hepatocellular carcinoma to construct miR-1180-3p relevant ceRNA regulatory network].
[Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].
Carcinoma, Intraductal, Noninfiltrating
Characteristics of ultrasonographic images of ductal carcinoma in situ with abnormalities of the ducts.
SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma.
Carcinoma, Medullary
Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.
Carcinoma, Non-Small-Cell Lung
A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells.
Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer.
Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis.
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR.
Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.
Comparison between atlas and convolutional neural network based automatic segmentation of multiple organs at risk in non-small cell lung cancer.
Concise genetic profile of lung carcinoma.
Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning.
Erlotinib as maintenance therapy in patients with advanced non-small cell lung cancer: a pooled analysis of three randomized trials.
Expression and prognostic value of E2F3 transcription factor in non-small cell lung cancer.
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1? levels under hypoxia.
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Long Noncoding RNA SNHG10 Sponges miR-543 to Upregulate Tumor Suppressive SIRT1 in Nonsmall Cell Lung Cancer.
Mining and validating the expression pattern and prognostic value of acetylcholine receptors in non-small cell lung cancer.
Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets.
Mutant-allele fraction heterogeneity is associated with non-small cell lung cancer patient survival.
Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling.
PHLPP2 as a novel metastatic and prognostic biomarker in non-small cell lung cancer patients.
Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data.
Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer.
pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.
Semiparametric integrative interaction analysis for non-small-cell lung cancer.
Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1.
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy.
Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
Survival analysis and functional annotation of long non-coding RNAs in lung adenocarcinoma.
The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death.
The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy.
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
TRIM65 negatively regulates p53 through ubiquitination.
Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
[Metastasis of non-small cell lung cancer to the atlas]
Carcinoma, Ovarian Epithelial
A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer.
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response.
MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis.
Nuclear envelope structural defect underlies the main cause of aneuploidy in ovarian carcinogenesis.
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.
Carcinoma, Papillary
Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.
Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network.
Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.
Carcinoma, Renal Cell
53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database.
A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis.
A Bayesian integrative approach for multi-platform genomic data: A kidney cancer case study.
A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.
A hidden Markov modeling approach for identifying tumor subclones in next-generation sequencing studies.
A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.
A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome.
A tale of two cancers: Complete genetic analysis of chromophobe renal cell carcinoma contrasts with clear cell renal cell carcinoma.
Adjuvant therapy for high-risk renal cell carcinoma after nephrectomy how many trials are positive? Only one or more than one.
Agonistic CD40 Antibodies in Cancer Treatment.
An Immune Atlas of Clear Cell Renal Cell Carcinoma.
An improved clear cell renal cell carcinoma stage prediction model based on gene sets.
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.
Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.
Assessment of Renal Cell Carcinoma by Texture Analysis in Clinical Practice: A Six-Site, Six-Platform Analysis of Reliability.
ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups.
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial.
BAP1 is Overexpressed in Black Compared with White patients with Mx-M1 Clear Cell Renal Cell Carcinoma: A report from the Cancer Genome Atlas.
Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining.
Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
Comprehensive analysis of competing endogenous RNA network and 3-mRNA signature predicting survival in papillary renal cell cancer.
Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma.
Comprehensive Analysis of the ATP-binding Cassette Subfamily B Across Renal Cancers Identifies ABCB8 Overexpression in Phenotypically Aggressive Clear Cell Renal Cell Carcinoma.
Comprehensive characterization of tumor mutation burden in clear cell renal cell carcinoma based on the three independent cohorts.
da Vinci robotic partial nephrectomy for renal cell carcinoma: an atlas of the four-arm technique.
Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer.
Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma.
Differential expression analysis of clear cell renal cell carcinomas in THE CANCER GENOME ATLAS distinguishes an aggressive subset enriched with chromosome 7 and 12 gains.
Differential Interactome Proposes Subtype-Specific Biomarkers and Potential Therapeutics in Renal Cell Carcinomas.
Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma.
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.
DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
Dysregulation of the miRNA biogenesis components DICER1, DROSHA, DGCR8 and AGO2 in clear cell renal cell carcinoma in both a Korean cohort and the cancer genome atlas kidney clear cell carcinoma cohort.
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.
Expression and clinical value of CD105 in renal cell carcinoma based on data mining in The Cancer Genome Atlas.
Expression of lactate/H? symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Fifteen-gene expression based model predicts the survival of clear cell renal cell carcinoma.
For robust big data analyses: a collection of 150 important pro-metastatic genes.
FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
Frequent KRAS Mutations in Oncocytic Papillary Renal Neoplasm with Inverted Nuclei.
Genetics: A molecular atlas of clear cell renal cell carcinoma.
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
Genomics and clinical correlates of renal cell carcinoma.
hsegHMM: hidden Markov model-based allele-specific copy number alteration analysis accounting for hypersegmentation.
Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis.
Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas.
Identification of topological features in renal tumor microenvironment associated with patient survival.
Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival.
Identifying molecular genetic features and oncogenic pathways of clear cell renal cell carcinoma through the anatomical (PADUA) scoring system.
Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features.
Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.
Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.
Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma.
Integrative Analysis of Multi-Genomic Data for Kidney Renal Cell Carcinoma.
Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.
Kidney cancer: Creating a molecular atlas of clear cell renal cell carcinoma genetics.
LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis.
LncNetP, a systematical lncRNA prioritization approach based on ceRNA and disease phenotype association assumptions.
Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma.
Long non-coding RNAs as prognostic biomarkers in papillary renal cell carcinoma.
Long noncoding RNA PVT1 inhibits renal cancer cell apoptosis by up-regulating Mcl-1.
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.
Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma.
Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining.
miRNA-target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer.
Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
Nonsense-mediated decay factor SMG7 sensitizes cells to TNF?-induced apoptosis via CYLD tumor suppressor and the noncoding oncogene Pvt1.
Nuclear and stromal expression of Manic fringe in renal cell carcinoma.
Otoferlin is a prognostic biomarker in patients with clear cell renal cell carcinoma: A systematic expression analysis.
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Parallel evolution of tumour subclones mimics diversity between tumours.
Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis.
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma.
PON1 hypermethylation is associated with progression of renal cell carcinoma.
Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Prognostic gene signature identification using causal structure learning: applications in kidney cancer.
Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC).
Prognostic Value of RNASEH2A-, CDK1-, and CD151-Related Pathway Gene Profiling for Kidney Cancers.
Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma.
Re: Axitinib versus Placebo as an Adjuvant Treatment of Renal Cell Carcinoma: Results from the Phase III, Randomized ATLAS Trial.
Recent advances in genitourinary tumors: A review focused on biology and systemic treatment.
Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
Replisome genes regulation by antitumor miR-101-5p in clear cell renal cell carcinoma.
RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes.
Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma.
SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.
Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target.
Surgical atlas. Cone/wedge resection of renal cell carcinoma.
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
The construction and analysis of competitive endogenous RNA (ceRNA) networks in metastatic renal cell carcinoma: a study based on The Cancer Genome Atlas.
The Early Diagnostic and Prognostic Value of BIRC5 in Clear-Cell Renal Cell Carcinoma Based on the Cancer Genome Atlas Data.
The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples.
The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma.
The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma.
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
Tumors masquerading as type 2 papillary renal cell carcinoma: pathologists' ever-expanding differential diagnosis for a heterogeneous group of entities.
Unsupervised Resolution of Histomorphologic Heterogeneity in Renal Cell Carcinoma Using a Brain Tumor-Educated Neural Network.
UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells.
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.
[Implications of TCGA Network Data on 2nd Generation Immunotherapy Concepts Based on PD-L1 and PD-1 Target Structures].
Carcinoma, Small Cell
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.
Carcinoma, Squamous Cell
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
?Np63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival.
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
A panel of Transcription factors identified by data mining can predict the prognosis of head and neck squamous cell carcinoma.
A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
A seven long-noncoding RNA signature predicts prognosis of lung squamous cell carcinoma.
A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma.
A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma.
A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications.
ADH7, miR-3065 and LINC01133 are associated with cervical cancer progression in different age groups.
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma.
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.
An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases.
Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma.
Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET.
Association between the CYP11 family and six cancer types.
Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.
Association of LINC00673 Genetic Variants with Progression of Oral Cancer.
Associations between proteasomal activator PA28? and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
Atlas-based delineation of lymph node levels in head and neck computed tomography images.
Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Cilia gene expression patterns in cancer.
Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.
Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma.
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA.
Comprehensive analysis of prognostic alternative splicing signature in cervical cancer.
Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma.
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Comprehensive genomic characterization of squamous cell lung cancers.
Correlation between RNA-Seq and microarrays results using TCGA data.
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways.
Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5'-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients.
Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.
Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.
Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.
Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.
Elevated KLF7 levels may serve as a prognostic signature and might contribute to progression of squamous carcinoma.
Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Expression of p42.3 in non-small cell lung cancer.
Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Factor analysis for survival time prediction with informative censoring and diverse covariates.
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).
Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.
Five extracellular matrix-associated genes upregulated in oral tongue squamous cell carcinoma: An integrated bioinformatics analysis.
FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma.
Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma.
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas.
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
High-affinity peptide ligand LXY30 for targeting ?3?1 integrin in non-small cell lung cancer.
HSD17B4, ACAA1, and PXMP4 in Peroxisome Pathway Are Down-Regulated and Have Clinical Significance in Non-small Cell Lung Cancer.
HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
Hypermethylation of the PTTG1IP promoter leads to low expression in early-stage non-small cell lung cancer.
Hypoxia-related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD-L1 squamous and adenocarcinoma NSCLC.
Hypoxic stress suppresses lung tumor-secreted exosomal miR101 to activate macrophages and induce inflammation.
Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.
Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis.
Identification of key classification features of early cervical squamous cell carcinoma.
Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.
Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules.
Identification of PGRMC1 as a Candidate Oncogene for Head and Neck Cancers and Its Involvement in Metabolic Activities.
Identification of Prognosis Associated microRNAs in HNSCC Subtypes Based on TCGA Dataset.
Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.
Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods.
Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.
Identification SYT13 as a novel biomarker in lung adenocarcinoma.
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer.
Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients.
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Integrated analysis of the prognostic values of RNA-binding proteins in head and neck squamous cell carcinoma.
Integrating omics data and protein interaction networks to prioritize driver genes in cancer.
Integrative analysis of genetic and epigenetic profiling of lung squamous cell carcinoma (LSCC) patients to identify smoking level relevant biomarkers.
Integrative genome-scale analysis of immune infiltration in esophageal carcinoma.
Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Long noncoding RNA HOXC13-AS positively affects cell proliferation and invasion in nasopharyngeal carcinoma via modulating miR-383-3p/HMGA2 axis.
LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer.
Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.
Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.
Methylation Signature Genes Identification of the Lung Squamous Cell Carcinoma Occurrence and Recognition Research.
miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma.
MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma.
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
MYCT1 Inhibits the Adhesion and Migration of Laryngeal Cancer Cells Potentially Through Repressing Collagen VI.
Non-coding RNAs profiling in head and neck cancers.
Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Pan-cancer analysis of TCGA data reveals notable signaling pathways.
Patterns of Transposable Element Expression and Insertion in Cancer.
PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer.
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features.
Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs.
Profile of sphingolipid-related genes and its association with prognosis highlights sphingolipid metabolism in oral cancer.
Prognostic alternative splicing signature in cervical squamous cell carcinoma.
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Protein tyrosine phosphatase, receptor type B is a potential biomarker and facilitates cervical cancer metastasis via epithelial-mesenchymal transition.
QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
Reconstruction and analysis of circRNA?miRNA?mRNA network in the pathology of cervical cancer.
Research on circadian clock genes in non-small-cell lung carcinoma.
Revealing Biological Pathways Implicated in Lung Cancer from TCGA Gene Expression Data Using Gene Set Enrichment Analysis.
Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.
Short-term RANKL exposure initiates a neoplastic transcriptional program in the basal epithelium of the murine salivary gland.
SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples.
Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine.
SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlas.
Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants.
SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.
TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1.
TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma.
The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3? pathway in non-small cell lung cancer.
The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
The management of localized esophageal squamous cell carcinoma: Western approach.
The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer.
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers.
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas.
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort.
Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer.
TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance.
Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the Cancer Genome Atlas database.
Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.
Where cancer genomics should go next: a clinician's perspective.
Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas.
[Study on the Difference of Gene Expression between Central and Peripheral Lung Squamous Cell Carcinoma Based on TCGA Database].
Carcinosarcoma
Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.
RNA-seq Identification of RACGAP1 as a Metastatic Driver in Uterine Carcinosarcoma.
The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
Cardiomyopathies
Ontological labels for automated location of anatomical shape differences.
Cardiomyopathy, Dilated
Atlas of the clinical genetics of human dilated cardiomyopathy.
Regional Multi-view Learning for Cardiac Motion Analysis: Application to Identification of Dilated Cardiomyopathy Patients.
Cardiomyopathy, Hypertrophic
Construction of a 4D statistical atlas of the cardiac anatomy and its use in classification.
Segmentation of 4D cardiac MR images using a probabilistic atlas and the EM algorithm.
Shocking truths about implantable cardioverter defibrillator monitoring zones.
Cardiotoxicity
Development and Validation of a Heart Atlas To Study Cardiac Exposure to Radiation Following Treatment for Breast Cancer.
Cardiovascular Diseases
1990-2010 global cardiovascular disease atlas.
A multimodal spatiotemporal cardiac motion atlas from MR and ultrasound data.
ATLAS OF CARDIOVASCULAR DISEASES.
Atlas of Cardiovascular Diseases.
Cardiovascular disease risk factors and preventive practices among adults--United States, 1994: a behavioral risk factor atlas. Behavioral Risk Factor Surveillance System State Coordinators.
Cardiovascular disease statistics from the European atlas: inequalities between high- and middle-income member countries of the ESC.
Epidemiology of cardiovascular disease: the new ESC Atlas and beyond.
European Society of Cardiology: Cardiovascular Disease Statistics 2017.
European Society of Cardiology: Cardiovascular Disease Statistics 2019.
Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control.
Introducing the Canadian Women's Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Diseases in Women.
Main Therapeutic Uses of Some Moroccan Hot Springs' Waters.
Stakeholder engagement for the New Zealand Atlas of Healthcare Variation: cardiovascular disease secondary prevention: VIEW-3.
The Canadian Women's Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women-Chapter 2: Scope of the Problem.
The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women-Chapter 3: Patient Perspectives.
Carotid Artery Injuries
Anatomic relationship of the internal carotid artery to the C1 vertebra: A case report of cervical reconstruction for chordoma and pilot study to assess the risk of screw fixation of the atlas.
Carotid Stenosis
Measuring cerebrovascular reactivity: the dynamic response to a step hypercapnic stimulus.
Carotid-Cavernous Sinus Fistula
Experiences with intraluminal occlusion with the Fogarty catheter in the treatment of carotid-cavernous sinus fistulas and other lesions at the base of the skull.
Cataract
Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome.
Congenital cataract with LSS gene mutations: a new case report.
Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor.
Functional polymorphisms of the Lss and Fdft1 genes in laboratory rats.
Identification of Differential Gene Expression Pattern in Lens Epithelial Cells Derived from Cataractous and Noncataractous Lenses of Shumiya Cataract Rat.
Lanosterol synthase mutations cause cholesterol deficiency-associated cataracts in the Shumiya cataract rat.
Lanosterol Synthase Pathway Alleviates Lens Opacity in Age-Related Cortical Cataract.
Stereotaxic atlas of the brain of Octodon degus.
Two cases of severe congenital hypotrichosis caused by compound heterozygous mutations in the LSS gene.
Central Nervous System Diseases
Current Status of Tissue Clearing and the Path Forward in Neuroscience.
Central Serous Chorioretinopathy
CHORIORETINAL FOLDS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY.
Cerebral Cortical Thinning
Cellular correlates of cortical thinning throughout the lifespan.
Cortical thickness and gyrification index measuring cognition in Parkinson's disease.
CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults.
Cerebral Hemorrhage
[Neuroprotective effect of batroxobin on experimental intracerebral hemorrhage in rats]
[Protective effect of procyanidins on experimental rats with intracerebral hemorrhage]
Cerebral Infarction
Regional cerebral blood flow changes in stroke imaged by Tc-99m HMPAO SPECT with corresponding anatomic image comparison.
Supratentorial Cerebral Arterial Territories for Computed Tomograms: A Mapping Study in 1160 Large Artery Infarcts.
[A case of cerebral infarction in young adult resulting in thrombotic occlusion of vertebral artery due to repeated contact stimulation of cervical rotation accompanied to systemic malformations such as atlantoaxial subluxation and atlas dysplasia].
Cerebral Palsy
Atlantoaxial rotatory subluxation, congenital absence of the posterior arch of the atlas, and cerebral palsy: an unusual triad.
Quantitative analysis of brain pathology based on MRI and brain atlases-Applications for cerebral palsy.
Cerebrospinal Fluid Leak
[Syringomyelia as a rare cause of respiratory insufficiency requiring ventilation]
Cerebrovascular Disorders
A Colour Atlas of Stroke: Cerebrovascular Disease and its Management.
Computational atlases of severity of white matter lesions in elderly subjects with MRI.
Probabilistic anatomic mapping of cerebral blood flow distribution of the middle cerebral artery.
Chagas Disease
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae.
Atlas of Mexican Triatominae (Reduviidae: Hemiptera) and vector transmission of Chagas disease.
Chediak-Higashi Syndrome
Images from the Haematologica atlas of hematologic cytology: Chediak-Higashi syndrome.
Cholangiocarcinoma
A Novel NIPBL-NACC1 Gene Fusion is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma.
A novel three?miRNA signature predicts survival in cholangiocarcinoma based on RNA?Seq data.
BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma.
Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.
Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data.
EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.
Identification of Mutator-Derived Alternative Splicing Signatures of Genomic Instability for Improving the Clinical Outcome of Cholangiocarcinoma.
Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients.
Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma.
Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
TESC Promotes TGF-?/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma.
The role of bile acid subtypes in the diagnosis of cholangiocarcinoma.
The role of miR-92b in cholangiocarcinoma patients.
Upregulation of miR?132?3p in cholangiocarcinoma tissues: A study based on RT?qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses.
Cholangitis, Sclerosing
Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis.
Cholelithiasis
Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse.
Chondrocalcinosis
Acute neck pain and fever as the first manifestation of chondrocalcinosis with calcification of the transverse ligament of the atlas. Five case-reports with a literature review.
Age-Related Prevalence of Periodontoid Calcification and Its Associations with Acute Cervical Pain.
Calcification of the transverse ligament of the atlas in chondrocalcinosis.
Calcification of the transverse ligament of the atlas in chondrocalcinosis: computed tomography study.
Calcium pyrophosphate dihydrate deposition in the transverse ligament of the atlas: an unusual cause of cervical myelopathy.
Characterisation of size and direction of osteophyte in knee osteoarthritis: a radiographic study.
The crowned dens syndrome. Evaluation with CT imaging.
[Calcium pyrophosphate dihydrate deposition disease in the transverse ligament of the atlas]
Chondroma
Isolated enchondroma of atlas.
Isolated enchondroma of the atlas.
Transoral-transpharyngeal approach to the anterior craniocervical junction. Ten-year experience with 72 patients.
Chondrosarcoma
Gene expression profiles in chondrosarcoma cells subjected to cyclic stretching and hydrostatic pressure. A cDNA array study.
[Surgical treatment of head and neck chondrosarcomas.]
Chordoma
Anatomic relationship of the internal carotid artery to the C1 vertebra: A case report of cervical reconstruction for chordoma and pilot study to assess the risk of screw fixation of the atlas.
Chordoma of the atlas.
Craniovertebral junction neoplasms in the pediatric population.
Transnasal Endoscopic Biopsy Approach to Atlas Tumor with X-ray Assisted and Related Radiographic Measure.
Transoral-transpharyngeal approach to the anterior craniocervical junction. Ten-year experience with 72 patients.
Choriocarcinoma
Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo.
Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
Cleft Lip
Another "new" form, the palagonia type of acrofacial dysostosis in a Sicilian family.
Clostridium Infections
Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico.
Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients.
Evaluation of a bedside scoring system for predicting clinical cure and recurrence of Clostridium difficile infections.
Coinfection
The origins and relatedness structure of mixed infections vary with local prevalence of P. falciparum malaria.
Colitis, Ulcerative
Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis.
Single-cell atlas of colonic CD8+ T cells in ulcerative colitis.
Colonic Neoplasms
A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
A 65?gene signature for prognostic prediction in colon adenocarcinoma.
A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers.
A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
A machine learning-based prognostic predictor for stage III colon cancer.
A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
A network view of microRNA and gene interactions in different pathological stages of colon cancer.
Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Aldolase B impairs DNA mismatch repair and induces apoptosis in colon adenocarcinoma.
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.
An immune-related model based on INHBA, JAG2 and CCL19 to predict the prognoses of colon cancer patients.
An Integrated Approach for Identifying Molecular Subtypes in Human Colon Cancer Using Gene Expression Data.
An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
An Integrated Pan-Cancer Analysis and Structure-Based Virtual Screening of GPR15.
Analysis of multi-omics differences in left-side and right-side colon cancer.
Analysis of risk factors for colon cancer progression.
Analysis of the Circadian Regulation of Cancer Hallmarks by a Cross-Platform Study of Colorectal Cancer Time-Series Data Reveals an Association with Genes Involved in Huntington's Disease.
Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
Analysis of the role of the interleukins in colon cancer.
Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells.
Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-?B/Snail signaling pathway.
Association analysis using somatic mutations.
Association between the CYP11 family and six cancer types.
Automated classification of protein subcellular localization in immunohistochemistry images to reveal biomarkers in colon cancer.
Bcl9 Depletion Modulates Endothelial Cell in Tumor Immune Microenvironment in Colorectal Cancer Tumor.
Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal cancer.
BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer.
Bringing Structural Implications and Deep Learning-Based Drug Identification for KRAS Mutants.
c-Myc directly targets an over-expression of pyruvate carboxylase in highly invasive breast cancer.
CD80 expression is upregulated by TP53 activation in human cancer epithelial cells.
Chromosomal Density of Cancer Up-Regulated Genes, Aberrant Enhancer Activity and Cancer Fitness Genes Are Associated with Transcriptional Cis-Effects of Broad Copy Number Gains in Colorectal Cancer.
Cilia gene expression patterns in cancer.
Classification of Colon Cancer Patients Based on the Methylation Patterns of Promoters.
Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis.
Clinical Significance and Prognostic Value of miR-28-5p in Colon Cancer.
CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
Colon cancer combined with obesity indicates improved survival- research on relevant mechanism.
Colon Cancer Tumor Location Defined by Gene Expression May Disagree With Anatomic Tumor Location.
Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma.
Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis.
Comprehensive Analysis of Cyclin Family Gene Expression in Colon Cancer.
Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.
Construction and validation of a metabolic risk model predicting prognosis of colon cancer.
Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer.
Controlling for cellular heterogeneity using single-cell deconvolution of gene expression reveals novel markers of colorectal tumors exhibiting microsatellite instability.
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Decreased Tumoral Expression of Colon-Specific Water Channel Aquaporin 8 Is Associated With Reduced Overall Survival in Colon Adenocarcinoma.
Deep Convolutional Neural Network-Based Lymph Node Metastasis Prediction for Colon Cancer Using Histopathological Images.
Deep Learning With Sampling in Colon Cancer Histology.
Deep learning-based tumor microenvironment analysis in colon adenocarcinoma histopathological whole-slide images.
Deep-Hipo: Multi-scale receptive field deep learning for histopathological image analysis.
Detecting Prognosis Risk Biomarkers for Colon Cancer Through Multi-Omics-Based Prognostic Analysis and Target Regulation Simulation Modeling.
Development and validation of a DNA repair gene signature for prognosis prediction in Colon Cancer.
Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma.
Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.
Diagnostic and prognostic values of forkhead box D4 gene in colonic adenocarcinoma.
Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours.
Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.
Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data.
DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression.
Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma.
Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer.
Effect of Different Expression of Immune-Related lncRNA on Colon Adenocarcinoma and Its Relation to Prognosis.
Egr?1 inhibits colon cancer cell proliferation, migration and invasion via regulating CDKL1 at the transcriptional level.
Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma.
Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma.
Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
Epistasis analysis of microRNAs on pathological stages in colon cancer based on an Empirical Bayesian Elastic Net method.
Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis.
Establishment of a 12-gene expression signature to predict colon cancer prognosis.
Evaluation of genome-wide genotyping concordance between tumor tissues and peripheral blood.
Exploiting DNA repair defects in colorectal cancer.
Exploration of the Associations of lncRNA Expression Patterns with Tumor Mutation Burden and Prognosis in Colon Cancer.
Expression of Hippo pathway genes and their clinical significance in colon adenocarcinoma.
Expression of TIPE family members in human colorectal cancer.
Extracellular vesicles from human umbilical cord mesenchymal stem cells treated with siRNA against ELFN1-AS1 suppress colon adenocarcinoma proliferation and migration.
EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells.
FOXA2 promotes the proliferation, migration and invasion, and epithelial mesenchymal transition in colon cancer.
Framing the potential of public frameshift peptides as immunotherapy targets in colon cancer.
Functional exploration of colorectal cancer genomes using Drosophila.
Functional network analysis reveals an immune tolerance mechanism in cancer.
FXR silencing in human colon cancer by DNA methylation and KRAS signaling.
G-DOC Plus - an integrative bioinformatics platform for precision medicine.
GABRD promotes progression and predicts poor prognosis in colorectal cancer.
Gene expression network analysis of lymph node involvement in colon cancer identifies AHSA2, CDK10, and CWC22 as possible prognostic markers.
Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism.
Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype.
GeneGazer: A Toolkit Integrating Two Pipelines for Personalized Profiling and Biosignature Identification.
Genome?scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Genomic and immunological features of microsatellite instability in colon cancer.
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
HER2 and APC Mutations Promote Altered Crypt-Villus Morphology and Marked Hyperplasia in the Intestinal Epithelium.
High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Higher ETV5 Expression Associates With Poor 5-Florouracil-Based Adjuvant Therapy Response in Colon Cancer.
HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2.
Identification and Validation of a Four-Long Non-coding RNA Signature Associated With Immune Infiltration and Prognosis in Colon Cancer.
Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
Identification of a 6-gene signature predicting prognosis for colorectal cancer.
Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer.
Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer.
Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer.
Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
Identification of Distinct Molecular Patterns and a Four-Gene Signature in Colon Cancer Based on Invasion-Related Genes.
Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
Identification of Molecular Targets for Predicting Colon Adenocarcinoma.
Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis.
Identification of prognostic miRNA biomarkers for predicting overall survival of colon adenocarcinoma and bioinformatics analysis: A study based on The Cancer Genome Atlas database.
Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis.
Identification of ROR? as a favorable biomarker for colon cancer.
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis.
Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data.
Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family members.
Impact of FGFR4 Gene Polymorphism on the Progression of Colorectal Cancer.
Improving the Prognosis of Colon Cancer through Knowledge-Based Clinical-Molecular Integrated Analysis.
Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence.
Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer.
Integrated analysis of gene expression signatures associated with colon cancer from three datasets.
Integrated Bioinformatics Analysis to Identify Abnormal Methylated Differentially Expressed Genes for Predicting Prognosis of Human Colon Cancer.
Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer.
ITGB4 is a novel prognostic factor in colon cancer.
KRAS mutations are negatively correlated with immunity in colon cancer.
Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
LINC00491 as a new molecular marker can promote the proliferation, migration and invasion of colon adenocarcinoma cells.
Long noncoding RNA LINC01234 promotes serine hydroxymethyltransferase 2 expression and proliferation by competitively binding miR-642a-5p in colon cancer.
MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGF?/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
Metastasis regulation by PPARD expression in cancer cells.
Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.
Mining the potential prognostic value of synaptosomal-associated protein 25 (SNAP25) in colon cancer based on stromal-immune score.
miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1.
MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer.
Molecular heterogeneity of guanine nucleotide binding-protein ? subunit 4 in left- and right-sided colon cancer.
Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients.
Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.
Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas.
Pan-cancer analysis of TCGA data reveals notable signaling pathways.
Pattern discovery and cancer gene identification in integrated cancer genomic data.
PPFIA4 Promotes Colon Cancer Cell Proliferation and Migration by Enhancing Tumor Glycolysis.
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Prognostic lncRNAs, miRNAs, and mRNAs Form a Competing Endogenous RNA Network in Colon Cancer.
Prognostic significance of chemokines CCL11 and CCL5 modulated by low-density lipoprotein cholesterol in colon cancer patients with normal body mass index.
Prognostic value of chloride channel accessory mRNA expression in colon cancer.
Proliferative and Invasive Colorectal Tumors in Pet Dogs Provide Unique Insights into Human Colorectal Cancer.
Proteomic characterization of peroxisome proliferator-activated receptor-? (PPAR?) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
Proteomic profiling reveals a signature for optimizing prognostic prediction in Colon Cancer.
Pseudouridylate Synthase 7 Promotes Cell Proliferation and Invasion in Colon Cancer Through Activating PI3K/AKT/mTOR Signaling Pathway.
Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation.
RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis.
Role of B7-H4 siRNA in Proliferation, Migration, and Invasion of LOVO Colorectal Carcinoma Cell Line.
SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer.
Screening of Differentiation-Specific Molecular Biomarkers for Colon Cancer.
SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target.
Single-cell genomic profile-based analysis of tissue differentiation in colorectal cancer.
Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer.
Systematic analysis of the function and prognostic value of RNA binding proteins in Colon Adenocarcinoma.
TFF2-CXCR4 Axis Is Associated with BRAF V600E Colon Cancer.
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
The LIM Protein Ajuba Augments Tumor Metastasis in Colon Cancer.
The predictive value of RNA binding proteins in colon adenocarcinoma.
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers.
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors.
Where cancer genomics should go next: a clinician's perspective.
Colorectal Neoplasms
A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.
A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers.
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy.
A universal molecular prognostic score for gastrointestinal tumors.
Aberrant methylation patterns in colorectal cancer: a meta-analysis.
Abnormal Eating Patterns Cause Circadian Disruption and Promote Alcohol-Associated Colon Carcinogenesis.
ALKAL1 gene silencing prevents colorectal cancer progression via suppressing Sonic Hedgehog (SHH) signaling pathway.
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.
An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease.
An Autophagy-Related Long Noncoding RNA Signature Contributes to Poor Prognosis in Colorectal Cancer.
An Integrated Bioinformatics Analysis Repurposes an Antihelminthic Drug Niclosamide for Treating HMGA2-Overexpressing Human Colorectal Cancer.
Analysis of Genes Involved in Ulcerative Colitis Activity and Tumorigenesis Through Systematic Mining of Gene Co-expression Networks.
Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
Application of open-access databases to determine functional connectivity between resveratrol-binding protein QR2 and colorectal carcinoma.
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer.
Assessment of intra-tumoural colorectal cancer prognostic biomarkers using RNA in situ hybridisation.
Association of Epigenetic Clock with Consensus Molecular Subtypes and Overall Survival of Colorectal Cancer.
Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis.
Association study of genetic variants in estrogen metabolic pathway genes and colorectal cancer risk and survival.
Atlas of colorectal tumours.
BHLHA15-Positive Secretory Precursor Cells Can Give Rise to Tumors in Intestine and Colon in Mice.
BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor.
Cancer stem cell associated eight gene-based signature predicts clinical outcomes of colorectal cancer.
Characteristic Analysis of Featured Genes Associated With Stemness Indices in Colorectal Cancer.
CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Circulating Long RNAs in Serum Extracellular Vesicles: Their Characterization and Potential Application as Biomarkers for Diagnosis of Colorectal Cancer.
CIRH1A augments the proliferation of RKO colorectal cancer cells.
Clinical correlates of circulating cell-free DNA tumor fraction.
Clinical, Pathology, Genetic, and Molecular Features of Colorectal Tumors in Adolescents and Adults 25 Years or Younger.
CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer.
Colorectal cancer atlas: An integrative resource for genomic and proteomic annotations from colorectal cancer cell lines and tissues.
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.
Colorectal Cancer Prognosis is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study.
Competing Endogenous RNA of Snail and Zeb1 UTR in Therapeutic Resistance of Colorectal Cancer.
Comprehensive Analysis of Prognostic and Genetic Signatures for General Transcription Factor III (GTF3) in Clinical Colorectal Cancer Patients Using Bioinformatics Approaches.
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer.
Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing.
Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer.
CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer.
Decoding the S-Nitrosoproteomic Atlas in Individualized Human Colorectal Cancer Tissues Using a Label-Free Quantitation Strategy.
Decreased copy-neutral loss of heterozygosity in African American colorectal cancers.
Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer.
Developmental genes significantly afflicted by aberrant promoter methylation and somatic mutation predict overall survival of late-stage colorectal cancer.
Differential Expression of PEG10 Contributes to Aggressive Disease in Early Versus Late-Onset Colorectal Cancer.
DNA methylation at an enhancer of the three prime repair exonuclease 2 gene (TREX2) is linked to gene expression and survival in laryngeal cancer.
Down-regulation of FN1 inhibits colorectal carcinogenesis by suppressing proliferation, migration, and invasion.
eIF6 Promotes Colorectal Cancer Proliferation and Invasion by Regulating AKT-Related Signaling Pathways.
ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.
Elucidating the Reprograming of Colorectal Cancer Metabolism Using Genome-Scale Metabolic Modeling.
Empowering biologists with multi-omics data: colorectal cancer as a paradigm.
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.
ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer.
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.
Establishment of multiple diagnosis models for colorectal cancer with artificial neural networks.
Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.
Evaluating patient-derived colorectal cancer-xenografts as preclinical models by comparison with patient clinical data.
Explore prognostic marker of colorectal cancer based on ceRNA network.
Expression and gene regulation network of TYMS and BCL2L1 in colorectal cancer based on data mining.
Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.
FAM98A associates with DDX1-C14orf166-FAM98B in a novel complex involved in colorectal cancer progression.
Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon ? pathway.
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes.
Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer.
Gene expression analysis of combined RNA-seq experiments using a receiver operating characteristic calibrated procedure.
Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer.
Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
HER2 activating mutations are targets for colorectal cancer treatment.
High Expression and Clinical Significance of Elafin in Colorectal Cancer.
High expression of IQGAP3 indicates poor prognosis in colorectal cancer patients.
High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
High-dose-rate intraoperative radiation therapy for colorectal cancer.
High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment.
Histopathological atlas of desmoplastic reaction characterization in colorectal cancer.
Histopathology classification and localization of colorectal cancer using global labels by weakly supervised deep learning.
How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?
HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer.
HS3ST2 and Its Related Molecules as Potential Biomarkers for Predicting Lymph Node Metastasis in Patients with Colorectal Cancer.
Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.
Hypermutated tumours across 11 cancer types show three distinct immune subtypes.
Identification of a 6-gene signature predicting prognosis for colorectal cancer.
Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Identification of key genes and biological processes contributing to colitis associated dysplasia in ulcerative colitis.
Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer.
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF.
Identification of the miRNA signature and key genes in colorectal cancer lymph node metastasis.
Identification of tumor microenvironment-related prognostic genes in colorectal cancer based on bioinformatic methods.
Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome.
Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer.
Implications of Circadian Rhythm Regulation by microRNAs in Colorectal Cancer.
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
In silico pathway analysis and tissue specific cis-eQTL for colorectal cancer GWAS risk variants.
In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells.
INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer.
Integrated multi-omics data analyses for exploring the co-occurring and mutually exclusive gene alteration events in colorectal cancer.
Integration and Analysis of Heterogeneous Colorectal Cancer Data for Translational Research.
Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.
Integrative Omics Analysis Reveals Post-Transcriptionally Enhanced Protective Host Response in Colorectal Cancers with Microsatellite Instability.
Intestinal Epithelial TBK1 Prevents Differentiation of T-helper 17 Cells and Tumorigenesis in Mice.
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
Joint association and classification analysis of multi-view data.
LINC00460 Hypomethylation Promotes Metastasis in Colorectal Carcinoma.
LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer.
Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/?-catenin signalling pathway and is a potential diagnostic biomarker.
LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer.
Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies.
Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer.
MFG-E8 overexpression promotes colorectal cancer progression via AKT/MMPs signalling.
MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
MiR-3614-5p Is a Potential Novel Biomarker for Colorectal Cancer.
miR-6883 Family miRNAs Target CDK4/6 to Induce G
miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer.
MLH1-Silenced and Non-Silenced Subgroups of Hypermutated Colorectal Carcinomas Have Distinct Mutational Landscapes.
Molecular and Functional Characterization of the Somatic PIWIL1/piRNA Pathway in Colorectal Cancer Cells.
Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implications.
Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer.
Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer.
Oncogenic Activity of Wrap53 in Human Colorectal Cancer In Vitro and in Nude Mouse Xenografts.
Oncogenic effect of PHLDB2 is associated with epithelial-mesenchymal transition and E-cadherin regulation in colorectal cancer.
Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.
Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer.
Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC).
Pattern discovery and cancer gene identification in integrated cancer genomic data.
Predicting responses to platin chemotherapy agents with biochemically-inspired machine learning.
Prognostic impact of cancer stem cell markers ABCB1, NEO1 and HIST1H2AE in colorectal cancer.
Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
Prognostic value of IL-34 in colorectal cancer patients.
Proteomics of Colorectal Cancer in a Genomic Context: First Large-Scale Mass Spectrometry-Based Analysis from the Cancer Genome Atlas.
PTGS2 Over-Expression: A Colorectal Carcinoma Initiator not an Invasive Factor.
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents.
pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing.
Quality control of single amino acid variations detected by tandem mass spectrometry.
Recent therapeutic advances in the treatment of colorectal cancer.
Ribosome Assembly Factor URB1 Contributes to Colorectal Cancer Proliferation via Transcriptional Activation of ATF4.
Sampling Based Tumor Recognition in Whole-slide Histology Image with Deep Learning Approaches.
Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.
Somatic microsatellite variability as a predictive marker for colorectal cancer and liver cancer progression.
STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability.
Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers.
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine.
The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study.
The Doppelgänger Effect: Hidden Duplicates in Databases of Transcriptome Profiles.
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis.
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.
The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer.
The somatic mutation landscape of premalignant colorectal adenoma.
TNNT1, negatively regulated by miR-873, promotes the progression of colorectal cancer.
TP53 loss creates therapeutic vulnerability in colorectal cancer.
Transcriptome analysis of copper homeostasis genes reveals coordinated upregulation of SLC31A1,SCO1, and COX11 in colorectal cancer.
TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/?-Catenin Signaling.
Tumor suppressive autophagy in intestinal stem cells controls gut homeostasis.
Twist1 and AP-1 cooperatively upregulate integrin ?5 expression to induce invasion and the epithelial-mesenchymal transition.
Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data.
WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis.
[Downregulation of OGDHL expression is associated with promoter hypermethylation in colorectal cancer].
Coma
ATLAS OF ELECTROENCEPHALOGRAPHY IN COMA AND CEREBRAL DEATH.
Location of Subcortical Microbleeds and Recovery of Consciousness After Severe Traumatic Brain Injury.
Communicable Diseases
A Colour Atlas of Infectious Diseases.
A cooperative study of sarcoidosis in Asia and Africa: analytic epidemiology.
A systematic examination of international funding flows for Ebola virus and Zika virus outbreaks 2014-2019: donors, recipients and funding purposes.
ATLAS OF INFECTIOUS DISEASES.
Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell™.
[Actual problems of creation of informational-analytical system for rapid control of epidemics of infectious diseases].
[Banks of biological resources in the system of basic epidemiological and clinical studies].
[Time trends in infectious disease mortality in Italy: 1969-1999]
Confusion
Characterizing spatially varying performance to improve multi-atlas multi-label segmentation.
[Injuries of the cervical spine in children]
Congenital Abnormalities
A Manual and Atlas of Orthopedic Surgery, General and Special, Including the History, Etiology, Pathology, Diagnosis, Prognosis, Prophylaxis and Treatment of Deformities.
Agenesis of the posterior arch of the atlas.
An atlas vertebra with a centrum? A case report of an abnormal atlas and axis.
An unusual form of occipitocervical assimilation presenting with spastic tetraparesis in a child.
Anteroposterior spondyloschisis of atlas with incurving of the posterior arch causing compressive myelopathy.
Aplasia of anterior arch of atlas associated with multiple congenital disorders: Case report.
Atlantoaxial dislocation with congenital "sandwich fusion" in the craniovertebral junction: a retrospective case series of 70 patients.
Atlantoaxial rotatory fixation. Radiographic study of its mechanism.
Birth defects atlas and compendium.
Cervical myelopathy caused by hypoplasia of the atlas: two case reports and review of the literature.
Cervical myelopathy caused by invaginated laminae of the axis associated with occipitalizaion of the atlas: Case report and literature review.
Clinical management of cranio-vertebral instability after whiplash, when guidelines should be adapted: A case report.
Congenital absence of the posterior arch of the atlas associated with a fracture of the anterior arch.
Congenital anomaly of the atlas misdiagnosed as posterior arch fracture of the atlas and atlantoaxial subluxation.
Congenital anterior midline cleft of the atlas and posterior atlanto-occipital fusion associated with symptomatic anterior atlantoaxial subluxation.
Congenital defect of the anterior arch of the atlas: a case report and review of the literature.
Congenital defect of the atlas and axis. A cause of misdiagnose when evaluating an acute neck trauma.
Congenital defects of the posterior arch of the atlas: a report of seven cases including an affected mother and son.
Congenital deformities of the hand: an atlas of their surgical treatment.
Congenital partial aplasia of the posterior arch of the atlas causing myelopathy: case report and review of the literature.
Creating a virtual surgical atlas of craniofacial procedures: Part I. Three-dimensional digital models of craniofacial deformities.
Incidence of congenital anomalies in a rural population of Jammu - A prospective study.
Incidental findings of posterior arch defects of the atlas in orthodontic patients: A case series.
Lateral subluxation of the atlas in rheumatoid arthritis.
Painful torticollis due to tubercular atlantoaxial rotatory fixation: A case report.
Posterior arch defects of the atlas: significance in trauma and literature review.
Primary Internal Fixation of Unilateral C1 Lateral Mass Sagittal Split Fractures: A Series of 3 Cases.
Quantitative Measurements of the Skull Base and Craniovertebral Junction in Congenital Occipitalization of the Atlas: A Computed Tomography-Based Anatomic Study.
Rotatory Subluxation and Facet Deformity in the Atlanto-occipital Joint in Patients with Chronic Atlantoaxial Rotatory Fixation: Two Case Reports.
Spinal compression due to atlantal vertebral malformation in two African lions (Panthera leo).
The frequency and clinical significance of congenital defects of the posterior and anterior arch of the atlas.
Three cases of bipartition of the atlas.
Three-dimensional morphology and kinematics of the craniovertebral junction in rheumatoid arthritis.
Transoral osteosynthesis c1 as a function-preserving option in the treatment of bipartite atlas deformity: a case report.
Unilateral lateral mass compression fractures of the axis.
Unsuspected atlas fracture and instability associated with oropharyngeal injury: case report.
Variants and deformities of atlas vertebrae in Eastern Anatolian people.
[2 cases of bone deformity at the cranio-vertebral junction, accompanying occipitalization of atlas and basilar impression]
[Application of spiral CT reconstruction in the forensic identification of atlantoaxial injuries]
[Capacity of monitoring system on birth defects during 1990s in China]
[Case 2. Congenital defect of the posterior arch of the atlas]
[Case of the month. Chiari I deformity and osteochondroma of the atlas]
[Clinical contribution on congenital abnormalities of the atlas]
[Congenital abnormalities of the arcs of the atlas]
[Diagnostic imaging in congenital abnormalities of the posterior arch of the atlas. Report of 2 cases and review of the literature]
[Mucopolysaccharidosis 6-A (Maroteaux-Lamy disease): comparison of clinical and pathologico-anatomic findings in a 27-year-old patient]
[Partial bilateral agenesis of the posterior arch of the atlas]
[Roles of computed tomography in the diagnosis and treatment of complex atlas pillow deformity].
[Sclerosis of the anterior arch of the atlas. A rare congenital abnormality]
[Spontaneous anterior atlanto-axial subluxation--a case story]
[The frequency and practical significance of congenital defect of the posterior arch of the atlas]
Congenital Microtia
Complete occipitalization of the atlas with bilateral external auditory canal atresia.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Aplasia of anterior arch of atlas associated with multiple congenital disorders: Case report.
Contracture
Atlantoaxial rotatory fixation. Radiographic study of its mechanism.
Corneal Wavefront Aberration
Custom optimization of intraocular lens asphericity.
Coronary Artery Disease
A collaborative resource to build consensus for automated left ventricular segmentation of cardiac MR images.
Multimodality imaging atlas of coronary atherosclerosis.
Coronary Disease
Coronary heart disease and hypertension among Jews immigrated to Israel from the Atlas Mountain region of North Africa.
European Society of Cardiology: Cardiovascular Disease Statistics 2017.
Insight Mechanism of the Selective Lanosterol Synthase Inhibitor: Molecular Modeling, Docking and Density Functional Theory Approaches.
Coronavirus Infections
A transcriptional regulatory atlas of coronavirus infection of human cells.
COVID-19
A molecular single-cell lung atlas of lethal COVID-19.
A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2.
A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
A single-cell atlas of the peripheral immune response to severe COVID-19.
An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.
An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19.
Collective aeromedical evacuations of SARS-CoV-2-related ARDS patients in a military tactical plane: a retrospective descriptive study.
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
COVID-19: Once upon a time in Portugal: A brief atlas of ongoing pandemic Portuguese research.
Cutaneous Manifestations of COVID-19: A Systematic Review.
Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.
In silico exploration of enzymes involved in sialic acid biosynthesis and their possible role in SARS-CoV-2 infection.
Introducing and Implementing HIV Self-Testing in Côte d'Ivoire, Mali, and Senegal: What Can We Learn From ATLAS Project Activity Reports in the Context of the COVID-19 Crisis?
Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection.
Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell™.
Reconcile the debate over protective effects of BCG vaccine against COVID-19.
SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells.
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.
Single-cell transcriptomic atlas of primate cardiopulmonary aging.
T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations.
The network effect: studying COVID-19 pathology with the Human Cell Atlas.
Coxa Vara
Risk factors of myelopathy at the atlantoaxial level in spondyloepiphyseal dysplasia congenita.
Cranial Nerve Diseases
Bony exostosis of the atlas with resultant cranial nerve palsy.
Occipital condyle fractures: clinical presentation and radiologic detection.
Craniocerebral Trauma
A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene Atlas array analysis.
Computation of axonal elongation in head trauma finite element simulation.
Fractures of the atlas: can we rely on the NICE guidelines for imaging the cervical spine after head injury?
Craniopharyngioma
Endoscopic endonasal transplanum transtuberculum approach for resection of retrochiasmatic craniopharyngioma.
Modified one-piece extended transbasal approach for translamina terminalis resection of retrochiasmatic third ventricular craniopharyngioma.
Orbitopterional Craniotomy Resection of Pediatric Suprasellar Craniopharyngioma.
Craniosynostoses
Morphogenesis of Canine Chiari Malformation and Secondary Syringomyelia: Disorders of Cerebrospinal Fluid Circulation.
The developing mouse coronal suture at single-cell resolution.
Crohn Disease
A cross-platform informatics system for the Gut Cell Atlas: integrating clinical, anatomical and histological data.
Imaging Crohn Disease: MR Enterography.
Pouchitis atlas for objective endoscopic diagnosis.
Small Bowel Crohn Disease at CT and MR Enterography: Imaging Atlas and Glossary of Terms.
Cross Infection
First year of mandatory reporting of healthcare-associated infections, pennsylvania: an infection control-chart abstractor collaboration.
Cryptorchidism
Pivotal role of the muscle-contraction pathway in cryptorchidism and evidence for genomic connections with cardiomyopathy pathways in RASopathies.
Cushing Syndrome
Atlas of iodocholesterol scintigraphy (NP-59) in Cushing's syndrome with CT and MR correlation.
Cystadenocarcinoma, Serous
A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma.
A novel scoring system for pivotal autophagy-related genes predicts outcomes after chemotherapy in advanced ovarian cancer patients.
Beclin-1 expression is retained in high-grade serous ovarian cancer yet is not essential for autophagy induction in vitro.
Biological Interpretation of Morphological Patterns in Histopathological Whole-Slide Images.
Chemoresistance-associated alternative splicing signatures in serous ovarian cancer.
Combination of Immune-Related Genomic Alterations Reveals Immune Characterization and Prediction of Different Prognostic Risks in Ovarian Cancer.
Discovery of microarray-identified genes associated with ovarian cancer progression.
Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer.
Evaluation of hierarchical models for integrative genomic analyses.
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.
Integration and comparison of different genomic data for outcome prediction in cancer.
Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells.
NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype.
Prognostic Role of Zinc Finger Homeobox 4 in Ovarian Serous Cystadenocarcinoma.
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
Two protein-coding genes act as a novel clinical signature to predict prognosis in patients with ovarian serous cystadenocarcinoma.
Cystadenoma, Serous
Mining TCGA data using Boolean implications.
Cystic Fibrosis
Varied clinical significance of ATP-binding cassette C sub-family members for lung adenocarcinoma.
Cystinosis
AJKD Atlas of Renal Pathology: Cystinosis.
Cystitis, Interstitial
Comment on "Presenting an Atlas of Hunner lesions in interstitial cystitis which can be identified with office cystoscopy" by Ronstrom and Lai, Neurourology and Urodynamics 2020;1-7. https://doi.org/10.1002/nau.24500.
Presenting an atlas of Hunner lesions in interstitial cystitis which can be identified with office cystoscopy.
Cysts
Development and reproducibility of a first metatarsophalangeal joint osteoarthritis magnetic resonance imaging scoring system.
Genotyping of human Echinococcus granulosus cyst in Morocco.
Isolated esophageal atresia with spontaneous recanalization: case report.
Surgical approach for synovial cyst of the atlantoaxial joint: a case report and review of the literature.
[Aneurysmal cyst of the atlas.]
[ANEURYSMATIC CYSTS OF THE POSTERIOR ARCH OF THE ATLAS.]
[Arachnoid cyst of the fourth ventricle. Case report]
[Giant aneurysmal cyst of the atlas and axis. Angiographical study.]
[Vertebrobasilar arterial thrombosis secondary to aneurysmatic cysts of the atlas and the epistropheus]
Cytomegalovirus Infections
AJKD Atlas of Renal Pathology: Cytomegalovirus Infection.
Deglutition Disorders
Abnormal bony protuberance of anterior atlas causing dysphagia. A rare congenital anomaly.
Esophageal pathology: a brief guide and atlas.
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
High-resolution manometry: an atlas of esophageal motility disorders and findings of GERD using esophageal pressure topography.
The photographic atlas of Spanish food consistency: a new tool for the treatment of dysphagia.
[Atlantoaxial malformation as a rare cause of dysphagia and snoring.]
Dehydration
Assessment of nutritional status in the Amazigh children of Amizmiz (Azgour Valley, High Atlas and Morocco).
[Study of acute dehydration in infants in a summer resort in the Middle Atlas: El Ksiba.]
Delirium
Relationships between preoperative cortical thickness, postoperative electroencephalogram slowing, and postoperative delirium.
Dementia
A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume.
Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
Label-free brain tissue imaging using large-area terahertz metamaterials.
New computer-aided diagnosis of dementia using positron emission tomography: brain regional sensitivity-mapping method.
Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size.
[Analysis of cerebral blood flow SPECT imaging on standard brain atlas in patients with dementia of Alzheimer type]
[Stepwise analysis of cerebral blood flow SPECT imaging on standard brain atlas in patients with dementia of Alzheimer's type]
Demyelinating Diseases
Myelin Water Atlas: A Template for Myelin Distribution in the Brain.
White matter atlas of the human spinal cord with estimation of partial volume effect.
Dermatitis
A prospective picture collection study for a grading atlas of radiation dermatitis for clinical trials in head-and-neck cancer patients.
Dermatitis, Atopic
Atlas of atopic dermatitis.
Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study Group. Early Treatment of the Atopic Child.
Dermatitis, Contact
Contact sensitivity to Atlas G-1441.
Dextrocardia
Review of myocardial viability using Nuclear Medicine imaging in rare cardiac malposition of dextrocardia - understanding right approach.
Diabetes Complications
Research Resource: dkCOIN, the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) Consortium Interconnectivity Network: A Pilot Program to Aggregate Research Resources Generated by Multiple Research Consortia.
Diabetes Mellitus
Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies.
Diabetes, Epstein-Barr virus and extranodal natural killer/T-cell lymphoma in India: Unravelling the plausible nexus.
Do we have enough ophthalmologists to manage vision-threatening diabetic retinopathy? A global perspective.
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.
Global prevalence and future of diabetes mellitus.
T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.
TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.
Diabetes Mellitus, Type 1
Diabetes in the young - a global view and worldwide estimates of numbers of children with type 1 diabetes.
MicroRNA expression in alpha and beta cells of human pancreatic islets.
Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes.
WITHDRAWN: IDF Diabetes Atlas: Worldwide Estimates of Incidence, Prevalence and Mortality of Type 1 Diabetes in Children and Adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Diabetes Mellitus, Type 2
An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study.
Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies.
Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
Patient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational atlas study.
SGI: Automatic clinical subgroup identification in omics datasets.
T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.
The dietetic workforce distribution geographic atlas provides insight into the inequitable access for dietetic services for people with type 2 diabetes in Australia.
Diabetic Nephropathies
AJKD Atlas of Renal Pathology: diabetic nephropathy.
Histopathological atlas of renal diseases: Diabetic nephropathy.
Diabetic Retinopathy
Atlas of diabetic retinopathy. A photographic study.
DiGeorge Syndrome
DGCR8/ZFAT-AS1 Promotes CDX2 Transcription in a PRC2 Complex-Dependent Manner to Facilitate the Malignant Biological Behavior of Glioma Cells.
Digestive System Neoplasms
The Impact of MicroRNA-133a on Prognosis and Clinicopathological Parameters for Digestive System Cancers: a Comprehensive Study Based on Meta-Analysis and TCGA Database.
Down Syndrome
Comparison of Whole Eye versus First-Surface Astigmatism in Down Syndrome.
Congenital defects of C1 arches and odontoid process in a child with Down's syndrome: A case presentation.
DISLOCATION OF THE ATLAS IN MONGOLISM: PRELIMINARY REPORT.
Fusions at the craniovertebral junction.
Intraobserver reproducibility and interobserver reliability of cervical spine measurements.
Occipitoatlantal and occipitoaxial hypermobility in Down syndrome.
Occult spinal canal stenosis due to C-1 hypoplasia in children with Down syndrome.
Persistent torticollis, facial asymmetry, grooved tongue, and dolicho-odontoid process in connection with atlas malformation complex in three family subjects.
Screw fixation of the upper cervical spine in the pediatric population. Clinical article.
Simulated Keratometry Repeatability in Subjects with and without Down Syndrome.
Subluxation of the atlas causing spinal cord compression in a case of Down's syndrome with a "manifestation of an occipital vertebra".
The human lanosterol synthase gene maps to chromosome 21q22.3.
The relationship between atlas hypoplasia and os odontoideum in children with Down syndrome: a preliminary case report.
[Instability of the atlas on the axis in mongolism]
[Spinal stenosis at the level of atlas in a boy with Down syndrome. A case report and literature review.]
[Spontaneous atlas dislocation in a child with trisomy 21 and rheumatoid arthritis]
Drug-Related Side Effects and Adverse Reactions
An atlas of G-protein coupled receptor expression and function in human subcutaneous adipose tissue.
Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management.
Dupuytren Contracture
Cellular census of human fibrosis defines functionally distinct stromal cell types and states.
Dysarthria
Probabilistic map of critical functional regions of the human cerebral cortex: Broca's area revisited.
Dyslipidemias
Ethnicity and socioeconomic status influence use of primary angioplasty in patients presenting with acute myocardial infarction.
Dysplastic Nevus Syndrome
A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
Dystonia
Reduction of cervical dystonia after an extended course of chiropractic manipulation: a case report.
Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystonia.
The optimal pallidal target in deep brain stimulation for dystonia: a study using a functional atlas based on nonlinear image registration.
[Little known sequelae of sprains of the cervical spine]
Dystonic Disorders
Connectome-Wide Phenotypical and Genotypical Associations in Focal Dystonia.
Ear Diseases
A Colour Atlas of Ear Disease.
Echinococcosis
Community perception and knowledge of cystic echinococcosis in the High Atlas Mountains, Morocco.
Control of cystic echinococcosis in the Middle Atlas, Morocco: Field evaluation of the EG95 vaccine in sheep and cesticide treatment in dogs.
Cystic echinococcosis in the Berber of the Mid Atlas mountains, Morocco: new insights into the natural history of the disease in humans.
Cystic Echinococcosis in Three Locations in the Middle Atlas, Morocco: Estimation of the Infection Rate in the Dog Reservoir.
Human cystic echinococcosis in Morocco: Ultrasound screening in the Mid Atlas through an Italian-Moroccan partnership.
Eczema
Color atlas: eczema.
Main Therapeutic Uses of Some Moroccan Hot Springs' Waters.
Ehlers-Danlos Syndrome
[Atlanto-axial, Atlanto-occipital dislocations, developmental cervical canal stenosis in the Ehlers-Danlos syndrome (author's transl)]
Elephantiasis
Gigantic neurofibromatosis of the orbit.
Global epidemiology of podoconiosis: A systematic review.
Mapping the geographical distribution of podoconiosis in Cameroon using parasitological, serological, and clinical evidence to exclude other causes of lymphedema.
The global atlas of podoconiosis.
Elephantiasis, Filarial
Complex emergencies and the control and elimination of neglected tropical diseases in Africa: developing a practical approach for implementing safe and effective mapping and intervention strategies.
Encephalitis
Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis.
[Atlas of nervous system diseases. 6. Autopsy case of subacute necrotic encephalitis]
Encephalitis, Tick-Borne
[The "natural focal diseases" medical and geographical atlas of Russia as a tool to analyze their incidence in the population].
Encephalocele
[Duraplasty with Neuropatch versus autologous fascia lata for Chiari I malformation with syringomyelia: a comparative study]
Encephalomyelitis
[Atlas series in neuropathology. (14). Pathology of encephalomyelitis. (2). Tuberculous meningitis]
[NEUROPATHOLOGICAL ATLAS. 3. PATHOLOGY OF DEMYELINATING ENCEPHALOMYELITIS (1)]
[NEUROPATHOLOGICAL ATLAS. 4. PATHOLOGY OF ENCEPHALOMYELITIS (2)]
Endemic Diseases
Longevity and selenium deficiency: evidence from the People's Republic of China.
Endocarditis
Infective endocarditis: An atlas of disease progression for describing, staging, coding, and understanding the pathology.
Endometrial Neoplasms
A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer.
A clinically applicable molecular-based classification for endometrial cancers.
A genome-wide view of microsatellite instability: old stories of cancer mutations revisited with new sequencing technologies.
A long noncoding RNAs signature to improve survival prediction in endometrioid endometrial cancer.
A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma.
Activating ESR1 mutations in hormone-resistant metastatic breast cancer.
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy.
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment.
Amplification of the NSD3-BRD4-CHD8 pathway in pelvic high-grade serous carcinomas of tubo-ovarian and endometrial origin.
An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
An Integrated Autophagy-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer: A Bioinformatics-Based Approach.
An miRNA signature associated with tumor mutation burden in endometrial cancer.
Analysis of carcinogenic signaling networks in endometrial cancer identifies RAB17 as a potential target.
ARID1A and CTNNB1/?-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification.
Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project.
Association between endometrial cancer risk classification and gene expression in the cancer genome atlas database.
Association between the CYP11 family and six cancer types.
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
Bioinformatic analysis of four miRNAs relevant to metastasis-regulated processes in endometrial carcinoma.
Bokhman Redux: Endometrial cancer "types" in the 21st century.
Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.
Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology.
Clear cell endometrial carcinoma and the TCGA classification.
Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas.
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway.
Comprehensive Analysis of ESRRA in Endometrial Cancer.
Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy.
Comprehensive serum proteomic analysis in early endometrial cancer.
Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.
Construction of a Glycolysis-related long noncoding RNA signature for predicting survival in endometrial cancer.
Cooperative driver pathway discovery via fusion of multi-relational data of genes, miRNAs and pathways.
DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden.
Decreased secretoglobin family 2A member 1expression is associated with poor outcomes in endometrial cancer.
Defining a mutational signature for endometrial cancer screening and early detection.
Deregulation of cell adhesion molecules is associated with progression and poor outcomes in endometrial cancer: Analysis of The Cancer Genome Atlas data.
Diagnostic Accuracy of Immunohistochemistry for Mismatch Repair Proteins as Surrogate of Microsatellite Instability Molecular Testing in Endometrial Cancer.
Discovery and validation of methylation markers for endometrial cancer.
DNA Methylation Signatures in Vaginal Fluid Samples for Detection of Cervical and Endometrial Cancer.
DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
Downregulation of HOXA11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway.
Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.
Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.
Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression.
Final Validation of the ProMisE Molecular Classifier for Endometrial Carcinoma in a Large Population-based Case Series.
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
Frequent mutations in the RPL22 gene and its clinical and functional implications.
Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method.
Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer.
Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
High APOBEC1 Complementation Factor Expression Positively Modulates the Proliferation, Invasion, and Migration of Endometrial Cancer Cells Through Regulating P53/P21 Signaling Pathway.
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.
High-Grade Endometrial Carcinomas: Classification with Molecular Insights.
Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.
Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Identification of candidate target genes for endometrial cancer, such as ANO1, using weighted gene co-expression network analysis.
Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer.
Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups.
Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy.
Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas.
L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).
Label propagation defines signaling networks associated with recurrently mutated cancer genes.
Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma.
LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.
Major clinical research advances in gynecologic cancer in 2013.
Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma.
MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer.
Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
Molecular characterization in the prediction of disease extent in endometrial carcinoma.
Molecular characterization of endometrial cancer and therapeutic implications.
Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.
Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
Molecular-targeted therapies and precision medicine for endometrial cancer.
New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines.
Oncomorphic TP53 Mutations in Gynecologic Cancers Lose the Normal Protein:Protein Interactions with the microRNA Microprocessing Complex.
Ornithine decarboxylase as a therapeutic target for endometrial cancer.
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification.
Pathology of Endometrial Carcinoma.
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells: Differences Across Histologic and TCGA-based Molecular Subgroups.
Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma.
Possible Human Papillomavirus 38 Contamination of Endometrial Cancer RNA Sequencing Samples in The Cancer Genome Atlas Database.
Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
PROGNOSTIC INTEGRATED IMAGE-BASED IMMUNE AND MOLECULAR PROFILING IN EARLY-STAGE ENDOMETRIAL CANCER.
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.
Proteomic analysis of malignant and benign endometrium according to obesity and insulin-resistance status using Reverse Phase Protein Array.
PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma.
Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas.
Recent Developments in Surgical Pathology of the Uterine Corpus.
Reclassifying endometrial carcinomas with a combined morphological and molecular approach.
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.
Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.
RNA-seq Reveals the Overexpression of IGSF9 in Endometrial Cancer.
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers.
ROR2 Is Epigenetically Regulated in Endometrial Cancer.
Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.
STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.
Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data.
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer.
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.
TCGA molecular groups of endometrial cancer: Pooled data about prognosis.
The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer.
The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future.
The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer.
The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role.
The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
The PVT1/miR-612/CENP-H/CDK1 axis promotes malignant progression of advanced endometrial cancer.
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
Triple-high expression of phosphatase and tensin homolog (PTEN), estrogen receptor (ER) and progesterone receptor (PR) may predict favorable prognosis for patients with Type I endometrial carcinoma.
Tumor Molecular Features Predict Endometrial Cancer Patients' Survival After Open or Minimally Invasive Surgeries.
Two critical positions in zinc finger domains are heavily mutated in three human cancer types.
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.
Upregulated delta-like protein 3 expression is a diagnostic and prognostic marker in endometrial cancer: A retrospective study.
Uterine serous carcinoma.
Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
Where cancer genomics should go next: a clinician's perspective.
[Clinical application of TCGA molecular classification in endometrial endometrioid carcinoma].
[In Process Citation].
Endometriosis
An atlas of endometriosis (third edition).
MRI atlas of ectopic endometriosis.
Single-cell transcriptomic analysis of endometriosis provides insights into fibroblast fates and immune cell heterogeneity.
Enteritis
Pouchitis atlas for objective endoscopic diagnosis.
Eosinophilic Granuloma
Craniovertebral junction neoplasms in the pediatric population.
Eosinophilic granuloma of the atlas and the occipital condyle in an adult.
Eosinophilic granuloma of the atlas presenting as torticollis in a child.
Eosinophilic granuloma of the spine involving C1 and pulmonary infiltration in young children - Presentation of two cases with a follow-up over 10 years including review of the literature.
Ependymoma
Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma.
[Preliminary analysis on the gene expression profiles of different types of gliomas with cDNA array]
Epilepsies, Partial
Development and Implementation of a Corriedale Ovine Brain Atlas for Use in Atlas-Based Segmentation.
Surgical Neuropathology of Focal Epilepsies: Textbook and Atlas.
Validation of semi-automated anatomically labeled SEEG contacts in a brain atlas for mapping connectivity in focal epilepsy.
Epilepsy
A high-resolution computational atlas of the human hippocampus from postmortem magnetic resonance imaging at 9.4 T.
A neurophysiological brain map: Spectral parameterization of the human intracranial electroencephalogram.
A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies.
Ablation dynamics during laser interstitial thermal therapy for mesiotemporal epilepsy.
An adaptive probabilistic atlas for anomalous brain segmentation in MR images.
Atlas of neuropathological lesions in epilepsy surgery: Hippocampal sclerosis, ILAE Type 1
Atlas of neuropathological lesions in epilepsy surgery: Hippocampal sclerosis, ILAE Type 2 (CA1 - predominant neuronal loss)
Atlas of neuropathological lesions in epilepsy surgery: Hippocampal sclerosis, ILAE Type 3 (CA4 predominant neuronal loss)
Atlas of neuropathological lesions in epilepsy surgery: No hippocampal sclerosis (ILAE classification 2013)
AURA: Atlas of UTR Regulatory Activity.
Automated white-matter tractography using a probabilistic diffusion tensor atlas: Application to temporal lobe epilepsy.
Automatic labeling of the fanning and curving shape of Meyer's loop for epilepsy surgery: an atlas extracted from high-definition fiber tractography.
Comparative study of joint bioinformatics analysis of underlying potential of 'neurimmiR', miR-212-3P/miR-132-3P, being involved in epilepsy and its emerging role in human cancer.
Construction of a neuroanatomical shape complex atlas from 3D MRI brain structures.
Electrical Stimulation of the Anterior Thalamus for Epilepsy: Clinical Outcome and Analysis of Efficient Target.
Epilepsy Care in the World: results of an ILAE/IBE/WHO Global Campaign Against Epilepsy survey.
FDG-PET images quantified by probabilistic atlas of brain and surgical prognosis of temporal lobe epilepsy.
Imaging the seizure onset zone with stereo-electroencephalography.
In vivo normative atlas of the hippocampal subfields using multi-echo susceptibility imaging at 7 Tesla.
MicroRNA-128 expression not associated with glioma-associated epilepsy in WHO grades 2 glioma: Data from the Cancer Genome Atlas (TCGA) project.
Objective PET study of glucose metabolism asymmetries in children with epilepsy: Implications for normal brain development.
Quantification of F-18 FDG PET images in temporal lobe epilepsy patients using probabilistic brain atlas.
The Epileptor model: a systematic mathematical analysis linked to the dynamics of seizures, refractory status epilepticus and depolarization block.
The Posterior Insula Shows Disrupted Brain Functional Connectivity in Female Migraineurs Without Aura Based on Brainnetome Atlas.
VEP atlas: An anatomic and functional human brain atlas dedicated to epilepsy patients.
Epilepsy, Temporal Lobe
A high-resolution computational atlas of the human hippocampus from postmortem magnetic resonance imaging at 9.4 T.
Automated white-matter tractography using a probabilistic diffusion tensor atlas: Application to temporal lobe epilepsy.
FDG-PET images quantified by probabilistic atlas of brain and surgical prognosis of temporal lobe epilepsy.
Quantification of F-18 FDG PET images in temporal lobe epilepsy patients using probabilistic brain atlas.
Epstein-Barr Virus Infections
Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).
Landscape of EBV-positive gastric cancer.
Erythema
Efficacy of a topical formulation of henna (Lawsonia inermis L.) in contact dermatitis in patients using prosthesis: A double-blind randomized placebo-controlled clinical trial.
[Quantitative assessment of cutaneous erythema]
Esophageal Atresia
A case series study of therapeutic implications of type IIIb4: a rare variant of esophageal atresia and distal tracheoesophageal fistula.
Atlas of esophageal atresia.
Isolated esophageal atresia with spontaneous recanalization: case report.
Pure esophageal atresia with normal outer appearance: case report.
Esophageal Motility Disorders
High-resolution manometry: an atlas of esophageal motility disorders and findings of GERD using esophageal pressure topography.
Esophageal Neoplasms
A genome-wide analysis of long noncoding RNA profile identifies differentially expressed lncRNAs associated with Esophageal cancer.
Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
Cancer-related long noncoding RNAs show aberrant expression profiles and competing endogenous RNA potential in esophageal adenocarcinoma.
Comprehensive Analysis of lncRNAs Related to the Prognosis of Esophageal Cancer Based on ceRNA Network and Cox Regression Model.
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.
Comprehensive multi-omics analysis identified core molecular processes in esophageal cancer and revealed GNGT2 as a potential prognostic marker.
Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLC?-NF-?B signaling pathway and VEGF-C/ Bcl-2 expression.
Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.
Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer.
Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer.
Identification of cluster of differentiation molecule-associated microRNAs as potential therapeutic targets for gastrointestinal cancer immunotherapy.
Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer.
LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1.
Long noncoding RNA SNHG12 suppresses esophageal squamous cell carcinoma progression through competing endogenous RNA networks.
MicroRNA-301b and its target gene synaptosome-associated protein 91 as important modulators in esophageal cancer: functional experiments.
Multiomic Analysis of Methylation and Transcriptome Reveals a Novel Signature in Esophageal Cancer.
Simultaneous targeting PI3K and PERK pathways promotes cell death and improves the clinical prognosis in esophageal squamous carcinoma.
The cox-filter method identifies respective subtype-specific lncRNA prognostic signatures for two human cancers.
The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer.
The use of large-scale cDNA analysis to profile differential gene expression in KYSE 410 human esophageal cancer cells after irradiation.
Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.
Esophageal Squamous Cell Carcinoma
A 10?microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.
Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer.
Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target.
Development and validation of an autophagy-related prognostic signature in esophageal cancer.
Emerging Multimodality Approaches to Treat Localized Esophageal Cancer.
ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.
Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas.
Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment.
LAMC1 upregulation via TGF? induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-?B-CXCL1-STAT3.
Para-aortic lymph node metastasis in lower Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy: a CT-based atlas and its clinical implications for Adjuvant Radiotherapy.
Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer.
Survival-associated alternative splicing signatures in esophageal carcinoma.
Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
[Data mining of esophageal squamous cell carcinoma from The Cancer Genome Atlas database].
Essential Hypertension
Lanosterol Synthase Gene Polymorphisms and Changes in Endogenous Ouabain in the Response to Low Sodium Intake.
Essential Tremor
Network Fingerprint of Stimulation-Induced Speech Impairment in Essential Tremor.
Exanthema
Dermatology for the nondermatologist: a problem-oriented system.
Exostoses
Bony exostosis of the atlas with resultant cranial nerve palsy.
Rare association of anatomical variations of the atlas and the occipital in a case with cranial deformation.
Symptomatic occipitocervical paracondylar process.
The vertebral artery: a review of anatomical, histopathological and functional factors influencing blood flow to the hindbrain.
Eye Diseases
Atlas of Eye Disease.
Eyelid Diseases
Diagnostic atlas of common eyelid diseases, johnathan j. Dutton, gregg s. Gavre, alan d. Proia.
Fanconi Syndrome
Mutation analysis of the GLUT2 gene in three unrelated Egyptian families with Fanconi-Bickel syndrome: revisited gene atlas for renumbering.
Fatty Liver
Hepatocyte nuclear factor 1? suppresses steatosis-associated liver cancer by inhibiting PPAR? transcription.
High Squalene Epoxidase in Tumors Predicts Worse Survival in Patients With Hepatocellular Carcinoma: Integrated Bioinformatic Analysis on NAFLD and HCC.
Fetal Alcohol Spectrum Disorders
Magnetic Resonance Microscopy Defines Ethanol-Induced Brain Abnormalities in Prenatal Mice: Effects of Acute Insult on Gestational Day 8.
Fibrocystic Breast Disease
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
Fibromuscular Dysplasia
A 10-year follow-up of extracranial-intracranial bypass for the treatment of bilateral giant internal carotid artery aneurysms in a patient with fibromuscular dysplasia: case report.
Fibromyalgia
Occipital neuralgia: anatomic considerations.
Fibrosarcoma
High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma.
Filariasis
Images from the Haematologica Atlas of Hematologic Cytology: filariasis.
Focal Infection
[The "natural focal diseases" medical and geographical atlas of Russia as a tool to analyze their incidence in the population].
Fractures, Spontaneous
Pathological fracture of the atlas secondary to plasmacytoma.
Spontaneous fracture of atlas of cervical spine affected by rheumatoid arthritis.
[Contribution to the study of dislocation of the atlas caused by pathological fracture of the dentata of the epistropheus.]
[Halo-fixator vest--indications and complications]
[Pathologic fracture of the odontoid process with lateral dislocation of the atlas]
[Primary osteosynthesis of the odontoid process: a multicenter study]
Fragile X Syndrome
Application of an automated parcellation method to the analysis of pediatric brain volumes.
Friedreich Ataxia
Pattern of Cerebellar Atrophy in Friedreich's Ataxia-Using the SUIT Template.
Frontotemporal Dementia
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia.
Frontotemporal Lobar Degeneration
The power of neuroimaging biomarkers for screening frontotemporal dementia.
Funnel Chest
Minor sternum and vertebral column congenital defects in Lisbon Identified Skeletal Collection.
Fused Kidney
[A case of cerebral infarction in young adult resulting in thrombotic occlusion of vertebral artery due to repeated contact stimulation of cervical rotation accompanied to systemic malformations such as atlantoaxial subluxation and atlas dysplasia].
Gallbladder Neoplasms
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer.
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer.
Gallstones
Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse.
Ganglioglioma
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.
Gastroesophageal Reflux
High-resolution manometry: an atlas of esophageal motility disorders and findings of GERD using esophageal pressure topography.
Gastrointestinal Diseases
Radiological atlas of gastrointestinal disease.
Radiological Atlas of Gastrointestinal Disease.
Gastrointestinal Neoplasms
An Integrated Bioinformatics Analysis Repurposes an Antihelminthic Drug Niclosamide for Treating HMGA2-Overexpressing Human Colorectal Cancer.
Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer.
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
Modeling the Dynamics of Let-7-Coupled Gene Regulatory Networks Linking Cell Proliferation to Malignant Transformation.
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Structural impact due to PPQEE deletion in multiple cancer associated protein - Integrin ?V: An In silico exploration.
Toxicogenomic outcomes predictive of forestomach carcinogenesis following exposure to benzo(a)pyrene: Relevance to human cancer risk.
Genetic Diseases, Inborn
An atlas of common metabolic and genetic diseases
Atlas of genetics and cytogenetics in oncology and haematology in 2013.
Atlas of the face in genetic disorders.
Atlas of the Face in Genetic Disorders.
Bone Dysplasias. An Atlas of Genetic Disorders of Skeletal Development (Fourth Edition).
Bone Dysplasias: An Atlas of Genetic Disorders of Skeletal Development, Second Edition.
Facial malformation atlas aims to aid diagnosis of genetic disorders in patients of non-European descent: National Human Genome Research Institute launches online database of facial phenotypes targeting diverse populations.
Review of: 'Bone dysplasia-an atlas of genetic disorders of skeletal development (fourth edition)' Edited by: Jürgen W Spranger, Paula W Brill, Christine Hall, Gen Nishimura, Andrea Superti-Furga, Sheila Unger. Published by: Oxford University Press, 2018.
Giant Cell Tumors
Giant cell tumor of the posterior arch of the atlas.
Mandible and tongue-splitting approach for giant cell tumor of axis.
[A case of giant cell tumor in atlas]
Gigantism
Mythology and Neurosurgery.
Glaucoma
Atlas of Glaucoma.
Atlas-based score for automatic glaucoma risk stratification.
Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis.
[Surgical therapy for glaucoma (author's transl)]
Glaucoma, Open-Angle
Data-Driven Parcellation Approaches Based on Functional Connectivity of Visual Cortices in Primary Open-Angle Glaucoma.
Glioblastoma
334?A Functional Screen Identifies miRNAs that Induce Radioresistance in Glioblastomas.
A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
A classification model for distinguishing copy number variants from cancer-related alterations.
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma.
A deep convolutional neural network for segmentation of whole-slide pathology images identifies novel tumour cell-perivascular niche interactions that are associated with poor survival in glioblastoma.
A developmental taxonomy of glioblastoma defined and maintained by microRNAs.
A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma.
A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
A functional screen identifies miRs that induce radioresistance in glioblastomas.
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.
A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis.
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State.
A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma.
A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma.
A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients with Glioblastoma Multiforme in The Cancer Genome Atlas Dataset.
A robust topology-based algorithm for gene expression profiling.
A Serum Proteomic Signature Predicting Survival in Patients with Glioblastoma.
A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival.
A Two-Sample Test for Equality of Means in High Dimension.
Acetylcholine Receptor Activation as a Modulator of Glioblastoma Invasion.
Actin-capping protein CapG is associated with prognosis, proliferation and metastasis in human glioma.
Advances in the genetics of glioblastoma: are we reaching critical mass?
Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysis.
AMP kinase promotes glioblastoma bioenergetics and tumour growth.
An anatomic transcriptional atlas of human glioblastoma.
An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.
An Inflammatory Landscape for Preoperative Neurologic Deficits in Glioblastoma.
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor ?1 and ?2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Anatomic Gene Expression Atlas Fuels Glioblastoma Discovery.
Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Application of the differential hybridization of Atlas Human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue.
Atlas of tissue culture; astrocytoma and glioblastoma.
Automated network analysis identifies core pathways in glioblastoma.
Bayesian genome- and epigenome-wide association studies with gene level dependence.
Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
Big data visualization identifies the multidimensional molecular landscape of human gliomas.
C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
CanDrA: cancer-specific driver missense mutation annotation with optimized features.
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4.
CDK5 Knockdown inhibits proliferation and induces apoptosis and Cell Cycle Arrest in Human Glioblastoma.
CLASSIFICATION OF TUMOR HISTOPATHOLOGY VIA SPARSE FEATURE LEARNING.
Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer.
COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma.
Comparative evaluation of isoform-level gene expression estimation algorithms for RNA-seq and exon-array platforms.
Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.
Concordance of Gene Expression and Functional Correlation Patterns across the NCI-60 Cell Lines and the Cancer Genome Atlas Glioblastoma Samples.
Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma.
Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma.
Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival.
Corticosteroids compromise survival in glioblastoma.
CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells.
Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells.
D3M: detection of differential distributions of methylation levels.
Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition.
Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma.
DEMARCATE: Density-based magnetic resonance image clustering for assessing tumor heterogeneity in cancer.
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
Detection of Isocitrate Dehydrogenase Mutated Glioblastomas Through Anomaly Detection Analytics.
Determining frequent patterns of copy number alterations in cancer.
Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma.
Development of a prediction model for radiosensitivity using the expression values of genes and long non-coding RNAs.
Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma.
Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
DINGO: differential network analysis in genomics.
Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis.
DMBT1 Homozygous Deletion in Diffuse Astrocytomas Is Associated With Unfavorable Clinical Outcome.
DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues.
DNA Methylation Analysis Identifies Patterns in Progressive Glioma Grades to Predict Patient Survival.
Double Minute Chromosomes in Glioblastoma Multiforme Are Revealed by Precise Reconstruction of Oncogenic Amplicons.
Drug repurposing for glioblastoma based on molecular subtypes.
EGFR/c-myc axis regulates TGF?/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas.
Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma.
Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas.
Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors.
Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.
Estimation of parent specific DNA copy number in tumors using high-density genotyping arrays.
Evaluation of hierarchical models for integrative genomic analyses.
Exploratory analysis of the copy number alterations in glioblastoma multiforme.
Expression of amyloid precursor-like protein 2 (APLP2) in glioblastoma is associated with patient prognosis.
Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts.
Expression Profiling of the MAP Kinase Phosphatase Family Reveals a Role for DUSP1 in the Glioblastoma Stem Cell Niche.
Factor analysis for survival time prediction with informative censoring and diverse covariates.
FAM46A expression is elevated in glioblastoma and predicts poor prognosis of patients.
FBXW7 induces apoptosis in glioblastoma cells by regulating HDAC7.
Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas.
Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model.
Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.
Glioblastoma Distance From the Subventricular Neural Stem Cell Niche Does Not Correlate With Survival.
GliomaDB: A Web Server for Integrating Glioma Omics Data and Interactive Analysis.
Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature.
Glycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes.
HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
High EMP3 expression might independently predict poor overall survival in glioblastoma and its expression is related to DNA methylation.
High Expression of FOXP2 Is Associated with Worse Prognosis in Glioblastoma.
High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
High expression of TIG3 predicts poor survival in patients with primary glioblastoma.
High expression of WDR1 in primary glioblastoma is associated with poor prognosis.
High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas.
High levels of WNT-5A in human glioma correlate with increased presence of tumor-associated microglia/monocytes.
High-Performance Computational Analysis of Glioblastoma Pathology Images with Database Support Identifies Molecular and Survival Correlates.
Highly Expressed CYBRD1 Associated with Glioma Recurrence Regulates the Immune Response of Glioma Cells to Interferon.
Highly expressed genes in human high grade gliomas: immunohistochemical analysis of data from the human protein atlas.
HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.
Human glioma growth is controlled by microRNA-10b.
Human Hematopoietic Signal peptide-containing Secreted 1 (hHSS1) modulates genes and pathways in glioma: implications for the regulation of tumorigenicity and angiogenesis.
Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.
Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5.
Hypoxic Roadmap of Glioblastoma-Learning about Directions and Distances in the Brain Tumor Environment.
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function.
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma.
Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme.
Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.
Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients.
Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic Analysis.
Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme.
Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
Identifying gene-environment interactions incorporating prior information.
iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes.
ILK silencing inhibits migration and invasion of more invasive glioblastoma cells by downregulating ROCK1 and Fascin-1.
Imaging Genomics in Gliomas.
Imaging-AMARETTO: An Imaging Genomics Software Tool to Interrogate Multiomics Networks for Relevance to Radiography and Histopathology Imaging Biomarkers of Clinical Outcomes.
Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas.
Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme.
Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas.
Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab.
Increased Vascular Adhesion Protein 1 (VAP-1) Levels are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas.
Inhibition of the Spectraplakin Protein Microtubule Actin Crosslinking Factor 1 Sensitizes Glioblastomas to Radiation.
Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
Integrated Cox's model for predicting survival time of glioblastoma multiforme.
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Integrated morphologic analysis for the identification and characterization of disease subtypes.
Integrated Transcriptomic Analysis of Necrosis-related Gene in Diffuse Gliomas.
Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
Integrating Genomic Data with Transcriptomic Data for Improved Survival Prediction for Adult Diffuse Glioma.
Integration and comparison of different genomic data for outcome prediction in cancer.
Integrative Analysis of Multi-Omics Data Based on Blockwise Sparse Principal Components.
Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.
Integrative Multi-omics Module Network Inference with Lemon-Tree.
Integrative, multimodal analysis of glioblastoma using TCGA molecular data, pathology images, and clinical outcomes.
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
Invariant Delineation of Nuclear Architecture in Glioblastoma Multiforme from The Cancer Genome Atlas Cohort.
Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.
Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing.
Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer.
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma.
Latent Feature Decompositions for Integrative Analysis of Multi-Platform Genomic Data.
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
LncRNA SNHG4 regulates miR-138/c-Met axis to promote the proliferation of glioblastoma cells.
Long non-coding RNA LBX2-AS1 enhances glioma proliferation through downregulating microRNA-491-5p.
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.
Low LINC00599 expression is a poor prognostic factor in glioma.
Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
MET Gain in Diffuse Astrocytomas is Associated with Poorer Outcome.
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.
MGSEA - a multivariate Gene set enrichment analysis.
microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-? Signaling in Glioblastoma.
MicroRNA signatures predict prognosis of patients with glioblastoma multiforme through the Cancer Genome Atlas.
MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.
Mining TCGA data using Boolean implications.
MiR-1225-5p acts as tumor suppressor in glioblastoma via targeting FNDC3B.
miR-4725-3p targeting stromal interacting molecule 1 signaling is involved in xanthohumol inhibition of glioma cell invasion.
MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
MIRAGAA--a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer.
miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers.
Modelling cancer progression using Mutual Hazard Networks.
Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
Molecular heterogeneity of glioblastoma and its clinical relevance.
Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
MORPHOLOGICAL SIGNATURES AND GENOMIC CORRELATES IN GLIOBLASTOMA.
Mouse models of glioblastoma: lessons learned and questions to be answered.
MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set.
MRI Atlas of IDH Wild-Type Supratentorial Glioblastoma: Probabilistic Maps of Phenotype, Management, and Outcomes.
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.
Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures.
Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of de novo Glioblastoma Patients.
Mutual exclusivity analysis identifies oncogenic network modules.
Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastoma.
Netrin-4 promotes glioblastoma cell proliferation through integrin ?4 signaling.
Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
Network modeling of the transcriptional effects of copy number aberrations in glioblastoma.
Network-based integrative clustering of multiple types of genomic data using non-negative matrix factorization.
New glioblastoma heterogeneity atlas - a shared resource.
New strategies in the molecular targeting of glioblastoma: how do you hit a moving target?
NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability.
Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition.
Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images.
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.
Oncogenic effects of miR-10b in glioblastoma stem cells.
Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma.
Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis.
Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.
Oxidative Stress-Part of the Solution or Part of the Problem in the Hypoxic Environment of a Brain Tumor.
PAGE-Net: Interpretable and Integrative Deep Learning for Survival Analysis Using Histopathological Images and Genomic Data.
Pan-cancer analysis of TCGA data reveals notable signaling pathways.
Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database.
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.
PHENOTYPIC CHARACTERIZATION OF BREAST INVASIVE CARCINOMA VIA TRANSFERABLE TISSUE MORPHOMETRIC PATTERNS LEARNED FROM GLIOBLASTOMA MULTIFORME.
Potential Drug Prediction of Glioblastoma Based on Drug Perturbation-Induced Gene Expression Signatures.
PRADA: Pipeline for RNA sequencing Data Analysis.
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
Probabilistic radiographic atlas of glioblastoma phenotypes.
Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.
Prognostic relevance of CSF and peri-tumoral edema volumes in glioblastoma.
Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion.
Prognostic role of Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified primary and recurrent glioblastomas.
Proteoglycans and their roles in brain cancer.
Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
PTK7 regulates Id1 expression in CD44-high glioma cells.
Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates.
RADIO-IBAG: RADIOMICS-BASED INTEGRATIVE BAYESIAN ANALYSIS OF MULTIPLATFORM GENOMIC DATA.
Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.
Rap2B promotes the proliferation and migration of human glioma cells via activation of the ERK pathway.
Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma.
Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
Relationship between Glioblastoma Heterogeneity and Survival Time: An MR Imaging Texture Analysis.
Reproducibility analysis of multi-institutional paired expert annotations and radiomic features of the Ivy Glioblastoma Atlas Project (Ivy GAP) dataset.
Reproducibility of SNV-calling in multiple sequencing runs from single tumors.
Retrospective clinical trial experimentally validates glioblastoma genome-wide pattern of DNA copy-number alterations predictor of survival.
Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
Sequencing the next generation of glioblastomas.
Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
Sex difference of mutation clonality in diffuse glioma evolution.
Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.
Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis.
Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.
Somatic mutations of PIK3R1 promote gliomagenesis.
Spatial habitats from multiparametric MR imaging are associated with signaling pathway activities and survival in glioblastoma.
Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns.
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.
Subtyping glioblastoma by combining miRNA and mRNA expression data using compressed sensing-based approach.
Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.
Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort.
SVD identifies transcript length distribution functions from DNA microarray data and reveals evolutionary forces globally affecting GBM metabolism.
System-scale network modeling of cancer using EPoC.
Systematic genetic analysis identifies Cis-eQTL target genes associated with glioblastoma patient survival.
Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma.
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma.
The human secretome atlas initiative: Implications in health and disease conditions.
The IFN-?/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
The landscape of the mesenchymal signature in brain tumours.
The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2.
The prognosis of glioblastoma: a large, multifactorial study.
The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas.
The transcription factor PPAR? is overexpressed and is associated with a favourable prognosis in IDH-wildtype primary glioblastoma.
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.
Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.
Towards Population-Based Histologic Stain Normalization of Glioblastoma.
Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival.
Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells.
Tumor Habitat-derived Radiomic Features at Pretreatment MRI That Are Prognostic for Progression-free Survival in Glioblastoma Are Associated with Key Morphologic Attributes at Histopathologic Examination: A Feasibility Study.
Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes.
Upregulation of DLX2 Confers a Poor Prognosis in Glioblastoma Patients by Inducing a Proliferative Phenotype.
Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.
Utilizing Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Analyze Interstitial Fluid Flow and Transport in Glioblastoma and the Surrounding Parenchyma in Human Patients.
Where cancer genomics should go next: a clinician's perspective.
Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.
Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme.
[Cathepsin S (CTSS) is highly expressed in temozolomide-resistant glioblastoma T98G cells and associated with poor prognosis].
[Glioblastomas: Gliomagenesis, genetics, angiogenesis, and microenvironment.]
Glioma
A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.
A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme.
A 63 signature genes prediction system is effective for glioblastoma prognosis.
A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma.
A Comparative Study of the Molecular Characteristics of Familial Gliomas and Other Cancers.
A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma.
A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association.
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
A gene expression-based study on immune cell subtypes and glioma prognosis.
A machine learning analysis of a "normal-like" IDH-WT diffuse glioma transcriptomic subgroup associated with prolonged survival reveals novel immune and neurotransmitter-related actionable targets.
A Methodology for Texture Feature-based Quality Assessment in Nucleus Segmentation of Histopathology Image.
A network model of a cooperative genetic landscape in brain tumors.
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State.
A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression.
A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma.
A novel analytical model of MGMT methylation pyrosequencing offers improved predictive performance in patients with gliomas.
A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level.
A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma.
A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
A novel miR-7156-3p-HOXD13 axis modulates glioma progression by regulating tumor cell stemness.
A novel radiological classification system for cerebral gliomas: The Brain-Grid.
A novel serum microRNA-based identification and classification biomarker of human glioma.
A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomas.
A Potential Prognostic Gene Signature for Predicting Survival for Glioblastoma Patients.
A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain.
A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma.
A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
A pseudogene-signature in glioma predicts survival.
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas.
A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.
A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients.
A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.
A Risk Signature Consisting of Eight m6A Methylation Regulators Predicts the Prognosis of Glioma.
A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma.
A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma.
A robust two-gene signature for glioblastoma survival prediction.
A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma.
A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas.
Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.
ACTL6A knockdown inhibits cell migration by suppressing the AKT signaling pathway and enhances the sensitivity of glioma cells to temozolomide.
ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme.
ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2Q607R.
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.
Advances in Translational Research in Neuro-oncology.
Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features.
Aging-related tumor associated fibroblasts changes could worsen the prognosis of GBM patients.
Allergy may confer better survival on patients with gliomas.
Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastoma.
Amino acid metabolism-related gene expression-based risk signature can better predict overall survival for glioma.
An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas.
An autophagy-related long non-coding RNA signature for glioma.
An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma.
An immune-related lncRNA signature for patients with anaplastic gliomas.
An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
Analysis of long non-coding RNAs in glioblastoma for prognosis prediction using weighted gene co-expression network analysis, Cox regression, and L1-LASSO penalization.
Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of SPATS2L in Patients With Glioma.
Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress GBM Tumor Growth.
ANXA1 as a Prognostic and Immune Microenvironmental Marker for Gliomas Based on Transcriptomic Analysis and Experimental Validation.
ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Association of genomic subtypes of lower-grade gliomas with shape features automatically extracted by a deep learning algorithm.
Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma.
Automatic disease stage classification of glioblastoma multiforme histopathological images using deep convolutional neural network.
Bayesian genome- and epigenome-wide association studies with gene level dependence.
Bayesian predictive modeling for genomic based personalized treatment selection.
BICD Cargo Adaptor 1 (BICD1) Downregulation Correlates with a Decreased Level of PD-L1 and Predicts a Favorable Prognosis in Patients with IDH1-Mutant Lower-Grade Gliomas.
Big data visualization identifies the multidimensional molecular landscape of human gliomas.
Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.
Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
Bioinformatic profiling identifies an immune-related risk signature for glioblastoma.
Bioinformatical analysis of Gene Expression Omnibus (GEO) database associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 pathways with glioblastoma development and prognosis.
Bioinformatics Analysis of the Expression of ATP Binding Cassette Subfamily C Member 3 (ABCC3) in Human Glioma.
Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis.
Blocking Wnt/?-catenin Signal Amplifies Anti-PD-1 Therapeutic Efficacy by Inhibiting Tumor Growth, Migration, and Promoting Immune Infiltration in Glioblastomas.
Brain atlas for assessing the impact of tumor location on perioperative quality of life in patients with high-grade glioma: A prospective population-based cohort study.
Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells.
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4.
CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.
CD48 is a key molecule of immunomodulation affecting prognosis in glioma.
CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas.
CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastoma.
CDK5 Knockdown inhibits proliferation and induces apoptosis and Cell Cycle Arrest in Human Glioblastoma.
CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas.
Characterization and prognostic significance of alternative splicing events in lower-grade diffuse gliomas.
Characterization of an endoplasmic reticulum stress-related signature to evaluate immune features and predict prognosis in glioma.
Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups.
Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma.
Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma.
Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients.
CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high?grade glioma.
CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Classification of diffuse lower-grade glioma based on immunological profiling.
Classifying lower grade glioma cases according to whole genome gene expression.
Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma.
Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma.
Clinical and molecular immune characterization of ERBB2 in glioma.
Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas.
Clinical Significance and Systematic Expression Analysis of the Thyroid Receptor Interacting Protein 13 (TRIP13) as Human Gliomas Biomarker.
Clinicopathologic implications of NF1 gene alterations in diffuse gliomas.
COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma.
Combinations of four or more CpGs methylation present equivalent predictive value for MGMT expression and temozolomide therapeutic prognosis in gliomas.
Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.
Combining generative models for multifocal glioma segmentation and registration.
Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.
Comprehensive analysis of a long non-coding RNA-associated competing endogenous RNA network in glioma.
Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma.
Comprehensive analysis of multi-omics data of recurrent gliomas identifies a recurrence-related signature as a novel prognostic marker.
Comprehensive Analysis of PD-1 Gene Expression, Immune Characteristics and Prognostic Significance in 1396 Glioma Patients.
Comprehensive Analysis Reveals a 4-Gene Signature in Predicting Response to Temozolomide in Low-Grade Glioma Patients.
Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma.
Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas.
Comprehensive Transcriptomic Analysis and Experimental Validation Identify lncRNA HOXA-AS2/miR-184/COL6A2 as the Critical ceRNA Regulation Involved in Low-Grade Glioma Recurrence.
Concurrence of chromosome 6 chromothripsis and glioblastoma metastasis.
Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
Connectomic profile and clinical phenotype in newly diagnosed glioma patients.
Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBP?.
Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA.
Copy number profiling across glioblastoma populations has implications for clinical trial design.
Correlation of alteration of HLA-F expression and clinical characterization in 593 brain glioma samples.
Correlation of immune phenotype with IDH mutation in diffuse glioma.
Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-?B activation.
D3M: detection of differential distributions of methylation levels.
Decreased CDKL2 expression is correlated with the progression and poor prognosis of glioma.
Deep Radiogenomics of Lower-Grade Gliomas: Convolutional Neural Networks Predict Tumor Genomic Subtypes Using MR Images.
Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas.
Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis.
Defining neoplastic diseases differently: An emerging paradigm from The Cancer Genome Atlas lower-grade gliomas project.
Deformable Registration of Glioma Images Using EM Algorithm and Diffusion Reaction Modeling.
Developing a lncRNA Signature to Predict the Radiotherapy Response of Lower-Grade Gliomas Using Co-expression and ceRNA Network Analysis.
Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.
Development and Validation of an Immune-Related Long Non-coding RNA Prognostic Model in Glioma.
Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma.
Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients.
Development of an Immune-Related Prognostic Index Associated With Glioblastoma.
Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication.
Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma.
Diffuse gliomas in patients aged 55?years or over: A suggestion for IDH mutation testing.
Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis.
DNA Methylation Analysis Identifies Patterns in Progressive Glioma Grades to Predict Patient Survival.
DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
Downregulation of ?-l-fucosidase 1 suppresses glioma progression by enhancing autophagy and inhibiting macrophage infiltration.
Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma.
Dysregulation of microRNA-128 expression in WHO grades 2 glioma is associated with glioma-associated epilepsy: Down-regulation of miR-128 induces glioma-associated seizure.
DZIP3 is a key factor to stratify IDH1 wild-type lower-grade gliomas.
Effect of CCL2 siRNA on proliferation and apoptosis in the U251 human glioma cell line.
Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma.
EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
EGFR/c-myc axis regulates TGF?/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas.
Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma.
Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
ELF1 Transcription Factor Enhances the Progression of Glioma via ATF5 promoter.
Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
Epigenetic age acceleration and clinical outcomes in gliomas.
Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.
Establishment and validation of an immune-based prognostic score model in glioblastoma.
Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.
Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: Towards a "minimal common brain"
Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.
Expert-validated CSF segmentation of MNI atlas enhances accuracy of virtual glioma growth patterns.
Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma.
Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts.
Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma.
Expression profiles and prognostic significance of WNT family members in glioma via bioinformatic analysis.
Expression Profiling of Glioblastoma Cell Lines Reveals Novel Extracellular Matrix-Receptor Genes Correlated With the Responsiveness of Glioma Patients to Ionizing Radiation.
EZH2 is a potential prognostic predictor of glioma.
Factor analysis for survival time prediction with informative censoring and diverse covariates.
FAM225B Is a Prognostic lncRNA for Patients with Recurrent Glioblastoma.
Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression.
FGF2 as a potential prognostic biomarker for proneural glioma patients.
FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients.
Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
FOXL1 overexpression is associated with poor outcome in patients with glioma.
FOXO4 expression is associated with the occurrence and outcome of seizures: An RNA-sequencing analysis of low-grade gliomas.
G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
GAL-9: A predictive biomarker negatively regulating immune response in glioma patients.
Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
Gene signatures based on therapy responsiveness provide guidance for combined radiotherapy and chemotherapy for lower grade glioma.
Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
Genetic, cellular, and connectomic characterization of the brain regions commonly plagued by glioma.
Genomic Analysis of the BMP Family in Glioblastomas.
Genomic profiling of lower-grade gliomas uncovers cohesive disease groups: implications for diagnosis and treatment.
Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma.
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.
Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase.
Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling.
Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium.
Glioma-Associated Stromal Cells Stimulate Glioma Malignancy by Regulating the Tumor Immune Microenvironment.
GliomaDB: A Web Server for Integrating Glioma Omics Data and Interactive Analysis.
Gliomas display distinct sex-based differential methylation patterns based on molecular subtype.
GLISTR: Glioma Image Segmentation and Registration.
HDAC3 Expression Correlates with the Prognosis and Grade of Patients with Glioma: A Diversification Analysis Based on Transcriptome and Clinical Evidence.
Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas.
Heterozygous IDH1R132H/WT created by "single base editing" inhibits human astroglial cell growth by downregulating YAP.
High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma.
High expression of GPNMB indicates an unfavorable prognosis in glioma: Combination of data from the GEO and CGGA databases and validation in tissue microarray.
High expression of PYCARD is an independent predictor of unfavorable prognosis and chemotherapy resistance in glioma.
High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment.
High IER5 Gene Expression Is Associated With Poor Prognosis in Glioma Patients.
High levels of WNT-5A in human glioma correlate with increased presence of tumor-associated microglia/monocytes.
High TRAF3IP3 Level Predicts Poor Prognosis of Patients with Gliomas.
High-dose radiation associated with improved survival in IDH-wildtype low-grade glioma.
Highly expressed genes in human high grade gliomas: immunohistochemical analysis of data from the human protein atlas.
Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma.
Homeobox genes gain trimethylation of histone H3 lysine 4 in glioblastoma tissue.
HOTAIR is a therapeutic target in glioblastoma.
HOTAIR upregulates an 18-gene cell cycle-related mRNA network in glioma.
HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.
HOXC8: a predictive glioma biomarker that induces epithelia-mesenchymal transition.
Hsa-mir-127 impairs survival of patients with glioma and promotes proliferation, migration and invasion of cancerous cells by modulating replication initiator 1.
Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5.
Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma.
Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Identification and validation of RNA-binding protein-related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma.
Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance.
Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme.
Identification of a DNA Repair-Related Multigene Signature as a Novel Prognostic Predictor of Glioblastoma.
Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients.
Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas.
Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma.
Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma.
Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower?grade glioma and prognosis prediction.
Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomas.
Identification of biomarkers for the transition from low-grade glioma to secondary glioblastoma by an integrated bioinformatic analysis.
Identification of COL6A1 as the Key Gene Associated with Antivascular Endothelial Growth Factor Therapy in Glioblastoma Multiforme.
Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic Analysis.
Identification of Four Enhancer-Associated Genes as Risk Signature for Diffuse Glioma Patients.
Identification of genes associated with cancer prognosis in glioma: In silico data analyses of Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA).
Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas.
Identification of hub genes related to prognosis in glioma.
Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling.
Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas.
Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling.
Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
Identification of long non-coding RNA HERC2P2 as a tumor suppressor in glioma.
Identification of N6-methyladenosine-related lncRNAs for patients with primary glioblastoma.
Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme.
Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining.
Identification of PIEZO1 as a potential prognostic marker in gliomas.
Identification of Retinol Binding Protein 1 Promoter Hypermethylation in Isocitrate Dehydrogenase 1 and 2 Mutant Gliomas.
Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study.
Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.
Identification of Secreted Phosphoprotein 1 (SPP1) as a Prognostic Factor in Lower-Grade Gliomas.
Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.
Identification of survival?associated key genes and long non?coding RNAs in glioblastoma multiforme by weighted gene co?expression network analysis.
Identification of the role of TRPM8 in glioblastoma and its effect on proliferation, apoptosis and invasion of the U251 human glioblastoma cell line.
Identification of three glioblastoma subtypes and a six-gene prognostic risk index based on the expression of growth factors and cytokines.
Identification of WHO II/III gliomas by 16 prognostic-related gene signatures using machine learning methods.
Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas.
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas.
IDH-mutant gliomas with additional class-defining molecular events.
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR.
IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.
IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/?-catenin pathway.
IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
Imaging-AMARETTO: An Imaging Genomics Software Tool to Interrogate Multiomics Networks for Relevance to Radiography and Histopathology Imaging Biomarkers of Clinical Outcomes.
Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis.
In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma.
Increased M1 Macrophages Infiltration Correlated With Poor Survival Outcomes and Radiation Response in Gliomas.
Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas.
Increased Vascular Adhesion Protein 1 (VAP-1) Levels are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas.
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma.
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis.
Integrated Analysis of RNA-Binding Proteins in Glioma.
Integrated Analysis of the Clinical and Molecular Characteristics of IDH Wild-Type Gliomas in the Chinese Glioma Genome Atlas.
Integrated analysis of the genomic and transcriptional profile of high-grade gliomas in different age groups.
Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma.
Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma.
Integrated metabolomics and lipidomics analyses reveal metabolic reprogramming in human glioma with IDH1 mutation.
Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration.
Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.
Integrated Transcriptomic Analysis of Necrosis-related Gene in Diffuse Gliomas.
Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
Integrating Genomic Data with Transcriptomic Data for Improved Survival Prediction for Adult Diffuse Glioma.
Integration and analysis of genome-scale data from gliomas.
Integrative Analysis of Cellular Morphometric Context Reveals Clinically Relevant Signatures in Lower Grade Glioma.
Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma.
Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma.
Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-?B(p65) Signaling.
Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma.
Joint segmentation and deformable registration of brain scans guided by a tumor growth model.
Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA network.
KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4.
Knockdown of long non-coding RNA SLC8A1-AS1 attenuates cell invasion and migration in glioma via suppression of Wnt/?-catenin signaling pathways.
Knockdown of MRPL42 suppresses glioma cell proliferation by inducing cell cycle arrest and apoptosis.
Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma.
Large-Scale Analysis Reveals the Specific Clinical and Immune Features of DGCR5 in Glioma.
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma.
LINC00467 promotes proliferation and invasion in glioma via interacting with miRNA-485-5p.
LITAF Enhances Radiosensitivity of Human Glioma Cells via the FoxO1 Pathway.
LncRNA PCED1B-AS1 activates the proliferation and restricts the apoptosis of glioma through cooperating with miR-194-5p/PCED1B axis.
lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR?106a?5p?mediated P38 MAPK signaling.
Local Delivery of Minocycline and Vorinostat Targets the Tumor Microenvironment to Inhibit the Recurrence of Glioma.
Long non-coding RNA EWSAT1 contributes to the proliferation and invasion of glioma by sponging miR-152-3p.
Long Non-coding RNA Expression Profiling Identifies a Four-Long Non-coding RNA Prognostic Signature for Isocitrate Dehydrogenase Mutant Glioma.
Long non-coding RNA Fer-1-like family member 4 is overexpressed in human glioblastoma and regulates the tumorigenicity of glioma cells.
Long non-coding RNA HCG11 modulates glioma progression through cooperating with miR-496/CPEB3 axis.
Long non-coding RNA LBX2-AS1 enhances glioma proliferation through downregulating microRNA-491-5p.
Long non-coding RNA LINC00346 regulates proliferation and apoptosis by targeting miR-128-3p/SZRD1 axis in glioma.
Long Non-Coding RNA LINC00662 Regulated Proliferation and Migration by Targeting miR-34a-5p/LMAN2L Axis in Glioma.
Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma.
Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network.
Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high-grade glioma.
Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker.
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk.
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.
Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines.
Low Expression of APOB mRNA or Its Hypermethylation Predicts Favorable Overall Survival in Patients with Low-Grade Glioma.
Low expression of CDHR1 is an independent unfavorable prognostic factor in glioma.
Low LINC00599 expression is a poor prognostic factor in glioma.
LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2.
Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
Magnetic Resonance Features of Lower-grade Gliomas in Prediction of the Reverse Phase Protein A.
MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
Mapping chromatin accessibility and active regulatory elements reveals pathological mechanisms in human gliomas.
Mapping neuroplastic potential in brain-damaged patients.
MAPT (Tau) expression is a biomarker for an increased rate of survival for low?grade glioma.
Melatonergic system-based two-gene index is prognostic in human gliomas.
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes.
Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.
MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma.
MicroRNA-128 expression not associated with glioma-associated epilepsy in WHO grades 2 glioma: Data from the Cancer Genome Atlas (TCGA) project.
MicroRNA-1298-3p inhibits proliferation and invasion of glioma cells by downregulating Nidogen-1.
MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.
MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells.
MicroRNA-21 expression in the prognosis of low-grade gliomas: data from the cancer genome atlas (TCGA) project.
MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
MicroRNA?301a/ZNRF3/wnt/??catenin signal regulatory crosstalk mediates glioma progression.
MicroRNA?422a functions as a tumor suppressor in glioma by regulating the Wnt/??catenin signaling pathway via RPN2.
Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.
MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas.
MiR-1225-5p acts as tumor suppressor in glioblastoma via targeting FNDC3B.
miR-129-5p targets Wnt5a to block PKC/ERK/NF-?B and JNK pathways in glioblastoma.
miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase.
MiR-137 inhibits the proliferation, invasion and migration of glioma via targeting to regulate EZH2.
miR-17-5p-CXCL14 axis related transcriptome profile and clinical outcome in diffuse gliomas.
miR-193a-3p Promotes the Invasion, Migration, and Mesenchymal Transition in Glioma through Regulating BTRC.
MiR-206 is down-regulated and suppresses cell proliferation by targeting FOXP1 in brain gliomas.
MiR-218 Inhibited Growth and Metabolism of Human Glioblastoma Cells by Directly Targeting E2F2.
MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.
miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells.
MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.
miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.
Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma.
Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.
Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas.
Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples.
Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy.
Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma.
Molecular classification of IDH-mutant glioblastomas based on gene expression profiles.
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
Molecular Mechanisms of KDELC2 on Glioblastoma Tumorigenesis and Temozolomide Resistance.
Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas.
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Molecular subtype impacts surgical resection in low-grade gliomas: A Chinese Glioma Genome Atlas database analysis.
Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients.
Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma.
Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade Gliomas.
Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.
Multi-project and Multi-profile joint Non-negative Matrix Factorization for cancer omic datasets.
Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas.
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.
Multiomics Profiling and Clustering of Low-Grade Gliomas Based on the Integrated Stress Status.
Mutant IDH1 and thrombosis in gliomas.
Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin.
Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters.
Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence.
Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence.
MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas.
N6-methyladenine-related genes affect biological behavior and the prognosis of glioma.
N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
NDRG1 prognosticates the natural course of disease in WHO grade II glioma.
Network-based integrative clustering of multiple types of genomic data using non-negative matrix factorization.
Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro.
Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas.
Non-Invasive Estimation of Glioma IDH1 Mutation and VEGF Expression by Histogram Analysis of Dynamic Contrast-Enhanced MRI.
Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-?B(p65) pathway.
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis.
Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
OSgbm: An Online Consensus Survival Analysis Web Server for Glioblastoma.
Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas.
Overexpression of EP300-interacting inhibitor of differentiation 3 predicts poor prognosis in patients with glioblastoma multiforme.
Overexpression of Fn14 in gliomas: tumor progression and poor prognosis.
Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.
Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.
Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.
Overexpression of PSAT1 Gene is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients with IDH1 Mutations and Chromosome 1p19q Codeletion.
Overexpression of Transforming Acidic Coiled Coil?Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma.
Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.
PABPC1 relevant bioinformatic profiling and prognostic value in gliomas.
Pan-cancer analyses reveal regulation and clinical outcome association of the shelterin complex in cancer.
Pan-cancer analysis of TCGA data reveals notable signaling pathways.
PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.
Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis.
PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations.
PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor.
PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation.
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.
Phytanoyl-CoA 2-Hydroxylase-Interacting Protein-Like Gene Is a Therapeutic Target Gene for Glioblastoma Multiforme.
Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.
PODNL1 promotes cell proliferation and migration in glioma via regulating Akt/mTOR pathway.
Polycomb group expression signatures in the malignant progression of gliomas.
Pre-treatment neutrophils count as a prognostic marker to predict chemotherapeutic response and survival outcomes in glioma: a single-center analysis of 288 cases.
Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.
Predicting the likelihood of postoperative seizure status based on mRNA sequencing in low-grade gliomas.
Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis.
Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma.
Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma.
Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients.
Prognostic Biomarker ZNF311 and Its Correlation With Tumor Progression and Immune Infiltrates in Glioma.
Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.
Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.
Prognostic Implications of the Complement Protein C1q in Gliomas.
Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation.
Prognostic power of a lipid metabolism gene panel for diffuse gliomas.
Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion.
Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
Prognostic significance of age related genes in patients with lower grade glioma.
Prognostic significance of MEOX2 in gliomas.
Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients.
Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.
Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.
Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.
PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
Quiescin Sulfhydryl Oxidase 1 Regulates the Proliferation, Migration and Invasion of Human Glioblastoma Cells via PI3K/Akt Pathway.
RAB34 was a progression- and prognosis-associated biomarker in gliomas.
RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition.
Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma.
Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.
Radiogenomics correlation between MR imaging features and mRNA-based subtypes in lower-grade glioma.
Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.
Radiomics Features Predict CIC Mutation Status in Lower Grade Glioma.
Radiomics in gliomas: A promising assistance ?for glioma clinical research.
Rap2B promotes the proliferation and migration of human glioma cells via activation of the ERK pathway.
Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults.
Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy.
Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.
Reduced expression of microRNA?206 regulates cell proliferation via cyclinD2 in gliomas.
Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients.
Regulation of gliomagenesis and stemness through acid sensor ASIC1a.
Regulation of prognosis-related Siglecs in the glioma microenvironment.
RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis.
RELB: A novel prognostic marker for glioblastoma as identified by population-based analysis.
RELL1, a novel oncogene, accelerates tumor progression and regulates immune infiltrates in glioma.
Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system.
Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells.
Retrospective Validation of a 168-Gene Expression Signature for Glioma Classification on a Single Molecule Counting Platform.
RGS16 promotes glioma progression and serves as a prognostic factor.
RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Role of endothelin receptor type B (EDNRB) in lung adenocarcinoma.
Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value.
RUNX1 and REXO2 are associated with the heterogeneity and prognosis of IDH wild type lower grade glioma.
RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGF? pathway-dependent manner.
Screening and functional prediction of differentially expressed circular RNAs in human glioma of different grades.
Screening of autophagy genes as prognostic indicators for glioma patients.
Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules.
Set-Wise Differential Interaction Between Copy Number Alterations and Gene Expressions of Lower-Grade Glioma Reveals Prognosis-Associated Pathways.
Seven genes for the prognostic prediction in patients with glioma.
Sex difference of mutation clonality in diffuse glioma evolution.
Sexual dimorphism in glioma glycolysis underlies sex differences in survival.
Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas.
Silencing of HAS2-AS1 mediates PI3K/AKT signaling pathway to inhibit cell proliferation, migration, and invasion in glioma.
Simulation of anisotropic growth of low-grade gliomas using diffusion tensor imaging.
Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme.
Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma.
Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis.
Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome.
Specific clinical and immune features of CD68 in glioma via 1,024 samples.
Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns.
Stanniocalcin 1 is a prognostic biomarker in glioma.
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.
Surgery of Insular Diffuse Gliomas-Part 2: Probabilistic Cortico-Subcortical Atlas of Critical Eloquent Brain Structures and Probabilistic Resection Map During Transcortical Awake Resection.
Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q.
Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma.
Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts.
Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma.
T cell atlas reveals route to glioma immunotherapy.
T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme.
T-Cell Exhaustion Status Under High and Low Levels of Hypoxia-Inducible Factor 1? Expression in Glioma.
Target identification reveals lanosterol synthase as a vulnerability in glioma.
TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.
TEAD4 is a novel independent predictor of prognosis in LGG patients with IDH mutation.
Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma.
TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma.
The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma.
The Cancer Genome Atlas expression profiles of low-grade gliomas.
The expression change of OTUD3-PTEN signaling axis in glioma cells.
The increasing expression of GPX7 related to the malignant clinical features leading to poor prognosis of glioma patients.
The Landscape of Viral Expression Reveals Clinically Relevant Viruses with Potential Capability of Promoting Malignancy in Lower-Grade Glioma.
The Neurogenic Compound P7C3 Regulates the Aerobic Glycolysis by Targeting Phosphoglycerate Kinase 1 in Glioma.
The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells.
The Prognostic Role of Glutathione Peroxidase 1 and Immune Infiltrates in Glioma Investigated Using Public Datasets.
The Prognostic Value of EMT in Glioma and its Role in the Glioma Immune Microenvironment.
The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas.
The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
The role of epigenetic modifications, long-range contacts, enhancers and topologically associating domains in the regulation of glioma grade-specific genes.
The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1.
The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.
Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma.
Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis.
Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
TLR2 promotes development and progression of human glioma via enhancing autophagy.
Transcription factor AP-4 (TFAP4)-upstream ORF coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the TFAP4/long noncoding RNA 00520/microRNA-520f-3p feedback loop.
Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas.
Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
Transcriptomic profiling identifies a DNA repair-related signature as a novel prognostic marker in lower-grade gliomas.
Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells.
Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survival.
Tumor mutational burden is associated with poor outcomes in diffuse glioma.
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1.
Tumor-associated macrophages based signaling pathway analysis and hub genes identification in glioma.
Twenty Metabolic Genes Based Signature Predicts Survival of Glioma Patients.
Two Unique Glioma Subtypes Revealed.
Ultrasensitive immunoprofiling of plasma extracellular vesicles identifies syndecan-1 as a potential tool for minimally invasive diagnosis of glioma.
Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes.
Unveiling new interdependencies between significant DNA methylation sites, gene expression profiles and glioma patients survival.
Up-regulation of ANKDR49, a poor prognostic factor, regulates cell proliferation of gliomas.
Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.
Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter.
Upregulation of DLX2 Confers a Poor Prognosis in Glioblastoma Patients by Inducing a Proliferative Phenotype.
Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients.
Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Uronic acid metabolic process-related gene expression-based signature predicts overall survival of glioma.
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53.
Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma.
Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.
Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme.
ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.
Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.
[Cathepsin S (CTSS) is highly expressed in temozolomide-resistant glioblastoma T98G cells and associated with poor prognosis].
[Increased TRIM5 is associated with a poor prognosis and immune infiltration in glioma patients].
[NEUROPATHOLOGICAL ATLAS. 1. THE PATHOLOGY OF GLIOMAS.]
Glomerulonephritis
AJKD Atlas of Renal Pathology: Anti-Glomerular Basement Membrane Antibody-Mediated Glomerulonephritis.
AJKD Atlas of Renal Pathology: Cryoglobulinemic Glomerulonephritis.
AJKD Atlas of Renal Pathology: Fibrillary Glomerulonephritis.
AJKD Atlas of Renal Pathology: Glomerulonephritis With Dominant C3.
AJKD Atlas of Renal Pathology: Pauci-immune Necrotizing Crescentic Glomerulonephritis.
AJKD Atlas of Renal Pathology: Postinfectious Glomerulonephritis.
AJKD Atlas of Renal Pathology: Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits.
AJKD Atlas of Renal Pathology: Subacute Bacterial Endocarditis-Associated Glomerulonephritis.
Histopathological atlas of renal diseases. Membranoproliferative glomerulonephritis.
Histopathological atlas of renal diseases: Acute post-streptococcal glomerulonephritis.
Glomerulonephritis, IGA
AJKD Atlas of Renal Pathology: IgA nephropathy.
Glomerulonephritis, Membranoproliferative
AJKD Atlas of Renal Pathology: Dense Deposit Disease.
AJKD Atlas of Renal Pathology: Membranoproliferative Glomerulonephritis.
Histopathological atlas of renal diseases. Membranoproliferative glomerulonephritis.
Glomerulonephritis, Membranous
AJKD Atlas of Renal Pathology: Membranous Nephropathy.
Histopathological atlas of renal diseases: membranous glomerulonephritis.
Glomerulosclerosis, Focal Segmental
AJKD Atlas of Renal Pathology: Cellular Variant of Focal Segmental Glomerulosclerosis.
AJKD Atlas of Renal Pathology: Focal Segmental Glomerulosclerosis.
AJKD Atlas of Renal Pathology: Hilar Variant of Focal Segmental Glomerulosclerosis.
AJKD Atlas of Renal Pathology: Tip Lesion Variant of Focal Segmental Glomerulosclerosis.
Histopathological atlas of renal diseases: Minimal Change disease and focal glomerulosclerosis.
Goiter, Endemic
Endemic goiter in Morocco (Skoura-Toundoute areas in the high atlas).
Goldenhar Syndrome
Persistent torticollis, facial asymmetry, grooved tongue, and dolicho-odontoid process in connection with atlas malformation complex in three family subjects.
Granuloma
Combined transmastoid middle fossa approach for giant cholesterol granuloma of the petrous apex: technique for "dual exhaust" drainage.
Radiologic appearance of chronic parapharyngeal Teflon granuloma.
Head and Neck Neoplasms
An oral keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer.
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma.
Atlas based segmentation in prone breast cancer radiation therapy.
CD44(+) tumor cells promote early angiogenesis in head and neck squamous cell carcinoma.
Chrysosplenol D Triggers Apoptosis through Heme Oxygenase-1 and Mitogen-Activated Protein Kinase Signaling in Oral Squamous Cell Carcinoma.
Clinical validation and applications for CT-based atlas for contouring the lower cranial nerves for head and neck cancer radiation therapy.
Correction: intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas.
Correction: Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas.
Does HPV Subtype Predict Outcomes in Head and Neck Cancers?
Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma.
Expression profiling of long non-coding RNA identifies linc-RoR as a prognostic biomarker in oral cancer.
Gene Expression Subtype Predicts Nodal Metastasis and Survival in Human Papillomavirus-Negative Head and Neck Cancer.
Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors.
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival.
High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
Human Endogenous Retrovirus Expression Is Associated with Head and Neck Cancer and Differential Survival.
Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.
Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.
Identification of the Immune-Related Genes in Tumor Microenvironment That Associated With the Recurrence of Head and Neck Squamous Cell Carcinoma.
Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
IL-10 and integrin signaling pathways are associated with head and neck cancer progression.
Immune Cluster and PPI Network Analyses Identified CXCR3 as a Key Node of Immunoregulation in Head and Neck Cancer.
Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.
Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas.
Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas.
Mass spectrometric analysis of SOX11-binding proteins in head and neck cancer cells demonstrates the interaction of SOX11 and HSP90?.
MicroRNA-Target Network Inference and Local Network Enrichment Analysis Identify Two microRNA Clusters with Distinct Functions in Head and Neck Squamous Cell Carcinoma.
Multiatlas approach with local registration goodness weighting for MRI-based electron density mapping of head and neck anatomy.
Novel deep learning-based survival prediction for oral cancer by analyzing tumor-infiltrating lymphocyte profiles through CIBERSORT.
Open Access Publishing of Textbooks and Guidelines for Otolaryngologists in Developing Countries.
Past and future impact of next-generation sequencing in head and neck cancer.
Proteomic profiling identifies PTK2/FAK as a driver of radioresistance in HPV negative head and neck cancer.
Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma.
Reformed smokers have survival benefits after head and neck cancer.
Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer.
The Cancer Genome Atlas findings in head and neck cancer: a renewed hope.
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers.
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.
TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy.
Use of a novel atlas for muscles of mastication to reduce inter observer variability in head and neck radiotherapy contouring.
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
[Effect of silencing LASP1 on biological behaviors of oral squamous cell carcinoma cells and IC50 of three anti-tumor drugs].
Head Injuries, Closed
Traumatic posterior atlantoaxial dislocation without neurological deficit: case report.
Headache Disorders
Delivery of care for migraine in the Asian Oceanian region: A cross-sectional study.
Prevalence and burden of headache in children and adolescents in Austria - a nationwide study in a representative sample of pupils aged 10-18?years.
Hearing Loss
Kimmerle's anomaly as a possible causative factor of chronic tension-type headaches and neurosensory hearing loss: case report and literature review.
Hearing Loss, Sudden
[Sudden hearing loss and the cranio-cervical junction]
Heart Block
Cell atlas of the fetal human heart and implications for autoimmune-mediated congenital heart block.
Heart Defects, Congenital
A Colour Atlas of Cardiac Surgery: Congenital Heart Disease.
A colour atlas of cardiac surgery: congenital heart disease. Vol 2.
An Atlas of Congenital Heart Disease.
AN ATLAS OF CONGENITAL HEART DISEASE: Compiled from the Museum of Congenital Heart Disease at Children's Hospital of Pittsburgh.
Maude Abbott: a biography.
Nomenclature for Pediatric and Congenital Cardiac Care: Unification of Clinical and Administrative Nomenclature - The 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Revision of the International Classification of Diseases (ICD-11).
Transcriptional atlas of cardiogenesis maps congenital heart disease interactome.
Voxelwise atlas rating for computer assisted diagnosis: Application to congenital heart diseases of the great arteries.
[A case of aplasia of the anterior arch of the atlas associated with cleft of the posterior arches of C1 and C2 and a congenital heart disease]
[A case of applasia of the anterior arch of the atlas associated with cleft of the posterior arches of C1 and C2 and a congenital heart diseases]
[The atlas of angiocardiography in congenital heart defects.]
Heart Diseases
Atlas of Congenital Cardiac Disease.
Atlas of geographic and racial/ethnic disparities in heart disease death rates for US men.
Atlas-based auto-segmentation for delineating the heart and cardiac substructures in breast cancer radiation therapy.
Chamber Specific Gene Expression Landscape of the Zebrafish Heart.
Dr. Maude Abbott's Atlas of Congenital Cardiac Disease.
Heart Disease Atlas.
Heart disease mortality in women: racial, ethnic, and geographic disparities.
Human atlas of the cardiac fiber architecture: study on a healthy population.
Maude Abbott: a biography.
Nomenclature for Pediatric and Congenital Cardiac Care: Unification of Clinical and Administrative Nomenclature - The 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Revision of the International Classification of Diseases (ICD-11).
Poverty, a risk factor overlooked: a cross-sectional cohort study comparing poverty rate and cardiovascular disease outcomes in the state of Florida.
Structural and Social Determinants of Health Factors Associated with County-Level Variation in Non-Adherence to Antihypertensive Medication Treatment.
Tetralogy of Fallot. The first 300 years.
Ventricular arrhythmias. A guide to their localisation.
WHO publishes definitive atlas on global heart disease and stroke epidemic.
William Osler, Maude Abbott, Paul Dudley White, and Helen Taussig: the origins of congenital heart disease in North America.
Heart Failure
Association of hospice utilization and publicly reported outcomes following hospitalization for pneumonia or heart failure: a retrospective cohort study.
ATLAS shows global undertreatment of heart failure.
ATLAS: high dose lisinopril is superior to low dose in heart failure.
Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study.
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study.
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.
Heart Failure Atlas, a major project of the Heart Failure Association in concert with the European Society of Cardiology.
Heart failure management in primary care: implications of the ATLAS study.
High dose lisinopril in heart failure: economic considerations.
Identification, diagnosis and treatment of heart failure: could we do better?
Impact of hospitals' Referral Region racial and ethnic diversity on 30-day readmission rates of older adults.
Introduction to the Canadian Cardiovascular Outcomes Research Team's (CCORT) Canadian Cardiovascular Atlas project.
Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.
Mode of death in heart failure: findings from the ATLAS trial.
The ATLAS study: low-dose versus high-dose lisinopril in heart failure.
The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019.
The Heart Failure Association Atlas: rationale, objectives, and methods.
The influence of dose of angiotensin I-converting enzyme inhibitor on systolic blood pressure variability in heart failure: a substudy of the Assessment of Treatment with Lisinopril and Survival in heart failure (ATLAS) trial.
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.
What does ATLAS really tell us about "high" dose angiotensin-converting enzyme inhibition in heart failure?
[Cardiac insufficiency: what treatment? what dose? For which patients? Converting enzyme inhibitors and diuretics]
[Clinical study of the month. The ATLAS study]
Heart Neoplasms
Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences.
Heart Septal Defects, Atrial
[A case of cerebral infarction in young adult resulting in thrombotic occlusion of vertebral artery due to repeated contact stimulation of cervical rotation accompanied to systemic malformations such as atlantoaxial subluxation and atlas dysplasia].
Hemangioma
Spectrum of scintigraphic appearance of liver hemangiomas.
[Atlas of dermatology: hemangioma simplex, portwine stain]
Hemangiosarcoma
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.
Hematologic Diseases
Atlas of blood disease on the internet.
Clinical Atlas of Blood Diseases.
Diseases of the Blood and Atlas of Hematology with Clinical and Hematologic Descriptions of the Blood Diseases Including a Section on Technic and Terminology.
Hematologic Neoplasms
An atlas of chromosomes in hematological malignancies. Example: 11q23 and MLL partners.
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Hematoma, Subdural
[An atlas of the clinico-pathological study of diseases of the nervous system. 2. Chronic subdural hematoma with spotaneous remission]
Hematoma, Subdural, Acute
Traumatic posterior atlantoaxial dislocation without neurological deficit: case report.
Hematoma, Subdural, Chronic
[An atlas of the clinico-pathological study of diseases of the nervous system. 2. Chronic subdural hematoma with spotaneous remission]
Hemifacial Spasm
Endoscopic-Assisted Microvascular Decompression of Ectatic Vertebral Artery for Hemifacial Spasm: Operative Video and Technical Nuances.
Hemiplegia
Cruciate paralysis and hemiplegia cruciata: report of three cases.
The Pathology of Rigors: Illustrated by a Case of Hemiplegia, from Dislocation of the Atlas, Preceded and Accompanied by Constant Shivering and Sense of Coldness.
[Carotid-vertebrobasilar anastomosis]
Hemochromatosis
Validation of a radiographic scoring system for haemochromatosis arthropathy.
Hemoptysis
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.
Hepatitis
Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.
Data harmonization process for creating the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Atlas.
Several microRNAs could predict survival in patients with hepatitis B-related liver cancer.
Hepatitis B
Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma.
Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy Efficacy.
Herpes Zoster
Computed three-dimensional atlas of subthalamic nucleus and its adjacent structures for deep brain stimulation in Parkinson's disease.
The raphe nuclei of the cat brain stem: a topographical atlas of their efferent projections as revealed by autoradiography.
Hidradenitis Suppurativa
An atlas of the morphological manifestations of hidradenitis suppurativa.
Hirschsprung Disease
A Colour Atlas of Surgery for Hirschsprung's Disease: Single Surgical Procedures, vol 21.
Histiocytosis
Atlantoaxial Langerhans cell histiocytosis radiographic characteristics and corresponding prognosis analysis.
Basilar Invagination Caused by Langerhans Cell Histiocytosis of the Atlas in an Adult: A Case Report.
CT-guided biopsy for Langerhans cell histiocytosis of the atlas: a case report and literature review.
Expert's comment concerning Grand Rounds case entitled "Langerhans cell histiocytosis of the atlas in an adult" (by Wo Quan Zhong, Liang Jiang, Qing Jun Ma, Zhong Jun Liu, Xiao Guang Liu, Feng Wei, Hui Shu Yuan, Geng Ting Dang).
Langerhans cell histiocytosis of the atlas in a female adult.
Langerhans cell histiocytosis of the atlas in an adult.
Langerhans cell histiocytosis of the atlas in the pediatric spine: total reconstitution of the bone lesion after nonoperative treatment. A report of two cases.
Langerhans cell histiocytosis of the atlas. A report of three cases.
Histiocytosis, Langerhans-Cell
Atlantoaxial Langerhans cell histiocytosis radiographic characteristics and corresponding prognosis analysis.
Basilar Invagination Caused by Langerhans Cell Histiocytosis of the Atlas in an Adult: A Case Report.
CT-guided biopsy for Langerhans cell histiocytosis of the atlas: a case report and literature review.
Langerhans cell histiocytosis of the atlas in a female adult.
Langerhans cell histiocytosis of the atlas in an adult.
Langerhans cell histiocytosis of the atlas in the pediatric spine: total reconstitution of the bone lesion after nonoperative treatment. A report of two cases.
Langerhans cell histiocytosis of the atlas. A report of three cases.
HIV Infections
An atlas of HIV-associated oral lesions: a new classification and diagnostic criteria.
Functional proteomic atlas of HIV infection in primary human CD4+ T cells.
Hoarseness
Plasmacytoma of the atlas presenting as hoarseness: a rare cause of unilateral vocal fold palsy.
Holoprosencephaly
Structure of the human Lanosterol synthase gene and its analysis as a candidate for holoprosencephaly (HPE1).
Huntington Disease
An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington's disease caudate nucleus.
Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.
Hydrocephalus
A framework for analysis of brain cine MR sequences.
Aneurysmatic bone cyst of the craniocervical region: Surgical technique.
Fiber feature map based landmark initialization for highly deformable DTI registration.
Microsurgical resection of giant intraventricular meningioma.
Multi-atlas segmentation of the hydrocephalus brain using an adaptive ventricle atlas.
[Mucopolysaccharidosis IV-A (Maroteaux-Lamy disease, severe form): incipient compressive myelopathy, cerebrospinal fluid fistula and tracheal stenosis in an adult patient]
Hypercholesterolemia
Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear.
Hyperlipidemias
Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing.
Hyperostosis
Bipartite atlas and hypertrophy of its anterior arch. A case report.
Cervical myelopathy caused by pseudoarthrosis between the atlas and axis associated with diffuse idiopathic skeletal hyperostosis.
The aetiology behind torticollis and variable spine defects in patients with Müllerian duct/renal aplasia-cervicothoracic somite dysplasia syndrome: 3D CT scan analysis.
Hyperostosis, Diffuse Idiopathic Skeletal
Cervical myelopathy caused by pseudoarthrosis between the atlas and axis associated with diffuse idiopathic skeletal hyperostosis.
Hyperoxaluria
AJKD Atlas of Renal Pathology: Oxalosis.
Hypersensitivity
A COLOUR ATLAS OF ALLERGY.
Allergy may confer better survival on patients with gliomas.
Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data across 27 Tissue Types.
Dataset reporting 4654 cow milk proteins listed according to lactation stages and milk fractions.
Effect of estrogen receptor ? binding on functional DNA methylation in breast cancer.
Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response.
Hypertension
Association of Processed Meats and Alcohol Consumption with Renal Cell Carcinoma: A Worldwide Population-Based Study.
Compression of the internal jugular vein by the transverse process of the atlas as the cause of cerebellar hemorrhage after supratentorial craniotomy.
Coronary heart disease and hypertension among Jews immigrated to Israel from the Atlas Mountain region of North Africa.
Independent Left Ventricular Morphometric Atlases Show Consistent Relationships with Cardiovascular Risk Factors: A UK Biobank Study.
Hypertension, Pulmonary
Cell landscape atlas for patients with chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy constructed using single-cell RNA sequencing.
Hypesthesia
[A surgical case of cervical canal stenosis caused by atlas hypoplasia in an elderly patient]
Hypoalbuminemia
Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation.
Hypoglossal Nerve Diseases
[Hypoglossal nerve palsy caused by hypoplasia of the atlas and ossification of the posterior longitudinal ligament]
Hypoglycemia
A New Preventive Strategy for Hypoglycemia Incorporating Added Food Diet in Patients with Type 2 Diabetes Who Received Sitagliptin Therapy.
Hypospadias
Hypospadias in the neonate.
Hypotension
Lisinopril: a review of its use in congestive heart failure.
Hypotrichosis
Bi-allelic Mutations in LSS, Encoding Lanosterol Synthase, Cause Autosomal-Recessive Hypotrichosis Simplex.
Two cases of severe congenital hypotrichosis caused by compound heterozygous mutations in the LSS gene.
Hypoventilation
The AR-8800--a new impedance pneumograph (plethysmograph) respiratory monitor.
Idiopathic Pulmonary Fibrosis
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis.
The Idiopathic Pulmonary Fibrosis Cell Atlas.
Ileus
Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation.
Immunoglobulin Light-chain Amyloidosis
AJKD Atlas of Renal Pathology: AL Amyloidosis.
Infarction, Middle Cerebral Artery
A digital map of middle cerebral artery infarcts associated with middle cerebral artery trunk and branch occlusion.
Detection of an unkown peak at 1.2 ppm in proton magnetic resonance spectra of cats with cerebral ischemic necrosis.
Rat brain digital stereotaxic white matter atlas with fine tract delineation in Paxinos space and its automated applications in DTI data analysis.
Infarction, Posterior Cerebral Artery
Digital map of posterior cerebral artery infarcts associated with posterior cerebral artery trunk and branch occlusion.
Infections
A Host Proteome Atlas of Streptococcus pyogenes Infection.
A Topographical Atlas of Shiga Toxin 2e Receptor Distribution in the Tissues of Weaned Piglets.
A unified atlas of CD8 T cell dysfunctional states in cancer and infection.
Active contour regularized semi-supervised learning for COVID-19 CT infection segmentation with limited annotations.
Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.
An updated atlas of human helminth infections: the example of East Africa.
Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.
Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico.
Atlas of brain proton magnetic resonance spectra. Part III: Viral infections.
Atlas of infections of the skin.
ATLAS trials: efficacy and safety of telavancin compared with vancomycin for the treatment of skin infections.
Bilateral atlas laminar hook combined with transarticular screw fixation for an unstable bursting atlantal fracture.
Cabotegravir Plus Rilpivirine: First Approval.
Changes in Racial and Ethnic Disparities in Estimated Diagnosis Rates of Heterosexually-acquired HIV Infection among Heterosexual Males in the United States, 2014-2018.
Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
Clostridioides difficile infections: Epidemiology, correlations and treatment in a Lebanese cohort with use of ATLAS scoring.
Co?expression of peripheral olfactory receptors with SARS?CoV?2 infection mediators: Potential implications beyond loss of smell as a COVID?19 symptom.
Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients.
Contemporary epidemiological overview of malaria in Madagascar: operational utility of reported routine case data for malaria control planning.
Craniovertebral fixation … a new technique of occipital - cervical fixation.
Cystic Echinococcosis in Three Locations in the Middle Atlas, Morocco: Estimation of the Infection Rate in the Dog Reservoir.
Defining Host Responses during Systemic Bacterial Infection through Construction of a Murine Organ Proteome Atlas.
Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Côte d'Ivoire, Mali and Senegal.
Developing a continental atlas of the distribution and trypanosomal infection of tsetse flies (Glossina species).
Epidemiological aspects of lungworm infections of goats in Morocco.
Epidemiological study of the cystic echinococcosis in Morocco.
Epidemiological surveys of, and research on, soil-transmitted helminths in Southeast Asia: a systematic review.
Establishment of a sentinel surveillance network for sexually transmissible infections and blood borne viruses in Aboriginal primary care services across Australia: the ATLAS project.
Estimating the global distribution and disease burden of intestinal nematode infections: Adding up the numbers - a review.
Evaluation of a bedside scoring system for predicting clinical cure and recurrence of Clostridium difficile infections.
Evaluation of the Atlas Helicobacter pylori stool antigen test for diagnosis of infection in adult patients.
Experience of nursing students regarding clinical support in the management of TB and HIV patients in a primary healthcare setting: a phenomenological study.
Factors affecting the geographic variability of antibiotic-resistant healthcare-associated infections in the United States using the CDC Antibiotic Resistance Patient Safety Atlas.
Feasibility of informing syndrome-level empiric antibiotic recommendations using publicly available antibiotic resistance datasets.
First year of mandatory reporting of healthcare-associated infections, pennsylvania: an infection control-chart abstractor collaboration.
Gastrointestinal and pulmonary nematode infections decrease goat productivity in Moroccan semi-arid conditions.
Geographical distribution of soil transmitted helminths and the effects of community type in South Asia and South East Asia - A systematic review.
Global numbers of infection and disease burden of soil transmitted helminth infections in 2010.
GPX-Macrophage Expression Atlas: a database for expression profiles of macrophages challenged with a variety of pro-inflammatory, anti-inflammatory, benign and pathogen insults.
Helicobacter pylori infection induced alteration of gene expression in human gastric cells.
High resolution mass spectrometry imaging of plant tissues: towards a plant metabolite atlas.
Human cystic echinococcosis in Morocco: Ultrasound screening in the Mid Atlas through an Italian-Moroccan partnership.
Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Investigation of the spread of human visceral leishmaniasis in central Tunisia.
Malaria impact of large dams in sub-Saharan Africa: maps, estimates and predictions.
MicroRNA expression profile in Lampetra morii upon Vibrio anguillarum infection and miR-4561 characterization targeting lip.
Mosquito cellular immunity at single-cell resolution.
N-glycome and N-glycoproteome of a hematophagous parasitic nematode Haemonchus.
NMR-based metabolic characterization of chicken tissues and biofluids: a model for avian research.
Non-traumatic atlanto-axial subluxation: Grisel's syndrome. Two case reports.
Otorhinolaryngology as "Made in Germany" since 1921: an international perspective.
Postsurgical pneumoencephaly in a patient with Klippel-Feil syndrome.
Radionuclide Imaging of Infection and Inflammation: A Pictorial Case-Based Atlas.
RNA atlas of human bacterial pathogens uncovers stress dynamics linked to infection.
RNA-Seq Based Identification of Candidate Parasitism Genes of Cereal Cyst Nematode (Heterodera avenae) during Incompatible Infection to Aegilops variabilis.
Root system architecture and receptivity to mycorrhizal infection in seedlings of Cedrus atlantica as affected by nitrogen source and concentration.
Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s.
Spectrum-Malaria: a user-friendly projection tool for health impact assessment and strategic planning by malaria control programmes in sub-Saharan Africa.
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum ?-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
System-wide coordinates of higher order functions in host-pathogen environment upon Mycobacterium tuberculosis infection.
Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA Guidance.
Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens.
The anterior retropharyngeal approach to the upper part of the cervical spine.
The global atlas of helminth infection: mapping the way forward in neglected tropical disease control.
Towards an atlas of human helminth infection in sub-Saharan Africa: the use of geographical information systems (GIS).
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
Unilateral lag-screw technique for an isolated anterior 1/4 atlas fracture.
[Actual problems of creation of informational-analytical system for rapid control of epidemics of infectious diseases].
[Progress in treatment of unstable atlas fracture].
[Stomatological atlas. Viral infection]
Inferior Wall Myocardial Infarction
Atlas of paced body surface QRS integral maps for localization of the site of origin of postinfarction ventricular tachycardia.
Infertility
A Colour Atlas of Gynaecological Surgery, vol 5: Infertility Surgery.
A Colour Atlas of Gynaecological Surgery. Volume 5. Infertility Surgery.
Atlas of Infertility.
Infertility, Male
The Male Fertility Gene Atlas: a web tool for collecting and integrating OMICS data in the context of male infertility.
Inflammatory Bowel Diseases
An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease.
Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study.
Influenza, Human
The Ontario Pharmacy Evidence Network Atlas of Community Pharmacy Influenza Immunizations.
Insulin Resistance
An atlas of G-protein coupled receptor expression and function in human subcutaneous adipose tissue.
Intellectual Disability
Atlas of mental retardation syndromes.
Atlas of Mental Retardation Syndromes. Visual Diagnosis of Facies and Physical Findings.
Atlas of Mental Retardation Syndromes: Visual Diagnosis of Facies and Physical Findings.
ATLAS OF MENTAL RETARDATION SYNDROMES: VISUAL DIAGNOSIS OF FACIES AND PHYSICAL FINDINGS.
Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome.
Mental retardation: An atlas of diseases with associated physical abnormalities.
Mental Retardation: An Atlas of Diseases with Associated Physical Abnormalities.
The WHO atlas on global resources for persons with intellectual disabilities: a right to health perspective.
Intervertebral Disc Degeneration
Congenital posterior atlas defect associated with anterior rachischisis and early cervical degenerative disc disease: a case study and review of the literature.
Intervertebral disc degeneration in a naturally occurring primate model: radiographic and biomechanical evidence.
Intervertebral Disc Displacement
Complex cervical spondylotic myelopathy: a report of two cases and literature review.
Lumbar discectomy is associated with higher rates of lumbar fusion.
Intestinal Polyposis
An atlas of oral lesions observed in the syndrome of oral melanosis with associated intestinal polyposis (Peutz-Jeghers syndrome).
Atlas of oral lesions observed in the syndrome of oral melanosis with associated intestinal polyposis (Peutz-Jeghers syndrome).
Intracranial Aneurysm
An angiographic atlas of intracranial arterial diameters associated with cerebral aneurysms.
Clinical Safety and Effectiveness of Stent-Assisted Coil Embolization with Neuroform Atlas Stent in Intracranial Aneurysm.
Initial experience and one-year follow-up with Neuroform Atlas Stent System for the treatment of brain aneurysms.
Initial multicentre experience using the neuroform atlas stent for the treatment of un-ruptured saccular cerebral aneurysms.
Letter: Low-Profile Visualized Intraluminal Support Jr Braided Stent Versus Atlas Self-Expandable Stent for Treatment of Intracranial Aneurysms: A Single Center Experience.
Low-Profile Visualized Intraluminal Support Jr Braided Stent Versus Atlas Self-Expandable Stent for Treatment of Intracranial Aneurysms: A Single Center Experience.
Microsurgery of Cerebral Aneurysms. An Atlas.
Midterm Outcomes After Low-Profile Visualization Endoluminal Support or Atlas Stent-Assisted Coiling of Intracranial Aneurysms: A Propensity Score Matching Analysis.
Multicenter Postmarket Analysis of the Neuroform Atlas Stent for Stent-Assisted Coil Embolization of Intracranial Aneurysms.
Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort.
Neuroform Atlas stent-assisted coiling of ruptured intracranial aneurysms: A multicenter study.
NeuroForm Atlas Stent-Assisted Coiling: Preliminary Results.
Outcomes of Stent-Assisted Coiling Using the Neuroform Atlas Stent in Unruptured Wide-Necked Intracranial Aneurysms.
Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms: One-Year Outcomes.
Pivotal trial of the Neuroform Atlas stent for treatment of posterior circulation aneurysms: one-year outcomes.
Preliminary experience of stent salvage using Neuroform Atlas stent for procedure-related complication during coil embolization of intracranial aneurysms.
Preliminary experience of stent-assisted coiling of wide-necked intracranial aneurysms with a single microcatheter.
Rescue Stenting Using Neuroform Atlas Stent During Coiling Protrusion for Ruptured Intracranial Aneurysms.
Safety and efficacy of the Neuroform Atlas for stent-assisted coiling of intracranial aneurysms: A multicenter experience.
Safety and Efficacy of the Neuroform Atlas Stent for Treatment of Intracranial Aneurysms : A Systematic Review and Meta-Analysis.
Stent-assisted coiling of cerebral aneurysms with the Neuroform Atlas stent.
Stent-assisted coiling of cerebral aneurysms: Head to head comparison between the Neuroform Atlas and EZ stents.
The low-profile Neuroform Atlas stent in the treatment of wide-necked intracranial aneurysms - immediate and midterm results: An Italian multicenter registry.
The Neuroform Atlas stent to assist coil embolization of intracranial aneurysms: a multicentre experience.
Two-center experience with Neuroform Atlas stent-assisted coil occlusion of broad-based intracranial aneurysms.
Usefulness of pointwise encoding time reduction with radial acquisition sequence in subtraction-based magnetic resonance angiography for follow-up of the Neuroform Atlas stent-assisted coil embolization for cerebral aneurysms.
Visualization of stent apposition after stent-assisted coiling of intracranial aneurysms using high resolution 3D fusion images acquired by C-arm CT.
Ischemic Attack, Transient
Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial.
Ischemic Stroke
Association of Computed Tomography Ischemic Lesion Location With Functional Outcome in Acute Large Vessel Occlusion Ischemic Stroke.
Development of a photochemical thrombosis investigation system to obtain a rabbit ischemic stroke model.
Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome.
Human Brain Atlases in Stroke Management.
Population-based Stroke Atlas for outcome prediction: method and preliminary results for ischemic stroke from CT.
Significance of early CT signs in acute stroke. A CT scan-diffusion MRI study.
Usefulness of brain atlases in neuroradiology: Current status and future potential.
Joint Diseases
Is joint effusion on MRI specific for haemophilia?
Scoring haemophilic arthropathy on X-rays: improving inter- and intra-observer reliability and agreement using a consensus atlas.
Validation of a radiographic scoring system for haemochromatosis arthropathy.
[Persistent cervico-occipital neuralgic syndrome caused by an unusual morphological abnormality of the atlas, simulating vertebral arthropathy.]
Joint Instability
3D-Printed Screw-Rod Auxiliary System for Unstable Atlas Fractures: A Retrospective Analysis.
A hypoplastic atlas and long odontoid process in a girl manifesting phenotypic features resembling spondyloepimetaphyseal dysplasia joint laxity syndrome.
Atlantoaxial Langerhans cell histiocytosis radiographic characteristics and corresponding prognosis analysis.
Kashin-Beck Disease
Accidental or linked: separated odontoid process fused to the enlarged anterior arch of the atlas associated with atlantoaxial subluxation in a Kashin-Beck disease patient.
Keratoconus
3D average human corneal models.
Comparison of Keratoconus Cone Location of Different Topo/tomographical Parameters.
Differentiating contact lens induced warpage from true keratoconus using corneal topography.
Stability of LASIK in topographically suspect keratoconus confirmed non-keratoconic by Artemis VHF digital ultrasound epithelial thickness mapping: 1-year follow-up.
Keratosis, Actinic
The many clinico-pathologic faces of actinic keratosis: an atlas.
Kidney Diseases
A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes.
AJKD Atlas of Renal Pathology: HIV-Associated Immune Complex Kidney Disease (HIVICK).
AJKD Atlas of Renal Pathology: Kidney Disease in Primary Sjögren Syndrome.
Atlas of Nontumor Pathology: Non-Neoplastic Kidney Diseases.
Availability, coverage, and scope of health information systems for kidney care across world countries and regions.
Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project.
Global coverage of health information systems for kidney disease: availability, challenges, and opportunities for development.
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Africa.
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in South Asia.
Kidney Single-Cell Atlas Reveals Myeloid Heterogeneity in Progression and Regression of Kidney Disease.
Recapitulating kidney development: Progress and challenges.
The Nuclear Receptor Signaling Atlas: development of a functional atlas of nuclear receptors.
Kidney Failure, Chronic
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States.
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.
Excerpts from the United States Renal Data Systems 2002 annual report: Atlas of end-stage renal disease in the United States.
Quantification of Tc-99m-ethyl cysteinate dimer brain single photon emission computed tomography images using statistical probabilistic brain atlas in depressive end-stage renal disease patients: Correlation with disease severity and symptom factors.
Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000-2015.
Kidney Neoplasms
An Accurate Tool for Uncovering Cancer Subtypes by Fast Kernel Learning Method to Integrate Multiple Profile Data.
Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.
Bcl9 Depletion Modulates Endothelial Cell in Tumor Immune Microenvironment in Colorectal Cancer Tumor.
Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma.
Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma.
DeepSec: a deep learning framework for secreted protein discovery in human body fluids.
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.
Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer.
FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
Kidney cancer: Creating a molecular atlas of clear cell renal cell carcinoma genetics.
Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma.
NOD2 maybe a biomarker for the survival of kidney cancer patients.
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
SEC61G is upregulated and required for tumor progression in human kidney cancer.
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.
Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population.
Klippel-Feil Syndrome
A Rare Presentation of Os Odontoideum with Multiple Vertebral Fusion in Type III Klippel-Feil Syndrome (KFS) - A Case Report.
Anomalous atlantoaxial portions of vertebral and posterior inferior cerebellar arteries.
Anomalous vertebral arteries in Klippel-Feil syndrome with occipitalized atlas: CT angiography.
Aplasia of anterior arch of atlas associated with multiple congenital disorders: Case report.
Cervical myelopathy caused by pseudoarthrosis between posterior arch of the atlas and lamina of the axis in Klippel-Feil syndrome: a case report.
Chiari I malformation accompanied by assimilation of the atlas, Klippel-Feil syndrome, and syringomyelia: case report.
Complete bipartition of the atlas in the Klippel-Feil syndrome. A radiologically illustrated case report.
Congenital anomalies of the cervical spine.
Duplicated odontoid process and atlas clefts associated to Klippel-Feil syndrome.
Occipital-C2 Transarticular Fixation for Occipitocervical Instability Associated With Occipitalization of the Atlas in Klippel-Feil Syndrome Patients by Using Intraoperative 3-Dimensional Navigation System.
Surgical treatment of Klippel-Feil syndrome with basilar invagination.
Surgical Treatment of Occipitocervical Dislocation with Atlas Assimilation and Klippel-Feil Syndrome Using Occipitalized C1 lateral Mass and C2 Fixation and Reduction Technique.
Kyphosis
Odontoid fractures complicated by fractures of the posterior arch of the atlas in the elderly over 85 years with severe thoracic kyphosis secondary to osteoporosis.
[Chiropractic diagnosis of the atlanto-occipital joint with reference to the Palmer-Sandberg-Gutman functional aspects from the traditional medic-radiologic viewpoint]
[Instability and misdiagnosed or neglected dislocations of the upper cervical spine in children. Apropos of 20 cases]
lanosterol synthase deficiency
Plant oxidosqualene metabolism: cycloartenol synthase-dependent sterol biosynthesis in Nicotiana benthamiana.
Skeletal anomalies and normal variants in patients with palatally displaced canines.
The human lanosterol synthase gene maps to chromosome 21q22.3.
Laryngeal Neoplasms
Acquired Uniparental Disomy Regions Are Associated with Disease Outcome in Patients with Oral Cavity and Oropharynx But Not Larynx Cancers.
An autophagy-related model of 4 key genes for predicting prognosis of patients with laryngeal cancer.
Five genes as a novel signature for predicting the prognosis of patients with laryngeal cancer.
Identification of prognostic immune genes in laryngeal cancer.
LncRNA LINC00888 upregulation predicts a worse survival of laryngeal cancer patients and accelerates the growth and mobility of laryngeal cancer cells through regulation of miR-378g/TFRC.
MicroRNA-548ac induces apoptosis in laryngeal squamous cell carcinoma cells by targeting transmembrane protein 158.
NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
Leiomyoma
Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
Leiomyosarcoma
Clinically Relevant Molecular Subtypes in Leiomyosarcoma.
Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
OSlms: A Web Server to Evaluate the Prognostic Value of Genes in Leiomyosarcoma.
The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.
Leishmaniasis
Entomological inventory of Phlebotomine sand flies and epidemiological study of leishmaniasis in Afourer, Azilal province, High Atlas, Morocco.
Leishmaniasis, Cutaneous
Epidemiologic study and molecular detection of Leishmania and sand fly species responsible of cutaneous leishmaniasis in Foum Jamâa (Azilal, Atlas of Morocco).
Phlebotomus sergenti in a cutaneous leishmaniasis focus in Azilal province (High Atlas, Morocco): molecular detection and genotyping of Leishmania tropica, and feeding behavior.
Spread of Leishmania major to the north of Algeria.
Wing size and shape variation of Phlebotomus papatasi (Diptera: Psychodidae) populations from the south and north slopes of the Atlas Mountains in Morocco.
Leishmaniasis, Visceral
Images from the Haematologica Atlas of Hematologic Cytology: visceral leishmaniasis.
Leprosy
An 1847 color atlas on leprosy.
[Diagnosis of Hansen's disease].
Lethargy
Mythology and Neurosurgery.
Leukemia
5-Methylcytosine RNA Modifications Promote Retrovirus Replication in an ALYREF Reader Protein-Dependent Manner.
A PML/RAR? direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia.
A Semantic Web-based System for Mining Genetic Mutations in Cancer Clinical Trials.
Bayesian predictive modeling for genomic based personalized treatment selection.
Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NF?B pathway and overexpressed in AML.
Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.
Gene expression profiling to identify the toxicities and potentially relevant disease outcomes due to endosulfan exposure.
High expression of FLT3 is a risk factor in leukemia.
Leukemia gene atlas--a public platform for integrative exploration of genome-wide molecular data.
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies studies and correlation with flt3 mutations and polyunsaturated fatty acid metabolism.
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Role of alternative polyadenylation dynamics in acute myeloid leukaemia at single-cell resolution.
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
Leukemia, Lymphoid
Long noncoding RNA DLEU2 predicts a poor prognosis and enhances malignant properties in laryngeal squamous cell carcinoma through the miR-30c-5p/PIK3CD/Akt axis.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Leukemia, Myeloid
A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development.
Leukemia, Myeloid, Acute
A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes.
An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.
An order independent algorithm for inferring gene regulatory network using quantile value for conditional independence tests.
Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia.
Bioinformatics Analysis to Determine Prognostic Mutations of 72 de novo Acute Myeloid Leukemia Cases from the Cancer Genome Atlas (TCGA) with 23 Most Common Mutations and no Abnormal Cytogenetics.
Bipartite network analysis reveals metabolic gene expression profiles that are highly associated with the clinical outcomes of acute myeloid leukemia.
Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NF?B pathway and overexpressed in AML.
Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia.
Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database.
Eya2, a Target Activated by Plzf, Is Critical for PLZF-RARA-Induced Leukemogenesis.
Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-?.
High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation.
ICN: Extracting interconnected communities in gene Co-expression networks.
Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Interpretation of personal genome sequencing data in terms of disease ranks based on mutual information.
lncRNA TP73-AS1 Regulates miR-21/PTEN Axis to Affect Cell Proliferation in Acute Myeloid Leukemia.
LncRNA VPS9D1-AS1 promotes cell proliferation in acute lymphoblastic leukemia through modulating GPX1 expression by miR-491-5p and miR-214-3p evasion.
Local sequence assembly reveals a high-resolution profile of somatic structural variations in 97 cancer genomes.
MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B.
MiR-29b-3p cooperates with miR-29c-3p to affect the malignant biological behaviors in T-cell acute lymphoblastic leukemia via TFAP2C/GPX1 axis.
Myeloid cell-targeted miR-146a mimic inhibits NF-?B-driven inflammation and leukemia progression in vivo.
PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.
Scalable Nonparametric Prescreening Method for Searching Higher-Order Genetic Interactions Underlying Quantitative Traits.
Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia.
SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia.
Somatic Functional Deletions of Upstream Open Reading Frame-Associated Initiation and Termination Codons in Human Cancer.
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.
The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia.
Transposable Element Expression in Acute Myeloid Leukemia Transcriptome and Prognosis.
U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.
Unsupervised Feature Selection Using an Integrated Strategy of Hierarchical Clustering with Singular Value Decomposition: An Integrative Biomarker Discovery Method with Application to Acute Myeloid Leukemia.
Leukemia, Promyelocytic, Acute
A PML/RAR? direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia.
Leukodystrophy, Globoid Cell
DTI registration in atlas based fiber analysis of infantile Krabbe disease.
Leukoencephalopathies
Characterization of Structural Connectivity of the Default Mode Network in Dogs using Diffusion Tensor Imaging.
Lipoma
Problem in diagnostic radiology.
Liposarcoma
A Rapid and Cost-Effective Gene Expression Assay for the Diagnosis of Well-Differentiated and Dedifferentiated Liposarcomas.
BMP2/BMPR1A is linked to tumour progression in dedifferentiated liposarcomas.
Liver Diseases
A Colour Atlas of Liver Disease.
A Colour Atlas of Liver Diseases.
The Human Liver Proteome Project (HLPP) Workshop during the 4(th) HUPO World Congress.
Liver Neoplasms
A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma.
A Five-Gene Signature Based on Stromal/Immune Scores in the Tumor Microenvironment and Its Clinical Implications for Liver Cancer.
Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer.
AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro.
Big Data-Based Identification of Multi-Gene Prognostic Signatures in Liver Cancer.
Cancer metastasis: issues and challenges.
Caprin-1 promotes HepG2 cell proliferation, invasion and migration and is associated with poor prognosis in patients with liver cancer.
CBX3/HP1? promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
CDCA8 as an independent predictor for a poor prognosis in liver cancer.
Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
Comparative clinical evaluation of atlas and deep-learning-based auto-segmentation of organ structures in liver cancer.
Comprehensive evaluation of SPATS2 expression and its prognostic potential in liver cancer.
Construction of circRNA-Based ceRNA Network to Reveal the Role of circRNAs in the Progression and Prognosis of Hepatocellular Carcinoma.
Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma.
Core liver homeostatic co-expression networks are preserved but respond to perturbations in an organism- and disease-specific manner.
Design of a liver cancer-specific selector for the analysis of circulating tumor DNA.
Downregulation of nucleolar and spindle-associated protein 1 expression suppresses liver cancer cell function.
Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
E2F3 promotes liver cancer progression under the regulation of circ-PRKAR1B.
Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.
Expression of eukaryotic translation initiation factor 3 subunit B in liver cancer and its prognostic significance.
Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in Liver Cancer and Their Clinical and Prognostic Significance.
Gene expression profiling to identify the toxicities and potentially relevant disease outcomes due to endosulfan exposure.
Gene profiling of HepG2 cells following nitidine chloride treatment: An investigation with microarray and Connectivity Mapping.
GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction.
GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival.
HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma.
Hematopoietic-substrate-1 associated protein X-1 (HAX-1) regulates liver cancer cells growth, metastasis, and angiogenesis through Akt.
Hepatocyte nuclear factor 1? suppresses steatosis-associated liver cancer by inhibiting PPAR? transcription.
High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.
High Expression B3GAT3 Is Related with Poor Prognosis of Liver Cancer.
High MAST2 mRNA expression and its role in diagnosis and prognosis of liver cancer.
High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma.
High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
HN1 as a diagnostic and prognostic biomarker for liver cancer.
Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Identification of copy number variation-driven genes for liver cancer via bioinformatics analysis.
Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis.
Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
Identification of Prognostic Stromal-Immune Score-Based Genes in Hepatocellular Carcinoma Microenvironment.
Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: An investigation based on GEO and TCGA databases.
Inhibition of EPS8L3 suppresses liver cancer progression and enhances efficacy of sorafenib treatment.
Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas.
Integrative single-cell transcriptome analysis reveals a subpopulation of fibroblasts associated with favorable prognosis of liver cancer patients.
Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients.
Investigation of PD-1H in DEN-induced mouse liver cancer model.
LncRNA PPP1R14B-AS1 Promotes Tumor Cell Proliferation and Migration via the Enhancement of Mitochondrial Respiration.
Long non-coding RNA BACE1-AS is an independent unfavorable prognostic factor in liver cancer.
Long Noncoding RNA SNHG10 Sponges miR-543 to Upregulate Tumor Suppressive SIRT1 in Nonsmall Cell Lung Cancer.
MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition.
MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1.
MicroRNA?486?5p functions as a tumor suppressor of proliferation and cancer stem?like cell properties by targeting Sirt1 in liver cancer.
Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma.
NT5DC2 is a novel prognostic marker in human hepatocellular carcinoma.
PopInf: An Approach for Reproducibly Visualizing and Assigning Population Affiliation in Genomic Samples of Uncertain Origin.
Predicting Functional Modules of Liver Cancer Based on Differential Network Analysis.
PRIM1 promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo.
Prognostic Value of a Novel Signature With Nine Hepatitis C Virus-Induced Genes in Hepatic Cancer by Mining GEO and TCGA Databases.
Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment.
Role of miR-182-5p overexpression in trichloroethylene-induced abnormal cell cycle functions in human HepG2 cells.
Several microRNAs could predict survival in patients with hepatitis B-related liver cancer.
Sex-biased differences in the correlation between epithelial-to-mesenchymal transition-associated genes in cancer cell lines.
Silencing of WWP2 inhibits adhesion, invasion, and migration in liver cancer cells.
SIMPLE is a good idea (and better with context learning).
Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
SLC25A11 serves as a novel prognostic biomarker in liver cancer.
Small Nucleolar RNA Host Gene 1 (SNHG1) and Chromosome 2 Open Reading Frame 48 (C2orf48) as Potential Prognostic Signatures for Liver Cancer by Constructing Regulatory Networks.
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients.
The impact of high co-expression of Sp1 and HIF1? on prognosis of patients with hepatocellular cancer.
The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer.
The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer.
Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma.
Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer.
Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
[Expression and clinical significance of chemokine CXCL10 and its receptor CXCR3 in hepatocellular carcinoma].
[Expression of microRNA-107 in hepatocellular carcinoma and its clinical significance].
Lordosis
Analysis of the cranio-cervical curvatures in subjects with migraine with and without neck pain.
Cervical lordosis: the effect of age and gender.
Comparative anatomy and 3D geometric morphometrics of the El Sidrón atlases (C1).
Impact of Isometric Contraction of Anterior Cervical Muscles on Cervical Lordosis.
Incidence and Risk Factors of Anterior Arch Fracture of The Atlas Following C1 Laminectomy Without Fusion.
Pediatric cervical spine in emergency: radiographic features of normal anatomy, variants and pitfalls.
The correlation between surface measurement of head and neck posture and the anatomic position of the upper cervical vertebrae.
[Chiropractic diagnosis of the atlanto-occipital joint with reference to the Palmer-Sandberg-Gutman functional aspects from the traditional medic-radiologic viewpoint]
Lung Diseases
A molecular cell atlas of the human lung from single-cell RNA sequencing.
Diagnostic atlas of non-neoplastic lung disease: a practical guide for surgical pathologists.
[Thorax--an atlas of radiographic images of childhood lung diseases]
Lung Diseases, Interstitial
Interactive high-resolution computed tomography digital atlas of interstitial lung disease.
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis.
Lung Injury
High-voltage electrocution-induced pulmonary injury and cerebellar hemorrhage with fractures in atlas.
Lung Neoplasms
A Colour Atlas of Sputum Cytology. The Early Diagnosis of Lung Cancer.
A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells.
A cross-platform comparison of affymetrix and Agilent microarrays reveals discordant miRNA expression in lung tumors of c-Raf transgenic mice.
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
A geometric atlas to predict lung tumor shrinkage for radiotherapy treatment planning.
A modifiable risk factors atlas of lung cancer: A Mendelian randomization study.
A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer.
A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy.
A polymorphism in miR-1262 regulatory region confers the risk of lung cancer in Chinese population.
A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis.
A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma.
Addressing the challenge of proper delineation of lymph node stations in modern radiotherapy for lung cancer.
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer.
Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.
An Accurate Tool for Uncovering Cancer Subtypes by Fast Kernel Learning Method to Integrate Multiple Profile Data.
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
Antimalarial drug pyrimethamine plays a dual role in anti-tumor proliferation and metastasis through targeting DHFR and TP.
Approaching the Increasing Complexity of Non-Small Cell Lung Cancer Taxonomy.
ARHGAP30 suppressed lung cancer cell proliferation, migration, and invasion through inhibition of the Wnt/?-catenin signaling pathway.
Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer.
Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
ATLAS: Randomized, Double-Blind, Placebo-Controlled, Phase IIIB Trial Comparing Bevacizumab Therapy With or Without Erlotinib, After Completion of Chemotherapy, With Bevacizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis.
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS).
Cancer cells are highly susceptible to accumulation of templated insertions linked to MMBIR.
Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1.
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Cell division cycle 20 overexpression predicts poor prognosis for patients with lung adenocarcinoma.
Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival.
CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.
Clinical applications of The Cancer Genome Atlas project (TCGA) for squamous cell lung carcinoma.
Clinical evaluation of atlas and deep learning based automatic contouring for lung cancer.
Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR.
Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.
Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
Comparison between atlas and convolutional neural network based automatic segmentation of multiple organs at risk in non-small cell lung cancer.
Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma.
Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer.
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Comprehensive identification of microRNA arm selection preference in lung cancer: miR-324-5p and -3p serve oncogenic functions in lung cancer.
Computed tomographic atlas for the new international lymph node map for lung cancer: A radiation oncologist perspective.
Concise genetic profile of lung carcinoma.
Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
Correlations of UGT1A1 gene polymorphisms with onset and prognosis of non-small cell lung cancer.
CPSF3 is a promising prognostic biomarker and predicts recurrence of non-small cell lung cancer.
Cyclin H Regulates Lung Cancer Progression as a Carcinoma Inducer.
Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures: How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients?
DeepLRHE: A Deep Convolutional Neural Network Framework to Evaluate the Risk of Lung Cancer Recurrence and Metastasis From Histopathology Images.
DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
Deubiquitinating enzyme USP41 promotes lung cancer cell proliferation and migration.
Development and Characterization of a Chest CT Atlas.
Differences in key genes in human alveolar macrophages between phenotypically normal smokers and nonsmokers: diagnostic and prognostic value in lung cancer.
Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian).
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning.
DNAJC12 promotes lung cancer growth by regulating the activation of ??catenin.
Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
Ectodermal?neural cortex 1 affects the biological function of lung cancer through the MAPK pathway.
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small cell lung cancer.
eIF2?, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
Endoplasmic reticulum chaperone GRP78/BiP is critical for mutant Kras-driven lung tumorigenesis.
Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma.
Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
Erlotinib as maintenance therapy in patients with advanced non-small cell lung cancer: a pooled analysis of three randomized trials.
Evaluation of the Oncogene Function of GOLPH3 and Correlated Regulatory Network in Lung Adenocarcinoma.
Exploring spatial patterns of mortality: the new atlas of United States mortality.
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Expression and prognostic value of E2F3 transcription factor in non-small cell lung cancer.
Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
Expression of Osteoprotegrin Is Enhanced in Lung Cancer Tissues and Promotes Aggressive Cellular Traits in H3122 Lung Cancer Cells.
Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer.
Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.
Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells.
Fibulin-5 inhibits Wnt/?-catenin signaling in lung cancer.
FOXH1 promotes lung cancer progression by activating the Wnt/?-catenin signaling pathway.
FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells.
Gene Panel of Persister Cells as a Prognostic Indicator for Tumor Repopulation After Radiation.
Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies.
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature.
Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study.
Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors.
HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor.
Hierarchical nucleus segmentation in digital pathology images.
High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification.
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis.
Histone-Related Genes Are Hypermethylated in Lung Cancer and Hypermethylated HIST1H4F Could Serve as a Pan-Cancer Biomarker.
HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer.
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1? levels under hypoxia.
Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis.
Identification of downstream signaling cascades of ACK1 and prognostic classifiers in non-small cell lung cancer.
Identification of lncRNA biomarkers for lung cancer through integrative cross-platform data analyses.
Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data.
Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD.
Identifying gene-gene interactions using penalized tensor regression.
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Impact of HFE variants and sex in lung cancer.
Increased CX3CL1 mRNA expression level is a positive prognostic factor in patients with lung adenocarcinoma.
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Individualized analysis of differentially expressed miRNAs with application to the identification of miRNAs deregulated commonly in lung cancer tissues.
Inhibition of lung cancer cells and Ras/Raf/MEK/ERK signal transduction by ectonucleoside triphosphate phosphohydrolase-7 (ENTPD7).
Integrating germline and somatic genetics to identify genes associated with lung cancer.
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer.
Interaction between the microbiome and TP53 in human lung cancer.
Interferon regulatory factor 6 correlates with the progression of non-small cell lung cancer and can be regulated by miR-320.
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
Key Common Genes in Obstructive Sleep Apnea and Lung Cancer are Associated with Prognosis of Lung Cancer Patients.
KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer.
Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells.
Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
Label-free quantitative proteomic analysis identifies the oncogenic role of FOXA1 in BaP-transformed 16HBE cells.
LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539.
LINC00501 Inhibits the Growth and Metastasis of Lung Cancer by Mediating miR-129-5p/HMGB1.
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.
lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/?-catenin signaling pathway.
lncRNA RPPH1 promotes non-small cell lung cancer progression through the miR-326/WNT2B axis.
Long non-coding RNA-HAGLR suppressed tumor growth of lung adenocarcinoma through epigenetically silencing E2F1.
Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
Long Noncoding RNA SNHG10 Sponges miR-543 to Upregulate Tumor Suppressive SIRT1 in Nonsmall Cell Lung Cancer.
Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression.
Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
LSR Promotes Cell Proliferation and Invasion in Lung Cancer.
MCM2-regulated functional networks in lung cancer by multi-dimensional proteomic approach.
MCMC implementation of the optimal Bayesian classifier for non-Gaussian models: model-based RNA-Seq classification.
MET Receptor Tyrosine Kinase Regulates the Expression of Co-Stimulatory and Co-Inhibitory Molecules in Tumor Cells and Contributes to PD-L1-Mediated Suppression of Immune Cell Function.
Methylation of RILP in lung cancer promotes tumor cell proliferation and invasion.
MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis.
Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer.
Mining and validating the expression pattern and prognostic value of acetylcholine receptors in non-small cell lung cancer.
miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer.
miR?146a?5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression.
Modeling clinical and molecular covariates of mutational process activity in cancer.
Molecular and Morphological Profiling of Lung Cancer: A Foundation for "Next-Generation" Pathologists and Oncologists.
Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
Multi-omics Data Integration by Generative Adversarial Network.
Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets.
Mutant-allele fraction heterogeneity is associated with non-small cell lung cancer patient survival.
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
National practice trends for the surgical management of lung cancer in the CMS population: an atlas of care.
National Working Group Meeting on ALK diagnostics in lung cancer.
Network-Based Isoform Quantification with RNA-Seq Data for Cancer Transcriptome Analysis.
Network-based stratification of tumor mutations.
Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes.
Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling.
Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous Kras LSL-G12V Driven Lung Cancer Mouse Model.
Nullifying the CDKN2A/B Locus Promotes Mutant K-ras Lung Tumorigenesis.
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee.
Penalized integrative semiparametric interaction analysis for multiple genetic datasets.
PHLPP2 as a novel metastatic and prognostic biomarker in non-small cell lung cancer patients.
Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation.
Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data.
Predicting tumor purity from methylation microarray data.
Prediction of prognosis of patients with lung cancer in combination with the immune score.
Prediction of Target-Drug Therapy by Identifying Gene Mutations in Lung Cancer With Histopathological Stained Image and Deep Learning Techniques.
Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data.
Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer.
Prostasin regulates PD-L1 expression in human lung cancer cells.
pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz.
Repurposing Methotrexate in Dampening SARS-CoV2-S1-Mediated IL6 Expression: Lessons Learnt from Lung Cancer.
Research on circadian clock genes in non-small-cell lung carcinoma.
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors.
RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens.
Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.
Sequencing Detects Lung Cancer in Blood.
Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.
Sestrin2 Expression Has Regulatory Properties and Prognostic Value in Lung Cancer.
Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1.
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy.
Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non-Small Cell Lung Cancer.
Survival analysis and functional annotation of long non-coding RNAs in lung adenocarcinoma.
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.
The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death.
The expression and prognostic significance of Drp1 in lung cancer: A bioinformatics analysis and immunohistochemistry.
The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy.
The Immune Heterogeneity Between Pulmonary Adenocarcinoma and Squamous Cell Carcinoma: A Comprehensive Analysis Based on lncRNA Model.
The impact of the Cancer Genome Atlas on lung cancer.
The International Association for the Study of Lung Cancer Lymph Node Map: A Radiologic Atlas and Review.
The Japan Lung Cancer Society-Japanese Society for Radiation Oncology consensus-based computed tomographic atlas for defining regional lymph node stations in radiotherapy for lung cancer.
The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.
The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.
The Outer Retinal Membrane Protein 1 Could Inhibit Lung Cancer Progression as a Tumor Suppressor.
The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma.
The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.
TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth.
TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.
TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes.
Trophinin-associated protein expression is an independent prognostic biomarker in lung adenocarcinoma.
Tumor immunity landscape in non-small cell lung cancer.
Uncovering the Pharmacological Mechanism of 2-Dodecyl-6-Methoxycyclohexa-2,5 -Diene-1,4-Dione Against Lung Cancer Based on Network Pharmacology and Experimental Evaluation.
Upregulation of SPP1 Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance.
Validating a Predictive Atlas of Tumor Shrinkage for Adaptive Radiotherapy of Locally Advanced Lung Cancer.
Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.
Variance component tests of multivariate mediation effects under composite null hypotheses.
Weakly Supervised Deep Learning for Whole Slide Lung Cancer Image Analysis.
[DNA damage associated genetic variants contribute to lung cancer susceptibility in a Han Chinese population].
[Inframunicipality distribution of lung cancer in the urban area of Grenoble]
[Metastasis of non-small cell lung cancer to the atlas]
Lupus Nephritis
AJKD Atlas of Renal Pathology: Focal and Diffuse Lupus Nephritis (ISN/RPS Class III and IV).
AJKD Atlas of Renal Pathology: Membranous Lupus Nephritis, ISN/RPS Class V.
AJKD Atlas of Renal Pathology: Minimal Mesangial and Mesangial Proliferative Lupus Nephritis (ISN/RPS Class I and II).
Lymphadenopathy
Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Lymphatic Metastasis
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.
Actin-Associated Gene Expression is Associated with Early Regional Metastasis of Tongue Cancer.
Comprehensive Analysis of Survival-Related lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Gastric Cancer.
Correlations of lncRNAs with cervical lymph node metastasis and prognosis of papillary thyroid carcinoma.
CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer.
DDX49 is a novel biomarker and therapeutic target for lung cancer metastases.
Development and validation of hub genes for lymph node metastasis in patients with prostate cancer.
FDG / PET-CT based lymph node atlas in breast cancer patients.
High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients.
HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/?-catenin signaling axis.
HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through ?-catenin/c-Myc signaling pathway.
Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets.
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Integrin ?4 promotes invasion and anoikis resistance of papillary thyroid carcinoma and is consistently overexpressed in lymphovascular tumor thrombus.
Long non-coding RNA LINC00997 silencing inhibits the progression and metastasis of colorectal cancer by sponging miR-512-3p.
Low metallothionein 1M (MT1M) is associated with thyroid cancer cell lines progression.
Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
miR-224, miR-147b and miR-31 associated with lymph node metastasis and prognosis for lung adenocarcinoma by regulating PRPF4B, WDR82 or NR3C2.
NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients.
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Para-aortic lymph node metastasis in lower Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy: a CT-based atlas and its clinical implications for Adjuvant Radiotherapy.
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma.
Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.
SOX7 blocks vasculogenic mimicry in oral squamous cell carcinoma.
The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer.
The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer.
Upregulation Of Protein Tyrosine Phosphatase Receptor Type C Associates To The Combination Of Hashimoto's Thyroiditis And Papillary Thyroid Carcinoma And Is Predictive Of A Poor Prognosis.
WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p/Snail Axis.
Lymphoma
Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.
Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas.
Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin.
SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma.
Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders.
Lymphoma, B-Cell
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
Network-adjusted Kendall's Tau Measure for Feature Screening with Application to High-dimensional Survival Genomic Data.
Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders.
Lymphoma, Large B-Cell, Diffuse
Network-adjusted Kendall's Tau Measure for Feature Screening with Application to High-dimensional Survival Genomic Data.
Lymphoma, Non-Hodgkin
A clinical atlas; lymphosarcoma.
Lymphoproliferative Disorders
Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders.
Macular Degeneration
Integration of eQTL and a Single-Cell Atlas in the Human Eye Identifies Causal Genes for Age-Related Macular Degeneration.
Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degeneration.
Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration.
Malaria
A comprehensive gene expression atlas of sex- and tissue-specificity in the malaria vector, Anopheles gambiae.
A cross-sectional analysis of ITN and IRS coverage in Namibia in 2013.
A global assessment of closed forests, deforestation and malaria risk.
A global model of malaria climate sensitivity: comparing malaria response to historic climate data based on simulation and officially reported malaria incidence.
A regional-scale, high resolution dynamical malaria model that accounts for population density, climate and surface hydrology.
A single-cell atlas of Plasmodium falciparum transmission through the mosquito.
A systematic review of changing malaria disease burden in sub-Saharan Africa since 2000: comparing model predictions and empirical observations.
A validation of the Malaria Atlas Project maps and development of a new map of malaria transmission in Sokoto, Nigeria: a cross-sectional study using geographic information systems.
An atlas of malaria in Africa.
Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project.
Contemporary epidemiological overview of malaria in Madagascar: operational utility of reported routine case data for malaria control planning.
Developing global maps of insecticide resistance risk to improve vector control.
Distribution of malaria exposure in endemic countries in Africa considering country levels of effective treatment.
Early life malaria exposure and academic performance.
High resolution population maps for low income nations: combining land cover and census in East Africa.
HIV-malaria co-infection: effects of malaria on the prevalence of HIV in East sub-Saharan Africa.
Human population, urban settlement patterns and their impact on Plasmodium falciparum malaria endemicity.
Impact of malaria interventions on child mortality in endemic African settings: comparison and alignment between LiST and Spectrum-Malaria model.
Malaria around large dams in Africa: effect of environmental and transmission endemicity factors.
Malaria Data by District: An open-source web application for increasing access to malaria information.
Malaria impact of large dams in sub-Saharan Africa: maps, estimates and predictions.
Malaria mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites.
malariaAtlas: an R interface to global malariometric data hosted by the Malaria Atlas Project.
Mapping Plasmodium falciparum Mortality in Africa between 1990 and 2015.
MicroRNA Tissue Atlas of the Malaria Mosquito
Mosquito cellular immunity at single-cell resolution.
Nets versus spraying: A spatial modelling approach reveals indoor residual spraying targets Anopheles mosquito habitats better than mosquito nets in Tanzania.
Online biomedical resources for malaria-related red cell disorders.
Possession of bed nets in Haut-Katanga (DRC): prevalence-elastic behaviour or performance of health care system delivery?
Providing open access data online to advance malaria research and control.
Quantifying Inequitable Access to Rapid Burn and Reconstructive Care through Geospatial Mapping.
Re-examining environmental correlates of Plasmodium falciparum malaria endemicity: a data-intensive variable selection approach.
Single-Cell RNA Sequencing Reveals Cellular Heterogeneity and Stage Transition under Temperature Stress in Synchronized Plasmodium falciparum Cells.
Spectrum-Malaria: a user-friendly projection tool for health impact assessment and strategic planning by malaria control programmes in sub-Saharan Africa.
The dominant Anopheles vectors of human malaria in the Americas: occurrence data, distribution maps and bionomic précis.
The impact of large and small dams on malaria transmission in four basins in Africa.
The Malaria Atlas Project: Developing Global Maps of Malaria Risk.
The Malaria Cell Atlas: Single parasite transcriptomes across the complete Plasmodium life cycle.
The origins and relatedness structure of mixed infections vary with local prevalence of P. falciparum malaria.
The potential of pregnant women as a sentinel population for malaria surveillance.
There and back again: malaria parasite single-cell transcriptomics comes full circle.
Vertical and horizontal equity of funding for malaria control: a global multisource funding analysis for 2006-2010.
[Creating a malaria risk atlas in Africa]
Malformations of Cortical Development
Brain Source Imaging in Preclinical Rat Models of Focal Epilepsy using High-Resolution EEG Recordings.
Malnutrition
Assessment of nutritional status in the Amazigh children of Amizmiz (Azgour Valley, High Atlas and Morocco).
[Influence of nutrition on the bone development of children]
Malocclusion
Ethnic differences in craniofacial and upper spine morphology between European and Asian children with skeletal Class III malocclusion.
Treatment effects of functional appliances in children with Class II malocclusion with and without morphologic deviations in the upper spine.
Mandibular Fractures
Mandibular condylar fractures and acute atlanto-axial subluxation. Part 1 - A new clinical and nosographic evidente.
Mania
Mapping mania symptoms based on focal brain damage.
Megacolon
Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation.
Melanoma
"Small" melanomas: relation of prognostic variables to diameter of primary superficial spreading melanomas.
7-dehydrocholesterol suppresses melanoma cell proliferation and invasion via Akt1/NF-?B signaling.
?-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.
A component overlapping attribute clustering (COAC) algorithm for single-cell RNA sequencing data analysis and potential pathobiological implications.
A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma.
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.
A hypergraph-based method for large-scale dynamic correlation study at the transcriptomic scale.
A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.
A multi-omics study on cutaneous and uveal melanoma.
A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
A Novel Autophagy-Related lncRNA Gene Signature to Improve the Prognosis of Patients with Melanoma.
A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
A secondary role for hypoxia and HIF1 in the regulation of (IFN?-induced) PD-L1 expression in melanoma.
A six-long non-coding RNA signature predicts prognosis in melanoma patients.
A systems approach reveals distinct metabolic strategies among the NCI-60 cancer cell lines.
A Targeted Proteomic Approach for Heat Shock Proteins Reveals DNAJB4 as a Suppressor for Melanoma Metastasis.
A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis.
A Targeted Quantitative Proteomic Method Revealed a Substantial Reprogramming of Kinome during Melanoma Metastasis.
A twelve-gene signature for survival prediction in malignant melanoma patients.
Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma.
Aberrant NEK2 expression might be an independent predictor for poor recurrence-free survival and overall survival of skin cutaneous melanoma.
Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.
Agonistic CD40 Antibodies in Cancer Treatment.
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth.
An Integrative Gene Expression and Mathematical Flux Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells.
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.
Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer.
Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-?/? V(D)J recombinations correlates with PD-1 expression.
Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
AutoEncoder-Based Computational Framework for Tumor Microenvironment Decomposition and Biomarker Identification in Metastatic Melanoma.
Better prognostic determination and feature characterization of cutaneous melanoma through integrative genomic analysis.
Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Melanoma.
Bioinformatic Analysis of Gene Expression for Melanoma Treatment.
Bioinformatics analysis to identify the critical genes, microRNAs and long noncoding RNAs in melanoma.
Bringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin Melanoma.
Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses.
Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma.
Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma.
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma.
CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix.
CDKN2A Deletion in Melanoma Excludes T Cell Infiltration by Repressing Chemokine Expression in a Cell Cycle-Dependent Manner.
Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms.
Characterization of Immune Infiltration and Construction of a Prediction Model for Overall Survival in Melanoma Patients.
Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas.
Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas.
Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.
Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma.
Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
Combining texture features of whole slide images improves prognostic prediction of recurrence-free survival for cutaneous melanoma patients.
Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis.
Comparing the genomes of cutaneous melanoma tumors to commercially available cell lines.
Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma.
Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients.
Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.
CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients.
Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor ? in Melanoma Mice.
Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma.
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome.
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics.
Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
Development and validation of autophagy-related-gene biomarker and nomogram for predicting the survival of cutaneous melanoma.
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma.
Dissecting the role of RNA modification regulatory proteins in melanoma.
Distinguishing Tumor and Stromal Sources of MicroRNAs Linked to Metastasis in Cutaneous Melanoma.
Downregulation of KCTD12 contributes to melanoma stemness by modulating CD271.
Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-?-induced apoptosis in tumor-repopulating cells of melanoma.
Driving in the melanoma landscape.
Dynamic Optical Coherence Tomography in Dermatology.
Early detection of primary cutaneous malignant melanoma. A color atlas.
Ectopic expression of KLK6 in MDA-MB-435 melanoma cells reduces tumorigenicity in vivo.
Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level.
Effects of B cell-activating factor on tumor immunity.
Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma.
Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-?B Pathway in Melanoma.
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.
Evaluation of melanoma antigen (MAGE) gene expression in human cancers using The Cancer Genome Atlas.
Evolved Resistance to Placental Invasion Secondarily Confers Increased Survival in Melanoma Patients.
Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.
Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes.
Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma.
Exploration of the Immune-Related Signatures and Immune Infiltration Analysis in Melanoma.
Expression of the Circadian Clock Gene BMAL1 Positively Correlates With Antitumor Immunity and Patient Survival in Metastatic Melanoma.
Expressions of HLA Class II Genes in Cutaneous Melanoma Were Associated with Clinical Outcome: Bioinformatics Approaches and Systematic Analysis of Public Microarray and RNA-Seq Datasets.
FARP1 Facilitates Cell Proliferation Through Modulating MAPK Signaling Pathway in Cutaneous Melanoma.
FUT8-AS1 Inhibits the Malignancy of Melanoma Through Promoting miR-145-5p Biogenesis and Suppressing NRAS/MAPK Signaling.
Gender Disparity and Mutation Burden in Metastatic Melanoma.
Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.
Gene Instability-Related lncRNA Prognostic Model of Melanoma Patients via Machine Learning Strategy.
Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D.
Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants.
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling.
High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma.
Hypermutation of DPYD Deregulates Pyrimidine Metabolism and Promotes Malignant Progression.
Identification and validation of immune-related lncRNA prognostic signatures for melanoma.
Identification and Validation of Prognostically Relevant Gene Signature in Melanoma.
Identification of a five-miRNA signature predicting survival in cutaneous melanoma cancer patients.
Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanoma.
Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma.
Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics.
Identification of key candidate genes involved in melanoma metastasis.
Identification of key genes and pathways for melanoma in the TRIM family.
Identification of Key miRNAs in the Treatment of Dabrafenib-Resistant Melanoma.
Identification of Long Non-coding and Messenger RNAs Differentially Expressed Between Primary and Metastatic Melanoma.
Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
Identification of prognostic genes and construction of a novel gene signature in the skin melanoma based on the tumor microenvironment.
Identification of prognostic mRNAs in metastatic cutaneous melanoma.
Identification of Prognostic Signatures for Predicting the Overall Survival of Uveal Melanoma Patients.
Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver Mutations.
Identifying gene-environment interactions incorporating prior information.
Identifying gene-gene interactions using penalized tensor regression.
Immune Microenvironment Related Competitive Endogenous RNA Network as Powerful Predictors for Melanoma Prognosis Based on WGCNA Analysis.
Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.
Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.
Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti-PD-1 Therapy.
In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
Increased Expression of T-Box Transcription Factor Protein 21 (TBX21) in Skin Cutaneous Melanoma Predicts Better Prognosis: A Study Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) Databases.
Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes.
Integrating multidimensional omics data for cancer outcome.
Integrative discovery of CD98 as a Melanoma Biomarker.
Interleukin 32 expression in human melanoma.
Interleukin-33 modulates immune responses in cutaneous melanoma in a context-specific way.
Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients.
Investigating the utility of human melanoma cell lines as tumour models.
Kinesin family member 18B: A contributor and facilitator in the proliferation and metastasis of cutaneous melanoma.
Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis.
Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis.
Long noncoding RNA LINC01291 promotes the aggressive properties of melanoma by functioning as a competing endogenous RNA for microRNA-625-5p and subsequently increasing IGF-1R expression.
Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma.
Lymphoscintigraphy in cutaneous melanoma: a total body atlas of sentinel node mapping.
Lymphoscintigraphy in cutaneous melanoma: an updated total body atlas of sentinel node mapping.
Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma.
Melanoma Is Skin Deep: A 3D Reconstruction Technique for Computerized Dermoscopic Skin Lesion Classification.
Metastasis of Uveal Melanoma with Monosomy-3 Is Associated with a Less Glycogenetic Gene Expression Profile and the Dysregulation of Glycogen Storage.
Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
microRNA-378a-5p iS a novel positive regulator of melanoma progression.
MicroRNA-92 Expression in CD133+ Melanoma Stem Cells Regulates Immunosuppression in the Tumor Microenvironment via Integrin-Dependent Activation of TGF?.
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma.
MiR-320a inhibits malignant phenotype of melanoma cells via targeting PBX3.
miRNA and mRNA expression profiling reveals potential biomarkers for metastatic cutaneous melanoma.
MMP7 sensitivity of mutant ECM proteins: An indicator of melanoma survival rates and T-cell infiltration.
Modeling clinical and molecular covariates of mutational process activity in cancer.
Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project.
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
Multi-Platform Omics Analysis for Identification of Molecular Characteristics and Therapeutic Targets of Uveal Melanoma.
NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma.
NEDD4 Negatively Regulates GITR via Ubiquitination in Immune Microenvironment of Melanoma.
neoANT-HILL: an integrated tool for identification of potential neoantigens.
Network Rewiring in Cancer: Applications to Melanoma Cell Lines and the Cancer Genome Atlas Patients.
No Causal Link between Phosphodiesterase Type 5 Inhibition and Melanoma.
NRASQ61K melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells.
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients.
Penalized integrative semiparametric interaction analysis for multiple genetic datasets.
PLK1 and NOTCH Positively Correlate in Melanoma and Their Combined Inhibition Results in Synergistic Modulations of Key Melanoma Pathways.
Population-level distribution and putative immunogenicity of cancer neoepitopes.
Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis.
Potential role of cyclin F mRNA expression in the survival of skin melanoma patients: Comprehensive analysis of the pathways altered due to cyclin F upregulation.
Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Predicting the Risk of Melanoma Metastasis Using an Immune Risk Score in the Melanoma Cohort.
PREVALENCE OF MISMATCH REPAIR GENE MUTATIONS IN UVEAL MELANOMA.
Profiling of prognostic alternative splicing in melanoma.
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma.
Prognostic genes of melanoma identified by weighted gene co-expression network analysis and drug repositioning using a network-based method.
Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma.
Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma.
Prognostic value of the expression of chemokines and their receptors in regional lymph nodes of melanoma patients.
Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival.
Proteogenomic analysis of melanoma brain metastases from distinct anatomical sites identifies pathways of metastatic progression.
pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.
Quantitative Proteomics Identifies Activation of Hallmark Pathways of Cancer in Patient Melanoma.
Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.
Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma.
RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.
Robust semiparametric gene-environment interaction analysis using sparse boosting.
Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma.
Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression.
Role of PLZF in melanoma progression.
Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.
Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases.
Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma.
Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts.
Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
Superpixel-Based Conditional Random Fields (SuperCRF): Incorporating Global and Local Context for Enhanced Deep Learning in Melanoma Histopathology.
Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts.
Systems analysis of barrier molecule and ARNT-related gene expression regulation in melanoma.
Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.
Targeted Therapies in Melanoma.
Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases.
TFPI2 Promotes Perivascular Migration in an Angiotropism Model of Melanoma.
The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma.
The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach.
The Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma.
The Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Bone Metastatic Melanoma.
The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness.
The genomic landscape of cutaneous melanoma.
The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
The Integrative Analysis Identifies Three Cancer Subtypes and Stemness Features in Cutaneous Melanoma.
The Molecular Context of Vulnerability for CDK9 Suppression in Triple Wild-Type Melanoma.
The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma.
The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.
The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.
The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.
The role of mitogen-activated protein targeting in melanoma beyond BRAFV600.
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma.
Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology.
Toward predicting metastatic progression of melanoma based on gene expression data.
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma.
Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance.
Tumor immunogenomic signatures improve a prognostic model of melanoma survival.
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy.
Tumor microenvironment immune-related lncRNA signature for patients with melanoma.
UBE2C overexpression in melanoma and its essential role in G2/M transition.
Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma.
Unraveling the human protein atlas of metastatic melanoma in the course of ultraviolet radiation-derived photo-therapy.
Vitamin D-VDR Signaling Inhibits Wnt/?-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma.
WIPI1, BAG1, and PEX3 Autophagy-Related Genes Are Relevant Melanoma Markers.
[Clinical aspects of cutaneous melanoma: atlas]
Melanosis
An atlas of oral lesions observed in the syndrome of oral melanosis with associated intestinal polyposis (Peutz-Jeghers syndrome).
Atlas of oral lesions observed in the syndrome of oral melanosis with associated intestinal polyposis (Peutz-Jeghers syndrome).
Meningioma
Cervical to Petrous Carotid Artery High-Flow Bypass for Carotid Artery Pseudoaneurysm Through Zygomatic Approach: 2-Dimensional Operative Video.
Clipping of Multiple Cerebral Aneurysms Through Cranioorbital Zygomatic Approach: 2-Dimensional Operative Video.
Combined Microscopic-Endoscopic Transmastoid Resection of a Petrous Meningioma: 2-Dimensional Operative Video.
Combined Petrosal Approach for Resection of Petroclival Meningioma with Endoscopic Assistance: Operative Video and Technical Nuances.
Craniovertebral junction neoplasms in the pediatric population.
Diaphragm Sellae Meningioma: Distinct Clinical, Anatomic, and Surgical Considerations: 2-Dimensional Operative Video.
Foramen Magnum Meningioma-The Attainment of the Intra-Arachnoidal Dissection: 2-Dimensional Operative Video.
Foramen Magnum Meningioma: Microsurgical Endoscopic-Controlled Resection via a Lateral Suboccipital Retrocondylar Approach with Preservation of Posterior Arch of Atlas Integrity.
Giant Ossified Clival Chondrosarcoma Resection: 2-Dimensional Operative Video.
Microsurgical Resection of a Parasellar Meningioma Invading the Cavernous Sinus, Bone, and Optic Canal: 2-Dimensional Operative Video.
Nuances of Olfactory Groove Meningioma Surgery: 2-Dimensional Operative Video.
Resection of Giant Invasive Parasagittal Atypical Meningioma With a Venous Graft Reconstruction of the Sagittal Sinus: 2-Dimensional Operative Video.
Resection of Pontine Cavernoma Through the Anterior Transpetrosal Approach: 2-Dimensional Operative Video.
Retrosigmoid Suprameatal Approach for Resection of Petrotentorial Cerebellopontine Angle Meningioma: Operative Video and Technical Nuances.
Simpson Grade I Removal of Tuberculum Sella Meningioma Through the Supraorbital Approach: 2-Dimensional Operative Video.
Simpson Grade I Resection of Type II Clinoidal Meningiomal Through Cranio-orbital Zygomatic Approach: 2-Dimensional Operative Video.
Surgical Treatment of Bilateral Optic Nerve Sheath Meningioma: 2-Dimensional Operative Video.
Transcondylar Approach for Resection of Medullary Cavernous Malformation: 2-Dimensional Operative Video.
Voxel-based lesion mapping of meningioma: a comprehensive lesion location mapping of 260 lesions.
Meningitis
Occipital neuralgia: anatomic considerations.
[Atlas of clinico-pathological study of diseases of the nervous system. 3. Case of cryptococcus meningitis]
[Atlas series in neuropathology. (14). Pathology of encephalomyelitis. (2). Tuberculous meningitis]
[Crowned dens syndrome: three new cases]
Meningocele
Tethering of the vertebral artery in the congenital arcuate foramen of the atlas vertebra: a possible cause of vertebral artery dissection in children.
Meningomyelocele
Heterotopic spinal cord? A curiosity.
Mesothelioma
Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy.
Colour atlas of mesothelioma.
Colour Atlas of Mesothelioma.
Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma.
Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types.
Mesothelioma in the age of "Omics": Before and after The Cancer Genome Atlas.
MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.
Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma.
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.
Mesothelioma, Malignant
Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma.
MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.
Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma.
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.
Metabolic Diseases
A practical guide for your daily activity: Atlas of Metabolic Diseases - Second Edition.
Atlas of common lysosomal and peroxisomal disorders - manual of metabolic diseases
Atlas of Inherited Metabolic Diseases, 3rd ed.
Metabolic Clinic Atlas: Organization of Care for Children with Inherited Metabolic Disease in Canada.
Single-cell analysis of human adipose tissue identifies depot and disease specific cell types.
Metabolic Syndrome
Comparative Transcriptional Profiling in HIV-Infected Patients Using Human Stress Arrays: Clues to Metabolic Syndrome.
methylenetetrahydrofolate dehydrogenase (nad+) deficiency
Shifting landscapes of human MTHFR missense-variant effects.
Metrorrhagia
A histological atlas for the Palinuridae (Crustacea: Decapoda: Achelata): A guide to parasite discovery and spotting the abnormal in spiny lobsters.
[Double gunshot head injury with lesion of the upper cervical vertebrae in a case of attempted suicide]
Migraine Disorders
Effect of Atlas Vertebrae Realignment in Subjects with Migraine: An Observational Pilot Study.
Electro-acupuncture inhibits C-fiber-evoked WDR neuronal activity of the trigeminocervical complex: Neurophysiological hypothesis of a complementary therapy for acute migraine modeled rats.
Estimating the savings associated with a migraine-free life: results from the Spanish Atlas.
Gene co-expression analysis identifies brain regions and cell types involved in migraine pathophysiology: a GWAS-based study using the Allen Human Brain Atlas.
Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas.
Incidence of ponticulus posterior of the atlas in migraine and cervicogenic headache.
Neck associated factors related to migraine in adolescents with painful temporomandibular disorders.
White matter changes in chronic and episodic migraine: a diffusion tensor imaging study.
Mitral Valve Insufficiency
Echocardiographic atlas of the mitral regurgitation.
Motor Neuron Disease
Identification of 17 Highly Expressed Genes within Mouse Lumbar Spinal Cord Anterior Horn Region from an In-Situ Hybridization Atlas of 3430 Genes: Implications for Motor Neuron Disease.
Mouth Neoplasms
A library-based ecological study to investigate the contribution of ethnicity to the incidence of oral cancer within health authorities in England and Wales.
Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma.
DLX6 promotes cell proliferation and survival in oral squamous cell carcinoma.
Epigenetic mediated silencing of EYA4 contributes to tumorigenesis in oral dysplastic cells.
HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma.
Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial-Mesenchymal Transition Score in Prognosis Prediction.
Oral submucous fibrosis stimulates invasion and epithelial-mesenchymal transition in oral squamous cell carcinoma by activating MMP-2 and IGF-IR.
Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells.
Transcriptional Biomarkers in Oral Cancer: An Integrative Analysis and the Cancer Genome Atlas Validation.
UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma.
WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p/Snail Axis.
Movement Disorders
Imaging of Anterior Nucleus of Thalamus Using 1.5T MRI for Deep Brain Stimulation Targeting in Refractory Epilepsy.
Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.
Targeting of the Subthalamic Nucleus for Deep Brain Stimulation: A Survey Among Parkinson Disease Specialists.
[Cephalization of the atlas as cause of spontaneous movement disorders in the vertebral artery region]
Mucopolysaccharidoses
[Mucopolysaccharidosis 6-A (Maroteaux-Lamy disease): comparison of clinical and pathologico-anatomic findings in a 27-year-old patient]
Mucopolysaccharidosis II
Vascular Ultrasound Measurements After Atlas Orthogonal Chiropractic Care in a Patient With Bow Hunter Syndrome.
Mucopolysaccharidosis IV
Persistent torticollis, facial asymmetry, grooved tongue, and dolicho-odontoid process in connection with atlas malformation complex in three family subjects.
Multiple Myeloma
Images from the Haematologica Atlas of Hematologic Cytology: plasma cell myeloma.
Widespread intronic polyadenylation diversifies immune cell transcriptomes.
Multiple Sclerosis
A lost piece of melanoma history.
An atlas on risk factors for multiple sclerosis: a Mendelian randomization study.
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
Atlas-based vs. individual-based deterministic tractography of corpus callosum in multiple sclerosis.
Correlating MR lesions and functional deficits in multiple sclerosis patients. Anatomical atlas registration.
Evaluation of Clinical Gait Analysis parameters in patients affected by Multiple Sclerosis: Analysis of kinematics.
Group specific vein-atlasing: An application for analyzing the venous system under normal and multiple sclerosis conditions.
Multicentre absolute myelin water content mapping: Development of a whole brain atlas and application to low-grade multiple sclerosis.
Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis.
Myelin Water Atlas: A Template for Myelin Distribution in the Brain.
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.
Thalamus Optimized Multi Atlas Segmentation (THOMAS): fast, fully automated segmentation of thalamic nuclei from structural MRI.
The 150th anniversary of the first depiction of the lesions of multiple sclerosis.
The effect of template selection on diffusion tensor voxel-based analysis results.
White matter atlas of the human spinal cord with estimation of partial volume effect.
Muscle Hypotonia
Acquired progressive hypotonia in infancy: consider compressive cervical myelopathy.
Muscle Spasticity
Spinal cord compression caused by ossification of the transverse ligament of the atlas.
[A surgical case of cervical canal stenosis caused by atlas hypoplasia in an elderly patient]
[Unusual coincidence of dens aplasia and atlas malformation with early childhood spastic tetraparesis. Case report on the differential diagnosis of inflammatory atlantoaxial dislocation]
Muscular Atrophy
[Atlas of nervous system diseases. 4. Autopsy case of progressive spinal muscular atrophy]
Muscular Atrophy, Spinal
[Atlas of nervous system diseases. 4. Autopsy case of progressive spinal muscular atrophy]
Muscular Diseases
Development of the zebrafish myoseptum with emphasis on the myotendinous junction.
[Atlas of myohistochemistry. 12. Congenital myopathy. 2]
Myasthenia Gravis
The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: focusing on T cells.
[Atlas of nervous system diseases. 5. Myasthenia gravis]
Mycetoma
[Mycetoma due to Streptomyces somaliensis seen in Algeria in the South area of the Atlas mountains]
Myocardial Infarction
A collaborative resource to build consensus for automated left ventricular segmentation of cardiac MR images.
A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent.
A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study.
Atlas-based quantification of cardiac remodeling due to myocardial infarction.
Ethnicity and socioeconomic status influence use of primary angioplasty in patients presenting with acute myocardial infarction.
Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome.
Impact of hospitals' Referral Region racial and ethnic diversity on 30-day readmission rates of older adults.
Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome.
Information maximizing component analysis of left ventricular remodeling due to myocardial infarction.
Introduction to the Canadian Cardiovascular Outcomes Research Team's (CCORT) Canadian Cardiovascular Atlas project.
Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p.
Novel Direct-Acting Anticoagulants for Risk Reduction in ACS.
Orthogonal decomposition of left ventricular remodelling in myocardial infarction.
Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.
Rivaroxaban in Patients Stabilized after a ST-Elevation Myocardial Infarction: Results from the ATLAS ACS 2-TIMI 51 Trial.
Rivaroxaban: a review of its use in acute coronary syndromes.
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies.
The "Dual-Pathway" Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2-TIMI 51 Trial.
The ATLAS ACS 2-TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects With Acute Coronary Syndrome ACS 2-Thrombolysis In Myocardial Infarction 51).
The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial.
The treatment of missing data in a large cardiovascular clinical outcomes study.
Myoma
Torsion of a Subserosal Myoma Managed by Gasless Laparoendoscopic Single-Site Myomectomy with In-Bag Manual Extraction.
Myositis
Occipital neuralgia: anatomic considerations.
Myxoma
[Aggressive angiomyxoma - case report].
Nasopharyngeal Carcinoma
Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array.
MIR106A-5p upregulation suppresses autophagy and accelerates malignant phenotype in nasopharyngeal carcinoma.
Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
Nasopharyngeal Neoplasms
Candida albicans osteomyelitis of the cervical spine.
Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array.
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Neoplasm Metastasis
A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.
A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy.
A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis.
Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.
Actin-Associated Gene Expression is Associated with Early Regional Metastasis of Tongue Cancer.
AKNA Is a Potential Prognostic Biomarker in Gastric Cancer and Function as a Tumor Suppressor by Modulating EMT-Related Pathways.
ALDH3A1 driving tumor metastasis is mediated by p53/BAG1 in lung adenocarcinoma.
Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma.
ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence.
Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.
ASPP1 deficiency promotes epithelial-mesenchymal transition, invasion and metastasis in colorectal cancer.
Bioinformatic analysis of four miRNAs relevant to metastasis-regulated processes in endometrial carcinoma.
Block-Constraint Robust Principal Component Analysis and its Application to Integrated Analysis of TCGA Data.
C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis.
CancerSEA: a cancer single-cell state atlas.
Candida albicans osteomyelitis of the cervical spine.
ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone.
Co-Expression Network Analysis Identified Gene Signatures in Osteosarcoma as a Predictive Tool for Lung Metastasis and Survival.
Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
Comprehensive Analysis of Survival-Related lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Gastric Cancer.
Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma.
Correlations of lncRNAs with cervical lymph node metastasis and prognosis of papillary thyroid carcinoma.
CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer.
DDX49 is a novel biomarker and therapeutic target for lung cancer metastases.
Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.
Development and validation of hub genes for lymph node metastasis in patients with prostate cancer.
Direct Targeting of CREB1 with Imperatorin Inhibits TGF?2-ERK Signaling to Suppress Esophageal Cancer Metastasis.
Distinctive Desmoplastic 3D Morphology Associated With BRAFV600E in Papillary Thyroid Cancers.
Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
Downregulation of Collagen COL4A6 Is Associated with Prostate Cancer Progression and Metastasis.
Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM.
Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer.
Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer.
Establishment and Validation of a Comprehensive Prognostic Model for Patients With HNSCC Metastasis.
Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis.
Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling.
FDG / PET-CT based lymph node atlas in breast cancer patients.
FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ?7-cm clear cell renal cell carcinomas.
GADD45B Facilitates Metastasis of Ovarian Cancer Through Epithelial-Mesenchymal Transition.
Global-scale profiling of differential expressed lysine acetylated proteins in colorectal cancer tumors and paired liver metastases.
Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization.
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients.
HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/?-catenin signaling axis.
HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through ?-catenin/c-Myc signaling pathway.
Hypertonicity-Affected Genes Are Differentially Expressed in Clear Cell Renal Cell Carcinoma and Correlate with Cancer-Specific Survival.
Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.
Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets.
Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses.
Identification of key genes involved in the metastasis of clear cell renal cell carcinoma.
Identification of Key mRNAs as Prediction Models for Early Metastasis of Pancreatic Cancer Based on LASSO.
Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer.
Identification of the potential biomarkers for the metastasis of rectal adenocarcinoma.
Images from the Haematologica Atlas of Hematologic Cytology: bone marrow metastases from gastric adenocarcinoma.
Imaging atlas for eligibility and on-study safety of potential shoulder adverse events in anti-NGF studies (Part 3).
Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development.
Impact of FGFR4 Gene Polymorphism on the Progression of Colorectal Cancer.
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer.
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma.
Integrin ?4 promotes invasion and anoikis resistance of papillary thyroid carcinoma and is consistently overexpressed in lymphovascular tumor thrombus.
Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.
KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28.
Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
Leptin Overexpression as a Poor Prognostic Factor for Colorectal Cancer.
lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis.
Long Non-coding RNA LINC00941 as a Potential Biomarker Promotes the Proliferation and Metastasis of Gastric Cancer.
Long non-coding RNA LINC00997 silencing inhibits the progression and metastasis of colorectal cancer by sponging miR-512-3p.
Long noncoding RNA H19 participates in metformin-mediated inhibition of gastric cancer cell invasion.
Long noncoding RNA SNHG12 indicates the prognosis of prostate cancer and accelerates tumorigenesis via sponging miR-133b.
Low metallothionein 1M (MT1M) is associated with thyroid cancer cell lines progression.
Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
Metastasis to the occipitocervical junction: A case report and review of the literature.
MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
MicroRNA?mRNA integrated analysis based on a case of well?differentiated thyroid cancer with both metastasis and metastatic recurrence.
MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.
miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells.
miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt/?-catenin signaling pathway.
miR-224, miR-147b and miR-31 associated with lymph node metastasis and prognosis for lung adenocarcinoma by regulating PRPF4B, WDR82 or NR3C2.
MiR-32 promotes tumorigenesis of colorectal cancer by targeting BMP5.
Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas.
Multilayer modelling of the human transcriptome and biological mechanisms of complex diseases and traits.
Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer.
Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer.
NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma.
NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
Overexpression and biological function of IQGAP3 in human pancreatic cancer.
Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients.
Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Painful osteolytic metastasis of the atlas: treatment with percutaneous vertebroplasty.
Para-aortic lymph node metastasis in lower Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy: a CT-based atlas and its clinical implications for Adjuvant Radiotherapy.
Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer.
Predictive value of protease-activated receptor-2 (PAR2 ) in cervical cancer metastasis.
Profiling of differentially expressed genes in LRRC4 overexpressed glioblastoma cells by cDNA array.
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma.
Prostasin regulates PD-L1 expression in human lung cancer cells.
Prostate Cancer Genomic Subtypes.
Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
Robust genomic copy number predictor of pan cancer metastasis.
Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.
Silencing of Growth Differentiation Factor-15 Promotes Breast Cancer Cell Invasion by Down-regulating Focal Adhesion Genes.
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases.
SOX7 blocks vasculogenic mimicry in oral squamous cell carcinoma.
Systematic mutation analysis in rare colorectal cancer presenting ovarian metastases.
Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases.
The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision-making from a fine-needle aspiration sample.
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination.
The Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Bone Metastatic Melanoma.
The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer.
The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer.
The ZNF304-integrin axis protects against anoikis in cancer.
Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway.
TP53 Mutation and Extraneural Metastasis of Glioblastoma: Insights From an Institutional Experience and Comprehensive Literature Review.
Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma.
Tumor Progression Locus 2 (Tpl2) Kinase Contributes Tumor Growth and Metastasis of Clear Cell Renal Cell Carcinoma.
Tumor?suppressive microRNA?223 targets WDR62 directly in bladder cancer.
Ultraviolet-A radiation induces changes in cyclin G gene expression in mouse melanoma B16-F1 cells.
Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans.
Upregulation Of Protein Tyrosine Phosphatase Receptor Type C Associates To The Combination Of Hashimoto's Thyroiditis And Papillary Thyroid Carcinoma And Is Predictive Of A Poor Prognosis.
USP19 Enhances MMP2/MMP9-Mediated Tumorigenesis in Gastric Cancer.
Vitamin D-VDR Signaling Inhibits Wnt/?-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the Cancer Genome Atlas database.
WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p/Snail Axis.
[Clinicopathological and molecular characteristics of Epstein-Barr virus associated gastric cancer: a single center large sample case investigation].
[Metastasis of non-small cell lung cancer to the atlas]
[Sarcoma of the proximal end of the humerus; metastasis to the atlas, localized by tomography.]
Neoplasm, Residual
Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: Towards a "minimal common brain"
Four- and five-color flow cytometry analysis of leukocyte differentiation pathways in normal bone marrow: A reference document based on a systematic approach by the GTLLF and GEIL.
Preoperative estimation of residual volume for WHO grade II glioma resected with intraoperative functional mapping.
Neoplasms
-
"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy.
'BRCAness' and its implications for platinum action in gynecologic cancer.
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma.
14-3-3? binds to and stabilizes phospho-beclin 1S295 and induces autophagy in hepatocellular carcinoma cells.
14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients.
144?GPR133 Promotes Glioblastoma Growth in Hypoxia.
15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.
18F-FDG PET/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks.
19q12 amplified and non-amplified subsets of high grade serous ovarian cancer with overexpression of cyclin E1 differ in their molecular drivers and clinical outcomes.
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
217?YAP Is Ready to Rac and Rho: Elucidation of a Novel YAP-Driven Network That Potentiates Brain Cancer Cell Dispersal and Confers Poor Survival in Patients.
29 immune-related genes pairs signature predict the prognosis of cervical cancer patients.
31 gene expression-based signatures serve as indicators of prognosis for patients with glioma.
334?A Functional Screen Identifies miRNAs that Induce Radioresistance in Glioblastomas.
3D modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
3D spatial organization and network-guided comparison of mutation profiles in Glioblastoma reveals similarities across patients.
4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T cells in Hepatocellular Carcinoma.
4-Hydroxytamoxifen enhances sensitivity of estrogen receptor ?-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion.
53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database.
6-lncRNA Assessment Model for Monitoring and Prognosis of HER2-Positive Breast Cancer: Based on Transcriptome Data.
7-dehydrocholesterol suppresses melanoma cell proliferation and invasion via Akt1/NF-?B signaling.
7-lncRNA Assessment Model for Monitoring and Prognosis of Breast Cancer Patients: Based on Cox Regression and Co-expression Analysis.
8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness.
90-gene signature assay for tissue origin diagnosis of brain metastases.
99mTc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma.
?-Actinin1 promotes tumorigenesis and epithelial-mesenchymal transition of gastric cancer via the AKT/GSK3?/?-Catenin pathway.
?-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.
?-hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells.
?2A-Adrenergic Receptor Inhibits the Progression of Cervical Cancer Through Blocking PI3K/AKT/mTOR Pathway.
?5-nAChR and survivin: Two potential biological targets in lung adenocarcinoma.
??elemene inhibits the generation of peritoneum effusion in pancreatic cancer via suppression of the HIF1A?VEGFA pathway based on network pharmacology.
?Np63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival.
?Np63?/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers.
A 10-gene expression signature of Notch pathway predicts recurrence in ovarian carcinoma.
A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ?7.
A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer.
A 10?microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
A 13-gene risk score system and a nomogram survival model for predicting the prognosis of clear cell renal cell carcinoma.
A 13-immune gene set signature for prediction of colon cancer prognosis.
A 14 immune-related gene signature predicts clinical outcomes of kidney renal clear cell carcinoma.
A 14-gene gemcitabine resistance gene signature is significantly associated with the prognosis of pancreatic cancer patients.
A 14-Marker Multiplexed Imaging Panel for Prognostic Biomarkers and Tumor Heterogeneity in Head and Neck Squamous Cell Carcinoma.
A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma.
A 15-Gene Signature and Prognostic Nomogram for Predicting Overall Survival in Non-Distant Metastatic Oral Tongue Squamous Cell Carcinoma.
A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
A 15-lncRNA signature predicts survival and functions as a ceRNA in patients with colorectal cancer.
A 16-gene expression signature to distinguish stage I from stage II lung squamous carcinoma.
A 16-gene signature predicting prognosis of patients with oral tongue squamous cell carcinoma.
A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
A 17-Gene Signature Predicted Prognosis in Renal Cell Carcinoma.
A 19?miRNA Support Vector Machine classifier and a 6?miRNA risk score system designed for ovarian cancer patients.
A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.
A 21?gene Support Vector Machine classifier and a 10?gene risk score system constructed for patients with gastric cancer.
A 23 gene-based molecular prognostic score precisely predicts overall survival of breast cancer patients.
A 3-DNA methylation signature as a novel prognostic biomarker in patients with sarcoma by bioinformatics analysis.
A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma.
A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
A 4-gene panel predicting the survival of patients with glioblastoma.
A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer.
A 4-gene signature predicts prognosis of uterine serous carcinoma.
A 4-gene-based hypoxia signature is associated with tumor immune microenvironment and predicts the prognosis of pancreatic cancer patients.
A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia.
A 4-miRNA signature to predict survival in glioblastomas.
A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
A 5-lncRNA Signature Associated with Smoking Predicts the Overall Survival of Patients with Muscle-Invasive Bladder Cancer.
A 5-MicroRNA Signature Identified from Serum MicroRNA Profiling Predicts Survival in Patients with Advanced Stage Non-Small Cell Lung Cancer.
A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients.
A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme.
A 6-lncRNA signature predicts prognosis of diffuse large B-cell lymphoma.
A 63 signature genes prediction system is effective for glioblastoma prognosis.
A 65?gene signature for prognostic prediction in colon adenocarcinoma.
A 6?gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients.
A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma.
A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma.
A 9?lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus?positive hepatocellular carcinoma.
A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma.
A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1.
A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis.
A Bayesian integrative approach for multi-platform genomic data: A kidney cancer case study.
A Bayesian Network Model of Head and Neck Squamous Cell Carcinoma Incorporating Gene Expression Profiles.
A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.
A bioinformatics approach to identify novel long, non-coding RNAs in breast cancer cell lines from an existing RNA-sequencing dataset.
A BRCA1/2 mutational signature and survival in ovarian high grade serous carcinoma.
A brief history of head and neck pathology.
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities.
A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature.
A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma.
A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer.
A Cartography of Siglecs and Sialyltransferases in Gynecologic Malignancies: Is There a Road Towards a Sweet Future?
A catalogue of somatic NRF2 gain-of-function mutations in cancer.
A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations.
A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration.
A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients.
A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.
A cis-eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma.
A classification model for distinguishing copy number variants from cancer-related alterations.
A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer.
A clinically applicable molecular-based classification for endometrial cancers.
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.
A cloud-based workflow to quantify transcript-expression levels in public cancer compendia.
A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma.
A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival.
A Co-Expression Network Reveals the Potential Regulatory Mechanism of lncRNAs in Relapsed Hepatocellular Carcinoma.
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.
A Colour Atlas of Neoplasia in the Cat, Dog and Horse.
A Colour Atlas of Ocular Tumours.
A Colour Atlas of Sputum Cytology. The Early Diagnosis of Lung Cancer.
A Colour Atlas of Tumour Histopathology.
A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
A Combined Effect of Expression Levels of Obesity-Related Genes and Clinical Factors on Cancer Survival Rate.
A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer.
A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
A Combined RNA Signature Predicts Recurrence Risk of Stage I-IIIA Lung Squamous Cell Carcinoma.
A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers.
A comparative genomics analysis of lung adenocarcinoma for Chinese population by using panel of recurrent mutations.
A Comparative in Silico Analysis of CD24's Prognostic Value in Human and Canine Prostate Cancer.
A Comparative Meta-Analysis and in silico Analysis of Differentially Expressed Genes and Proteins in Canine and Human Bladder Cancer.
A comparative study of multiple instance learning methods for cancer detection using T-cell receptor sequences.
A Comparative Study of the Molecular Characteristics of Familial Gliomas and Other Cancers.
A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma.
A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.
A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data.
A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify MYO16-AS1 as an Oncogenic lncRNA in Bladder Cancer.
A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC.
A component overlapping attribute clustering (COAC) algorithm for single-cell RNA sequencing data analysis and potential pathobiological implications.
A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma.
A comprehensive analysis of breast cancer microbiota and host gene expression.
A Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer(1,2.)
A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
A comprehensive analysis of prognosis prediction models based on pathway?level, gene?level and clinical information for glioblastoma.
A comprehensive analysis of SNPs and CNVs identifies novel markers associated with disease outcomes in colorectal cancer.
A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma.
A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells.
A Comprehensive Bioinformatics Analysis of UBE2C in Cancers.
A comprehensive characterization of mitochondrial DNA mutations in glioblastoma multiforme.
A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection.
A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies.
A comprehensive function analysis of LMO2 in different breast cancer subtypes.
A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.
A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.
A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.
A comprehensive investigation using meta-analysis and bioinformatics on miR-34a-5p expression and its potential role in head and neck squamous cell carcinoma.
A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer.
A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer.
A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer.
A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association.
A comprehensive overview of genomic imprinting in breast and its deregulation in cancer.
A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor.
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits.
A Comprehensive Prognostic and Immune Analysis of SLC41A3 in Pan-Cancer.
A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma.
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
A Comprehensive Review of Genomics and Noncoding RNA in Gliomas.
A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis.
A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
A comprehensively characterized cell line panel highly representative of clinical ovarian high-grade serous carcinomas.
A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer.
A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.
A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma.
A cross-cancer metastasis signature in the microRNA-mRNA axis of paired tissue samples.
A deep convolutional neural network for segmentation of whole-slide pathology images identifies novel tumour cell-perivascular niche interactions that are associated with poor survival in glioblastoma.
A deep imputation and inference framework for estimating personalized and race-specific causal effects of genomic alterations on PSA.
A Deep Network for Joint Registration and Reconstruction of Images with Pathologies.
A deformable digital brain atlas system according to Talairach and Tournoux.
A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline.
A Designer Cross-reactive DNA Immunotherapeutic Vaccine that Targets Multiple MAGE-A Family Members Simultaneously for Cancer Therapy.
A developmental taxonomy of glioblastoma defined and maintained by microRNAs.
A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients.
A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma.
A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy.
A DNA methylation signature to improve survival prediction of gastric cancer.
A DNA methylation-associated nomogram predicts the overall survival of osteosarcoma.
A drug-biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia.
A dual immune signature of CD8+ T cells and MMP9 improves the survival of patients with hepatocellular carcinoma.
A Dynamic Scale-Free Network Particle Swarm Optimization for Extracting Features on Multi-Omics Data.
A dynamic transcriptomic atlas of cytokine-induced killer cells.
A fast and accurate SNP detection algorithm for next-generation sequencing data.
A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.
A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.
A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma.
A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma.
A Five-Gene Prognostic Nomogram Predicting Disease-Free Survival of Differentiated Thyroid Cancer.
A Five-Gene Signature Based on Stromal/Immune Scores in the Tumor Microenvironment and Its Clinical Implications for Liver Cancer.
A five-gene signature for predicting overall survival of esophagus adenocarcinoma.
A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma.
A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma.
A five-gene signature to predict the overall survival time of patients with esophageal squamous cell carcinoma.
A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer.
A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction.
A five-immune-related genes-based prognostic signature for colorectal cancer.
A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma.
A five-long non-coding RNA signature with the ability to predict overall survival of patients with lung adenocarcinoma.
A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
A five-miRNA expression signature predicts survival in hepatocellular carcinoma.
A five-miRNA signature predicts survival in gastric cancer using bioinformatics analysis.
A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer.
A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer.
A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer.
A four-gene signature associated with clinical features can better predict prognosis in prostate cancer.
A four-gene signature for prognosis in breast cancer patients with hypermethylated IL15RA.
A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma.
A Four-Gene-Based Prognostic Model Predicts Overall Survival in Patients With Cutaneous Melanoma.
A four-gene-based prognostic model predicts overall survival in patients with hepatocellular carcinoma.
A Four-Gene-Based Risk Score With High Prognostic Value in Gastric Cancer.
A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer.
A four-long noncoding RNA signature predicts survival of hepatocellular carcinoma patients.
A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma.
A four-mRNA model to improve the prediction of breast cancer prognosis.
A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
A fourteen-lncRNA risk score system for prognostic prediction of patients with non-small cell lung cancer.
A framework for identifying dysregulated chromatin regulators as master regulators in human cancer.
A framework for organizing cancer-related variations from existing databases, publications and NGS data using a High-performance Integrated Virtual Environment (HIVE).
A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data.
A functional network of gastric-cancer-associated splicing events controlled by dysregulated splicing factors.
A functional screen identifies miRs that induce radioresistance in glioblastomas.
A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.
A future of cancer prevention and cures: highlights of the Centennial Meeting of the American Association for Cancer Research.
A FXYD5/TGF??/SMAD positive feedback loop drives epithelial?to?mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.
A Galaxy Implementation of Next-Generation Clustered Heatmaps for Interactive Exploration of Molecular Profiling Data.
A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine.
A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity.
A gene expression profile associated with perineural invasion identifies a subset of HNSCC at risk of post-surgical recurrence.
A gene expression signature for predicting response to neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma.
A gene expression signature of Retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer.
A gene expression-based immune signature for lung adenocarcinoma prognosis.
A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.
A gene expression-based study on immune cell subtypes and glioma prognosis.
A Gene Gravity Model for the Evolution of Cancer Genomes: A Study of 3,000 Cancer Genomes across 9 Cancer Types.
A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma.
A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors.
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.
A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma.
A generalizable data-driven multicellular model of pancreatic ductal adenocarcinoma.
A generative model for brain tumor segmentation in multi-modal images.
A genetic risk score for glioblastoma multiforme based on copy number variations.
A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability.
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
A genome-wide analysis of long noncoding RNA profile identifies differentially expressed lncRNAs associated with Esophageal cancer.
A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis.
A genome-wide comprehensively analyses of long noncoding RNA profiling and metastasis associated lncRNAs in renal cell carcinoma.
A genome-wide positioning systems network algorithm for in silico drug repurposing.
A genome-wide view of microsatellite instability: old stories of cancer mutations revisited with new sequencing technologies.
A Genomic-Clinicopathologic Nomogram for the Prediction of Lymph Node Invasion in Prostate Cancer.
A Genomic-Clinicopathologic Nomogram Predicts Survival for Patients with Laryngeal Squamous Cell Carcinoma.
A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.
A geographic analysis of prostate cancer mortality in the United States, 1970-89.
A geometric atlas to predict lung tumor shrinkage for radiotherapy treatment planning.
A Global and Integrated Analysis of CINSARC-Associated Genetic Defects.
A global immune gene expression signature for human cancers.
A global integrated analysis of UNC5C down-regulation in cancers: insights from mechanism and combined treatment strategy.
A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer.
A Glycolysis-Based Long Non-coding RNA Signature Accurately Predicts Prognosis in Renal Carcinoma Patients.
A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma.
A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma.
A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma.
A graph-based multi-sample test for identifying pathways associated with cancer progression.
A graph-embedded deep feedforward network for disease outcome classification and feature selection using gene expression data.
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
A hidden Markov modeling approach for identifying tumor subclones in next-generation sequencing studies.
A High Epigenetic Risk Score Shapes the Non-Inflamed Tumor Microenvironment in Breast Cancer.
A high-resolution transcriptome map of cell cycle reveals novel connections between periodic genes and cancer.
A HPV16-related prognostic indicator for head and neck squamous cell carcinoma.
A human protein atlas for normal and cancer tissues based on antibody proteomics.
A Hybrid Ensemble Approach for Identifying Robust Differentially Methylated Loci in Pan-Cancers.
A hypergraph-based method for large-scale dynamic correlation study at the transcriptomic scale.
A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas.
A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer.
A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients.
A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
A joint analysis of metabolomics and genetics of breast cancer.
A Joint Graphical Model for Inferring Gene Networks Across Multiple Subpopulations and Data Types.
A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase C?II.
A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.
A landscape of synthetic viable interactions in cancer.
A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.
A library-based ecological study to investigate the contribution of ethnicity to the incidence of oral cancer within health authorities in England and Wales.
A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers.
A Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Epithelial Ovarian Cancer.
A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion.
A long non-coding RNA expression signature to predict survival of patients with colon adenocarcinoma.
A long non-coding RNA signature for predicting survival in patients with colorectal cancer.
A long non-coding RNA signature in glioblastoma multiforme predicts survival.
A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma.
A long noncoding RNA-microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas.
A long noncoding RNAs signature to improve survival prediction in endometrioid endometrial cancer.
A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis.
A luminal breast cancer genome atlas: progress and barriers.
A lymph node metastasis-related protein-coding genes combining with long noncoding RNA signature for breast cancer survival prediction.
A machine learning analysis of a "normal-like" IDH-WT diffuse glioma transcriptomic subgroup associated with prolonged survival reveals novel immune and neurotransmitter-related actionable targets.
A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer.
A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.
A machine learning-based prognostic predictor for stage III colon cancer.
A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis.
A mechanistic insight into the anti-metastatic role of the prostate specific antigen.
A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expression.
A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma.
A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma.
A Methodology for Texture Feature-based Quality Assessment in Nucleus Segmentation of Histopathology Image.
A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
A methylation-driven gene panel predicts survival in patients with colon cancer.
A micro-peptide encoded by HOXB-AS3 promotes the proliferation and viability of oral squamous cell carcinoma cell lines by directly binding with IGF2BP2 to stabilize c-Myc.
A micro-RNA expression signature for human NAFLD progression.
A microRNA disease signature associated with lymph node metastasis of lung adenocarcinoma.
A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma.
A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
A MicroRNA Expression Signature as Prognostic Marker for Oropharyngeal Squamous Cell Carcinoma.
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
A microRNA-based signature predicts local-regional failure and overall survival after pancreatic cancer resection.
A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
A Minimal DNA Methylation Signature in Oral Tongue Squamous Cell Carcinoma Links Altered Methylation with Tumor Attributes.
A miRNA signature for defining aggressive phenotype and prognosis in gliomas.
A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer.
A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.
A mixture copula Bayesian network model for multimodal genomic data.
A model for predicting prognosis in patients with esophageal squamous cell carcinoma based on joint representation learning.
A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
A model of twenty-three metabolic-related genes predicting overall survival for lung adenocarcinoma.
A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?
A modular master regulator landscape controls cancer transcriptional identity.
A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer.
A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates.
A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability.
A Molecular Subtype Model for Liver HBV-Related Hepatocellular Carcinoma Patients Based on Immune-Related Genes.
A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma.
A Multi-Gene Model Effectively Predicts the Overall Prognosis of Stomach Adenocarcinomas With Large Genetic Heterogeneity Using Somatic Mutation Features.
A Multi-Method Approach for Proteomic Network Inference in 11 Human Cancers.
A multi-omics approach for identifying important pathways and genes in human cancer.
A multi-omics study on cutaneous and uveal melanoma.
A multi-scale integrated analysis identifies KRT8 as a pan-cancer early biomarker.
A Multi-Source Data Fusion Framework for Revealing the Regulatory Mechanism of Breast Cancer Immune Evasion.
A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.
A Multigene Assay Identifying Distinct Prognostic Subtypes of Clear Cell Renal Cell Carcinoma with Differential Response to Tyrosine Kinase Inhibition.
A multilevel assessment of the social determinants associated with the late stage diagnosis of breast cancer.
A Multiomics Graph Database System for Biological Data Integration and Cancer Informatics.
A multiscale statistical mechanical framework integrates biophysical and genomic data to assemble cancer networks.
A murine preclinical syngeneic transplantation model for breast cancer precision medicine.
A naive Bayes algorithm for tissue origin diagnosis (TOD-Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system.
A network medicine approach to build a comprehensive atlas for the prognosis of human cancer.
A network model of a cooperative genetic landscape in brain tumors.
A network view of microRNA and gene interactions in different pathological stages of colon cancer.
A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes.
A Network-Based Model of Oncogenic Collaboration for Prediction of Drug Sensitivity.
A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
A network-based signature to predict the survival of non-smoking lung adenocarcinoma.
A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.
A Neural Network Framework for Predicting the Tissue-of-Origin of 15 Common Cancer Types Based on RNA-Seq Data.
A New ?0-Regularized Log-Linear Poisson Graphical Model with Applications to RNA Sequencing Data.
A new clinical prognostic nomogram for liver cancer based on immune score.
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State.
A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma.
A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression.
A new m6A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder.
A new method for mining information of co-expression network based on multi-cancers integrated data.
A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.
A new prognostic strategy based on four DNA repair-associated lncRNAs for hepatocellular carcinoma.
A New RBPs-Related Signature Predicts the Prognosis of Colon Adenocarcinoma Patients.
A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients.
A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population.
A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.
A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
A newly identified lncRNA H1FX-AS1 targets DACT1 to inhibit cervical cancer via sponging miR-324-3p.
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
A NF-?B signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.
A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.
A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
A nomogram based on a gene signature for predicting the prognosis of patients with head and neck squamous cell carcinoma.
A Nomogram Based on a Three-Gene Signature Derived from AATF Coexpressed Genes Predicts Overall Survival of Hepatocellular Carcinoma Patients.
A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer.
A nomogram combining PPAR? expression profiles and clinical factors predicts survival in patients with hepatocellular carcinoma.
A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study.
A non-negative matrix factorization method for detecting modules in heterogeneous omics multi-modal data.
A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma.
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma.
A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence.
A novel 4-gene prognostic signature for hypermutated colorectal cancer.
A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis.
A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma.
A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck.
A NOVEL AND EFFICIENT ALGORITHM FOR DE NOVO DISCOVERY OF MUTATED DRIVER PATHWAYS IN CANCER.
A Novel and Robust Long Noncoding RNA Panel to Predict the Prognosis of Pancreatic Cancer.
A Novel Apoptosis-Related Gene Signature Predicts Biochemical Recurrence of Localized Prostate Cancer After Radical Prostatectomy.
A Novel Approach to Evaluating Cancer Driver Gene Mutation Densities: Cytoskeleton-related Gene Candidates.
A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression.
A novel assessing system for predicting the prognosis of gastric cancer.
A novel autophagy-related genes prognostic risk model and validation of autophagy-related oncogene VPS35 in breast cancer.
A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer.
A Novel Autophagy-Related lncRNA Gene Signature to Improve the Prognosis of Patients with Melanoma.
A novel autophagy-related lncRNA prognostic risk model for breast cancer.
A novel autophagy-related lncRNA survival model for lung adenocarcinoma.
A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
A Novel circRNA-miRNA-mRNA Hub Regulatory Network in Lung Adenocarcinoma.
A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.
A novel CpG-based signature for survival prediction of lung adenocarcinoma patients.
A novel CpG-methylation-based nomogram predicts survival in colorectal cancer.
A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer.
A novel definition of microvessel density in renal cell carcinoma: Angiogenesis plus vasculogenic mimicry.
A novel discriminating colorectal cancer model for differentiating normal and tumor tissues.
A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level.
A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer.
A novel DNA methylation-based model that effectively predicts prognosis in hepatocellular carcinoma.
A Novel Early-Stage Lung Adenocarcinoma Prognostic Model Based on Feature Selection With Orthogonal Regression.
A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients.
A novel epigenetic signature for overall survival prediction in patients with breast cancer.
A novel ferroptosis related gene signature is associated with prognosis in patients with ovarian serous cystadenocarcinoma.
A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma.
A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma.
A Novel Ferroptosis-Related Gene Model for Overall Survival Predictions of Bladder Urothelial Carcinoma Patients.
A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer.
A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.
A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer.
A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
A novel four-gene of iron metabolism-related and methylated for prognosis prediction of hepatocellular carcinoma.
A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer.
A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling.
A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas.
A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas.
A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers.
A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer.
A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer.
A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer.
A novel genomic-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
A Novel Identified Long Non-coding RNA, lncRNA MEF2C-AS1, Inhibits Cervical Cancer via Regulation of miR-592/RSPO1.
A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
A Novel Immune-Related Competing Endogenous RNA Network Predicts Prognosis of Acute Myeloid Leukemia.
A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer.
A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
A novel immune-related prognostic index for predicting breast cancer overall survival.
A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma.
A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis.
A novel immunogenomic prognostic signature in lung squamous carcinoma.
A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
A Novel Integrated Metabolism-Immunity Gene Expression Model Predicts the Prognosis of Lung Adenocarcinoma Patients.
A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors.
A Novel Intercellular Communication-Associated Gene Signature for Prognostic Prediction and Clinical Value in Patients With Lung Adenocarcinoma.
A Novel lncRNA HOXC-AS3 Acts as a miR-3922-5p Sponge to Promote Breast Cancer Metastasis.
A novel lncRNA signature prediction effect and comparison with clinical staging systems for postoperative HBV-HCC patients.
A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma.
A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
A novel long non-coding RNA-based prognostic signature for renal cell carcinoma patients with stage IV and histological grade G4.
A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer.
A Novel m6A Gene Signature Associated With Regulatory Immune Function for Prognosis Prediction in Clear-Cell Renal Cell Carcinoma.
A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome.
A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer.
A novel metabolic gene signature-based nomogram to predict overall survival in breast cancer.
A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
A Novel Method for Cancer Subtyping and Risk Prediction Using Consensus Factor Analysis.
A Novel Method to Detect Functional microRNA Regulatory Modules by Bicliques Merging.
A novel method to identify gene interaction patterns.
A novel methylation signature predicts inferior outcome of patients with PDAC.
A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data.
A novel microRNA signature predicts survival in liver hepatocellular carcinoma after hepatectomy.
A novel microRNA signature predicts survival in stomach adenocarcinoma.
A novel microRNA signature predicts vascular invasion in hepatocellular carcinoma.
A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
A novel miR-0308-3p revealed by miRNA-seq of HBV-positive hepatocellular carcinoma suppresses cell proliferation and promotes G1/S arrest by targeting double CDK6/Cyclin D1 genes.
A novel miR-7156-3p-HOXD13 axis modulates glioma progression by regulating tumor cell stemness.
A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation.
A Novel MKL Method for GBM Prognosis Prediction by Integrating Histopathological Image and Multi-omics Data.
A novel model for identification of prognostic indicator for clinical outcome of squamous cell lung carcinoma.
A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients.
A novel network control model for identifying personalized driver genes in cancer.
A Novel Nine Apoptosis-Related Genes Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma and its Associations with Immune Infiltration.
A Novel NIPBL-NACC1 Gene Fusion is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma.
A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer Patients.
A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patients.
A Novel Prognostic Biomarker of Luminal Breast Cancer: High CD39 Expression Is Related to Poor Survival.
A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma.
A Novel Prognostic Index Based on the Analysis of Glycolysis-Related Genes in Head and Neck Squamous Cell Carcinomas.
A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
A novel prognostic model based on epithelial-mesenchymal transition-related genes predicts patient survival in gastric cancer.
A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers.
A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
A novel prognostic nomogram based on 5 long non-coding RNAs in clear cell renal cell carcinoma.
A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
A Novel Prognostic Score Based on ZG16 for Predicting CRC Survival.
A novel prognostic signature of immune-related genes for patients with colorectal cancer.
A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma.
A Novel Prognostic Signature of mRNA-lncRNA in Breast Cancer.
A novel prognostic signature of seven genes for the prediction in patients with thymoma.
A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM.
A Novel Promoter CpG-Based Signature for Long-Term Survival Prediction of Breast Cancer Patients.
A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis.
A Novel Risk Model Based on Autophagy Pathway Related Genes for Survival Prediction in Lung Adenocarcinoma.
A Novel Risk Model Based on Lipid Metabolism-Associated Genes Predicts Prognosis and Indicates Immune Microenvironment in Breast Cancer.
A novel risk score based on a combined signature of 10 immune system genes to predict bladder cancer prognosis.
A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
A novel risk score model for stomach adenocarcinoma based on the expression levels of 10 genes.
A novel risk score system of immune genes associated with prognosis in endometrial cancer.
A novel RNA binding protein-associated prognostic model to predict overall survival in hepatocellular carcinoma patients.
A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma.
A novel RNA sequencing-based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma.
A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
A Novel RNA-Binding Protein-Based Nomogram for Predicting Survival of Patients with Gastric Cancer.
A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
A novel scoring method based on RNA-Seq immunograms describing individual cancer-immunity interactions.
A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes.
A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
A novel scoring system for pivotal autophagy-related genes predicts outcomes after chemotherapy in advanced ovarian cancer patients.
A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes.
A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
A novel serum microRNA-based identification and classification biomarker of human glioma.
A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma.
A novel seven?miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer.
A novel signature based on microvascular invasion predicts the recurrence of HCC.
A Novel Signature Based on mTORC1 Pathway in Hepatocellular Carcinoma.
A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration.
A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer.
A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
A Novel Signature for Predicting Prognosis of Smoking-Related Squamous Cell Carcinoma.
A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma.
A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy.
A novel similarity score based on gene ranks to reveal genetic relationships among diseases.
A Novel Six-Gene Signature for Prognosis Prediction in Ovarian Cancer.
A Novel Six-Gene-Based Prognostic Model Predicts Survival and Clinical Risk Score for Gastric Cancer.
A novel six-microRNA-based model to improve prognosis prediction of breast cancer.
A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme.
A novel small-molecule activator of Sirtuin-1 induces autophagic cell death/mitophagy as a potential therapeutic strategy in glioblastoma.
A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer.
A Novel Sulforaphane-Regulated Gene Network in Suppression of Breast Cancer-Induced Osteolytic Bone Resorption.
A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomas.
A Novel Three-lncRNA Signature Predicts the Overall Survival of HNSCC Patients.
A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
A novel three?miRNA signature predicts survival in cholangiocarcinoma based on RNA?Seq data.
A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation.
A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients.
A novel tumor suppressor gene
A novel workflow for cancer blood biomarker identification.
A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients.
A pan-cancer analysis based on weighted gene co-expression network analysis identifies the biomarker utility of lamin B1 in human tumors.
A pan-cancer analysis of alternative splicing events reveals novel tumor-associated splice variants of matriptase.
A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy.
A pan-cancer analysis of prognostic genes.
A pan-cancer analysis of the clinical and genetic portraits of somatostatin receptor expressing tumor as a potential target of peptide receptor imaging and therapy.
A Pan-cancer Analysis of the Expression and Clinical Relevance of Small Nucleolar RNAs in Human Cancer.
A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment.
A Pan-Cancer Analysis of the Oncogenic Role of Twinfilin Actin Binding Protein 1 in Human Tumors.
A pan-cancer analysis of the prognostic and immunological role of ?-actin (ACTB) in human cancers.
A Pan-Cancer Analysis of the Prognostic Value and Expression of Adenylate Cyclase 7 (ADCY7) in Human Tumors.
A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-? Superfamily.
A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning.
A pan-cancer atlas of cancer hallmark-associated candidate driver lncRNAs.
A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces.
A Pan-Cancer Compendium of Genes Deregulated by Somatic Genomic Rearrangement across More Than 1,400 Cases.
A pan-cancer genome-wide analysis reveals tumour dependencies by induction of nonsense-mediated decay.
A pan-cancer modular regulatory network analysis to identify common and cancer-specific network components.
A pan-cancer perspective analysis reveals the opposite prognostic significance of CD133 in lower grade glioma and papillary renal cell carcinoma.
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential.
A pan-cancer proteomic perspective on The Cancer Genome Atlas.
A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy.
A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells.
A Pan-Cancer Study of Epidermal Growth Factor-Like Domains 6/7/8 as Therapeutic Targets in Cancer.
A pan-cancer study of the transcriptional regulation of uricogenesis in human tumours: pathological and pharmacological correlates.
A pan-cancer transcriptomic study showing tumor specific alterations in central metabolism.
A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer.
A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma.
A panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancer.
A panel of 7 prognosis-related long non-coding RNAs to improve platinum-based chemoresistance prediction in ovarian cancer.
A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
A panel of collagen genes are associated with prognosis of patients with gastric cancer and regulated by microRNA-29c-3p: an integrated bioinformatics analysis and experimental validation.
A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer.
A panel of eight autophagy-related long non-coding RNAs is a good predictive parameter for clear cell renal cell carcinoma.
A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma.
A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
A panel of novel detection and prognostic methylated DNA markers in primary non-small cell lung cancer and serum DNA.
A panel of Transcription factors identified by data mining can predict the prognosis of head and neck squamous cell carcinoma.
A pathologist-designed imaging system for anatomic pathology signout, teaching, and research.
A pathology atlas of the human cancer transcriptome.
A pathways-based prediction model for classifying breast cancer subtypes.
A PDZ Protein GIPC3 Positively Modulates Hedgehog Signaling and Melanoma Growth.
A pilot study on the prevalence of DNA palindromes in breast cancer genomes.
A Pipeline to Call Multilevel Expression Changes between Cancer and Normal Tissues and Its Applications in Repurposing Drugs Effective for Gastric Cancer.
A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma.
A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer.
A polymorphism in miR-1262 regulatory region confers the risk of lung cancer in Chinese population.
A Positive Feedback Loop Between DICER1 and Differentiation Transcription Factors Is Important for Thyroid Tumorigenesis.
A positive feedback loop consisting of C12orf59/NF-?B/CDH11 promotes gastric cancer invasion and metastasis.
A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer.
A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
A potential peptide therapeutic derived from the juxtamembrane domain of the epidermal growth factor receptor.
A Potential Prognostic Gene Signature for Predicting Survival for Glioblastoma Patients.
A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen.
A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients.
A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.
A powerful nonparametric method for detecting differentially co-expressed genes: distance correlation screening and edge-count test.
A Practical Guide to The Cancer Genome Atlas (TCGA).
A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets.
A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables.
A predictive analysis approach for paediatric and adult high-grade glioma: miRNAs and network insight.
A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab.
A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
A Primer on a Hepatocellular Carcinoma Bioresource Bank Using the Cancer Genome Atlas Guidelines: Practical Issues and Pitfalls.
A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain.
A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis.
A probabilistic multi-omics data matching method for detecting sample errors in integrative analysis.
A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection.
A prognosis-predictive nomogram of ovarian cancer with two immune-related genes: CDC20B and PNPLA5.
A prognosis-related based method for miRNA selection on liver hepatocellular carcinoma prediction.
A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma.
A prognostic 11-DNA methylation signature for lung squamous cell carcinoma.
A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining.
A prognostic 3-long noncoding RNA signature for patients with gastric cancer.
A Prognostic 4-Gene Expression Signature for Squamous Cell Lung Carcinoma.
A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma.
A Prognostic Autophagy-Related Gene Pair Signature and Small-Molecule Drugs for Hepatocellular Carcinoma.
A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
A prognostic five long-noncoding RNA signature for patients with rectal cancer.
A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
A prognostic long non-coding RNA-associated competing endogenous RNA network in head and neck squamous cell carcinoma.
A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma.
A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer.
A Prognostic Model Based on RNA Binding Protein Predicts Clinical Outcomes in Hepatocellular Carcinoma Patients.
A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma.
A Prognostic Model Based on Six Metabolism-Related Genes in Colorectal Cancer.
A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
A Prognostic Model Based on the Immune-Related lncRNAs in Colorectal Cancer.
A prognostic model composed of four long noncoding RNAs predicts the overall survival of Asian patients with hepatocellular carcinoma.
A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
A prognostic model for lung adenocarcinoma patient survival with a focus on four miRNAs.
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study.
A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma.
A Prognostic Molecular Signature of N?-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database.
A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
A Prognostic Nomogram Based on Immune Scores Predicts Postoperative Survival for Patients with Hepatocellular Carcinoma.
A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung Adenocarcinoma.
A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside.
A Prognostic Nomogram for Predicting Overall Survival in Pediatric Wilms Tumor Based on an Autophagy-related Gene Signature.
A Prognostic Nomogram Model Based on mRNA Expression of DNA Methylation-Driven Genes for Gastric Cancer.
A Prognostic Prediction Model Developed Based on Four CpG Sites and Weighted Correlation Network Analysis Identified DNAJB1 as a Novel Biomarker for Pancreatic Cancer.
A prognostic prediction system for hepatocellular carcinoma based on gene co-expression network.
A prognostic predictive model constituted with gene mutations of APC, BRCA2, CDH1, SMO, and TSC2 in colorectal cancer.
A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations.
A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma.
A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
A Proof of Concept for Biomarker-Guided Targeted Therapy against Ovarian Cancer Based on Patient-Derived Tumor Xenografts.
A proposal for updating the staging of endometrial cancer.
A prospective picture collection study for a grading atlas of radiation dermatitis for clinical trials in head-and-neck cancer patients.
A prospective study revealing the role of an immune-related eRNA, WAKMAR2, in breast cancer.
A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data.
A Protective Role for RHOJ in NonSmall Cell Lung Cancer Based on Integrated Bioinformatics Analysis.
A protein and mRNA expression-based classification of gastric cancer.
A Proteomic Approach to Understand the Clinical Significance of Acute Myeloid Leukemia-Derived Extracellular Vesicles Reflecting Essential Characteristics of Leukemia.
A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease.
A putative competing endogenous RNA network in cisplatin-resistant lung adenocarcinoma cells identifying potentially rewarding research targets.
A Pyroptosis-Related Gene Signature for Predicting Survival in Glioblastoma.
A qRT-PCR and Gene Functional Enrichment Study Focused on Downregulation of miR-141-3p in Hepatocellular Carcinoma and Its Clinicopathological Significance.
A quantitative atlas of histone modification signatures from human cancer cells.
A quantitative model based on clinically relevant MRI features differentiates lower grade gliomas and glioblastoma.
A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas.
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.
A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients with Glioblastoma Multiforme in The Cancer Genome Atlas Dataset.
A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients.
A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
A random forest classifier predicts recurrence risk in patients with ovarian cancer.
A Random Walk Based Cluster Ensemble Approach for Data Integration and Cancer Subtyping.
A Rapid and Cost-Effective Gene Expression Assay for the Diagnosis of Well-Differentiated and Dedifferentiated Liposarcomas.
A Rational Approach to Target the Epidermal Growth Factor Receptor in Glioblastoma.
A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.
A Recurrence-Specific Gene-Based Prognosis Prediction Model for Lung Adenocarcinoma through Machine Learning Algorithm.
A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles.
A regularized multivariate regression approach for eQTL analysis.
A regulatory loop among CD276, miR-29c-3p, and Myc exists in cancer cells against natural killer cell cytotoxicity.
A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable.
A resource of ribosomal RNA-depleted RNA-Seq data from different normal adult and fetal human tissues.
A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight.
A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.
A risk prediction model of DNA methylation improves prognosis evaluation and indicates gene targets in prostate cancer.
A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
A risk score model with five long non-coding RNAs for predicting prognosis in gastric cancer: an integrated analysis combining TCGA and GEO datasets.
A risk score staging system based on the expression of seven genes predicts the outcome of bladder cancer.
A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
A Risk Score System Based on the Methylation Levels of 15 RNAs in Breast Cancer.
A Risk Signature Consisting of Eight m6A Methylation Regulators Predicts the Prognosis of Glioma.
A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma.
A Risk Signature with Autophagy-Related Long Noncoding RNAs for Predicting the Prognosis of Clear Cell Renal Cell Carcinoma: Based on the TCGA Database and Bioinformatics.
A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma.
A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma.
A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer.
A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts.
A Robust 6-lncRNA Prognostic Signature for Predicting the Prognosis of Patients With Colorectal Cancer Metastasis.
A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer.
A Robust Circular RNA-Associated Three-Gene Prognostic Signature for Patients with Gastric Cancer.
A robust ferroptosis-related gene signature predicts overall survival in clear cell renal cell carcinoma.
A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer.
A robust nine-gene prognostic signature associated with tumour doubling time for hepatocellular carcinoma.
A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer.
A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
A robust topology-based algorithm for gene expression profiling.
A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma.
A robust two-gene signature for glioblastoma survival prediction.
A role for activated Cdc42 in glioblastoma multiforme invasion.
A role for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapy.
A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.
A Role for Histone H2B Variants in Endocrine-Resistant Breast Cancer.
A scoping review and proposed workflow for multi-omic rare disease research.
A secondary role for hypoxia and HIF1 in the regulation of (IFN?-induced) PD-L1 expression in melanoma.
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression.
A self-updating road map of The Cancer Genome Atlas.
A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma.
A Serum Proteomic Signature Predicting Survival in Patients with Glioblastoma.
A Set of Markers Related to Viral Infection Has a Sex-sensitive Prognostic Value in Papillary Thyroid Carcinoma.
A set of molecular markers predicts chemosensitivity to Mitomycin-C following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis.
A Seven Immune-Related lncRNAs Model to Increase the Predicted Value of Lung Adenocarcinoma.
A seven long-noncoding RNA signature predicts prognosis of lung squamous cell carcinoma.
A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma.
A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.
A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma.
A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.
A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer.
A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma.
A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer.
A seven-nuclear receptor-based prognostic signature in breast cancer.
A Short Atlas of Intraocular Tumors.
A signature of 13 autophagy?related gene pairs predicts prognosis in hepatocellular carcinoma.
A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients.
A signature of 24 aging?related gene pairs predict overall survival in gastric cancer.
A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
A signature of estimate-stromal-immune score-based genes associated with the prognosis of lung adenocarcinoma.
A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma.
A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.
A Simple Competing Endogenous RNA Network Identifies Novel mRNA, miRNA, and lncRNA Markers in Human Cholangiocarcinoma.
A single cell atlas of the human liver tumor microenvironment.
A single-cell and spatially resolved atlas of human breast cancers.
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy.
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer.
A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma.
A six-gene prognostic model predicts overall survival in bladder cancer patients.
A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction.
A six-gene-based signature for breast cancer radiotherapy sensitivity estimation.
A six-genotype genetic prognostic model for papillary thyroid cancer.
A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme.
A six-long non-coding RNA signature predicts prognosis in melanoma patients.
A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.
A six-microRNA risk score model predicts prognosis in esophageal squamous cell carcinoma.
A six-microRNA set as prognostic indicators for bile duct cancer.
A six-microRNA signature can better predict overall survival of patients with esophagus adenocarcinoma.
A six-microRNA signature predicts survival of patients with uterine corpus endometrial carcinoma.
A six-microRNA signature to predict outcomes of patients with gastric cancer.
A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma.
A small-molecule activator induces ULK1-modulating autophagy-associated cell death in triple negative breast cancer.
A Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver Cancer.
A Sparse and Low-Rank Regression Model for Identifying the Relationships Between DNA Methylation and Gene Expression Levels in Gastric Cancer and the Prediction of Prognosis.
A stemness-based eleven-gene signature correlates with the clinical outcome of hepatocellular carcinoma.
A strategy to identify dominant point mutant modifiers of a quantitative trait.
A strategy to identify housekeeping genes suitable for analysis in breast cancer diseases.
A Study of TP53 RNA Splicing Illustrates Pitfalls of RNA-seq Methodology.
A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors.
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes.
A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-?.
A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.
A survey and evaluation of Web-based tools/databases for variant analysis of TCGA data.
A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival.
A Survey of Regulatory Interactions Among RNA Binding Proteins and MicroRNAs in Cancer.
A SUV39H1-low chromatin state characterises and promotes migratory properties of cervical cancer cells.
A systematic analysis of a potential metabolism-related prognostic signature for breast cancer patients.
A systematic analysis of immune genes and overall survival in cancer patients.
A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.
A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes.
A systematic atlas of chaperome deregulation topologies across the human cancer landscape.
A systematic comparison of normalization methods for eQTL analysis.
A Systematic Evaluation of Feature Selection and Classification Algorithms Using Simulated and Real miRNA Sequencing Data.
A systematic survey of HOX and TALE expression profiling in human cancers.
A systematic view of computational methods for identifying driver genes based on somatic mutation data.
A systems-based framework to computationally describe putative transcription factors and signaling pathways regulating glycan biosynthesis.
A tale of two cancers: Complete genetic analysis of chromophobe renal cell carcinoma contrasts with clear cell renal cell carcinoma.
A Targeted Bioinformatics Assessment of Adrenocortical Carcinoma Reveals Prognostic Implications of GABA System Gene Expression.
A Targeted Proteomic Approach for Heat Shock Proteins Reveals DNAJB4 as a Suppressor for Melanoma Metastasis.
A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis.
A Targeted Quantitative Proteomic Method Revealed a Substantial Reprogramming of Kinome during Melanoma Metastasis.
A ten-long non-coding RNA signature for predicting prognosis of patients with cervical cancer.
A ten-microRNA expression signature predicts survival in glioblastoma.
A Ten-N6-Methyladenosine (m6A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma.
A thirteen?gene set efficiently predicts the prognosis of glioblastoma.
A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancer.
A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction.
A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
A Three-Gene Classifier Associated With MicroRNA-Mediated Regulation Predicts Prostate Cancer Recurrence After Radical Prostatectomy.
A three-gene expression signature associated with positive surgical margins in tongue squamous cell carcinomas: Predicting surgical resectability from tumour biology?
A three-gene expression-based risk score can refine the European LeukemiaNet AML classification.
A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma.
A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy.
A Three-Metabolic-Genes Risk Score Model Predicts Overall Survival in Clear Cell Renal Cell Carcinoma Patients.
A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis.
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
A three-microRNA signature predicts clinical outcome in breast cancer patients.
A three-mRNA status risk score has greater predictive ability compared with a lncRNA-based risk score for predicting prognosis in patients with hepatocellular carcinoma.
A three?lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
A tissue-based draft map of the murine MHC class I immunopeptidome.
A tool to facilitate clinical biomarker studies - a tissue dictionary based on the Human Protein Atlas.
A topological approach for cancer subtyping from gene expression data.
A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma.
A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.
A TP53-based immune prognostic model for muscle-invasive bladder cancer.
A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database.
A Transcriptional Program for Detecting TGFbeta-induced EMT in Cancer.
A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk.
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications.
A Transcriptomic Signature for Risk-Stratification and Recurrence Prediction in Intrahepatic Cholangiocarcinoma.
A transcriptomic signature of tertiary Gleason 5 predicts worse clinicopathological outcome.
A transcriptomic study for identifying cardia- and non-cardia-specific gastric cancer prognostic factors using genetic algorithm-based methods.
A Translational Pipeline for Overall Survival Prediction of Breast Cancer Patients by Decision-Level Integration of Multi-Omics Data.
A tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma.
A tumor microenvironment-related mRNA-ncRNA signature for prediction early relapse and chemotherapeutic sensitivity in early-stage lung adenocarcinoma.
A tumor-associated splice-isoform of MAP2K7 drives dedifferentiation in MBNL1-low cancers via JNK activation.
A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer.
A twelve-gene signature for survival prediction in malignant melanoma patients.
A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
A two-gene-based prognostic signature for pancreatic cancer.
A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma.
A Two-Sample Test for Equality of Means in High Dimension.
A unified atlas of CD8 T cell dysfunctional states in cancer and infection.
A Unique Subset of Epithelial Ovarian Cancers with Platinum Sensitivity and PARP Inhibitor Resistance.
A united risk model of 11 immune?related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients.
A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study.
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram.
A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues.
A weighted exact test for mutually exclusive mutations in cancer.
A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.
A zinc finger protein gene signature enables bladder cancer treatment stratification.
AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health.
ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma.
ABC-GWAS: Functional Annotation of Estrogen Receptor-Positive Breast Cancer Genetic Variants.
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
ABCC9, NKAPL, and TMEM132C are potential diagnostic and prognostic markers in triple-negative breast cancer.
Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma.
Aberrant Dyskerin Expression Is Related to Proliferation and Poor Survival in Endometrial Cancer.
Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.
Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.
Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing.
Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer.
Aberrant expression of PlncRNA-1 and TUG1: potential biomarkers for gastric cancer diagnosis and clinically monitoring cancer progression.
Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer.
Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer.
Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer.
Aberrant methylation patterns in colorectal cancer: a meta-analysis.
Aberrant methylation?mediated decrease of lncRNA HNF1A?AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Aberrant miR-1246 expression promotes radioresistance in non-small cell lung cancer: a potential prognostic biomarker and radiotherapy sensitization target.
Aberrant MUC1-TRIM46-KRTCAP2 Chimeric RNAs in High-Grade Serous Ovarian Carcinoma.
Aberrant NEK2 expression might be an independent predictor for poor recurrence-free survival and overall survival of skin cutaneous melanoma.
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer.
Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC.
Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma.
Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer.
Aberrantly Methylated and Expressed Genes as Prognostic Epigenetic Biomarkers for Colon Cancer.
Aberrantly methylated-differentially expressed genes and pathways in Epstein-Barr virus-associated gastric cancer.
Aberration hubs in protein interaction networks highlight actionable targets in cancer.
Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas.
Aberrations of Chromosomes 1 and 16 in Breast Cancer: A Framework for Cooperation of Transcriptionally Dysregulated Genes.
Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
Abnormal Eating Patterns Cause Circadian Disruption and Promote Alcohol-Associated Colon Carcinogenesis.
Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Abnormal expression of mRNA, microRNA alteration and aberrant DNA methylation patterns in rectal adenocarcinoma.
Abnormal Expressions of DNA Glycosylase Genes NEIL1, NEIL2, and NEIL3 Are Associated with Somatic Mutation Loads in Human Cancer.
Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition.
Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.
Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing.
Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer.
Absence of an embryonic stem cell DNA methylation signature in human cancer.
Absent in melanoma 1-like (AIM1L) serves as a novel candidate for overall survival in hepatocellular carcinoma.
Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer.
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers.
ACBD3 is up-regulated in gastric cancer and promotes cell cycle G1-to-S transition in an AKT-dependent manner.
Accessible Pipeline for Translational Research Using TCGA: Examples of Relating Gene Mechanism to Disease-Specific Outcomes.
Accounting for differential variability in detecting differentially methylated regions.
Accounting for intraoperative brain shift ascribable to cavity collapse during intracranial tumor resection.
Accounting for tumor purity improves cancer subtype classification from DNA methylation data.
Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.
Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent.
Accurate computation of survival statistics in genome-wide studies.
Accurate diagnosis of prostate cancer using logistic regression.
Accurate Segmentation of Nuclear Regions with Multi-Organ Histopathology Images Using Artificial Intelligence for Cancer Diagnosis in Personalized Medicine.
Accurity: Accurate tumor purity and ploidy inference from tumor-normal WGS data by jointly modelling somatic copy number alterations and heterozygous germline single-nucleotide-variants.
ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients.
ACE: A Workbench using Evolutionary Genetic Algorithms for analyzing association in TCGA Data.
Acetyl-11-keto-?-boswellic Acid Inhibits Precancerous Breast Lesion MCF-10AT Cells via Regulation of LINC00707/miR-206 that Reduces Estrogen Receptor-?.
ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker.
ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPAR? pathway.
Acquired resistance to PRMT5 inhibition induces concomitant collateral sensitivity to paclitaxel.
Acquired Uniparental Disomy Regions Are Associated with Disease Outcome in Patients with Oral Cavity and Oropharynx But Not Larynx Cancers.
ACS publishes 2nd edition of Cancer Atlas.
Actin-Associated Gene Expression is Associated with Early Regional Metastasis of Tongue Cancer.
Actin-binding protein Profilin1 promotes aggressiveness of clear cell renal cell carcinoma cells.
Actin-capping protein CapG is associated with prognosis, proliferation and metastasis in human glioma.
Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway.
Actin?like protein 8 executes a promoting function in the malignant progression of endometrial cancer: identification of a promising biomarker.
Actionable gene alterations in an Asian population with triple-negative breast cancer.
Actionable gene-based classification toward precision medicine in gastric cancer.
Activating ESR1 mutations in hormone-resistant metastatic breast cancer.
Activation of an endogenous retrovirus-associated long non-coding RNA in human adenocarcinoma.
Activation of dopamine receptor D1 inhibits glioblastoma tumorigenicity by regulating autophagic activity.
Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer.
Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.
Activation of the DDR Pathway Leads to the Down-Regulation of the TGF? Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma.
Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
Active deformation fields: Dense deformation field estimation for atlas-based segmentation using the active contour framework.
ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins.
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes.
ACTL6A knockdown inhibits cell migration by suppressing the AKT signaling pathway and enhances the sensitivity of glioma cells to temozolomide.
Acute Tumor Transition Angle on Computed Tomography Predicts Chromosomal Instability Status of Primary Gastric Cancer: Radiogenomics Analysis from TCGA and Independent Validation.
Acyl-CoA Thioesterase 8 and 11 as Novel Biomarkers for Clear Cell Renal Cell Carcinoma.
ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment.
ADAMTS12 acts as a cancer promoter in colorectal cancer via activating the Wnt/?-catenin signaling pathway in vitro.
ADAMTS12 acts as a tumor microenvironment related cancer promoter in gastric cancer.
ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy.
Adaptation of a 3D prostate cancer atlas for transrectal ultrasound guided target-specific biopsy.
Adaptive Multiview Nonnegative Matrix Factorization Algorithm for Integration of Multimodal Biomedical Data.
ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancer.
Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers.
Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated ?-Catenin Activation Compared with Squamous Cell Carcinoma.
Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer.
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis.
ADH7, miR-3065 and LINC01133 are associated with cervical cancer progression in different age groups.
Adhesion GPCRs in Kidney Development and Disease.
Adipophilin as prognostic biomarker in clear cell renal cell carcinoma.
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy.
Adjuvant treatment of endometrial cancer in molecular era: Are we ready to move on?
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment.
ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration.
Adrenal Pathology in the Adult: A Urological Pathologist's Perspective.
Adrenal tumors provide insight into the role of cortisol in NK cell activity.
Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer.
Adrenocortical cancer cell line mutational profile reveals aggressive genetic background.
Adrenocortical Carcinoma Steroid Profiles: In Silico Pan-Cancer Analysis of TCGA Data Uncovers Immunotherapy Targets for Potential Improved Outcomes.
Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
ADRM1 as a therapeutic target in hepatocellular carcinoma.
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.
Advanced Non-Small Cell Lung Cancer Patients With Low Tumor Mutation Burden Might Derive Benefit From Immunotherapy.
Advanced urothelial cancer: a radiology update.
Advances in the genetics of glioblastoma: are we reaching critical mass?
Advances in Translational Research in Neuro-oncology.
Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets.
Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features.
Adverse Drug Event-based Stratification of Tumor Mutations: A Case Study of Breast Cancer Patients Receiving Aromatase Inhibitors.
Adverse Drug Events-based Tumor Stratification for Ovarian Cancer Patients Receiving Platinum Therapy.
Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues.
Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer.
Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer.
Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer.
Age-associated genes in human mammary gland drive human breast cancer progression.
Age-related copy number variations and expression levels of F-box protein FBXL20 predict ovarian cancer prognosis.
Age-Related Differences in Molecular Profiles for Immune Checkpoint Blockade Therapy.
Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Age-related somatic mutations in the cancer genome.
Age-related variations in gene expression patterns of renal cell carcinoma.
Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.
Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels.
Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma.
Aggregation of cohorts for histopathological diagnosis with deep morphological analysis.
Aggresome-Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma.
Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.
Aging-Associated Alterations in Mammary Epithelia and Stroma Revealed by Single-Cell RNA Sequencing.
Aging-related tumor associated fibroblasts changes could worsen the prognosis of GBM patients.
Agonistic CD40 Antibodies in Cancer Treatment.
AHNAK Nucleoprotein 2 Performs a Promoting Role in the Proliferation and Migration of Uveal Melanoma Cells.
AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro.
Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
AKNA Is a Potential Prognostic Biomarker in Gastric Cancer and Function as a Tumor Suppressor by Modulating EMT-Related Pathways.
Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis.
AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.
AKT3 is a key regulator of head and neck squamous cell carcinoma.
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma.
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer.
Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.
Alcohol consumption and breast tumor gene expression.
Aldehyde Dehydrogenase 1-related Genes in Triple-negative Breast Cancer Investigated Using Network Analysis.
Aldehyde oxidase 1 promoted the occurrence and development of colorectal cancer by up-regulation of expression of CD133.
ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
ALDH1A3 correlates with luminal phenotype in prostate cancer.
ALDH3A1 driving tumor metastasis is mediated by p53/BAG1 in lung adenocarcinoma.
ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.
ALDOLASE A regulates invasion of bladder cancer cells via E-cadherin-EGFR signaling.
Aldolase B impairs DNA mismatch repair and induces apoptosis in colon adenocarcinoma.
ALK gene alterations in cancer: biological aspects and therapeutic implications.
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.
ALKAL1 gene silencing prevents colorectal cancer progression via suppressing Sonic Hedgehog (SHH) signaling pathway.
ALKBH5 gene is a novel biomarker that predicts the prognosis of pancreatic cancer: A retrospective multicohort study.
All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.
Allelic imbalance of somatic mutations in cancer genomes and transcriptomes.
Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysis.
Allergy may confer better survival on patients with gliomas.
Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastoma.
Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
ALPL regulates the aggressive potential of high grade serous ovarian cancer cells via a non-canonical WNT pathway.
Alteration and prognostic values of collagen gene expression in patients with gastric cancer under different treatments.
Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer.
Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma.
Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas.
Alterations in Eukaryotic Elongation Factor complex proteins (EEF1s) in cancer and their implications in epigenetic regulation.
Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma.
Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer.
Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer.
Alterations in the Gut Microbiome and Suppression of Histone Deacetylases by Resveratrol Are Associated with Attenuation of Colonic Inflammation and Protection Against Colorectal Cancer.
Alterations in TP53 Are a Potential Biomarker of Bladder Cancer Patients Who Benefit From Immune Checkpoint Inhibition.
Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity.
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.
Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma.
Altered expression and splicing of ESRP1 in malignant melanoma correlates with epithelial-mesenchymal status and tumor-associated immune cytolytic activity.
Altered expression of polycomb group genes in glioblastoma multiforme.
Altered gene expression along the glycolysis-cholesterol synthesis axis is associated with outcome in pancreatic cancer.
Altered gene expression in glycolysis-cholesterol synthesis axis correlates with outcome of triple-negative breast cancer.
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors.
Altered molecular profile in thyroid cancers from patients affected by the Three Mile Island nuclear accident.
Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer.
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer.
Altered RNA editing in 3' UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors.
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma.
Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results.
Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.
Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma.
Alternative splicing events are prognostic in hepatocellular carcinoma.
Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.
Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer.
Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma.
Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma.
Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
Alzheimer's Disease Susceptibility Genes in Malignant Breast Tumors.
Amino acid metabolism-related gene expression-based risk signature can better predict overall survival for glioma.
Aminothiol WR1065 induces differential gene expression in the presence of wild-type p53.
AML through the prism of molecular genetics.
AMP kinase promotes glioblastoma bioenergetics and tumour growth.
AMP?activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
AMPK Inhibition Suppresses the Malignant Phenotype of Pancreatic Cancer Cells in Part by Attenuating Aerobic Glycolysis.
Amplification of 1q32.1 refines the molecular classification of endometrial carcinoma.
Amplification of DNA damage-inducible transcript 3 (DDIT3) is associated with myxoid liposarcoma-like morphology and homologous lipoblastic differentiation in dedifferentiated liposarcoma.
Amplification of the bromodomain-containing protein 4 gene in ovarian high-grade serous carcinoma is associated with worse prognosis and survival.
Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer.
Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma.
Amplification of the NSD3-BRD4-CHD8 pathway in pelvic high-grade serous carcinomas of tubo-ovarian and endometrial origin.
An 11-lncRNA expression could be potential prognostic biomarkers in head and neck squamous cell carcinoma.
An 18-gene signature based on glucose metabolism and DNA methylation improves prognostic prediction for urinary bladder cancer.
An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.
An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.
An 8?gene signature predicts the prognosis of cervical cancer following radiotherapy.
An aberrant DNA methylation signature for predicting hepatocellular carcinoma.
An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.
An Accurate Tool for Uncovering Cancer Subtypes by Fast Kernel Learning Method to Integrate Multiple Profile Data.
An aggressive subtype of stage I lung adenocarcinoma with molecular and prognostic characteristics typical of advanced lung cancers.
An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.
An alternative splicing signature model for predicting hepatocellular carcinoma-specific survival.
An analysis of alternative classification schemes for medical atlas mapping.
An analysis of mutational signatures of synonymous mutations across 15 cancer types.
An anatomic transcriptional atlas of human glioblastoma.
An ancestry informative marker panel design for individual ancestry estimation of Hispanic population using whole exome sequencing data.
An angiogenesis-related long noncoding RNA signature correlates with prognosis in patients with hepatocellular carcinoma.
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer.
An atlas of altered expression of deubiquitinating enzymes in human cancer.
An Atlas of the Human Kinome Reveals the Mutational Landscape Underlying Dysregulated Phosphorylation Cascades in Cancer.
An atlas of the tissue and blood metagenome in cancer reveals novel links between bacteria, viruses and cancer.
An atlas of transposable element-derived alternative splicing in cancer.
An Atlas of Tumour Radiology.
An Atlas of Tumours Involving the Central Nervous System.
An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas.
An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients.
An Autophagy-related Long Non-coding RNA Signature for Breast Cancer.
An autophagy-related long non-coding RNA signature for glioma.
An autophagy-related long non-coding RNA signature for patients with colorectal cancer.
An Autophagy-Related Long Noncoding RNA Signature Contributes to Poor Prognosis in Colorectal Cancer.
An autophagy-related model of 4 key genes for predicting prognosis of patients with laryngeal cancer.
An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
An Effective Hypoxia-Related Long Non-Coding RNAs Assessment Model for Prognosis of Clear Cell Renal Carcinoma.
An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors.
An Eight-CpG-based Methylation Classifier for Preoperative Discriminating Early and Advanced-Late Stage of Colorectal Cancer.
An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer.
An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma.
An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases.
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth.
An energy metabolism-based eight-gene signature correlates with the clinical outcome of esophagus carcinoma.
An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients.
An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
An epithelial-mesenchymal transition-related long non-coding RNA signature to predict overall survival and immune microenvironment in kidney renal clear cell carcinoma.
An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer.
An expanded landscape of human long noncoding RNA.
An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer.
An expression signature model to predict lung adenocarcinoma-specific survival.
An Immune Atlas of Clear Cell Renal Cell Carcinoma.
An Immune Cell-Based Signature Associating With EMT Phenotype Predicts Postoperative Overall Survival of ESCC.
An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle-invasive bladder cancer (MIBC).
An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma.
An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers.
An Immune-Gene-Based Classifier Predicts Prognosis in Patients With Cervical Squamous Cell Carcinoma.
An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma.
An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma.
An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
An immune-related model based on INHBA, JAG2 and CCL19 to predict the prognoses of colon cancer patients.
An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients.
An immune-related risk gene signature predicts the prognosis of breast cancer.
An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
An immune-related signature that to improve prognosis prediction of breast cancer.
An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.
An Immunogenomic Investigation of Oral Cavity Squamous Cell Carcinoma in Patients Aged 45?Years and Younger.
An immunogenomic signature for molecular classification in hepatocellular carcinoma.
An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy.
An Immunogram for an Individualized Assessment of the Antitumor Immune Response in Patients With Hepatocellular Carcinoma.
An immunohistochemical panel of three small ubiquitin-like modifier genes predicts outcomes of patients with triple-negative breast cancer.
An improved clear cell renal cell carcinoma stage prediction model based on gene sets.
An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier.
An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment.
An independently validated survival nomogram for lower grade glioma.
An individualized gene expression signature for prediction of lung adenocarcinoma metastases.
An individualized prognostic signature and multi?omics distinction for early stage hepatocellular carcinoma patients with surgical resection.
An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups.
An Inflammation-Immunity Classifier of 11 Chemokines for Prediction of Overall Survival in Head and Neck Squamous Cell Carcinoma.
An Inflammatory Landscape for Preoperative Neurologic Deficits in Glioblastoma.
An Informatics-assisted Label-free Approach for Personalized Tissue Membrane Proteomics: Case Study on Colorectal Cancer.
An Information Theoretical Multilayer Network Approach to Breast Cancer Transcriptional Regulation.
An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer.
An Innovative Prognostic Model Based on Four Genes in Asian Patient with Gastric Cancer.
An insight into the promoter methylation of PHF20L1 and the gene association with metastasis in breast cancer.
An integrated analysis for long noncoding RNAs and microRNAs with the mediated competing endogenous RNA network in papillary renal cell carcinoma.
An integrated analysis of cancer genes in clear cell renal cell carcinoma.
An integrated analysis of genome-wide DNA methylation and gene expression data in hepatocellular carcinoma.
An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma.
An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer.
An integrated analysis reveals the oncogenic function of lncRNA LINC00511 in human ovarian cancer.
An Integrated Approach for Identifying Molecular Subtypes in Human Colon Cancer Using Gene Expression Data.
An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression.
An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
An Integrated Autophagy-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer: A Bioinformatics-Based Approach.
An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.
An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer.
An Integrated Bioinformatics Analysis Repurposes an Antihelminthic Drug Niclosamide for Treating HMGA2-Overexpressing Human Colorectal Cancer.
An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer.
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
An integrated inspection of the somatic mutations in a lung squamous cell carcinoma using next-generation sequencing.
An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma.
An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
An integrated model of clinical information and gene expression for prediction of survival in ovarian cancer patients.
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
An integrated network of microRNA and gene expression in ovarian cancer.
An Integrated Pan-Cancer Analysis and Structure-Based Virtual Screening of GPR15.
An integrated prediction model of recurrence in endometrial endometrioid cancers.
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
An Integrated Three-Long Non-coding RNA Signature Predicts Prognosis in Colorectal Cancer Patients.
An integration architecture designed to deal with the issues of biological scope, scale and complexity.
An integrative analysis of the age-associated multi-omic landscape across cancers.
An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1-Positive Lung Adenocarcinomas.
An Integrative Analysis Reveals the Underlying Association Between CTNNB1 Mutation and Immunotherapy in Hepatocellular Carcinoma.
An integrative approach for in silico glioma research.
An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
An Integrative Computational Approach Based on Expression Similarity Signatures to Identify Protein-Protein Interaction Networks in Female-Specific Cancers.
An Integrative Gene Expression and Mathematical Flux Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells.
An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription.
An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
An Integrative Model of miRNA and mRNA Expression Signature for Patients of Breast Invasive Carcinoma with Radiotherapy Prognosis.
An integrative somatic mutation analysis to identify pathways linked with survival outcomes across 19 cancer types.
An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors.
An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer.
An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment.
An miRNA signature associated with tumor mutation burden in endometrial cancer.
An mRNA characterization model predicting survival in patients with invasive breast cancer based on The Cancer Genome Atlas database.
An N6-Methyladenosine-Related Gene Set Variation Score as a Prognostic Tool for Lung Adenocarcinoma.
An Online Atlas for Exploring Spatio-Temporal Patterns of Cancer Mortality (1972-2011) and Incidence (1995-2008) in Taiwan.
An ontology-based method for assessing batch effect adjustment approaches in heterogeneous datasets.
An optimal prognostic model based on gene expression for clear cell renal cell carcinoma.
An oral keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer.
An order independent algorithm for inferring gene regulatory network using quantile value for conditional independence tests.
An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients.
An overactive neddylation pathway serves as a therapeutic target and MLN4924 enhances the anticancer activity of cisplatin in pancreatic cancer.
An overview of environmental arsenic issues and exposure risks in Uruguay.
An R package for divergence analysis of omics data.
An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma.
An unusual case of multiple papillary fibroelastoma, review of literature.
An update of the classical Bokhman's dualistic model of endometrial cancer.
Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.
Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.
Analysis and Validation of circRNA-miRNA Network in Regulating m6A RNA Methylation Modulators Reveals CircMAP2K4/miR-139-5p/YTHDF1 Axis Involving the Proliferation of Hepatocellular Carcinoma.
Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study.
Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers.
Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies
Analysis of Bulk RNA Sequencing Data Reveals Novel Transcription Factors Associated With Immune Infiltration Among Multiple Cancers.
Analysis of carcinogenic signaling networks in endometrial cancer identifies RAB17 as a potential target.
Analysis of Cellular Feature Differences of Astrocytomas with Distinct Mutational Profiles Using Digitized Histopathology Images.
Analysis of chemotherapeutic response in ovarian cancers using publicly available high-throughput data.
Analysis of Class I Major Histocompatibility Complex Gene Transcription in Human Tumors Caused by Human Papillomavirus Infection.
Analysis of clinical characteristics of macrophage capping protein (CAPG) gene expressed in glioma based on TCGA data and clinical experiments.
Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma.
Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.
Analysis of Colorectal Cancer-Associated Alternative Splicing Based on Transcriptome.
Analysis of competing endogenous RNA network to identify the key RNAs associated with prostate adenocarcinoma.
Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.
Analysis of cyclin E co-expression genes reveals nuclear transcription factor Y subunit alpha is an oncogene in gastric cancer.
Analysis of Cyclin-Dependent Kinase 1 as an Independent Prognostic Factor for Gastric Cancer Based on Statistical Methods.
Analysis of differentially expressed genes in hepatocellular carcinoma using cDNA arrays.
Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer.
Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.
Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer.
Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.
Analysis of expression profile of miRNA in stomach adenocarcinoma.
Analysis of gene co?expression network reveals prognostic significance of CNFN in patients with head and neck cancer.
Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes.
Analysis of Genes Involved in Ulcerative Colitis Activity and Tumorigenesis Through Systematic Mining of Gene Co-expression Networks.
Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
Analysis of Genetic Alterations Related to DNA Methylation in Testicular Germ Cell Tumors Based on Data Mining.
Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor beta Pathway Short title: Prognostic significance of TGF-? signature in liver cancer.
Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
Analysis of immune-related signatures of colorectal cancer identifying two different immune phenotypes: Evidence for immune checkpoint inhibitor therapy.
Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.
Analysis of interactions between the epigenome and structural mutability of the genome using Genboree Workbench tools.
Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Analysis of key genes and signaling pathways involved in Helicobacter pylori-associated gastric cancer based on The Cancer Genome Atlas database and RNA sequencing data.
Analysis of Key Genes Regulating the Warburg Effect in Patients with Gastrointestinal Cancers and Selective Inhibition of This Metabolic Pathway in Liver Cancer Cells.
Analysis of key genes reveal lysine demethylase 5B promotes prostate cancer progression.
Analysis of LAGEs Family Gene Signature and Prognostic Relevance in Breast Cancer.
Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival.
Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Analysis of Matched Tumor and Normal Profiles Reveals Common Transcriptional and Epigenetic Signals Shared across Cancer Types.
Analysis of methylation-driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma.
Analysis of METTL3 and METTL14 in hepatocellular carcinoma.
Analysis of microRNA expression profiles reveals a 5?microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma.
Analysis of microRNA-target interactions across diverse cancer types.
Analysis of morphological characteristics of IDH-mutant/wildtype brain tumors using whole-lesion phenotype analysis.
Analysis of mRNA expression differences in bladder cancer metastasis based on TCGA datasets.
Analysis of multi-omics differences in left-side and right-side colon cancer.
Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics.
Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk.
Analysis of PD-1 related immune transcriptional profile in different cancer types.
Analysis of PI3K pathway components in human cancers.
Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-? Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer.
Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.
Analysis of risk factors for colon cancer progression.
Analysis of RNA expression of normal and cancer tissues reveals high correlation of COP9 gene expression with respiratory chain complex components.
Analysis of single nucleotide variants of HFE gene and association to survival in The Cancer Genome Atlas GBM data.
Analysis of single-cell transcriptomes links enrichment of olfactory receptors with cancer cell differentiation status and prognosis.
Analysis of spatial aggregation.
Analysis of TERT Isoforms across TCGA, GTEx and CCLE Datasets.
Analysis of TGCA data reveals genetic and epigenetic changes and biological function of MUC family genes in colorectal cancer.
Analysis of the "centrosome-ome" identifies MCPH1 deletion as a cause of centrosome amplification in human cancer.
Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumour.
Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor ?1 and ?2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma.
Analysis of the cancer genome atlas data to determine the correlation between PROX1 and TERT in hepatocellular carcinoma.
Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma.
Analysis of the Circadian Regulation of Cancer Hallmarks by a Cross-Platform Study of Colorectal Cancer Time-Series Data Reveals an Association with Genes Involved in Huntington's Disease.
Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma.
Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of SPATS2L in Patients With Glioma.
Analysis of the exome aggregation consortium (ExAC) database suggests that the BAP1-tumor predisposition syndrome is underreported in cancer patients.
Analysis of the expression and genetic alteration of CLDN18 in gastric cancer.
Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.
Analysis of the function of MAGE-A in esophageal carcinoma by bioinformatics.
Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis.
Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.
Analysis of the long non-coding RNA LINC01614 in non-small cell lung cancer.
Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
Analysis of the PD-1 Ligands Among Gastrointestinal Cancer Patients: Focus on Cancer Immunity.
Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer via Bioinformatics Methods.
Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Analysis of the Role and Regulatory Mechanism of hsa-miR-504 in Cervical Cancer Based on The Cancer Genome Atlas Database.
Analysis of the role of Frizzled 2 in different cancer types.
Analysis of the role of the interleukins in colon cancer.
Analysis of the TCGA Dataset Reveals that Subsites of Laryngeal Squamous Cell Carcinoma are Molecularly Distinct.
Analysis of Threshold Change of Tumor Mutation Burden in Gastric Cancer.
Analysis of tumor mutation burden combined with immune infiltrates in endometrial cancer.
Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas.
Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies.
Analyzing cancer gene expression data through the lens of normal tissue-specificity.
Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.
Analyzing the disease module associated with osteosarcoma via a network- and pathway-based approach.
Analyzing the influence of IL18 in regulation of YAP1 in breast oncogenesis using cBioportal.
Analyzing the LncRNA, miRNA, and mRNA Regulatory Network in Prostate Cancer with Bioinformatics Software.
Analyzing the Role of DICER1 Germline Variations in Papillary Thyroid Carcinoma.
Anatomical specificity of O6-methylguanine DNA methyltransferase protein expression in glioblastomas.
Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry.
Ancestry-specific predisposing germline variants in cancer.
Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity.
Androgen metabolism genes in prostate cancer health disparities.
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts.
Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
Angiogenesis-Related Gene Expression Signatures Predicting Prognosis in Gastric Cancer Patients.
Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma.
Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Acts as Diagnostic Biomarker and Adverse Prognostic Factor of Hepatocellular Carcinoma (HCC): Evidence from Bioinformatic Analysis.
Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes.
Angiopoietin pathway gene expression associated with poor breast cancer survival.
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.
ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence.
ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation.
Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis.
ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
ANKRD22 is involved in the progression of prostate cancer.
ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control.
ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data.
Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe.
Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling.
Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells.
Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes.
Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress GBM Tumor Growth.
Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells.
Antibodies for profiling the human proteome-The Human Protein Atlas as a resource for cancer research.
Antimalarial drug pyrimethamine plays a dual role in anti-tumor proliferation and metastasis through targeting DHFR and TP.
Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.
Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer.
Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma.
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.
Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer Analysis.
ANXA1 as a Prognostic and Immune Microenvironmental Marker for Gliomas Based on Transcriptomic Analysis and Experimental Validation.
ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast Cancer.
AP-2? expression in papillary thyroid carcinoma predicts tumor progression and poor prognosis.
AP001056.1, A Prognosis-Related Enhancer RNA in Squamous Cell Carcinoma of the Head and Neck.
APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner.
Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-?B/Snail signaling pathway.
APLN: A potential novel biomarker for cervical cancer.
APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.
APOBEC3B expression and its prognostic potential in breast cancer.
APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status.
APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
ApoM is an important potential protective factor in the pathogenesis of primary liver cancer.
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
APPL1 promotes the migration of gastric cancer cells by regulating Akt2 phosphorylation.
Application of a co?expression network for the analysis of aggressive and non?aggressive breast cancer cell lines to predict the clinical outcome of patients.
Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma.
Application of ARID1A to murine formalin-fixed paraffin embedded tissue using immunohistochemistry.
Application of Atlas of Cancer Signalling Network in preclinical studies.
Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.
Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.
Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
Application of the differential hybridization of Atlas Human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue.
Application of the High-throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma.
Applying graph database technology for analyzing perturbed co-expression networks in cancer.
Approaching the Increasing Complexity of Non-Small Cell Lung Cancer Taxonomy.
AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature.
Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
Are vitamins relevant to cancer risks? A Mendelian randomization investigation.
ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer.
ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.
ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.
ARHGAP30 suppressed lung cancer cell proliferation, migration, and invasion through inhibition of the Wnt/?-catenin signaling pathway.
ARHGAP6 Promotes Apoptosis and Inhibits Glycolysis in Lung Adenocarcinoma Through STAT3 Signaling Pathway.
ARID1A and CTNNB1/?-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification.
ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas.
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer.
ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Arm Selection Preference of MicroRNA-193a Varies in Breast Cancer.
ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.
Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia.
Array-based analysis of gene expression in childhood acute lymphoblastic leukemia.
ARRB2 promotes colorectal cancer growth through triggering WTAP.
Arthur Purdy Stout (1885-1967), a pioneer of surgical pathology: a survey of his Notes on the Education of an "Oncological" Surgical Pathologist.
Artificial intelligence and big data facilitated targeted drug discovery.
Artificial intelligence grading of breast cancer: a promising method to refine prognostic classification for management precision.
Artificial Intelligence-based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data.
Aryl hydrocarbon receptor nuclear translocator promotes the proliferation and invasion of clear cell renal cell carcinoma cells potentially by affecting the glycolytic pathway.
ASEQ: fast allele-specific studies from next-generation sequencing data.
ASH2L drives proliferation and sensitivity to bleomycin and other genotoxins in Hodgkin's lymphoma and testicular cancer cells.
ASPM is a Novel Candidate Gene Associated with Colorectal Cancer Cell Growth.
ASPP1 deficiency promotes epithelial-mesenchymal transition, invasion and metastasis in colorectal cancer.
Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer.
Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles.
Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-?/? V(D)J recombinations correlates with PD-1 expression.
Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.
Assessing reproducibility and veracity across machine learning techniques in biomedicine: A case study using TCGA data.
Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.
Assessing the clinical utility of cancer genomic and proteomic data across tumor types.
Assessing the clinical utility of genomic expression data across human cancers.
Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling.
Assessing the miRNA sponge potential of RUNX1T1 in t(8;21) acute myeloid leukemia.
Assessing the Relationship Between Leukocyte Telomere Length and Cancer Risk/Mortality in UK Biobank and TCGA Datasets With the Genetic Risk Score and Mendelian Randomization Approaches.
Assessment for prognostic value of differentially expressed genes in immune microenvironment of clear cell renal cell carcinoma.
Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel.
Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma.
Assessment of intra-tumoural colorectal cancer prognostic biomarkers using RNA in situ hybridisation.
Assessment of intratumoral heterogeneity with mutations and gene expression profiles.
Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing.
Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma.
Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer.
Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational study.
Assessment of Renal Cell Carcinoma by Texture Analysis in Clinical Practice: A Six-Site, Six-Platform Analysis of Reliability.
Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival.
Assessment of tumor mutation burden calculation from gene panel sequencing data.
Assisted differential network analysis for gene expression data.
Assisted estimation of gene expression graphical models.
Associating lncRNAs with small molecules via bilevel optimization reveals cancer-related lncRNAs.
Association Analysis between Body Mass Index and Genomic DNA Methylation across 15 Major Cancer Types.
Association analysis of a chemo-response signature identified within The Cancer Genome Atlas aimed at predicting genetic risk for chemo-response in ovarian cancer.
Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls.
Association analysis using somatic mutations.
Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer.
Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer.
Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns.
Association between copy-number alteration of +20q, -14q and -18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma.
Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women.
Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project.
Association between DNA damage repair gene somatic mutations and immune-related gene expression in ovarian cancer.
Association between endometrial cancer risk classification and gene expression in the cancer genome atlas database.
Association between expression of random gene sets and survival is evident in multiple cancer types and may be explained by sub-classification.
Association between FAT1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinoma.
Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma.
Association between Genetic and Immunological Background of Hepatocellular Carcinoma and Expression of Programmed Cell Death-1.
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.
Association between histone lysine methyltransferase KMT2C mutation and clinicopathological factors in breast cancer.
Association Between Hypoxia-Inducible Factor-2? (HIF-2?) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET.
Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma.
Association between Morphologic CT Imaging Traits and Prognostically Relevant Gene Signatures in Women with High-Grade Serous Ovarian Cancer: A Hypothesis-generating Study.
Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple negative breast cancer.
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy.
Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Association between the CYP11 family and six cancer types.
Association Between the Microsatellite Instability Status and the Efficacy of Postoperative Adjuvant Chemoradiotherapy in Patients With Gastric Cancer.
Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma.
Association between tumor mutation burden and immune infiltration in ovarian cancer.
Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.
Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options.
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.
Association of BAX hypermethylation with coronary heart disease is specific to individuals aged over 70.
Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
Association of C8orf4 expression with its methylation status, aberrant ?-catenin expression, and the development of cervical squamous cell carcinoma.
Association of cancer mortality with postdiagnosis overweight and obesity using body mass index.
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.
Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival.
Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer.
Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer.
Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.
Association of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinoma.
Association of Epigenetic Clock with Consensus Molecular Subtypes and Overall Survival of Colorectal Cancer.
Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.
Association of expression quantitative trait loci for long noncoding RNAs with lung cancer risk in Asians.
Association of genomic subtypes of lower-grade gliomas with shape features automatically extracted by a deep learning algorithm.
Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma.
Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms.
Association of LINC00673 Genetic Variants with Progression of Oral Cancer.
Association of lnc-IL17RA-11 with increased radiation sensitivity and improved prognosis of HPV-positive HNSCC.
Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.
Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis.
Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis.
Association of MSH2 Expression With Tumor Mutational Burden and the Immune Microenvironment in Lung Adenocarcinoma.
Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma.
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy.
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.
Association of Processed Meats and Alcohol Consumption with Renal Cell Carcinoma: A Worldwide Population-Based Study.
Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades.
Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma.
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma.
Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.
Association of variably methylated tumour DNA regions with overall survival for invasive lobular breast cancer.
Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk.
Association study of genetic variants in estrogen metabolic pathway genes and colorectal cancer risk and survival.
Associations between gene expression profiles of invasive breast cancer and Breast Imaging Reporting and Data System MRI lexicon.
Associations between proteasomal activator PA28? and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
Associations of high expression of miR-106b-5p detected from FFPE sample with poor prognosis of RCC patients.
Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer.
Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis.
Associations of PIK3CA mutations with clinical features and prognosis in gastric cancer.
Associations of two-pore domain potassium channels and triple negative breast cancer subtype in The Cancer Genome Atlas: systematic evaluation of gene expression and methylation.
ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen.
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Atezolizumab potentiates Tcell-mediated cytotoxicity and coordinates with FAK to suppress cell invasion and motility in PD-L1+ triple negative breast cancer cells.
ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.
Atlas and histologic classification of tumors of the rat mammary gland.
Atlas construction and spatial normalisation to facilitate radiation-induced late effects research in childhood cancer.
Atlas maps cancer mortality among nonwhites.
ATLAS OF BONE TUMORS: including tumorlike lesions.
Atlas of Cancer in Scotland 1975-1980. Incidence and epidemiological perspective.
Atlas of cancer incidence in Norway 1970-1979.
Atlas of cancer incidence in the former German Democratic Republic 1978-1982.
Atlas of Cancer Mortality for U.S. Counties.
Atlas of Cancer Mortality For U.S. Counties: 1950-1969.
Atlas of cancer mortality in central Europe.
Atlas of Cancer Mortality in England and Wales 1968–1978.
Atlas of Cancer Mortality in the European Economic Community.
Atlas of cancer mortality in the European Union and the European Economic Area 1993-1997.
Atlas of cancer mortality in the People's Republic of China. An aid for cancer control and research.
Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps.
ATLAS of chest tumors.
Atlas of Ex Vivo Prostate Tissue and Cancer Images Using Confocal Laser Endomicroscopy: A Project for Intraoperative Positive Surgical Margin Detection During Radical Prostatectomy.
Atlas of eyelid and conjunctival tumors
Atlas of genetics and cytogenetics in oncology and haematology in 2013.
Atlas of Genetics and Cytogenetics in Oncology and Haematology, year 2003.
Atlas of intraocular tumours
Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
Atlas of Tumor Pathology: Sect. II, Fasc. 6. Tumors of the Peripheral Nervous System.
Atlas of Tumor Radiology: The Vertebral Column.
Atlas of Tumors of the Facial Skeleton.
Atlas of Tumour Radiology: The Chest.
Atlas to patient registration with brain tumor based on a mesh-free method.
Atlas-based automatic segmentation of MR images: validation study on the brainstem in radiotherapy context.
Atlas-based segmentation of brain tumor images using a Markov random field-based tumor growth model and non-rigid registration.
Atlas-based segmentation of pathological MR brain images using a model of lesion growth.
ATM mutations as an independent prognostic factor and potential biomarker for immune checkpoint therapy in endometrial cancer.
ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment.
ATM/RB1 mutations predict shorter overall survival in urothelial cancer.
ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer.
ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation.
Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry.
Atypical de Quervain's thyroiditis diagnosed as atypia of undetermined significance by cytology and suspicious for cancer by Afirma Genomic Sequencing Classifier.
Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.
Augmenting disease maps: a Bayesian meta-analysis approach.
AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
AURKB: a promising biomarker in clear cell renal cell carcinoma.
Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor.
Aurovertin B exerts potent antitumor activity against triple-negative breast cancer in vivo and in vitro via regulating ATP synthase activity and DUSP1 expression.
Authentication of differential gene expression in oral squamous cell carcinoma using machine learning applications.
Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder.
Autocrine TGF? Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment.
Autocrined leptin promotes proliferation of non-small cell lung cancer (NSCLC) via PI3K/AKT and p53 pathways.
Autoencoded DNA methylation data to predict breast cancer recurrence: Machine learning models and gene-weight significance.
AutoEncoder-Based Computational Framework for Tumor Microenvironment Decomposition and Biomarker Identification in Metastatic Melanoma.
Autologous reference types can confound the detection of somatic mutation in solid cancers.
Automated analysis of immunohistochemistry images identifies candidate location biomarkers for cancers.
Automated clear cell renal carcinoma grade classification with prognostic significance.
AUTOMATED COMPARISON OF PROTEIN SUBCELLULAR LOCATION PATTERNS BETWEEN IMAGES OF NORMAL AND CANCEROUS TISSUES.
Automated deconvolution of structured mixtures from heterogeneous tumor genomic data.
Automated Grading of Gliomas using Deep Learning in Digital Pathology Images: A modular approach with ensemble of convolutional neural networks.
Automated network analysis identifies core pathways in glioblastoma.
Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of GCM2, ITPRIPL1 and CCDC181 for Detection of Early Breast Cancer and Surgical Treatment Response.
Automatic disease stage classification of glioblastoma multiforme histopathological images using deep convolutional neural network.
Automatic extraction of cell nuclei from H&E-stained histopathological images.
Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer.
Autophagy-related gene P4HB: a novel diagnosis and prognosis marker for kidney renal clear cell carcinoma.
Autophagy-related genes are potential diagnostic and prognostic biomarkers in prostate cancer.
Autophagy-related genes contribute to malignant progression and have a clinical prognostic impact in colon adenocarcinoma.
Autophagy-Related Long Non-coding RNA Is a Prognostic Indicator for Bladder Cancer.
Autophagy-Related Long Non-coding RNA Signature as Indicators for the Prognosis of Uveal Melanoma.
Autophagy-related long non-coding RNA signature for ovarian cancer.
Autophagy-related long noncoding RNAs can predict prognosis in patients with bladder cancer.
Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma.
Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma.
Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
B-CAN: a resource sharing platform to improve the operation, visualization and integrated analysis of TCGA breast cancer data.
B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers.
B3GNT3: A prognostic biomarker associated with immune cell infiltration in pancreatic adenocarcinoma.
B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors.
BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples.
BAG2 Overexpression Correlates with Growth and Poor Prognosis of Esophageal Squamous Cell Carcinoma.
Banding Together: A Systematic Comparison of The Cancer Genome Atlas and the Mitelman Database.
BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma.
BAP1 functions as a tumor promoter in prostate cancer cells through EMT regulation.
BAP1 is Overexpressed in Black Compared with White patients with Mx-M1 Clear Cell Renal Cell Carcinoma: A report from the Cancer Genome Atlas.
BarH-like homeobox 1 induces the progression of cell malignant phenotype in endometrial carcinoma through the regulation of ERK/MEK signaling pathway.
BART Cancer: a web resource for transcriptional regulators in cancer genomes.
Base excision repair regulates PD-L1 expression in cancer cells.
Base of tongue cancer-is it tongue cancer located at the base of the tongue, or is it a type of lingual tonsil cancer? The perspective from a genomic analysis.
Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions.
Basilar invagination associated with an intercarotid paraganglioma--case report.
BATF acts as an oncogene in non-small cell lung cancer.
Bayesian genome- and epigenome-wide association studies with gene level dependence.
Bayesian graphical models for computational network biology.
Bayesian Hierarchical Varying-sparsity Regression Models with Application to Cancer Proteogenomics.
Bayesian inference for latent biologic structure with determinantal point processes (DPP).
Bayesian inference of hub nodes across multiple networks.
Bayesian Network Marker Selection via the Thresholded Graph Laplacian Gaussian Prior.
Bayesian predictive modeling for genomic based personalized treatment selection.
Bayesian semi-nonnegative matrix tri-factorization to identify pathways associated with cancer phenotypes.
Bayesian variable selection for parametric survival model with applications to cancer omics data.
Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
BBCancer: an expression atlas of blood-based biomarkers in the early diagnosis of cancers.
BCAT1 Overexpression Promotes Proliferation, Invasion, and Wnt Signaling in Non-Small Cell Lung Cancers.
BCAT1 overexpression regulates proliferation and c?Myc/GLUT1 signaling in head and neck squamous cell carcinoma.
BCL-2 system analysis identifies high-risk colorectal cancer patients.
BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer.
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
BCL2 Regulation According to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.
BCL7B is a potential novel diagnosis and prognosis biomarker for sarcomas using bioinformatics analysis.
Bcl9 Depletion Modulates Endothelial Cell in Tumor Immune Microenvironment in Colorectal Cancer Tumor.
BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer.
BCNTB bioinformatics: the next evolutionary step in the bioinformatics of breast cancer tissue banking.
BEclear: Batch Effect Detection and Adjustment in DNA Methylation Data.
Beclin-1 expression is retained in high-grade serous ovarian cancer yet is not essential for autophagy induction in vitro.
BEETL-fastq: a searchable compressed archive for DNA reads.
Before and After: Comparison of Legacy and Harmonized TCGA Genomic Data Commons' Data.
Benchmark of long non-coding RNA quantification for RNA sequencing of cancer samples.
Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle.
Benzodiazepines use and breast cancer risk: A population-based study and gene expression profiling evidence.
BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer.
Beta-1 syntrophin (SNTB1) regulates colorectal cancer progression and stemness via regulation of the Wnt/?-catenin signaling pathway.
Better prognostic determination and feature characterization of cutaneous melanoma through integrative genomic analysis.
Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.
Beyond genomics: critical evaluation of cell line utility for ovarian cancer research.
Beyond Synthetic Lethality: Charting the Landscape of Pairwise Gene Expression States Associated with Survival in Cancer.
Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity.
BGN and COL11A1 Regulatory Network Analysis in Colorectal Cancer (CRC) Reveals That BGN Influences CRC Cell Biological Functions and Interacts with miR-6828-5p.
BHLHA15-Positive Secretory Precursor Cells Can Give Rise to Tumors in Intestine and Colon in Mice.
BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
Biased Expression of the FOXP3?3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance.
Biased Influences of Low Tumor Purity on Mutation Detection in Cancer.
BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
BICD Cargo Adaptor 1 (BICD1) Downregulation Correlates with a Decreased Level of PD-L1 and Predicts a Favorable Prognosis in Patients with IDH1-Mutant Lower-Grade Gliomas.
Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
Big data visualization identifies the multidimensional molecular landscape of human gliomas.
Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer.
Big Data-Based Identification of Multi-Gene Prognostic Signatures in Liver Cancer.
Big genes are big mutagen targets: a connection to cancerous, spherical cells?
Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells.
Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
Biobanking: An Important Resource for Precision Medicine in Glioblastoma.
Biocomputing: Numerical simulation of glioblastoma growth and comparison with conventional irradiation margins.
Biocomputing: numerical simulation of glioblastoma growth using diffusion tensor imaging.
Biodistribution of the ¹?F-FPPRGD? PET radiopharmaceutical in cancer patients: an atlas of SUV measurements.
Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Bioinformatic analyses reveal the key pathways and genes in the CXCR4 mediated mesenchymal subtype of glioblastoma.
Bioinformatic analysis and in vitro validation of a five-microRNA signature as a prognostic biomarker of hepatocellular carcinoma.
Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Melanoma.
Bioinformatic analysis of four miRNAs relevant to metastasis-regulated processes in endometrial carcinoma.
Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.
Bioinformatic Analysis of Gene Expression for Melanoma Treatment.
Bioinformatic Analysis of Hepatocellular Carcinoma Cell Lines to the Efficacy of Nimotuzumab.
Bioinformatic analysis of PFN2 dysregulation and its prognostic value in head and neck squamous carcinoma.
Bioinformatic analysis of RNA-seq data unveiled critical genes in rectal adenocarcinoma.
Bioinformatic analysis of the prognostic value of the lncRNAs encoding snoRNAs in hepatocellular carcinoma.
Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal cancer.
Bioinformatic Analysis Reveals an Immune/Inflammatory-Related Risk Signature for Oral Cavity Squamous Cell Carcinoma.
Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
Bioinformatic and integrated analysis identifies an lncRNA-miRNA-mRNA interaction mechanism in gastric adenocarcinoma.
Bioinformatic approaches to interrogating vitamin D receptor signaling.
Bioinformatic Exploration for Prognostic Significance of Sphingolipid Metabolism-Related Genes in Invasive Ductal Carcinoma Using the Cancer Genome Atlas Cohort.
Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
Bioinformatic identification of differentially expressed genes associated with prognosis of locally advanced lymph node-positive prostate cancer.
Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma.
Bioinformatic identification of prognostic indicators in bladder cancer.
Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer.
Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small-Cell Lung Cancer.
Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
Bioinformatic profiling identifies a platinum-resistant-related risk signature for ovarian cancer.
Bioinformatic profiling identifies an immune-related risk signature for glioblastoma.
Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment.
Bioinformatic screening and experimental analysis identify SFRP1 as a prognostic biomarker for tongue squamous cell carcinomas.
Bioinformatical analysis of Gene Expression Omnibus (GEO) database associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 pathways with glioblastoma development and prognosis.
Bioinformatical identification of key genes regulated by IGF2BP2-mediated RNA N6-methyladenosine and prediction of prognosis in hepatocellular carcinoma.
Bioinformatics analyses and biological function of lncRNA ZFPM2-AS1 and ZFPM2 gene in hepatocellular carcinoma.
Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC).
Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Bioinformatics analysis based on immune-autophagy-related lncRNAs combined with immune infiltration in bladder cancer.
Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma.
Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer.
Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer.
Bioinformatics analysis for the identification of differentially expressed genes and related signaling pathways in H. pylori-CagA transfected gastric cancer cells.
Bioinformatics Analysis Identifies IL6ST as a Potential Tumor Suppressor Gene for Triple-Negative Breast Cancer.
Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid Leukemia Associated with DNMT3A Mutation.
Bioinformatics Analysis of a Prognostic miRNA Signature and Potential Key Genes in Pancreatic Cancer.
Bioinformatics Analysis of Autophagy-related lncRNAs in Esophageal Carcinoma.
Bioinformatics Analysis of Differentially Expressed Genes and miRNAs in Low-Grade Gliomas.
Bioinformatics analysis of esophageal cancer unveils an integrated mRNA-lncRNA signature for predicting prognosis.
Bioinformatics analysis of gene expression data for the identification of critical genes in breast invasive carcinoma.
Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
Bioinformatics analysis of gene expression profiles to identify causal genes in luminal B2 breast cancer.
Bioinformatics Analysis of KIF1A Expression and Gene Regulation Network in Ovarian Carcinoma.
Bioinformatics analysis of laryngeal squamous cell carcinoma: seeking key candidate genes and pathways.
Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis.
Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.
Bioinformatics analysis of prognosis-related long non-coding RNAs in invasive breast carcinoma.
Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Bioinformatics analysis of RNA sequencing data reveals multiple key genes in uterine corpus endometrial carcinoma.
Bioinformatics analysis of RNA-seq data revealed critical genes in colon adenocarcinoma.
Bioinformatics analysis of SRSF1-controlled gene networks in colorectal cancer.
Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma.
Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
Bioinformatics Analysis of the Expression of ATP Binding Cassette Subfamily C Member 3 (ABCC3) in Human Glioma.
Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer.
Bioinformatics analysis of the interactions among lncRNA, miRNA and mRNA expression, genetic mutations and epigenetic modifications in hepatocellular carcinoma.
Bioinformatics analysis of the prognosis and biological significance of VCAN in gastric cancer.
Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer.
Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma.
Bioinformatics analysis reveals biomarkers with cancer stem cell characteristics in kidney renal clear cell carcinoma.
Bioinformatics Analysis Reveals Biomarkers With Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma.
Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma.
Bioinformatics analysis reveals the competing endogenous RNA (ceRNA) coexpression network in the tumor microenvironment and prognostic biomarkers in soft tissue sarcomas.
Bioinformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer.
Bioinformatics analysis suggests that COL4A1 may play an important role in gastric carcinoma recurrence.
Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma.
Bioinformatics Analysis to Determine Prognostic Mutations of 72 de novo Acute Myeloid Leukemia Cases from the Cancer Genome Atlas (TCGA) with 23 Most Common Mutations and no Abnormal Cytogenetics.
Bioinformatics analysis to identify the critical genes, microRNAs and long noncoding RNAs in melanoma.
Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma.
Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment.
Bioinformatics analysis to screen the key prognostic genes in ovarian cancer.
Bioinformatics Analysis to Screen the Key Prognostic Genes in Tumor Microenvironment of Bladder Cancer.
Bioinformatics and functional analyses of key genes in smoking-associated lung adenocarcinoma.
Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Bioinformatics and survival analysis of glia maturation factor-? in pan-cancers.
Bioinformatics approaches in the study of cancer.
Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma.
Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma.
Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma.
Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma.
Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Bioinformatics-based analysis of the association between the A1-chimaerin (CHN1) gene and gastric cancer.
Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Biologic Pathways Underlying Prognostic Radiomics Phenotypes from Paired MRI and RNA Sequencing in Glioblastoma.
Biological and clinical influences of NPM1 in acute myeloid leukemia patients with DNMT3A mutations.
Biological and Clinical Significance of GATA3 Detected from TCGA Database and FFPE Sample in Bladder Cancer Patients.
Biological and Clinicopathological Implications of Beta-3-N-acetylglucosaminyltransferase 8 in Triple-negative Breast Cancer.
Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response.
Biological information and functional analysis reveal the role of discoidin domain receptor 1 in oral squamous cell carcinoma.
Biological Interpretation of Morphological Patterns in Histopathological Whole-Slide Images.
Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.
Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary Melanomas.
Biologics in combination with chemotherapy for gastric cancer: is this the answer?
Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features.
Biomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma.
Biomarker expression analysis in different age groups revealed age was a risk factor for breast cancer.
Biomarker Identification through Multiomics Data Analysis of Prostate Cancer Prognostication Using a Deep Learning Model and Similarity Network Fusion.
Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma.
Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-? Correlates with Gastric Cancer Progression and Poor Prognosis.
Biomarkers of erlotinib response in non-small cell lung cancer tumors that do not harbor the more common epidermal growth factor receptor mutations.
BioMethyl: An R package for Biological Interpretation of DNA Methylation Data.
Biosynthetic energy cost for amino acids decreases in cancer evolution.
BioXpress: an integrated RNA-seq-derived gene expression database for pan-cancer analysis.
Bipartite network analysis reveals metabolic gene expression profiles that are highly associated with the clinical outcomes of acute myeloid leukemia.
Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma.
Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care.
Bladder cancer genomics.
Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Bladder cancer.
Block-Constraint Robust Principal Component Analysis and its Application to Integrated Analysis of TCGA Data.
Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis.
Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer.
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma.
Blocking the PD-1/PD-L1 axis in dendritic cell-stimulated Cytokine-Induced Killer Cells with pembrolizumab enhances their therapeutic effects against hepatocellular carcinoma.
Blocking Wnt/?-catenin Signal Amplifies Anti-PD-1 Therapeutic Efficacy by Inhibiting Tumor Growth, Migration, and Promoting Immune Infiltration in Glioblastomas.
Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer.
Blood-derived DNA methylation predictors of mortality discriminate tumor and healthy tissue in multiple organs.
BloodPAC Data Commons for Liquid Biopsy Data.
BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma.
BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell.
BMP2/BMPR1A is linked to tumour progression in dedifferentiated liposarcomas.
BNIP3 contributes to cisplatin-induced apoptosis in ovarian cancer cells.
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.
Body mass index-associated molecular characteristics involved in tumor immune and metabolic pathways.
Bokhman Redux: Endometrial cancer "types" in the 21st century.
Bone marrow stromal antigen 2 (BST-2) DNA is demethylated in breast tumors and breast cancer cells.
Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.
Bone sialoprotein-?v?3 integrin axis promotes breast cancer metastasis to the bone.
Book and new media reviews: atlas of eyelid and conjunctival tumors
Borderline ovarian tumors: a web-based atlas.
Both EZH2 and JMJD6 regulate cell cycle genes in breast cancer.
Bottom-up, integrated -omics analysis identifies broadly dosage-sensitive genes in breast cancer samples from TCGA.
BRAF
BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer.
BRAF mutations are associated with increased iron regulatory protein-2 expression in colorectal tumorigenesis.
BRAF-positive multifocal and unifocal papillary thyroid cancer show different messenger RNA expressions.
BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
BRAFnon-V600E more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAFV600E but without a survival advantage.
BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma.
BRAFV600E-induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT.
Brain atlas deformation in the presence of small and large space-occupying tumors.
Brain atlas for assessing the impact of tumor location on perioperative quality of life in patients with high-grade glioma: A prospective population-based cohort study.
Brain cancer mortality in the United States, 1986 to 1995: a geographic analysis.
Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas.
BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different.
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas.
BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
BrcaSeg: A Deep Learning Approach for Tissue Quantification and Genomic Correlations of Histopathological Images.
BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor.
BreakTrans: uncovering the genomic architecture of gene fusions.
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Breast Cancer Case Identification Based on Deep Learning and Bioinformatics Analysis.
Breast cancer classification: linking molecular mechanisms to disease prognosis.
Breast cancer in Colombia: a growing challenge for the healthcare system.
Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Breast cancer survival prediction using seven prognostic biomarker genes.
Breast Cancer Type Classification Using Machine Learning.
Breast MRI radiomics: comparison of computer- and human-extracted imaging phenotypes.
Bregmannian consensus clustering for cancer subtypes analysis.
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer.
Bringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin Melanoma.
Bringing Structural Implications and Deep Learning-Based Drug Identification for KRAS Mutants.
Brn3a/Pou4f1 Functions as a Tumor Suppressor by Targeting c-MET/STAT3 Signaling in Thyroid Cancer.
Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.
Bromodomain-containing Protein 4 Is a Favourable Prognostic Factor in Breast Cancer Patients.
BSND and ATP6V1G3: Novel Immunohistochemical Markers for Chromophobe Renal Cell Carcinoma.
BSND is a Novel Immunohistochemical Marker for Oncocytic Salivary Gland Tumors.
BSSV: Bayesian based somatic structural variation identification with whole genome DNA-seq data.
BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma.
BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining.
BTNL9 is frequently downregulated and inhibits proliferation and metastasis via the P53/CDC25C and P53/GADD45 pathways in breast cancer.
BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma.
Building a semantic web-based metadata repository for facilitating detailed clinical modeling in cancer genome studies.
Building radiation-resistant model in triple-negative breast cancer to screen radioresistance-related molecular markers.
Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses.
c-Myc directly targets an over-expression of pyruvate carboxylase in highly invasive breast cancer.
C-Myc regulates PD-L1 expression in esophageal squamous cell carcinoma.
c-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc/miR-29b-3p/CDK6 axis.
C-MYC, HIF-1?, ERG, TKT, and GSTP1: an Axis in Prostate Cancer?
C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis.
C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomas.
C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
C/EBP? enhances efficacy of sorafenib in hepatoblastoma.
C16?ceramide and sphingosine 1?phosphate/S1PR2 have opposite effects on cell growth through mTOR signaling pathway regulation.
C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells.
C1QTNF6 as a Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
C3, C3AR1, HLA-DRA, and HLA-E as potential prognostic biomarkers for renal clear cell carcinoma.
C3: connect separate connected components to form a succinct disease module.
C8orf48 inhibits the tumorigenesis of colorectal cancer by regulating the MAPK signaling pathway.
Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells.
CA9 Silencing Promotes Mitochondrial Biogenesis, Increases Putrescine Toxicity and Decreases Cell Motility to Suppress ccRCC Progression.
CACNA1C is a prognostic predictor for patients with ovarian cancer.
CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma.
Cadherins Associate with Distinct Stem Cell-Related Transcription Factors to Coordinate the Maintenance of Stemness in Triple-Negative Breast Cancer.
CaDrA: A Computational Framework for Performing Candidate Driver Analyses Using Genomic Features.
CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma.
CAFE MOCHA: An Integrated Platform for Discovering Clinically Relevant Molecular Changes in Cancer-An Example of Distant Metastasis- and Recurrence-Linked Classifiers in Head and Neck Squamous Cell Carcinoma.
Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer.
Calponin 3 suppresses proliferation, migration and invasion of non-small cell lung cancer cells.
CAMUR: Knowledge extraction from RNA-seq cancer data through equivalent classification rules.
CamurWeb: a classification software and a large knowledge base for gene expression data of cancer.
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma.
Cancer Association Study of Aminoacyl-tRNA Synthetase Signaling Network in Glioblastoma.
Cancer atlas maps out sample worries.
Cancer beyond organ and tissue specificity: next-generation-sequencing gene mutation data reveal complex genetic similarities across major cancers.
Cancer Cell Lines Are Useful Model Systems for Medical Research.
Cancer cells are highly susceptible to accumulation of templated insertions linked to MMBIR.
Cancer diagnosis with DNA molecular computation.
Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data.
Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Cancer driver mutation prediction through Bayesian integration of multi-omic data.
Cancer Essential Genes Stratified Lung Adenocarcinoma Patients with Distinct Survival Outcomes and Identified a Subgroup from the Terminal Respiratory Unit Type with Different Proliferative Signatures in Multiple Cohorts.
Cancer gene expression profiles associated with clinical outcomes to chemotherapy treatments.
Cancer Genetic Network Inference Using Gaussian Graphical Models.
Cancer genome analysis informatics.
Cancer genome sequencing: the challenges ahead.
Cancer Genomic Profiling in Colorectal Cancer: Current Challenges in Subtyping Colorectal Cancers Based on Somatic and Germline Variants.
Cancer genomic research at the crossroads: realizing the changing genetic landscape as intratumoral spatial and temporal heterogeneity becomes a confounding factor.
Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypes.
Cancer mapping as an epidemiologic research resource in China.
Cancer mapping: why not use absolute scales?
Cancer maps of Finland: an example of small area-based mapping.
Cancer Markers Selection Using Network-Based Cox Regression: A Methodological and Computational Practice.
Cancer metastasis: issues and challenges.
Cancer Morbidity Atlas of the Saarland: an outline of the model project for the analysis of health and environmental data in the Saarland.
Cancer Mortality Atlas of the European Economic Community.
Cancer mutational burden is shaped by G4 DNA, replication stress and mitochondrial dysfunction.
Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1.
Cancer prognosis prediction using somatic point mutation and copy number variation data: a comparison of gene-level and pathway-based models.
Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.
Cancer proliferation gene discovery through functional genomics.
Cancer research in the era of next-generation sequencing and big data calls for intelligent modeling.
Cancer Specific Long Noncoding RNAs Show Differential Expression Patterns and Competing Endogenous RNA Potential in Hepatocellular Carcinoma.
Cancer stem cell associated eight gene-based signature predicts clinical outcomes of colorectal cancer.
Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis.
Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments.
Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development.
Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma.
Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer.
Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma.
Cancer subtype identification using somatic mutation data.
Cancer Subtype Recognition Based on Laplacian Rank Constrained Multiview Clustering.
Cancer Susceptibility Candidate 9 (CASC9) Promotes Colorectal Cancer Carcinogenesis via mTOR-Dependent Autophagy and Epithelial-Mesenchymal Transition Pathways.
Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma.
Cancer systems biology: signal processing for cancer research.
Cancer Type Prediction and Classification Based on RNA-sequencing Data.
Cancer type-dependent correlations between TP53 mutations and antitumor immunity.
Cancer-associated 53BP1 mutations induce DNA damage repair defects.
Cancer-associated fibroblasts are associated with poor prognosis in solid type of lung adenocarcinoma in a machine learning analysis.
Cancer-Associated Fibroblasts Positively Correlate with Dedifferentiation and Aggressiveness of Thyroid Cancer.
Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma.
Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis.
Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint.
Cancer-Associated Point Mutations in the DLC1 Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased Function.
Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic.
Cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway.
Cancer-related long noncoding RNAs show aberrant expression profiles and competing endogenous RNA potential in esophageal adenocarcinoma.
Cancer-specific expression quantitative loci are affected by expression dysregulation.
Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies.
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution.
Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation.
Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma.
Cancer/testis antigens (CTAs) expression in resected lung cancer.
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Cancer3D: understanding cancer mutations through protein structures.
CancerGenes: a gene selection resource for cancer genome projects.
Cancerin: A computational pipeline to infer cancer-associated ceRNA interaction networks.
CancerMIRNome: an interactive analysis and visualization database for miRNome profiles of human cancer.
CancerSEA: a cancer single-cell state atlas.
CancerSiamese: one-shot learning for predicting primary and metastatic tumor types unseen during model training.
CancerSplicingQTL: a database for genome-wide identification of splicing QTLs in human cancer.
Candidate genes in gastric cancer identified by constructing a weighted gene co-expression network.
Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer.
Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.
CanDrA: cancer-specific driver missense mutation annotation with optimized features.
CanDriS: posterior profiling of cancer-driving sites based on two-component evolutionary model.
canEvolve: A Web Portal for Integrative Oncogenomics.
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4.
Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma.
Cannabinoids promote progression of HPV positive head and neck squamous cell carcinoma via p38 MAPK activation.
CanVar: A resource for sharing germline variation in cancer patients.
caOmicsV: an R package for visualizing multidimensional cancer genomic data.
CAPRI: efficient inference of cancer progression models from cross-sectional data.
Caprin-1 promotes HepG2 cell proliferation, invasion and migration and is associated with poor prognosis in patients with liver cancer.
Carbonic Anhydrase 4 serves as a Clinicopathological Biomarker for Outcomes and Immune Infiltration in Renal Cell Carcinoma, Lower Grade Glioma, Lung Adenocarcinoma and Uveal Melanoma.
Carbonic-anhydrase IX expression is increased in thyroid cancer tissue and represents a potential therapeutic target to eradicate thyroid tumor-initiating cells.
Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target.
Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.
CARD11 alteration as a candidate biomarker of skin cutaneous melanoma treated with immune checkpoint blockade.
CARD11 is a prognostic biomarker and correlated with immune infiltrates in uveal melanoma.
Cardiac Regeneration and Tumor Growth-What Do They Have in Common?
CARS as a Prognosis Factor in Clear Cell Renal Cell Carcinoma and Its Association with Tumor Immunity.
Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
CAS-viewer: web-based tool for splicing-guided integrative analysis of multi-omics cancer data.
CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
Cascaded Wx: A Novel Prognosis-Related Feature Selection Framework in Human Lung Adenocarcinoma Transcriptomes.
Case Report: Exome sequencing reveals recurrent RETSAT mutations and a loss-of-function POLDIP2 mutation in a rare undifferentiated tongue sarcoma.
Case Report: Novel RPGRIP1L Gene Mutations Identified by Whole Exome Sequencing in a Patient With Multiple Primary Tumors.
Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining.
Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.
Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors.
Cathepsin A knockdown decreases the proliferation and invasion of A549 lung adenocarcinoma cells.
Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer.
CausalMGM: an interactive web-based causal discovery tool.
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer.
CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses.
CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer.
CBX3/HP1? promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer.
CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer.
CCAAT/Enhancer Binding Protein ? Is Dispensable for Development of Lung Adenocarcinoma.
CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis.
CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis.
CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid-derived suppressor cells.
CCNB2 and AURKA overexpression may cause atypical mitosis in Japanese cortisol-producing adrenocortical carcinoma with TP53 somatic variant.
CCNB2, NUSAP1 and TK1 are associated with the prognosis and progression of hepatocellular carcinoma, as revealed by co-expression analysis.
CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors.
CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes.
CCR4, CCR8, and P2RY14 as Prognostic Factors in Head and Neck Squamous Cell Carcinoma Are Involved in the Remodeling of the Tumor Microenvironment.
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.
CCR7 Has Potential to Be a Prognosis Marker for Cervical Squamous Cell Carcinoma and an Index for Tumor Microenvironment Change.
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma.
CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary.
Cd11b(+) myeloid cells support hepatic metastasis through down-regulation of angiopoietin-like 7 in cancer cells.
CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer.
CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment.
cd2sbgnml: bidirectional conversion between CellDesigner and SBGN formats.
CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix.
CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3?/?-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer.
CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment.
CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
CD44 SNP rs187115: A novel biomarker signature that predicts survival in resectable pancreatic ductal adenocarcinoma.
CD44 splice isoform switching determines breast cancer stem cell state.
CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
CD44(+) tumor cells promote early angiogenesis in head and neck squamous cell carcinoma.
CD44-Mediated Adhesion to Hyaluronic Acid Contributes to Mechanosensing and Invasive Motility.
CD48 is a key molecule of immunomodulation affecting prognosis in glioma.
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer.
CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer.
CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma.
CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma.
CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas.
CD74+ macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinoma.
CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer.
CDC25B induces cellular senescence and correlates with tumor suppression in a p53-dependent manner.
CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1? Pathway.
CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
CDCA2 promotes tumorigenesis and induces radioresistance in oesophageal squamous cell carcinoma cells.
CDCA8 as an independent predictor for a poor prognosis in liver cancer.
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer.
CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastoma.
CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target.
CDK4/6 inhibition is more active against the glioblastoma proneural subtype.
CDK4/6 inhibitor suppresses gastric cancer with CDKN2A mutation.
CDK4/RB/E2Fs axis as potential therapeutic target of endometrial cancer.
CDK5 Knockdown inhibits proliferation and induces apoptosis and Cell Cycle Arrest in Human Glioblastoma.
CDK6 inhibits lymphoid cell infiltration and represents a prognostic marker in HPV+ squamous cell carcinoma of head and neck.
CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients.
CDKN2A Alterations and Response to Immunotherapy in Solid Tumors.
CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma.
CDKN2A Deletion in Melanoma Excludes T Cell Infiltration by Repressing Chemokine Expression in a Cell Cycle-Dependent Manner.
CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1-Wild-Type Tumor With Frequent CIC Genomic Alterations and 1p/19q-Codeletion.
CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma in vitro.
cDNA expression array analysis of DNA repair genes in human glioma cells that lack or express DNA-PK.
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.
CDSeqR: fast complete deconvolution for gene expression data from bulk tissues.
CDX2 and Muc2 immunohistochemistry as prognostic markers in stage II colon cancer.
CEACAM Gene Family Mutations Associated With Inherited Breast Cancer Risk - A Comparative Oncology Approach to Discovery.
CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a.
Celastrol induces lipophagy via the LXR?/ABCA1 pathway in clear cell renal cell carcinoma.
Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection.
Cell division cycle 20 overexpression predicts poor prognosis for patients with lung adenocarcinoma.
Cell division cycle 45 promotes papillary thyroid cancer progression via regulating cell cycle.
Cell Polarity Protein Pals1-Associated Tight Junction Expression Is a Favorable Prognostic Marker in Clear Cell Renal Cell Carcinoma.
Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
Cell Surface Proteomics of N-Linked Glycoproteins for Typing of Human Lymphocytes.
Cell-Free DNA Analysis by Whole-Exome Sequencing for Hepatocellular Carcinoma: A Pilot Study in Thailand.
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer.
Cell-Intrinsic Tumorigenic Functions of PPAR? in Bladder Urothelial Carcinoma.
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types.
Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms.
Cellular heterogeneity landscape in laryngeal squamous cell carcinoma.
Cellular models of development of ovarian high-grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis.
CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
CeNETs analysis reveals the prognostic value of a signature integration from five lncRNAs in breast cancer.
Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma.
Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival.
Ceramide Pathway Regulators Predict Clinical Prognostic Risk and Affect the Tumor Immune Microenvironment in Lung Adenocarcinoma.
Ceramide species are elevated in human breast cancer and are associated with less aggressiveness.
Cerebellar 'transcriptome' reveals cell-type and stage-specific expression during postnatal development and tumorigenesis.
CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas.
ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone.
CERNA SEARCH METHOD IDENTIFIED A MET-ACTIVATED SUBGROUP AMONG EGFR DNA AMPLIFIED LUNG ADENOCARCINOMA PATIENTS.
Cervical chordoma in a domestic ferret (Mustela putorius furo) with pulmonary metastasis.
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
CFHR3 is a potential novel biomarker for hepatocellular carcinoma.
cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.
CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer.
Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers.
Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety.
Changes in correlation between promoter methylation and gene expression in cancer.
Changes in gene expression profile induced by the anticancer agent Aplidine in Molt-4 leukemic cell lines.
Changes in microRNA expression associated with metastasis and survival in patients with uveal melanoma.
Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.
Changes of N6-methyladenosine modulators promote breast cancer progression.
Chaperonin-Containing TCP1 Subunit 6A Is a Prognostic Potential Biomarker That Correlates With the Presence of Immune Infiltrates in Colorectal Cancer.
Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues.
Characteristic Analysis of Featured Genes Associated With Stemness Indices in Colorectal Cancer.
Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.
Characteristics of B lymphocyte infiltration in HPV+ head and neck squamous cell carcinoma.
Characteristics of The Cancer Genome Atlas cases relative to U.S. general population cancer cases.
Characterization and prognostic significance of alternative splicing events in lower-grade diffuse gliomas.
Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia.
Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma.
Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma.
Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.
Characterization of a prognostic four?gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma.
Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients.
Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
Characterization of an endoplasmic reticulum stress-related signature to evaluate immune features and predict prognosis in glioma.
Characterization of bidirectional gene pairs in The Cancer Genome Atlas (TCGA) dataset.
Characterization of cancer-related somatic mutations in the adenosine A2B receptor.
Characterization of cell lines derived from tumors induced by TC-1 cells in mice preimmunized against HPV16 E7 oncoprotein.
Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer.
Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer.
Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.
Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes.
Characterization of gene expression profiles of esophageal cancer patients with different nonsynonymous tumor mutation burden.
Characterization of hazard infiltrating immune cells and relative risk genes in bladder urothelial carcinoma.
Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach.
Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma.
Characterization of Hepatocellular Carcinoma Cell Lines Using a Fractionation-Then-Sequencing Approach Reveals Nuclear-Enriched HCC-Associated lncRNAs.
Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems.
Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups.
Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted Therapy.
Characterization of Immune Infiltration and Construction of a Prediction Model for Overall Survival in Melanoma Patients.
Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.
Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.
Characterization of long non-coding RNA and messenger RNA profiles in laryngeal cancer by weighted gene co-expression network analysis.
Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing.
Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.
Characterization of Neoantigen Load Subgroups in Gynecologic and Breast Cancers.
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.
Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.
Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy.
Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.
Characterization of somatic mutation-associated microenvironment signatures in acute myeloid leukemia patients based on TCGA analysis.
Characterization of Squamous Cell Lung Cancers from Appalachian Kentucky.
Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study.
Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma.
Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors.
Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy.
Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Characterization of the prognostic values of CXCR family in gastric cancer.
Characterization of the prognostic values of the NDRG family in gastric cancer.
Characterization of tissue histopathology via predictive sparse decomposition and spatial pyramid matching.
Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma.
Characterization of Tumor Blood Vasculature Expression of Human Invasive Bladder Cancer by Laser Capture Microdissection and Transcriptional Profiling.
Characterization of Tumor-Suppressor Gene Inactivation Events in 33 Cancer Types.
Characterization of tumors with ultralow tumor mutational burden in Japanese cancer patients.
Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer.
Characterizing Cancer-Specific Networks by Integrating TCGA Data.
Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas.
Characterizing DNA methylation alterations from The Cancer Genome Atlas.
Characterizing genomic differences of human cancer stratified by the TP53 mutation status.
Characterizing mutation-expression network relationships in multiple cancers.
Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations.
Characterizing the cancer-associated microbiome with small RNA sequencing data.
Characterizing the heterogeneity in 5-aminolevulinic acid-induced fluorescence in glioblastoma.
Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing.
Characterizing the landscape of peritoneal exosomal microRNAs in patients with ovarian cancer by high-throughput sequencing.
Charting a shared epigenetic pathway to CD8+ T cell dysfunction in infection and cancer.
CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers.
CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer.
CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma.
Checkpoint Genes at the Cancer Side of the Immunological Synapse in Bladder Cancer.
Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity.
Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival rates.
Chemokine C-C motif ligand 21 synergized with programmed death-ligand 1 blockade restrains tumor growth.
Chemokine receptor 4 expression is correlated with the occurrence and prognosis of gastric cancer.
Chemoresistance-associated alternative splicing signatures in serous ovarian cancer.
CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process.
CHFR?mediated epithelial?to?mesenchymal transition promotes metastasis in human breast cancer cells.
CHI3L1, NTRK2, 1p/19q and IDH Status Predicts Prognosis in Glioma.
ChimerDB 3.0: an enhanced database for fusion genes from cancer transcriptome and literature data mining.
Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine.
CHMP4C regulates lung squamous carcinogenesis and progression through cell cycle pathway.
Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.
Cholangiolar pattern and albumin in situ hybridisation enable a diagnosis of intrahepatic cholangiocarcinoma.
Cholesterol uptake and regulation in high-grade and lethal prostate cancers.
Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers.
Chr20q Amplification Defines a Distinct Molecular Subtype of Microsatellite Stable Colorectal Cancer.
Chromaffin cell biology: inferences from The Cancer Genome Atlas.
Chromatin-regulating genes are associated with postoperative prognosis and isocitrate dehydrogenase mutation in astrocytoma.
Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
Chromoanagenesis Landscape in 10,000 TCGA Patients.
ChromoHub V2: cancer genomics.
Chromosomal breaks at FRA18C: association with reduced DOK6 expression, altered oncogenic signaling and increased gastric cancer survival.
Chromosomal Density of Cancer Up-Regulated Genes, Aberrant Enhancer Activity and Cancer Fitness Genes Are Associated with Transcriptional Cis-Effects of Broad Copy Number Gains in Colorectal Cancer.
Chromosomal instability as a prognostic marker in cervical cancer.
Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis.
Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated Gliomas.
Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.
Chromosome 3p loss in the progression and prognosis of head and neck cancer.
Chromosome-wide gene dosage rebalance may benefit tumor progression.
Chrysosplenol D Triggers Apoptosis through Heme Oxygenase-1 and Mitogen-Activated Protein Kinase Signaling in Oral Squamous Cell Carcinoma.
CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer.
Cilia gene expression patterns in cancer.
CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Cinobufagin Triggers Defects in Spindle Formation and Cap-Dependent Translation in Liver Cancer Cells by Inhibiting the AURKA-mTOR-eIF4E Axis.
circ?0000212 promotes cell proliferation of colorectal cancer by sponging miR?491 and modulating FOXP4 expression.
circCCND1 Regulates Oxidative Stress and FGF9 to Enhance Chemoresistance of Non-Small Cell Lung Cancer via Sponging miR-187-3p.
circExp database: an online transcriptome platform for human circRNA expressions in cancers.
CircITGA7 Suppresses Gastric Cancer Progression Through miR-1471/MTDH Axis.
CircMMP11 acts as a ce-circRNA in breast cancer progression by regulating miR-1204.
circMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-?/Smad and EGFR pathways.
circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer.
Circular RNA hsa_circ_0000993 inhibits metastasis of gastric cancer cells.
Circular RNA hsa_circ_0005114-miR-142-3p/miR-590-5p-adenomatous polyposis coli protein axis as a potential target for treatment of glioma.
Circular RNA hsa_circ_0072995 promotes breast cancer cell migration and invasion through sponge for miR-30c-2-3p.
Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration.
Circular RNA-Associated Competing Endogenous RNA Network and Prognostic Nomogram for Patients With Colorectal Cancer.
Circular RNAs and their associations with breast cancer subtypes.
Circular RNA_PDHX Promotes the Proliferation and Invasion of Prostate Cancer by Sponging MiR-378a-3p.
Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1.
Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis.
Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma.
Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer.
Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia.
Circulating Long RNAs in Serum Extracellular Vesicles: Their Characterization and Potential Application as Biomarkers for Diagnosis of Colorectal Cancer.
Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.
Circulating PD-1 mRNA in Peripheral Blood is a Potential Biomarker for Predicting Survival of Breast Cancer Patients.
Circulating Tumor Cells: Fluid Surrogates of Solid Tumors.
CIRH1A augments the proliferation of RKO colorectal cancer cells.
Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy.
Cistrome Cancer: A Web Resource for Integrative Gene Regulation Modeling in Cancer.
CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer.
CITED1 promotes proliferation of papillary thyroid cancer cells via the regulation of p21 and p27.
CK2 Activity Mediates the Aggressive Molecular Signature of Glioblastoma Multiforme by Inducing Nerve/Glial Antigen (NG)2 Expression.
CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high?grade glioma.
CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma.
CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
CKS2 modulates cell-cycle progression of tongue squamous cell carcinoma cells partly via modulating the cellular distribution of DUTPase.
Clarifying the biological significance of the CHK2 K373E somatic mutation discovered in The Cancer Genome Atlas database.
Claspin Overexpression Promotes Tumor Progression and Predicts Poor Clinical Outcome in Prostate Cancer.
Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype.
Classical pathology and mutational load of breast cancer - integration of two worlds.
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.
Classification and Prognosis Prediction from Histopathological Images of Hepatocellular Carcinoma by a Fully Automated Pipeline Based on Machine Learning.
Classification models for clear cell renal carcinoma stage progression, based on tumor RNAseq expression trained supervised machine learning algorithms.
Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.
Classification of breast cancer patients using somatic mutation profiles and machine learning approaches.
Classification of Cancer Types Using Graph Convolutional Neural Networks.
Classification of diffuse lower-grade glioma based on immunological profiling.
Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles.
Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology.
Classification of Genes Based on Age-Related Differential Expression in Breast Cancer.
Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes.
Classification of Histology Sections via Multispectral Convolutional Sparse Coding.
Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes.
Classification of lung adenocarcinoma transcriptome subtypes from pathological images using deep convolutional networks.
Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling.
Classification of Tumor Histology via Morphometric Context.
CLASSIFICATION OF TUMOR HISTOPATHOLOGY VIA SPARSE FEATURE LEARNING.
Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma.
Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data.
Classifying cancer genome aberrations by their mutually exclusive effects on transcription.
Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.
Claudin-1, A Double-Edged Sword in Cancer.
Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.
Claudin-7 indirectly regulates the integrin/FAK signaling pathway in human colon cancer tissue.
CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.
CLDN10 single nucleotide polymorphism rs1325774 alters the risk of breast cancer in south chinese women.
Clear cell endometrial carcinoma and the TCGA classification.
Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Clinical and biologic roles of PDGFRA in papillary thyroid cancer: a study based on immunohistochemical and in vitro analyses.
Clinical and biological implications of IDH1/2 in acute myeloid leukemia with DNMT3Amut.
Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma.
Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma.
Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma.
Clinical and genomic landscape of hepatocellular carcinoma subtypes with various proportions of nonleukocyte stromal cells.
Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer.
Clinical and Molecular Correlates of NLRC5 Expression in Patients With Melanoma.
Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer.
Clinical and molecular immune characterization of ERBB2 in glioma.
Clinical and molecular models of glioblastoma multiforme survival.
Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia.
Clinical and prognostic effects of CDKN2A, CDKN2B and CDH13 promoter methylation in ovarian cancer: a study using meta-analysis and TCGA data.
Clinical and Prognostic Significance of TZAP Expression in Cervical Cancer.
Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
Clinical and Survival Impact of Sex-Determining Region Y-Box 2 in Colorectal Cancer: An Integrated Analysis of the Immunohistochemical Study and Bioinformatics Analysis.
Clinical applicability of renin-angiotensin system inhibitors in cancer treatment.
Clinical application of three-dimensional printing in the personalized treatment of complex spinal disorders.
Clinical applications of next-generation sequencing in colorectal cancers.
Clinical applications of The Cancer Genome Atlas project (TCGA) for squamous cell lung carcinoma.
Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.
Clinical characteristics and prognostic value of MEX3A mRNA in liver cancer.
Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas.
Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences.
Clinical correlates of circulating cell-free DNA tumor fraction.
Clinical correlates of subventricular zone-contacting glioblastomas: a meta-analysis.
Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis.
Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case-control study.
Clinical evaluation of multi-atlas based segmentation of lymph node regions in head and neck and prostate cancer patients.
Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database.
Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas.
Clinical Impact of RANK Signalling in Ovarian Cancer.
Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer.
Clinical implementation of stereotaxic brain implant optimization.
Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.
Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study.
Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.
Clinical implications of chromatin accessibility in human cancers.
Clinical Importance of Epstein?Barr Virus-Associated Gastric Cancer.
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer.
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
Clinical performance of E2Fs 1-3 in kidney clear cell renal cancer, evidence from bioinformatics analysis.
Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.
Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer.
Clinical relevance of cytoskeleton associated proteins for ovarian cancer.
Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).
Clinical relevance of mutant-allele tumor heterogeneity and lung adenocarcinoma.
Clinical research in small genomically stratified patient populations.
Clinical response of a patient to anti-PD-1 immunotherapy and the immune landscape of testicular germ cell tumors.
Clinical role and biological function of CDK5 in hepatocellular carcinoma: A study based on immunohistochemistry, RNA-seq and
Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining.
Clinical signi?cance and prognostic value of SOX7 expression in liver and pancreatic carcinoma.
Clinical significance and biological mechanisms of glutathione S-transferase mu gene family in colon adenocarcinoma.
Clinical significance and biological role of cancer-derived Type I collagen in lung and esophageal cancers.
Clinical significance and biological roles of cyclins in gastric cancer.
Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification.
Clinical significance and effect of MTDH/AEG-1 in bladder urothelial cancer: a study based on immunohistochemistry, RNA-seq, and in vitro verification.
Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Clinical Significance And Integrative Analysis Of Kinesin Family Member 18B In Lung Adenocarcinoma.
Clinical significance and potential mechanisms of miR-223-3p and miR-204-5p in squamous cell carcinoma of head and neck: a study based on TCGA and GEO.
Clinical significance and prognostic role of an immune-related gene signature in gastric adenocarcinoma.
Clinical Significance and Prognostic Value of miR-28-5p in Colon Cancer.
Clinical significance and prospective molecular mechanism of C?C motif chemokine receptors in patients with early?stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.
Clinical Significance and Systematic Expression Analysis of the Thyroid Receptor Interacting Protein 13 (TRIP13) as Human Gliomas Biomarker.
Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma.
Clinical Significance of ?-Lactamase Expression in Colorectal Cancer.
Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma.
Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma.
Clinical significance of APOB inactivation in hepatocellular carcinoma.
Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma.
Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.
Clinical significance of EPHX2 deregulation in prostate cancer.
Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma.
Clinical significance of FBXO17 gene expression in high-grade glioma.
Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.
Clinical significance of high expression of miR-452-5p in lung squamous cell carcinoma.
Clinical significance of long non-coding RNA DUXAP8 and its protein coding genes in hepatocellular carcinoma.
Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer.
Clinical significance of long noncoding RNA maternally expressed gene 3 in acute promyelocytic leukemia.
Clinical significance of long noncoding RNA MNX1-AS1 in human cancers: a meta-analysis of cohort studies and bioinformatics analysis based on TCGA datasets.
Clinical significance of LSECtin and its association with PVR in non-small-cell lung cancer patients.
Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism.
Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR.
Clinical significance of miRNA host gene promoter methylation in prostate cancer.
Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinoma.
Clinical significance of signal regulatory protein alpha (SIRP?) expression in esophageal squamous cell carcinoma.
Clinical Significance of the Interleukin 24 mRNA Level in Head and Neck Squamous Cell Carcinoma and Its Subgroups: An In Silico Investigation.
Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma.
Clinical significance of ZNF750 gene expression, a novel tumor suppressor gene, in esophageal squamous cell carcinoma.
Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype.
Clinical target sequencing for precision medicine of breast cancer.
Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma.
Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer.
Clinical usefulness of gastric adenocarcinoma predictive long intergenic noncoding RNA in human malignancies: A meta-analysis.
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma.
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
Clinical value and potential pathways of miR-183-5p in bladder cancer: A study based on miRNA-seq data and bioinformatics analysis.
Clinical value and potential targets of miR-224-5p in hepatocellular carcinoma validated by a TCGA- and GEO- based study.
Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways.
Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways.
Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases.
Clinical value of miRNA-122 in the diagnosis and prognosis of various types of cancer.
Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.
Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
Clinical, Pathology, Genetic, and Molecular Features of Colorectal Tumors in Adolescents and Adults 25 Years or Younger.
Clinically Relevant microRNAs in Ovarian Cancer.
Clinically Relevant Molecular Subtypes in Leiomyosarcoma.
Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas.
Clinicopathologic and Genomic Factors Associated With Oncologic Outcome in Patients With Stage III to IV Chromophobe Renal Cell Carcinoma.
Clinicopathologic implications of NF1 gene alterations in diffuse gliomas.
Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis.
Clinicopathologic significance of protein lysine methyltransferases in cancer.
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.
Clinicopathological and Prognostic Characteristics of RAD51 in Colorectal Cancer.
Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma.
Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer.
Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
Clinicopathological and Prognostic Value of Long Noncoding RNA SNHG15 in Human Cancers: a Meta-Analysis and Bioinformatics.
Clinicopathological Features of Triple-Negative Breast Cancer Epigenetic Subtypes.
Clinicopathological Implication of Long Non-Coding RNAs SOX2 Overlapping Transcript and Its Potential Target Gene Network in Various Cancers.
Clinicopathological significance of microRNA-21 in extracellular vesicles of pleural lavage fluid of lung adenocarcinoma and its functions inducing the mesothelial to mesenchymal transition.
Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
Clinicopathological Significance of MTUS1 Expression in Patients With Renal Cell Carcinoma.
Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas.
Clinicopathological significance of ribosomal protein S6 kinase A6 in lung squamous cell carcinoma: an immunohistochemical and RNA-seq study.
Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data.
Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosis.
Clinicopathological, immune and molecular correlates of PD-L2 methylation in gastric adenocarcinomas.
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.
CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data.
Cloud-Scale Genomic Signals Processing for Robust Large-Scale Cancer Genomic Microarray Data Analysis.
ClpP regulates breast cancer cell proliferation, invasion and apoptosis by modulating the Src/PI3K/Akt signaling pathway.
Clustering analysis of microRNA and mRNA expression data from TCGA using maximum edge-weighted matching algorithms.
Clustering distributions with the marginalized nested Dirichlet process.
Clustering of mRNA-Seq data based on alternative splicing patterns.
Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates.
CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer.
CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma.
CNAPE: A Machine Learning Method for Copy Number Alteration Prediction from Gene Expression.
CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.
CNOT4 enhances the efficacy of anti-PD-1 immunotherapy in a model of non-small cell lung cancer.
CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway.
CNV Analysis of the Correlation between Preoperative Lymph Node Metastasis and Prognosis of Early Tongue Cancer.
Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
Co-amplification of genes in chromosome 8q24: a robust prognostic marker in hepatocellular carcinoma.
Co-expression analysis and ceRNA network reveal eight novel potential lncRNA biomarkers in hepatocellular carcinoma.
Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma.
Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer.
Co-Expression Network Analysis Identified Gene Signatures in Osteosarcoma as a Predictive Tool for Lung Metastasis and Survival.
Co-Expression Network Analysis Identified LTF in Association with Metastasis Risk and Prognosis in Clear Cell Renal Cell Carcinoma.
Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma.
Co-expression Network Analysis of Biomarkers for Adrenocortical Carcinoma.
Co-expression network analysis of long noncoding RNAs (IncRNAs) and cancer genes revealsSFTA1P and CASC2abnormalities in lung squamous cell carcinoma.
Co-Expression of Coxsackievirus/Adenovirus Receptors and Desmoglein 2 in Lung Adenocarcinoma: A Comprehensive Analysis of Bioinformatics and Tissue Microarrays.
Co-localized genomic regulation of miRNA and mRNA via DNA methylation affects survival in multiple tumor types.
Co-occurrence and Mutual Exclusivity Analysis of DNA Methylation Reveals Distinct Subtypes in Multiple Cancers.
Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
Co-Occurring Alteration of NOTCH and DDR Pathways Serves as Novel Predictor to Efficacious Immunotherapy in NSCLC.
Co?expression of peripheral olfactory receptors with SARS?CoV?2 infection mediators: Potential implications beyond loss of smell as a COVID?19 symptom.
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer.
Coexistence of YWHAZ amplification predicts better prognosis in muscle-invasive bladder cancer with CDKN2A or TP53 loss.
Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis.
Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer.
Coexpression and expression quantitative trait loci analyses of the angiogenesis gene-gene interaction network in prostate cancer.
Coexpression Module Construction by Weighted Gene Coexpression Network Analysis and Identify Potential Prognostic Markers of Breast Cancer.
Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients.
Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer.
Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes.
CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network.
Coiled-coil domain containing 109B is a HIF1?-regulated gene critical for progression of human gliomas.
COL1A1 Is a Potential Prognostic Biomarker and Correlated with Immune Infiltration in Mesothelioma.
COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma.
COL5A2 Promotes Proliferation and Invasion in Prostate Cancer and Is One of Seven Gleason-Related Genes That Predict Recurrence-Free Survival.
Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.
Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis.
Collagen type VI regulates the CDK4/6-p-Rb signaling pathway and promotes ovarian cancer invasiveness, stemness, and metastasis.
Collective effects of long-range DNA methylations predict gene expressions and estimate phenotypes in cancer.
Colon cancer combined with obesity indicates improved survival- research on relevant mechanism.
Colon Cancer Tumor Location Defined by Gene Expression May Disagree With Anatomic Tumor Location.
Colon cancer-specific diagnostic and prognostic biomarkers based on genome-wide abnormal DNA methylation.
Colon Cancer-Upregulated Long Non-Coding RNA lincDUSP Regulates Cell Cycle Genes and Potentiates Resistance to Apoptosis.
Colonoscopy Atlas of Colon Polyps and Neoplasms.
Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.
Colorectal Cancer Prognosis is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study.
Colorectal cancer stages transcriptome analysis.
Colorectal Cancer with Residual Polyp of Origin: A Model of Malignant Transformation.
Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.
Combination of Immune-Related Genomic Alterations Reveals Immune Characterization and Prediction of Different Prognostic Risks in Ovarian Cancer.
Combination of lysine-specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer.
Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer.
Combination of PD1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.
Combination of TNM staging and pathway based risk score models in patients with gastric cancer.
Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks.
Combinatorial Ranking of Gene Sets to Predict Disease Relapse: The Retinoic Acid Pathway in Early Prostate Cancer.
Combinatory inhibition of TRIM65 and MDM2 in lung cancer cells.
Combined bi-occipital suboccipital transsinus transtentorial approach for resection of a pineal region falcotentorial meningioma: operative video and technical nuances.
Combined Frontotemporal Transbasal Approach for the Resection of a Giant Rathke's Cleft Cyst: Operative Video and Technical Nuances.
Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer.
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.
Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.
Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer.
Combined Pre- and Retrovascular Extraoral Approach for Tumors at Lateral Mass of the Atlas.
Combined RNA/tissue profiling identifies novel Cancer/testis genes.
Combined signature of nine immune-related genes: a novel risk score for predicting prognosis in hepatocellular carcinoma.
Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach.
Combined targeting of TGF-?, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.
Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers.
Combining Bioinformatics and Experiments to Identify and Verify Key Genes with Prognostic Values in Endometrial Carcinoma.
Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection.
Combining data from TCGA and GEO databases and reverse transcription quantitative PCR validation to identify gene prognostic markers in lung cancer.
Combining dependent P-values with an empirical adaptation of Brown's method.
Combining DNA methylation and RNA sequencing data of cancer for supervised knowledge extraction.
Combining generative models for multifocal glioma segmentation and registration.
Combining multi-dimensional data to identify a key signature (gene and miRNA) of cisplatin-resistant gastric cancer.
Combining multi-dimensional data to identify key genes and pathways in gastric cancer.
Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA.
Combining texture features of whole slide images improves prognostic prediction of recurrence-free survival for cutaneous melanoma patients.
Comment on "DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification".
Commentary on "Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation." Kapur P, Peña-Llopis S, Christie A, Zhrebker L, Pavía-Jiménez A, Rathmell WK, Xie XJ, Brugarolas J. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX. Lancet Oncol 2013; 14(2):159-67. [Epub 2013 Jan 16]. doi: 10.1016/S1470-2045(12)70584-3.
Commentary on: "An integrated metabolic atlas of clear cell renal cell carcinoma." Hakimi AA, Reznik E, Lee CH, Creighton CJ, Brannon AR, Luna A, Aksoy BA, Liu EM, Shen R, Lee W, Chen Y, Stirdivant SM, Russo P, Chen YB, Tickoo SK, Reuter VE, Cheng EH, Sander C, Hsieh JJ.: Cancer Cell. 2016 Jan 11;29(1):104-16.
Commentary on: "Comprehensive molecular characterization of papillary renal-cell carcinoma." Cancer Genome Atlas Research Network.: N Engl J Med. 2016 Jan 14;374(2):135-45.
Common polymorphic inversions at 17q21.31 and 8p23.1 associate with cancer prognosis.
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer.
Comparative analyses of gene copy number and mRNA expression in GBM tumors and GBM xenografts.
Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer.
Comparative analysis of histologically classified oligodendrogliomas reveals characteristic molecular differences between subgroups.
Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.
Comparative analysis of oncogenes identified by microarray and RNA-sequencing as biomarkers for clinical prognosis.
Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma.
Comparative analysis of somatic copy-number alterations across different human cancer types reveals two distinct classes of breakpoint hotspots.
Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian Cancer.
Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
Comparative evaluation of isoform-level gene expression estimation algorithms for RNA-seq and exon-array platforms.
Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma.
Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations.
Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis.
Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.
Comparative molecular characterization of typical and exceptional responders in glioblastoma.
Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns.
Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma.
Comparative STAT3-Regulated Gene Expression Profile in Renal Cell Carcinoma Subtypes.
Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Comparative transcriptomes of adenocarcinomas and squamous cell carcinomas reveal molecular similarities that span classical anatomic boundaries.
Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma.
Comparing gene expression data from formalin-fixed, paraffin embedded tissues and qPCR with that from snap-frozen tissue and microarrays for modeling outcomes of patients with ovarian carcinoma.
Comparing somatic mutation-callers: beyond Venn diagrams.
Comparing the genomes of cutaneous melanoma tumors to commercially available cell lines.
Comparison between two amplicon-based sequencing panels of different scales in the detection of somatic mutations associated with gastric cancer.
Comparison of algorithms for the detection of cancer drivers at subgene resolution.
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Comparison of commonly used solid tumor targeted gene sequencing panels for estimating tumor mutation burden shows analytical and prognostic concordance within the cancer genome atlas cohort.
Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
Comparison of normalization approaches for gene expression studies completed with high-throughput sequencing.
Comparison of pathway and gene-level models for cancer prognosis prediction.
Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer.
Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue.
Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma.
Competing endogenous RNA (ceRNA) hypothetic model based on comprehensive analysis of long non-coding RNA expression in lung adenocarcinoma.
Competing Endogenous RNA and Coexpression Network Analysis for Identification of Potential Biomarkers and Therapeutics in association with Metastasis Risk and Progression of Prostate Cancer.
Competing Endogenous RNA in Colorectal Cancer: An Analysis for Colon, Rectum, and Rectosigmoid Junction.
Competing endogenous RNA network analysis reveals potential long non-coding RNAs as predictive biomarkers of gastric cancer.
Competing endogenous RNA network and prognostic nomograms for hepatocellular carcinoma patients who underwent R0 resection.
Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
Competing Endogenous RNA of Snail and Zeb1 UTR in Therapeutic Resistance of Colorectal Cancer.
Competing endogenous RNA regulatory network in papillary thyroid carcinoma.
Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis.
Competitive Endogenous RNA Network Construction and Comparison of Lung Squamous Cell Carcinoma in Smokers and Nonsmokers.
Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.
Complement and coagulation cascades pathway correlates with chemosensitivity and overall survival in patients with soft tissue sarcoma.
Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma.
Complement factor H-deficient mice develop spontaneous hepatic tumors.
Complete disease remission in a TP53 and KRAS co-mutated brain oligometastatic lung cancer patient after immuno-chemotherapy and surgical resection: a case report.
Complicated prognostic values of CCL28 in breast cancer by subtype.
Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Comprehensive Analyses of the Infiltrating Immune Cell Landscape and Its Clinical Significance in Hepatocellular Carcinoma.
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.
Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
Comprehensive analysis based on DNA methylation and RNA-seq reveals hypermethylation of the up-regulated WT1 gene with potential mechanisms in PAM50 subtypes of breast cancer.
Comprehensive Analysis Identifying Wnt Ligands Gene Family for Biochemical Recurrence in Prostate Adenocarcinoma and Construction of a Nomogram.
Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression.
Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma.
Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
Comprehensive analysis of a long non-coding RNA-associated competing endogenous RNA network in glioma.
Comprehensive analysis of a long noncoding RNA-associated competing endogenous RNA network in colorectal cancer.
Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma.
Comprehensive Analysis of a Nine-Gene Signature Related to Tumor Microenvironment in Lung Adenocarcinoma.
Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer.
Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
Comprehensive Analysis of Aberrantly Expressed Competitive Endogenous RNA Network and Identification of Prognostic Biomarkers in Pheochromocytoma and Paraganglioma.
Comprehensive analysis of aberrantly expressed microRNA profiles reveals potential biomarkers of human lung adenocarcinoma progression.
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer.
Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
Comprehensive Analysis of Aerobic Exercise-Related Genes Identifies CDCA4 That Promotes the Progression of Osteosarcoma.
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
Comprehensive analysis of alternative splicing profiling reveals novel events associated with prognosis and the infiltration of immune cells in prostate cancer.
Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma.
Comprehensive Analysis of APA Events and Their Association With Tumor Microenvironment in Lung Adenocarcinoma.
Comprehensive Analysis of ATP6V1s Family Members in Renal Clear Cell Carcinoma With Prognostic Values.
Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer.
Comprehensive analysis of autophagy-related prognostic genes in breast cancer.
Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico.
Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer.
Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA.
Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer.
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in oral squamous cell carcinoma.
Comprehensive Analysis of Competing Endogenous RNA (ceRNA) Network Based on RNAs Differentially Expressed in Lung Adenocarcinoma Using The Cancer Genome Atlas (TCGA) Database.
Comprehensive analysis of competing endogenous RNA network and 3-mRNA signature predicting survival in papillary renal cell cancer.
Comprehensive Analysis of Competing Endogenous RNA Network Focusing on Long Noncoding RNA Involved in Cirrhotic Hepatocellular Carcinoma.
Comprehensive analysis of competing endogenous RNA networks associated with cholangiocarcinoma.
Comprehensive analysis of competitive endogenous RNA associated with immune infiltration in lung adenocarcinoma.
Comprehensive analysis of competitive endogenous RNAs network associated with head and neck squamous cell carcinoma.
Comprehensive analysis of competitive endogenous RNAs network reveals potential prognostic lncRNAs in gastric cancer.
Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.
Comprehensive analysis of CTLA-4 in the tumor immune microenvironment of 33 cancer types.
Comprehensive Analysis of Cyclin Family Gene Expression in Colon Cancer.
Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia.
Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Comprehensive analysis of differentially expressed genes reveals the promotive effects of UBE2T on colorectal cancer cell proliferation.
Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Comprehensive analysis of DNA methylation and gene expression profiles in cholangiocarcinoma.
Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma.
Comprehensive analysis of dysregulated lncRNAs, miRNAs and mRNAs with associated ceRNA network in esophageal squamous cell carcinoma.
Comprehensive Analysis of ESRRA in Endometrial Cancer.
Comprehensive Analysis of Expression and Prognostic Value of GATAs in Lung Cancer.
Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer.
Comprehensive analysis of expression profiles of long non?coding RNAs with associated ceRNA network involved in gastric cancer progression.
Comprehensive Analysis of Expression Regulation for RNA m6A Regulators With Clinical Significance in Human Cancers.
Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in Pancreatic Cancer.
Comprehensive analysis of ferritin subunits expression and positive correlations with tumor-associated macrophages and T regulatory cells infiltration in most solid tumors.
Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Comprehensive analysis of gene expression and DNA methylation data identifies potential biomarkers and functional epigenetic modules for lung adenocarcinoma.
Comprehensive Analysis of Gene Expression Changes and Validation in Hepatocellular Carcinoma.
Comprehensive Analysis of Gene Expression Profiles Identifies a P4HA1-Related Gene Panel as a Prognostic Model in Colorectal Cancer Patients.
Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma.
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer.
Comprehensive Analysis of Glycolysis-Related Genes for Prognosis, Immune Features, and Candidate Drug Development in Colon Cancer.
Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer.
Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma.
Comprehensive analysis of key genes, microRNAs and long non-coding RNAs in hepatocellular carcinoma.
Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.
Comprehensive analysis of lncRNA-associated ceRNA network reveals the novel potential of lncRNA, miRNA and mRNA biomarkers in human rectosigmoid junction cancer.
Comprehensive analysis of lncRNA-associated competing endogenous RNA network in tongue squamous cell carcinoma.
Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Comprehensive Analysis of lncRNAs Related to the Prognosis of Esophageal Cancer Based on ceRNA Network and Cox Regression Model.
Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics.
Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.
Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification.
Comprehensive analysis of long non?coding RNA?messenger RNA?microRNA co?expression network identifies cell cycle?related lncRNA in hepatocellular carcinoma.
Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma.
Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data.
Comprehensive analysis of metastasis-related genes reveals a gene signature predicting the survival of colon cancer patients.
Comprehensive analysis of microenvironment-related genes in lung adenocarcinoma.
Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
Comprehensive analysis of multi Ewing sarcoma microarray datasets identifies several prognosis biomarkers.
Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma.
Comprehensive analysis of normal adjacent to tumor transcriptomes.
Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Comprehensive Analysis of PD-1 Gene Expression, Immune Characteristics and Prognostic Significance in 1396 Glioma Patients.
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.
Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma.
Comprehensive analysis of prognostic alternative splicing signature in cervical cancer.
Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer.
Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.
Comprehensive analysis of prognostic immune-related genes associated with the tumor microenvironment of pancreatic ductal adenocarcinoma.
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer.
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma.
Comprehensive Analysis of Prognostic Markers for Acute Myeloid Leukemia Based on Four Metabolic Genes.
Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Comprehensive Analysis of Survival-Related lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Gastric Cancer.
Comprehensive analysis of the aberrantly expressed lncRNA?associated ceRNA network in breast cancer.
Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer.
Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma.
Comprehensive Analysis of the ATP-binding Cassette Subfamily B Across Renal Cancers Identifies ABCB8 Overexpression in Phenotypically Aggressive Clear Cell Renal Cell Carcinoma.
Comprehensive analysis of the cancer driver genes in breast cancer demonstrates their roles in cancer prognosis and tumor microenvironment.
Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.
Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer.
Comprehensive analysis of the expression and prognosis for TNFAIPs in head and neck cancer.
Comprehensive analysis of the expression of SLC30A family genes and prognosis in human gastric cancer.
Comprehensive analysis of the expression of sodium/potassium-ATPase ? subunits and prognosis of ovarian serous cystadenocarcinoma.
Comprehensive analysis of the functions and prognostic significance of RNA-binding proteins in bladder urothelial carcinoma.
Comprehensive Analysis of the Functions and Prognostic Value of RNA-Binding Proteins in Thyroid Cancer.
Comprehensive analysis of the GATA transcription factor gene family in breast carcinoma using gene microarrays, online databases and integrated bioinformatics.
Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development.
Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma.
Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer.
Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
Comprehensive Analysis of the Immune-Oncology Targets and Immune Infiltrates of N 6-Methyladenosine-Related Long Noncoding RNA Regulators in Breast Cancer.
Comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network for bladder cancer.
Comprehensive analysis of the lncRNA?associated competing endogenous RNA network in breast cancer.
Comprehensive analysis of the long non-coding RNA-associated competitive endogenous RNA network reveals novel prognostic biomarkers in Wilms' tumor.
Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells.
Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma.
Comprehensive Analysis of the Prognostic Role and Mutational Characteristics of m6A-Related Genes in Lung Squamous Cell Carcinoma.
Comprehensive Analysis of the Relationship Between Metabolic Reprogramming and Immune Function in Prostate Cancer.
Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing.
Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Comprehensive analysis of Transcription Factors identified novel prognostic biomarker in human bladder cancer.
Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.
Comprehensive Analysis Reveals a 4-Gene Signature in Predicting Response to Temozolomide in Low-Grade Glioma Patients.
Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma.
Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment.
Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma.
Comprehensive and Integrative Analysis Reveals the Diagnostic, Clinicopathological and Prognostic Significance of Polo-Like Kinase 1 in Hepatocellular Carcinoma.
Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis.
Comprehensive assessment of PD-L1 and PD-L2 dysregulation in gastrointestinal cancers.
Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries.
Comprehensive bioinformatics analysis of the characterization and determination underlying mechanisms of over-expression and co-expression of genes residing on 20q in colorectal cancer.
Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancer.
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications.
Comprehensive Characterization of Alternative mRNA Splicing Events in Glioblastoma: Implications for Prognosis, Molecular Subtypes, and Immune Microenvironment Remodeling.
Comprehensive Characterization of Alternative Polyadenylation in Human Cancer.
Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.
Comprehensive Characterization of Cancer Driver Genes and Mutations.
Comprehensive characterization of cancer-testis genes in testicular germ cell tumor.
Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Comprehensive Characterization of Immunological Profiles and Clinical Significance in Hepatocellular Carcinoma.
Comprehensive Characterization of Integrin Subunit Genes in Human Cancers.
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients.
Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Comprehensive characterization of the rRNA metabolism-related genes in human cancer.
Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
Comprehensive characterization of tumor mutation burden in clear cell renal cell carcinoma based on the three independent cohorts.
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma.
Comprehensive DNA Methylation-transcriptome Profiles Association Analysis During the Treatment of Acute Myelocytic Leukemia.
Comprehensive epigenetic analysis of the signature genes in lung adenocarcinoma.
Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
Comprehensive Evaluation of Prostate-Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role.
Comprehensive evaluation of SPATS2 expression and its prognostic potential in liver cancer.
Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
Comprehensive expression analysis of miRNA in breast cancer at the miRNA and isomiR levels.
Comprehensive expression analysis suggests functional overlapping of human FOX transcription factors in cancer.
Comprehensive expression-based isoform biomarkers predictive of drug responses based on isoform co-expression networks and clinical data.
Comprehensive gene and pathway analysis of cervical cancer progression.
Comprehensive genomic analysis of microenvironment phenotypes in ovarian cancer.
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.
Comprehensive genomic characterization of squamous cell lung cancers.
Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.
Comprehensive Genomic Profiling of Androgen-Receptor-Negative Canine Prostate Cancer.
Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients.
Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy.
Comprehensive identification of microRNA arm selection preference in lung cancer: miR-324-5p and -3p serve oncogenic functions in lung cancer.
Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer.
Comprehensive Immunohistochemical Study of the SWI/SNF Complex Expression Status in Gastric Cancer Reveals an Adverse Prognosis of SWI/SNF Deficiency in Genomically Stable Gastric Carcinomas.
Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.
Comprehensive investigation of alternative splicing and development of a prognostic risk score for prostate cancer based on six-gene signatures.
Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma.
Comprehensive investigation of the clinical significance and molecular mechanisms of plasmacytoma variant translocation 1 in sarcoma using genome-wide RNA sequencing data.
Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset.
Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis.
Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma.
Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer.
Comprehensive microRNA profiling of prostate cancer cells after ionizing radiation treatment.
Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma.
Comprehensive molecular and clinical characterization of SLC1A5 in human cancers.
Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction Between Esophageal and Gastric Adenocarcinomas.
Comprehensive molecular characterization of gastric adenocarcinoma.
Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer.
Comprehensive molecular characterization of mitochondrial genomes in human cancers.
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
Comprehensive molecular characterization of urothelial bladder carcinoma.
Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease.
Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients.
Comprehensive multi-omics analysis identified core molecular processes in esophageal cancer and revealed GNGT2 as a potential prognostic marker.
Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma.
Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications.
Comprehensive pathway-related genes signature for prognosis and recurrence of ovarian cancer.
Comprehensive Profile Analysis Identifies Three Key Genes Related to Stemness in Thyroid Carcinoma.
Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Comprehensive profiling of immune-related genes in soft tissue sarcoma patients.
Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer.
Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including Its Variant Morphologies.
Comprehensive RNA Sequencing in Adenoma-Cancer Transition Identified Predictive Biomarkers and Therapeutic Targets of Human CRC.
Comprehensive serum proteomic analysis in early endometrial cancer.
Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis.
Comprehensive Transcriptomic Analysis and Experimental Validation Identify lncRNA HOXA-AS2/miR-184/COL6A2 as the Critical ceRNA Regulation Involved in Low-Grade Glioma Recurrence.
Comprehensive Transcriptomic Analysis Identifies ST8SIA1 as a Survival-Related Sialyltransferase Gene in Breast Cancer.
Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.
Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer.
Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression.
Comprehensive Validation of Snapback Primer-Based Melting Curve Analysis to Detect Nucleotide Variation in the Codon 12 and 13 of KRAS Gene.
Computational analysis for identification of the extracellular matrix molecules involved in endometrial cancer progression.
Computational Analysis of Drug Resistance Network in Lung Adenocarcinoma.
Computational analysis of fused co-expression networks for the identification of candidate cancer gene biomarkers.
Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer.
Computational assessment of stomach tumor volume from multi-slice computerized tomography images in presence of type 2 cancer.
Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.
Computational Detection of Breast Cancer Invasiveness with DNA Methylation Biomarkers.
Computational ecosystems for data-driven medical genomics.
Computational identification of micro-structural variations and their proteogenomic consequences in cancer.
Computational Identification of Sex-Biased Biomarker MicroRNAs and Genes Associated with Immune Infiltration in Breast Cancer.
Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.
Computational Methods and Correlation of Exon-skipping Events with Splicing, Transcription, and Epigenetic Factors.
Computational staining of pathology images to study the tumor microenvironment in lung cancer.
Computational Tumor Infiltration Phenotypes Enable the Spatial and Genomic Analysis of Immune Infiltration in Colorectal Cancer.
Computerized axial tomography (CAT): the value in the diagnosis of bone and soft tissue tumours.
Computerized Classification of Prostate Cancer Gleason Scores from Whole Slide Images.
Concise genetic profile of lung carcinoma.
Concordance of Gene Expression and Functional Correlation Patterns across the NCI-60 Cell Lines and the Cancer Genome Atlas Glioblastoma Samples.
Concurrence of chromosome 6 chromothripsis and glioblastoma metastasis.
Condition-adaptive fused graphical lasso (CFGL): An adaptive procedure for inferring condition-specific gene co-expression network.
Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.
Conditional mutual inclusive information enables accurate quantification of associations in gene regulatory networks.
CONFIGURE: A pipeline for identifying context specific regulatory modules from gene expression data and its application to breast cancer.
Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Congenital irreducible atlantoaxial dislocation associated with cervical intramedullary astrocytoma causing progressive spastic quadriparesis.
Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium.
Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.
Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
Connexin 43 C-terminus directly inhibits the hyperphosphorylation of Akt/ERK through protein-protein interactions in glioblastoma.
Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
Consensus molecular subtype classification of colorectal adenomas.
Consequences of anorectal cancer atlas implementation in the cooperative group setting: Radiobiologic analysis of a prospective randomized in silico target delineation study.
Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBP?.
Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.
Construction and analysis of a ceRNA network and patterns of immune infiltration in bladder cancer.
Construction and analysis of a lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in oral cancer.
Construction and Analysis of a Long Non-Coding RNA-Associated Competing Endogenous RNA Network Identified Potential Prognostic Biomarkers in Luminal Breast Cancer.
Construction and analysis of an aberrant lncRNA-miRNA-mRNA network associated with papillary thyroid cancer.
Construction and analysis of circular RNA molecular regulatory networks in clear cell renal cell carcinoma.
Construction and Analysis of Competing Endogenous RNA Networks for Breast Cancer Based on TCGA Dataset.
Construction and analysis of dysregulated lncRNA-associated ceRNA network in colorectal cancer.
Construction and analysis of macrophage infiltration related circRNA-miRNA-mRNA regulatory networks in hepatocellular carcinoma.
Construction and Analysis of the Tumor-Specific mRNA-miRNA-lncRNA Network in Gastric Cancer.
Construction and Comprehensive Analyses of a Competing Endogenous RNA Network in Tumor-Node-Metastasis Stage I Hepatocellular Carcinoma.
Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer.
Construction and comprehensive analysis of dysregulated long non-coding RNA-associated competing endogenous RNA network in clear cell renal cell carcinoma.
Construction and Comprehensive Prognostic Analysis of a lncRNA-miRNA-mRNA Regulatory Network and Tumor Immune Cell Infiltration in Colorectal Cancer.
Construction and Evaluation of a Risk Score Model for Autophagy-Related Genes in Esophageal Adenocarcinoma.
Construction and integrated analysis of crosstalking ceRNAs networks in laryngeal squamous cell carcinoma.
Construction and Investigation of a lncRNA-Associated ceRNA Regulatory Network in Cholangiocarcinoma.
Construction and Investigation of an LINC00284-Associated Regulatory Network in Serous Ovarian Carcinoma.
Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Construction and Investigation of MicroRNA-mRNA Regulatory Network of Gastric Cancer with Helicobacter pylori Infection.
Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma.
Construction and Validation of a 7-Immune Gene Model for Prognostic Assessment of Esophageal Carcinoma.
Construction and Validation of a Ferroptosis-Related Prognostic Model for Gastric Cancer.
Construction and validation of a metabolic risk model predicting prognosis of colon cancer.
Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor.
Construction and Validation of a Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer.
Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer.
Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma.
Construction and Validation of a Protein Prognostic Model for Lung Squamous Cell Carcinoma.
Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma.
Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer.
Construction and validation of a seven-gene signature for predicting overall survival in patients with kidney renal clear cell carcinoma via an integrated bioinformatics analysis.
Construction and validation of a seven-microRNA signature as a prognostic tool for lung squamous cell carcinoma.
Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Construction and Validation of a Universal Applicable Prognostic Signature for Gastric Cancer Based on Seven Immune-Related Gene Correlated With Tumor Associated Macrophages.
Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases.
Construction and validation of an immunity-related prognostic signature for breast cancer.
Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma.
Construction and validation of an RNA-binding protein-associated prognostic model for colorectal cancer.
Construction and Verification of a Hypoxia-Related 4-lncRNA Model for Prediction of Breast Cancer.
Construction and verification of a prognostic risk model based on immunogenomic landscape analysis of bladder caner.
Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
Construction of a 13-Gene Signature as a Novel Prognostic Marker for Patients with Clear Cell Renal Cell Carcinoma and the Role of XCR1 in Cell Proliferation.
Construction of a 13-microRNA-based signature and prognostic nomogram for predicting overall survival in patients with hepatocellular carcinoma.
Construction of a 14-lncRNA risk score system predicting survival of children with acute myelocytic leukemia.
Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
Construction of a ceRNA network of hub genes affecting immune infiltration in ovarian cancer identified by WGCNA.
Construction of a circRNA-miRNA-mRNA Network Related to Macrophage Infiltration in Hepatocellular Carcinoma.
Construction of a circRNA-miRNA-mRNA Regulatory Network Reveals Potential Mechanism and Treatment Options for Osteosarcoma.
Construction of a circRNA-Related ceRNA Prognostic Regulatory Network in Breast Cancer.
Construction of a circRNA-Related Prognostic Risk Score Model for Predicting the Immune Landscape of Lung Adenocarcinoma.
Construction of a circular RNA-microRNA-messengerRNA regulatory network in stomach adenocarcinoma.
Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non?small cell lung cancer.
Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma.
Construction of a Competitive Endogenous RNA Network and Identification of Potential Regulatory Axis in Gastric Cancer.
Construction of a Competitive Endogenous RNA Network for Pancreatic Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis and a Prognosis Model.
Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.
Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes.
Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer.
Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.
Construction of a Glycolysis-related long noncoding RNA signature for predicting survival in endometrial cancer.
Construction of a lipid metabolism-related and immune-associated prognostic signature for hepatocellular carcinoma.
Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
Construction of a metastasis-associated ceRNA network reveals a prognostic signature in lung cancer.
Construction of a MicroRNA-Based Nomogram for Prediction of Lung Metastasis in Breast Cancer Patients.
Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events.
Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma.
Construction of a nine DNA repair-related gene prognostic classifier to predict prognosis in patients with endometrial carcinoma.
Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis.
Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.
Construction of a novel methylation-related prognostic model for colorectal cancer based on microsatellite status.
Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features.
Construction of a prognosis-predicting model based on autophagy-related genes for hepatocellular carcinoma (HCC) patients.
Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
Construction of a prognostic model based on nine immune-related genes and identification of small molecule drugs for hepatocellular carcinoma (HCC).
Construction of a prognostic model for lung squamous cell carcinoma based on seven N6-methylandenosine-related autophagy genes.
Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer.
Construction of a prognostic value model in papillary renal cell carcinoma by immune-related genes.
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Construction of a risk signature for adrenocortical carcinoma using immune-related genes.
Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data.
Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer.
Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer.
Construction of an immune-related gene signature to predict survival and treatment outcome in gastric cancer.
Construction of an immune-related genes nomogram for the preoperative prediction of axillary lymph node metastasis in triple-negative breast cancer.
Construction of an immune-related signature with prognostic value for colon cancer.
Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma.
Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma.
Construction of ceRNA networks reveals differences between distal and proximal colon cancers.
Construction of circRNA-Based ceRNA Network to Reveal the Role of circRNAs in the Progression and Prognosis of Hepatocellular Carcinoma.
Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma.
Construction of competing endogenous RNA network and identification of novel molecular biomarkers in colon cancer: A bioinformatic analysis.
Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Construction of Gene Modules and Analysis of Prognostic Biomarkers for Cervical Cancer by Weighted Gene Co-Expression Network Analysis.
Construction of immune-related risk signature for renal papillary cell carcinoma.
Construction of immune-related risk signature for uveal melanoma.
Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer.
Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
Construction of Novel DNA Methylation-Based Prognostic Model to Predict Survival in Glioblastoma.
Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma.
Construction of prognostic microRNA signature for human invasive breast cancer by integrated analysis.
Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma.
Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
Construction of Protein-related Risk Score Model in Bladder Urothelial Carcinoma.
Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics.
Consulting prostate cancer cohort data uncovers transcriptional control: Regulation of the MARCH6 gene.
Context-Dependent Role of IKK? in Cancer.
Context-Specific Coordinately Regulatory Network Prioritize Breast Cancer Genetic Risk Factors.
ContrastRank: a new method for ranking putative cancer driver genes and classification of tumor samples.
Contribution of alternative splicing to breast cancer metastasis.
Contribution of upregulated aminoacyl-tRNA biosynthesis to metabolic dysregulation in gastric cancer.
Contributions and prognostic values of m6 A RNA methylation regulators in non-small-cell lung cancer.
Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
Controlling for cellular heterogeneity using single-cell deconvolution of gene expression reveals novel markers of colorectal tumors exhibiting microsatellite instability.
Conventionally used reference genes are not outstanding for normalization of gene expression in human cancer research.
Convergent Usage of Amino Acids in Human Cancers as A Reversed Process of Tissue Development.
Convolutional neural network models for cancer type prediction based on gene expression.
Cooperation Between the Inflammation and Coagulation Systems Promotes the Survival of Circulating Tumor Cells in Renal Cell Carcinoma Patients.
Cooperative driver pathway discovery via fusion of multi-relational data of genes, miRNAs and pathways.
Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.
COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC.
Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients.
Copy number alterations identify a smoking-associated expression signature predictive of poor outcome in head and neck squamous cell carcinoma.
Copy Number Alterations in Tumor Genomes Deleting Antineoplastic Drug Targets Partially Compensated by Complementary Amplifications.
Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants.
Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma.
Copy number gains at chr3p25 and chr11p11 are associated with lymph node involvement and survival in muscle-invasive bladder tumors.
Copy number of 8q24.3 drives HSF1 expression and patient outcome in cancer: an individual patient data meta-analysis.
Copy number profiling across glioblastoma populations has implications for clinical trial design.
Copy Number Profiling of MammaPrint™ Genes Reveals Association with the Prognosis of Breast Cancer Patients.
Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients.
Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.
Copy number variation: A prognostic marker for young patients with squamous cell carcinoma of the oral tongue.
Copy-number analysis identified new prognostic marker in acute myeloid leukemia.
Copy-number variation of MCL1 predicts overall survival of non-small-cell lung cancer in a Southern Chinese population.
Corded and Hyalinized and Spindled Endometrioid Endometrial Carcinoma: A Clinicopathologic and Molecular Analysis of 9 Tumors Based on the TCGA Classifier.
Core liver homeostatic co-expression networks are preserved but respond to perturbations in an organism- and disease-specific manner.
CORO6 Promotes Cell Growth and Invasion of Clear Cell Renal Cell Carcinoma via Activation of WNT Signaling.
Correction to: The Cancer Omics Atlas: an integrative resource for cancer omics annotations.
Correction: intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas.
Correction: Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas.
Correlate tumor mutation burden with immune signatures in human cancers.
Correlating bladder cancer risk genes with their targeting microRNAs using MMiRNA-Tar.
Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Co-expression Analysis and Clinical Validation.
Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
Correlation between gene expression and mutator phenotype predicts homologous recombination deficiency and outcome in ovarian cancer.
Correlation Between High Expression of FOXA2 and Improved Overall Survival in Ovarian Cancer Patients.
Correlation Between Infection Status of Epstein-Barr Virus and (18)F-Fluorodeoxyglucose Uptake in Patients with Advanced Gastric Cancer.
Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma.
Correlation Between Prognostic Biomarker SLC1A5 and Immune Infiltrates in Various Types of Cancers Including Hepatocellular Carcinoma.
Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
Correlation between RNA-Seq and microarrays results using TCGA data.
Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma.
Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.
Correlation of carbonic anhydrase 9 (CA9) with pathological T-stage and prognosis in patients with oral tongue squamous cell carcinoma.
Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.
Correlation of immune phenotype with IDH mutation in diffuse glioma.
Correlation of NUF2 Over-expression with Poorer Patient Survival in Multiple Cancers.
Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival.
Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer.
Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Correlation Patterns Between DNA Methylation and Gene Expression in The Cancer Genome Atlas.
Correlations between stemness indices for hepatocellular carcinoma, clinical characteristics, and prognosis.
Correlations Between the Characteristics of Alternative Splicing Events, Prognosis, and the Immune Microenvironment in Breast Cancer.
Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis.
Correlations of lncRNAs with cervical lymph node metastasis and prognosis of papillary thyroid carcinoma.
Correlations of UGT1A1 gene polymorphisms with onset and prognosis of non-small cell lung cancer.
Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome Atlas.
Corticosteroids compromise survival in glioblastoma.
CoSMeD: a user-friendly web server to estimate 5-year survival probability of left-sided and right-sided colorectal cancer patients using molecular data.
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.
Cost-efficiency tradeoff is optimized in various cancer types revealed by genome-wide analysis.
Covariate-driven factorization by thresholding for multiblock data.
Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
CPEM: Accurate cancer type classification based on somatic alterations using an ensemble of a random forest and a deep neural network.
CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies.
CpG methylation signature predicts prognosis in breast cancer.
CpG-methylation-based risk score predicts progression in colorectal cancer.
CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.
CPS1 expression and its prognostic significance in lung adenocarcinoma.
CPSF3 is a promising prognostic biomarker and predicts recurrence of non-small cell lung cancer.
Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics.
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
CREDO: Highly confident disease-relevant A-to-I RNA-editing discovery in breast cancer.
CRI iAtlas: an interactive portal for immuno-oncology research.
Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NF?B pathway in hepatocellular carcinoma.
CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast Cancer.
CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma.
CRISPR/Cas9-Based Positive Screens for Cancer-Related Traits.
Critical genes in head and neck squamous cell carcinoma revealed by bioinformatic analysis of gene expression data.
Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis.
Cross-cancer profiling of molecular alterations within the human autophagy interaction network.
Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer.
Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Cross-talk and clinical value of m[superscript 6]A regulatory gene in bladder cancer.
Cross-tissue organization of the fibroblast lineage.
Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.
CrossHub: a tool for multi-way analysis of The Cancer Genome Atlas (TCGA) in the context of gene expression regulation mechanisms.
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Crumbs protein homolog 3 (CRB3) expression is associated with oestrogen and progesterone receptor positivity in breast cancer.
CRY2 missense mutations suppress P53 and enhance cell growth.
CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway.
CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.
CT-detected extramural venous invasion-related gene signature for the overall survival prediction in patients with gastric cancer.
CtBP2 is associated with angiogenesis and regulates the apoptosis of prostate cancer cells.
CTCF loss mediates unique DNA hypermethylation landscapes in human cancers.
CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients.
CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma.
CTLPScanner: a web server for chromothripsis-like pattern detection.
Cullin-5 (CUL5) as a potential prognostic marker in a pan-cancer analysis of human tumors.
Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-?B activation.
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
Curation of the Pancreatic Ductal Adenocarcinoma Subset of the Cancer Genome Atlas Is Essential for Accurate Conclusions about Survival-Related Molecular Mechanisms.
Curcumin Has Anti-Proliferative and Pro-Apoptotic Effects on Tongue Cancer in vitro: A Study with Bioinformatics Analysis and in vitro Experiments.
Current Challenges and Opportunities in Treating Glioblastoma.
Current dichotomy between traditional molecular biological and omic research in cancer biology and pharmacology.
Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation.
CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer.
CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma.
CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors.
CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer.
CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.
CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia.
CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients.
CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma.
CXCL3 overexpression affects the malignant behavior of oral squamous cell carcinoma cells via the MAPK signaling pathway.
CXCL5 expression in tumor tissues is associated with poor prognosis in patients with pancreatic cancer.
CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates.
CXCL5/CXCL8 is a promising potential prognostic and tumor microenvironment-related cluster in hepatocellular carcinoma.
CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells.
CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma.
CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.
CXCR3 Expression and Genome-Wide 3' Splice Site Selection in the TCGA Breast Cancer Cohort.
Cyanidin Curtails Renal Cell Carcinoma Tumorigenesis.
Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway.
Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor ? in Melanoma Mice.
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Cyclin H Regulates Lung Cancer Progression as a Carcinoma Inducer.
Cyclin-Dependent Kinase 1 (CDK1) is Co-Expressed with CDCA5: Their Functions in Gastric Cancer Cell Line MGC-803.
Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma.
Cyclin-Dependent Kinase and Antioxidant Gene Expression in Cancers with Poor Therapeutic Response.
Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer.
CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma.
Cystatin 2 leads to a worse prognosis in patients with gastric cancer.
Cystatin-B Negatively Regulates the Malignant Characteristics of Oral Squamous Cell Carcinoma Possibly Via the Epithelium Proliferation/Differentiation Program.
Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/?-Catenin-Mediated EMT and Tumour Metastasis.
Cytidine monophosphate N-acetylneuraminic acid synthetase enhances invasion of human triple-negative breast cancer cells.
Cyto-biological effects of microRNA-424-5p on human colorectal cancer cells.
Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
Cytopathology of Follicular Cell Nodules.
Cytoplasmic Pattern p53 Immunoexpression in Pelvic and Endometrial Carcinomas With TP53 Mutation Involving Nuclear Localization Domains: An Uncommon But Potential Diagnostic Pitfall With Clinical Implications.
Cytoplasmic SQSTM1/ P62 Accumulation Predicates a Poor Prognosis in Patients with Malignant Tumor.
Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma.
Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells.
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy.
Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer.
D-CCA: A Decomposition-based Canonical Correlation Analysis for High-Dimensional Datasets.
D-GPM: A Deep Learning Method for Gene Promoter Methylation Inference.
D3M: detection of differential distributions of methylation levels.
DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden.
Data Fusion Techniques for the Integration of Multi-Domain Genomic Data from Uveal Melanoma.
Data integration to prioritize drugs using genomics and curated data.
Data mining analysis of the prognostic impact of N6-methyladenosine regulators in patients with endometrial adenocarcinoma.
Data Mining and Expression Analysis of Differential lncRNA ADAMTS9-AS1 in Prostate Cancer.
Data mining combined with experiments to validate CEP55 as a prognostic biomarker in colorectal cancer.
Data Mining Identifies Six Proteins that Can Act as Prognostic Markers for Head and Neck Squamous Cell Carcinoma.
Data mining in clinical big data: the frequently used databases, steps, and methodological models.
Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
Data mining of micrornas in breast carcinogenesis which may be a potential target for cancer prevention.
Data mining of the expression and regulatory role of BCAT1 in hepatocellular carcinoma.
Data mining The Cancer Genome Atlas in the era of precision cancer medicine.
Data mining-based study of collagen type III alpha 1 (COL3A1) prognostic value and immune exploration in pan-cancer.
Data normalization considerations for digital tumor dissection.
Data on SVCT2 transporter expression and localization in cancer cell lines and tissues.
Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition.
Data-Driven Discovery of Molecular Targets for Antibody-Drug Conjugates in Cancer Treatment.
Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma.
Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas.
Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors.
Dataset of segmented nuclei in hematoxylin and eosin stained histopathology images of ten cancer types.
dbGENVOC: database of GENomic Variants of Oral Cancer, with special reference to India.
DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma.
DDN-AS1-miR-15a/16-TCF3 feedback loop regulates tumor progression in cervical cancer.
DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity.
DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma.
DDX3X is Epigenetically Repressed in Renal Cell Carcinoma and Serves as a Prognostic Indicator and Therapeutic Target in Cancer Progression.
DDX3X promotes the biogenesis of a subset of miRNAs and the potential roles they played in cancer development.
DDX49 is a novel biomarker and therapeutic target for lung cancer metastases.
De novo discovery of mutated driver pathways in cancer.
De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer.
De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma.
De novo pathway-based biomarker identification.
De novo, systemic, deleterious amino acid substitutions are common in large cytoskeleton-related protein coding regions.
DEAD-box helicase 27 plays a tumor-promoter role by regulating the stem cell-like activity of human colorectal cancer cells.
Death receptor 6 promotes ovarian cancer cell migration through KIF11.
Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma.
Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer.
Deciphering N6-Methyladenosine-Related Genes Signature to Predict Survival in Lung Adenocarcinoma.
Deciphering the associations between gene expression and copy number alteration using a sparse double Laplacian shrinkage approach.
Deciphering the Correlation between Breast Tumor Samples and Cell Lines by Integrating Copy Number Changes and Gene Expression Profiles.
Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma.
Deciphering the genetic alterations in matrix metallo-proteinase gene family and its putative association with head and neck squamous cell carcinoma.
Deciphering the genomic and lncRNA landscapes of aerobic glycolysis identifies potential therapeutic targets in pancreatic cancer.
Deciphering the metabolic role of AMPK in cancer multi-drug resistance.
Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer.
Deciphering the Oncogenic Role of VPS28 Modulated by miR-491-5p in Breast Cancer Cells Using In Silico and Functional Analysis.
Decision tree-based classifiers for lung cancer diagnosis and subtyping using TCGA miRNA expression data.
Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
Decoding and Systematization of Medical Imaging Features of Multiple Human Malignancies.
Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020.
Decoding the LncRNA transcriptome of esophageal cancer: identification of clinically relevant LncRNAs.
Deconvolution and network analysis of IDH-mutant lower grade glioma predict recurrence and indicate therapeutic targets.
Deconvolution and phylogeny inference of structural variations in tumor genomic samples.
Deconvolution of DNA methylation identifies differentially methylated gene regions on 1p36 across breast cancer subtypes.
Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer.
Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma.
Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis.
Decreased CDKL2 expression is correlated with the progression and poor prognosis of glioma.
Decreased copy-neutral loss of heterozygosity in African American colorectal cancers.
Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Decreased decorin expression in the tumor microenvironment.
Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma.
Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Decreased expression of ARID1A invasively downregulates the expression of ribosomal proteins in hepatocellular carcinoma.
Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Decreased expression of COLEC10 predicts poor overall survival in patients with hepatocellular carcinoma.
Decreased Expression of CPEB3 Predicts a Poor Prognosis in Patients with Melanoma: A Study Based on TCGA Data.
Decreased expression of EFCC1 and its prognostic value in lung adenocarcinoma.
Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
Decreased expression of HDAC8 indicates poor prognosis in patients with intrahepatic cholangiocarcinoma.
Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma.
Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell.
Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma.
Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer.
Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Decreased expression of TRPM4 is associated with unfavorable prognosis and aggressive progression of endometrial carcinoma.
Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
Decreased secretoglobin family 2A member 1expression is associated with poor outcomes in endometrial cancer.
Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
Decreased SPTLC1 expression predicts worse outcomes in ccRCC patients.
Decreased Tumoral Expression of Colon-Specific Water Channel Aquaporin 8 Is Associated With Reduced Overall Survival in Colon Adenocarcinoma.
Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration.
DECtp: Calling Differential Gene Expression Between Cancer and Normal Samples by Integrating Tumor Purity Information.
Deep Convolutional Neural Network-Based Lymph Node Metastasis Prediction for Colon Cancer Using Histopathological Images.
Deep generative neural network for accurate drug response imputation.
Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer.
Deep Learning for Automatic Subclassification of Gastric Carcinoma Using Whole-Slide Histopathology Images.
Deep learning for diagnosis and survival prediction in soft tissue sarcoma.
Deep Learning Implicitly Handles Tissue Specific Phenomena to Predict Tumor DNA Accessibility and Immune Activity.
Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study.
Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
Deep learning predicts chromosomal instability from histopathology images.
Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.
Deep Learning With Sampling in Colon Cancer Histology.
Deep learning-based classification of mesothelioma improves prediction of patient outcome.
Deep learning-based cross-classifications reveal conserved spatial behaviors within tumor histological images.
Deep learning-based gene selection in comprehensive gene analysis in pancreatic cancer.
Deep learning-based model for predicting progression in patients with head and neck squamous cell carcinoma.
Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.
Deep learning-based ovarian cancer subtypes identification using multi-omics data.
Deep learning-based six-type classifier for lung cancer and mimics from histopathological whole slide images: a retrospective study.
Deep learning-based survival prediction for multiple cancer types using histopathology images.
Deep learning-based tumor microenvironment analysis in colon adenocarcinoma histopathological whole-slide images.
Deep Neural Network Analysis of Pathology Images With Integrated Molecular Data for Enhanced Glioma Classification and Grading.
Deep Radiogenomics of Lower-Grade Gliomas: Convolutional Neural Networks Predict Tumor Genomic Subtypes Using MR Images.
Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma.
Deep sequencing and comprehensive expression analysis identifies several molecules potentially related to human poorly differentiated hepatocellular carcinoma.
Deep Subspace Mutual Learning For Cancer Subtypes Prediction.
Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas.
Deep-Hipo: Multi-scale receptive field deep learning for histopathological image analysis.
Deep-Learning-Based Characterization of Tumor-Infiltrating Lymphocytes in Breast Cancers From Histopathology Images and Multiomics Data.
deepBase v3.0: expression atlas and interactive analysis of ncRNAs from thousands of deep-sequencing data.
DeepLRHE: A Deep Convolutional Neural Network Framework to Evaluate the Risk of Lung Cancer Recurrence and Metastasis From Histopathology Images.
DeepRePath: Identifying the Prognostic Features of Early-Stage Lung Adenocarcinoma Using Multi-Scale Pathology Images and Deep Convolutional Neural Networks.
DeepSec: a deep learning framework for secreted protein discovery in human body fluids.
DeepSurvNet: deep survival convolutional network for brain cancer survival rate classification based on histopathological images.
DEFB4A is a potential prognostic biomarker for colorectal cancer.
Deficiency of mismatch repair genes is less frequently observed in signet ring cell compared with non-signet ring cell gastric cancer.
Deficiency of NEIL3 Enhances the Chemotherapy Resistance of Prostate Cancer.
Defining a mutational signature for endometrial cancer screening and early detection.
Defining neoplastic diseases differently: An emerging paradigm from The Cancer Genome Atlas lower-grade gliomas project.
Defining Signatures of Arm-Wise Copy Number Change and Their Associated Drivers in Kidney Cancers.
Defining the Na(+)/H(+) exchanger NHE1 interactome in triple-negative breast cancer cells.
Definition of a novel vascular invasion-associated multi-gene signature for predicting survival in patients with hepatocellular carcinoma.
Deformable registration of brain tumor images via a statistical model of tumor-induced deformation.
Deformable Registration of Glioma Images Using EM Algorithm and Diffusion Reaction Modeling.
DeFusion: a denoised network regularization framework for multi-omics integration.
Degradation of CCNB1 mediated by APC11 through UBA52 ubiquitination promotes cell cycle progression and proliferation of non-small cell lung cancer cells.
Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.
Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence.
DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients.
Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients.
Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma.
Deletions at SLC18A1 increased the risk of CRC and lower SLC18A1 expression associated with poor CRC outcome.
Delineation atlas of the Circle of Willis and the large intracranial arteries for evaluation of doses to neurovascular structures in pediatric brain tumor patients treated with radiation therapy.
Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.
Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups.
Delta-like ligand-Notch1 signalling is selectively modulated by HPV16 E6 to promote squamous cell proliferation and correlates with cervical cancer prognosis.
DEMARCATE: Density-based magnetic resonance image clustering for assessing tumor heterogeneity in cancer.
Demethylation and Overexpression of CSF2 are Involved in Immune Response, Chemotherapy Resistance, and Poor Prognosis in Colorectal Cancer.
Demethylator phenotypes in acute myeloid leukemia.
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.
Dependency of the Cancer-Specific Transcriptional Regulation Circuitry on the Promoter DNA Methylome.
Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
Depletion of FOXM1 via MET targeting underlies establishment of a DNA damage-induced senescence program in gastric cancer.
Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1.
Depletion of VAX2 Restrains the Malignant Progression of Papillary Thyroid Carcinoma by Modulating ERK Signaling Pathway.
Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways.
Deregulation of cell adhesion molecules is associated with progression and poor outcomes in endometrial cancer: Analysis of The Cancer Genome Atlas data.
Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma.
Design of a liver cancer-specific selector for the analysis of circulating tumor DNA.
Designing gene panels for tumor mutational burden estimation: the need to shift from 'correlation' to 'accuracy'.
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome.
Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5'-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients.
Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.
Detect differentially methylated regions using non-homogeneous hidden Markov model for methylation array data.
Detecting copy number alterations in RNA-Seq using SuperFreq.
Detecting Disease Specific Pathway Substructures through an Integrated Systems Biology Approach.
Detecting Prognosis Risk Biomarkers for Colon Cancer Through Multi-Omics-Based Prognostic Analysis and Target Regulation Simulation Modeling.
Detecting the potential cancer association or metastasis by multi-omics data analysis.
Detection and analysis of stable and flexible genes towards a genome signature framework in cancer.
Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.
Detection of chromosome structural variation by targeted next-generation sequencing and a deep learning application.
Detection of Isocitrate Dehydrogenase Mutated Glioblastomas Through Anomaly Detection Analytics.
Detection of miRNA regulatory effect on triple negative breast cancer transcriptome.
Detection of multiple perturbations in multi-omics biological networks.
Detection of Productively Rearranged TcR-? V-J Sequences in TCGA Exome Files: Implications for Tumor Immunoscoring and Recovery of Antitumor T-cells.
Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer.
Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma.
Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
Determining breast cancer histological grade from RNA-sequencing data.
Determining frequent patterns of copy number alterations in cancer.
Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas.
Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer.
Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Deubiquitinating enzyme USP41 promotes lung cancer cell proliferation and migration.
Develop a circular RNA-related regulatory network associated with prognosis of gastric cancer.
Developing a lncRNA Signature to Predict the Radiotherapy Response of Lower-Grade Gliomas Using Co-expression and ceRNA Network Analysis.
Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model.
Developing a radiosensitivity gene signature for Caucasian patients with breast cancer.
Developing the atlas of cancer in Queensland: methodological issues.
Developing ZNF Gene Signatures Predicting Radiosensitivity of Patients with Breast Cancer.
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics.
Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer.
Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma.
Development and Clinical Validation of a Seven-Gene Prognostic Signature Based on Multiple Machine Learning Algorithms in Kidney Cancer.
Development and evaluation of a deep neural network for histologic classification of renal cell carcinoma on biopsy and surgical resection slides.
Development and External Validation of a Novel Immune Checkpoint-Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma.
Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients.
Development and internal validation of a novel model and markers to identify the candidates for lymph node metastasis in patients with prostate cancer.
Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer.
Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma.
Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies.
Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma.
Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma.
Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma.
Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma.
Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer.
Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma.
Development and Validation of a Deep-learning Model to Assist With Renal Cell Carcinoma Histopathologic Interpretation.
Development and validation of a DNA repair gene signature for prognosis prediction in Colon Cancer.
Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer.
Development and validation of a ferroptosis-related prognostic model in pancreatic cancer.
Development and Validation of a Five-immune gene pair Signature in Endometrial carcinoma.
Development and validation of a five-immune gene prognostic risk model in colon cancer.
Development and validation of a five-lncRNA signature with prognostic value in colon cancer.
Development and validation of a four-lipid metabolism gene signature for diagnosis of pancreatic cancer.
Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Development and Validation of a Gene Signature for Prediction of Relapse in Stage I Testicular Germ Cell Tumors.
Development and validation of a hypoxia-related prognostic signature for breast cancer.
Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.
Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
Development and validation of a m6A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma.
Development and validation of a m6A-related gene signature for predicting the prognosis of hepatocellular carcinoma.
Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer.
Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma.
Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma.
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis.
Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Development and Validation of a Nine-Redox-Related Long Noncoding RNA Signature in Renal Clear Cell Carcinoma.
Development and validation of a nomogram based on stromal score to predict progression-free survival of patients with papillary thyroid carcinoma.
Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer.
Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.
Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.
Development and validation of a novel 15-CpG-based signature for predicting prognosis in triple-negative breast cancer.
Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma.
Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.
Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma.
Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer.
Development and Validation of a Novel Metabolic-Related Signature Predicting Overall Survival for Pancreatic Cancer.
Development and validation of a novel mRNA signature for predicting early relapse in non-small cell lung cancer.
Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
Development and Validation of a Novel Prognostic Model for Acute Myeloid Leukemia Based on Immune-Related Genes.
Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma.
Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia.
Development and validation of a novel survival model for acute myeloid leukemia based on autophagy-related genes.
Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer.
Development and validation of a prediction model for lung adenocarcinoma based on RNA-binding protein.
Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma.
Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
Development and validation of a prognostic model for kidney renal clear cell carcinoma based on RNA binding protein expression.
Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Development and validation of a prognostic nomogram for patients with lung adenocarcinoma based on a novel 6-DNA repair-related gene signature.
Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma.
Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer.
Development and validation of a prognostic signature for preoperative prediction of overall survival in gastric cancer patients.
Development and validation of a risk prediction model and nomogram for colon adenocarcinoma based on methylation-driven genes.
Development and Validation of a RNA Binding Protein-Associated Prognostic Model for Hepatocellular Carcinoma.
Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma.
Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.
Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.
Development and validation of a robust multigene signature as an aid to predict early relapse in stage I-III clear cell and papillary renal cell cancer.
Development and validation of a Super learner-based model for predicting survival in Chinese Han patients with resected colorectal cancer.
Development and validation of a survival model based on autophagy-associated genes for predicting prognosis of hepatocellular carcinoma.
Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes.
Development and validation of a survival model for lung adenocarcinoma based on autophagy-associated genes.
Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma.
Development and validation of a three-immune-related gene signature prognostic risk model in papillary thyroid carcinoma.
Development and validation of a three-long noncoding RNA signature for predicting prognosis of patients with gastric cancer.
Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients.
Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.
Development and validation of an autophagy-related prognostic signature in esophageal cancer.
Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma.
Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma.
Development and Validation of an Immune-Related Long Non-coding RNA Prognostic Model in Glioma.
Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis.
Development and validation of an immune-related prognostic signature in lung adenocarcinoma.
Development and validation of an individual alternative splicing prognostic signature in gastric cancer.
Development and validation of an individualized diagnostic signature in thyroid cancer.
Development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer.
Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma.
Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma.
Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma.
Development and validation of an oxidative stress-associated prognostic risk model for melanoma.
Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma.
Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.
Development and validation of autophagy-related-gene biomarker and nomogram for predicting the survival of cutaneous melanoma.
Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma.
Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
Development and validation of hub genes for lymph node metastasis in patients with prostate cancer.
Development and validation of m6A regulators' prognostic significance for endometrial cancer.
Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
Development and validation of nomogram with tumor microenvironment-related genes and clinical factors for predicting overall survival of endometrial cancer.
Development and Validation of Novel Biomarkers Related to M2 Macrophages Infiltration by Weighted Gene Co-Expression Network Analysis in Prostate Cancer.
Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer.
Development and validation of prognostic index based on autophagy-related genes in patient with head and neck squamous cell carcinoma.
Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Development and validation of prognostic model based on the analysis of autophagy-related genes in colon cancer.
Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
Development and validation of RNA binding protein-applied prediction model for gastric cancer.
Development and validation of the trans-omics model for pancreatic adenocarcinoma.
Development and verification of an immune-related gene pairs prognostic signature in ovarian cancer.
Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma.
Development of a five-protein signature for predicting the prognosis of head and neck squamous cell carcinoma.
Development of a four-gene prognostic model for clear cell renal cell carcinoma based on transcriptome analysis.
Development of a Four-mRNA Expression-Based Prognostic Signature for Cutaneous Melanoma.
Development of a Histopathology Informatics Pipeline for Classification and Prediction of Clinical Outcomes in Subtypes of Renal Cell Carcinoma.
Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Development of a miRNA-seq based prognostic signature in lung adenocarcinoma.
Development of a multi-gene-based immune prognostic signature in ovarian Cancer.
Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data.
Development of a novel 7 immune-related genes prognostic model for oral cancer: A study based on TCGA database.
Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma.
Development of a Novel Autophagy-related Prognostic Signature for Serous Ovarian Cancer.
Development of a novel gene signature in patients without Helicobacter pylori infection gastric cancer.
Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer.
Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma.
Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.
Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer.
Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients.
Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Development of a novel six-long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma.
Development of a Novel Six-miRNA-Based Model to Predict Overall Survival Among Colon Adenocarcinoma Patients.
Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia.
Development of a prediction model for radiosensitivity using the expression values of genes and long non-coding RNAs.
Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients.
Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.
Development of a prognostic index of colon adenocarcinoma based on immunogenomic landscape analysis.
Development of a prognostic model of glioma based on immune-related genes.
Development of a Prognostic Nomogram for Acute Myeloid Leukemia on IGHD Gene Family.
Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers.
Development of a Prognostic Signature Based on Autophagy-related Genes for Head and Neck Squamous Cell Carcinoma.
Development of a prognostic signature for esophageal cancer based on nine immune related genes.
Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.
Development of a risk scoring system for patients with papillary thyroid cancer.
Development of a RNA sequencing-based prognostic gene signature in multiple myeloma.
Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Development of a Ten-lncRNA Signature Prognostic Model for Breast Cancer Survival: A Study with the TCGA Database.
Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells.
Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma.
Development of an Autophagy Score Signature for Predicting Overall Survival in Papillary Renal Cell Carcinoma.
Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients.
Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma.
Development of an IFN? response-related signature for predicting the survival of cutaneous melanoma.
Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
Development of an Immune-Related Prognostic Index Associated With Glioblastoma.
Development of an immune-related prognostic index associated with hepatocellular carcinoma.
Development of an Immune-Related Prognostic Signature in Breast Cancer.
Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma.
Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma.
Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication.
Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.
Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
Development of Multiscale Transcriptional Regulatory Network in Esophageal Cancer Based on Integrated Analysis.
Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma.
Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database.
Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma.
Development of prognostic signatures for intermediate-risk papillary thyroid cancer.
Development of RNA binding proteins expression signature for prognosis prediction in gastric cancer patients.
Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas.
Development of the Australian Cancer Atlas: spatial modelling, visualisation, and reporting of estimates.
Developmental genes significantly afflicted by aberrant promoter methylation and somatic mutation predict overall survival of late-stage colorectal cancer.
Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis.
DGCR8/ZFAT-AS1 Promotes CDX2 Transcription in a PRC2 Complex-Dependent Manner to Facilitate the Malignant Biological Behavior of Glioma Cells.
Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.
Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.
Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma.
Diagnostic Accuracy of Immunohistochemistry for Mismatch Repair Proteins as Surrogate of Microsatellite Instability Molecular Testing in Endometrial Cancer.
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Diagnostic and prognostic implications of ribosomal protein transcript expression patterns in human cancers.
Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas.
Diagnostic and prognostic value of ABC transporter family member ABCG1 gene in clear cell renal cell carcinoma.
Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma.
Diagnostic and prognostic value of HABP2 as a novel biomarker for endometrial cancer.
Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Diagnostic and prognostic value of MATN3 expression in gastric carcinoma: TCGA database mining.
Diagnostic and prognostic value of MCM3 and its interacting proteins in hepatocellular carcinoma.
Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma.
Diagnostic and prognostic value of the BEX family in lung adenocarcinoma.
Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus?related hepatocellular carcinoma.
Diagnostic and prognostic values of forkhead box D4 gene in colonic adenocarcinoma.
Diagnostic and prognostic values of integrin ? subfamily mRNA expression in colon adenocarcinoma.
Diagnostic and prognostic values of upregulated SPC25 in patients with hepatocellular carcinoma.
Diagnostic and therapeutic potencies of miR-18a-5p in mixed-type gastric adenocarcinoma.
Diagnostic model of combined ceRNA and DNA methylation related genes in esophageal carcinoma.
Diagnostic potential of extracellular vesicle-associated microRNA-10b and tumor markers for lung adenocarcinoma.
Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.
Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.
Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular Subtyping.
Diallyl disulfide induces ERK phosphorylation and alters gene expression profiles in human colon tumor cells.
DIANA-miTED: a microRNA tissue expression database.
Difference in tumor mutation burden between squamous cell carcinoma in the oral cavity and larynx.
Differences between carcinoma of the cecum and ascending colon: Evidence based on clinical and embryological data.
Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.
Differences in gene-expression profiles in breast cancer between African and European-ancestry women.
Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants.
Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian).
Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas.
Differences in somatic mutation landscape of hepatocellular carcinoma in Asian American and European American populations.
Differences in T cell immune-related lncRNA and mRNA expression patterns between right- and left-sided colorectal cancers.
Differences in the early stage gene expression profiles of lung adenocarcinoma and lung squamous cell carcinoma.
Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved.
Different miR-21-3p isoforms and their different features in colorectal cancer.
Different splicing isoforms of ERCC1 affect the expression of its overlapping genes CD3EAP and PPP1R13L, and indicate a potential application in non-small cell lung cancer treatment.
Differential alternative RNA splicing and transcription events between tumors from African American and White patients in The Cancer Genome Atlas.
Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein.
Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors.
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours.
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
Differential effect of GLUT1 overexpression on survival and tumor immune microenvironment of human papilloma virus type 16-positive and -negative cervical cancer.
Differential Effect of Smoking on Gene Expression in Head and Neck Cancer Patients.
Differential expression analysis of clear cell renal cell carcinomas in THE CANCER GENOME ATLAS distinguishes an aggressive subset enriched with chromosome 7 and 12 gains.
Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer.
Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma.
Differential expression and significance of PD-L1, IDO-1 and B7-H4 in human lung cancer.
Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel Towards Prostate Cancer Relapse.
Differential Expression of ADP/ATP Carriers as a Biomarker of Metabolic Remodeling and Survival in Kidney Cancers.
Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.
Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy.
Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma.
Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling.
Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma.
Differential Expression of PEG10 Contributes to Aggressive Disease in Early Versus Late-Onset Colorectal Cancer.
Differential expression of pyruvate dehydrogenase E1A and its inactive phosphorylated form among breast cancer subtypes.
Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma.
Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Differential expressions of integrin-linked kinase, ?-parvin and cofilin 1 in high-fat diet induced prostate cancer progression in a transgenic mouse model.
Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer.
Differential gene expression of tumor-infiltrating CD4+ T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis.
Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis.
Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.
Differential gene methylation patterns in cancerous and non?cancerous cells.
Differential genetic mutations of ectoderm, mesoderm, and endoderm-derived tumors in TCGA database.
Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities.
Differential Interactome Proposes Subtype-Specific Biomarkers and Potential Therapeutics in Renal Cell Carcinomas.
Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns.
Differential microRNA expression profiles associated with microsatellite status reveal possible epigenetic regulation of microsatellite instability in gastric adenocarcinoma.
Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer.
Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes.
Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency.
Differential Regulation and Targeting of Estrogen Receptor ? Turnover in Invasive Lobular Breast Carcinoma.
Differential regulation of TGF-?-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.
Differentially expressed and survival-related proteins of lung adenocarcinoma with bone metastasis.
Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma.
Differentially expressed genes and key molecules of BRCA1/2-mutant breast cancer: evidence from bioinformatics analyses.
Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.
Differentially Expressed Genes Associated With Prognosis in Locally Advanced Lymph Node-Negative Prostate Cancer.
Differentially expressed long noncoding RNAs and regulatory mechanism of LINC02407 in human gastric adenocarcinoma.
Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes.
Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
Diffuse gliomas in patients aged 55?years or over: A suggestion for IDH mutation testing.
DiffVar: a new method for detecting differential variability with application to methylation in cancer and aging.
Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response.
Digital Inference of Immune Microenvironment Reveals Low-Risk Subtype of Early Lung Adenocarcinoma.
Diminished LINC00173 expression induced miR-182-5p accumulation promotes cell proliferation, migration and apoptosis inhibition via AGER/NF-?B pathway in non-small-cell lung cancer.
DINGO: differential network analysis in genomics.
Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma.
Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of ?-catenin stabilization in cancer stem cells.
Direct Targeting of CREB1 with Imperatorin Inhibits TGF?2-ERK Signaling to Suppress Esophageal Cancer Metastasis.
Discordance of Somatic Mutations Between Asian and Caucasian Patient Populations with Gastric Cancer.
Discovering Cancer Subtypes via an Accurate Fusion Strategy on Multiple Profile Data.
Discovering Condition-Specific Gene Co-Expression Patterns Using Gaussian Mixture Models: A Cancer Case Study.
Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes.
Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile.
Discovering functional impacts of miRNAs in cancers using a causal deep learning model.
Discovering key regulatory mechanisms from single-factor and multi-factor regulations in glioblastoma utilizing multi-dimensional data.
Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies.
Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
Discovering the mechanism and involvement of the methylation of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and its special locus region in gastric cancer.
Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.
DiscoverSL: An R package for Multi-omic data driven prediction of synthetic lethality in cancers.
Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
Discovery and Validation of a Metastasis-Related Prognostic and Diagnostic Biomarker for Melanoma Based on Single Cell and Gene Expression Datasets.
Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer.
Discovery and validation of methylation markers for endometrial cancer.
Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma.
Discovery in context: leveraging multidimensional glioblastoma datasets to identify targetable regulatory networks.
Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.
Discovery of a Novel Dual-Target Inhibitor of ERK1 and ERK5 That Induces Regulated Cell Death to Overcome Compensatory Mechanism in Specific Tumor Types.
Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Discovery of a novel three-long non-coding RNA signature for predicting the prognosis of patients with gastric cancer.
Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy.
Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo.
Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer.
Discovery of bladder cancer biomarkers in paired pre- and postoperative urine samples.
Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer.
Discovery of core genes in colorectal cancer by weighted gene co-expression network analysis.
Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma.
Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
Discovery of microarray-identified genes associated with ovarian cancer progression.
Discovery of multi-dimensional modules by integrative analysis of cancer genomic data.
Discovery of mutated subnetworks associated with clinical data in cancer.
Discovery of Pancreatic Ductal Adenocarcinoma-Related Aberrant Glycosylations: A Multilateral Approach of Lectin Microarray-Based Tissue Glycomic Profiling With Public Transcriptomic Datasets.
Discovery of two-level modular organization from matched genomic data via joint matrix tri-factorization.
Discriminating early- and late-stage cancers using multiple kernel learning on gene sets.
Disease characterization using a partial correlation-based sample-specific network.
Dishevelled segment polarity protein 3 (DVL3): a novel and easily applicable recurrence predictor in localised prostate adenocarcinoma.
DiSNEP: a Disease-Specific gene Network Enhancement to improve Prioritizing candidate disease genes.
Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology.
Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian versus Western Populations.
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer.
Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms is associated with poor prognosis in head and neck cancer.
Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.
Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis.
Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
Dissecting the expression landscape of cytochromes P450 in hepatocellular carcinoma: towards novel molecular biomarkers.
Dissecting the expression landscape of mitochondrial genes in lung squamous cell carcinoma and lung adenocarcinoma.
Dissecting the role of RNA modification regulatory proteins in melanoma.
Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma.
Dissecting tRNA-derived fragment complexities using personalized transcriptomes reveals novel fragment classes and unexpected dependencies.
Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
Distinct co-expression networks using multi-omic data reveal novel interventional targets in HPV-positive and negative head-and-neck squamous cell cancer.
Distinct diagnostic and prognostic values of ?-aminobutyric acid type A receptor family genes in patients with colon adenocarcinoma.
Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast Cancer.
Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma.
Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy.
Distinct Metabolic Features of Seminoma and Embryonal Carcinoma Revealed by Combined Transcriptome and Metabolome Analyses.
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma.
Distinct pattern of one-carbon metabolism, a nutrient-sensitive pathway, in invasive breast cancer: A metabolomic study.
Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma.
Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.
Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma.
Distinct prognostic value of mRNA expression of guanylate-binding protein genes in skin cutaneous melanoma.
Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma.
Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database CancerCoCoPUTs for cancer-specific codon usage.
Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response.
Distinct telomere length and molecular signatures in seminoma and non-seminoma of testicular germ cell tumor.
Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
Distinctive Desmoplastic 3D Morphology Associated With BRAFV600E in Papillary Thyroid Cancers.
Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients.
Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor.
Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
Distinguishing potential bacteria-tumor associations from contamination in a secondary data analysis of public cancer genome sequence data.
Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data.
Distinguishing Tumor and Stromal Sources of MicroRNAs Linked to Metastasis in Cutaneous Melanoma.
Distributed usability evaluation of the Pennsylvania Cancer Atlas.
Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Distribution and prognostic value of tumor?infiltrating T cells in breast cancer.
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning.
Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts.
Distribution-based measures of tumor heterogeneity are sensitive to mutation calling and lack strong clinical predictive power.
DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
Divining Responder Populations from Survival Data.
DIY: Visualizing the immune landscape of tumors using transcriptome and methylome data.
DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF??B pathway.
DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.
DLX6 promotes cell proliferation and survival in oral squamous cell carcinoma.
DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
DMBT1 Homozygous Deletion in Diffuse Astrocytomas Is Associated With Unfavorable Clinical Outcome.
DMCM: A Data-adaptive Mutation Clustering Method to Identify Cancer-related Mutation Clusters.
DMDRMR-Mediated Regulation of m6A-Modified CDK4 by m6A Reader IGF2BP3 Drives ccRCC Progression.
DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification.
DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes.
DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors.
DNA Damage Repair Gene Set as a Potential Biomarker for Stratifying Patients with High Tumor Mutational Burden.
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas.
DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues.
DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter.
DNA hypermethylation of aurora kinase A in hepatitis C virus?positive hepatocellular carcinoma.
DNA Methylation Analysis Identifies Patterns in Progressive Glioma Grades to Predict Patient Survival.
DNA methylation analysis improves the prognostication of acute myeloid leukemia.
DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs.
DNA methylation and gene expression profiles characterize epigenetic regulation of lncRNAs in colon adenocarcinoma.
DNA Methylation and Genetic Aberrations in Gastric Cancer.
DNA methylation and hormone receptor status in breast cancer.
DNA methylation at an enhancer of the three prime repair exonuclease 2 gene (TREX2) is linked to gene expression and survival in laryngeal cancer.
DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients.
DNA methylation biomarkers for head and neck squamous cell carcinoma.
DNA methylation biomarkers for the occurrence of lung adenocarcinoma from TCGA data mining.
DNA methylation changes involved in the tumor increase in F2 males born to gestationally arsenite-exposed F1 male mice.
DNA methylation data-based molecular subtype classification and prediction in patients with gastric cancer.
DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies.
DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry.
DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.
DNA methylation markers for diagnosis and prognosis of common cancers.
DNA Methylation Markers from Negative Surgical Margins Can Predict Recurrence of Oral Squamous Cell Carcinoma.
DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma.
DNA methylation of Hugl-2 is a prognostic biomarker in kidney renal clear cell carcinoma.
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.
DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon ? signature.
DNA methylation of metallothionein genes is associated with the clinical features of renal cell carcinoma.
DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.
DNA methylation profiling analysis identifies a DNA methylation signature for predicting prognosis and recurrence of lung adenocarcinoma.
DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics.
DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma.
DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature.
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.
DNA Methylation Profiling Reveals Prognostically Significant Groups in Pediatric Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry.
DNA methylation profiling to predict recurrence risk in stage ? lung adenocarcinoma: Development and validation of a nomogram to clinical management.
DNA Methylation Regulates Alternative Polyadenylation via CTCF and the Cohesin Complex.
DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.
DNA methylation signature of smoking in lung cancer is enriched for exposure signatures in newborn and adult blood.
DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
DNA methylation signatures associated with prognosis of gastric cancer.
DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
DNA Methylation Signatures in Vaginal Fluid Samples for Detection of Cervical and Endometrial Cancer.
DNA methylation subgroups in melanoma are associated with proliferative and immunological processes.
DNA methylation subtypes for ovarian cancer prognosis.
DNA Methylation Targets Influenced by Bisphenol A and/or Genistein Are Associated with Survival Outcomes in Breast Cancer Patients.
DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas.
DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
DNA Methylation-Based Method to Differentiate Malignant from Benign Thyroid Lesions.
DNA methylation-mediated Klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma.
DNA methylation-mediated silencing of miR-204 is a potential prognostic marker for papillary thyroid carcinoma.
DNA methylation-regulated microRNA pathways in ovarian serous cystadenocarcinoma: A meta-analysis.
DNA methylome and transcriptome analysis established a model of four differentially methylated positions (DMPs) as a diagnostic marker in esophageal adenocarcinoma early detection.
DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk.
DNA polymerase theta repression enhances the docetaxel responsiveness in metastatic castration-resistant prostate cancer.
DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination.
DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer.
DNA Repair and Signaling in Immune-Related Cancer Therapy.
DNA Repair Gene Expression Adjusted by the PCNA Metagene Predicts Survival in Multiple Cancers.
DNA repair gene expression is associated with differential prognosis between HPV16 and HPV18 positive cervical cancer patients following radiation therapy.
DNA repair gene expression is increased in HPV positive head and neck squamous cell carcinomas.
DNA repair genes are associated with tumor tissue differentiation and immune environment in lung adenocarcinoma: a bioinformatics analysis based on big data.
DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride.
DNA-methylated gene markers for colorectal cancer in TCGA database.
DNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia.
DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression.
DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p.
DNAJC12 promotes lung cancer growth by regulating the activation of ??catenin.
DNASE1L2, as a Carcinogenic Marker, Affects the Phenotype of Breast Cancer Cells Via Regulating Epithelial-Mesenchymal Transition Process.
DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection.
DNF: A differential network flow method to identify rewiring drivers for gene regulatory networks.
DNMIVD: DNA methylation interactive visualization database.
DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma.
DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies.
DNMT3A overexpression is associated with aggressive behavior and enteroblastic differentiation of gastric adenocarcinoma.
DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
DNMT3B7 expression promotes tumor progression to a more aggressive phenotype in breast cancer cells.
DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS.
DOCK4 Is a Platinum-Chemosensitive and Prognostic-Related Biomarker in Ovarian Cancer.
Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Does HPV Subtype Predict Outcomes in Head and Neck Cancers?
Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review.
Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.
DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes.
Double Minute Chromosomes in Glioblastoma Multiforme Are Revealed by Precise Reconstruction of Oncogenic Amplicons.
Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway.
Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
Down-regulation and clinical significance of miR-7-2-3p in papillary thyroid carcinoma with multiple detecting methods.
Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Down-Regulation of MiR-181c-5p Promotes Epithelial-to-Mesenchymal Transition in Laryngeal Squamous Cell Carcinoma via Targeting SERPINE1.
Down-regulation of MiR-365 as a novel indicator to assess the progression and metastasis of hepatocellular carcinoma.
Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma.
Down-regulation of solute carrier family 10 member 1 is associated with early recurrence and poorer prognosis of hepatocellular carcinoma.
Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.
Down-regulation of TROP-2 Predicts Poor Prognosis of Hepatocellular Carcinoma Patients.
Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma.
Downregulated expression of ARHGAP10 correlates with advanced stage and high Ki-67 index in breast cancer.
Downregulated expression of CFHL1 is associated with unfavorable prognosis in postoperative patients with hepatocellular carcinoma.
Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/?-catenin signaling in breast cancer.
Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis.
Downregulated mRNA Expression of ZNF385B Is an Independent Predictor of Breast Cancer.
Downregulated SPINK4 is associated with poor survival in colorectal cancer.
Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses.
Downregulation of ?-l-fucosidase 1 suppresses glioma progression by enhancing autophagy and inhibiting macrophage infiltration.
Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation.
Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells.
Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis.
Downregulation of CISD2 Has Prognostic Value in Non-Small Cell Lung Cancer and Inhibits the Tumorigenesis by Inducing Mitochondrial Dysfunction.
Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Downregulation of Collagen COL4A6 Is Associated with Prostate Cancer Progression and Metastasis.
Downregulation of cyclin-dependent kinase 8 by microRNA-148a suppresses proliferation and invasiveness of papillary thyroid carcinomas.
Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma.
Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.
Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition.
Downregulation of fibroblast growth factor 5 inhibits cell growth and invasion of human nonsmall-cell lung cancer cells.
Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis.
Downregulation of HOXA11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway.
Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Downregulation of KCTD12 contributes to melanoma stemness by modulating CD271.
Downregulation of lncRNA RPLP0P2 inhibits cell proliferation, invasion and migration, and promotes apoptosis in colorectal cancer.
Downregulation of long non-coding RNA DUXAP10 inhibits proliferation, migration, and invasion of renal cell carcinoma.
Downregulation of long non-coding RNA MR4435-2HG suppresses breast cancer progression via the Wnt/?-catenin signaling pathway.
Downregulation of long noncoding RNA LINC00683 associated with unfavorable prognosis in prostate cancer based on TCGA.
Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma.
Downregulation Of microRNA-133b And Its Clinical Value In Non-Small Cell Lung Cancer.
Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT.
Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1.
Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins.
Downregulation of miR?136?5p in hepatocellular carcinoma and its clinicopathological significance.
Downregulation of miR?486?5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.
Downregulation of miRNA-126-3p is associated with progression of and poor prognosis for lung squamous cell carcinoma.
Downregulation of N-myc and STAT Interactor Protein Predicts Aggressive Tumor Behavior and Poor Prognosis in Invasive Ductal Carcinoma.
Downregulation of NDUFB6 due to 9p24.1-p13.3 loss is implicated in metastatic clear cell renal cell carcinoma.
Downregulation of nucleolar and spindle-associated protein 1 expression suppresses liver cancer cell function.
Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.
Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Downregulation of PARVA promotes metastasis by modulating integrin-linked kinase activity and regulating MAPK/ERK and MLC2 signaling in prostate cancer.
Downregulation of PDIA3 inhibits proliferation and invasion of human acute myeloid leukemia cells.
Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer.
Downregulation of regulator of G protein signaling 2 expression in breast invasive carcinoma of no special type: Clinicopathological associations and prognostic relevance.
Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-?-induced apoptosis in tumor-repopulating cells of melanoma.
Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.
Downregulation of SPINK13 Promotes Metastasis by Regulating uPA in Ovarian Cancer Cells.
Downregulation of ST3GAL5 is associated with muscle invasion, high grade and a poor prognosis in patients with bladder cancer.
Downregulation of the DNA Repair Gene DDB2 by Arecoline Is through p53's DNA-Binding Domain and Is Correlated with Poor Outcome of Head and Neck Cancer Patients with Betel Quid Consumption.
Downregulation of transient receptor potential cation channel, subfamily C, member 1 contributes to drug resistance and high histological grade in ovarian cancer.
Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma.
Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer.
Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers.
Downstream neighbor of SON (DONSON) is associated with unfavorable survival across diverse cancers with oncogenic properties in clear cell renal cell carcinoma.
Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion.
Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.
DPP9: Comprehensive In Silico Analyses of Loss of Function Gene Variants and Associated Gene Expression Signatures in Human Hepatocellular Carcinoma.
DR4-Ser424 O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death.
Driver gene mutations based clustering of tumors: methods and applications.
DriverDBv2: a database for human cancer driver gene research.
DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies.
Driving in the melanoma landscape.
Drug and disease signature integration identifies synergistic combinations in glioblastoma.
Drug Normalization for Cancer Therapeutic and Druggable Genome Target Discovery.
Drug repurposing for glioblastoma based on molecular subtypes.
Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes.
DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer.
DSN1 is a prognostic biomarker and correlated with clinical characterize in breast cancer.
Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
Dual Hyper-graph Regularized Supervised NMF for Selecting Differentially Expressed Genes and Tumor Classification.
Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
Dual oxidase 1 and NADPH oxidase 2 exert favorable effects in cervical cancer patients by activating immune response.
Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer.
Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM.
Dual role of endothelial Myct1 in tumor angiogenesis and tumor immunity.
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells.
Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
DUBR suppresses migration and invasion of human lung adenocarcinoma cells via ZBTB11-mediated inhibition of oxidative phosphorylation.
DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer.
DUSP4/MKP2 overexpression is associated with BRAF(V600E) mutation and aggressive behavior of papillary thyroid cancer.
Dusting off old books: comments on classic gynecologic pathology books of yesteryear.
Dynamic changes of driver genes' mutations across clinical stages in nine cancer types.
Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis.
Dynamic Control of Mitochondrial Ca2+ Levels as a Survival Strategy of Cancer Cells.
Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer.
Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinoma.
Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.
Dyregulation of the lncRNA TPT1-AS1 positively regulates QKI expression and predicts a poor prognosis for patients with breast cancer.
DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts.
Dysregulated circRNAs and ceRNA network in esophageal squamous cell carcinoma.
Dysregulated lncRNA-miRNA-mRNA Network Reveals Patient Survival-Associated Modules and RNA Binding Proteins in Invasive Breast Carcinoma.
Dysregulated microRNAs in laryngeal cancer: a comprehensive meta-analysis using a robust rank aggregation approach.
Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis.
Dysregulation in nucleic acid-sensing pathway genes is associated with cancer patients' prognosis.
Dysregulation of cystathionine ?-lyase promotes prostate cancer progression and metastasis.
Dysregulation of DNA methylation patterns may identify patients with breast cancer resistant to endocrine therapy: A predictive classifier based on differentially methylated regions.
Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.
Dysregulation of KIF14 regulates the cell cycle and predicts poor prognosis in cervical cancer: a study based on integrated approaches.
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.
Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.
Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.
Dysregulation of sphingolipid metabolic enzymes leads to high levels of sphingosine-1-phosphate and ceramide in human hepatocellular carcinoma.
Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer.
Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.
Dysregulation of the miRNA biogenesis components DICER1, DROSHA, DGCR8 and AGO2 in clear cell renal cell carcinoma in both a Korean cohort and the cancer genome atlas kidney clear cell carcinoma cohort.
Dysregulation, functional implications, and prognostic ability of the circadian clock across cancers.
e-Driver: a novel method to identify protein regions driving cancer.
E26 transformation (ETS)?specific related transcription factor?3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
E2F, HSF2, and miR-26 in thyroid carcinoma: bioinformatic analysis of RNA-sequencing data.
E2F3 promotes liver cancer progression under the regulation of circ-PRKAR1B.
E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle.
Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies.
Early genetic aberrations in patients with sporadic colorectal cancer.
Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma.
Early Stage Biomarkers Screening of Prostate Cancer Based on Weighted Gene Coexpression Network Analysis.
Early-onset Colorectal Cancer is Distinct From Traditional Colorectal Cancer.
Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features.
EARN: an ensemble machine learning algorithm to predict driver genes in metastatic breast cancer.
ECGene: A Literature-Based Knowledgebase of Endometrial Cancer Genes.
Ectodermal-neural cortex 1 as a novel biomarker predicts poor prognosis and induces metastasis in breast cancer by promoting Wnt/?-catenin pathway.
Ectodermal?neural cortex 1 affects the biological function of lung cancer through the MAPK pathway.
Ectopic Otoconin 90 expression in triple negative breast cancer cell lines is associated with metastasis functions.
Edgetic perturbation signatures represent known and novel cancer biomarkers.
eEF2K as a novel metastatic and prognostic biomarker in gastric cancer patients.
Effect of AGER on the biological behavior of non?small cell lung cancer H1299 cells.
Effect of CCL2 siRNA on proliferation and apoptosis in the U251 human glioma cell line.
Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells.
Effect of claudin 1 on cell proliferation, migration and apoptosis in human cervical squamous cell carcinoma.
Effect of COL4A1 Expression on the Survival of Neoadjuvant Chemotherapy Breast Cancer Patients.
Effect of CXCR5-Positive Cell Infiltration on the Immune Contexture and Patient Prognosis in Head and Neck Squamous Cell Carcinoma.
Effect of Different Expression of Immune-Related lncRNA on Colon Adenocarcinoma and Its Relation to Prognosis.
Effect of differential hypoxia-related gene expression on glioblastoma.
Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level.
Effect of estrogen receptor ? binding on functional DNA methylation in breast cancer.
Effect of FAM196B in human lung adenocarcinoma.
Effect of high variation in transcript expression on identifying differentially expressed genes in RNA-seq analysis.
Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer.
Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.
Effect of let-7c on the PI3K/Akt/FoxO signaling pathway in hepatocellular carcinoma.
Effect of m6A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma.
Effect of myeloid ecotropic viral integration site (MEIS) family genes on tumor microenvironment remodeling and its potential therapeutic effect.
Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer.
Effect of nicastrin on hepatocellular carcinoma proliferation and apoptosis through PI3K/AKT signalling pathway modulation.
Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients.
Effect of upregulation of DD3 on early detection and prognosis in prostate cancer.
Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma.
Effects of ABT-737 combined with irradiation treatment on uterine cervical cancer cells.
Effects of AKT1 E17K mutation hotspots on the biological behavior of breast cancer cells.
Effects of Alternative Splicing Events on Acute Myeloid Leukemia.
Effects of Arsenic (+3 Oxidation State) Methyltransferase Gene Polymorphisms and Expression on Bladder Cancer: Evidence from a Systematic Review, Meta-analysis and TCGA Dataset.
Effects of B cell-activating factor on tumor immunity.
Effects of CORO2A on Cell Migration and Proliferation and Its Potential Regulatory Network in Breast Cancer.
Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures.
Effects of hub genes on the clinicopathological and prognostic features of lung adenocarcinoma.
Effects of Hypoxia in Intestinal Tumors on Immune Cell Behavior in the Tumor Microenvironment.
Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer.
Effects of m6A RNA methylation regulators on endometrial cancer.
Effects of NRP1 on angiogenesis and vascular maturity in endothelial cells are dependent on the expression of SEMA4D.
Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma.
Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.
Efficacy and pharmacodynamics of niraparib in BRCA-mutant and wild-type intracranial triple-negative breast cancer murine models.
Efficient exploration of pan-cancer networks by generalized covariance selection and interactive web content.
Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine.
Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.
EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck Cancers.
EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma.
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small cell lung cancer.
EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
EGFRvIII-specific CAR-T cells produced by piggyBac transposon exhibit efficient growth suppression against hepatocellular carcinoma.
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC.
EGOT lncRNA in head and neck squamous cell carcinomas.
Egr?1 inhibits colon cancer cell proliferation, migration and invasion via regulating CDKL1 at the transcriptional level.
EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
eIF2?, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
eIF6 Promotes Colorectal Cancer Proliferation and Invasion by Regulating AKT-Related Signaling Pathways.
eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway.
Eight immune-related genes predict survival outcomes and immune characteristics in breast cancer.
Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.
Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.
Eight-gene prognostic signature associated with hypoxia and ferroptosis for gastric cancer with general applicability.
Eight-gene signature predicts recurrence in lung adenocarcinoma.
Elastic Net-Based Identification of a Multigene Combination Predicting the Survival of Patients with Cervical Cancer.
Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: An Radiation Therapy Oncology Group Consensus Panel Contouring Atlas.
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas.
Elementary screening of lymph node metastatic-related genes in gastric cancer based on the co-expression network of messenger RNA, microRNA and long non-coding RNA.
Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report.
Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data.
Elevated CELSR3 expression is associated with hepatocarcinogenesis and poor prognosis.
Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer.
Elevated COX-2 Expression Promotes Angiogenesis Through EGFR/p38-MAPK/Sp1-Dependent Signalling in Pancreatic Cancer.
Elevated DKK1 expression is an independent unfavorable prognostic indicator of survival in head and neck squamous cell carcinoma.
Elevated double-strand break repair protein RAD50 predicts poor prognosis in hepatitis B virus-related hepatocellular carcinoma: A study based on Chinese high-risk cohorts.
Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma.
Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosis.
Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma.
Elevated expression of ASF1B correlates with poor prognosis in human lung adenocarcinoma.
Elevated Expression of LYPD3 Is Associated with Lung Adenocarcinoma Carcinogenesis and Poor Prognosis.
Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients.
Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer.
Elevated expression of protein arginine methyltransferase 5 predicts the poor prognosis of breast cancer.
Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer.
Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
Elevated FAM3C promotes cell epithelial- mesenchymal transition and cell migration in gastric cancer.
Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma.
Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.
Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data.
Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma.
Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.
Elevated integrin ?6 expression is involved in the occurrence and development of lung adenocarcinoma, and predicts a poor prognosis: a study based on immunohistochemical analysis and bioinformatics.
Elevated KLF7 levels may serve as a prognostic signature and might contribute to progression of squamous carcinoma.
Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma.
Elevated MRE11 expression associated with progression and poor outcome in prostate cancer.
Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
Elevated MYO10 Predicts Poor Prognosis and its Deletion Hampers Proliferation and Migration Potentials of Cells Through Rewiring PI3K/Akt Signaling in Cervical Cancer.
Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes.
Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma.
Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics.
Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer.
Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Elevated TRIP13 drives cell proliferation and drug resistance in bladder cancer.
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.
Eleven immune-gene pairs signature associated with TP53 predicting the overall survival of gastric cancer: a retrospective analysis of large sample and multicenter from public database.
ELF1 Transcription Factor Enhances the Progression of Glioma via ATF5 promoter.
ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.
ELF5 isoform expression is tissue-specific and significantly altered in cancer.
Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
Elucidating feed-forward apoptosis signatures in breast cancer datasets: Higher FOS expression associated with a better outcome.
Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma.
Elucidating the Reprograming of Colorectal Cancer Metabolism Using Genome-Scale Metabolic Modeling.
Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers.
Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion.
Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion.
Elucidation of the Genomic-Epigenomic Interaction Landscape of Aggressive Prostate Cancer.
Embedding of Genes Using Cancer Gene Expression Data: Biological Relevance and Potential Application on Biomarker Discovery.
Emerging biomarkers and targeted therapies in urothelial carcinoma.
Emerging landscape of oncogenic signatures across human cancers.
Emerging molecular classifications and therapeutic implications for gastric cancer.
Emerging Multimodality Approaches to Treat Localized Esophageal Cancer.
Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer.
Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
Emerging targets for glioblastoma stem cell therapy.
Emerging Therapies in the Management of Advanced-Stage Gastric Cancer.
EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells.
Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma.
Empowering biologists with multi-omics data: colorectal cancer as a paradigm.
EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer.
EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database.
EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures.
Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt Experience.
Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas.
ENAM gene associated with T classification and inhibits proliferation in renal clear cell carcinoma.
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.
Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma.
Endometrial Adenocarcinomas With No Specific Molecular Profile: Morphologic Features and Molecular Alterations of "Copy-number Low" Tumors.
Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.
Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
Endometrial Cancers in BRCA1 or BRCA2 Germline Mutation Carriers: Assessment of Homologous Recombination DNA Repair Defects.
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition.
Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Endometrial Carcinomas with a "Serous" Component in Young Women Are Enriched for DNA Mismatch Repair Deficiency, Lynch Syndrome, and POLE Exonuclease Domain Mutations.
Endoplasmic reticulum chaperone GRP78/BiP is critical for mutant Kras-driven lung tumorigenesis.
Endoscopic Endonasal Approach for Resection of a Pediatric Craniopharyngioma: Operative Video and Technical Nuances.
Endoscopic management of a lower clival chondroid chordoma: case report.
Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors.
Endothelial cells promote triple-negative breast cancer cell metastasis via PAI-1 and CCL5 signaling.
Endothelial-mesenchymal transition harnesses HSP90?-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma.
Endothelin therapeutics in cancer: Where are we?
Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.
Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.
Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma.
Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but not Decreased Promoter Methylation in Colorectal Cancer.
Enhanced expression of FGF19 predicts poor prognosis in patients with non-small cell lung cancer.
Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma.
Enhanced expression of histone chaperone APLF associate with breast cancer.
Enhanced expression of microtubule-associated protein 7 functioned as a contributor to cervical cancer cell migration and is predictive of adverse prognosis.
Enhanced expression of queuine tRNA-ribosyltransferase 1 (QTRT1) predicts poor prognosis in lung adenocarcinoma.
Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.
Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemia.
Enhanced fatty acid oxidation mediated by CPT1C promotes gastric cancer progression.
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition.
Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma.
Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
Enhanced MAPK signaling drives ETS1-mediated induction of miR-29b leading to downregulation of TET1 and changes in epigenetic modifications in a subset of lung SCC.
Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway.
Enhancing identification of cancer types via lowly-expressed microRNAs.
Enhancing the sensitivity of ovarian cancer cells to olaparib via microRNA-20b-mediated cyclin D1 targeting.
ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway.
EnMCB: an R/bioconductor package for predicting disease progression based on methylation correlated blocks using ensemble models.
Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis.
Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients.
Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas.
Enrichment of FGFR3-TACC3 Fusions in Patients With Bladder Cancer Who Are Young, Asian, or Have Never Smoked.
enRoute: dynamic path extraction from biological pathway maps for exploring heterogeneous experimental datasets.
Ensemble outlier detection and gene selection in triple-negative breast cancer data.
Entropy-based Consensus Clustering for Patient Stratification.
Eosinophilic granuloma of the atlas presenting as torticollis in a child.
EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients.
Eph family co-expression patterns define unique clusters predictive of cancer phenotype.
EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma.
EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers.
Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumors.
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.
Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma.
Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors.
Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.
Epidermal Growth Factor Receptor Mutations in Resectable Non-Small Cell Lung Cancer Patients and their Potential Role in the Immune Landscape.
Epididymal protein 3A is upregulated and promotes cell proliferation in non-small cell lung cancer.
Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin.
Epigenetic age acceleration and clinical outcomes in gliomas.
Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis.
Epigenetic Aging Signatures Are Coherently Modified in Cancer.
Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome-wide Methylation Analysis.
Epigenetic Alterations Associated with the Overall Survival and Recurrence Free Survival among Oral Squamous Cell Carcinoma Patients.
Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes.
Epigenetic analysis identifies factors driving racial disparity in prostate cancer.
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer.
Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.
Epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer.
Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype.
Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
Epigenetic mediated silencing of EYA4 contributes to tumorigenesis in oral dysplastic cells.
Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia.
Epigenetic pathways and glioblastoma treatment.
Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia.
Epigenetic regulation of IQGAP2 promotes ovarian cancer progression via activating Wnt/?-catenin signaling.
Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-?B Pathway in Melanoma.
Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer.
Epigenetic regulation on the gene expression signature in esophagus adenocarcinoma.
Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer.
Epigenetic Scanning of KEAP1 CpG Sites Uncovers New Molecular-Driven Patterns in Lung Adeno and Squamous Cell Carcinomas.
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
Epigenetic signature predicts overall survival clear cell renal cell carcinoma.
Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer.
Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types.
Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
Epigenetic silencing of the synthesis of immunosuppressive Siglec ligand glycans by NF-?B/EZH2/YY1 axis in early-stage colon cancers.
Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.
Epigenetic silencing of ZIC4 contributes to cancer progression in hepatocellular carcinoma.
Epigenetic Study of Esophageal Carcinoma Based on Methylation, Gene Integration and Weighted Correlation Network Analysis.
Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.
Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression.
Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma.
Epigenetic Variation Analysis Leads to Biomarker Discovery in Gastric Adenocarcinoma.
Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 (ZNF671) Predicts Poor Prognosis in Multiple Solid Tumors.
Epigenetic-smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early-stage NSCLC patients.
Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells.
Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients.
Epigenetically regulated Fibronectin leucine rich transmembrane protein 2 (FLRT2) shows tumor suppressor activity in breast cancer cells.
Epigenetically regulated gene expression profiles reveal four molecular subtypes with prognostic and therapeutic implications in colorectal cancer.
Epigenetically silenced candidate tumor suppressor genes in prostate cancer: identified by modelling methylation stratification and applied to progression prediction.
Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLC?-NF-?B signaling pathway and VEGF-C/ Bcl-2 expression.
Epigenetics in breast cancer: what's new?
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers.
Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms.
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.
Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.
Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types.
Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.
Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia.
Epistasis analysis of microRNAs on pathological stages in colon cancer based on an Empirical Bayesian Elastic Net method.
Epithelial Hypoxia-Inducible Factor 2? Facilitates the Progression of Colon Tumors through Recruiting Neutrophils.
Epithelial Splicing Regulatory Protein (ESPR1) Expression in an Unfavorable Prognostic Factor in Prostate Cancer Patients.
Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma.
Epithelial-to-mesenchymal transition and its association with PD-L1 and CD8 in thyroid cancer.
Epiviz File Server: Query, Transform and Interactively Explore Data from Indexed Genomic Files.
Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
Epstein-Barr Virus MicroRNA Expression Increases Aggressiveness of Solid Malignancies.
Epstein-Barr Virus miR-BART17-5p Promotes Migration and Anchorage-Independent Growth by Targeting Kruppel-Like Factor 2 in Gastric Cancer.
Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response.
Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations.
Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality.
ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer.
ER? is a negative regulator of PD-L1 gene transcription in breast cancer.
ER?-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.
Eradication of hepatocellular carcinoma by NKG2D-specific CAR T-cells.
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer.
ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.
ErbB4 acts as a suppressor in colitis and its associated carcinoma by negatively regulating cholesterol metabolism.
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.
ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.
ERCC6L, a DNA helicase, is involved in cell proliferation and associated with survival and progress in breast and kidney cancers.
ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma.
ERR1 and PGC1? associated mitochondrial alterations correlate with pan-cancer disparity in African Americans.
Error-prone DNA polymerase and oxidative stress increase the incidences of A to G mutations in tumors.
Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.
ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation.
Ese-3 Inhibits the Proliferation, Migration, and Invasion of HaCaT Cells by Downregulating PSIP1 and NUCKS1.
ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma.
ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-?B/Cyclin D1 pathway.
Esophageal cancer lymph node metastasis-associated gene signature optimizes overall survival prediction of esophageal cancer.
ESR1 as a recurrence-related gene in intrahepatic cholangiocarcinoma: a weighted gene coexpression network analysis.
ESR1-stabilizing lncRNA TMPO-AS1 promotes hormone-refractory breast cancer progression.
ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells.
Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature.
Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis.
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project.
Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer.
Establishment and Validation of a Comprehensive Prognostic Model for Patients With HNSCC Metastasis.
Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Establishment and Validation of a Prognostic Risk Model for Autophagy-Related Genes in Clear Cell Renal Cell Carcinoma.
Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.
Establishment and validation of an immune-associated signature in lung adenocarcinoma.
Establishment and validation of an immune-based prognostic score model in glioblastoma.
Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Establishment of a 12-gene expression signature to predict colon cancer prognosis.
Establishment of a 5-gene risk model related to regulatory T cells for predicting gastric cancer prognosis.
Establishment of a 7-miRNA-Based Risk Score System for Predicting Prognosis of Pancreatic Cancer.
Establishment of a CALU, AURKA, and MCM2 gene panel for discrimination of metastasis from primary colon and lung cancers.
Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients.
Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection.
Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer.
Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response.
Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment.
Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes.
Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in Head and Neck Squamous Cell Carcinoma.
Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis.
Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets.
Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma.
Establishment of a Risk Signature Based on m6A RNA Methylation Regulators That Predicts Poor Prognosis in Renal Cell Carcinoma.
Establishment of a SVM classifier to predict recurrence of ovarian cancer.
Establishment of an immune microenvironment-based prognostic predictive model for gastric cancer.
Establishment of an immune-related gene prognostic model for head and neck tumors.
Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.
Establishment of cohesion 1 homolog 2 facilitates cell aggressive behaviors and induces poor prognosis in renal cell carcinoma.
Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis.
Establishment of multiple diagnosis models for colorectal cancer with artificial neural networks.
Establishment of Novel DNA Methylation-Based Prostate Cancer Subtypes and a Risk-Predicting Eight-Gene Signature.
Establishment of Novel Prostate Cancer Risk Subtypes and A Twelve-Gene Prognostic Model.
Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient.
Estimating gene expression from DNA methylation and copy number variation: A deep learning regression model for multi-omics integration.
Estimating relative mitochondrial DNA copy number using high throughput sequencing data.
Estimation of Heterogeneous Restricted Mean Survival Time Using Random Forest.
Estimation of Hub Genes and Infiltrating Immune Cells in Non-Smoking Females with Lung Adenocarcinoma by Integrated Bioinformatic Analysis.
Estimation of parent specific DNA copy number in tumors using high-density genotyping arrays.
Estimation of Prognostic Marker Genes by Public Microarray Data in Patients with Ovarian Serous Cystadenocarcinoma.
Estimation of the proteomic cancer co-expression sub networks by using association estimators.
Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.
Estrogen receptor ? is involved in the regulation of ITGA8 methylation in estrogen receptor-positive breast cancer.
Estrogen receptor alpha (ER?/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.
Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.
Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.
Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway.
Estrogen-related receptor alpha copy number variation is associated with ovarian cancer histological grade.
Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy Efficacy.
ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes.
Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
Eva-1 homolog A promotes papillary thyroid cancer progression and epithelial-mesenchymal transition via the Hippo signalling pathway.
Evaluating and sharing global genetic ancestry in biomedical datasets.
Evaluating cell lines as tumour models by comparison of genomic profiles.
Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
Evaluating patient-derived colorectal cancer-xenografts as preclinical models by comparison with patient clinical data.
Evaluating prognostic value and relevant gene signatures of tumor microenvironment characterization in esophageal carcinoma.
Evaluating somatic tumor mutation detection without matched normal samples.
Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer.
Evaluating the molecule-based prediction of clinical drug responses in cancer.
Evaluating the Predictability of Cancer Types from 536 Somatic Mutations: A New Dataset.
Evaluating the Prognostic Value of microRNA-203 in Solid Tumors Based on a Meta-Analysis and the Cancer Genome Atlas (TCGA) Datasets.
Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma.
Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification.
Evaluation framework for the multilevel macroscopic models of solid tumor growth in the glioma case.
Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types.
Evaluation of circulating small extracellular vesicles derived miRNAs as biomarkers of early colon cancer: a comparison with plasma total miRNAs.
Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational Study.
Evaluation of CpG-SNPs in miRNA promoters and risk of breast cancer.
Evaluation of delineating the target volume by radiation therapists in breast cancer patients.
Evaluation of Elafin Immunohistochemical Expression as Marker of Cervical Cancer Severity.
Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.
Evaluation of FGFR1 as a diagnostic biomarker for ovarian cancer using TCGA and GEO datasets.
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Evaluation of genetic variants in autophagy pathway genes as prognostic biomarkers for breast cancer.
Evaluation of genome-wide genotyping concordance between tumor tissues and peripheral blood.
Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters.
Evaluation of hierarchical models for integrative genomic analyses.
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Evaluation of immune infiltrating of thyroid cancer based on the intrinsic correlation between pair-wise immune genes.
Evaluation of integrative clustering methods for the analysis of multi-omics data.
Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.
Evaluation of MEDAG gene expression in papillary thyroid microcarcinoma: associations with histological features, regional lymph node metastasis and prognosis.
Evaluation of melanoma antigen (MAGE) gene expression in human cancers using The Cancer Genome Atlas.
Evaluation of potential regulatory function of breast cancer risk locus at 6q25.1.
Evaluation of somatic copy number estimation tools for whole-exome sequencing data.
Evaluation of the Cancer of Bladder Risk Assessment (COBRA) Score in the Cancer Genome Atlas (TCGA) Bladder Cancer Cohort.
Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis.
Evaluation of the prognostic significances of ?-secretase genes in pancreatic cancer.
Evaluation of the prognostic value of CBXs in gastric cancer patients.
Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic Analysis.
Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis.
Evaluation on the diagnostic and prognostic values of long non-coding RNA BLACAT1 in common types of human cancer.
Evi-1 Influence on Clinical Progress of Colorectal Cancer Patients.
EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma.
EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.
EVI1 overexpression promotes ovarian cancer progression by regulating estrogen signaling.
EVI1 splice variants modulate functional responses in ovarian cancer cells.
EVI2B Is a New Prognostic Biomarker in Metastatic Melanoma with IFNgamma Associated Immune Infiltration.
Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: Towards a "minimal common brain"
Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas.
Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort.
Evidence that the viral oncoproteins E6 and E7 of HPV induce the expression of a functional IL-2R on cervical cancer cells.
Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer.
Evolved Resistance to Placental Invasion Secondarily Confers Increased Survival in Melanoma Patients.
Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.
Examination of Independent Prognostic Power of Gene Expressions and Histopathological Imaging Features in Cancer.
Examination of the expression and prognostic significance of DLGAPs in gastric cancer using the TCGA database and bioinformatic analysis.
Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B virus?positive cirrhosis.
Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes.
Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of POLD1 and MLH1.
ExoceRNA atlas: A database of cancer ceRNAs in human blood exosomes.
Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment.
Exogenous regucalcin negatively regulates the progression of cervical adenocarcinoma.
Exome Sequencing in BRCA1- and BRCA2-Negative Greek Families Identifies MDM1 and NBEAL1 as Candidate Risk Genes for Hereditary Breast Cancer.
Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients.
ExonSkipDB: functional annotation of exon skipping event in human.
Exonuclease 1 expression is associated with clinical progression, metastasis, and survival prognosis of prostate cancer.
Exosomal circRNA in Digestive System Tumors: The Main Player or Coadjuvants?
Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA signature might be a potential biomarker for predicting prognosis of papillary thyroid carcinoma.
Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
Exosome-related lncRNAs as predictors of HCC patient survival: a prognostic model.
Exostosin1 as a novel prognostic and predictive biomarker for squamous cell lung carcinoma: A study based on bioinformatics analysis.
Experiences with intraluminal occlusion with the Fogarty catheter in the treatment of carotid-cavernous sinus fistulas and other lesions at the base of the skull.
Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer.
Explaining Gene Expression Using Twenty-One MicroRNAs.
Exploiting DNA repair defects in colorectal cancer.
Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma.
Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment.
Exploration of DNA Methylation-Driven Genes in Papillary Thyroid Carcinoma Based on the Cancer Genome Atlas.
Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis.
Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer.
Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer.
Exploration of Genomic, Proteomic, and Histopathological Image Data Integration Methods for Clinical Prediction.
Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
Exploration of Potential Roles of m6A Regulators in Colorectal Cancer Prognosis.
Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
Exploration of the Associations of lncRNA Expression Patterns with Tumor Mutation Burden and Prognosis in Colon Cancer.
Exploration of the diagnostic value and molecular mechanism of miR?1 in prostate cancer: A study based on meta?analyses and bioinformatics.
Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma.
Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma.
Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
Exploration of the Immune-Related Signatures and Immune Infiltration Analysis in Melanoma.
Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma.
Exploratory analysis of the copy number alterations in glioblastoma multiforme.
Explore prognostic biomarker of bladder cancer based on competing endogenous network.
Explore prognostic marker of colorectal cancer based on ceRNA network.
Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.
Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Exploring cancer genomic data from The Cancer Genome Atlas Project.
Exploring drivers of gene expression in the Cancer Genome Atlas.
Exploring epigenetic biomarkers of universal specificities and commonalities among pan-cancer cohorts in The Cancer Genome Atlas.
Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database.
Exploring phenotype patterns of breast cancer within somatic mutations: a modicum in the intrinsic code.
Exploring prognostic genes in ovarian cancer stage-related coexpression network modules.
Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network.
Exploring specific prognostic biomarkers in triple-negative breast cancer.
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser.
Exploring the differences between early-onset gastric cancer and traditional-onset gastric cancer.
Exploring the Effect of Differentially Expressed Long Non-coding RNAs Driven by Copy Number Variation on Competing Endogenous RNA Network by Mining Lung Adenocarcinoma Data.
Exploring the Impact of Single-Nucleotide Polymorphisms on Translation.
Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation.
Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis.
Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis.
Exploring the role of Mir204/211 in HNSCC by the combination of bioinformatic analysis of ceRNA and transcription factor regulation.
Exploring the survival prognosis of lung adenocarcinoma based on the cancer genome atlas database using artificial neural network.
Exposing the cancer genome atlas as a SPARQL endpoint.
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis.
Expression analysis of microRNA as prognostic biomarkers in colorectal cancer.
Expression and Bioinformatics-Based Functional Analysis of UAP1 in Lung Adenocarcinoma.
Expression and Circulating Levels of Perlecan in Breast Cancer - Implications for Oestrogen Dependent Stromal Remodeling.
Expression and Clinical Relevance of SOX9 in Gastric Cancer.
Expression and clinical significance of AURKB gene in lung adenocarcinoma: Analysis based on the data-mining of bioinformatic database.
Expression and clinical significance of CMTM1 in hepatocellular carcinoma.
Expression and clinical significance of CPS1 in glioblastoma multiforme.
Expression and clinical significance of KLK5-8 in endometrial cancer.
Expression and clinical significance of miR-3615 in hepatocellular carcinoma.
Expression and clinical significance of PDK family in breast cancer based on data mining.
Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis.
Expression and clinical significance of ubiquitin?specific?processing protease 34 in diffuse large B?cell lymphoma.
Expression and clinical significance profile analysis of S100 family members in human acute myeloid leukemia.
Expression and clinical value of CD105 in renal cell carcinoma based on data mining in The Cancer Genome Atlas.
Expression and clinical value of SALL4 in renal cell carcinomas.
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Expression and Function of Eicosanoid-Producing Cytochrome P450 Enzymes in Solid Tumors.
Expression and Function of Toll-Like Receptor 10 (TLR10) in Diffuse Large B Cell Lymphoma, Acute Myeloid Leukemia, and Glioma.
Expression and gene regulation network of RBM8A in hepatocellular carcinoma based on data mining.
Expression and gene regulation network of TYMS and BCL2L1 in colorectal cancer based on data mining.
Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma.
Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
Expression and potential molecular mechanisms of miR?204?5p in breast cancer, based on bioinformatics and a meta?analysis of 2,306 cases.
Expression and potential prognostic value of histone family gene signature in breast cancer.
Expression and prognostic analyses of the insulin-like growth factor 2 mRNA binding protein family in human pancreatic cancer.
Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
Expression and Prognostic Characteristics of Ferroptosis-Related Genes in Colon Cancer.
Expression and Prognostic Characteristics of m6 A RNA Methylation Regulators in Breast Cancer.
Expression and Prognostic Characteristics of m6A RNA Methylation Regulators in Colon Cancer.
Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.
Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.
Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses.
Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma.
Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Expression and prognostic significance of Niemann-Pick C1-Like 1 in colorectal cancer: a retrospective cohort study.
Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells.
Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
Expression and prognostic value of E2F3 transcription factor in non-small cell lung cancer.
Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.
Expression and prognostic value of SULT1A2 in bladder cancer.
Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer.
Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
Expression array analysis of the hepatocyte growth factor invasive program.
Expression Atlas update-an integrated database of gene and protein expression in humans, animals and plants.
Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma.
Expression Changes Confirm Genomic Variants Predicted to Result in Allele-Specific, Alternative mRNA Splicing.
Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645 cases from 9 microarray datasets.
Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases.
Expression level of ACOT7 influences the prognosis in acute myeloid leukemia patients.
Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma.
Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses.
Expression levels of lncRNAs are prognostic for hepatocellular carcinoma overall survival.
Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer.
Expression mode and prognostic value of FXYD family members in colon cancer.
Expression of amyloid precursor-like protein 2 (APLP2) in glioblastoma is associated with patient prognosis.
Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas.
Expression of AOX1 Predicts Prognosis of Clear Cell Renal Cell Carcinoma.
Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma.
Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature.
Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.
Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.
Expression of Cell Division Cycle Protein 45 in Tissue Microarrays and the CDC45 Gene by Bioinformatics Analysis in Human Hepatocellular Carcinoma and Patient Outcomes.
Expression of Class III Beta-Tubulin Is Associated with Invasive Potential and Poor Prognosis in Thyroid Carcinoma.
Expression of Coiled-Coil Domain Containing 34 (CCDC34) and its Prognostic Significance in Pancreatic Adenocarcinoma.
Expression of collagen type 1 alpha 1 indicates lymph node metastasis and poor outcomes in squamous cell carcinomas of the lung.
Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
Expression of DUSP4 transcript variants as a potential biomarker for colorectal cancer.
Expression of epithelial-mesenchymal transition-related genes increases with copy number in multiple cancer types.
Expression of eukaryotic translation initiation factor 3 subunit B in liver cancer and its prognostic significance.
Expression of exportin-1 in diffuse large B-cell lymphoma: immunohistochemistry and TCGA analyses.
Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas.
Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.
Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.
Expression of Genomic Instability-Related Molecules: Cyclin F, RRM2 and SPDL1 and Their Prognostic Significance in Pancreatic Adenocarcinoma.
Expression of Hippo pathway genes and their clinical significance in colon adenocarcinoma.
Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.
Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer.
Expression of Immune System-Related Membrane Receptors CD40, RANK, BAFFR and LT?R is Associated with Clinical Outcome of Operated Non-Small-Cell Lung Cancer Patients.
Expression of immunoproteasome genes is regulated by cell-intrinsic and -extrinsic factors in human cancers.
Expression of KIF18A Is Associated with Increased Tumor Stage and Cell Proliferation in Prostate Cancer.
Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in Liver Cancer and Their Clinical and Prognostic Significance.
Expression of lactate/H? symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Expression of LDL receptor-related proteins (LRPs) in common solid malignancies correlates with patient survival.
Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer.
Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.
Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinoma.
Expression of long non-coding RNA SFTA1P and its function in non-small cell lung cancer.
Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome.
Expression of MicroRNA-9 is Associated With Overall Survival in Breast Cancer Patients.
Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.
Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence.
Expression of miR-18a-5p, miR-144-3p, and miR-663b in colorectal cancer and their association with cholesterol homeostasis.
Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells.
Expression of miR-486-5p and its signi?cance in lung squamous cell carcinoma.
Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome.
Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas.
Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.
Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells.
Expression of Osteoprotegrin Is Enhanced in Lung Cancer Tissues and Promotes Aggressive Cellular Traits in H3122 Lung Cancer Cells.
Expression of p42.3 in non-small cell lung cancer.
Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer.
Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.
Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes.
Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.
Expression of RSK4 in lung adenocarcinoma tissue and its clinicopathological value: a study based on RNA-seq data and immunohistochemistry.
Expression of serine peptidase inhibitor Kunitz type 1 in differentiated thyroid cancer.
Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.
Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts.
Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Expression of the BAD pathway is a marker of triple-negative status and poor outcome.
Expression of the Body-Weight Signaling Players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer.
Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
Expression of the Circadian Clock Gene BMAL1 Positively Correlates With Antitumor Immunity and Patient Survival in Metastatic Melanoma.
Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis.
Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Expression of the microRNA-143/145 cluster is decreased in hepatitis B virus-associated hepatocellular carcinoma and may serve as a biomarker for tumorigenesis in patients with chronic hepatitis B.
Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.
Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression.
Expression of the Topoisomerase II Alpha (TOP2A) Gene in Lung Adenocarcinoma Cells and the Association with Patient Outcomes.
Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer.
Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma.
Expression of TIPE family members in human colorectal cancer.
Expression of UBE2C in lung adenocarcinoma based on database analysis and its clinical significance.
Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
Expression of WW domain-containing oxidoreductase and its clinical implication in endometrial adenocarcinoma patients with metabolic syndrome.
Expression of yhwaz and gene regulation network in hepatocellular carcinoma.
Expression pattern analysis and drug differential sensitivity of cancer-associated fibroblasts in triple-negative breast cancer.
Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.
Expression pattern and prognostic value of circadian clock genes in pancreatic adenocarcinoma.
Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma.
Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancer.
Expression patterns and a prognostic model of m6A-associated regulators in prostate adenocarcinoma.
Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
Expression patterns and prognostic value of m6A-related genes in colorectal cancer.
Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.
Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.
Expression patterns of immune checkpoints in acute myeloid leukemia.
Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancers.
Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma.
Expression Profile Analysis Identifies a Novel Seven Immune-Related Gene Signature to Improve Prognosis Prediction of Glioblastoma.
Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
Expression profile analysis identifies IER3 to predict overall survival and promote lymph node metastasis in tongue cancer.
Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.
Expression Profile Analysis of m6A RNA Methylation Regulators Indicates They Are Immune Signature Associated and Can Predict Survival in Kidney Renal Cell Carcinoma.
Expression profile analysis of prognostic long non-coding RNA in adult acute myeloid leukemia by weighted gene co-expression network analysis (WGCNA).
Expression Profile and Prognostic Values of HOXA Family Members in Laryngeal Squamous Cell Cancer.
Expression profile of SYNE3 and bioinformatic analysis of its prognostic value and functions in tumors.
Expression profile of Toll?like receptors in human breast cancer.
Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.
Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma.
Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
Expression profiles analysis reveals an integrated miRNA-lncRNA signature to predict survival in ovarian cancer patients with wild-type BRCA1/2.
Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.
Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
Expression profiles and prognostic significance of WNT family members in glioma via bioinformatic analysis.
Expression Profiles of Endometrial Carcinoma by Integrative Analysis of TCGA Data.
Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.
Expression Profiling of Calcium Channels and Calcium-Activated Potassium Channels in Colorectal Cancer.
Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
Expression profiling of gastric adenocarcinoma using cDNA array.
Expression Profiling of Glioblastoma Cell Lines Reveals Novel Extracellular Matrix-Receptor Genes Correlated With the Responsiveness of Glioma Patients to Ionizing Radiation.
Expression profiling of long non-coding RNA identifies linc-RoR as a prognostic biomarker in oral cancer.
Expression Profiling of the MAP Kinase Phosphatase Family Reveals a Role for DUSP1 in the Glioblastoma Stem Cell Niche.
Expression profiling of ubiquitin-related genes in LKB1 mutant lung adenocarcinoma.
Expression QTL-based analyses reveal candidate causal genes and loci across five tumor types.
Expression QTL-based analyses reveal the mechanisms underlying colorectal cancer predisposition.
Expression ratio of the TGF?-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response.
Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.
Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis.
Expression Status and Prognostic Value of m6A RNA Methylation Regulators in Lung Adenocarcinoma.
Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Expression, Clinical Significance, and Functional Prediction of MNX1 in Breast Cancer.
Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein.
Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma.
Expression, methylation and prognostic feature of EMILIN2 in Low-Grade-Glioma.
Expressional Subpopulation of Cancers Determined by G64, a Co-regulated Module.
Expressions of HLA Class II Genes in Cutaneous Melanoma Were Associated with Clinical Outcome: Bioinformatics Approaches and Systematic Analysis of Public Microarray and RNA-Seq Datasets.
ExSurv: A Web Resource for Prognostic Analyses of Exons Across Human Cancers Using Clinical Transcriptomes.
Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer.
Extending information retrieval methods to personalized genomic-based studies of disease.
Extending TCGA queries to automatically identify analogous genomic data from dbGaP.
Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues.
Extensive rewiring of epithelial-stromal co-expression networks in breast cancer.
Extracellular acidity in tumor tissue upregulates programmed cell death protein 1 expression on tumor cells via proton-sensing G protein-coupled receptors.
Extracellular matrix transcriptome dynamics in hepatocellular carcinoma.
Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
Extracellular vesicles from human umbilical cord mesenchymal stem cells treated with siRNA against ELFN1-AS1 suppress colon adenocarcinoma proliferation and migration.
Extracranial meningioma in the parapharyngeal space.
Extracting a biologically relevant latent space from cancer transcriptomes with variational autoencoders.
Extreme down-regulation of chromosome Y and cancer risk in men.
Extreme lateral transcondylar approach for resection of ventrally based meningioma of the craniovertebral junction and upper cervical spine.
Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling.
Eya2, a Target Activated by Plzf, Is Critical for PLZF-RARA-Induced Leukemogenesis.
EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells.
EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
EZH2 is a potential prognostic predictor of glioma.
FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.
Factor analysis for survival time prediction with informative censoring and diverse covariates.
Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking.
FADS1 is a Prognostic Biomarker in Bladder Cancer: A Study Based on TCGA Data.
FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
FAM213A is linked to prognostic significance in acute myeloid leukemia through regulation of oxidative stress and myelopoiesis.
FAM46A expression is elevated in glioblastoma and predicts poor prognosis of patients.
FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of ?-catenin.
FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p).
FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway.
FAM83A Is a Prognosis Signature and Potential Oncogene of Lung Adenocarcinoma.
FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways.
FAM83H-AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma.
FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/?-catenin pathway.
FAM98A associates with DDX1-C14orf166-FAM98B in a novel complex involved in colorectal cancer progression.
Family with Sequence Similarity 83 Member H Promotes the Viability and Metastasis of Cervical Cancer Cells and Indicates a Poor Prognosis.
Family-based exome sequencing combined with linkage analyses identifies rare susceptibility variants of MUC4 for gastric cancer.
FARP1 boosts CDC42 activity from integrin ?v?5 signaling and correlates with poor prognosis of advanced gastric cancer.
FARP1 Facilitates Cell Proliferation Through Modulating MAPK Signaling Pathway in Cutaneous Melanoma.
Fast approximate inference for variable selection in Dirichlet process mixtures, with an application to pan-cancer proteomics.
Fast Bayesian inference in large Gaussian graphical models.
Fastbreak: a tool for analysis and visualization of structural variations in genomic data.
FastDMA: An Infinium HumanMethylation450 Beadchip Analyzer.
FastMM: an efficient toolbox for personalized constraint-based metabolic modeling.
FAT1, a direct transcriptional target of E2F1, suppresses cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
FAT4-USP51 complex regulates the proliferation and invasion of endometrial cancer via Hippo pathway.
Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer.
Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer.
Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma.
Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon ? pathway.
Fatty Acid-Binding Protein 4 (FABP4) Suppresses Proliferation and Migration of Endometrial Cancer Cells via PI3K/Akt Pathway.
Fatty acid-binding protein 5 predicts poor prognosis in patients with uveal melanoma.
Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations.
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells.
FBXO2 Promotes Proliferation of Endometrial Cancer by Ubiquitin-Mediated Degradation of FBN1 in the Regulation of the Cell Cycle and the Autophagy Pathway.
FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
FBXW7 induces apoptosis in glioblastoma cells by regulating HDAC7.
FBXW7? is a tumor-suppressive and prognosis-related FBXW7 transcript isoform in ovarian serous cystadenocarcinoma.
Feasibility of deep learning-based fully automated classification of microsatellite instability in tissue slides of colorectal cancer.
Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).
Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.
Feature selection and survival modeling in The Cancer Genome Atlas.
Feature Selection for Breast Cancer Classification by Integrating Somatic Mutation and Gene Expression.
Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer.
Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma.
Ferroptosis Driver SOCS1 and Suppressor FTH1 Independently Correlate With M1 and M2 Macrophage Infiltration in Head and Neck Squamous Cell Carcinoma.
Ferroptosis Suppressive Genes Correlate with Immunosuppression in Glioblastoma.
Ferroptosis-Related Gene Model to Predict Overall Survival of Ovarian Carcinoma.
Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.
Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma.
Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression.
Ferroptosis-Related Gene-Based Prognostic Model and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis.
Fetal and neonatal hepatic tumors.
Fewer tumour-specific PD-1+CD8+ TILs in high-risk "Infiltrating" HPV- HNSCC.
FEZF1 is an Independent Predictive Factor for Recurrence and Promotes Cell Proliferation and Migration in Cervical Cancer.
FGD1 exhibits oncogenic properties in hepatocellular carcinoma through regulating cell morphology, autophagy and mitochondrial function.
FGF2 as a potential prognostic biomarker for proneural glioma patients.
FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ER? and PRB?4 isoform to MYC regulatory sequences.
FGFR1 is associated with c-MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti-angiogenic therapy.
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response.
FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma.
FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients.
FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan.
FGMD: A novel approach for functional gene module detection in cancer.
FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
FHOD1 is upregulated in gastric cancer and promotes the proliferation and invasion of gastric cancer cells.
FI-Net: Identification of Cancer Driver Genes by Using Functional Impact Prediction Neural Network.
Fiber feature map based landmark initialization for highly deformable DTI registration.
Fibrinogen?like?protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencing.
Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma.
Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.
Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Fibroblast-specific ERK5 deficiency changes tumor vasculature and exacerbates tumor progression in a mouse model.
Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.
Fibulin-5 inhibits Wnt/?-catenin signaling in lung cancer.
Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma.
Fifteen-gene expression based model predicts the survival of clear cell renal cell carcinoma.
Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients.
Filtering High-Dimensional Methylation Marks With Extremely Small Sample Size: An Application to Gastric Cancer Data.
Final Validation of the ProMisE Molecular Classifier for Endometrial Carcinoma in a Large Population-based Case Series.
Financially Effective Test-Algorithm to Identify an Aggressive, EGFR-amplified Variant of IDH-Wildtype, Lower-Grade Diffuse Glioma.
Finding the lost treasures in exome sequencing data.
Findings from the Section on Bioinformatics and Translational Informatics.
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.
Fine-Tuning and training of densenet for histopathology image representation using TCGA diagnostic slides.
Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in BRAFV600E Papillary Thyroid Carcinoma.
FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures.
Five extracellular matrix-associated genes upregulated in oral tongue squamous cell carcinoma: An integrated bioinformatics analysis.
Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer.
Five genes as a novel signature for predicting the prognosis of patients with laryngeal cancer.
Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis.
Five lncRNAs associated with the survival of hepatocellular carcinoma: a comprehensive study based on WGCNA and competing endogenous RNA network.
Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer.
Five miRNAs considered as molecular targets for predicting neuroglioma.
Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing.
Five-CpG-based prognostic signature for predicting survival in hepatocellular carcinoma patients.
Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate Adenocarcinoma.
Five-long non-coding RNA risk score system for the effective prediction of gastric cancer patient survival.
Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
Flat cells come full sphere: Are mutant cytoskeletal-related proteins oncoprotein-monsters or useful immunogens?
FMO1 gene expression independently predicts favorable recurrence-free survival of classical papillary thyroid cancer.
Focal Adhesion Kinase and ?-Catenin Cooperate to Induce Hepatocellular Carcinoma.
Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.
Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network.
Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Foot notes: an atlas of selected neoplasms on the feet (part one).
Foot notes: an atlas of selected neoplasms on the feet (Part Two).
For robust big data analyses: a collection of 150 important pro-metastatic genes.
Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma.
Formin-like 1 (FMNL1) Is Associated with Glioblastoma Multiforme Mesenchymal Subtype and Independently Predicts Poor Prognosis.
Four Immune-Related Genes (FN1, UGCG, CHPF2 and THBS2) as Potential Diagnostic and Prognostic Biomarkers for Carbon Nanotube-Induced Mesothelioma.
Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma.
Four lncRNAs associated with breast cancer prognosis identified by coexpression network analysis.
Four long noncoding RNAs act as biomarkers in lung adenocarcinoma.
Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
Four Low Expression LncRNAs are Associated with Prognosis of Human Lung Adenocarcinoma.
Four Novel Prognostic Genes Related to Prostate Cancer Identified Using Co-expression Structure Network Analysis.
Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer.
Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue.
Four specific biomarkers associated with the progression of glioblastoma multiforme in older adults identified using weighted gene co-expression network analysis.
Four transcription profile-based models identify novel prognostic signatures in oesophageal cancer.
Four-miRNA signature as a prognostic tool for lung adenocarcinoma.
FOXA1, GATA3 and PPAR? Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.
FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ?7-cm clear cell renal cell carcinomas.
FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
FOXD2-AS1 Predicts Dismal Prognosis for Oral Squamous Cell Carcinoma and Regulates Cell Proliferation.
FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
FOXH1 promotes lung cancer progression by activating the Wnt/?-catenin signaling pathway.
FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
FOXL1 overexpression is associated with poor outcome in patients with glioma.
FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma.
FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.
FOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition.
FOXM1 functions collaboratively with PLAU to promote gastric cancer progression.
FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/?-catenin signaling.
FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.
FOXO4 expression is associated with the occurrence and outcome of seizures: An RNA-sequencing analysis of low-grade gliomas.
FOXP3?induced LINC00885 promotes the proliferation and invasion of cervical cancer cells.
FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells.
Fractionation-Dependent Radiosensitization by Molecular Targeting of Nek1.
Frailness and resilience of gene networks predicted by detection of co-occurring mutations via a stochastic perturbative approach.
Framing the potential of public frameshift peptides as immunotherapy targets in colon cancer.
Frequency and prognostic value of mutations associated with the homologous recombination DNA repair pathway in a large pan cancer cohort.
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma.
Frequent copy number gains of SLC2A3 and ETV1 in testicular embryonal carcinomas.
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
Frequent KRAS Mutations in Oncocytic Papillary Renal Neoplasm with Inverted Nuclei.
Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Frequent mutations in the RPL22 gene and its clinical and functional implications.
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes.
Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencing.
Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.
Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer.
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma.
From genome to phenome: Predicting multiple cancer phenotypes based on somatic genomic alterations via the genomic impact transformer.
From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors.
From molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancer.
From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
From TCGA to treatment.
From tobacco smoking to cancer mutational signature: a mediation analysis strategy to explore the role of epigenetic changes.
FSIP1 is correlated with estrogen receptor status and poor prognosis.
FTO mRNA expression in the lower quartile is associated with bad prognosis in clear cell renal cell carcinoma based on TCGA data mining.
FUBP1 mediates the growth and metastasis through TGF?/Smad signaling in pancreatic adenocarcinoma.
Fully Automatic Calibration of Tumor-Growth Models Using a Single mpMRI Scan.
Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma : ATM, ATR and FA in lung carcinoma.
Functional analysis of lncRNAs based on competitive endogenous RNA in tongue squamous cell carcinoma.
Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors.
Functional and genomic analyses reveal therapeutic potential of targeting ?-catenin/CBP activity in head and neck cancer.
Functional Assessment of Four Novel Immune-Related Biomarkers in the Pathogenesis of Clear Cell Renal Cell Carcinoma.
Functional characterization of somatic mutations in cancer using network-based inference of protein activity.
Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41.
Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility.
Functional Effects of let-7g Expression in Colon Cancer Metastasis.
Functional exploration of colorectal cancer genomes using Drosophila.
Functional Genomic Analyses of the 21q22.3 Locus Identifying Functional Variants and Candidate Gene YBEY for Breast Cancer Risk.
Functional Genomics Profiling of Bladder Urothelial Carcinoma MicroRNAome as a Potential Biomarker.
Functional Heterogeneity of Reelin in the Oral Squamous Cell Carcinoma Microenvironment.
Functional implications of PABPC1 in the development of ovarian cancer.
Functional Long Noncoding RNAs (lncRNAs) in Clear Cell Kidney Carcinoma Revealed by Reconstruction and Comprehensive Analysis of the lncRNA-miRNA-mRNA Regulatory Network.
Functional network analysis reveals an immune tolerance mechanism in cancer.
Functional normalization of 450k methylation array data improves replication in large cancer studies.
Functional Signatures in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Sex-Based Differences in Transcriptomic Studies.
Functional Significance of Aurora Kinases-p53 Protein Family Interactions in Cancer.
Functional Variant in 3'UTR of FAM13A Is Potentially Associated with Susceptibility and Survival of Lung Squamous Carcinoma.
Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma.
Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy.
Functions and Clinical Significance of UPF3a Expression in Human Colorectal Cancer.
Functions of endothelin-1 in apoptosis and migration in hepatocellular carcinoma.
FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma.
Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data.
FusionGDB: fusion gene annotation DataBase.
FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.
FUT8-AS1 Inhibits the Malignancy of Melanoma Through Promoting miR-145-5p Biogenesis and Suppressing NRAS/MAPK Signaling.
Future Directions in Glioblastoma Therapy.
FXR silencing in human colon cancer by DNA methylation and KRAS signaling.
FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas.
FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-?1 and NF-?B Pathways.
FYN promotes gastric cancer metastasis by activating STAT3-mediated epithelial-mesenchymal transition.
G-DOC Plus - an integrative bioinformatics platform for precision medicine.
G3BP1 may serve as a potential biomarker of proliferation, apoptosis, and prognosis in oral squamous cell carcinoma.
G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
GAB2 Amplification in Squamous Cell Lung Cancer of Non-Smokers.
GABRD promotes progression and predicts poor prognosis in colorectal cancer.
GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signalling in a GABA-independent manner.
GABRQ expression is a potential prognostic marker for patients with clear cell renal cell carcinoma.
GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer.
GADD45B Facilitates Metastasis of Ovarian Cancer Through Epithelial-Mesenchymal Transition.
GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate Cancer.
Gain of function in somatic TP53 mutations is associated with immune-rich breast tumors and changes in tumor-associated macrophages.
Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer.
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth.
GAL-9: A predictive biomarker negatively regulating immune response in glioma patients.
Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells.
Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis.
Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival.
Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases.
GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer.
Gastric cancer in proximal site exerts poorer survival outcome with divergent genetic features than distal site.
Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.
Gastric Cancer With Primitive Enterocyte Phenotype: An Aggressive Subgroup of Intestinal-type Adenocarcinoma.
Gastric cancer-associated microRNA expression signatures: integrated bioinformatics analysis, validation, and clinical significance.
Gastric cancer: The times they are a-changin'.
Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features.
Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Gastric Normal Adjacent Mucosa Versus Healthy and Cancer Tissues: Distinctive Transcriptomic Profiles and Biological Features.
Gastric-type gene expression and phenotype in non-terminal respiratory unit type adenocarcinoma of the lung with invasive mucinous adenocarcinoma morphology.
Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
Gastrointestinal adenocarcinoma analysis identifies promoter methylation-based cancer subtypes and signatures.
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.
GCNT4 is Associated with Prognosis and Suppress Cell Proliferation in Gastric Cancer.
GDISC: a web portal for integrative analysis of gene-drug interaction for survival in cancer.
GE-mini: a mobile APP for large-scale gene expression visualization.
GEDS: A Gene Expression Display Server for mRNAs, miRNAs and Proteins.
GEJ cancers: gastric or esophageal tumors? searching for the answer according to molecular identity.
GEMINI: a computationally-efficient search engine for large gene expression datasets.
Gender Differential Transcriptome in Gastric and Thyroid Cancers.
Gender Disparity and Mutation Burden in Metastatic Melanoma.
Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer.
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature.
Gene Alterations of N6-Methyladenosine (m6A) Regulators in Colorectal Cancer: A TCGA Database Study.
Gene Amplification-Driven Long Noncoding RNA SNHG17 Regulates Cell Proliferation and Migration in Human Non-Small-Cell Lung Cancer.
Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer.
Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma.
Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
Gene Biomarkers Derived from Clinical Data of Hepatocellular Carcinoma.
Gene Characteristics and Prognostic Values of m6A RNA Methylation Regulators in Nonsmall Cell Lung Cancer.
Gene Co-Expression Analysis of Human RNASEH2A Reveals Functional Networks Associated with DNA Replication, DNA Damage Response, and Cell Cycle Regulation.
Gene Coexpression Analyses Differentiate Networks Associated with Diverse Cancers Harboring TP53 Missense or Null Mutations.
Gene coexpression network analysis revealed biomarkers correlated with blast cells and survival in acute myeloid leukemia.
Gene Copy Number and Post-Transductional Mechanisms Regulate TRAP1 Expression in Human Colorectal Carcinomas.
Gene Expression Along with Genomic Copy Number Variation and Mutational Analysis Were Used to Develop a 9-Gene Signature for Estimating Prognosis of COAD.
Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer.
Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy.
Gene expression analysis of combined RNA-seq experiments using a receiver operating characteristic calibrated procedure.
Gene expression analysis reveals a pitfall in the molecular research of prostate tumors relevant to Gleason score.
Gene expression and immune infiltration in melanoma patients with different mutation burden.
Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells.
Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer.
Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.
Gene Expression Changes and Associated Pathways Involved in the Progression of Prostate Cancer Advanced Stages.
Gene Expression Changes Associated with Dedifferentiation in Liposarcoma Predict Overall Survival.
Gene expression markers of Tumor Infiltrating Leukocytes.
Gene expression network analysis of lymph node involvement in colon cancer identifies AHSA2, CDK10, and CWC22 as possible prognostic markers.
Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features.
Gene expression patterns associated with tumor-infiltrating CD4+ and CD8+ T cells in invasive breast carcinomas.
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer.
Gene Expression Patterns Unveil New Insights in Papillary Thyroid Cancer.
Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
Gene expression profile in BALB/c-3T3 cells transformed with beryllium sulfate.
Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway.
Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma.
Gene Expression Profiles Identified Novel Urine Biomarkers for Diagnosis and Prognosis of High-Grade Bladder Urothelial Carcinoma.
Gene expression profiles in chondrosarcoma cells subjected to cyclic stretching and hydrostatic pressure. A cDNA array study.
Gene expression profiles of hepatoma cell line BEL-7402.
Gene expression profiles of hepatoma cell line HLE.
Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method.
Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters.
Gene expression profiles of pancreatic cancer and stromal desmoplasia.
Gene expression profiling combined with functional analysis identify integrin beta1 (ITGB1) as a potential prognosis biomarker in triple negative breast cancer.
Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
Gene expression profiling in women with breast cancer in a Saudi population.
Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort.
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia.
Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?
Gene Expression Subtype Predicts Nodal Metastasis and Survival in Human Papillomavirus-Negative Head and Neck Cancer.
Gene Instability-Related lncRNA Prognostic Model of Melanoma Patients via Machine Learning Strategy.
Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
Gene mutation patterns of Chinese acute myeloid leukemia patients by targeted next-generation sequencing and bioinformatic analysis.
Gene network analysis using SWIM reveals interplay between the transcription factor-encoding genes HMGA1, FOXM1, and MYBL2 in triple-negative breast cancer.
Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma.
Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer.
Gene Panel of Persister Cells as a Prognostic Indicator for Tumor Repopulation After Radiation.
Gene profiling of HepG2 cells following nitidine chloride treatment: An investigation with microarray and Connectivity Mapping.
Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Gene regulation and prognostic indicators of lung squamous cell carcinoma: TCGA-derived miRNA/mRNA sequencing and DNA methylation data.
Gene Regulatory Network Analysis for Triple-Negative Breast Neoplasms by Using Gene Expression Data.
Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism.
Gene regulatory network analysis with drug sensitivity reveals synergistic effects of combinatory chemotherapy in gastric cancer.
Gene set enrichment analysis and meta-analysis identified 12 key genes regulating and controlling the prognosis of lung adenocarcinoma.
Gene set enrichment analysis and meta-analysis to identify six key genes regulating and controlling the prognosis of esophageal squamous cell carcinoma.
Gene Signature and Identification of Clinical Trait-Related m6 A Regulators in Pancreatic Cancer.
Gene Signature Associated With Bromodomain Genes Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma.
Gene signature associated with neuro-endocrine activity predicting prognosis of pancreatic carcinoma.
Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer.
Gene signature for prediction of radiosensitivity in human papillomavirus-negative head and neck squamous cell carcinoma.
Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes.
Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype.
Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma.
Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer.
Gene signatures based on therapy responsiveness provide guidance for combined radiotherapy and chemotherapy for lower grade glioma.
Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database.
Gene signatures of m5C regulators may predict prognoses of patients with head and neck squamous cell carcinoma.
Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
Gene-based comparative analysis of tools for estimating copy number alterations using whole-exome sequencing data.
Gene-expression signature predicts survival benefit from postoperative chemoradiotherapy in head and neck squamous cell carcinoma.
Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Gene-Gene Interaction Analysis for the Survival Phenotype Based on the Kaplan-Meier Median Estimate.
Gene-gene interaction network analysis of hepatocellular carcinoma using bioinformatic software.
Gene-gene interaction network analysis of ovarian cancer using TCGA data.
Gene-Microbiome Co-expression Networks in Colon Cancer.
GeneGazer: A Toolkit Integrating Two Pipelines for Personalized Profiling and Biosignature Identification.
Generating a focused view of disease ontology cancer terms for pan-cancer data integration and analysis.
Generation and validation of affinity reagents on a proteome-wide level.
Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis.
Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer.
Genes Involved in the PD-L1 Pathway Might Associate with Radiosensitivity of Patients with Gastric Cancer.
Genes Located on 18q23 Are Epigenetic Markers and Have Prognostic Significance for Patients with Head and Neck Cancer.
Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers.
Genetic alteration and clinical significance of SUMOylation regulators in multiple cancer types.
Genetic alteration in notch pathway is associated with better prognosis in renal cell carcinoma.
Genetic alteration in phosphofructokinase family promotes growth of muscle-invasive bladder cancer.
Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data mining.
Genetic alterations and PIK3CA gene mutations and amplifications analysis in cervical cancer by racial groups in the United States.
Genetic Alterations and Transcriptional Expression of m6A RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma.
Genetic alterations associated with 18F-fluorodeoxyglucose positron emission tomography/computed tomography in head and neck squamous cell carcinoma.
Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.
Genetic Alterations of TRAF Proteins in Human Cancers.
Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas.
Genetic Analysis of Functional Rare Germline Variants across Nine Cancer Types from an Electronic Health Record Linked Biobank.
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.
Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D.
Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.
Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs).
Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas.
Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy.
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma.
Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer.
Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies.
Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model.
Genetic and microenvironmental differences in non-smoking lung adenocarcinoma patients compared with smoking patients.
Genetic and molecular analyses reveal G6PC as a key element connecting glucose metabolism and cell cycle control in ovarian cancer.
Genetic and transcriptomic analyses in a rare case of HPV-related oropharyngeal squamous cell carcinoma combined with small cell carcinoma.
Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort.
Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer.
Genetic characterization of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.
Genetic comprehension of organophosphate flame retardants, an emerging threat to prostate cancer.
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells.
Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors.
Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment.
Genetic mechanisms of immune evasion in colorectal cancer.
Genetic network and gene set enrichment analyses identify MND1 as potential diagnostic and therapeutic target gene for lung adenocarcinoma.
Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ?10 ng/ml at initial biopsy.
Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
Genetic profile and biological implication of PIN2/TRF1-interacting telomerase inhibitor 1 (PinX1) in human cancers: an analysis using The Cancer Genome Atlas.
Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer.
Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas.
Genetic Profiling of Breast Cancer with and Without Preexisting Metabolic Disease.
Genetic risk score for ovarian cancer based on chromosomal-scale length variation.
Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy.
Genetic variants in chromatin-remodeling pathway associated with lung cancer risk in a Chinese population.
Genetic variants in ERBB4 is associated with chronic hepatitis B virus infection.
Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk.
Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer.
Genetic variants in the Folic acid Metabolic Pathway Genes predict outcomes of metastatic Colorectal Cancer patients receiving first-line Chemotherapy.
Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma.
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.
Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.
Genetic variations in Hippo pathway genes influence bladder cancer risk in a Chinese population.
Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma.
Genetics and biology of prostate cancer.
Genetics and imaging of pheochromocytomas and paragangliomas: current update.
Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.
Genetics: New molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas.
Genetics: new molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas.
Genetics: The Cancer Genome Atlas maps papillary thyroid cancer.
GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems.
Genome and transcriptome profiling of FBXW family in human prostate cancer.
Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.
Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer.
Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.
Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia.
Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development.
Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas.
Genome-wide age-related DNA methylation changes in blood and other tissues relate to histone modification, expression and cancer.
Genome-wide analyses of long noncoding RNA expression profiles in lung adenocarcinoma.
Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort.
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.
Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.
Genome-wide analysis of DNA methylation in bronchial washings.
Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.
Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer.
Genome-wide analysis of lncRNAs, miRNAs, and mRNAs forming a prognostic scoring system in esophageal squamous cell carcinoma.
Genome-Wide Analysis of Lung Adenocarcinoma Identifies Novel Prognostic Factors and a Prognostic Score.
Genome-Wide Analysis of Methylation-Driven Genes and Identification of an Eight-Gene Panel for Prognosis Prediction in Breast Cancer.
Genome-wide analysis of noncoding regulatory mutations in cancer.
Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Genome-wide analysis reveals the association between alternative splicing and DNA methylation across human solid tumors.
Genome-wide analysis to identify a novel distant metastasis-related gene signature predicting survival in patients with gastric cancer.
Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.
Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors.
Genome-wide association analysis reveals regulation of at-risk loci by DNA methylation in prostate cancer.
Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens.
Genome-wide cDNA microarray screening to correlate gene expression profile with survival in patients with advanced lung cancer.
Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-?.
Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes.
Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis.
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.
Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA.
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.
Genome-Wide DNA Methylation Profiling of Esophageal Squamous Cell Carcinoma from Global High-Incidence Regions Identifies Crucial Genes and Potential Cancer Markers.
Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer.
Genome-wide identification of a competing endogenous RNA network in cholangiocarcinoma.
Genome-Wide Identification of a Novel Autophagy-Related Signature for Colorectal Cancer.
Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
Genome-Wide Identification of Autophagy Prognostic Signature in Pancreatic Cancer.
Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer.
Genome-wide investigation of the clinical significance and prospective molecular mechanism of minichromosome maintenance protein family genes in patients with Lung Adenocarcinoma.
GENOME-WIDE METHYLATION ANALYSIS IDENTIFIES GENES SPECIFIC TO BREAST CANCER HORMONE RECEPTOR STATUS AND RISK OF RECURRENCE.
Genome-wide methylation and expression profiling identify a novel epigenetic signature in gastrointestinal pan-adenocarcinomas.
Genome-wide methylation and expression profiling identify methylation-associated genes in colorectal cancer.
Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.
Genome-wide microRNA analysis identifies miR-188-3p as novel prognostic marker and molecular factor involved in colorectal carcinogenesis.
Genome-wide miRNA methylome analysis in oral cancer: possible biomarkers associated with patient survival.
Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer.
Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma.
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.
Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma.
Genome-wide profiling of prognosis-related alternative splicing signatures in sarcoma.
Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer.
Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer.
Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early stage Pancreatic Ductal Adenocarcinoma.
Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
Genome-wide screening for the G-protein-coupled receptor (GPCR) pathway-related therapeutic gene RGS19 (regulator of G protein signaling 19) in bladder cancer.
Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance.
Genome?scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Genome?wide investigation of the clinical implications and molecular mechanism of long noncoding RNA LINC00668 and protein?coding genes in hepatocellular carcinoma.
Genomewide cDNA microarray screening of genes related to benefits and toxicities of platinum-based chemotherapy in patients with advanced lung cancer.
Genomic aberrations in young and elderly  breast cancer patients.
Genomic alterations and abnormal expression of APE2 in multiple cancers.
Genomic Alterations and Targeted Therapy in Gastric and Esophageal Adenocarcinoma.
Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing.
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence.
Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.
Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma.
Genomic alterations in lung adenocarcinoma.
Genomic alterations in mucins across cancers.
Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.
Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis.
Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature.
Genomic analysis and clinical implications of immune cell infiltration in gastric cancer.
Genomic analysis and selective small molecule inhibition identifies BCL-X(L) as a critical survival factor in a subset of colorectal cancer.
Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia.
Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM.
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types.
Genomic analysis of pancreatic cancer reveals 3 molecular subtypes with different clinical outcomes.
Genomic Analysis of the BMP Family in Glioblastomas.
Genomic analysis of the prognostic effect of tumor-associated neutrophil-related genes across 15 solid cancer types: an immune perspective.
Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.
Genomic Analysis of Tumor Microenvironment Immune Types across 14 Solid Cancer Types: Immunotherapeutic Implications.
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.
Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Genomic and Functional Approaches to Understanding Cancer Aneuploidy.
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival.
Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer.
Genomic and immunologic correlates of LAG-3 expression in cancer.
Genomic and immunological features of microsatellite instability in colon cancer.
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer.
Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma.
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background.
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies.
Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma.
Genomic basis for RNA alterations in cancer.
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer.
Genomic Characterization of Differentiated Thyroid Carcinoma.
Genomic characterization of five commonly used endometrial cancer cell lines.
Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment.
Genomic characterization of metastatic breast cancers.
Genomic Characterization of Non-Invasive Differentiated-Type Gastric Cancer in the Japanese Population.
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs.
Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type.
Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study.
Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.
Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.
Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors.
Genomic determinants of somatic copy number alterations across human cancers.
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.
Genomic Estimates of Aneuploid Content in Glioblastoma Multiforme and Improved Classification.
Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis.
Genomic Identification of RNA Editing Through Integrating Omics Datasets and the Clinical Relevance in Hepatocellular Carcinoma.
Genomic insights into head and neck cancer.
Genomic Instability Promoted by Overexpression of Mismatch Repair Factors in Yeast: A Model for Understanding Cancer Progression.
Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer.
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma.
Genomic landscape and mutational impacts of recurrently mutated genes in cancers.
Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma.
Genomic landscape of metastatic colorectal cancer.
Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?
Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer.
Genomic landscape of squamous cell carcinoma of the lung.
Genomic Mapping and Survival Prediction in Glioblastoma: Molecular Subclassification Strengthened by Hemodynamic Imaging Biomarkers.
Genomic pattern of intratumor heterogeneity predicts the risk of progression in early stage diffuse large B-cell lymphoma.
Genomic Positional Dissection of RNA Editomes in Tumor and Normal Samples.
Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions?
Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.
Genomic profiling of lower-grade gliomas uncovers cohesive disease groups: implications for diagnosis and treatment.
Genomic profiling of microRNA target genes in colorectal cancer.
Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective.
Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer.
Genomic regression analysis of coordinated expression.
Genomic Signature of Mismatch Repair Deficiency in Areca Nut-Related Oral Cancer.
Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses.
Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer.
Genomic stability at the coding regions of the multidrug transporter gene ABCB1: insights into the development of alternative drug resistance mechanisms in human leukemia cells.
Genomic stratification based on microenvironment immune types and PD-L1 for tailoring therapeutic strategies in bladder cancer.
Genomic stratification based on radiosensitivity and PD-L1 for tailoring therapeutic strategies in cervical cancer.
Genomic variations in the counterpart normal controls of lung squamous cell carcinomas.
Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer.
Genomic, transcriptomic, epigenetic, and immune profiling of mucinous breast cancer.
Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer.
Genomics and advances towards precision medicine for head and neck squamous cell carcinoma.
Genomics and clinical correlates of renal cell carcinoma.
Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
Genomics Education for the Public: Perspectives of Genomic Researchers and ELSI Advisors.
Genomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studies.
Genomics of squamous cell lung cancer.
Genomics Score Based on Genome-Wide Network Analysis for Prediction of Survival in Gastric Cancer: A Novel Prognostic Signature.
Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective.
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
Geographic pathology revisited: development of an atlas of cancer in India.
Geographic variation in prostate cancer mortality rates among white males in the united states.
Geographical clusters and common patterns in cancer mortality of the Federal Republic of Germany.
Geographical patterns of cancer mortality in Spain.
Geospatial disparities and the underlying causes of major cancers for women in Taiwan.
Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme.
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
Germline Alterations in RASAL1 in Cowden Syndrome Patients Presenting with Follicular Thyroid Cancer and in Individuals with Apparently Sporadic Epithelial Thyroid Cancer.
Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants.
Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest.
Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer.
Germline cytoskeletal and extra-cellular matrix-related single nucleotide variations associated with distinct cancer survival rates.
Germline Genetic Association between Stromal Interaction Molecule 1 (STIM1) and Clinical Outcomes in Breast Cancer Patients.
Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer.
Germline mutations in DNA repair genes in lung adenocarcinoma.
Germline mutations in PPFIBP2 are associated with lethal prostate cancer.
Germline PARP4 mutations in patients with primary thyroid and breast cancers.
Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene.
Gestational arsenite exposure augments hepatic tumors of C3H mice by promoting senescence in F1 and F2 offspring via different pathways.
Gestational high-fat diet and bisphenol A exposure heightens mammary cancer risk.
GeTallele: A Method for Analysis of DNA and RNA Allele Frequency Distributions.
Ghrelin and cancer progression.
Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond.
Giant cell tumor of the posterior arch of the atlas.
Gigantic neurofibromatosis of the orbit.
GJA1 Expression and Its Prognostic Value in Cervical Cancer.
GLAD: a mixed-membership model for heterogeneous tumor subtype classification.
Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study.
Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
GLI3 repressor determines Hedgehog pathway activation and is required for response to SMO antagonist glasdegib in AML.
Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations.
Glioblastoma cell secretome: Analysis of three glioblastoma cell lines reveal 148 non-redundant proteins.
Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated ?? T lymphocytes.
Glioblastoma Distance From the Subventricular Neural Stem Cell Niche Does Not Correlate With Survival.
Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Glioblastoma genetics: in rapid flux.
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?
Glioblastoma stem-like cells give rise to tumour endothelium.
Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.
Glioblastoma: Biology, Genetics, and Behavior.
Glioblastoma: Imaging Genomic Mapping Reveals Sex-specific Oncogenic Associations of Cell Death.
Glioblastoma: molecular pathways, stem cells and therapeutic targets.
Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase.
Glioma Grading Using Cell Nuclei Morphologic Features in Digital Pathology Images.
Glioma grading using structural magnetic resonance imaging and molecular data.
Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor.
Glioma stem cell (GSC)-derived autoschizis-like products confer GSC niche properties involving M1-like tumor-associated macrophages.
Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling.
Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium.
Glioma-Associated Stromal Cells Stimulate Glioma Malignancy by Regulating the Tumor Immune Microenvironment.
GliomaDB: A Web Server for Integrating Glioma Omics Data and Interactive Analysis.
Gliomas display distinct sex-based differential methylation patterns based on molecular subtype.
Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature.
GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on co?expression network analysis.
GLISTR: Glioma Image Segmentation and Registration.
Global Alternative Splicing Defects in Human Breast Cancer Cells.
Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma.
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Global analysis of tRNA and translation factor expression reveals a dynamic landscape of translational regulation in human cancers.
Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to Both Tumorigenesis and Recurrence.
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes.
Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Global identification and characterization of tRNA-derived RNA fragment landscapes across human cancers.
Global mapping of cancers: The Cancer Genome Atlas and beyond.
Global transcriptional downregulation of TREX and nuclear trafficking machinery as pan-senescence phenomena: evidence from human cells and tissues.
Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma.
Global transcriptomic analysis identifies SERPINE1 as a prognostic biomarker associated with epithelial-to-mesenchymal transition in gastric cancer.
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer.
Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer.
Glucose-regulated protein 94 deficiency induces squamous cell metaplasia and suppresses PTEN-null driven endometrial epithelial tumor development.
Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization.
Glutamine synthetase promotes tumor invasion in hepatocellular carcinoma through mediating epithelial-mesenchymal transition.
Glutamine-fructose-6-phosphate transaminase 2 (GFPT2) promotes the EMT of serous ovarian cancer by activating the hexosamine biosynthetic pathway to increase the nuclear location of ?-catenin.
Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data.
Glycerophospholipids pathways and chromosomal instability in gastric cancer: Global lipidomics analysis.
Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/?-catenin signaling and is regulated by miR-133a-3p.
Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures.
Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine.
Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment.
Glycolysis-Based Genes Associated with the Clinical Outcome of Pancreatic Ductal Adenocarcinoma Identified by The Cancer Genome Atlas Data Analysis.
Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma.
Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
Glycolytic expression in lower-grade glioma reveals an epigenetic association between IDH mutation status and PDL1/2 expression.
Glycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes.
Glycyrrhizic Acid-Induced Differentiation Repressed Stemness in Hepatocellular Carcinoma by Targeting c-Jun N-Terminal Kinase 1.
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction.
GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling.
GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors.
GPR12 inhibits migration and promotes apoptosis in esophageal cancer and hypopharyngeal cancer cells.
GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.
GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival.
GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60.
GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
GRNdb: decoding the gene regulatory networks in diverse human and mouse conditions.
Group Lasso Regularized Deep Learning for Cancer Prognosis from Multi-Omics and Clinical Features.
Growth Differentiation Factor 15 is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for Invasiveness.
Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells.
GRWD1 directly interacts with p53 and negatively regulates p53 transcriptional activity.
GSDMD is required for effector CD8+ T cell responses to lung cancer cells.
GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival.
GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGF?R2 in colorectal cancer.
GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
Guidelines for Clinical Target Volume Definition for Perineural Spread of Major Salivary Gland Cancers.
Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region.
GWAS meets TCGA to illuminate mechanisms of cancer predisposition.
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-?-Catenin Signaling in Colorectal Cancer.
H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia.
H19, a Long Non-coding RNA, Mediates Transcription Factors and Target Genes through Interference of MicroRNAs in Pan-Cancer.
Hallmark microRNA signature in liquid biopsy identifies hepatocellular carcinoma and differentiates it from liver metastasis.
HAMP Downregulation Contributes to Aggressive Hepatocellular Carcinoma via Mechanism Mediated by Cyclin4-Dependent Kinase-1/STAT3 Pathway.
HAND2-AS1: A functional cancer-related long non-coding RNA.
HAO2 inhibits malignancy of clear cell renal cell carcinoma by promoting lipid catabolic process.
Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma.
Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies.
Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer.
HARVESTMAN: a framework for hierarchical feature learning and selection from whole genome sequencing data.
HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome.
HAVCR1 expression might be a novel prognostic factor for gastric cancer.
HAX1 enhances the survival and metastasis of non-small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway.
HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas.
HCG18 Participates in Vascular Invasion of Hepatocellular Carcinoma by Regulating Macrophages and Tumor Stem Cells.
HDAC is indispensable for IFN-?-induced B7-H1 expression in gastric cancer.
HDAC10 as a potential therapeutic target in ovarian cancer.
HDAC6-dependent ciliophagy is involved in ciliary loss and cholangiocarcinoma growth in human cells and murine models.
HDAC9 Is Preferentially Expressed in Dedifferentiated Hepatocellular Carcinoma Cells and Is Involved in an Anchorage-Independent Growth.
HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma.
Head and neck cancer: global burden and regional trends in India.
Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-?B Pathways.
Head and Neck Paragangliomas-A Genetic Overview.
Head and neck squamous cancer progression is marked by CLIC4 attenuation in tumor epithelium and reciprocal stromal upregulation of miR-142-3p, a novel post-transcriptional regulator of CLIC4.
Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling via PHLPP1 in colorectal cancer.
Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Heat shock proteins create a signature to predict the clinical outcome in breast cancer.
HEATR1 promotes proliferation in gastric cancer in vitro and in vivo.
Hedgehog Interacting Protein 1 is a Prognostic Marker and Suppresses Cell Metastasis in Gastric Cancer.
HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas.
HeLa nucleic acid contamination in The Cancer Genome Atlas leads to the misidentification of HPV18.
Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer.
Hematopoietic Gene Expression Regulation Through m6A Methylation Predicts Prognosis in Stage III Colorectal Cancer.
Hematopoietic-substrate-1 associated protein X-1 (HAX-1) regulates liver cancer cells growth, metastasis, and angiogenesis through Akt.
Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas.
Hepatitis B virus-X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma.
Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles.
Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
Hepatocyte nuclear factor 1? suppresses steatosis-associated liver cancer by inhibiting PPAR? transcription.
Hepcidin Downregulation Correlates With Disease Aggressiveness And Immune Infiltration in Liver Cancers.
HER2 activating mutations are targets for colorectal cancer treatment.
HER2 and APC Mutations Promote Altered Crypt-Villus Morphology and Marked Hyperplasia in the Intestinal Epithelium.
HER2-Low Breast Cancer: Molecular Characteristics and Prognosis.
HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor.
HER3 expression and MEK activation in non-small-cell lung carcinoma.
HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
Hereditary multiple exostoses and cervical ventral protuberance causing dysphagia. A case report.
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
HEROD: a human ethnic and regional specific omics database.
Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts.
Heterogeneity of genomic profile in patients with HER2-positive breast cancer.
Heterogeneity of MSI-H gastric cancer identifies a subtype with worse survival.
Heterogeneity of PTEN and PPAR-? in cancer and their prognostic application to bladder cancer.
Heterogeneity of tumor-infiltrating lymphocytes ascribed to local immune status rather than neoantigens by multi-omics analysis of glioblastoma multiforme.
Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
Heterozygous IDH1R132H/WT created by "single base editing" inhibits human astroglial cell growth by downregulating YAP.
Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte/macrophage infiltration into the clear cell renal cell carcinoma microenvironment.
Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.
HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing data.
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma.
Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling.
Hierarchical HotNet: identifying hierarchies of altered subnetworks.
Hierarchical Normalized Completely Random Measures for Robust Graphical Modeling.
Hierarchical nucleus segmentation in digital pathology images.
HIF1? is not a target of 14q deletion in clear cell renal cancer.
HIF1A expression correlates with increased tumor immune and stromal signatures and aggressive phenotypes in human cancers.
HIF3A DNA methylation, obesity and weight gain, and breast cancer risk among Mexican American women.
High Abundance of Intratumoral ?? T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
High ADAMTS18 expression is associated with poor prognosis in stomach adenocarcinoma.
High ANKZF1 expression is associated with poor overall survival and recurrence-free survival in colon cancer.
High APOBEC1 Complementation Factor Expression Positively Modulates the Proliferation, Invasion, and Migration of Endometrial Cancer Cells Through Regulating P53/P21 Signaling Pathway.
High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer.
High BLM Expression Predicts Poor Clinical Outcome and Contributes to Malignant Progression in Human Cholangiocarcinoma.
High BMI1 Expression with Low CD8+ and CD4+ T Cell Activity Could Promote Breast Cancer Cell Survival: A Machine Learning Approach.
High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
High CD3D/CD4 ratio predicts better survival in muscle-invasive bladder cancer.
High CXCR2 expression predicts poor prognosis in adult patients with acute myeloid leukemia.
High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
High EGFL7 expression may predict poor prognosis in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.
High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
High ELF4 expression in human cancers is associated with worse disease outcomes and increased resistance to anticancer drugs.
High EMP3 expression might independently predict poor overall survival in glioblastoma and its expression is related to DNA methylation.
High Expression and Clinical Significance of Elafin in Colorectal Cancer.
High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma.
High Expression Levels of ACTN1 and ACTN3 Indicate Unfavorable Prognosis in Acute Myeloid Leukemia.
High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis.
High expression levels of centromere protein A plus upregulation of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway affect chemotherapy response and prognosis in patients with breast cancer.
High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets.
High Expression of ABRACL Is Associated with Tumorigenesis and Affects Clinical Outcome in Gastric Cancer.
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.
High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
High expression of AK1 predicts inferior prognosis in acute myeloid leukemia patients undergoing chemotherapy.
High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
High expression of Annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma.
High Expression of ANXA2 Pseudogene ANXA2P2 Promotes an Aggressive Phenotype in Hepatocellular Carcinoma.
High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition.
High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor?positive breast cancer.
High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia.
High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity.
High expression of citron kinase predicts poor prognosis of prostate cancer.
High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia.
High expression of COL5A2, a member of COL5 family, indicates the poor survival and facilitates cell migration in gastric cancer.
High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma.
High expression of DLC family proteins predicts better prognosis and inhibits tumor progression in NSCLC.
High expression of DLG3 is associated with decreased survival from breast cancer.
High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients.
High expression of DOCK2 indicates good prognosis in acute myeloid leukemia.
High expression of EMP1 predicts a poor prognosis and correlates with immune infiltrates in bladder urothelial carcinoma.
High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes.
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers.
High expression of fibronectin 1 indicates poor prognosis in gastric cancer.
High expression of FLT3 is a risk factor in leukemia.
High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma.
High Expression of FOXP2 Is Associated with Worse Prognosis in Glioblastoma.
High expression of GALNT7 promotes invasion and proliferation of glioma cells.
High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients.
High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer.
High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma.
High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma.
High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma.
High expression of IQGAP3 indicates poor prognosis in colorectal cancer patients.
High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.
High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma.
High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis.
High Expression of Long Noncoding RNA 01410 Serves as a Potential Diagnostic and Prognostic Marker in Patients with Colorectal Cancer.
High expression of matrix metalloproteinases 16 is associated with the aggressive malignant behavior and poor survival outcome in colorectal carcinoma.
High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer.
High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer.
High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation.
High expression of miR-195 is related to favorable prognosis in cytogenetically normal acute myeloid leukemia.
High Expression of miR-206 Predicts Adverse Outcomes: A Potential Therapeutic Target for Esophageal Cancer.
High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.
High expression of miR-532-5p, a tumor suppressor, leads to better prognosis in ovarian cancer both in vivo and in vitro.
High expression of MiR-98 is a good prognostic factor in acute myeloid leukemia patients treated with chemotherapy alone.
High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients.
High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer.
High expression of MUC20 drives tumorigenesis and predicts poor survival in endometrial cancer.
High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.
High expression of NME1 correlates with progression and poor prognosis in patients of hepatocellular carcinoma.
High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer.
High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma.
High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations.
High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma.
High expression of PKM2 synergizes with PD-L1 in tumor cells and immune cells to predict worse survival in human lung adenocarcinoma.
High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
High Expression of PLOD1 Drives Tumorigenesis and Affects Clinical Outcome in Gastrointestinal Carcinoma.
High expression of PYCARD is an independent predictor of unfavorable prognosis and chemotherapy resistance in glioma.
High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
High expression of SIX1 is an independent predictor of poor prognosis in endometrial cancer.
High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy.
High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.
High expression of spermatogenesis associated serine rich 2 promotes tumorigenicity in esophageal squamous cell carcinoma cells and is associated with poor patient prognosis.
High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment.
High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
High Expression of the Long Noncoding RNA SNHG15 in Cancer Tissue Samples Predicts an Unfavorable Prognosis of Cancer Patients: A Meta-Analysis.
High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer.
High expression of TIG3 predicts poor survival in patients with primary glioblastoma.
High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis.
High expression of TRIM36 is associated with radiosensitivity in gastric cancer.
High Expression of UBB, RAC1, and ITGB1 Predicts Worse Prognosis among Nonsmoking Patients with Lung Adenocarcinoma through Bioinformatics Analysis.
High expression of USP18 is associated with the growth of colorectal carcinoma.
High expression of WDR1 in primary glioblastoma is associated with poor prognosis.
High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.
High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme.
High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas.
High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC.
High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma.
High GJB2 mRNA expression and its prognostic significance in lung adenocarcinoma: a study based on the TCGA database.
High IER5 Gene Expression Is Associated With Poor Prognosis in Glioma Patients.
High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia.
High integrin ?3 expression is associated with poor prognosis in patients with non-small cell lung cancer.
High KCNQ1OT1 expression might independently predict shorter survival of colon adenocarcinoma.
High KDM1A Expression Associated with Decreased CD8+T Cells Reduces the Breast Cancer Survival Rate in Patients with Breast Cancer.
High KIF11 expression is associated with poor outcome of NSCLC.
High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells.
High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome.
High Level of Legumain Was Correlated With Worse Prognosis and Peritoneal Metastasis in Gastric Cancer Patients.
High Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma.
High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer.
High levels of WNT-5A in human glioma correlate with increased presence of tumor-associated microglia/monocytes.
High MAST2 mRNA expression and its role in diagnosis and prognosis of liver cancer.
High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
High Membranous Expression of Fatty Acid Transport Protein 4 Is Associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma.
High metallothionein predicts poor survival in glioblastoma multiforme.
High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma.
High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.
High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma.
High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.
High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.
High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer.
High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer.
High polymerase ? expression associated with increased CD8+T cells improves survival in patients with non-small cell lung cancer.
High preoperative levels of circulating SFRP5 predict better prognosis in colorectal cancer patients.
High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer.
High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer.
High risk human papilloma viruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer.
High S100A9+ cell density predicts a poor prognosis in hepatocellular carcinoma patients after curative resection.
High SEC61G expression predicts poor prognosis in patients with Head and Neck Squamous Cell Carcinomas.
High selectivity of PI3K? inhibitors in SETD2-mutated renal clear cell carcinoma.
High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma.
High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer.
High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer.
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy.
High SPINK1 Expression Predicts Poor Prognosis and Promotes Cell Proliferation and Metastasis of Hepatocellular Carcinoma.
High SQLE Expression and Gene Amplification Correlates with Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
High Squalene Epoxidase in Tumors Predicts Worse Survival in Patients With Hepatocellular Carcinoma: Integrated Bioinformatic Analysis on NAFLD and HCC.
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.
High TGF-?1 expression predicts poor disease prognosis in hepatocellular carcinoma patients.
High TRAF3IP3 Level Predicts Poor Prognosis of Patients with Gliomas.
High TRIAP1 expression in penile carcinoma is associated with high risk of recurrence and poor survival.
High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities.
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.
High ubiquitin conjugating enzyme E2 T mRNA expression and its prognostic significance in lung adenocarcinoma: A study based on the TCGA database.
High VHL Expression Reverses Warburg Phenotype and Enhances Immunogenicity in Kidney Tumor Cells.
High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database.
High-affinity peptide ligand LXY30 for targeting ?3?1 integrin in non-small cell lung cancer.
High-confidence coding and noncoding transcriptome maps.
High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing.
High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification.
High-dimensional covariance matrices tests for analyzing multi-tumor gene expression data.
High-dimensional genomic data bias correction and data integration using MANCIE.
High-Grade Endometrial Carcinomas: Classification with Molecular Insights.
High-grade gliomas located in the right hemisphere are associated with worse quality of life.
High-Performance Computational Analysis of Glioblastoma Pathology Images with Database Support Identifies Molecular and Survival Correlates.
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.
High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment.
High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection.
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis.
High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets.
High-throughput Single-cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma.
Higher cytolytic score correlates with an immunosuppressive tumor microenvironment and reduced survival in glioblastoma.
Higher ETV5 Expression Associates With Poor 5-Florouracil-Based Adjuvant Therapy Response in Colon Cancer.
Higher expression of cation transport regulator-like protein 1 (CHAC1) predicts of poor outcomes in uveal melanoma (UM) patients.
Higher expression of cell division cycle-associated protein 5 predicts poorer survival outcomes in hepatocellular carcinoma.
Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.
Higher variety and quantity of microRNA-139-5p isoforms confer suppressive role in hepatocellular carcinoma.
Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.
Highly accurate diagnosis of papillary thyroid carcinomas based on personalized pathways coupled with machine learning.
Highly connected, non-redundant microRNA functional control in breast cancer molecular subtypes.
Highly Expressed CYBRD1 Associated with Glioma Recurrence Regulates the Immune Response of Glioma Cells to Interferon.
Highly parallel identification of essential genes in cancer cells.
Highly robust model of transcription regulator activity predicts breast cancer overall survival.
HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer.
Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature.
Hippo Pathway Core Genes Based Prognostic Signature and Immune Infiltration Patterns in Lung Squamous Cell Carcinoma.
Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants.
Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme.
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro.
Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.
Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer.
Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer.
Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122.
Histone Methyltransferases Useful in Gastric Cancer Research.
Histone modifications affect differential regulation of TGF?- induced NADPH oxidase 4 (NOX4) by wild-type and mutant p53.
Histone-Related Genes Are Hypermethylated in Lung Cancer and Hypermethylated HIST1H4F Could Serve as a Pan-Cancer Biomarker.
Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer.
Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma.
Histopathological Image Classification Using Discriminative Feature-Oriented Dictionary Learning.
Histopathological imaging-based cancer heterogeneity analysis via penalized fusion with model averaging.
Histopathological Imaging?Environment Interactions in Cancer Modeling.
Histopathological typing in diffuse malignant epithelioid mesothelioma: implication for prognosis and molecular basis.
Histopathology classification and localization of colorectal cancer using global labels by weakly supervised deep learning.
Histopathology of transgenic mouse mammary tumors (a short atlas).
HistoQC: An Open-Source Quality Control Tool for Digital Pathology Slides.
HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
HK3 is correlated with immune infiltrates and predicts response to immunotherapy in non-small cell lung cancer.
HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer.
HLA class I binding of mutant EGFR peptides in NSCLC is associated with improved survival.
HLA class I restricted epitopes prediction of common tumor antigens in white and East Asian populations: Implication on antigen selection for cancer vaccine design.
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer.
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas.
HMGA2 and high-grade serous ovarian carcinoma.
HMGCS2 in metabolic pathways was associated with overall survival in hepatocellular carcinoma: A LASSO-derived study.
HN1 as a diagnostic and prognostic biomarker for liver cancer.
HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.
HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression.
HNRNPD interacts with ZHX2 regulating the vasculogenic mimicry formation of glioma cells via linc00707/miR-651-3p/SP2 axis.
HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway.
hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing.
Homeobox B4 inhibits breast cancer cell migration by directly binding to StAR-related lipid transfer domain protein 13.
Homeobox genes gain trimethylation of histone H3 lysine 4 in glioblastoma tissue.
Homeodomain-containing gene 10 inhibits cell apoptosis and promotes cell invasion and migration in osteosarcoma cell lines.
Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer.
Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma.
Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma.
Homozygous deletions at 3p22, 5p14, 6q15, and 9p21 result in aberrant expression of tumor suppressor genes in gastric cancer.
HOPX homeobox methylation in differentiated thyroid cancer and its clinical relevance.
Hormone Receptor-Status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape.
Hormone therapy use and breast tissue DNA methylation: analysis of epigenome wide data from the normal breast study.
HOTAIR rs7958904 polymorphism is associated with increased cervical cancer risk in a Chinese population.
Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
HotSpot3D web server: an integrated resource for mutation analysis in protein 3D structures.
HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
How Can Gene-Expression Information Improve Prognostic Prediction in TCGA Cancers: An Empirical Comparison Study on Regularization and Mixed Cox Models.
How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?
How Young Is Too Young in Breast Cancer?-Young Breast Cancer Is Not a Unique Biological Subtype.
HOX Transcript Antisense RNA HOTAIR Abrogates Vasculogenic Mimicry by Targeting the AngiomiR-204/FAK Axis in Triple Negative Breast Cancer Cells.
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.
HOXB2 is a Putative Tumour Promotor in Human Bladder Cancer.
HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/?-catenin signaling axis.
HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.
HOXC11 Expression Is Associated with the Progression of Colon Adenocarcinoma and Is a Prognostic Biomarker.
HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma.
HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through ?-catenin/c-Myc signaling pathway.
HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1.
HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma.
HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2.
HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer.
HPASubC: A suite of tools for user subclassification of human protein atlas tissue images.
HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis.
HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity.
HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer.
HPV transcript expression affects cervical cancer response to chemoradiation.
HPV-related methylation-based reclassification and risk stratification of cervical cancer.
HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.
HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
HS3ST2 and Its Related Molecules as Potential Biomarkers for Predicting Lymph Node Metastasis in Patients with Colorectal Cancer.
Hsa-mir-127 impairs survival of patients with glioma and promotes proliferation, migration and invasion of cancerous cells by modulating replication initiator 1.
hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3.
hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.
HSD17B4, ACAA1, and PXMP4 in Peroxisome Pathway Are Down-Regulated and Have Clinical Significance in Non-small Cell Lung Cancer.
hsegHMM: hidden Markov model-based allele-specific copy number alteration analysis accounting for hypersegmentation.
HSF2 regulates aerobic glycolysis by suppression of FBP1 in hepatocellular carcinoma.
HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
HSP70 promotes tumor progression by stabilizing Skp2 expression in gastric cancer cells.
HSP70/HSP90-Organizing Protein Contributes to Gastric Cancer Progression in an Autocrine Fashion and Predicts Poor Survival in Gastric Cancer.
HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma.
HTLV-1-associated genes as potential biomarkers for endometrial cancer.
HTR1D, TIMP1, SERPINE1, MMP3 and CNR2 affect the survival of patients with colon adenocarcinoma.
HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression.
Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
Human ALKBH6 Is Required for Maintenance of Genomic Stability and Promoting Cell Survival During Exposure of Alkylating Agents in Pancreatic Cancer.
Human cancer long non-coding RNA transcriptomes.
Human cytomegalovirus may promote tumour progression by upregulating arginase-2.
Human Endogenous Retrovirus Expression Is Associated with Head and Neck Cancer and Differential Survival.
Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.
Human genetics: international projects and personalized medicine.
Human glioma growth is controlled by microRNA-10b.
Human Hematopoietic Signal peptide-containing Secreted 1 (hHSS1) modulates genes and pathways in glioma: implications for the regulation of tumorigenicity and angiogenesis.
Human nuclear receptors (NRs) genes have prognostic significance in hepatocellular carcinoma patients.
Human Papilloma Viruses and Breast Cancer.
Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.
Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
Human papillomavirus dysregulates the cellular apparatus controlling the methylation status of H3K27 in different human cancers to consistently alter gene expression regardless of tissue of origin.
Human RECQL5 promotes metastasis and resistance to cisplatin in non-small cell lung cancer.
Human Schlafen 5 regulates reversible epithelial and mesenchymal transitions in breast cancer by suppression of ZEB1 transcription.
Human somatic cells deficient for RAD52 are impaired for viral integration and compromised for most aspects of homology-directed repair.
Human sperm-associated antigen 4 as a potential biomarker of glioblastoma progression and prognosis.
Human sperm-associated antigen 4 as a potential prognostic biomarker of lung squamous cell carcinoma.
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
Humanin Promotes Tumor Progression in Experimental Triple Negative Breast Cancer.
Humanized yeast genetic interaction mapping predicts synthetic lethal interactions of FBXW7 in breast cancer.
HuR Promotes Ovarian Cancer Cell Proliferation by Regulating TIMM44 mRNA Stability.
HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
Hyaluronan-mediated motility receptor expression functions as a prognostic biomarker in uterine carcinosarcoma based on bioinformatics analysis.
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.
Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian Cancer.
Hybrid Stem Cell States: Insights Into the Relationship Between Mammary Development and Breast Cancer Using Single-Cell Transcriptomics.
Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal Cancer Cells via Regulating NF-?B Signaling Pathway.
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome.
Hyper-graph Regularized Constrained NMF for Selecting Differentially Expressed Genes and Tumor Classification.
Hyperglycemia promotes Snail-induced epithelial-mesenchymal transition of gastric cancer via activating ENO1 expression.
Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
Hypermethylated KLF9 Is An Independent Prognostic Factor For Favorable Outcome In Breast Cancer.
Hypermethylated WNT10A and its clinical significance in colorectal cancer.
Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer.
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.
Hypermethylation of EIF4E promoter is associated with early onset of gastric cancer.
Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis.
Hypermethylation of LATS2 Promoter and Its Prognostic Value in IDH-Mutated Low-Grade Gliomas.
Hypermethylation of MDFI promoter with NSCLC is specific for females, non-smokers and people younger than 65.
Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma.
Hypermethylation of the PTTG1IP promoter leads to low expression in early-stage non-small cell lung cancer.
Hypermethylation of the PZP gene is associated with hepatocellular carcinoma cell proliferation, invasion and migration.
Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer.
Hypermutated tumours across 11 cancer types show three distinct immune subtypes.
Hypermutation of DPYD Deregulates Pyrimidine Metabolism and Promotes Malignant Progression.
Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin.
Hypertonicity-Affected Genes Are Differentially Expressed in Clear Cell Renal Cell Carcinoma and Correlate with Cancer-Specific Survival.
Hypertrophic posterior arch of atlas causing cervical myelopathy.
Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.
Hypomethylation of CTCFL promoters as a noninvasive biomarker in plasma from patients with hepatocellular carcinoma.
Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.
Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors.
Hypomethylation-activated cancer-testis gene SPANXC promotes cell metastasis in lung adenocarcinoma.
Hypothesis: Obesity Is Associated with a Lower Mutation Threshold in Colon Cancer.
Hypothyroidism induces oxidative stress and DNA damage in breast.
Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment.
Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail: A potential role of Sox9.
Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma.
Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment.
Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer.
Hypoxia-driven splicing into noncoding isoforms regulates the DNA damage response.
Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5.
Hypoxia-induced HIF1? dependent COX2 promotes ovarian cancer progress.
Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis.
Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment.
Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Hypoxia-regulated lncRNA CRPAT4 promotes cell migration via regulating AVL9 in clear cell renal cell carcinomas.
Hypoxia-related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD-L1 squamous and adenocarcinoma NSCLC.
Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer.
Hypoxic stress suppresses lung tumor-secreted exosomal miR101 to activate macrophages and induce inflammation.
HYR-2 plays an anti-lung cancer role by regulating PD-L1 and Akkermansia muciniphila.
I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms.
iCAGES: integrated CAncer GEnome Score for comprehensively prioritizing driver genes in personal cancer genomes.
ICN: Extracting interconnected communities in gene Co-expression networks.
ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
ID2 promotes survival of glioblastoma cells during metabolic stress by regulating mitochondrial function.
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function.
Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery.
Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.
Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Identification and analysis of genes associated with lung adenocarcinoma by integrated bioinformatics methods.
Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma.
Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Identification and analysis of survival-associated ceRNA triplets in prostate adenocarcinoma.
Identification and Characterization of Alternatively Spliced Transcript Isoforms of IRX4 in Prostate Cancer.
Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.
Identification and characterization of HPV-independent cervical cancers.
Identification and Characterization of MicroRNAs Associated with Somatic Copy Number Alterations in Cancer.
Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Identification and Characterization of Senescence Phenotype in Lung Adenocarcinoma with High Drug Sensitivity.
Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell Carcinoma.
Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma.
Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.
Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.
Identification and Experimental Validation of Immune-Associate lncRNAs for Predicting Prognosis in Cervical Cancer.
Identification and external validation of a novel miRNA signature for lymph node metastasis prediction in submucosal-invasive gastric cancer patients.
Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Identification and functional analysis of risk-related microRNAs for the prognosis of patients with bladder urothelial carcinoma.
Identification and functional analysis of the risk microRNAs associated with cerebral low-grade glioma prognosis.
Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Identification and Immunocorrelation of Prognosis-Related Genes Associated With Development of Muscle-Invasive Bladder Cancer.
Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma.
Identification and integrated analysis of hepatocellular carcinoma-related circular RNA signature.
Identification and meta-analysis of copy number variation-driven circadian clock genes for colorectal cancer.
Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer.
Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer.
Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer.
Identification and prognostic value of anterior gradient protein 2 expression in breast cancer based on tissue microarray.
Identification and prognostic value of metabolism-related genes in gastric cancer.
Identification and validation a TGF-?-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method.
Identification and validation of 12 immune-related genes as a prognostic signature for colon adenocarcinoma.
Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas.
Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.
Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma.
Identification and validation of a five apoptosis-related genes signature for prediction of disease-free survival for testicular germ cell tumors.
Identification and Validation of a Four-Long Non-coding RNA Signature Associated With Immune Infiltration and Prognosis in Colon Cancer.
Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma.
Identification and validation of a Hedgehog pathway-based 3-gene prognostic signature for gastric cancers.
Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer.
Identification and validation of a metabolism-related model and associated with tumor-infiltrating lymphocytes in p53 mutant lung adenocarcinoma patients.
Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.
Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer.
Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma.
Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer.
Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma.
Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma.
Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer.
Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer.
Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer.
Identification and validation of a prognostic index based on a metabolic-genomic landscape analysis of ovarian cancer.
Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
Identification and Validation of a Prognostic Model Based on Three Autophagy-Related Genes in Hepatocellular Carcinoma.
Identification and validation of a prognostic proteomic signature for cervical cancer.
Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy.
Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer.
Identification and validation of a ten-gene set variation score as a diagnostic and prognostic stratification tool in hepatocellular carcinoma.
Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Identification and validation of a tumor-infiltrating Treg transcriptional signature conserved across species and tumor types.
Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma.
Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients.
Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma.
Identification and validation of an eight-gene expression signature for predicting high Fuhrman grade renal cell carcinoma.
Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5+ CD8+ T cell abundance.
Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma.
Identification and validation of an immune prognostic signature in colorectal cancer.
Identification and Validation of an Immune-Associated RNA-Binding Proteins Signature to Predict Clinical Outcomes and Therapeutic Responses in Glioma Patients.
Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma.
Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma.
Identification and Validation of an Immune-Related RNA Signature to Predict Survival of Patients With Head and Neck Squamous Cell Carcinoma.
Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer.
Identification and validation of an individualized autophagy-clinical prognostic index in bladder cancer patients.
Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients.
Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes.
Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
Identification and Validation of Circulating MicroRNA Signatures for Breast Cancer Early Detection Based on Large Scale Tissue-Derived Data.
Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis.
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy.
Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets.
Identification and Validation of Hub Genes Associated With Hepatocellular Carcinoma Via Integrated Bioinformatics Analysis.
Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients.
Identification and validation of hypoxic markers of glioblastoma multiforme in methylation, somatic CNV characteristics based on large-scale samples.
Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.
Identification and validation of immune-related lncRNA prognostic signatures for melanoma.
Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma.
Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis.
Identification and validation of L Antigen Family Member 3 as an immune-related biomarker associated with the progression of papillary thyroid cancer.
Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer.
Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer.
Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis.
Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma.
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia.
Identification and validation of potential long non-coding RNA biomarkers in predicting survival of patients with head and neck squamous cell carcinoma.
Identification and validation of potential novel biomarkers to predict distant metastasis in differentiated thyroid cancer.
Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia.
Identification and validation of potential target genes in papillary thyroid cancer.
Identification and validation of prognosis-related DLX5 methylation as an epigenetic driver in myeloid neoplasms.
Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy.
Identification and Validation of Prognostically Relevant Gene Signature in Melanoma.
Identification and validation of RNA-binding protein-related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma.
Identification and validation of seven prognostic long non-coding RNAs in oral squamous cell carcinoma.
Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia.
Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Identification and Validation of SNP-Containing Genes With Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis.
Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma.
Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies.
Identification and Validation of STAT6 as a Prognostic and Predictive Biomarker in Acute Myeloid Leukemia.
Identification and validation of stemness-related lncRNA prognostic signature for breast cancer.
Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer.
Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy.
Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.
Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Identification and validation of the prognostic value of immune-related genes in non-small cell lung cancer.
Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.
Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis.
Identification and validation of tumor microenvironment-related genes of prognostic value in lung adenocarcinoma.
Identification and validation of tumor microenvironment-related lncRNA prognostic signature for uveal melanoma.
Identification and Validation of Two Lung Adenocarcinoma-Development Characteristic Gene Sets for Diagnosing Lung Adenocarcinoma and Predicting Prognosis.
Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.
Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer.
Identification and verification of a ten-gene signature predicting overall survival for ovarian cancer.
Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma.
Identification and verification of the prognostic value of the glutathione S-transferase Mu genes in gastric cancer.
Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs.
Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
Identification Hub Genes in Colorectal Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Clinical Validation in vivo and vitro.
Identification immunophenotyping of lung adenocarcinomas based on the tumor microenvironment.
Identification key genes, key miRNAs and key transcription factors of lung adenocarcinoma.
Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.
Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer.
Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma.
Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma.
Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol?associated hepatocellular carcinoma using weighted gene co?expression network analysis.
Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis.
Identification of 9-Core Immune-Related Genes in Bladder Urothelial Carcinoma Prognosis.
Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Identification of a 15-pseudogene based prognostic signature for predicting survival and antitumor immune response in breast cancer.
Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
Identification of a 5-Gene Metabolic Signature for Predicting Prognosis Based on an Integrated Analysis of Tumor Microenvironment in Lung Adenocarcinoma.
Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
Identification of a 5?lncRNA signature?based risk scoring system for survival prediction in colorectal cancer.
Identification of a 5?microRNA signature and hub miRNA?mRNA interactions associated with pancreatic cancer.
Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma.
Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
Identification of a 6-gene signature predicting prognosis for colorectal cancer.
Identification of a circadian gene signature that predicts overall survival in lung adenocarcinoma.
Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.
Identification of a competing endogenous RNA axis "SVIL-AS1/miR-103a/ICE1" associated with chemoresistance in lung adenocarcinoma by comprehensive bioinformatics analysis.
Identification of a competing endogenous RNA axis related to gastric cancer.
Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma.
Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma.
Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme.
Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer.
Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate Cancer.
Identification of a DNA Repair-Related Multigene Signature as a Novel Prognostic Predictor of Glioblastoma.
Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck.
Identification of a ferroptosis-related gene signature predictive model in colon cancer.
Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma.
Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.
Identification of a Five-CpG Signature with Diagnostic Value in Thyroid Cancer.
Identification of a Five-Gene Prognostic Model and Its Potential Drug Repurposing in Colorectal Cancer Based on TCGA, GTEx and GEO Databases.
Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients.
Identification of a five-gene signature for predicting the progression and prognosis of stage I endometrial carcinoma.
Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma.
Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer.
Identification of a five-gene signature with prognostic value in colorectal cancer.
Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Identification of a five-miRNA signature predicting survival in cutaneous melanoma cancer patients.
Identification of a Four Hypoxia-Associated Long Non-Coding RNA Signature and Establishment of a Nomogram Predicting Prognosis of Clear Cell Renal Cell Carcinoma.
Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.
Identification of a four-long non-coding RNA signature in predicting breast cancer survival.
Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanoma.
Identification of a gene expression signature predicting survival in oral cavity squamous cell carcinoma using Monte Carlo cross validation.
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?
Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Identification of a Gene Set Correlated With Immune Status in Ovarian Cancer by Transcriptome-Wide Data Mining.
Identification of a Gene Signature for Renal Cell Carcinoma-Associated Fibroblasts Mediating Cancer Progression and Affecting Prognosis.
Identification of a Gene-Related Risk Signature in Melanoma Patients Using Bioinformatic Profiling.
Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer.
Identification of a glycolysis-related gene signature associated with clinical outcome for patients with lung squamous cell carcinoma.
Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.
Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas.
Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Identification of a Human Papillomavirus-Associated Oncogenic miRNA Panel in Human Oropharyngeal Squamous Cell Carcinoma Validated by Bioinformatics Analysis of The Cancer Genome Atlas.
Identification of a Hypoxia-Associated Signature for Lung Adenocarcinoma.
Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer.
Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer.
Identification of a long non-coding RNA signature for predicting prognosis and biomarkers in lung adenocarcinoma.
Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma.
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1? levels under hypoxia.
Identification of a metabolic-related gene signature predicting the overall survival for patients with stomach adenocarcinoma.
Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients.
Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma.
Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm.
Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-?C in clear cell Renal Cell Carcinoma patients.
Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma.
Identification of a nine-gene prognostic signature for gastric carcinoma using integrated bioinformatics analyses.
Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma.
Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer.
Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma.
Identification of a novel cell cycle-related gene signature predicting survival in patients with gastric cancer.
Identification of a novel CpG methylation signature to predict prognosis in lung squamous cell carcinoma.
Identification of a novel DNA repair-related prognostic signature predicting survival of patients with hepatocellular carcinoma.
Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks.
Identification of a Novel Epigenetic Signature CHFR as a Potential Prognostic Gene Involved in Metastatic Clear Cell Renal Cell Carcinoma.
Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC.
Identification of a Novel Epithelial-to-Mesenchymal-related Gene Signature in Predicting Survival of Patients with Hepatocellular Carcinoma.
Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.
Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Identification of a Novel Glycolysis-Related Gene Signature Correlates With the Prognosis and Therapeutic Responses in Patients With Clear Cell Renal Cell Carcinoma.
Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma.
Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma.
Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer.
Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy.
Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer.
Identification of a novel immune-related microRNA prognostic model in clear cell renal cell carcinoma.
Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer.
Identification of a novel microRNA recurrence-related signature and risk stratification system in breast cancer.
Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining.
Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method.
Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma.
Identification of a Novel Protein-Based Signature to Improve Prognosis Prediction in Renal Clear Cell Carcinoma.
Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.
Identification of a Novel Transcription Factor Prognostic Index for Breast Cancer.
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.
Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif.
Identification of a panel of mitotic spindle-related genes as a signature predicting survival in lung adenocarcinoma.
Identification of a potential prognostic lncRNA-miRNA-mRNA signature in endometrial cancer based on the competing endogenous RNA network.
Identification of a Potential Regulatory Variant for Colorectal Cancer Risk Mapping to 3p21.31 in Chinese Population.
Identification of a potential target for treatment of squamous cell carcinoma of the tongue: follistatin.
Identification of a Potentially Functional microRNA-mRNA Regulatory Network in Lung Adenocarcinoma Using a Bioinformatics Analysis.
Identification of a prognosis?associated signature associated with energy metabolism in triple?negative breast cancer.
Identification of a prognostic 4-mRNA signature in laryngeal squamous cell carcinoma.
Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Identification of a Prognostic Colorectal Cancer Model Including LncRNA FOXP4-AS1 and LncRNA BBOX1-AS1 Based on Bioinformatics Analysis.
Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma.
Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma.
Identification of a Prognostic Index Based on a Metabolic-Genomic Landscape Analysis of Hepatocellular Carcinoma (HCC).
Identification of a prognostic long noncoding RNA signature in lung squamous cell carcinoma: a population-based study with a mean follow-up of 3.5?years.
Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.
Identification of a Prognostic Signature Model with Tumor Microenvironment for predicting Disease-free Survival after Radical Prostatectomy.
Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma.
Identification of a protein signature for predicting overall survival of hepatocellular carcinoma: a study based on data mining.
Identification of a putative competitive endogenous RNA network for lung adenocarcinoma using TCGA datasets.
Identification of a Rat Mammary Tumor Risk Locus That Is Syntenic with the Commonly Amplified 8q12.1 and 8q22.1 Regions in Human Breast Cancer Patients.
Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment.
Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma.
Identification of a RNA-Seq Based Prognostic Signature with Seven Immune-Related lncRNAs for Lung Adenocarcinoma.
Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma.
Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
Identification of a Set of Genes Improving Survival Prediction in Kidney Renal Clear Cell Carcinoma through Integrative Reanalysis of Transcriptomic Data.
Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma.
Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
Identification of a six lncRNAs signature as novel diagnostic biomarkers for cervical cancer.
Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma.
Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
Identification of a six-gene signature associated with tumor mutation burden for predicting prognosis in patients with invasive breast carcinoma.
Identification of a Six-Gene Signature for Predicting the Overall Survival of Cervical Cancer Patients.
Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Identification of a six-gene signature with prognostic value for patients with endometrial carcinoma.
Identification of a six-lncRNA signature based on a competing endogenous RNA network for predicting the risk of tumour recurrence in bladder cancer patients.
Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method.
Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma.
Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients.
Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses.
Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma.
Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer.
Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma.
Identification of a three-m6A related gene risk score model as a potential prognostic biomarker in clear cell renal cell carcinoma.
Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Identification of a three-miRNA signature as a novel prognostic model for papillary renal cell carcinoma.
Identification of a Transcriptional Prognostic Signature From Five Metabolic Pathways in Oral Squamous Cell Carcinoma.
Identification of a transcriptomic signature with excellent survival prediction for squamous cell carcinoma of the cervix.
Identification of a TSPY co-expression network associated with DNA hypomethylation and tumor gene expression in somatic cancers.
Identification of a tumor microenvironment-associated prognostic gene signature in bladder cancer by integrated bioinformatic analysis.
Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer.
Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis.
Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients With Pancreatic Cancer.
Identification of a universal 6-lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma.
Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinoma.
Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Identification of Aberrantly Methylated Differentially CpG Sites in Hepatocellular Carcinoma and Their Association With Patient Survival.
Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.
Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Identification of aberrantly methylated differentially expressed genes in glioblastoma multiforme and their association with patient survival.
Identification of aberrantly methylated differentially expressed genes in prostate carcinoma using integrated bioinformatics.
Identification of Aging-Related Genes Associated With Clinical and Prognostic Features of Hepatocellular Carcinoma.
Identification of AK4 as a novel therapeutic target for serous ovarian cancer.
Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
Identification of an 11-Autophagy-Related-Gene Signature as Promising Prognostic Biomarker for Bladder Cancer Patients.
Identification of an 11-lncRNA signature with high performance for predicting the prognosis of hepatocellular carcinoma using bioinformatics analysis.
Identification of an alternative splicing signature as an independent factor in colon cancer.
Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC).
Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype.
Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower?grade glioma and prognosis prediction.
Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer.
Identification of an autophagy-related gene signature predicting overall survival for hepatocellular carcinoma.
Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.
Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma.
Identification of an Autophagy-Related Signature Predicting Overall Survival for Papillary Thyroid Carcinoma.
Identification of an eight-gene prognostic signature for lung adenocarcinoma.
Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis.
Identification of an eleven-miRNA signature to predict the prognosis of endometrial cancer.
Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
Identification of an IFN-?-associated gene signature for the prediction of overall survival among glioblastoma patients.
Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.
Identification of an Immune Gene Signature Based on Tumor Microenvironment Characteristics in Colon Adenocarcinoma.
Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma.
Identification of an immune prognostic 11-gene signature for lung adenocarcinoma.
Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.
Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients.
Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
Identification of an immune-related long noncoding RNA signature that predicts prognosis in breast cancer patients.
Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer.
Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma.
Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer.
Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer.
Identification of an immune-related RNA-binding protein signature to predict survival and targeted therapy responses in liver cancer.
Identification of an immune-related signature indicating the dedifferentiation of thyroid cells.
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles.
Identification of an Individualized Immune-Related Prognostic Risk Score in Lung Squamous Cell Cancer.
Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
Identification of an lncRNA?miRNA?mRNA interaction mechanism in breast cancer based on bioinformatic analysis.
Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomas.
Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer.
Identification of Aneuploid Circulating Tumor Cells in Soft-Tissue Sarcoma Patients: A Pilot Study.
Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis.
Identification of ARHGEF38, NETO2, GOLM1, and SAPCD2 Associated With Prostate Cancer Progression by Bioinformatic Analysis and Experimental Validation.
Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
Identification of Arp2/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma.
Identification of ATP8B1 as a Tumor Suppressor Gene for Colorectal Cancer and Its Involvement in Phospholipid Homeostasis.
Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma.
Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Identification of biomarkers associated with diagnosis and prognosis of gastroesophageal junction adenocarcinoma-a study based on integrated bioinformatics analysis in GEO and TCGA database.
Identification of biomarkers associated with histological grade and prognosis of gastric cancer by co-expression network analysis.
Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma.
Identification of biomarkers correlated with diagnosis and prognosis of endometrial cancer using bioinformatics analysis.
Identification of biomarkers for acute leukemia via machine learning-based stemness index.
Identification of Biomarkers for Breast Cancer Using Databases.
Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices.
Identification of biomarkers of chromophobe renal cell carcinoma by weighted gene co-expression network analysis.
Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis.
Identification of biomarkers predicting the chemotherapeutic outcomes of capecitabine and oxaliplatin in patients with gastric cancer.
Identification of biomarkers related to CD8+ T cell infiltration with gene co-expression network in clear cell renal cell carcinoma.
Identification of Biomarkers Related to Prognosis of Bladder Transitional Cell Carcinoma.
Identification of breast cancer associated variants that modulate transcription factor binding.
Identification of breast cancer prognostic modules via differential module selection based on weighted gene Co-expression network analysis.
Identification of breast cancer-related circRNAs by analysis of microarray and RNA-sequencing data: An observational study.
Identification of cancer risk lncRNAs and cancer risk pathways regulated by cancer risk lncRNAs based on genome sequencing data in human cancers.
Identification of cancer stem cell-related biomarkers in intestinal-type and diffuse-type gastric cancer by stemness index and weighted correlation network analysis.
Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
Identification of Cancer-Specific Methylation of Gene Combination for the Diagnosis of Bladder Cancer.
Identification of cancer/testis antigen 2 gene as a potential hepatocellular carcinoma therapeutic target by hub gene screening with topological analysis.
Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma.
Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases.
Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Identification of candidate genes and prognostic value analysis in patients with PDL1-positive and PDL1-negative lung adenocarcinoma.
Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis.
Identification of candidate genes encoding tumor-specific neoantigens in early- and late-stage colon adenocarcinoma.
Identification of candidate RNA signatures in triple-negative breast cancer by the construction of a competing endogenous RNA network with integrative analyses of Gene Expression Omnibus and The Cancer Genome Atlas data.
Identification of candidate target genes for endometrial cancer, such as ANO1, using weighted gene co-expression network analysis.
Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer.
Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma.
Identification of CD28 and PTEN as novel prognostic markers for cervical cancer.
Identification of CDC20 as a Novel Biomarker in Diagnosis and Treatment of Wilms Tumor.
Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer.
Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma.
Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
Identification of circRNA-miRNA-mRNA networks contributes to explore underlying pathogenesis and therapy strategy of gastric cancer.
Identification of circRNA-miRNA-mRNA regulatory network in gastric cancer by analysis of microarray data.
Identification of circular RNA-microRNA-messenger RNA regulatory network in hepatocellular carcinoma by integrated analysis.
Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer.
Identification of cluster of differentiation molecule-associated microRNAs as potential therapeutic targets for gastrointestinal cancer immunotherapy.
Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues.
Identification of COL6A1 as the Key Gene Associated with Antivascular Endothelial Growth Factor Therapy in Glioblastoma Multiforme.
Identification of colorectal cancer-associated macrophage biomarkers by integrated bioinformatic analysis.
Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells.
Identification of complex genomic rearrangements in cancers using CouGaR.
Identification of copy number variation-driven genes for liver cancer via bioinformatics analysis.
Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma.
Identification of core differentially methylated genes in glioma.
Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Identification of Core Genes and Pathways in Medulloblastoma by Integrated Bioinformatics Analysis.
Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic Analysis.
Identification of Core Genes Involved in the Progression of Cervical Cancer Using an Integrative mRNA Analysis.
Identification of Core Genes Related to Progression and Prognosis of Hepatocellular Carcinoma and Small-Molecule Drug Predication.
Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis.
Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis.
Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis.
Identification of CTLA-4 associated with tumor microenvironment and competing interactions in triple negative breast cancer by co-expression network analysis.
Identification of DAPK1 Promoter Hypermethylation as a Biomarker for Intra-Epithelial Lesion and Cervical Cancer: A Meta-Analysis of Published Studies, TCGA, and GEO Datasets.
Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC.
Identification of deregulation mechanisms specific to cancer subtypes.
Identification of DGUOK-AS1 as a Prognostic Factor in Breast Cancer by Bioinformatics Analysis.
Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Identification of diagnostic long non?coding RNA biomarkers in patients with hepatocellular carcinoma.
Identification of differential expressed lncRNAs in human thyroid cancer by a genome-wide analyses.
Identification of differentially expressed genes and biological characteristics of colorectal cancer by integrated bioinformatics analysis.
Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data.
Identification of differentially expressed genes and their upstream regulators in colorectal cancer.
Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array.
Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
Identification of Differentially Expressed Genes Induced by Aberrant Methylation in Oral Squamous Cell Carcinomas Using Integrated Bioinformatic Analysis.
Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing.
Identification of differentially expressed metastatic genes and their signatures to predict the overall survival of uveal melanoma patients by bioinformatics analysis.
Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets.
Identification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine.
Identification of discrepancy between CTLA4 expression and CTLA4 activation in gastric cancer.
Identification of Disease-miRNA Networks Across Different Cancer Types Using SWIM.
Identification of Distinct Molecular Patterns and a Four-Gene Signature in Colon Cancer Based on Invasion-Related Genes.
Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer.
Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically.
Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
Identification of DNA methylation signature to predict prognosis in gastric adenocarcinoma.
Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas.
Identification of DNA methylation-regulated differentially-expressed genes and related pathways using Illumina 450K BeadChip and bioinformatic analysis in gastric cancer.
Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer.
Identification of down-regulated microRNAs in thyroid cancer and their potential functions.
Identification of downstream signaling cascades of ACK1 and prognostic classifiers in non-small cell lung cancer.
Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
Identification of driver genes regulating immune cell infiltration in cervical cancer by multiple omics integration.
Identification of Drivers of Aneuploidy in Breast Tumors.
Identification of druggable cancer driver genes amplified across TCGA datasets.
Identification of Dysregulated Competitive Endogenous RNA Networks Driven by Copy Number Variations in Malignant Gliomas.
Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
Identification of dysregulated long non-coding RNAs/microRNAs/mRNAs in TNM I stage lung adenocarcinoma.
Identification of dysregulated miRNAs-genes network in ovarian cancer: An integrative approach to uncover the molecular interactions and oncomechanisms.
Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.
Identification of EMT-Related Gene Signatures to Predict the Prognosis of Patients With Endometrial Cancer.
Identification of endometrial cancer methylation features using combined methylation analysis methods.
Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma.
Identification of ENTPD8 and cytidine in pancreatic cancer by metabolomic and transcriptomic conjoint analysis.
Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.
Identification of epigenetic modulators in human breast cancer by integrated analysis of DNA methylation and RNA-Seq data.
Identification of Epithelial-Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma.
Identification of Epithelial-Mesenchymal Transition-Related lncRNAs that Associated With the Prognosis and Immune Microenvironment in Colorectal Cancer.
Identification of ESM1 overexpressed in head and neck squamous cell carcinoma.
Identification of essential genes for cancer immunotherapy.
Identification of Expression Signatures For Non-Small-Cell Lung Carcinoma Subtype Classification.
Identification of F5 as a Prognostic Biomarker in Patients with Gastric Cancer.
Identification of FADS1 Through Common Gene Expression Profiles for Predicting Survival in Patients with Bladder Cancer.
Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Identification of Five Genes as a Potential Biomarker for Predicting Progress and Prognosis in Adrenocortical Carcinoma.
Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico.
Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma.
Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis.
Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma.
Identification of Four Enhancer-Associated Genes as Risk Signature for Diffuse Glioma Patients.
Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways.
Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment.
Identification of four genes associated with cutaneous metastatic melanoma.
Identification of four hub genes associated with adrenocortical carcinoma progression by WGCNA.
Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma.
Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.
Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
Identification of FOXM1 as a specific marker for triple?negative breast cancer.
Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast Cancer.
Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
Identification of functional long non-coding RNAs in gastric cancer by bioinformatics analysis.
Identification of G-protein signaling modulator 2 as a diagnostic and prognostic biomarker of pancreatic adenocarcinoma: an exploration of its regulatory mechanisms.
Identification of G2 and S Phase-Expressed-1 as a Potential Biomarker in Patients with Prostate Cancer.
Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer.
Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer.
Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics.
Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer.
Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage.
Identification of gene-specific DNA methylation signature for Colorectal Cancer.
Identification of genes and pathways involved in kidney renal clear cell carcinoma.
Identification of genes associated with cancer prognosis in glioma: In silico data analyses of Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA).
Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases.
Identification of genes associated with gastric cancer survival and construction of a nomogram to improve risk stratification for patients with gastric cancer.
Identification of genes associated with histologic tumor grade of esophageal squamous cell carcinoma.
Identification of Genes Associated with Lung Adenocarcinoma Prognosis.
Identification of genes associated with survival of breast cancer patients.
Identification of Genes Associated with the Metastasis of Pheochromocytoma/Paraganglioma Based on Weighted Gene Coexpression Network Analysis.
Identification of genes involved in the regulation of TERT in hepatocellular carcinoma.
Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.
Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Identification of Genes Related to Immune Infiltration in the Tumor Microenvironment of Cutaneous Melanoma.
Identification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells conditionally expressing RelA.
Identification of genes that correlate clear cell renal cell carcinoma and obesity and exhibit potential prognostic value.
Identification of genes that predict the biochemical recurrence of prostate cancer.
Identification of Genes Whose Expression Overlaps Age Boundaries and Correlates with Risk Groups in Paediatric and Adult Acute Myeloid Leukaemia.
Identification of Genetic and Epigenetic Variants Associated with Breast Cancer Prognosis by Integrative Bioinformatics Analysis.
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.
Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer.
Identification of genomic features associated with immunotherapy response in gastrointestinal cancers.
Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression.
Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
Identification of glycolysis related pathways in pancreatic adenocarcinoma and liver hepatocellular carcinoma based on TCGA and GEO datasets.
Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma.
Identification of GSN and LAMC2 as Key Prognostic Genes of Bladder Cancer by Integrated Bioinformatics Analysis.
Identification of HCC-Related Genes Based on Differential Partial Correlation Network.
Identification of hedgehog signaling as a potential oncogenic driver in an aggressive subclass of human hepatocellular carcinoma: A reanalysis of the TCGA cohort.
Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses.
Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer.
Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas.
Identification of hsa_circ_0002024 as a prognostic competing endogenous RNA (ceRNA) through the hsa_miR_129-5p/Anti-Silencing Function 1B Histone Chaperone (ASF1B) axis in renal cell carcinoma.
Identification of Hub Driving Genes and Regulators of Lung Adenocarcinoma based on the Gene Co-expression Network.
Identification of Hub Gene TIMP1 and Relative ceRNAs Regulatory Network in Colorectal Cancer.
Identification of Hub Genes and Analysis of Prognostic Values in Hepatocellular Carcinoma by Bioinformatics Analysis.
Identification of hub genes and compounds controlling ovarian cancer stem cell characteristics via stemness indices analysis.
Identification of Hub Genes and Construction of a Transcriptional Regulatory Network Associated With Tumor Recurrence in Colorectal Cancer by Weighted Gene Co-expression Network Analysis.
Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
Identification of Hub Genes and Pathways of Triple Negative Breast Cancer by Expression Profiles Analysis.
Identification of hub genes and small molecule therapeutic drugs related to breast cancer with comprehensive bioinformatics analysis.
Identification of hub genes associated with adult acute myeloid leukemia progression through weighted gene co-expression network analysis.
Identification of Hub Genes Associated With Development and Microenvironment of Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis and Differential Gene Expression Analysis.
Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.
Identification of hub genes associated with esophageal cancer progression using bioinformatics analysis.
Identification of hub genes associated with neutrophils infiltration in colorectal cancer.
Identification of hub genes associated with outcome of clear cell renal cell carcinoma.
Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
Identification of hub genes associated with the pathogenesis of diffuse large B-cell lymphoma subtype one characterized by host response via integrated bioinformatic analyses.
Identification of hub genes in bladder cancer based on weighted gene co-expression network analysis from TCGA database.
Identification of hub genes in colon cancer via bioinformatics analysis.
Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis.
Identification of Hub Genes in Gastric Cancer with High Heterogeneity Based on Weighted Gene Co-Expression Network.
Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis.
Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics.
Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
Identification of hub lncRNAs in head and neck cancer based on weighted gene co-expression network analysis and experiments.
Identification of Hub Prognosis-Associated Oxidative Stress Genes in Pancreatic Cancer Using Integrated Bioinformatics Analysis.
Identification of hub prognosis-associated oxidative stress genes in skin cutaneous melanoma using integrated bioinformatic analysis.
Identification of hyper-rewired genomic stress non-oncogene addiction genes across 15 cancer types.
Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling.
Identification of IGF-1-enhanced cytokine expressions targeted by miR-181d in glioblastomas via an integrative miRNA/mRNA regulatory network analysis.
Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas.
Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma.
Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile.
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.
Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
Identification of Immune-Related Cells and Genes in Tumor Microenvironment of Clear Cell Renal Cell Carcinoma.
Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer.
Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis.
Identification of Immune-Related Risk Signatures for the Prognostic Prediction in Oral Squamous Cell Carcinoma.
Identification of Immune-Related Therapeutically Relevant Biomarkers in Breast Cancer and Breast Cancer Stem Cells by Transcriptome-Wide Analysis: A Clinical Prospective Study.
Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma.
Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling.
Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
Identification of Important Modules and Biomarkers in Breast Cancer Based on WGCNA.
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Identification of influential observations in high-dimensional cancer survival data through the rank product test.
Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells.
Identification of integrin drug targets for 17 solid tumor types.
Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer.
Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis.
Identification of JAK2 and FOXM1 expression as novel candidate biomarkers for predicting the benefit of immunotherapy in lung squamous cell carcinoma.
Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.
Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis.
Identification of key candidate genes involved in melanoma metastasis.
Identification of key classification features of early cervical squamous cell carcinoma.
Identification of key differentially expressed MicroRNAs in cancer patients through pan-cancer analysis.
Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
Identification of Key Differentially Expressed Transcription Factors in Glioblastoma.
Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer.
Identification of Key Gene and Pathways for the Prediction of Peritoneal Metastasis of Gastric Cancer by Co-expression Analysis.
Identification of key genes and biological processes contributing to colitis associated dysplasia in ulcerative colitis.
Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma.
Identification of key genes and microRNAs involved in kidney Wilms tumor by integrated bioinformatics analysis.
Identification of key genes and miRNAs markers of papillary thyroid cancer.
Identification of key genes and multiple molecular pathways of metastatic process in prostate cancer.
Identification of key genes and pathways associated with cholangiocarcinoma development based on weighted gene correlation network analysis.
Identification of Key Genes and Pathways Associated With Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
Identification of key genes and pathways associated with topotecan treatment using multiple bioinformatics tools.
Identification of key genes and pathways between type I and type II endometrial cancer using bioinformatics analysis.
Identification of key genes and pathways by bioinformatics analysis with TCGA RNA sequencing data in hepatocellular carcinoma.
Identification of key genes and pathways downstream of the ?-catenin-TCF7L1 complex in pancreatic cancer cells using bioinformatics analysis.
Identification of Key Genes and Pathways in Female Lung Cancer Patients Who Never Smoked by a Bioinformatics Analysis.
Identification of Key Genes and Pathways in Pancreatic Cancer Gene Expression Profile by Integrative Analysis.
Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis.
Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
Identification of key genes as potential biomarkers for triple?negative breast cancer using integrating genomics analysis.
Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma.
Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.
Identification of key genes controlling cancer stem cell characteristics in gastric cancer.
Identification of key genes for guiding chemotherapeutic management in ovarian cancer using translational bioinformatics.
Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
Identification of key genes in endometrioid endometrial adenocarcinoma via TCGA database.
Identification of key genes in prostate cancer gene expression profile by bioinformatics.
Identification of key genes in the tumor microenvironment of lung adenocarcinoma.
Identification of Key Genes in Thyroid Cancer Microenvironment.
Identification of key genes involved in the development and progression of early-onset colorectal cancer by co-expression network analysis.
Identification of key genes involved in the metastasis of clear cell renal cell carcinoma.
Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer.
Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis.
Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.
Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis.
Identification of Key Genes With Differential Correlations in Lung Adenocarcinoma.
Identification of Key lncRNA-mRNA Pairs and Functional lncRNAs in Breast Cancer by Integrative Analysis of TCGA Data.
Identification of key lncRNAs as prognostic prediction models for colorectal cancer based on LASSO.
Identification of key long non-coding RNAs in gastric adenocarcinoma.
Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database.
Identification of Key miRNAs in the Treatment of Dabrafenib-Resistant Melanoma.
Identification of key modules and genes associated with breast cancer prognosis using WGCNA and ceRNA network analysis.
Identification of key modules and hub genes in glioblastoma multiforme based on co-expression network analysis.
Identification of key modules and prognostic markers in adrenocortical carcinoma by weighted gene co-expression network analysis.
Identification of Key mRNAs as Prediction Models for Early Metastasis of Pancreatic Cancer Based on LASSO.
Identification of key pathways and genes in
Identification of key pathways and genes in colorectal cancer to predict the prognosis based on mRNA interaction network.
Identification of key pathways and genes in endometrial cancer using bioinformatics analyses.
Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses.
Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma.
Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
Identification of key transcription factors in endometrial cancer by systems bioinformatics analysis.
Identification of KIF18B as a Hub Candidate Gene in the Metastasis of Clear Cell Renal Cell Carcinoma by Weighted Gene Co-expression Network Analysis.
Identification of laminin ?2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma.
Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Identification of LBX2 as a novel causal gene of lung adenocarcinoma.
Identification of LINC01615 as potential metastasis-related long noncoding RNA in hepatocellular carcinoma.
Identification of LINC02310 as an enhancer in lung adenocarcinoma and investigation of its regulatory network via comprehensive analyses.
Identification of liver metastasis-associated genes in human colon carcinoma by mRNA profiling.
Identification of lnc RNAs Related to Prognosis of Patients With Colorectal Cancer.
Identification of lncRNA biomarkers for lung cancer through integrative cross-platform data analyses.
Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer.
Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules.
Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Identification of lncRNAs associated with lung squamous cell carcinoma prognosis in the competitive endogenous RNA network.
Identification of Long Non-coding and Messenger RNAs Differentially Expressed Between Primary and Metastatic Melanoma.
Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database.
Identification of long non-coding RNA signatures in triple-negative breast cancer.
Identification of long non-coding RNAs biomarkers associated with progression of endometrial carcinoma and patient outcomes.
Identification of Long Non-Coding RNAs for Predicting Prognosis Among Patients with Thymoma.
Identification of long non-coding RNAs that stimulate cell survival in bladder cancer.
Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.
Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysis.
Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Identification of low abundance microbiome in clinical samples using whole genome sequencing.
Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
Identification of LPCAT1 expression as a potential prognostic biomarker guiding treatment choice in acute myeloid leukemia.
Identification of Lymph Node Metastasis-Related Key Genes and Prognostic Risk Model in Bladder Cancer by Co-Expression Analysis.
Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival.
Identification of markers associated with brain metastasis from breast cancer through bioinformatics analysis and verification in clinical samples.
Identification of markers associated with global changes in DNA methylation regulation in cancers.
Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
Identification of metabolism genes related to hepatocarcinogenesis and progression in type 2 diabetes mellitus via co-expression networks analysis.
Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer.
Identification of metabolism-associated genes and pathways involved in different stages of clear cell renal cell carcinoma.
Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model.
Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Identification of Metastasis-Associated Genes in Triple-Negative Breast Cancer Using Weighted Gene Co-expression Network Analysis.
Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma.
Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas.
Identification of Methylation-Regulated Differentially Expressed Genes and Related Pathways in Hepatocellular Carcinoma: A Study Based on TCGA Database and Bioinformatics Analysis.
Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
Identification of microenvironment-related genes with prognostic value in clear cell renal cell carcinoma.
Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR.
Identification of MicroRNA-Related Tumorigenesis Variants and Genes in the Cancer Genome Atlas (TCGA) Data.
Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.
Identification of MicroRNAs as Diagnostic Biomarkers for Breast Cancer Based on the Cancer Genome Atlas.
Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma.
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC.
Identification of miR-200c and miR141-Mediated lncRNA-mRNA Crosstalks in Muscle-Invasive Bladder Cancer Subtypes.
Identification of miR-21-5p and miR-210-3p serum levels as biomarkers for patients with papillary renal cell carcinoma: a multicenter analysis.
Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas.
Identification of miRNA Biomarkers for Diverse Cancer Types Using Statistical Learning Methods at the Whole-Genome Scale.
Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
Identification of miRNA-Mediated Subpathways as Prostate Cancer Biomarkers Based on Topological Inference in a Machine Learning Process Using Integrated Gene and miRNA Expression Data.
Identification of miRNA-mRNA crosstalk in laryngeal squamous cell carcinoma.
Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia Survival.
Identification of miRNAs, mRNAs, lncRNAs, and circRNAs associated with hepatocellular carcinoma recurrence after interferon treatment.
Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.
Identification of modules and novel prognostic biomarkers in liver cancer through integrated bioinformatics analysis.
Identification of molecular heterogeneity of hepatocellular carcinoma based on immune gene expression signatures.
Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
Identification of Molecular Targets for Predicting Colon Adenocarcinoma.
Identification of MT1E as a novel tumor suppressor in hepatocellular carcinoma.
Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling.
Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Identification of mutated driver pathways in cancer using a multi-objective optimization model.
Identification of Mutated Peptides in Bladder Cancer From Exomic Sequencing Data Reveals Negative Correlation Between Mutation-Specific Immunoreactivity and Inflammation.
Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma.
Identification of Mutator-Derived Alternative Splicing Signatures of Genomic Instability for Improving the Clinical Outcome of Cholangiocarcinoma.
Identification of NAA40 as a Potential Prognostic Marker for Aggressive Liver Cancer Subtypes.
Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer.
Identification of new biomarkers in immune microenvironment of testicular germ cell tumour.
Identification of new Wilms tumour predisposition genes: an exome sequencing study.
Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.
Identification of Notch signaling pathway gene mutations as a prognostic biomarker for bladder cancer.
Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.
Identification of novel antioxidant gene signature to predict the prognosis of patients with gastric cancer.
Identification of novel autophagy-related lncRNAs associated with a poor prognosis of colon adenocarcinoma through bioinformatics analysis.
Identification of novel biomarkers affecting the metastasis of colorectal cancer through bioinformatics analysis and validation through qRT-PCR.
Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis.
Identification of Novel CD74-NRG2? Fusion From Comprehensive Profiling of Lung Adenocarcinoma in Japanese Never or Light Smokers.
Identification of novel cell glycolysis related gene signature predicting survival in patients with breast cancer.
Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer.
Identification of novel diagnostic and prognostic biomarkers for hepatocellular carcinoma.
Identification of novel diagnostic biomarkers for thyroid carcinoma.
Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients.
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
Identification of novel genes in testicular cancer microenvironment based on ESTIMATE algorithm-derived immune scores.
Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics.
Identification of Novel lncRNA Markers in Glioblastoma Multiforme and Their Clinical Significance: A Study Based on Multiple Sequencing Data.
Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model.
Identification of novel methylated DNA marker ZNF569 for head and neck squamous cell carcinoma.
Identification of Novel microRNA Prognostic Markers Using Cascaded Wx, a Neural Network-Based Framework, in Lung Adenocarcinoma Patients.
Identification of novel mRNA-miRNA-lncRNA competing endogenous RNA network associated with prognosis of breast cancer.
Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.
Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells.
Identification of novel prognosis-related genes associated with cancer using integrative network analysis.
Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
Identification of novel prognostic genes of triple-negative breast cancer using meta-analysis and weighted gene co-expressed network analysis.
Identification of novel prognostic indicators for triple-negative breast cancer patients through integrative analysis of cancer genomics data and protein interactome data.
Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM.
Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme.
Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer.
Identification of nuclear export signal in KLLN suggests potential role in proteasomal degradation in cancer cells.
Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis.
Identification of oncogenic long noncoding RNAs CASC9 and LINC00152 in oral carcinoma through genome-wide comprehensive analysis.
Identification of ovarian cancer driver genes by using module network integration of multi-omics data.
Identification of P2RY13 as an immune-related prognostic biomarker in lung adenocarcinoma: A public database-based retrospective study.
Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma.
Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining.
Identification of PGRMC1 as a Candidate Oncogene for Head and Neck Cancers and Its Involvement in Metabolic Activities.
Identification of PIEZO1 as a potential prognostic marker in gliomas.
Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status.
Identification of potential autophagy-associated lncRNA in prostate cancer.
Identification of potential biomarkers and candidate small molecule drugs in glioblastoma.
Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods.
Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
Identification of potential biomarkers and their clinical significance in gastric cancer using bioinformatics analysis methods.
Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis.
Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis.
Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer.
Identification of Potential BRAF Inhibitor Joint Therapy Targets in PTC based on WGCAN and DCGA.
Identification of potential CpG sites for oral squamous cell carcinoma diagnosis via integrated analysis of DNA methylation and gene expression.
Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Identification of Potential Crucial Genes Associated with Carcinogenesis of Clear Cell Renal Cell Carcinoma.
Identification of Potential Crucial Genes Associated With the Pathogenesis and Prognosis of Endometrial Cancer.
Identification of potential crucial genes associated with the pathogenesis and prognosis of pancreatic adenocarcinoma.
Identification of potential crucial genes associated with the pathogenesis and prognosis of prostate cancer.
Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.
Identification of Potential Diagnostic and Prognostic Values of P4HA1 Expression in Lung Cancer, Breast Cancer, and Head and Neck Cancer.
Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma.
Identification of Potential Driver Genes Based on Multi-Genomic Data in Cervical Cancer.
Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets.
Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer.
Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis.
Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
Identification of potential key genes in esophageal adenocarcinoma using bioinformatics.
Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning.
Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
Identification of potential prognostic biomarkers for breast cancer using WGCNA and PPI integrated techniques.
Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Recurrence in Patients with Cervical Cancer.
Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
Identification of potential prognostic long non-coding RNA for predicting survival in intrahepatic cholangiocarcinoma.
Identification of potential prognostic long non?coding RNA signatures based on a competing endogenous RNA network in lung adenocarcinoma.
Identification of potential prognostic markers associated with lung metastasis in breast cancer by coexpression network analysis.
Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma.
Identification of potential prognostic small nucleolar RNA biomarkers for predicting overall survival in patients with sarcoma.
Identification of potential prognostic TF-associated lncRNAs for predicting survival in ovarian cancer.
Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis.
Identification of Potential Signatures and Their Functions for Acute Lymphoblastic Leukemia: A Study Based on the Cancer Genome Atlas.
Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis.
Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Gastric Carcinoma using Bioinformatics Analysis.
Identification of Prion Disease-Related Somatic Mutations in the Prion Protein Gene (PRNP) in Cancer Patients.
Identification of Prognosis Associated microRNAs in HNSCC Subtypes Based on TCGA Dataset.
Identification of prognosis-associated immune genes and exploration of immune cell infiltration in colorectal cancer.
Identification of prognosis-related alternative splicing events in kidney renal clear cell carcinoma.
Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis.
Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.
Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer.
Identification of prognostic aging-related genes associated with immunosuppression and inflammation in head and neck squamous cell carcinoma.
Identification of prognostic alternative splicing events in sarcoma.
Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.
Identification of Prognostic alternative splicing signatures and their clinical significance in uveal melanoma.
Identification of prognostic alternative splicing signatures in uveal melanoma.
Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer.
Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data.
Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma.
Identification of prognostic and subtype-specific potential miRNAs in thymoma.
Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis.
Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma.
Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network.
Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
Identification of prognostic biomarkers of hepatocellular carcinoma via long noncoding RNA expression and copy number alterations.
Identification of Prognostic Candidate Genes in Breast Cancer by Integrated Bioinformatic Analysis.
Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.
Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
Identification of prognostic genes and construction of a novel gene signature in the skin melanoma based on the tumor microenvironment.
Identification of Prognostic Genes and Pathways in Lung Adenocarcinoma Using a Bayesian Approach.
Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
Identification of prognostic genes in kidney renal clear cell carcinoma by RNA?seq data analysis.
Identification of Prognostic Genes in Leiomyosarcoma by Gene Co-Expression Network Analysis.
Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis.
Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma.
Identification of prognostic immune genes in laryngeal cancer.
Identification of Prognostic Immune-Related Genes by Integrating mRNA Expression and Methylation in Lung Adenocarcinoma.
Identification of Prognostic Immune-Related Genes in Pancreatic Adenocarcinoma and Establishment of a Prognostic Nomogram: A Bioinformatic Study.
Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer.
Identification of prognostic long intergenic non-coding RNAs as competing endogenous RNAs with KRAS mutations in colorectal cancer.
Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles.
Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach.
Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.
Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Identification of prognostic miRNA biomarkers for predicting overall survival of colon adenocarcinoma and bioinformatics analysis: A study based on The Cancer Genome Atlas database.
Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.
Identification of Prognostic miRNAs Associated With Immune Cell Tumor Infiltration Predictive of Clinical Outcomes in Patients With Non-Small Cell Lung Cancer.
Identification of prognostic mRNAs in metastatic cutaneous melanoma.
Identification of Prognostic Related Genes of Tumor Microenvironment Derived From Esophageal Cancer Patients.
Identification of prognostic risk factors for esophageal adenocarcinoma using bioinformatics analysis.
Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma.
Identification of prognostic signature of non-small cell lung cancer based on TCGA methylation data.
Identification of Prognostic Signatures for Predicting the Overall Survival of Uveal Melanoma Patients.
Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
Identification of Prognostic Stromal-Immune Score-Based Genes in Hepatocellular Carcinoma Microenvironment.
Identification of prognostic tumor-infiltrating immune cells in endometrial adenocarcinoma.
Identification of Prostate Cancer-Related Circular RNA Through Bioinformatics Analysis.
Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ.
Identification of putative actionable alterations in clinically relevant genes in breast cancer.
Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map.
Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Identification of Radioresponsive Genes in Esophageal Cancer from Longitudinal and Single Cell Exome Sequencing.
Identification of Radiotherapy-Associated Genes in Lung Adenocarcinoma by an Integrated Bioinformatics Analysis Approach.
Identification of rare germline copy number variations over-represented in five human cancer types.
Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma.
Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.
Identification of recurrent and novel mutations by whole?genome sequencing of colorectal tumors from the Han population in Shanghai, eastern China.
Identification of reference genes and miRNAs for qRT-PCR in human esophageal squamous cell carcinoma.
Identification of reference miRNAs in human tumors by TCGA miRNA-seq data.
Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis.
Identification of Retinol Binding Protein 1 Promoter Hypermethylation in Isocitrate Dehydrogenase 1 and 2 Mutant Gliomas.
Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia.
Identification of RNA binding protein interacting with circular RNA and hub candidate network for hepatocellular carcinoma.
Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
Identification of RNA Transcript Makers Associated With Prognosis of Kidney Renal Clear Cell Carcinoma by a Competing Endogenous RNA Network Analysis.
Identification of RNA-binding protein SNRPA1 for prognosis in prostate cancer.
Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study.
Identification of ROR? as a favorable biomarker for colon cancer.
Identification of SARS-CoV-2 Proteins Binding Human mRNAs As a Novel Signature Predicting Overall Survival in Hepatocellular Carcinoma.
Identification of SCARA5 Gene as a Potential Immune-Related Biomarker for Triple-Negative Breast Cancer by Integrated Analysis.
Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.
Identification of Secreted Phosphoprotein 1 (SPP1) as a Prognostic Factor in Lower-Grade Gliomas.
Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma.
Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer.
Identification of Sets of Cytoskeletal Related and Adhesion-related Coding Region Mutations in the TCGA Melanoma Dataset that Correlate with a Negative Outcome.
Identification of Seven Aberrantly Methylated and Expressed Genes in Adrenocortical Carcinoma.
Identification of Signatures of Prognosis Prediction for Melanoma Using a Hypoxia Score.
Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods.
Identification of Six Autophagy-Related-lncRNA Prognostic Biomarkers in Uveal Melanoma.
Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma.
Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Identification of Somatic Mutations in Dementia-related Genes in Cancer Patients.
Identification of Somatic Mutations in Papanicolaou Smear DNA and Plasma Circulating Cell-Free DNA for Detection of Endometrial and Epithelial Ovarian Cancers: A Pilot Study.
Identification of special key genes for alcohol-related hepatocellular carcinoma through bioinformatic analysis.
Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation.
Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.
Identification of spliceosome components pivotal to breast cancer survival.
Identification of stage-specific biomarkers in lung adenocarcinoma based on RNA-seq data.
Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis.
Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model.
Identification of Subpathway Signatures For Ovarian Cancer Prognosis by Integrated Analyses of High-Throughput miRNA and mRNA Expression.
Identification of subtype-specific genes signature by WGCNA for prognostic prediction in diffuse type gastric cancer.
Identification of supervised and sparse functional genomic pathways.
Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma.
Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD.
Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses.
Identification of synthetic chemosensitivity genes paired with BRAF for BRAF/MAPK inhibitors.
Identification of Target Genes Related to Sulfasalazine in Triple-Negative Breast Cancer Through Network Pharmacology.
Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF.
Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver Mutations.
Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.
Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer.
Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology.
Identification of the angiogenesis related genes for predicting prognosis of patients with gastric cancer.
Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer.
Identification of the copy number variant biomarkers for breast cancer subtypes.
Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer.
Identification of the Functions and Prognostic Values of RNA Binding Proteins in Bladder Cancer.
Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
Identification of the hub genes and prognostic indicators of gastric cancer and correlation of indicators with tumor-infiltrating immune cell levels.
Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Identification of the Immune-Related Genes in Tumor Microenvironment That Associated With the Recurrence of Head and Neck Squamous Cell Carcinoma.
Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated with an Immunosuppressive Tumor Microenvironment.
Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
Identification of the key miRNAs associated with survival time in stomach adenocarcinoma.
Identification of the key transcription factors in esophageal squamous cell carcinoma.
Identification of the miRNA signature and key genes in colorectal cancer lymph node metastasis.
Identification of the miRNA signature associated with survival in patients with ovarian cancer.
Identification of the miRNA-mRNA regulatory pathways and a miR-21-5p based nomogram model in clear cell renal cell carcinoma.
Identification of the Mutational Landscape of Gynecological Malignancies.
Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular Carcinoma.
Identification of the PCA29 gene signature as a predictor in prostate cancer.
Identification of the potential biomarkers for the metastasis of rectal adenocarcinoma.
Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: An investigation based on GEO and TCGA databases.
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients.
Identification of the Prognostic Value of Immune-Related Genes in Esophageal Cancer.
Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
Identification of the RP11-21C4.1/SVEP1 gene pair associated with FAT2 mutations as a potential biomarker in gastric cancer.
Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer.
Identification of therapeutic targets applicable to clinical strategies in ovarian cancer.
Identification of Three Autophagy-Related Long Non-Coding RNAs as a Novel Head and Neck Squamous Cell Carcinoma Prognostic Signature.
Identification of Three Key Genes Associated with Hepatocellular Carcinoma Progression Based on Co-expression Analysis.
Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma.
Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
Identification of three predictors of gastric cancer progression and prognosis.
Identification of thresholds for dichotomizing DNA methylation data.
Identification of TNIK as a novel potential drug target in thyroid cancer based on protein druggability prediction.
Identification of topological features in renal tumor microenvironment associated with patient survival.
Identification of TP53 mutation associated-immunotype and prediction of survival in patients with hepatocellular carcinoma.
Identification of transcriptional isoforms associated with survival in cancer patient.
Identification of tRNA-derived ncRNAs in TCGA and NCI-60 panel cell lines and development of the public database tRFexplorer.
Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development.
Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer.
Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer.
Identification of tumor microenvironment-related prognostic genes in colorectal cancer based on bioinformatic methods.
Identification of Tumor Microenvironment-Related Prognostic Genes in Sarcoma.
Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma.
Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Identification of Tumor Tissue of Origin with RNA-Seq Data and Using Gradient Boosting Strategy.
Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data.
Identification of two methylated fragments of an SDC2 CpG island using a sliding window technique for early detection of colorectal cancer.
Identification of two molecular subtypes of dysregulated immune lncRNAs in ovarian cancer.
Identification of two novel biomarkers of rectal carcinoma progression and prognosis via co-expression network analysis.
Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.
Identification of TYROBP and C1QB as Two Novel Key Genes With Prognostic Value in Gastric Cancer by Network Analysis.
Identification of ubiquitination-related genes in human glioma as indicators of patient prognosis.
Identification of UGP2 as a progression marker that promotes cell growth and motility in human glioma.
Identification of unanimous immune subtypes for different hormone receptor phenotypes of human breast cancer with potential prognostic significance.
Identification of Vitamin D-related gene signature to predict colorectal cancer prognosis.
Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
Identification of WHO II/III gliomas by 16 prognostic-related gene signatures using machine learning methods.
Identification of MSC-AS1, a novel lncRNA for the diagnosis of laryngeal cancer.
Identification prognosis-associated immune genes in colon adenocarcinoma.
Identification SYT13 as a novel biomarker in lung adenocarcinoma.
Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma.
Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.
Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes.
Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression.
Identify clear cell renal cell carcinoma related genes by gene network.
Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
Identifying a miRNA signature for predicting the stage of breast cancer.
Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
Identifying a novel 5-gene signature predicting clinical outcomes in acute myeloid leukemia.
Identifying a Potential Key Gene, TIMP1, Associated with Liver Metastases of Uveal Melanoma by Weight Gene Co-Expression Network Analysis.
Identifying an Eight-Gene Signature to Optimize Overall Survival Prediction of Esophageal Adenocarcinoma Using Bioinformatics Analysis of ceRNA Network.
Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.
Identifying Cancer Driver lncRNAs Bridged by Functional Effectors through Integrating Multi-omics Data in Human Cancers.
Identifying Cancer Drivers Using DRIVE: A Feature-Based Machine Learning Model for a Pan-Cancer Assessment of Somatic Missense Mutations.
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Identifying candidate agents for lung adenocarcinoma by walking the human interactome.
Identifying candidate drivers of drug response in heterogeneous cancer by mining high throughput genomics data.
Identifying causal networks linking cancer processes and anti-tumor immunity using Bayesian network inference and metagene constructs.
Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival.
Identifying Common Genes Related to Platelet and Immunity for Lung Adenocarcinoma Prognosis Prediction.
Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
Identifying differentially expressed genes from cross-site integrated data based on relative expression orderings.
Identifying Differentially Expressed MicroRNAs Between Cirrhotic and Non-Cirrhotic Hepatocellular Carcinoma and Exploring Their Functions Using Bioinformatic Analysis.
Identifying drug candidates for hepatocellular carcinoma based on differentially expressed genes.
Identifying FBLN1 (Gene ID: 2192) as a Potential Melanoma Biomarker for Melanoma based on an Analysis of microRNA Expression Profiles in the GEO and TCGA Databases.
Identifying Functional Modules in Co-Regulatory Networks Through Overlapping Spectral Clustering.
Identifying gene expression patterns associated with drug-specific survival in cancer patients.
Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis.
Identifying Gene Network Rewiring by Integrating Gene Expression and Gene Network Data.
Identifying gene-environment interactions incorporating prior information.
Identifying gene-gene interactions using penalized tensor regression.
Identifying glioblastoma gene networks based on hypergeometric test analysis.
Identifying GNG4 might play an important role in colorectal cancer TMB.
Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis.
Identifying hub genes of papillary thyroid carcinoma in the TCGA and GEO database using bioinformatics analysis.
Identifying Hypoxia Characteristics to Stratify Prognosis and Assess the Tumor Immune Microenvironment in Renal Cell Carcinoma.
Identifying Interaction Clusters for MiRNA and MRNA Pairs in TCGA Network.
Identifying Long Non-coding RNA of Prostate Cancer Associated With Radioresponse by Comprehensive Bioinformatics Analysis.
Identifying M1 Macrophage-Related Genes Through a Co-expression Network to Construct a Four-Gene Risk-Scoring Model for Predicting Thyroid Cancer Prognosis.
Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.
Identifying microRNA/mRNA dysregulations in ovarian cancer.
Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis.
Identifying miRNA-mRNA Integration Set Associated With Survival Time.
Identifying miRNA-mRNA Pairs and Novel miRNAs from Hepatocelluar Carcinoma miRNomes and TCGA Database.
Identifying MMP14 and COL12A1 as a potential combination of prognostic biomarkers in pancreatic ductal adenocarcinoma using integrated bioinformatics analysis.
Identifying molecular genetic features and oncogenic pathways of clear cell renal cell carcinoma through the anatomical (PADUA) scoring system.
Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data.
Identifying Mutually Exclusive Gene Sets with Prognostic Value and Novel Potential Driver Genes in Patients with Glioblastoma.
Identifying novel biomarkers in hepatocellular carcinoma by weighted gene co-expression network analysis.
Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in Gastric Cancer.
Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects.
Identifying Personalized Metabolic Signatures in Breast Cancer.
Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas.
Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.
Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Identifying prognostic lncRNAs based on a ceRNA regulatory network in laryngeal squamous cell carcinoma.
Identifying Prognostic Significance of RCL1 and Four-Gene Signature as Novel Potential Biomarkers in HCC Patients.
Identifying Putative Susceptibility Genes and Evaluating Their Associations with Somatic Mutations in Human Cancers.
Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation.
Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas.
Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
Identifying the p65-Dependent Effect of Sulforaphene on Esophageal Squamous Cell Carcinoma Progression via Bioinformatics Analysis.
Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma.
Identifying the Transcriptional Regulatory Network Associated With Extrathyroidal Extension in Papillary Thyroid Carcinoma by Comprehensive Bioinformatics Analysis.
Identifying the tumor-progressive gene expression profile in high-risk papillary thyroid cancer.
Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis.
IDH clonal heterogeneity segregates a subgroup of non-1p/19q codeleted gliomas with unfavourable clinical outcome.
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas.
IDH-mutant gliomas with additional class-defining molecular events.
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
IDH1 gene mutation activates Smad signaling molecules to regulate the expression levels of cell cycle and biological rhythm genes in human glioma U87?MG cells.
IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR.
IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.
IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression.
IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/?-catenin pathway.
IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer.
IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
IGFBP3 as an indicator of lymph node metastasis and unfavorable prognosis for papillary thyroid carcinoma.
IGFLR1 as a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates.
IgG Fc Binding Protein (FCGBP) is Down-Regulated in Metastatic Lesions and Predicts Survival in Metastatic Colorectal Cancer Patients.
iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes.
IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.
IGSF1: A novel oncogene regulates the thyroid cancer progression.
IL-10 and integrin signaling pathways are associated with head and neck cancer progression.
IL-13R?2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma.
IL-17 signaling pathway plays a key role in laryngeal squamous cell carcinoma with ethnic specificity.
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.
ILK silencing inhibits migration and invasion of more invasive glioblastoma cells by downregulating ROCK1 and Fascin-1.
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
IMAGE-DRIVEN BIOPHYSICAL TUMOR GROWTH MODEL CALIBRATION.
Imaging Genomics in Gliomas.
Imaging-AMARETTO: An Imaging Genomics Software Tool to Interrogate Multiomics Networks for Relevance to Radiography and Histopathology Imaging Biomarkers of Clinical Outcomes.
Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features.
Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
IMIX: a multivariate mixture model approach to association analysis through multi-omics data integration.
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.
Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis.
Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment.
Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis.
Immune Cell Infiltration and Identifying Genes of Prognostic Value in the Papillary Renal Cell Carcinoma Microenvironment by Bioinformatics Analysis.
Immune cell landscape analysis reveals prognostic immune cells and its potential mechanism in squamous cell lung carcinoma.
Immune cells and signatures characterize tumor microenvironment and predict outcome in ovarian and endometrial cancers.
Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma.
Immune Cluster and PPI Network Analyses Identified CXCR3 as a Key Node of Immunoregulation in Head and Neck Cancer.
Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer.
Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma.
Immune DNA signature of T-cell infiltration in breast tumor exomes.
Immune Gene Expression Is Associated with Genomic Aberrations in Breast Cancer.
Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes.
Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas.
Immune implication of an autophagy-related prognostic signature in uveal melanoma.
Immune implication of FAM83D gene in hepatocellular carcinoma.
Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer.
Immune Infiltration in Invasive Lobular Breast Cancer.
Immune Infiltration Landscape in Clear Cell Renal Cell Carcinoma Implications.
Immune Infiltration Profiling in Nonsmall Cell Lung Cancer and Their Clinical Significance: Study Based on Gene Expression Measurements.
Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma.
Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location.
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy.
Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature.
Immune landscape of papillary thyroid cancer and immunotherapeutic implications.
Immune Landscape of Thyroid Cancers: New Insights.
Immune microenvironment of the gene signature reflecting the standardised uptake value on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in head and neck squamous cell carcinoma.
Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response.
Immune Microenvironment Related Competitive Endogenous RNA Network as Powerful Predictors for Melanoma Prognosis Based on WGCNA Analysis.
Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer.
Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome.
Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma.
Immune profiles in primary squamous cell carcinoma of the head and neck.
Immune Profiles of Tumor Microenvironment and Clinical Prognosis among Women with Triple-Negative Breast Cancer.
Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.
Immune profiling reveals prognostic genes in high-grade serous ovarian cancer.
Immune prognostic risk score model in acute myeloid leukemia with normal karyotype.
Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma.
Immune signature profiling identified prognostic factors for gastric cancer.
Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions.
Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity.
Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression.
Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients.
Immune-Omics Networks of CD27, PD1, and PDL1 in Non-Small Cell Lung Cancer.
Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.
Immune-related gene signature predicts overall survival of gastric cancer patients with varying microsatellite instability status.
Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer.
Immune-Related Genes Are Prognostic Markers for Prostate Cancer Recurrence.
Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.
Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma.
Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma.
Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma.
Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer.
Immune-related somatic mutation genes are enriched in PDACs with diabetes.
Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer.
Immuno-stimultory/regulatory gene expression patterns in advanced ovarian cancer.
Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics.
Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological, and survival analyses.
Immunogenicity and Immune Silence in Human Cancer.
Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer.
Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer.
Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme.
Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family members.
Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-?/? Recombinations.
Immunoglobulin superfamily genes are novel prognostic biomarkers for breast cancer.
Immunoglobulin superfamily member 10 is a novel prognostic biomarker for breast cancer.
Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq.
Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma.
Immunohistochemical Analysis Revealed a Correlation between Musashi-2 and Cyclin-D1 Expression in Patients with Oral Squamous Cells Carcinoma.
Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas.
Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder.
Immunohistochemical Expression of Five Protein Combinations Revealed as Prognostic Markers in Asian Oral Cancer.
Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers.
Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition.
Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma.
Immunoregulatory gene expression and response to bevacizumab in ovarian cancer - An analysis of the cancer genome atlas.
Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients.
Immunoscoring by correlating MHC class II and TCR expression: high level immune functions represented by the KIRP dataset of TCGA.
Immunotherapy in triple-negative breast cancer.
Impact of accumulated alterations in driver and passenger genes on response to radiation therapy.
Impact of age at diagnosis on racial disparities in endometrial cancer patients.
Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.
Impact of cancer atlases on cancer epidemiology: experience of the Danish Atlas of Cancer Incidence.
Impact of CD144 gene expression on outcomes in stage III gastric cancer patients.
Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma.
Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer.
Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups.
Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development.
Impact of FGFR4 Gene Polymorphism on the Progression of Colorectal Cancer.
Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Impact of glioblastoma multiforme associated mutations on the structure and function of MAP/microtubule affinity regulating kinase 4.
Impact of HFE variants and sex in lung cancer.
Impact of Interferon-? Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer.
Impact of KMN network genes on progression and prognosis of non-small cell lung cancer.
Impact of Lin28 on lymph node metastasis in papillary thyroid carcinoma.
Impact of Long Non-coding RNAs Associated With Microenvironment on Survival for Bladder Cancer Patients.
Impact of miRNA sequence on miRNA expression and correlation between miRNA expression and cell cycle regulation in breast cancer cells.
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer.
Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
Impact of negative lymph nodes on colon cancer survival and exploring relevant transcriptomics differences through real-world data analyses.
Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer.
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types.
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.
Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy.
Impact of SRY-Box Transcription Factor 11 Gene Polymorphisms on Oral Cancer Risk and Clinicopathologic Characteristics.
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer.
Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types.
IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
Impacts of RETN genetic polymorphism on breast cancer development.
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.
Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness.
IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors.
Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.
Implications of Circadian Rhythm Regulation by microRNAs in Colorectal Cancer.
Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma.
Improved detection of gene fusions by applying statistical methods reveals oncogenic RNA cancer drivers.
Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation status.
Improved survival associated with somatic PIK3CA mutations in copy-number low endometrioid endometrial adenocarcinoma.
Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti-PD-1 Therapy.
Improvement in prediction of prostate cancer prognosis with somatic mutational signatures.
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels.
Improving our understanding of papillary renal cell carcinoma with integrative genomic analysis.
Improving prediction performance of colon cancer prognosis based on the integration of clinical and multi-omics data.
Improving the overall survival prognosis prediction accuracy: A 9-gene signature in CRC patients.
Improving the Prognosis of Colon Cancer through Knowledge-Based Clinical-Molecular Integrated Analysis.
Imputing missing RNA-sequencing data from DNA methylation by using a transfer learning-based neural network.
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing.
In North America, Some Ovarian Cancers Express the Oncogenes of Preventable Human Papillomavirus HPV-18.
In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC.
In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
In silico analysis of the immune microenvironment in bladder cancer.
In silico analysis reveals a shared immune signature in CASP8-mutated carcinomas with varying correlations to prognosis.
In Silico Discovery of Candidate Drugs against Covid-19.
In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma.
In Silico Identification of Contradictory Role of ADAMTS5 in Hepatocellular Carcinoma.
In Silico Identification of Crucial Genes and Specific Pathways in Hepatocellular Cancer.
In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition.
In silico Identification of SFRP1 as a Hypermethylated Gene in Colorectal Cancers.
In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
In Silico Inference of Synthetic Cytotoxic Interactions from Paclitaxel Responses.
In silico investigation of heparanase-correlated genes in breast cancer subtypes.
In silico pathway analysis and tissue specific cis-eQTL for colorectal cancer GWAS risk variants.
In silico prediction of housekeeping long intergenic non-coding RNAs reveals HKlincR1 as an essential player in lung cancer cell survival.
In silico repurposing the Rac1 inhibitor NSC23766 for treating PTTG1-high expressing clear cell renal carcinoma.
In silico study of cancer stage-specific DNA methylation pattern in White breast cancer patients based on TCGA dataset.
In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells.
In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast Cancer.
In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
In-Depth Proteomics Analysis to Identify Biomarkers of Papillary Thyroid Cancer Patients Older Than 45 Years with Different Degrees of Lymph Node Metastases.
Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy.
Inactivation of SMARCA2 by promoter hypermethylation drives lung cancer development.
INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression.
INBIA: a boosting methodology for proteomic network inference.
Incidence and mortality of bone cancer among children, adolescents and young adults of Brazil.
Incidental gallbladder cancer at cholecystectomy.
Incorporating genetic networks into case-control association studies with high-dimensional DNA methylation data.
Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients.
Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study.
Increased CX3CL1 mRNA expression level is a positive prognostic factor in patients with lung adenocarcinoma.
Increased DHRS12 expression independently predicts poor survival in patients with high-grade serous ovarian cancer.
Increased DSG2 plasmatic levels identified by transcriptomic-based secretome analysis is a potential prognostic biomarker in laryngeal carcinoma.
Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab.
Increased expression of Cyclin F in liver cancer predicts poor prognosis: A study based on TCGA database.
Increased Expression of Gremlin1 Promotes Proliferation and Epithelial Mesenchymal Transition in Gastric Cancer Cells and Correlates With Poor Prognosis of Patients With Gastric Cancer.
Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
Increased Expression of KNSTRN in Lung Adenocarcinoma Predicts Poor Prognosis: A Bioinformatics Analysis Based on TCGA Data.
Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence.
Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis.
Increased expression of methionine sulfoxide reductases B3 is associated with poor prognosis in gastric cancer.
Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.
Increased Expression of PDK4 Was Displayed in Gastric Cancer and Exhibited an Association With Glucose Metabolism.
Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma.
Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma.
Increased Expression of T-Box Transcription Factor Protein 21 (TBX21) in Skin Cutaneous Melanoma Predicts Better Prognosis: A Study Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) Databases.
Increased Expression of TICRR Predicts Poor Clinical Outcomes: A Potential Therapeutic Target for Papillary Renal Cell Carcinoma.
Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis.
Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma.
Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer.
Increased EXT1 gene copy number correlates with increased mRNA level predicts short disease-free survival in hepatocellular carcinoma without vascular invasion.
Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers.
Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.
Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma.
Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis.
Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas.
Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma.
Increased Proportion of Variance Explained and Prediction Accuracy of Survival of Breast Cancer Patients with Use of Whole-Genome Multiomic Profiles.
Increased RBM12 expression predicts poor prognosis in hepatocellular carcinoma based on bioinformatics.
Increased Risk of Acute Myelogenous Leukemia After Early Onset but Not Late-Onset Colorectal Cancer.
Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular Breast Cancer and Normal PAM50 Subtype.
Increased SPC24 in prostatic diseases and diagnostic value of SPC24 and its interacting partners in prostate cancer.
Increased Vascular Adhesion Protein 1 (VAP-1) Levels are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas.
Increased VEGF-A in solid type of lung adenocarcinoma reduces the patients' survival.
Indel detection from DNA and RNA sequencing data with transIndel.
Independent prognostic genes and mechanism investigation for colon cancer.
Independent prognostic miRNAs for bladder urothelial carcinoma.
Independent validation of early-stage NSCLC prognostic scores incorporating epigenetic and transcriptional biomarkers with gene-gene interactions and main effects.
Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial-Mesenchymal Transition Score in Prognosis Prediction.
Individualized analysis of differentially expressed miRNAs with application to the identification of miRNAs deregulated commonly in lung cancer tissues.
Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes.
Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
Individualized Prediction of Survival by a 10-Long Non-coding RNA-Based Prognostic Model for Patients With Breast Cancer.
Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis.
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer.
Indoleamine 2,3-dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and is Associated with Type II Hypersensitivity/Autoimmunity.
Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer.
Inducing multiple antibodies to treat squamous cell esophageal carcinoma.
Induction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study.
Inference of phenotype-relevant transcriptional regulatory networks elucidates cancer type-specific regulatory mechanisms in a pan-cancer study.
Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.
Inferring Aberrant Signal Transduction Pathways in Ovarian Cancer from TCGA Data.
Inferring active and prognostic ligand-receptor pairs with interactions in survival regression models.
Inferring disease subtypes from clusters in explanation space.
Inferring gene expression networks with hubs using a degree weighted Lasso approach.
Inferring Personalized and Race-Specific Causal Effects of Genomic Aberrations on Gleason Scores: A Deep Latent Variable Model.
Inferring perturbation profiles of cancer samples.
Inferring regulatory element landscapes and transcription factor networks from cancer methylomes.
Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Inferring tumour purity and stromal and immune cell admixture from expression data.
Infiltrating T cells increase IDO1 expression in glioblastoma and contribute to decreased patient survival.
Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer.
Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer.
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma.
Influence of BRCA1 Germline Mutations in the Somatic Mutational Burden of Triple-Negative Breast Cancer.
Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration.
Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Breast Cancer Patients.
Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Information theoretic sub-network mining characterizes breast cancer subtypes in terms of cancer core mechanisms.
ING3 promotes prostate cancer growth by activating the androgen receptor.
ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
INHBA is a novel mediator regulating cellular senescence and immune evasion in colorectal cancer.
INHBA is a prognostic predictor for patients with colon adenocarcinoma.
INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.
Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78.
Inhibition of DKC1 induces telomere-related senescence and apoptosis in lung adenocarcinoma.
Inhibition of EPS8L3 suppresses liver cancer progression and enhances efficacy of sorafenib treatment.
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.
Inhibition of Glycolysis in Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate.
Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma.
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade.
Inhibition of insulin-like growth factor 1 signaling synergistically enhances the tumor suppressive role of triptolide in triple-negative breast cancer cells.
Inhibition of lung cancer cells and Ras/Raf/MEK/ERK signal transduction by ectonucleoside triphosphate phosphohydrolase-7 (ENTPD7).
Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development.
Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.
Inhibition of pentose phosphate pathway suppresses acute myelogenous leukemia.
Inhibition of Proliferation by Knockdown of Transmembrane (TMEM) 168 in Glioblastoma Cells via Suppression of Wnt/?-Catenin Pathway.
Inhibition of Splicing Factor 3b Subunit 1 (SF3B1) Reduced Cell Proliferation, Induced Apoptosis and Resulted in Cell Cycle Arrest by Regulating Homeobox A10 (HOXA10) Splicing in AGS and MKN28 Human Gastric Cancer Cells.
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.
Inhibition of the Spectraplakin Protein Microtubule Actin Crosslinking Factor 1 Sensitizes Glioblastomas to Radiation.
Inhibition of the Wnt/?-catenin pathway enhances antitumor immunity in ovarian cancer.
Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells.
Inhibitors of STAT3, ?-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors.
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.
INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT.
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
Insights from Global Analyses of Long Noncoding RNAs in Breast Cancer.
Insights from multidimensional analyses of the pan-cancer DNA methylome heterogeneity and the uncanonical CpG-gene associations.
Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.
Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.
Insulin-Induced Gene 2 Expression Is Associated with Breast Cancer Metastasis.
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer.
Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer.
Insulin-Like Growth Factor and SLC12A7 Dysregulation: A Novel Signaling Hallmark of Non-Functional Adrenocortical Carcinoma.
Insulin-Like Growth Factor Binding Protein 5-A Probable Target of Kidney Renal Papillary Renal Cell Carcinoma.
INTEGRATE: gene fusion discovery using whole genome and transcriptome data.
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.
Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
Integrated analyses identify potential prognostic markers for uveal melanoma.
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma.
Integrated analysis highlights multiple long non?coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma.
Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
Integrated analysis identifies oxidative stress genes associated with progression and prognosis in gastric cancer.
Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
Integrated analysis of a competing endogenous RNA network in renal cell carcinoma using bioinformatics tools.
Integrated Analysis of a Competing Endogenous RNA Network Revealing a Prognostic Signature for Cervical Cancer.
Integrated analysis of a competing endogenous RNA network reveals key lncRNAs as potential prognostic biomarkers for human bladder cancer.
Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
Integrated Analysis of a Risk Score System Predicting Prognosis and a ceRNA Network for Differentially Expressed lncRNAs in Multiple Myeloma.
Integrated analysis of ceRNA network and tumor-infiltrating immune cells in esophageal cancer.
Integrated Analysis of ceRNA Network Reveals Prognostic and Metastasis Associated Biomarkers in Breast Cancer.
Integrated analysis of circular RNA-associated ceRNA network in cervical cancer: Observational Study.
Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma.
Integrated analysis of competing endogenous RNA in esophageal carcinoma.
Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma.
Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma.
Integrated analysis of competing endogenous RNA networks revealing five prognostic biomarkers associated with colorectal cancer.
Integrated Analysis of DEAD-Box Helicase 56: A Potential Oncogene in Osteosarcoma.
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Integrated analysis of differentially expressed profiles and construction of a competing endogenous long non-coding RNA network in renal cell carcinoma.
Integrated Analysis of Distant Metastasis-Associated Genes and Potential Drugs in Colon Adenocarcinoma.
Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer.
Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma.
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer.
Integrated analysis of gene expression signatures associated with colon cancer from three datasets.
Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.
Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers.
Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma.
Integrated Analysis of Germ Cell Tumors.
Integrated analysis of HPV-mediated immune alterations in cervical cancer.
Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients.
Integrated analysis of hypoxia-induced miR-210 signature as a potential prognostic biomarker of hepatocellular carcinoma: a study based on The Cancer Genome Atlas.
Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma.
Integrated analysis of lncRNA CTD-2357A8.3 expression and its potential roles in head and neck squamous cell carcinoma.
Integrated analysis of lncRNA-associated ceRNA network reveals potential biomarkers for the prognosis of hepatitis B virus-related hepatocellular carcinoma.
Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma.
Integrated Analysis of lncRNA-Mediated ceRNA Network Reveals a Prognostic Signature for Hepatocellular Carcinoma.
Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.
Integrated analysis of long non-coding RNA?associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Integrated analysis of long non-coding RNAs in human gastric cancer: An in silico study.
Integrated analysis of long non?coding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database.
Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma.
Integrated analysis of long noncoding RNA interactions reveals the potential role in progression of human papillary thyroid cancer.
Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets.
Integrated analysis of metabolome in a EUS-FNA sample with transcriptome in the TCGA cohort of pancreatic head and body/tail adenocarcinoma.
Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
Integrated Analysis of Microarray and RNA-Seq Data for the Identification of Hub Genes and Networks Involved in the Pancreatic Cancer.
Integrated Analysis of MicroRNA (miRNA) and mRNA Profiles Reveals Reduced Correlation between MicroRNA and Target Gene in Cancer.
Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma.
Integrated Analysis of RNA-Binding Proteins Associated With the Prognosis and Immunosuppression in Squamous Cell Carcinoma of Head and Neck.
Integrated Analysis of RNA-Binding Proteins in Glioma.
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals distinct cancer-associated fibroblasts in head and neck squamous cell carcinoma.
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
Integrated analysis of the E2F transcription factors across cancer types.
Integrated Analysis of the Functions and Prognostic Values of RNA Binding Proteins in Lung Squamous Cell Carcinoma.
Integrated analysis of the functions of RNA binding proteins in clear cell renal cell carcinoma.
Integrated analysis of the genomic and transcriptional profile of high-grade gliomas in different age groups.
Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer.
Integrated Analysis of the Prognosis-Associated RNA-Binding Protein Genes and Candidate Drugs in Renal Papillary Cell Carcinoma.
Integrated analysis of the prognostic values of RNA-binding proteins in head and neck squamous cell carcinoma.
Integrated analysis of the roles and prognostic value of RNA binding proteins in lung adenocarcinoma.
Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.
Integrated Analysis of the Transcriptome Profile Reveals the Potential Roles Played by Long Noncoding RNAs in Immunotherapy for Sarcoma.
Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
Integrated analysis of transcription factors and targets co-expression profiles reveals reduced correlation between transcription factors and target genes in cancer.
Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma.
Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database.
Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma.
Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.
Integrated Analysis Reveals hsa-miR-142 as a Representative of a Lymphocyte-Specific Gene Expression and Methylation Signature.
Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma.
Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.
Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
Integrated Analysis to Identify a Redox-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Integrated Approaches for the Use of Large Datasets to Identify Rational Therapies for the Treatment of Lung Cancers.
Integrated Bioinformatic Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Endometrial Cancer.
Integrated bioinformatic analysis of RNA binding proteins in hepatocellular carcinoma.
Integrated Bioinformatical Analysis Identifies GIMAP4 as an Immune-Related Prognostic Biomarker Associated With Remodeling in Cervical Cancer Tumor Microenvironment.
Integrated Bioinformatics analysis and clinical validation reveals that high expression of mucin 1 in intrahepatic cholangiocarcinoma predicts recurrence after curative resection.
Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.
Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Integrated Bioinformatics Analysis of DNA Methylation Biomarkers in Thyroid Cancer Based on TCGA Database.
Integrated bioinformatics analysis of the association between apolipoprotein E expression and patient prognosis in papillary thyroid carcinoma.
Integrated bioinformatics analysis revealing independent prognostic long non-coding RNAs DNAH17-AS1 and RP11-400N13.2 and their potential oncogenic roles in colorectal cancer.
Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer.
Integrated Bioinformatics Analysis the Function of RNA Binding Proteins (RBPs) and Their Prognostic Value in Breast Cancer.
Integrated bioinformatics analysis to identify 15 hub genes in breast cancer.
Integrated Bioinformatics Analysis to Identify Abnormal Methylated Differentially Expressed Genes for Predicting Prognosis of Human Colon Cancer.
Integrated bioinformatics analysis to screen hub genes in the lymph node metastasis of thyroid cancer.
Integrated Cancer Subtyping using Heterogeneous Genome-Scale Molecular Datasets.
Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes.
Integrated case-control and somatic-germline interaction analyses of soft-tissue sarcoma.
Integrated Cox's model for predicting survival time of glioblastoma multiforme.
Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.
Integrated Dissection of lncRNA-Perturbated Triplets Reveals Novel Prognostic Signatures Across Cancer Types.
Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma.
Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8+ T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.
Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma.
Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets.
Integrated genomic analyses of ovarian carcinoma.
Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas.
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.
Integrated genomic and functional microRNA analysis identifies miR-30-5p as a tumor suppressor and potential therapeutic nanomedicine in head and neck cancer.
Integrated genomic and methylation profile analysis to identify candidate tumor marker genes in patients with colorectal cancer.
Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.
Integrated genomic profiling identifies microRNA-92a regulation of IQGAP2 in locally advanced rectal cancer.
Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations.
Integrated immune gene expression signature and molecular classification in gastric cancer: New insights.
Integrated metabolomics and lipidomics analyses reveal metabolic reprogramming in human glioma with IDH1 mutation.
Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration.
Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A.
Integrated miRNA profiling and bioinformatics analyses reveal upregulated miRNAs in gastric cancer.
Integrated Molecular Characterization of Uterine Carcinosarcoma.
Integrated morphologic analysis for the identification and characterization of disease subtypes.
Integrated multi-omics analysis of the clinical relevance and potential regulatory mechanisms of splicing factors in hepatocellular carcinoma.
Integrated multi-omics data analyses for exploring the co-occurring and mutually exclusive gene alteration events in colorectal cancer.
Integrated multiomic predictors for ovarian cancer survival.
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact.
Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent regulation of the activator protein 1 (AP-1) pathway.
Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer.
Integrated pan-cancer of AURKA expression and drug sensitivity analysis reveals increased expression of AURKA is responsible for drug resistance.
Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
Integrated PPI- and WGCNA-Retrieval of Hub Gene Signatures Shared Between Barrett's Esophagus and Esophageal Adenocarcinoma.
Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.
Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer.
Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma.
Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.
Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma.
Integrated TCGA analysis implicates lncRNA CTB-193M12.5 as a prognostic factor in lung adenocarcinoma.
Integrated Theory- and Data-driven Feature Selection in Gene Expression Data Analysis.
Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients.
Integrated transcriptomic analysis of distance-related field cancerization in rectal cancer patients.
Integrated Transcriptomic Analysis of Necrosis-related Gene in Diffuse Gliomas.
Integrating Clinical and Genetic Analysis of Perineural Invasion in Head and Neck Squamous Cell Carcinoma.
Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
Integrating data from heterogeneous DNA microarray platforms.
Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinoma.
Integrating Genomic Data with Transcriptomic Data for Improved Survival Prediction for Adult Diffuse Glioma.
Integrating genomics in head and neck cancer treatment: Promises and pitfalls.
Integrating germline and somatic genetics to identify genes associated with lung cancer.
Integrating Germline and Somatic Mutation Information for the Discovery of Biomarkers in Triple-Negative Breast Cancer.
Integrating germline and somatic variation information using genomic data for the discovery of biomarkers in prostate cancer.
Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
Integrating high-throughput microRNA and mRNA expression data to identify risk mRNA signature for pancreatic cancer prognosis.
Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Integrating multi-omics data through deep learning for accurate cancer prognosis prediction.
Integrating multi-omics for uncovering the architecture of cross-talking pathways in breast cancer.
Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders.
Integrating multidimensional omics data for cancer outcome.
Integrating multiple omics data for the discovery of potential Beclin-1 interactions in breast cancer.
Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Integrating of genomic and transcriptomic profiles for the prognostic assessment of breast cancer.
Integrating omics data and protein interaction networks to prioritize driver genes in cancer.
Integrating Protein-Protein Interaction Networks and Somatic Mutation Data to Detect Driver Modules in Pan-Cancer.
Integrating spatial gene expression and breast tumour morphology via deep learning.
Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.
Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma.
Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal.
Integration and analysis of genome-scale data from gliomas.
Integration and Analysis of Heterogeneous Colorectal Cancer Data for Translational Research.
Integration and comparison of different genomic data for outcome prediction in cancer.
Integration of a bacterial gene sequence into a chronic eosinophilic leukemia patient's genome as part of a fusion gene linker.
Integration of gene profile to explore the hub genes of lung adenocarcinoma: A quasi-experimental study.
Integration of Genomic and Transcriptomic Markers Improves the Prognosis Prediction of Acute Promyelocytic Leukemia.
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification.
Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancer.
Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance.
Integration of metabolomic and transcriptomic data reveals metabolic pathway alteration in breast cancer and impact of related signature on survival.
Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
Integration of miRNA-regulatory networks in hepatic stellate cells identifies TIMP3 as a key factor in chronic liver disease.
Integration of Multi-Modal Biomedical Data to Predict Cancer Grade and Patient Survival.
Integration of Multi-omics Data for Gene Regulatory Network Inference and Application to Breast Cancer.
Integration of Online Omics-Data Resources for Cancer Research.
Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Integration of Survival and Binary Data for Variable Selection and Prediction: A Bayesian Approach.
Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power.
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
Integrative analysis and machine learning on cancer genomics data using the Cancer Systems Biology Database (CancerSysDB).
Integrative analysis and validation of dysregulated long non-coding RNAs in colon cancer.
Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer.
Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes.
Integrative analysis of BSG expression in NPC through immunohistochemistry and public high-throughput gene expression data.
Integrative Analysis of Cancer Omics Data for Prognosis Modeling.
Integrative Analysis of CD133 mRNA in Human Cancers Based on Data Mining.
Integrative Analysis of Cellular Morphometric Context Reveals Clinically Relevant Signatures in Lower Grade Glioma.
Integrative analysis of ceRNA network and DNA methylation associated with gene expression in malignant pheochromocytomas: a study based on The Cancer Genome Atlas.
Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
Integrative analysis of common genes and driver mutations implicated in hormone stimulation for four cancers in women.
Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma.
Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications.
Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast Cancer.
Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma.
Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma.
Integrative analysis of gene alterations and immunoexpression profiles of cell cycle checkpoints in oral squamous cell carcinoma.
Integrative analysis of gene expression profiles reveals specific signaling pathways associated with pancreatic duct adenocarcinoma.
Integrative analysis of genetic and epigenetic profiling of lung squamous cell carcinoma (LSCC) patients to identify smoking level relevant biomarkers.
Integrative analysis of genomic alteration, immune cells infiltration and prognosis of lung squamous cell carcinoma (LUSC) to identify smoking-related biomarkers.
Integrative Analysis of Genomic and Clinical Data Reveals Intrinsic Characteristics of Bladder Urothelial Carcinoma Progression.
Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma.
Integrative Analysis of Histopathological Images and Genomic Data Predicts Clear Cell Renal Cell Carcinoma Prognosis.
Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma.
Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.
Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer.
Integrative Analysis of Long Noncoding RNA (lncRNA), microRNA (miRNA) and mRNA Expression and Construction of a Competing Endogenous RNA (ceRNA) Network in Metastatic Melanoma.
Integrative Analysis of Methylation and Copy Number Variations of Prostate Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis.
Integrative Analysis of MicroRNA and Gene Interactions for Revealing Candidate Signatures in Prostate Cancer.
Integrative analysis of miRNA and mRNA expression profiles reveals a novel mRNA/miRNA signature to improve risk classification for patients with gastric cancer.
Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2.
Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma.
Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation.
Integrative Analysis of Multi-Genomic Data for Kidney Renal Cell Carcinoma.
Integrative Analysis of Multi-Omics Data Based on Blockwise Sparse Principal Components.
Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer.
Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Integrative analysis of pathological images and multi-dimensional genomic data for early-stage cancer prognosis.
Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.
Integrative analysis of the gastric cancer long non-coding RNA-associated competing endogenous RNA network.
Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer.
Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer.
Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma.
Integrative Analysis Reveals Comprehensive Altered Metabolic Genes Linking with Tumor Epigenetics Modification in Pan-Cancer.
Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis.
Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
Integrative analysis with a system of semiparametric projection non-linear regression models.
Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1).
Integrative Bioinformatics Analysis Identifies NEK2 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma.
Integrative bioinformatics analysis of KPNA2 in six major human cancers.
Integrative bioinformatics analysis of prognostic alternative splicing signatures in gastric cancer.
Integrative Bioinformatics Approaches to Screen Potential Prognostic Immune-Related Genes and Drugs in the Cervical Cancer Microenvironment.
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma.
Integrative clinical genomics of metastatic cancer.
Integrative clustering of high-dimensional data with joint and individual clusters.
Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm.
Integrative Clustering Reveals a Novel Subtype of Soft Tissue Sarcoma With Poor Prognosis.
Integrative Comparison of mRNA Expression Patterns in Breast Cancers from Caucasian and Asian Americans with Implications for Precision Medicine.
Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Integrative discovery of CD98 as a Melanoma Biomarker.
Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma.
Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.
Integrative epigenetic and genetic pan-cancer somatic alteration portraits.
Integrative eQTL-based analyses reveal the biology of breast cancer risk loci.
Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets.
Integrative expression quantitative trait locus-based analysis of colorectal cancer identified a functional polymorphism regulating SLC22A5 expression.
Integrative gene set analysis of multi-platform data with sample heterogeneity.
Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.
Integrative genome-scale analysis of immune infiltration in esophageal carcinoma.
Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.
Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in czech republic and in the United States.
Integrative genomic analyses identify WDR12 as a novel oncogene involved in glioblastoma.
Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer.
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.
Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation.
Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer.
Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas.
Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma.
Integrative modeling identifies genetic ancestry-associated molecular correlates in human cancer.
Integrative Models of Histopathological Image Features and Omics Data Predict Survival in Head and Neck Squamous Cell Carcinoma.
Integrative module analysis of HCC gene expression landscapes.
Integrative molecular characterization of Chinese prostate cancer specimens.
Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
Integrative Multi-omics Module Network Inference with Lemon-Tree.
Integrative network analysis for survival-associated gene-gene interactions across multiple genomic profiles in ovarian cancer.
Integrative network analysis of TCGA data for ovarian cancer.
Integrative Network Analysis Reveals a MicroRNA-Based Signature for Prognosis Prediction of Epithelial Ovarian Cancer.
Integrative Network Fusion: A Multi-Omics Approach in Molecular Profiling.
Integrative omics analysis reveals effective stratification and potential prognosis markers of pan-gastrointestinal cancers.
Integrative Omics Analysis Reveals Post-Transcriptionally Enhanced Protective Host Response in Colorectal Cancers with Microsatellite Instability.
Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains.
Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications.
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer.
Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
Integrative subtype discovery in glioblastoma using iCluster.
Integrative transcriptome analysis identified a BMP signaling pathway-regulated lncRNA AC068643.1 in IDH mutant and wild-type glioblastomas.
Integrative transcriptome data mining for identification of core lncRNAs in breast cancer.
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer.
Integrative, multi-omics, analysis of blood samples improves model predictions: applications to cancer.
Integrative, multimodal analysis of glioblastoma using TCGA molecular data, pathology images, and clinical outcomes.
Integrin ?-5 as a potential biomarker of head and neck squamous cell carcinoma.
Integrin ?1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells.
Integrin ?11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence.
Integrin ?4 promotes invasion and anoikis resistance of papillary thyroid carcinoma and is consistently overexpressed in lymphovascular tumor thrombus.
Integrin ?5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker.
Integrin ?6?4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
Integrin alphavbeta3 enhances ?-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivity.
Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer.
Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma.
Integrin gene expression profiles of human hepatocellular carcinoma.
Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients.
Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomas.
Interaction between the microbiome and TP53 in human lung cancer.
Interaction of Age at Diagnosis with Transcriptional Profiling in Papillary Thyroid Cancer.
Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Interaction-Based Feature Selection for Uncovering Cancer Driver Genes Through Copy Number-Driven Expression Level.
Interactions between Germline and Somatic Mutated Genes in Aggressive Prostate Cancer.
Interactions between tumor mutation burden and immune infiltration in ovarian cancer.
Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis.
Interfaces to PeptideAtlas: a case study of standard data access systems.
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non-Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab.
Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma.
Interferon regulatory factor 6 correlates with the progression of non-small cell lung cancer and can be regulated by miR-320.
Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Interferon-?-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation.
Interferon-Induced Protein 44 Correlated With Immune Infiltration Serves as a Potential Prognostic Indicator in Head and Neck Squamous Cell Carcinoma.
Interferon-Induced Transmembrane Protein 3 Shapes an Inflamed Tumor Microenvironment and Identifies Immuno-Hot Tumors.
Interferon-lambda (IFNL) germline variations and their significance for HCC and PDAC progression: an analysis of The Cancer Genome Atlas (TCGA) data.
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.
Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer.
Interhemispheric transcallosal approach for resection of intraventricular central neurocytoma.
Interleukin 1?/1RA axis in colorectal cancer regulates tumor invasion, proliferation and apoptosis via autophagy.
Interleukin 32 expression in human melanoma.
Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
Interleukin-1 receptor-associated kinase 1 correlates with metastasis and invasion in endometrial carcinoma.
Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma.
Interleukin-33 in human gliomas: Expression and prognostic significance.
Interleukin-33 modulates immune responses in cutaneous melanoma in a context-specific way.
Interleukin-6 and tumor necrosis factor alpha in synovial fluid are associated with progression of radiographic knee osteoarthritis in subjects with previous meniscectomy.
Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition.
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data.
Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients.
Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer.
Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).
Interpretation of personal genome sequencing data in terms of disease ranks based on mutual information.
Interpretation of somatic POLE mutations in endometrial carcinoma.
Interpretation of T cell states from single-cell transcriptomics data using reference atlases.
Interpreting the Molecular Mechanisms of Yinchenhao Decoction on Hepatocellular Carcinoma through Absorbed Components Based on Network Pharmacology.
InterSIM: Simulation tool for multiple integrative 'omic datasets'.
Intestinal Epithelial TBK1 Prevents Differentiation of T-helper 17 Cells and Tumorigenesis in Mice.
Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas.
Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer.
Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer.
Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.
Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
Intratumor heterogeneity and homologous recombination deficiency of high-grade serous ovarian cancer are associated with prognosis and molecular subtype and change in treatment course.
Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients.
Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer.
Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation.
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion.
Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma.
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.
Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer.
Intrinsic cisplatin resistance in lung and ovarian cancer cells propagating in medium acutely depleted of folate.
Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma.
Intrinsic Molecular Subclassification of Urothelial Carcinoma of the Bladder: Are We Finally there?
Introduction: an histology atlas of the rodent mammary gland and human breast during normal postnatal development and in cancer.
Invalidation of mitophagy by FBP1-mediated repression promotes apoptosis in breast cancer.
Invariant Delineation of Nuclear Architecture in Glioblastoma Multiforme from The Cancer Genome Atlas Cohort.
Inverse correlation between Naa10p and Pirh2 expression and the combined prognostic value in oral squamous cell carcinoma patients.
Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer.
Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology.
Investigating a multigene prognostic assay based on significant pathways for Luminal A breast cancer through gene expression profile analysis.
Investigating cellular network heterogeneity and modularity in cancer: a network entropy and unbalanced motif approach.
Investigating MicroRNA and transcription factor co-regulatory networks in colorectal cancer.
Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma.
Investigating skewness to understand gene expression heterogeneity in large patient cohorts.
Investigating the functional implications of reinforcing feedback loops in transcriptional regulatory networks.
Investigating the natural history and prognostic nature of NTRK gene fusions in solid tumors.
Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer.
Investigating the utility of human melanoma cell lines as tumour models.
Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases.
Investigation of miRNA- and lncRNA-mediated competing endogenous RNA network in cholangiocarcinoma.
Investigation of PD-1H in DEN-induced mouse liver cancer model.
Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
Investigation of the clinical significance and molecular mechanism of miR-21-5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation.
Investigation of the putative role of antisense transcripts as regulators of sense transcripts by correlation analysis of sense-antisense pairs in colorectal cancers.
Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis.
Investments in cancer genomics: who benefits and who decides.
Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated 188Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor.
Involvement of dual-strand of the miR-144 duplex and their targets in the pathogenesis of lung squamous cell carcinoma.
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
IODNE: An integrated optimization method for identifying the deregulated subnetwork for precision medicine in cancer.
Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.
IPCT: Integrated Pharmacogenomic Platform of Human Cancer Cell Lines and Tissues.
IPI59: An Actionable Biomarker to Improve Treatment Response in Serous Ovarian Carcinoma Patients.
IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma.
IRE1? and IGF signaling predict resistance to an endoplasmic reticulum stress-inducing drug in glioblastoma cells.
IRF1 association with tumor immune microenvironment and use as a diagnostic biomarker for colorectal cancer recurrence.
IRF1-mediated immune cell infiltration is associated with metastasis in colon adenocarcinoma.
IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma.
IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis.
Iron metabolism gene expression and prognostic features of hepatocellular carcinoma.
Is papillary thyroid microcarcinoma a biologically different disease? A propensity score-matched analysis.
Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer?
Ischemia Induces Quiescence and Autophagy Dependence in Hepatocellular Carcinoma.
Ischemia Is Related to Tumour Genetics in Uveal Melanoma.
isma: an R package for the integrative analysis of mutations detected by multiple pipelines.
Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type.
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.
Isoform specific gene expression analysis of KRAS in the prognosis of lung adenocarcinoma patients.
Isoform switch of pyruvate kinase m1 indeed occurs but not to pyruvate kinase m2 in human tumorigenesis.
IsoformSwitchAnalyzeR: Analysis of changes in genome-wide patterns of alternative splicing and its functional consequences.
IsoMiRmap-fast, deterministic, and exhaustive mining of isomiRs from short RNA-seq datasets.
Italian Atlas of Cancer Mortality.
ITD assembler: an algorithm for internal tandem duplication discovery from short-read sequencing data.
ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
ITGA3 Is Associated With Immune Cell Infiltration and Serves as a Favorable Prognostic Biomarker for Breast Cancer.
ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer.
ITGB4 is a novel prognostic factor in colon cancer.
ITGBL1 promotes EMT, invasion and migration by activating NF-?B signaling pathway in prostate cancer.
ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers.
ITPKA1 Promotes Growth, Migration and Invasion of Renal Cell Carcinoma via Activation of mTOR Signaling Pathway.
iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-?B(p65) Signaling.
JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer.
JAK2 expression is correlated with the molecular and clinical features of breast cancer as a favorable prognostic factor.
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management.
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
Joint analysis of expression profiles from multiple cancers improves the identification of microRNA-gene interactions.
Joint analysis of multiple high-dimensional data types using sparse matrix approximations of rank-1 with applications to ovarian and liver cancer.
JOINT AND INDIVIDUAL VARIATION EXPLAINED (JIVE) FOR INTEGRATED ANALYSIS OF MULTIPLE DATA TYPES.
Joint association and classification analysis of multi-view data.
Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma.
Joint estimation of multiple mixed graphical models for pan-cancer network analysis.
Joint Lp-Norm and L2,1-Norm Constrained Graph Laplacian PCA for Robust Tumor Sample Clustering and Gene Network Module Discovery.
Joint reconstruction of multiple gene networks by simultaneously capturing inter-tumor and intra-tumor heterogeneity.
Joint segmentation and deformable registration of brain scans guided by a tumor growth model.
JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4.
Jumonji domain-containing protein 6 functions as a marker of head and neck squamous cell carcinoma at advanced stage with no effect on prognosis.
Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.
KALRN mutations promote antitumor immunity and immunotherapy response in cancer.
Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
Karyopherin subunit-? 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma.
KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non-small cell lung cancer.
KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.
KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma.
KCNQ1OT1 facilitates progression of non-small-cell lung carcinoma via modulating miRNA-27b-3p/HSP90AA1 axis.
KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma.
KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D.
KDM4A as a prognostic marker of oral squamous cell carcinoma: Evidence from tissue microarray studies in a multicenter cohort.
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden.
KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials.
Kelch-like protein 14 promotes proliferation and migration of ovarian cancer cells.
Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas.
Keratin 80 promotes migration and invasion of colorectal carcinoma by interacting with PRKDC via activating the AKT pathway.
Kernel Fusion Method for Detecting Cancer Subtypes via Selecting Relevant Expression Data.
Key Candidate Genes - VSIG2 of Colon Cancer Identified by Weighted Gene Co-Expression Network Analysis.
Key Common Genes in Obstructive Sleep Apnea and Lung Cancer are Associated with Prognosis of Lung Cancer Patients.
Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study.
Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
Key Genes in Stomach Adenocarcinoma Identified via Network Analysis of RNA-Seq Data.
Key genes in youth colorectal cancer based on data mining and verification by reverse transcription-quantitative PCR.
Key microRNAs and hub genes associated with poor prognosis in lung adenocarcinoma.
Key miRNAs and target genes played roles in the development of clear cell renal cell carcinoma.
Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing.
Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-? and chemotherapeutic gemcitabine-induced necroptosis.
Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer.
Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis.
Keynote lecture. Etiologic insights from cancer mapping.
Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA network.
KIAA0101 in Malignant Pleural Mesothelioma: a Potential Diagnostic and Prognostic Marker.
KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT).
KIAA1211 plays an oncogenic role in human non-small cell lung cancer.
KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA.
KIAA1522 Promotes the Progression of Hepatocellular Carcinoma via the Activation of the Wnt/?-Catenin Signaling Pathway.
Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma.
KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer.
KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers.
KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma.
KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis.
KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosis.
KIF15 upregulation promotes leiomyosarcoma cell growth via promoting USP15-mediated DEK deubiquitylation.
KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
KIF18B promotes tumor progression through activating the Wnt/?-catenin pathway in cervical cancer.
KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK/STAT3 signaling pathway.
KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo.
KIF3C is associated with favorable prognosis in glioma patients and may be regulated by PI3K/AKT/mTOR pathway.
KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
KIF4A: A potential biomarker for prediction and prognostic of prostate cancer.
Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.
Kinase-substrate Edge Biomarkers Provide a More Accurate Prognostic Prediction in ER-negative Breast Cancer.
Kinesin Family Member 11 Enhances the Self-Renewal Ability of Breast Cancer Cells by Participating in the Wnt/?-Catenin Pathway.
Kinesin family member 18B: A contributor and facilitator in the proliferation and metastasis of cutaneous melanoma.
Kinesin Family Member C1 (KIFC1) Accelerates Proliferation and Invasion of Endometrial Cancer Cells Through Modulating the PI3K/AKT Signaling Pathway.
Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
Kinome-Wide Screening with Small Interfering RNA Identified Polo-like Kinase 1 as a Key Regulator of Proliferation in Oral Cancer Cells.
Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells.
KIT performed as a driver gene candidate affecting the survival status of patients with stomach adenocarcinoma.
KLF13 suppresses the proliferation and growth of colorectal cancer cells through transcriptionally inhibiting HMGCS1-mediated cholesterol biosynthesis.
KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer.
KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28.
KLHL5 knockdown increases cellular sensitivity to anticancer drugs.
KM-express: an integrated online patient survival and gene expression analysis tool for the identification and functional characterization of prognostic markers in breast and prostate cancers.
KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer.
Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signaling.
Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer.
Knockdown of carbohydrate sulfotransferase 12 decreases the proliferation and mobility of glioblastoma cells via the WNT/?-catenin pathway.
Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis.
Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells.
Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B.
Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo.
Knockdown of ISOC1 suppresses cell proliferation in pancreatic cancer in vitro.
Knockdown of long non-coding RNA PVT1 induces apoptosis and cell cycle arrest in clear cell renal cell carcinoma through the epidermal growth factor receptor pathway.
Knockdown of long non-coding RNA SLC8A1-AS1 attenuates cell invasion and migration in glioma via suppression of Wnt/?-catenin signaling pathways.
Knockdown of MAPK14 inhibits the proliferation and migration of clear cell renal cell carcinoma by downregulating the expression of CDC25B.
Knockdown of MRPL42 suppresses glioma cell proliferation by inducing cell cycle arrest and apoptosis.
Knockdown of MUC16 (CA125) Enhances the Migration and Invasion of Hepatocellular Carcinoma Cells.
Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation.
Knockdown of POLQ interferes the development and progression of hepatocellular carcinoma through regulating cell proliferation, apoptosis and migration.
Knockdown of RAC1 and VASP gene expression inhibits breast cancer cell migration.
Knockdown of RhoC Inhibits Oral Squamous Cell Carcinoma Cell Invasion and Metastasis via Regulation of HMGA2.
Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway.
Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells.
Knockdown of spindle pole body component 25 homolog inhibits cell proliferation and cycle progression in prostate cancer.
Knockdown of STIL suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway.
Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23.
Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells.
Knockdown of TNF receptor-associated factor 2 (TRAF2) modulates in vitro growth of TRAIL-treated prostate cancer cells.
Knockdown of TOR signaling pathway regulator suppresses cell migration and invasion in non-small cell lung cancer via the regulation of epithelial-to-mesenchymal transition.
Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancer.
Knockoff Boosted Tree for Model-Free Variable Selection.
Knowledge-driven genomic interactions: an application in ovarian cancer.
KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma.
KRAB ZNF explorer - the online tool for the exploration of the transcriptomic profiles of KRAB-ZNF factors in The Cancer Genome Atlas.
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
KRAS G12D mutation predicts lower TMB and drives immune suppression in lung adenocarcinoma.
KRAS gene status in gastric signet-ring cell carcinoma patients and acts as biomarker of MEK inhibitor.
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix.
KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.
KRAS mutations are negatively correlated with immunity in colon cancer.
KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy.
KRASG12C Mutation Is Associated with Increased Risk of Recurrence in Surgically Resected Lung Adenocarcinoma.
KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis.
KRT6A Promotes EMT and Cancer Stem Cell Transformation in Lung Adenocarcinoma.
KRT7 promotes epithelial?mesenchymal transition in ovarian cancer via the TGF??/Smad2/3 signaling pathway.
KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Krüppel-Like Factor 7 is a Marker of Aggressive Gastric Cancer and Poor Prognosis.
L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).
L2,1-Extreme Learning Machine: An Efficient Robust Classifier for Tumor Classification.
Label propagation defines signaling networks associated with recurrently mutated cancer genes.
Label-free quantitative proteomic analysis identifies the oncogenic role of FOXA1 in BaP-transformed 16HBE cells.
Lack of APC somatic mutation is associated with early-onset colorectal cancer in African Americans.
Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer.
Lactate dehydrogenase A silencing in IDH mutant gliomas.
Lactate Dehydrogenase-A (LDH-A) Preserves Cancer Stemness and Recruitment of Tumor-Associated Macrophages to Promote Breast Cancer Progression.
Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness.
Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis.
Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma.
LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma.
LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.
LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer.
LAMC1 upregulation via TGF? induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-?B-CXCL1-STAT3.
Lamin B2 binding to minichromosome maintenance complex component 7 promotes non-small cell lung carcinogenesis.
Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis.
Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Landscape characterization of chimeric RNAs in colorectal cancer.
Landscape of B cell immunity and related immune evasion in human cancers.
Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging.
Landscape of cancer diagnostic biomarkers from specifically expressed genes.
Landscape of cell heterogeneity and evolutionary trajectory in ulcerative colitis-associated colon cancer revealed by single-cell RNA sequencing.
Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq.
Landscape of EBV-positive gastric cancer.
Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma.
Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
Landscape of Genome-Wide DNA Methylation of Colorectal Cancer Metastasis.
Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma.
Landscape of Microsatellite Instability Across 39 Cancer Types.
Landscape of tumor suppressor long noncoding RNAs in breast cancer.
Large Scale Comparison of Gene Expression Levels by Microarrays and RNAseq Using TCGA Data.
Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma.
Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer.
Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma.
Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma.
Large-Scale Analysis Reveals the Specific Clinical and Immune Features of DGCR5 in Glioma.
Large-scale DNA methylation expression analysis across 12 solid cancers reveals hypermethylation in the calcium-signaling pathway.
Large-scale inference of competing endogenous RNA networks with sparse partial correlation.
Large-scale profiling of microRNAs for The Cancer Genome Atlas.
Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.
Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.
Large-Scale Transcriptome Analysis Identified a Novel Cancer Driver Genes Signature for Predicting the Prognostic of Patients With Hepatocellular Carcinoma.
Large-scale transcriptome analysis identified RNA methylation regulators as novel prognostic signatures for lung adenocarcinoma.
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma.
Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.
Laser-assisted microsurgical resection of thoracic intramedullary spinal cord ependymoma.
LASSO?based Cox?PH model identifies an 11?lncRNA signature for prognosis prediction in gastric cancer.
LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
Latency-associated Peptide Identifies Immunoevasive Subtype Gastric Cancer With Poor Prognosis and Inferior Chemotherapeutic Responsiveness.
Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis.
Latent Feature Decompositions for Integrative Analysis of Multi-Platform Genomic Data.
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer.
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signalling and other protein groups of regulatory functions.
LCK expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme.
LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma.
LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition.
Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care.
Learning a Latent Space of Highly Multidimensional Cancer Data.
Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma.
Learning regulatory programs by threshold SVD regression.
Learning subgroup-specific regulatory interactions and regulator independence with PARADIGM.
LEF1-AS1, a long-noncoding RNA, promotes malignancy in glioblastoma.
LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer.
LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/?-catenin signaling pathway and epithelial-mesenchymal transition.
Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma.
Lentivirus-mediated shRNA targeting MUTYH inhibits malignant phenotypes of bladder cancer SW780 cells.
Leptin Is Associated with Poor Clinical Outcomes and Promotes Clear Cell Renal Cell Carcinoma Progression.
Leptin Overexpression as a Poor Prognostic Factor for Colorectal Cancer.
Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer.
Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression.
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women.
Leptomeningeal Metastasis from Adrenocortical Carcinoma: A Case Report.
Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients.
Let-7i-5p enhances cell proliferation, migration and invasion of ccRCC by targeting HABP4.
Letrozole targets the human ether-a-go-go-related gene potassium current in glioblastoma.
Leukocyte immunoglobulin-like receptor subfamily B member 1 potentially acts as a diagnostic and prognostic target in certain subtypes of adenocarcinoma.
Levels of 4EBP1/eIF4E Activation in Renal Cell Carcinoma Could Differentially Predict Its Early and Late Recurrence.
Leveraging global gene expression patterns to predict expression of unmeasured genes.
Leveraging methylation to identify the potential causal genes associated with survival in lung adenocarcinoma and lung squamous cell carcinoma.
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
Leveraging protein dynamics to identify cancer mutational hotspots using 3D structures.
LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder Affects Cell Functions.
LGR6 activates the Wnt/?-catenin signaling pathway and forms a ?-catenin/TCF7L2/LGR6 feedback loop in LGR6high cervical cancer stem cells.
LHX6, An Independent Prognostic Factor, Inhibits Lung Adenocarcinoma Progression through Transcriptional Silencing of ?-catenin.
Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma.
LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
Limb-bud and heart as a novel biomarker for gastric intestinal type adenocarcinoma.
LIMCH1 suppress the growth of lung cancer by interacting with HUWE1 to sustain p53 stability.
LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases.
LIMS1 Promotes Pancreatic Cancer Cell Survival Under Oxygen-Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation.
LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells.
LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway.
LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p.
LINC00294 induced by GRP78 promotes cervical cancer development by promoting cell cycle transition.
LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription.
LINC00460 Hypomethylation Promotes Metastasis in Colorectal Carcinoma.
LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539.
LINC00461 affects the survival of patients with renal cell carcinoma by acting as a competing endogenous RNA for microRNA?942.
LINC00467 promotes proliferation and invasion in glioma via interacting with miRNA-485-5p.
LINC00491 as a new molecular marker can promote the proliferation, migration and invasion of colon adenocarcinoma cells.
LINC00501 Inhibits the Growth and Metastasis of Lung Cancer by Mediating miR-129-5p/HMGB1.
LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665/AKT3 axis.
LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway.
Linc00662 Promotes Tumorigenesis and Progression by Regulating miR-497-5p/AVL9 Axis in Colorectal Cancer.
LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-? pathway in gastric cancer.
LINC00675 Suppresses Cell Proliferation and Migration via Downregulating the H3K4me2 Level at the SPRY4 Promoter in Gastric Cancer.
LINC00675 suppresses proliferative, migration and invasion of clear cell renal cell carcinoma via the Wnt/?-catenin pathway.
LINC00707 accelerates the proliferation, migration and invasion of clear cell renal cell carcinoma.
LINC00844 promotes proliferation and migration of hepatocellular carcinoma by regulating NDRG1 expression.
Linc00941 Is a Novel Transforming Growth Factor ? Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6.
LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis.
LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
LINC01133 promotes the progression of cervical cancer by sponging miR-4784 to up-regulate AHDC1.
LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells.
LINC01296 promotes proliferation, migration, and invasion of HCC cells by targeting miR-122-5P and modulating EMT activity.
LINC01305 inhibits malignant progression of cervical cancer via miR-129-5p/Sox4 axis.
LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis.
LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
LINC01816 promotes the migration, invasion and epithelial?mesenchymal transition of thyroid carcinoma cells by sponging miR?34c?5p and regulating CRABP2 expression levels.
LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers.
LINC02499, a novel liver-specific long non-coding RNA with potential diagnostic and prognostic value, inhibits hepatocellular carcinoma cell proliferation, migration, and invasion.
LINC02535 co-functions with PCBP2 to regulate DNA damage repair in cervical cancer by stabilizing RRM1 mRNA.
LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR-203b-3p activity and facilitating BCL2L1 expression.
LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer.
LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis.
LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.
LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1.
LINE-1 Retrotransposition Promotes the Development and Progression of Lung Squamous Cell Carcinoma by Disrupting the Tumor-Suppressor Gene FGGY.
Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas.
Linear motif atlas for phosphorylation-dependent signaling.
Link synthetic lethality to drug sensitivity of cancer cells.
LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
Linking cancer genome to proteome: NCI's investment into proteogenomics.
Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer.
Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness.
Linking signaling pathways to transcriptional programs in breast cancer.
Lipase member H is a downstream molecular target of hypoxia inducible factor-1? and promotes papillary thyroid carcinoma cell migration in BCPAP and KTC-1 cell lines.
Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma.
Lipocalin-1 Expression as a Prognosticator Marker of Survival in Breast Cancer Patients.
Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-?B/snail/hexokinase3 signaling axis in colorectal cancer.
Liprin-?1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton.
LITAF Enhances Radiosensitivity of Human Glioma Cells via the FoxO1 Pathway.
Liver X Receptor ? Related to Tumor Progression and Ribosome Gene Expression in Papillary Thyroid Cancer.
Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma.
Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma.
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.
LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation.
LMSM: A modular approach for identifying lncRNA related miRNA sponge modules in breast cancer.
LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Lnc2Catlas: an atlas of long noncoding RNAs associated with risk of cancers.
LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.
LnCeCell: a comprehensive database of predicted lncRNA-associated ceRNA networks at single-cell resolution.
lncExplore: a database of pan-cancer analysis and systematic functional annotation for lncRNAs from RNA-sequencing data.
LncNetP, a systematical lncRNA prioritization approach based on ceRNA and disease phenotype association assumptions.
lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
LncRNA and mRNA expression profiles of glioblastoma multiforme (GBM) reveal the potential roles of lncRNAs in GBM pathogenesis.
lncRNA and mRNA signature for prognosis prediction of glioblastoma.
LncRNA and mRNA signatures associated with neoadjuvant chemoradiotherapy downstaging effects in rectal cancer.
LncRNA CASC9 interacts with CPSF3 to regulate TGF-? signaling in colorectal cancer.
LncRNA CCAT2 promotes proliferation and suppresses apoptosis of colorectal cancer cells.
LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.
LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma.
LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR?20b?5p/SOS1 axis.
LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p.
LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer.
LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
LncRNA FAM83A-AS1 promotes lung adenocarcinoma progression by enhancing the pre-mRNA stability of FAM83A.
lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/?-catenin signaling pathway.
LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer.
lncRNA FOXD3-AS1 is associated with clinical progression and regulates cell migration and invasion in breast cancer.
LncRNA H19 regulates PI3K-Akt signal pathway by functioning as a ceRNA and predicts poor prognosis in colorectal cancer: integrative analysis of dysregulated ncRNA-associated ceRNA network.
LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis.
LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer.
LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1.
LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3.
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1.
LncRNA KCNQ1OT1 activated by c-Myc promotes cell proliferation via interacting with FUS to stabilize MAP3K1 in acute promyelocytic leukemia.
LncRNA LINC00668 promotes the progression of breast cancer by inhibiting apoptosis and accelerating cell cycle.
LncRNA LINC00888 upregulation predicts a worse survival of laryngeal cancer patients and accelerates the growth and mobility of laryngeal cancer cells through regulation of miR-378g/TFRC.
LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma.
LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a.
LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
LncRNA MCM3AP-AS1 Regulates Epidermal Growth Factor Receptor and Autophagy to Promote Hepatocellular Carcinoma Metastasis by Interacting with miR-455.
LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression.
LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci.
LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer.
LncRNA NEAT1 promotes autophagy via regulating miR-204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma.
LncRNA NEAT1 Promotes Deterioration of Hepatocellular Carcinoma Based on In Vitro Experiments, Data Mining, and RT-qPCR Analysis.
LncRNA PCAT6: A potential biomarker for diagnosis and prognosis of bladder cancer.
LncRNA PCED1B-AS1 activates the proliferation and restricts the apoptosis of glioma through cooperating with miR-194-5p/PCED1B axis.
LncRNA PPP1R14B-AS1 Promotes Tumor Cell Proliferation and Migration via the Enhancement of Mitochondrial Respiration.
LncRNA PVT1 as an effective biomarker for cancer diagnosis and detection based on transcriptome data and meta-analysis.
lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis.
LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
LncRNA ROR1?AS1 high expression and its prognostic significance in liver cancer.
LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer.
lncRNA RPPH1 promotes non-small cell lung cancer progression through the miR-326/WNT2B axis.
lncRNA small nucleolar RNA host gene 12 promotes renal cell carcinoma progression by modulating the miR?200c?5p/collagen type XI ?1 chain pathway.
LncRNA SNHG15 predicts poor prognosis in uveal melanoma and its potential pathways.
LncRNA SNHG4 regulates miR-138/c-Met axis to promote the proliferation of glioblastoma cells.
LncRNA SNHG6 plays an oncogenic role in colorectal cancer and can be used as a prognostic biomarker for solid tumors.
LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-?/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.
lncRNA SNHG7 affects malignant tumor behaviors through downregulation of EZH2 in uveal melanoma cell lines.
lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma.
LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer.
LncRNA ST7-AS1 is a Potential Novel Biomarker and Correlated With Immune Infiltrates for Breast Cancer.
LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK ssignalling pathway.
LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
lncRNA TP73-AS1 Regulates miR-21/PTEN Axis to Affect Cell Proliferation in Acute Myeloid Leukemia.
lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR?106a?5p?mediated P38 MAPK signaling.
LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis.
LncRNA VPS9D1-AS1 promotes cell proliferation in acute lymphoblastic leukemia through modulating GPX1 expression by miR-491-5p and miR-214-3p evasion.
LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma.
LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
lncRNAs classifier to accurately predict the recurrence of thymic epithelial tumors.
LncRNAs KB-1836B5, LINC00566 and FAM27L are associated with the survival time of patients with ovarian cancer.
LncRNAs SNHG12 and LINC00152 were associated with progression of patients with papillary thyroid carcinoma.
LncSpA: LncRNA Spatial Atlas of Expression across Normal and Cancer Tissues.
Loading-induced antitumor capability of murine and human urine.
LOC550643, a Long Non-coding RNA, Acts as Novel Oncogene in Regulating Breast Cancer Growth and Metastasis.
Local Delivery of Minocycline and Vorinostat Targets the Tumor Microenvironment to Inhibit the Recurrence of Glioma.
Local sequence assembly reveals a high-resolution profile of somatic structural variations in 97 cancer genomes.
Locus-Specific Characterization of Human Endogenous Retrovirus Expression in Prostate, Breast, and Colon Cancers.
Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer.
Long intergenic non-coding RNA expression signature in human breast cancer.
Long Intergenic Non-Coding RNA LINC00885 Promotes Tumorigenesis of Cervical Cancer by Upregulating MACC1 Expression Through Serving as a Competitive Endogenous RNA for microRNA-432-5p.
Long Intergenic Non-coding RNA Profiles of Pheochromocytoma and Paraganglioma: A Novel Prognostic Biomarker.
Long ncRNA MALAT1 promotes cell proliferation, migration, and invasion in prostate cancer via sponging miR-145.
Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGF? and focal adhesion kinase (FAK) signaling.
Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-511.
Long non-coding RNA AB007962 is downregulated in gastric cancer and associated with poor prognosis.
Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/?-catenin signalling pathway and is a potential diagnostic biomarker.
Long non-coding RNA BACE1-AS is an independent unfavorable prognostic factor in liver cancer.
Long Non-coding RNA BTG3-7:1 and JUND Co-regulate C21ORF91 to Promote Triple-Negative Breast Cancer Progress.
Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
Long non-coding RNA CASC19 is associated with the progression and prognosis of advanced gastric cancer.
Long non-coding RNA CASC2 in solid tumors: A meta-analysis.
Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression.
Long non-coding RNA ERICH3-AS1 is an unfavorable prognostic factor for gastric cancer.
Long non-coding RNA EWSAT1 contributes to the proliferation and invasion of glioma by sponging miR-152-3p.
Long non-coding RNA expression profile can predict early recurrence in hepatocellular carcinoma after curative resection.
Long Non-Coding RNA Expression Profiles for the Characterization of Different Bladder Cancer Grade.
Long Non-coding RNA Expression Profiling Identifies a Four-Long Non-coding RNA Prognostic Signature for Isocitrate Dehydrogenase Mutant Glioma.
Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer.
Long non-coding RNA Fer-1-like family member 4 is overexpressed in human glioblastoma and regulates the tumorigenicity of glioma cells.
Long non-coding RNA FLJ33360 participates in ovarian cancer progression by sponging miR-30b-3p.
Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma.
Long non-coding RNA HCG11 modulates glioma progression through cooperating with miR-496/CPEB3 axis.
Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma.
Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma.
Long non-coding RNA LINC00346 regulates proliferation and apoptosis by targeting miR-128-3p/SZRD1 axis in glioma.
Long non-coding RNA LINC00460 predicts poor survival and promotes cell viability in pancreatic cancer.
Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis.
Long Non-Coding RNA LINC00662 Regulated Proliferation and Migration by Targeting miR-34a-5p/LMAN2L Axis in Glioma.
Long Non-coding RNA LINC00941 as a Potential Biomarker Promotes the Proliferation and Metastasis of Gastric Cancer.
Long non-coding RNA LINC00997 silencing inhibits the progression and metastasis of colorectal cancer by sponging miR-512-3p.
Long non-coding RNA LINC01234 regulates proliferation, migration and invasion via HIF-2? pathways in clear cell renal cell carcinoma cells.
Long Non-coding RNA LINC01969 Promotes Ovarian Cancer by Regulating the miR-144-5p/LARP1 Axis as a Competing Endogenous RNA.
Long Non-coding RNA LINC02195 as a Regulator of MHC I Molecules and Favorable Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
Long Non-Coding RNA LINC02747 Promotes the Proliferation of Clear Cell Renal Cell Carcinoma by Inhibiting miR-608 and Activating TFE3.
Long non-coding RNA Lucat1 is a poor prognostic factor and demonstrates malignant biological behavior in clear cell renal cell carcinoma.
Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3? Signaling Pathway.
Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer.
Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1.
Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates renal cancer cell migration via cofilin-1.
Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p.
Long non-coding RNA MSC-AS1 facilitates the proliferation and glycolysis of gastric cancer cells by regulating PFKFB3 expression.
Long non-coding RNA MYOSLID functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-29c-3p in gastric cancer.
Long non-coding RNA OTUD6B-AS1 overexpression inhibits the proliferation, invasion and migration of colorectal cancer cells via downregulation of microRNA-3171.
Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma.
Long non-coding RNA profiling links subgroup classification of endometrioid endometrial carcinomas with trithorax and polycomb complex aberrations.
Long Non-coding RNA RP11-480I12.5 Promotes the Proliferation, Migration, and Invasion of Breast Cancer Cells Through the miR-490-3p-AURKA-Wnt/?-Catenin Axis.
Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Long non-coding RNA SLC25A25-AS1 exhibits oncogenic roles in non-small cell lung cancer by regulating the microRNA-195-5p/ITGA2 axis.
Long non-coding RNA small nucleolar RNA host gene 7 is upregulated and promotes cell proliferation in thyroid cancer.
Long Non-coding RNA SNHG12 Functions as a Competing Endogenous RNA to Regulate MDM4 Expression by Sponging miR-129-5p in Clear Cell Renal Cell Carcinoma.
Long Non-Coding RNA SNHG14 Impedes Viability, Migration and Invasion of Endometrial Carcinoma Cells Through Modulating miR-93-5p/ZBTB7A Axis.
Long non-coding RNA SNHG15 in various cancers: a meta and bioinformatic analysis.
Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression.
Long non-coding RNA SNHG16 as a potential biomarker in hepatocellular carcinoma: A meta-analysis.
Long non-coding RNA SNHG6 is upregulated in prostate cancer and predicts poor prognosis.
Long non-coding RNA SNHG8 promotes autophagy as a ceRNA to upregulate ATG7 by sponging microRNA-588 in colorectal cancer.
Long non-coding RNA TCL6 enhances preferential toxicity of paclitaxel to renal cell carcinoma cells.
Long Non-coding RNA TMEM220-AS1 Suppressed Hepatocellular Carcinoma by Regulating the miR-484/MAGI1 Axis as a Competing Endogenous RNA.
Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma.
Long Non-Coding RNA TUG1 Expression Is Associated with Different Subtypes in Human Breast Cancer.
Long Non-Coding RNA UBA6-AS1 Promotes the Malignant Properties of Glioblastoma by Competitively Binding to microRNA-760 and Enhancing Homeobox A2 Expression.
Long non-coding RNA USP30-AS1 aggravates the malignant progression of cervical cancer by sequestering microRNA-299-3p and thereby overexpressing PTP4A1.
Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network.
Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer.
Long non-coding RNA-HAGLR suppressed tumor growth of lung adenocarcinoma through epigenetically silencing E2F1.
Long non-coding RNAs as prognostic biomarkers in papillary renal cell carcinoma.
Long non-coding RNAs as prognostic markers in human breast cancer.
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis.
Long Non-coding RNAs in Myeloid Malignancies.
Long non-coding RNAs may serve as biomarkers in breast cancer combined with primary lung cancer.
Long non-coding RNAs RP5-821D11.7, APCDD1L-AS1 and RP11-277P12.9 were associated with the prognosis of lung squamous cell carcinoma.
Long non?coding RNA DLEU1 promotes cell proliferation of glioblastoma multiforme.
Long non?coding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRT?PCR and meta?analysis of 393 cases.
Long non?coding RNA JPX promotes gastric cancer progression by regulating CXCR6 and autophagy via inhibiting miR?197.
Long non?coding RNA MLK7?AS1 promotes proliferation in human colorectal cancer via downregulation of p21 expression.
Long non?coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4.
Long non?coding RNA ZSCAN16?AS1 promotes the malignant properties of hepatocellular carcinoma by decoying microRNA?451a and consequently increasing ATF2 expression.
Long non?coding RNA?based risk scoring system predicts prognosis of alcohol?related hepatocellular carcinoma.
Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Long noncoding RNA ALOX12-AS1 inhibits cervical cancer cells proliferation via targeting miR-3171.
Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
Long noncoding RNA CYTOR in cancer: A TCGA data review.
Long noncoding RNA DANCR in various cancers: a meta-analysis and bioinformatics.
Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis.
Long noncoding RNA DLEU2 predicts a poor prognosis and enhances malignant properties in laryngeal squamous cell carcinoma through the miR-30c-5p/PIK3CD/Akt axis.
Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients.
Long noncoding RNA FER1L4 acts as an oncogenic driver in human pan-cancer.
Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p.
Long noncoding RNA H19 participates in metformin-mediated inhibition of gastric cancer cell invasion.
Long noncoding RNA HCG22 suppresses proliferation and metastasis of bladder cancer cells by regulation of PTBP1.
Long noncoding RNA HCP5 suppresses skin cutaneous melanoma development by regulating RARRES3 gene expression via sponging miR-12.
Long Noncoding RNA HOTTIP Serves as an Independent Predictive Biomarker for the Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
Long noncoding RNA HOXC13-AS positively affects cell proliferation and invasion in nasopharyngeal carcinoma via modulating miR-383-3p/HMGA2 axis.
Long noncoding RNA HOXD-AS1 in various cancers: a meta-analysis and TCGA data review.
Long noncoding RNA KTN1 antisense RNA 1exerts an oncogenic function in lung adenocarcinoma by regulating DEP domain containing 1 expression via activating epithelial-mesenchymal transition.
Long Noncoding RNA LINC-PINT Suppresses Cell Proliferation, Invasion, and EMT by Blocking Wnt/?-Catenin Signaling in Glioblastoma.
Long Noncoding RNA Linc00152 Functions as a Tumor Propellant in Pan-Cancer.
Long noncoding RNA LINC00173 is downregulated in cervical cancer and inhibits cell proliferation and invasion by modulating the miR-182-5p/FBXW7 axis.
Long Noncoding RNA LINC00265 Targets EGFR and Promotes Deterioration of Colorectal Cancer: A Comprehensive Study Based on Data Mining and in vitro Validation.
Long noncoding RNA LINC00284 facilitates cell proliferation in papillary thyroid cancer via impairing miR-3127-5p targeted E2F7 suppression.
Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis.
Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer.
Long Noncoding RNA LINC01134 Promotes Hepatocellular Carcinoma Metastasis via Activating AKT1S1 and NF-?B Signaling.
Long noncoding RNA LINC01234 promotes serine hydroxymethyltransferase 2 expression and proliferation by competitively binding miR-642a-5p in colon cancer.
Long noncoding RNA LINC01291 promotes the aggressive properties of melanoma by functioning as a competing endogenous RNA for microRNA-625-5p and subsequently increasing IGF-1R expression.
Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker.
Long noncoding RNA LINC02418 regulates MELK expression by acting as a ceRNA and may serve as a diagnostic marker for colorectal cancer.
Long Noncoding RNA LIPE-AS1 Drives Prostate Cancer Progression by Functioning as a Competing Endogenous RNA for microRNA-654-3p and Thereby Upregulating Hepatoma-Derived Growth Factor.
Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852.
Long noncoding RNA MEG3 play an important role in osteosarcoma development through sponging microRNAs.
Long noncoding RNA MGC27382 inhibits proliferation and metastasis of non-small cell lung cancer cells via down-regulating AKT/GSK3? pathway.
Long Noncoding RNA MIR210HG Promotes the Warburg Effect and Tumor Growth by Enhancing HIF-1? Translation in Triple-Negative Breast Cancer.
Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Long noncoding RNA NALT1-induced gastric cancer invasion and metastasis via NOTCH signaling pathway.
Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
Long noncoding RNA POU6F2-AS1 regulates lung cancer aggressiveness through sponging miR-34c-5p to modulate KCNJ4 expression.
Long noncoding RNA PVT1 acts as an oncogenic driver in human pan-cancer.
Long noncoding RNA PVT1 inhibits renal cancer cell apoptosis by up-regulating Mcl-1.
Long Noncoding RNA RP11-334E6.12 Promotes the Proliferation, Migration and Invasion of Breast Cancer Cells Through the EMT Pathway by Activating the STAT3 Cascade.
Long Noncoding RNA RP11-357H14.17 Plays an Oncogene Role in Gastric Cancer by Activating ATF2 Signaling and Enhancing Treg Cells.
Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database.
Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma.
Long Noncoding RNA SNHG10 Sponges miR-543 to Upregulate Tumor Suppressive SIRT1 in Nonsmall Cell Lung Cancer.
Long noncoding RNA SNHG12 indicates the prognosis of prostate cancer and accelerates tumorigenesis via sponging miR-133b.
Long noncoding RNA SNHG12 suppresses esophageal squamous cell carcinoma progression through competing endogenous RNA networks.
Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1? in clear cell renal cell carcinoma.
Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance.
Long Noncoding RNA TTC39A-AS1 Promotes Breast Cancer Tumorigenicity by Sponging MicroRNA-483-3p and Thereby Upregulating MTA2.
Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
Long noncoding RNA, LINC00460, as a prognostic biomarker in head and neck squamous cell carcinoma (HNSCC).
Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer.
Long-chain non-coding RNA LINC01554 promotes NGFR expression and inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma by binding to microRNA-3681-3p.
Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model.
Long-Noncoding RNA FGD5-AS1 Enhances the Viability, Migration, and Invasion of Glioblastoma Cells by Regulating the miR-103a-3p/TPD52 Axis.
Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide.
Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature.
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk.
Longitudinal Analysis of Gene Expression Changes During Cervical Carcinogenesis Reveals Potential Therapeutic Targets.
Longitudinal Analysis of Human Pancreatic Adenocarcinoma Development Reveals Transient Gene Expression Signatures.
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.
Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas.
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair Deficiency.
Loss of BAP1 Results in Growth Inhibition and Enhances Mesenchymal-Epithelial Transition in Kidney Tumor Cells.
Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients.
Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer.
Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression.
Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines.
Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer.
Loss of Estrogen Receptors is Associated with Increased Tumor Aggression in Laryngeal Squamous Cell Carcinoma.
Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.
Loss of Expression of a Novel Chromatin Remodeler SMARCA1 in Soft Tissue Sarcoma.
Loss of FGL1 induces epithelial?mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma.
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion.
Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.
Loss of Integrase Interactor 1 (INI1) Expression in a Subset of Differentiated Thyroid Cancer.
Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination.
Loss of microRNA-21 leads to profound stromal remodeling and short survival in K-Ras-driven mouse models of pancreatic cancer.
Loss of MLH1 confers resistance to PI3K? inhibitors in renal clear cell carcinoma with SETD2 mutation.
Loss of progesterone receptor through epigenetic regulation is associated with poor prognosis in solid tumors.
Loss of PTPN4 activates STAT3 to promote the tumor growth in rectal cancer.
LOSS OF RUNX1 IS ASSOCIATED WITH AGGRESSIVE LUNG ADENOCARCINOMAS.
Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients.
Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker.
Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC.
Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition.
Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer.
Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.
Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Low BCL7A expression predicts poor prognosis in ovarian cancer.
Low CBS expression can identify patients who benefit from adjuvant chemotherapy in gastric cancer.
Low CFB expression is independently associated with poor overall and disease-free survival in patients with lung adenocarcinoma.
Low CYP24A1 mRNA expression and its role in prognosis of breast cancer.
Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma.
Low EIF2B5 expression predicts poor prognosis in ovarian cancer.
Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma.
Low expression of A-kinase anchor protein 5 predicts poor prognosis in non-mucin producing stomach adenocarcinoma based on TCGA data.
Low Expression of APOB mRNA or Its Hypermethylation Predicts Favorable Overall Survival in Patients with Low-Grade Glioma.
Low expression of CDHR1 is an independent unfavorable prognostic factor in glioma.
Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
Low expression of developing brain homeobox 2 (Dbx2) may serve as a biomarker to predict poor prognosis in endometrial cancer.
Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
Low expression of IL6R predicts poor prognosis for lung adenocarcinoma.
Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
Low expression of KCNN3 may affect drug resistance in ovarian cancer.
Low expression of LACTB promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma.
Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
Low expression of microRNA-1908 predicts a poor prognosis for patients with ovarian cancer.
Low expression of miR-125a-5p is associated with poor prognosis in patients with gastric cancer.
Low Expression of miR-375 and miR-190b Differentiates Grade 3 Patients with Endometrial Cancer.
Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.
Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma.
Low expression of RGL4 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.
Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma.
Low expression of ryanodine receptor 2 is associated with poor prognosis in thyroid carcinoma.
Low expression of the androgen-induced tumor suppressor gene PLZF and lethal prostate cancer.
Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection.
Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome.
Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme.
Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma.
Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa.
Low KRT15 expression is associated with poor prognosis in patients with breast invasive carcinoma.
Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients.
Low LINC00599 expression is a poor prognostic factor in glioma.
Low Mast Cell Density Predicts Poor Prognosis in Oral Squamous Cell Carcinoma and Reduces Survival in Head and Neck Squamous Cell Carcinoma.
Low metallothionein 1M (MT1M) is associated with thyroid cancer cell lines progression.
Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
Low microRNA150 expression is associated with activated carcinogenic pathways and a poor prognosis in patients with breast cancer.
Low mutation burden and differential tumor-infiltrating immune cells correlate with lymph node metastasis in colorectal cancer.
Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma.
Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma.
Low-dose mono(2-ethylhexyl) phthalate promotes ovarian cancer development through PPAR?-dependent PI3K/Akt/NF-?B pathway.
Low-Level Expression of MTUS1 Is Associated with Poor Survival in Patients with Lung Adenocarcinoma.
Low-Rank Atlas Image Analyses in the Presence of Pathologies.
Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).
Lower expression of LINC00092 in lung adenocarcinoma might mean poorer prognosis: A study based on data mining and bioinformatics.
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3.
Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis.
Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer.
LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2.
LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype.
LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer.
LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110?.
LPRP: A Gene-Gene Interaction Network Construction Algorithm and Its Application in Breast Cancer Data Analysis.
LRG1 May Accelerate the Progression of ccRCC via the TGF-? Pathway.
LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer.
LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer.
LRRC17 Is Linked to Prognosis of Ovarian Cancer Through a p53-dependent Anti-apoptotic Function.
LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining.
LRRC52-AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer.
LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma.
LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer.
LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
LSR Promotes Cell Proliferation and Invasion in Lung Cancer.
LUAD transcriptomic profile analysis of d-limonene and potential lncRNA chemopreventive target.
LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
LUM Expression and Its Prognostic Significance in Gastric Cancer.
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection.
Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment.
Lung cancer transcriptomes refined with laser capture microdissection.
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.
Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer.
LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.
Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.
Lymphotoxin-? receptor-NIK signaling induces alternative RELB/NF-?B2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
Lysyl oxidase assists tumor?initiating cells to enhance angiogenesis in hepatocellular carcinoma.
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.
LZAP promotes the proliferation and invasiveness of cervical carcinoma cells by targeting AKT and EMT.
M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome.
M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer.
M3C: Monte Carlo reference-based consensus clustering.
m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.
m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.
m6A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1.
m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
m6A RNA Methylation Regulator YTHDF1 Correlated With Immune Microenvironment Predicts Clinical Outcomes and Therapeutic Efficacy in Breast Cancer.
m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
m6A RNA Methylation Regulators Elicit Malignant Progression and Predict Clinical Outcome in Hepatocellular Carcinoma.
m6A RNA methylation regulators have prognostic value in papillary thyroid carcinoma.
m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma.
m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma.
m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
m6A RNA modification modulates PI3K/Akt/mTOR signal pathway in Gastrointestinal Cancer.
M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
MACC1 promotes angiogenesis in cholangiocarcinoma by upregulating VEGFA.
Machine learning analysis identifies genes differentiating triple negative breast cancers.
Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
Machine learning analysis of TCGA cancer data.
Machine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortality.
Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics.
Machine learning and network-based models to identify genetic risk factors to the progression and survival of colorectal cancer.
Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
Machine Learning Approaches to Classify Primary and Metastatic Cancers Using Tissue of Origin-Based DNA Methylation Profiles.
Machine learning approaches to decipher hormone and HER2 receptor status phenotypes in breast cancer.
Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.
Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma.
Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients.
Machine learning identifies 10 feature miRNAs for lung squamous cell carcinoma.
Machine Learning Identifies Robust Matrisome Markers and Regulatory Mechanisms in Cancer.
Machine Learning Models to Predict Primary Sites of Metastatic Cervical Carcinoma From Unknown Primary.
Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Machine Learning Supports Long Noncoding RNAs as Expression Markers for Endometrial Carcinoma.
Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data.
Machine learning-based prediction of survival prognosis in cervical cancer.
Machine-based morphologic analysis of glioblastoma using whole-slide pathology images uncovers clinically relevant molecular correlates.
Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes.
Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
Maftools: efficient and comprehensive analysis of somatic variants in cancer.
MAGE-A11 Expression Predicts Patient Prognosis in Head and Neck Squamous Cell Carcinoma.
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.
MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition.
MAGI-2 downregulation: a potential predictor of tumor progression and early recurrence in Han Chinese patients with prostate cancer.
MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2.
Magnetic Resonance Features of Lower-grade Gliomas in Prediction of the Reverse Phase Protein A.
Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities.
Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
Magnetic resonance imaging-based radiomic features for extrapolating infiltration levels of immune cells in lower-grade gliomas.
Major clinical research advances in gynecologic cancer in 2013.
Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.
Making Use of Cancer Genomic Databases.
MAL2 promotes proliferation, migration, and invasion through regulating epithelial-mesenchymal transition in breast cancer cell lines.
Malignancy in Pheochromocytoma or Paraganglioma: Integrative Analysis of 176 Cases in TCGA.
Malignant Evaluation and Clinical Prognostic Values of M6A RNA Methylation Regulators in Prostate Cancer.
Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer.
Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis.
Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.
MAN1B1 is associated with poor prognosis and modulates proliferation and apoptosis in bladder cancer.
Mandible and tongue-splitting approach for giant cell tumor of axis.
Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma.
MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway.
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer.
MAPK-RAP1A Signaling Enriched in Hepatocellular Carcinoma Is Associated With Favorable Tumor-Infiltrating Immune Cells and Clinical Prognosis.
MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple?negative breast cancer cells.
Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening.
Mapping Driver Mutations to Histopathological Subtypes in Papillary Thyroid Carcinoma: Applying a Deep Convolutional Neural Network.
Mapping in epidemiological studies and control of cancer: experiences from Slovakia.
Mapping small area cancer mortality: a residential coding story.
Mapping the Germline and Somatic Mutation Interaction Landscape in Indolent and Aggressive Prostate Cancers.
Mapping Tumor-Specific Expression QTLs in Impure Tumor Samples.
Maps and atlases of cancer mortality: a review of a useful tool to trigger new questions.
MAPT (Tau) expression is a biomarker for an increased rate of survival for low?grade glioma.
MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma.
MARCH8 Suppresses Tumor Metastasis and Mediates Degradation of STAT3 and CD44 in Breast Cancer Cells.
MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis.
MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Marginal false discovery rates for penalized regression models.
Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma.
Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.
Martrilin-3 (MATN3) Overexpression in Gastric Adenocarcinoma and its Prognostic Significance.
Mass spectrometric analysis of SOX11-binding proteins in head and neck cancer cells demonstrates the interaction of SOX11 and HSP90?.
Massive benign osteoblastoma of the suboccipital bone and foramen magnum region.
Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas.
Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations.
Master regulators, regulatory networks, and pathways of glioblastoma subtypes.
Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor Progression.
Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target in lung adenocarcinoma.
Matrisome-Associated Gene Expression Patterns Correlating with TIMP2 in Cancer.
Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
Maximizing the Utility of Cancer Transcriptomic Data.
MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia.
MCAM abnormal expression and clinical outcome associations are highly cancer dependent as revealed through pan-cancer analysis.
MCM2 and NUSAP1 Are Potential Biomarkers for the Diagnosis and Prognosis of Pancreatic Cancer.
MCM2-regulated functional networks in lung cancer by multi-dimensional proteomic approach.
MCM5 Aggravates the HDAC1-Mediated Malignant Progression of Lung Cancer.
MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
MCMC implementation of the optimal Bayesian classifier for non-Gaussian models: model-based RNA-Seq classification.
MCT1 regulates aggressive and metabolic phenotypes in bladder cancer.
MCTS1 Directly Binds to TWF1 and Synergistically Modulate Cyclin D1 and C-Myc Translation in Luminal A/B Breast Cancer Cells.
MDEHT: a Multivariate Approach for Detecting Differential Expression of MicroRNA Isoform Data in RNA Sequencing Studies.
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability.
Measuring DNA Copy Number Variation Using High-Density Methylation Microarrays.
Mechanism of chromosome rearrangement arising from single-strand breaks.
Mechanism of Fuzheng Kang'ai Formula () Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer.
Mechanism of VIPR1 gene regulating human lung adenocarcinoma H1299 cells.
Mechanism- and Immune Landscape-Based Ranking of Therapeutic Responsiveness of 22 Major Human Cancers to Next Generation Anti-CTLA-4 Antibodies.
Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma.
MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.
MeCP2 Promotes Colorectal Cancer Metastasis by Modulating ZEB1 Transcription.
MedCo: Enabling Secure and Privacy-Preserving Exploration of Distributed Clinical and Genomic Data.
Medical management of gastric cancer: a 2017 update.
Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.
MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGF?/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
MEGSA: A Powerful and Flexible Framework for Analyzing Mutual Exclusivity of Tumor Mutations.
Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma.
MEK1 Inhibitor Combined with Irradiation Reduces Migration of Breast Cancer Cells Including miR-221 and ZEB1 EMT Marker Expression.
Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer.
Melatonergic system-based two-gene index is prognostic in human gliomas.
Melatonin/PGC1A/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning.
Melittin inhibits proliferation, migration and invasion of bladder cancer cells by regulating key genes based on bioinformatics and experimental assays.
MELK is Upregulated in Advanced Clear Cell Renal Cell Carcinoma and Promotes Disease Progression by Phosphorylating PRAS40.
Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies.
Membrane protein-regulated networks across human cancers.
Meningioma of the foramen magnum: a series of 40 cases.
MEpurity: estimating tumor purity using DNA methylation data.
Merged Affinity Network Association Clustering: Joint multi-omic/clinical clustering to identify disease endotypes.
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
Mesothelin expression is associated with poor outcomes in breast cancer.
Mesothelioma in the age of "Omics": Before and after The Cancer Genome Atlas.
MET Gain in Diffuse Astrocytomas is Associated with Poorer Outcome.
MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitor.
MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
MET Inhibition in Clear Cell Renal Cell Carcinoma.
MET Receptor Tyrosine Kinase Regulates the Expression of Co-Stimulatory and Co-Inhibitory Molecules in Tumor Cells and Contributes to PD-L1-Mediated Suppression of Immune Cell Function.
Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck Cancer.
Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes.
Meta-analysis of gene expression studies in endometrial cancer identifies gene expression profiles associated with aggressive disease and patient outcome.
Meta-analysis of microarray datasets identify several chromosome segregation-related cancer/testis genes potentially contributing to anaplastic thyroid carcinoma.
Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes.
Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
Meta-Analysis Reveals the Prognostic Relevance of Nuclear and Membrane-Associated Bile Acid Receptors in Gastric Cancer.
Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer.
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Metabolic and signalling network maps integration: application to cross-talk studies and omics data analysis in cancer.
Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response.
Metabolic deregulation in prostate cancer.
Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes.
Metabolic gene signature for predicting breast cancer recurrence using transcriptome analysis.
Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma.
Metabolic Plasticity in Ovarian Cancer Stem Cells.
Metabolic reprogramming-associated genes predict overall survival for rectal cancer.
Metabolism-associated molecular classification of hepatocellular carcinoma.
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation.
Metabolomic alterations and chromosomal instability status in gastric cancer.
MetaCancer: A deep learning-based pan-cancer metastasis prediction model developed using multi-omics data.
Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/?-catenin signaling pathway.
Metastasis of Uveal Melanoma with Monosomy-3 Is Associated with a Less Glycogenetic Gene Expression Profile and the Dysregulation of Glycogen Storage.
Metastasis regulation by PPARD expression in cancer cells.
Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.
Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cells.
MethCNA: a database for integrating genomic and epigenomic data in human cancer.
MethCORR infers gene expression from DNA methylation and allows molecular analysis of ten common cancer types using fresh-frozen and formalin-fixed paraffin-embedded tumor samples.
Methodological issues in the development of the Canadian Cancer Incidence Atlas.
Methodology to study the three-dimensional spatial distribution of prostate cancer and their dependence on clinical parameters.
Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles.
Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastoma.
Methylation analysis highlights novel prognostic criteria in human-metastasized melanoma.
Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer.
Methylation and expression of non-clustered protocadherins encoding genes and risk of precancerous gastric lesions in a high-risk population.
Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
Methylation changes in the TFAP2E promoter region are associated with BRAF mutation and poorer overall & disease free survival in colorectal cancer.
Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma.
Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women.
Methylation gene KCNC1 is associated with overall survival in patients with seminoma.
Methylation of immune-regulatory cytokine genes and pancreatic cancer outcomes.
Methylation of MGMT and ADAMTS14 in normal colon MUCOSA: biomarkers of a field defect for cancerization preferentially targeting elder African-Americans.
Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma.
Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.
Methylation of RILP in lung cancer promotes tumor cell proliferation and invasion.
Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer.
Methylation of the Promoter Region of the Tight Junction Protein-1 by DNMT1 Induces EMT-like Features in Multiple Myeloma.
Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis.
Methylation Signature Genes Identification of the Lung Squamous Cell Carcinoma Occurrence and Recognition Research.
Methylation silencing of TGF-? receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.
Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in Immune-Related Gene Expression.
Methylation-Based Signatures for Gastroesophageal Tumor Classification.
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma.
Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma.
Methylation-independent CRIP1 expression is a potential biomarker affecting prognosis in cytogenetically normal acute myeloid leukemia.
Methylation?driven genes PMPCAP1, SOWAHC and ZNF454 as potential prognostic biomarkers in lung squamous cell carcinoma.
MethylMix 2.0: an R package for identifying DNA methylation genes.
Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
MethyMer: Design of combinations of specific primers for bisulfite sequencing of complete CpG islands.
METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma.
Mex3a expression and survival analysis of bladder urothelial carcinoma.
MEX3C regulates lipid metabolism to promote bladder tumorigenesis through JNK pathway.
MEXPRESS update 2019.
MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data.
MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer.
MFG-E8 overexpression promotes colorectal cancer progression via AKT/MMPs signalling.
Mg2+ Transporters in Digestive Cancers.
MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer.
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.
MGP Promotes Colon Cancer Proliferation by Activating the NF-?B Pathway through Upregulation of the Calcium Signaling Pathway.
MGSEA - a multivariate Gene set enrichment analysis.
MHC class II associated stomach cancer mutations correlate with lack of subsequent tumor development.
MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.
Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.
Microarray analyses reveal genes related to progression and prognosis of esophageal squamous cell carcinoma.
Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma.
Microarray analysis of the differential transformation mediated by Kirsten and Harvey Ras oncogenes in a human colorectal adenocarcinoma cell line.
Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Microarray expression profile of microRNAs in lung adenocarcinoma patients with the Cancer Genome Atlas and its clinical validation.
Microarray profiling of differentially expressed lncRNAs and mRNAs in lung adenocarcinomas and bioinformatics analysis.
Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
Microarray-based data mining reveals key genes and potential therapeutic drugs for Cadmium-induced prostate cell malignant transformation.
Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.
Microarray-based identification of genes associated with prognosis and drug resistance in ovarian cancer.
Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma.
MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling.
MicroRNA and transcription factor co-regulatory networks and subtype classification of seminoma and non-seminoma in testicular germ cell tumors.
microRNA and transcription factor mediated regulatory network for ovarian cancer : Regulatory network of ovarian cancer.
MicroRNA Biomarkers for Patients With Muscle-Invasive Bladder Cancer Undergoing Selective Bladder-Sparing Trimodality Treatment.
MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinoma.
microRNA expression patterns across seven cancers are highly correlated and dominated by evolutionarily ancient families.
MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
MicroRNA expression profile and TNM staging system predict survival in patients with lung adenocarcinoma.
MicroRNA Expression Profile Distinguishes Glioblastoma Stem Cells from Differentiated Tumor Cells.
microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study.
MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets.
MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma.
MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma.
microRNA from brush biopsy to characterize oral squamous cell carcinoma epithelium.
MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung.
MicroRNA let-7d targets thrombospondin-1 and inhibits the activation of human pancreatic stellate cells.
MicroRNA Machinery Genes as Novel Biomarkers for Cancer.
MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.
MicroRNA Profile for Diagnostic and Prognostic Biomarkers in Thyroid Cancer.
MicroRNA profiles in five pairs of early gastric cancer tissues and adjacent non-cancerous tissues.
microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity.
microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-? Signaling in Glioblastoma.
MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma.
MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal papillary cell carcinoma.
MicroRNA signature predicts survival in papillary thyroid carcinoma.
MicroRNA signatures predict prognosis of patients with glioblastoma multiforme through the Cancer Genome Atlas.
MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer.
MicroRNA-101 suppresses colorectal cancer progression by negative regulation of Rap1b.
MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma.
MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review.
MicroRNA-1224 Inhibits Tumor Metastasis in Intestinal-Type Gastric Cancer by Directly Targeting FAK.
MicroRNA-1249 targets four-jointed box kinase 1 and reduces cell proliferation, migration and invasion of colon adenocarcinoma.
microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway.
MicroRNA-128 expression not associated with glioma-associated epilepsy in WHO grades 2 glioma: Data from the Cancer Genome Atlas (TCGA) project.
MicroRNA-1296 Facilitates Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Targeting SFPQ.
MicroRNA-1298-3p inhibits proliferation and invasion of glioma cells by downregulating Nidogen-1.
MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL.
MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1.
MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells.
MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1.
MicroRNA-153 inhibits tumor progression in esophageal squamous cell carcinoma by targeting SNAI1.
MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers.
MicroRNA-17 as a promising diagnostic biomarker of gastric cancer: An investigation combining TCGA, GEO, meta-analysis, and bioinformatics.
MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis.
MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma.
MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis.
MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells.
MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival.
MicroRNA-203 Increases Cell Radiosensitivity via Directly Targeting Bmi-1 in Hepatocellular Carcinoma.
MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability.
MicroRNA-21 expression in the prognosis of low-grade gliomas: data from the cancer genome atlas (TCGA) project.
microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1.
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma.
microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis.
MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis.
MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value.
MicroRNA-223-5p targets long non-coding RNA TP73 antisense RNA1 to promote the invasion of gastric cancer.
MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.
MicroRNA-301b and its target gene synaptosome-associated protein 91 as important modulators in esophageal cancer: functional experiments.
microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2.
MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples.
MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer.
MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.
MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B.
MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
MicroRNA-3690 promotes cell proliferation and cell cycle progression by altering DKK3 expression in human thyroid cancer.
MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/?-Catenin Signaling.
MicroRNA-375 suppresses the growth and invasion of fibrolamellar carcinoma.
microRNA-378a-5p iS a novel positive regulator of melanoma progression.
MicroRNA-490-3p inhibits proliferation and stimulates apoptosis of ESCC cells via MAPK1 downregulation.
MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1.
MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients.
MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.
MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
MicroRNA-548ac induces apoptosis in laryngeal squamous cell carcinoma cells by targeting transmembrane protein 158.
MicroRNA-550a is associated with muscle system conferring poorer survival for esophageal cancer.
MicroRNA-587 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting Ribosomal Protein SA.
MicroRNA-6071 Suppresses Glioblastoma Progression Through the Inhibition of PI3K/AKT/mTOR Pathway by Binding to ULBP2.
MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer.
MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1.
MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients with Stage II/III Colorectal Cancer.
MicroRNA-92 Expression in CD133+ Melanoma Stem Cells Regulates Immunosuppression in the Tumor Microenvironment via Integrin-Dependent Activation of TGF?.
MicroRNA-96 is a potential tumor repressor by inhibiting NPTX2 in renal cell carcinoma.
MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.
MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study.
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma.
MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma.
MicroRNA-mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients.
MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer.
MicroRNA-Related Genetic Variants Associated with Survival of Head and Neck Squamous Cell Carcinoma.
MicroRNA-Related Prognosis Biomarkers from High-Throughput Sequencing Data of Colorectal Cancer.
MicroRNA-Target Network Inference and Local Network Enrichment Analysis Identify Two microRNA Clusters with Distinct Functions in Head and Neck Squamous Cell Carcinoma.
MicroRNA?29?3p regulates the ??catenin pathway by targeting IGF1 to inhibit the proliferation of prolactinoma cells.
MicroRNA?301a/ZNRF3/wnt/??catenin signal regulatory crosstalk mediates glioma progression.
MicroRNA?34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
MicroRNA?34a?5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase?2 silencing.
MicroRNA?486?5p functions as a tumor suppressor of proliferation and cancer stem?like cell properties by targeting Sirt1 in liver cancer.
MicroRNA?mRNA integrated analysis based on a case of well?differentiated thyroid cancer with both metastasis and metastatic recurrence.
MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.
MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma.
MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.
MicroRNAs Associated With Colon Cancer: New Potential Prognostic Markers and Targets for Therapy.
MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets.
MicroRNAs associated with microvascular invasion in hepatocellular carcinoma and their prognostic impacts in patients undergoing hepatic resection.
MicroRNAs Expression Patterns Predict Tumor Mutational Burden in Colorectal Cancer.
MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid Leukemia.
Microsatellite genotyping reveals a signature in breast cancer exomes.
Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.
Microsatellite Instability-Related ACVR2A Mutations Partially Account for Decreased Lymph Node Metastasis in MSI-H Gastric Cancers.
Microsatellite instability: an update.
Microsurgical resection of giant intraventricular meningioma.
Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.
MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.
Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
Mind Bomb 1 Promotes Pancreatic Cancer Proliferation by Activating ?-Catenin Signaling.
Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma.
Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer.
Minimalist approaches to cancer tissue-of-origin classification by DNA methylation.
Minimum error calibration and normalization for genomic copy number analysis.
Mining and validating the expression pattern and prognostic value of acetylcholine receptors in non-small cell lung cancer.
Mining Database for the Clinical Significance and Prognostic Value of ESRP1 in Cutaneous Malignant Melanoma.
Mining featured biomarkers associated with vascular invasion in HCC by bioinformatics analysis with TCGA RNA sequencing data.
Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma.
Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
Mining of prognosis-related genes in cervical squamous cell carcinoma immune microenvironment.
Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.
Mining TCGA Data for Key Biomarkers Related to Immune Microenvironment in Endometrial cancer by Immune Score and Weighted Correlation Network Analysis.
Mining TCGA data using Boolean implications.
Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.
Mining TCGA database for screening and identification of hub genes in kidney renal clear cell carcinoma microenvironment.
Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma.
Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer.
Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.
Mining the plasma-proteome associated genes in patients with gastro-esophageal cancers for biomarker discovery.
Mining the potential prognostic value of synaptosomal-associated protein 25 (SNAP25) in colon cancer based on stromal-immune score.
Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.
MINTbase v2.0: a comprehensive database for tRNA-derived fragments that includes nuclear and mitochondrial fragments from all The Cancer Genome Atlas projects.
MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5.
miR-10a and miR-204 as a Potential Prognostic Indicator in Low-Grade Gliomas.
MiR-1225-5p acts as tumor suppressor in glioblastoma via targeting FNDC3B.
miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4.
miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1.
miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
MIR-1265 regulates cellular proliferation and apoptosis by targeting calcium binding protein 39 in gastric cancer and, thereby, impairing oncogenic autophagy.
miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer.
MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7.
Mir-1287 suppresses the proliferation, invasion, and migration in hepatocellular carcinoma by targeting PIK3R3.
miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer.
miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase.
MiR-133a-3p inhibits the malignant progression of esophageal cancer by targeting CDCA8.
MiR-137 inhibits the proliferation, invasion and migration of glioma via targeting to regulate EZH2.
MiR-139 in digestive system tumor diagnosis and detection: Bioinformatics and meta-analysis.
miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery.
miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.
miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
miR-143 inhibits renal cell carcinoma cells metastatic potential by suppressing ABL2.
MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer.
miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma.
miR-155-5p Promotes Cell Proliferation and Migration of Clear Cell Renal Cell Carcinoma by Targeting PEG3.
miR-17-5p promotes migration and invasion in breast cancer cells by repressing netrin 4.
MiR-17-92 cluster promotes hepatocarcinogenesis.
miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression.
miR-184 delays cell proliferation, migration and invasion in prostate cancer by directly suppressing DLX1.
miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.
MiR-188-3p/GPR26 modulation functions as a potential regulator in manipulating glioma cell properties.
miR-192 is Overexpressed and Promotes Cell Proliferation in Prostate Cancer.
miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
miR-192/215-5p act as tumor suppressors and link Crohn's disease and colorectal cancer by targeting common metabolic pathways: An integrated informatics analysis and experimental study.
MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2.
MiR-195 restrains lung adenocarcinoma by regulating CD4+ T cell activation via the CCDC88C/Wnt signaling pathway: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatic analysis.
miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
miR-195/miR-497 Regulate CD274 Expression of Immune Regulatory Ligands in Triple-Negative Breast Cancer.
miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications.
MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.
miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression.
miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells.
Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.
miR-210 is induced by hypoxia and regulates neural cell adhesion molecule in prostate cells.
miR-22 Regulates Invasion, Gene Expression and Predicts Overall Survival in Patients with Clear Cell Renal Cell Carcinoma.
miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells.
miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt/?-catenin signaling pathway.
MiR-224 expression increases radiation sensitivity of glioblastoma cells.
miR-224, miR-147b and miR-31 associated with lymph node metastasis and prognosis for lung adenocarcinoma by regulating PRPF4B, WDR82 or NR3C2.
miR-23a-5p inhibits cell proliferation and invasion in pancreatic ductal adenocarcinoma by suppressing ECM1 expression.
miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
miR-27b-3p Inhibits Invasion, Migration and Epithelial-mesenchymal Transition in Gastric Cancer by Targeting RUNX1 and Activation of the Hippo Signaling Pathway.
MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
MiR-29b-3p cooperates with miR-29c-3p to affect the malignant biological behaviors in T-cell acute lymphoblastic leukemia via TFAP2C/GPX1 axis.
MiR-301a Promotes Cell Proliferation by Repressing PTEN in Renal Cell Carcinoma.
miR-301b and NR3C2 co-regulate cells malignant properties and have the potential to be independent prognostic factors in breast cancer.
MiR-301b-3p Promotes the Occurrence and Development of Breast Cancer Cells via Targeting HOXA5.
miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2.
miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma.
miR-30e-5p represses angiogenesis and metastasis by directly targeting AEG-1 in squamous cell carcinoma of the head and neck.
miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10.
MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
miR-3187-3p enhances migration and invasion by targeting PER2 in head and neck squamous cell carcinomas.
MiR-32 promotes tumorigenesis of colorectal cancer by targeting BMP5.
MiR-320a inhibits malignant phenotype of melanoma cells via targeting PBX3.
MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data.
MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1.
miR-331-3p regulates expression of neuropilin-2 in glioblastoma.
miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.
MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas.
miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.
miR-3607, a biomarker of hepatocellular carcinoma invasion and aggressiveness: Its relationship with epithelial-mesenchymal transition process.
MiR-3614-5p Is a Potential Novel Biomarker for Colorectal Cancer.
miR-3677-5p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with prognosis.
miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.
miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways.
MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.
MiR-374b-5p inhibits KDM5B-induced epithelial-mesenchymal transition in pancreatic cancer.
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.
MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses.
MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
miR-410-3p suppresses breast cancer progression by targeting Snail.
miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo Signaling in Thyroid Cancer.
miR-4286 is Involved in Connections Between IGF-1 and TGF-? Signaling for the Mesenchymal Transition and Invasion by Glioblastomas.
miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer.
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
miR-4709 overexpression facilitates cancer proliferation and invasion via downregulating NR3C2 and is an unfavorable prognosis factor in colon adenocarcinoma.
miR-4725-3p targeting stromal interacting molecule 1 signaling is involved in xanthohumol inhibition of glioma cell invasion.
miR-484 is associated with disease recurrence and promotes migration in prostate cancer.
miR-486 is involved in the pathogenesis of acute myeloid leukemia by regulating JAK-STAT signaling.
miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1.
miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro.
miR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression.
miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-?-catenin pathway.
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A.
MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.
miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells.
MiR-5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer.
miR-588 is a prognostic marker in gastric cancer.
miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
miR-663a inhibits tumor growth and invasion by regulating TGF-?1 in hepatocellular carcinoma.
miR-6883 Family miRNAs Target CDK4/6 to Induce G
MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling.
MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2.
miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer.
MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.
MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.
miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
MiR-93-5p Promotes Cell Proliferation through Down-Regulating PPARGC1A in Hepatocellular Carcinoma Cells by Bioinformatics Analysis and Experimental Verification.
miR-934 as a Prognostic Marker Facilitates Cell Proliferation and Migration of Pancreatic Tumor by Targeting PROX1.
miR-939-3p promotes epithelial-mesenchymal transition and may be used as a prognostic marker in hepatocellular carcinoma.
miR-940 potentially promotes proliferation and metastasis of endometrial carcinoma through regulation of MRVI1.
MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2.
miR-944 Suppresses EGF-Induced EMT in Colorectal Cancer Cells by Directly Targeting GATA6.
MiR-96-5p inhibition induces cell apoptosis in gastric adenocarcinoma.
MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR.
miR-TV: an interactive microRNA Target Viewer for microRNA and target gene expression interrogation for human cancer studies.
MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer.
MIR106A-5p upregulation suppresses autophagy and accelerates malignant phenotype in nasopharyngeal carcinoma.
miR129-1 regulates protein phosphatase 1D protein expression under hypoxic conditions in non-small cell lung cancer cells harboring a TP53 mutation.
MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays.
MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
miR?146a?5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression.
miR?223?3p regulates cell growth and apoptosis via FBXW7 suggesting an oncogenic role in human testicular germ cell tumors.
miR?888 regulates cancer progression by targeting multiple targets in lung adenocarcinoma.
MIRAGAA--a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer.
miRCancerdb: a database for correlation analysis between microRNA and gene expression in cancer.
miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers.
miRcorrNet: machine learning-based integration of miRNA and mRNA expression profiles, combined with feature grouping and ranking.
miRFA: an automated pipeline for microRNA functional analysis with correlation support from TCGA and TCPA expression data in pancreatic cancer.
miRGTF-net: Integrative miRNA-gene-TF network analysis reveals key drivers of breast cancer recurrence.
miRLAB: An R Based Dry Lab for Exploring miRNA-mRNA Regulatory Relationships.
miRNA and mRNA expression analysis reveals potential sex-biased miRNA expression.
miRNA and mRNA expression profiling reveals potential biomarkers for metastatic cutaneous melanoma.
miRNA arm switching identifies novel tumour biomarkers.
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.
miRNA biomarkers for predicting overall survival outcomes for head and neck squamous cell carcinoma.
MiRNA expression patterns are associated with tumor mutational burden in lung adenocarcinoma.
miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma.
miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7 in vitro.
miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation.
miRNA-145/miRNA-205 inhibits proliferation and invasion of uveal melanoma cells by targeting NPR1/CDC42.
miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
MiRNA-181d Expression Significantly Affects Treatment Responses to Carmustine Wafer Implantation.
miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.
miRNA-194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1.
miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma.
MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method.
miRNA-mRNA Associated With Survival in Endometrial Cancer.
miRNA-mRNA Regulatory Network and Factors Associated with Prediction of Prognosis in Hepatocellular Carcinoma.
miRNA-target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer.
miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database.
miRTissue: a web application for the analysis of miRNA-target interactions in human tissues.
Misannotated Multi-Nucleotide Variants in Public Cancer Genomics Datasets Lead to Inaccurate Mutation Calls with Significant Implications.
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma.
Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer.
Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression.
Mitochondrial DNA copy number variation across human cancers.
Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells.
Mitochondrial Respiratory Defect Enhances Hepatoma Cell Invasiveness via STAT3/NFE2L1/STX12 Axis.
Mitofusin-2 Promotes the Epithelial-Mesenchymal Transition-Induced Cervical Cancer Progression.
Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer.
Mitotically associated long non-coding RNA is a tumor promoter in anaplastic thyroid cancer.
Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
MI_DenseNetCAM: A Novel Pan-Cancer Classification and Prediction Method Based on Mutual Information and Deep Learning Model.
MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension.
MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer.
MLH1 Promoter Methylation and Prediction/Prognosis of Gastric Cancer: A Systematic Review and Meta and Bioinformatic Analysis.
MLH1-Silenced and Non-Silenced Subgroups of Hypermutated Colorectal Carcinomas Have Distinct Mutational Landscapes.
MLN4924 inhibits cell proliferation by targeting the activated neddylation pathway in endometrial carcinoma.
MMP14 predicts a poor prognosis in patients with colorectal cancer.
MMP16 is a marker of poor prognosis in gastric cancer promoting proliferation and invasion.
MMP25 Regulates Immune Infiltration Level and Survival Outcome in Head and Neck Cancer Patients.
MMP7 sensitivity of mutant ECM proteins: An indicator of melanoma survival rates and T-cell infiltration.
MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.
MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.
Model based on GA and DNN for prediction of mRNA-Smad7 expression regulated by miRNAs in breast cancer.
Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma.
MODEL FREE ESTIMATION OF GRAPHICAL MODEL USING GENE EXPRESSION DATA.
Modeling clinical and molecular covariates of mutational process activity in cancer.
Modeling Gene-Wise Dependencies Improves the Identification of Drug Response Biomarkers in Cancer Studies.
Modeling the Dynamics of Let-7-Coupled Gene Regulatory Networks Linking Cell Proliferation to Malignant Transformation.
Modeling the effects of EMT-immune dynamics on carcinoma disease progression.
Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation.
Modelling cancer progression using Mutual Hazard Networks.
Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches.
Models for Predicting Stage in Head and Neck Squamous Cell Carcinoma using Proteomic and Transcriptomic Data.
Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer.
Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1.
MODMatcher: multi-omics data matcher for integrative genomic analysis.
Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma.
Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy.
Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells.
Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation.
MOGSA: Integrative Single Sample Gene-set Analysis of Multiple Omics Data.
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
Molecular analysis of Chinese oesophageal squamous cell carcinoma identifies novel subtypes associated with distinct clinical outcomes.
Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma.
Molecular and Clinical Characterization of CCT2 Expression and Prognosis via Large-Scale Transcriptome Profile of Breast Cancer.
Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.
Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas.
Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy.
Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma.
Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
Molecular and Functional Characterization of the Somatic PIWIL1/piRNA Pathway in Colorectal Cancer Cells.
Molecular and Genomic Alterations in Glioblastoma Multiforme.
Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression.
Molecular and Immune Correlates of PDCD1 (PD-1), PD-L1 (CD274), and PD-L2 (PDCD1LG2) DNA Methylation in Triple Negative Breast Cancer.
Molecular and Morphological Profiling of Lung Cancer: A Foundation for "Next-Generation" Pathologists and Oncologists.
Molecular basis of distinct oestrogen responses in endometrial and breast cancer.
Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers.
Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.
Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.
Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression.
Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project.
Molecular Characteristics, Prognostic Value, and Immune Characteristics of m6A Regulators Identified in Head and Neck Squamous Cell Carcinoma.
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers.
Molecular Characterization and Clinical Relevance of RNA Binding Proteins in Colorectal Cancer.
Molecular characterization in the prediction of disease extent in endometrial carcinoma.
Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature.
Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population.
Molecular characterization of colorectal cancer: A five-gene prognostic signature based on RNA-binding proteins.
Molecular characterization of endometrial cancer and therapeutic implications.
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.
Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets.
Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women.
Molecular characterization of long-term survivors of hepatocellular carcinoma.
Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing.
Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
Molecular characterization of lung cancer: A two-miRNA prognostic signature based on cancer stem-like cells related genes.
Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium: Representation in All 4 TCGA Groups.
Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer.
Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature.
Molecular Characterization of Second Primary Endometrial Cancer.
Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Molecular characterization of ulcerative colitis-associated colorectal carcinomas.
Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast Cancer.
Molecular classification of endometrial cancers translated into practice.
Molecular Classification of Gastric Adenocarcinoma.
Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.
Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE.
Molecular classification of gastric cancer.
Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group.
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas.
Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes.
Molecular differences across invasive lung adenocarcinoma morphological subgroups.
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives.
Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer.
Molecular features in young vs elderly breast cancer patients and the impacts on survival disparities by age at diagnosis.
Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status.
Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma.
Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.
Molecular Genetics of Endometrial Carcinoma.
Molecular genomic profiling of adrenocortical cancers in clinical practice.
Molecular heterogeneity at the network level: high-dimensional testing, clustering and a TCGA case study.
Molecular heterogeneity of glioblastoma and its clinical relevance.
Molecular heterogeneity of guanine nucleotide binding-protein ? subunit 4 in left- and right-sided colon cancer.
Molecular homology between canine spontaneous oral squamous cell carcinomas and human head-and-neck squamous cell carcinomas reveals disease drivers and therapeutic vulnerabilities.
Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung Cancer.
Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors.
Molecular insights into the transcriptional regulatory role of thyroid hormones in ovarian cancer.
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH).
Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.
Molecular Mechanisms of KDELC2 on Glioblastoma Tumorigenesis and Temozolomide Resistance.
Molecular mechanisms of OLIG2 transcription factor in brain cancer.
Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer.
Molecular modelling and docking of Mus musculus HMGB1 inflammatory protein with CGA.
Molecular Network-Based Drug Prediction in Thyroid Cancer.
Molecular Network-Based Identification of Circular RNA-Associated ceRNA Network in Papillary Thyroid Cancer.
Molecular network-based identification of competing endogenous RNAs in bladder cancer.
Molecular Network-Based Identification of Competing Endogenous RNAs in Thyroid Carcinoma.
Molecular Oncology of Gynecologic Tumors.
Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
Molecular pathological classification of colorectal cancer.
Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines.
Molecular Pathway Analysis of Mutation Data for Biomarkers Discovery and Scoring of Target Cancer Drugs.
Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy.
Molecular phenotyping using networks, diffusion, and topology: soft tissue sarcoma.
Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer.
Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
Molecular profile reveals immune-associated markers of lymphatic invasion in human colon adenocarcinoma.
Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas.
Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content.
Molecular profiling of transcription factors pinpoints MYC-estrogen related receptor ?-regulatory factor X5 panel for characterizing the immune microenvironment and predicting the efficacy of immune checkpoint inhibitors in renal cell carcinoma.
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma-A meta-analysis approach.
Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy.
Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer.
Molecular Signatures for Tumor Classification: An Analysis of The Cancer Genome Atlas Data.
Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas.
Molecular Signatures of Epithelial Ovarian Cancer: Analysis of Associations with Tumor Characteristics and Epidemiologic Risk Factors.
Molecular Subgroups of Glioblastoma- an Assessment by Immunohistochemical Markers.
Molecular subtype classification of papillary renal cell cancer using miRNA expression.
Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma.
Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients.
Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.
Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients.
Molecular Subtypes of Oral Squamous Cell Carcinoma Based on Immunosuppression Genes Using a Deep Learning Approach.
Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
Molecular subtyping of prostate cancer.
Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics Data.
Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.
Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma.
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
Molecular-targeted therapies and precision medicine for endometrial cancer.
Monitoring methylation-driven genes as prognostic biomarkers in patients with lung squamous cell cancer.
Monitoring of Technical Variation in Quantitative High-Throughput Datasets.
Monitoring response to transarterial chemoembolization in hepatocellular carcinoma using 18F-Fluorothymidine Positron Emission Tomography.
Monocarboxylate transporters in breast cancer and adipose tissue are novel biomarkers and potential therapeutic targets.
Monocarboxylate transporter 1 is an independent prognostic factor in esophageal squamous cell carcinoma.
Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma.
Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
MORC4 Promotes Chemoresistance of Luminal A/B Breast Cancer via STAT3-Mediated MID2 Upregulation.
Morphologic and molecular analysis of early-onset gastric cancer.
Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma.
Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.
Morphologic, Immunophenotypic and Molecular Features of Hypermutation in Colorectal Carcinomas with Mutations in DNA Polymerase ? (POLE).
Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implications.
MORPHOLOGICAL SIGNATURES AND GENOMIC CORRELATES IN GLIOBLASTOMA.
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Morphometic analysis of TCGA glioblastoma multiforme.
Morphoproteomic characterization of lung squamous cell carcinoma fragmentation, a histological marker of increased tumor invasiveness.
Mosaic mutations in blood DNA sequence are associated with solid tumor cancers.
Most Commonly Mutated Genes in High-Grade Serous Ovarian Carcinoma Are Nonessential for Ovarian Surface Epithelial Stem Cell Transformation.
motifbreakR: an R/Bioconductor package for predicting variant effects at transcription factor binding sites.
Mouse models of glioblastoma: lessons learned and questions to be answered.
MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma.
MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set.
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
MR1 overexpression correlates with poor clinical prognosis in glioma patients.
MRE11A Isoform Expression Associated with Outcome Following Radiotherapy in Muscle-Invasive Bladder Cancer does not Alter Cell Survival and DNA Double-Strand Break Repair Following Ionising Radiation.
MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma.
MRI Atlas of IDH Wild-Type Supratentorial Glioblastoma: Probabilistic Maps of Phenotype, Management, and Outcomes.
MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade Gliomas.
MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks.
MRI-Based Deep-Learning Method for Determining Glioma MGMT Promoter Methylation Status.
MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma.
mRNA Expression of SLC5A5 and SLC2A Family Genes in Papillary Thyroid Cancer: An Analysis of The Cancer Genome Atlas.
mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers.
MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway.
MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients.
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.
MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy.
MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients.
MTA2 as a Potential Biomarker and Its Involvement in Metastatic Progression of Human Renal Cancer by miR-133b Targeting MMP-9.
MTAP deficiency-induced metabolic reprogramming creates a vulnerability to co-targeting de novo purine synthesis and glycolysis in pancreatic cancer.
MTBP Is Overexpressed in Triple-Negative Breast Cancer and Contributes to Its Growth and Survival.
mTOR Signalling in Head and Neck Cancer: Heads Up.
MTSS1 hypermethylation is associated with prostate cancer progression.
MUC1-C integrates activation of the IFN-? pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Mucin 17 inhibits the progression of human gastric cancer by limiting inflammatory responses through a MYH9-p53-RhoA regulatory feedback loop.
Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.
Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.
Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer.
Mucinous and non-mucinous colorectal cancers show differential expression of chemotherapy metabolism and resistance genes.
MUDENG Expression Profiling in Cohorts and Brain Tumor Biospecimens to Evaluate Its Role in Cancer.
Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.
Multi-dimensional data integration algorithm based on random walk with restart.
Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures.
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme.
Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma.
Multi-kinase inhibitors and cisplatin for head and neck cancer treatment in vitro.
Multi-marker analysis of genomic annotation on gastric cancer GWAS data from Chinese populations.
Multi-network approach to identify differentially methylated gene communities in cancer.
Multi-Objective Optimization Algorithm to Discover Condition-Specific Modules in Multiple Networks.
Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network.
Multi-Omic Analyses of the m5C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma.
Multi-Omic Regulation of the PAM50 Gene Signature in Breast Cancer Molecular Subtypes.
Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma.
Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma.
Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma.
Multi-Omics Analysis of the Expression and Prognosis for FKBP Gene Family in Renal Cancer.
Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
Multi-omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma.
Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
Multi-omics analysis to identify driving factors in colorectal cancer.
Multi-omics analysis to identify susceptibility genes for colorectal cancer.
Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks.
Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer.
Multi-omics approach to infer cancer therapeutic targets on chromosome 20q across tumor types.
Multi-omics approaches identify SF3B3 and SIRT3 as candidate autophagic regulators and druggable targets in invasive breast carcinoma.
Multi-omics characterization and validation of invasiveness-related molecular features across multiple cancer types.
Multi-omics characterization and validation of MSI-related molecular features across multiple malignancies.
Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment.
Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD.
Multi-omics Data Integration by Generative Adversarial Network.
Multi-Omics Database Analysis of Aminoacyl-tRNA Synthetases in Cancer.
Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets.
Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer.
Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy.
Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes.
Multi-omics Perspective on the Tumor Microenvironment based on PD-L1 and CD8 T-Cell Infiltration in Urothelial Cancer.
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer.
Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response.
Multi-platform analysis of methylation-regulated genes in human lung adenocarcinoma.
Multi-Platform Omics Analysis for Identification of Molecular Characteristics and Therapeutic Targets of Uveal Melanoma.
Multi-project and Multi-profile joint Non-negative Matrix Factorization for cancer omic datasets.
Multi-Scale Modeling for Image Analysis of Brain Tumor Studies.
Multi-slice low-rank tensor decomposition based multi-atlas segmentation: Application to automatic pathological liver CT segmentation.
Multi-Stability and Consequent Phenotypic Plasticity in AMPK-Akt Double Negative Feedback Loop in Cancer Cells.
Multi-step screening of neoantigens' HLA- and TCR-interfaces improves prediction of survival.
Multi-task multi-modal learning for joint diagnosis and prognosis of human cancers.
Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas.
Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma.
Multicenter validation of prostate tumor localization using multiparametric MRI and prior knowledge.
Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma.
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
Multifactorial deep learning reveals pan-cancer genomic tumor clusters with distinct immunogenomic landscape and response to immunotherapy.
Multigene sets for clinical application in glioma.
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.
Multilayer modelling of the human transcriptome and biological mechanisms of complex diseases and traits.
Multilevel omic data clustering reveals variable contribution of methylator phenotype to integrative cancer subtypes.
Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma.
Multimodal 3D DenseNet for IDH Genotype Prediction in Gliomas.
Multiomic Analysis of Methylation and Transcriptome Reveals a Novel Signature in Esophageal Cancer.
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma.
Multiomic analysis of the function of SPOCK1 across cancers: an integrated bioinformatics approach.
Multiomic Integration of Public Oncology Databases in Bioconductor.
Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer.
Multiomics Differences in Lung Squamous Cell Carcinoma Patients with High Radiosensitivity Index Compared with Those with Low Radiosensitivity Index.
Multiomics integrative analysis for gene signatures and prognostic values of m6A regulators in pancreatic adenocarcinoma: a retrospective study in The Cancer Genome Atlas project.
Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1.
Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma.
Multiomics Profiling and Clustering of Low-Grade Gliomas Based on the Integrated Stress Status.
Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment.
Multiplatform-based molecular subtypes of non-small-cell lung cancer.
Multiple breast cancer risk variants are associated with differential transcript isoform expression in tumors.
Multiple gene dysfunctions lead to high cancer-susceptibility: evidences from a whole-exome sequencing study.
Multiple genetic variants predict the progression-free survival of bevacizumab plus chemotherapy in advanced ovarian cancer: A retrospective study.
Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis.
Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
Multiple network algorithm for epigenetic modules via the integration of genome-wide DNA methylation and gene expression data.
Multiple Omics Data Integration to Identify Long Noncoding RNA Responsible for Breast Cancer-Related Mortality.
Multiple-kernel learning for genomic data mining and prediction.
Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma.
Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer.
Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer.
Multiscale Embedded Gene Co-expression Network Analysis.
Multiscale integration of -omic, imaging, and clinical data in biomedical informatics.
Multiscale Modeling of Inflammation-Induced Tumorigenesis Reveals Competing Oncogenic and Oncoprotective Roles for Inflammation.
Multiscale mutation clustering algorithm identifies pan-cancer mutational clusters associated with pathway-level changes in gene expression.
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.
Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of de novo Glioblastoma Patients.
Multivariate Bayesian meta-analysis: joint modelling of multiple cancer types using summary statistics.
Multivariate gene expression-based survival predictor model in esophageal adenocarcinoma.
Municipal distribution of breast cancer mortality among women in Spain.
MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures.
Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma.
Mutant IDH1 and thrombosis in gliomas.
Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin.
Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters.
Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain.
Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibition.
Mutant-allele fraction heterogeneity is associated with non-small cell lung cancer patient survival.
Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence.
muTarget: A platform linking gene expression changes and mutation status in solid tumors.
Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.
Mutation Drivers of Immunological Responses to Cancer.
Mutation load estimation model as a predictor of the response to cancer immunotherapy.
Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Mutation or loss of p53 differentially modifies TGF? action in ovarian cancer.
Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data.
Mutation profile of non-small cell lung cancer revealed by next generation sequencing.
Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer.
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma.
Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status.
Mutational Heterogeneity in Human Cancers: Origin and Consequences.
Mutational landscape and significance across 12 major cancer types.
Mutational landscape differences between young-onset and older-onset breast cancer patients.
Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy.
Mutational Landscape of the Essential Autophagy Gene BECN1 in Human Cancers.
Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.
Mutational load and mutational patterns in relation to age in head and neck cancer.
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.
Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.
Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary.
Mutational Signatures Are Critical for Proper Estimation of Purifying Selection Pressures in Cancer Somatic Mutation Data When Using the dN/dS Metric.
Mutational spectrum and prognostic stratification of intermediate-risk acute myeloid leukemia.
Mutations in Coagulation
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma.
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1.
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
Mutations in the notch signalling pathway are associated with enhanced anti-tumour immunity in colorectal cancer.
Mutations of Chromatin Structure Regulating Genes in Human Malignancies.
Mutations of p53 associated with pancreatic cancer and therapeutic implications.
Mutual exclusivity analysis identifies oncogenic network modules.
MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
My personal mutanome: a computational genomic medicine platform for searching network perturbing alleles linking genotype to phenotype.
MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
MYC DNA Methylation in Prostate Tumor Tissue Is Associated with Gleason Score.
MYCT1 Inhibits the Adhesion and Migration of Laryngeal Cancer Cells Potentially Through Repressing Collagen VI.
MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas.
Myeloid cell-targeted miR-146a mimic inhibits NF-?B-driven inflammation and leukemia progression in vivo.
Myeloid translocation genes differentially regulate colorectal cancer programs.
Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma.
MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.
N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: A large-scale multicenter study.
N-myc downstream-regulated gene 2 promotes the protein stability of estrogen receptor beta via inhibition of ubiquitin-protein ligase E3A to suppress colorectal cancer.
N6 -methyladenosine (m6 A) RNA modification of G protein-coupled receptor 133 increases proliferation of lung adenocarcinoma.
N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes.
N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
N6-methyladenosine (m6A) RNA methylation signature as a predictor of stomach adenocarcinoma outcomes and its association with immune checkpoint molecules.
N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma.
N6-methyladenosine associated prognostic model in hepatocellular carcinoma.
N6-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling.
N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer.
N6-Methyladenosine Related Long Non-Coding RNAs and Immune Cell Infiltration in the Tumor Microenvironment of Gastric Cancer.
N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma.
N6-methyladenosine-related Genomic Targets are Altered in Breast Cancer Tissue and Associated with Poor Survival.
N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients.
N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.
N6?methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.
NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma.
NAP1L1 Functions as a Tumor Promoter via Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma.
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
NAT1 is a critical prognostic biomarker and inhibits proliferation of colorectal cancer through modulation of PI3K/Akt/mTOR.
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC.
Natural Agents-Mediated Targeting of Histone Deacetylases.
Natural Product Regulates Autophagy in Cancer.
NaviCom: a web application to create interactive molecular network portraits using multi-level omics data.
NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
NCAPG Is a Promising Therapeutic Target Across Different Tumor Types.
NCAPG promotes the progression of lung adenocarcinoma via the TGF-? signaling pathway.
NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
NCEH1 may be a prognostic biomarker for pancreatic cancer.
ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer.
ncRNA-eQTL: a database to systematically evaluate the effects of SNPs on non-coding RNA expression across cancer types.
ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.
NDRG1 prognosticates the natural course of disease in WHO grade II glioma.
NDRG1 suppresses vasculogenic mimicry and tumor aggressiveness in gastric carcinoma.
NDRG2 and TLR7 as novel DNA methylation prognostic signatures for acute myelocytic leukemia.
NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.
NDUFA4L2 is associated with clear cell renal cell carcinoma malignancy and is regulated by ELK1.
Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastoma.
Nearing saturation of cancer driver gene discovery.
NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
NEDD4 Negatively Regulates GITR via Ubiquitination in Immune Microenvironment of Melanoma.
Needles in a haystack: finding recurrent genomic changes in breast cancer.
Negative Correlation between miR-200c and Decorin Plays an Important Role in the Pathogenesis of Colorectal Carcinoma.
Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.
NEIL1 p.Gln282Stop variant is predominantly localized in the cytoplasm and exhibits reduced activity in suppressing mutations.
NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma.
NEK2 serves as a prognostic biomarker for hepatocellular carcinoma.
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival.
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer.
neoANT-HILL: an integrated tool for identification of potential neoantigens.
Neoantigen landscape in metastatic nasopharyngeal carcinoma.
Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma.
Neonatal aphakia retards ocular growth and alters scleral gene expression in rhesus monkeys.
Neoplasms of the atlas and axis.
Neoplastic Transformation of Human Mesenchymal Stromal Cells Mediated via LIN28B.
NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals.
Nestin and CD34 expression in colorectal cancer predicts improved overall survival.
Nestin+/CD31+ cells in the hypoxic perivascular niche regulate glioblastoma chemoresistance by upregulating JAG1 and DLL4.
Net-based cancer atlas shows new cancer trends in India.
netboxr: Automated discovery of biological process modules by network analysis in R.
NetNorM: Capturing cancer-relevant information in somatic exome mutation data with gene networks for cancer stratification and prognosis.
Netrin-4 promotes glioblastoma cell proliferation through integrin ?4 signaling.
Network analysis based on low-rank method for mining information on integrated data of multi-cancers.
Network analysis identifies DAPK3 as a potential biomarker for lymphatic invasion and colon adenocarcinoma prognosis.
Network analysis of aging acceleration reveals systematic properties of 11 types of cancers.
Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
Network analysis of miRNA targeting m6A-related genes in patients with esophageal cancer.
Network integration of multi-tumour omics data suggests novel targeting strategies.
Network Meta-Analysis on the Effects of DNA Damage Response-Related Gene Mutations on Overall Survival of Breast Cancer Based on TCGA Database.
Network modeling of the transcriptional effects of copy number aberrations in glioblastoma.
Network Rewiring in Cancer: Applications to Melanoma Cell Lines and the Cancer Genome Atlas Patients.
Network signatures of survival in glioblastoma multiforme.
Network-adjusted Kendall's Tau Measure for Feature Screening with Application to High-dimensional Survival Genomic Data.
Network-Based Approach to Identify the Antiproliferative Mechanisms of Bruceine D in Breast Cancer From the Cancer Genome Atlas.
Network-based identification of key master regulators associated with an immune-silent cancer phenotype.
Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer.
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.
Network-based integrative clustering of multiple types of genomic data using non-negative matrix factorization.
Network-Based Isoform Quantification with RNA-Seq Data for Cancer Transcriptome Analysis.
Network-based machine learning and graph theory algorithms for precision oncology.
Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Network-based multi-task learning models for biomarker selection and cancer outcome prediction.
Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma.
Network-based stratification of tumor mutations.
Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer.
Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.
Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro.
Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas.
Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor.
Neuropilin-1 predicts poor prognosis and promotes tumor metastasis through epithelial-mesenchymal transition in gastric cancer.
Neuropilin-2 promotes growth and progression of papillary thyroid cancer cells.
Neutrophil Extracellular Traps (NETs) Promote Pro-Metastatic Phenotype in Human Breast Cancer Cells through Epithelial-Mesenchymal Transition.
Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer.
Nevus sebaceus is associated with unusual neoplasms. An atlas.
New agents and new targets for renal cell carcinoma.
New Analysis Framework Incorporating Mixed Mutual Information and Scalable Bayesian Networks for Multimodal High Dimensional Genomic and Epigenomic Cancer Data.
New and Emerging Biomarkers in Endocrine Pathology.
New cancer mortality atlas.
New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care.
New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx.
New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
New horizons in bladder cancer research.
New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer.
New insights into the molecular profile of lung adenocarcinoma and implications for therapy.
New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines.
New Perspectives on Pheochromocytoma and Paraganglioma: Towards a Molecular Classification.
New strategies in the molecular targeting of glioblastoma: how do you hit a moving target?
News.
Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
Next generation sequencing approach for detecting 491 fusion genes from human cancer.
Next generation sequencing has lower sequence coverage and poorer SNP-detection capability in the regulatory regions.
Next generation sequencing in gastric or gastroesophageal adenocarcinoma.
Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Next Generation Sequencing: The Next Iteration of Personalized Medicine: Next generation sequencing, along with expanding databases like The Cancer Genome Atlas, has the potential to aid rational drug discovery and streamline clinical trials.
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.
Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
Next-Generation Sequencing Reveals High Uncommon EGFR Mutations and Tumour Mutation Burden in a Subgroup of Lung Cancer Patients.
Next-generation sequencing, cancer and molecular diagnostics: an interview with Elaine Mardis.
Next-Generation Sequencing-Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer: Potential Implications for Clinical Management.
Next-generation sequencing-based identification of EGFR and NOTCH2 complementary mutations in non-small cell lung cancer.
NExUS: Bayesian simultaneous network estimation across unequal sample sizes.
NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer.
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma.
NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype.
NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma.
NFIB promotes the migration and progression of kidney renal clear cell carcinoma by regulating PINK1 transcription.
NFIX downregulation independently predicts poor prognosis in lung adenocarcinoma, but not in squamous cell carcinoma.
NGFI-A Binding Protein 2 Promotes EGF-Dependent HNSCC Cell Invasion.
NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
NICE-3-knockdown induces cell cycle arrest and autophagy in lung adenocarcinoma cells via the AKT/mTORC1 signaling pathway.
Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer.
Nicotinamide nucleotide transhydrogenase acts as a new prognosis biomarker in hepatocellular carcinoma.
Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes.
Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling.
NIMA related kinase 2 promotes gastric cancer cell proliferation via ERK/MAPK signaling.
Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.
Nine-long non-coding ribonucleic acid signature can improve the survival prediction of colorectal cancer.
Niraparib Suppresses Cholangiocarcinoma Tumor Growth by Inducing Oxidative and Replication Stress.
NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival.
NK homeobox 2.2 functions as tumor suppressor in colorectal cancer due to DNA methylation.
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy.
NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas.
NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma.
NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma.
NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/?-catenin signalling pathway in clear cell renal cell carcinoma.
NME4 may enhance non?small cell lung cancer progression by overcoming cell cycle arrest and promoting cellular proliferation.
NMIIA promotes tumor growth and metastasis by activating the Wnt/?-catenin signaling pathway and EMT in pancreatic cancer.
NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability.
No Causal Link between Phosphodiesterase Type 5 Inhibition and Melanoma.
NOD2 maybe a biomarker for the survival of kidney cancer patients.
Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
Nomogram based on immune scores for predicting the survival of patients with esophageal squamous cell carcinoma.
Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
Nomogram model characterized by mutant genes and clinical indexes to identify high-risk patients with stage III/IV colorectal cancer.
Non-coding RNAs profiling in head and neck cancers.
Non-coding single nucleotide variants affecting estrogen receptor binding and activity.
Non-diffeomorphic registration of brain tumor images by simulating tissue loss and tumor growth.
Non-Negative Symmetric Low-Rank Representation Graph Regularized Method for Cancer Clustering Based on Score Function.
Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to Cisplatin.
Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.
Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.
Noncoding RNAs Serve as the Deadliest Universal Regulators of all Cancers.
Nonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinoma.
Nonredundant, Highly Connected MicroRNAs Control Functionality in Breast Cancer Networks.
Nonsense-mediated decay factor SMG7 sensitizes cells to TNF?-induced apoptosis via CYLD tumor suppressor and the noncoding oncogene Pvt1.
Norepinephrine Enhances Aerobic Glycolysis and May Act as a Predictive Factor for Immunotherapy in Gastric Cancer.
Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition.
Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
Normalized lmQCM: An Algorithm for Detecting Weak Quasi-Cliques in Weighted Graph with Applications in Gene Co-Expression Module Discovery in Cancers.
Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous Kras LSL-G12V Driven Lung Cancer Mouse Model.
Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-?B(p65) pathway.
Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer.
NOTCH4 Is a Novel Prognostic Marker that Correlates with Colorectal Cancer Progression and Prognosis.
Novel Application of Junction Trees to the Interpretation of Epigenetic Differences among Lung Cancer Subtypes.
Novel Autophagy-Related Gene Signature Investigation for Patients With Oral Squamous Cell Carcinoma.
Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis.
Novel biomarkers in bladder cancer.
Novel CpG-SNPs in the gastric acid secretion pathway GNAI3 and susceptibility to gastric cancer.
Novel deep learning-based survival prediction for oral cancer by analyzing tumor-infiltrating lymphocyte profiles through CIBERSORT.
Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells.
Novel drug candidate for the treatment of several soft?tissue sarcoma histologic subtypes: A computational method using survival?associated gene signatures for drug repurposing.
Novel drug candidates for treating esophageal carcinoma: A study on differentially expressed genes, using connectivity mapping and molecular docking.
Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas.
Novel functional variants in the Notch pathway and survival of Chinese colorectal cancer.
Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia.
Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images.
Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma.
Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis.
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.
Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data.
Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing.
Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.
Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
Novel long non-coding RNA LINC02532 promotes gastric cancer cell proliferation, migration, and invasion in vitro.
Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors.
Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.
Novel Methylation Patterns Predict Outcome in Uveal Melanoma.
Novel methylation-driven genes identified as prognostic indicators for lung squamous cell carcinoma.
Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.
Novel miRNA Predicts Survival and Prognosis of Cholangiocarcinoma Based on RNA-seq Data and In Vitro Experiments.
Novel miRNA-mRNA interactions conserved in essential cancer pathways.
Novel Molecular Subtypes Associated With 5mC Methylation and Their Role in Hepatocellular Carcinoma Immunotherapy.
Novel nomograms based on immune and stromal scores for predicting the disease-free and overall survival of patients with hepatocellular carcinoma undergoing radical surgery.
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53.
Novel oxidative stress-related prognostic biomarkers for melanoma associated with tumor metastasis.
Novel points of attack for targeted cancer therapy.
Novel prognostic genes and subclasses of acute myeloid leukemia revealed by survival analysis of gene expression data.
Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma.
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types.
Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma.
Novel targets in the treatment of advanced gastric cancer: a perspective review.
Novel Therapies for Tongue Squamous Cell Carcinoma Patients with High-Grade Tumors.
Novel three?lncRNA signature predicts survival in patients with pancreatic cancer.
Novel transcription-induced fusion RNAs in prostate cancer.
NPRL2 reduces the niraparib sensitivity of castration-resistant prostate cancer via interacting with UBE2M and enhancing neddylation.
NPTX1 promotes metastasis via integrin/FAK signaling in gastric cancer.
NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer.
NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells.
NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma.
NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand.
NRASQ61K melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells.
NRF2 Activation in Cancer: From DNA to Protein.
Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma.
Nrf2/HO-1 Axis Regulates the Angiogenesis of Gastric Cancer via Targeting VEGF.
NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer.
NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents.
NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
NT5DC2 is a novel prognostic marker in human hepatocellular carcinoma.
NT5DC2 promotes leiomyosarcoma tumour cell growth via stabilizing unpalmitoylated TEAD4 and generating a positive feedback loop.
NT5E/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma.
NTP/NIEHS Global Contributions to Toxicologic Pathology.
NTRK1 Fusion in Glioblastoma Multiforme.
Nuclear and stromal expression of Manic fringe in renal cell carcinoma.
Nuclear envelope structural defect underlies the main cause of aneuploidy in ovarian carcinogenesis.
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Nuclear Localization of PTTG1 Promotes Migration and Invasion of Seminoma Tumor through Activation of MMP-2.
Nuclear Receptor Coactivator 5 is Correlated with Progression in Breast Carcinoma.
Nuclear Transglutaminase 2 interacts with topoisomerase II? to promote DNA damage repair in lung cancer cells.
Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.
NUCLEI SEGMENTATION VIA SPARSITY CONSTRAINED CONVOLUTIONAL REGRESSION.
Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.
Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma.
Nucleophosmin 1 overexpression correlates with 18F-FDG PET/CT metabolic parameters and improves diagnostic accuracy in patients with lung adenocarcinoma.
Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling.
Nucleophosmin Mutations Induce Chemosensitivity in THP-1 Leukemia Cells by Suppressing NF-?B Activity and Regulating Bax/Bcl-2 Expression.
Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma.
NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma.
NUDT5 as a novel drug target and prognostic biomarker for ER-positive breast cancer.
NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection.
Nullifying the CDKN2A/B Locus Promotes Mutant K-ras Lung Tumorigenesis.
NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway.
NUT midline carcinomas and their differentials by a single molecular profiling method: a new promising diagnostic strategy illustrated by a case report.
Obesity and genes related to lipid metabolism predict poor survival in oral squamous cell carcinoma.
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies studies and correlation with flt3 mutations and polyunsaturated fatty acid metabolism.
Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.
Object-oriented regression for building predictive models with high dimensional omics data from translational studies.
Observed correlation between the expression levels of catalytic subunit, C?2, of cyclic adenosine monophosphate-dependent protein kinase and prostate cancer aggressiveness.
Observed Survival Interval: A Supplement to TCGA Pan-Cancer Clinical Data Resource.
Occipital neuralgia: anatomic considerations.
Occipito-cervical Reconstruction Through Direct Lateral and Posterior Approach or the Treatment of Primary Osteosarcoma in the Atlas: A Case Report.
Occupation and cancer in London: an investigation into nasal and bladder cancer using the Cancer Atlas.
OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma.
Octogenarians' Breast Cancer Is Associated with an Unfavorable Tumor Immune Microenvironment and Worse Disease-Free Survival.
ODC1 promotes proliferation and mobility via the AKT/GSK3?/?-catenin pathway and modulation of acidotic microenvironment in human hepatocellular carcinoma.
Oestrogen receptor alpha in papillary thyroid carcinoma: association with clinical features and BRAFV600E mutation.
Of fractal and Fourier: A measure for local shape complexity for neurological applications.
OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer.
OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients.
OIP5-AS1 modulates epigenetic regulator HDAC7 to enhance non-small cell lung cancer metastasis via miR-140-5p.
OLA1 is a potential prognostic molecular biomarker for endometrial cancer and promotes tumor progression.
Oligodendroglial tumours: subventricular zone involvement and seizure history are associated with CIC mutation status.
OMCD: OncomiR Cancer Database.
Omics AnalySIs System for PRecision Oncology (OASISPRO): A Web-based Omics Analysis Tool for Clinical Phenotype Prediction.
Omics data-driven analysis identifies laminin-integrin-mediated signaling pathway as a determinant for cell differentiation in oral squamous cell carcinoma.
Omics Pipe: a community-based framework for reproducible multi-omics data analysis.
Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis.
On the impact of batch effect correction in TCGA isomiR expression data.
On the reproducibility of TCGA ovarian cancer microRNA profiles.
Onco-Multi-OMICS Approach: A New Frontier in Cancer Research.
OncoBinder facilitates interpretation of proteomic interaction data by capturing coactivation pairs in cancer.
Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis.
Oncogene inference optimization using constraint-based modelling incorporated with protein expression in normal and tumour tissues.
Oncogene or tumor suppressor? Long noncoding RNAs role in patient's prognosis varies depending on disease type.
Oncogene-dependent function of BRG1 in hepatocarcinogenesis.
Oncogenes expand during evolution to withstand somatic amplification.
Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification.
Oncogenic Activity of Wrap53 in Human Colorectal Cancer In Vitro and in Nude Mouse Xenografts.
Oncogenic and prognostic role of CKAP2L in hepatocellular carcinoma.
Oncogenic B-Myb Is Associated With Deregulation of the DREAM-Mediated Cell Cycle Gene Expression Program in High Grade Serous Ovarian Carcinoma Clinical Tumor Samples.
Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma.
Oncogenic effect of PHLDB2 is associated with epithelial-mesenchymal transition and E-cadherin regulation in colorectal cancer.
Oncogenic effects of miR-10b in glioblastoma stem cells.
Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer.
Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.
Oncogenic K-Ras4B Dimerization Enhances Downstream Mitogen-activated Protein Kinase Signaling.
Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma.
Oncogenic long noncoding RNA landscape in breast cancer.
Oncogenic miR?132 sustains proliferation and self?renewal potential by inhibition of polypyrimidine tract?binding protein 2 in glioblastoma cells.
Oncogenic Properties of NEAT1 in Prostate Cancer Cells Depend on the CDC5L-AGRN Transcriptional Regulation Circuit.
Oncogenic Properties of the Antisense lncRNA COMET in BRAF- and RET-Driven Papillary Thyroid Carcinomas.
Oncogenic Role and Prognostic Value of MicroRNA-937-3p in Patients with Breast Cancer.
Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma.
Oncogenic Signaling Pathways in The Cancer Genome Atlas.
Oncogenic SNORD12B activates the AKT-mTOR-4EBP1 signaling in esophageal squamous cell carcinoma via nucleus partitioning of PP-1?.
Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.
Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth.
Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation.
Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma.
Oncogenomic portals for the visualization and analysis of genome-wide cancer data.
Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.
Oncological and prognostic impact of lymphovascular invasion in Colorectal Cancer patients.
OncomiR: an online resource for exploring pan-cancer microRNA dysregulation.
Oncomorphic TP53 Mutations in Gynecologic Cancers Lose the Normal Protein:Protein Interactions with the microRNA Microprocessing Complex.
oncoNcRNA: A Web Portal for Exploring the Non-Coding RNAs with Oncogenic Potentials in Human Cancers.
Oncoplastic surgery for breast cancer based on tumour location and a quadrant-per-quadrant atlas.
Oncotator: Cancer Variant Annotation Tool.
OncotRF: an online resource for exploration of tRNA-derived fragments in human cancers.
OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
Opa interacting protein 5 acts as an oncogene in bladder cancer.
OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis.
OpenHealth Platform for Interactive Contextualization of Population Health Open Data.
Opportunities of next-generation sequencing in non-muscle invasive bladder cancer outcome prediction.
Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.
Opposite Roles of BAP1 in Overall Survival of Uveal Melanoma and Cutaneous Melanoma.
Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC.
Optical Coherence Tomography: A Novel Imaging Method for Post-lumpectomy Breast Margin Assessment-A Multi-reader Study.
Optimal Bayesian Transfer Learning for Count Data.
Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
Optimal selection of genetic variants for adjustment of population stratification in European association studies.
Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer.
Optimal treatment for metastatic bladder cancer.
Optimisation of cancer classification by machine learning generates an enriched list of candidate drug targets and biomarkers.
Optimization of cell lines as tumour models by integrating multi-omics data.
Optimization of deep learning methods for visualization of tumor heterogeneity and brain tumor grading through digital pathology.
Optimization of Population Frequency Cutoffs for Filtering Common Germline Polymorphisms from Tumor-Only Next-Generation Sequencing Data.
Optimization of Signal Decomposition Matched Filtering (SDMF) for Improved Detection of Copy-Number Variations.
Optimization to detect TP53 mutations in circulating cell-free tumor DNA from patients with serous epithelial ovarian cancer.
Optimized prostate biopsy via a statistical atlas of cancer spatial distribution.
Oral submucous fibrosis stimulates invasion and epithelial-mesenchymal transition in oral squamous cell carcinoma by activating MMP-2 and IGF-IR.
ORBIT: a multiresolution framework for deformable registration of brain tumor images.
Ordino: a visual cancer analysis tool for ranking and exploring genes, cell lines, and tissue samples.
Original Article/Liver hMex-3A is associated with poor prognosis and contributes to the progression of hepatocellular carcinoma.
Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression.
Ornithine decarboxylase as a therapeutic target for endometrial cancer.
Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
OSacc: Gene Expression-Based Survival Analysis Web Tool For Adrenocortical Carcinoma.
OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts.
OScc: an online survival analysis web server to evaluate the prognostic value of biomarkers in cervical cancer.
OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B-cell lymphoma.
OSeac: An Online Survival Analysis Tool for Esophageal Adenocarcinoma.
OSgbm: An Online Consensus Survival Analysis Web Server for Glioblastoma.
OSkirc: a web tool for identifying prognostic biomarkers in kidney renal clear cell carcinoma.
OSlms: A Web Server to Evaluate the Prognostic Value of Genes in Leiomyosarcoma.
OSmfs: An Online Interactive Tool to Evaluate Prognostic Markers for Myxofibrosarcoma.
Otoferlin is a prognostic biomarker in patients with clear cell renal cell carcinoma: A systematic expression analysis.
OTUD4: A Potential Prognosis Biomarker for Multiple Human Cancers.
Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer.
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.
Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma.
Outlier reset CUSUM for the exploration of copy number alteration data.
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.
Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma.
Over-Expression and Prognostic Significance of HHLA2, a New Immune Checkpoint Molecule, in Human Clear Cell Renal Cell Carcinoma.
Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer.
Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway.
Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-?B signaling in hepatocellular carcinoma.
Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma.
Over-expression of vitronectin correlates with impaired survival in gastric cancers.
Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib.
Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma.
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.
Overexpressed somatic alleles are enriched in functional elements in Breast Cancer.
Overexpression and biological function of IQGAP3 in human pancreatic cancer.
Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1(+) immune cells in Epstein-Barr virus-associated gastric cancer: the prognostic implications.
Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma.
Overexpression of ?3, ?3 and ?2 chains of laminin-332 is associated with poor prognosis in pancreatic ductal adenocarcinoma.
Overexpression of ADAR1 into the cytoplasm correlates with a better prognosis of patients with oral squamous cells carcinoma.
Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.
Overexpression of ASPM, CDC20, and TTK Confer a Poorer Prognosis in Breast Cancer Identified by Gene Co-expression Network Analysis.
Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8.
Overexpression of BHLHE41, correlated with DNA hypomethylation in 3'UTR region, promotes the growth of human clear cell renal cell carcinoma.
Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma.
Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer.
Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells.
Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity.
Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.
Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas.
Overexpression of chemokine receptor lymphotactin receptor 1 has prognostic value in clear cell renal cell carcinoma.
Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma.
Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.
Overexpression of COL24A1 in Hepatocellular Carcinoma Predicts Poor Prognosis: A Study Based on Multiple Databases, Clinical Samples and Cell Lines.
Overexpression of CPXM2 predicts an unfavorable prognosis and promotes the proliferation and migration of gastric cancer.
Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.
Overexpression of E74-like transformation-specific transcription factor 3 promotes cellular proliferation and predicts poor prognosis in ovarian cancer.
Overexpression of eIF3D in Lung Adenocarcinoma Is a New Independent Prognostic Marker of Poor Survival.
Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
Overexpression of EP300-interacting inhibitor of differentiation 3 predicts poor prognosis in patients with glioblastoma multiforme.
Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer.
Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer.
Overexpression of Fn14 in gliomas: tumor progression and poor prognosis.
Overexpression of FNDC1 in Gastric Cancer and its Prognostic Significance.
Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis.
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.
Overexpression of GIHCG is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma.
Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients.
Overexpression of HMGA1 Figures as a Potential Prognostic Factor in Endometrioid Endometrial Carcinoma (EEC).
Overexpression of HOTTIP promotes proliferation and drug resistance of lung adenocarcinoma by regulating AKT signaling pathway.
Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Overexpression of hsa-miR-125a-5p enhances proliferation, migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7.
Overexpression of HSD17B4 exerts tumor suppressive function in adrenocortical carcinoma and is not associated with hormone excess.
Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
Overexpression of ING3 is associated with attenuation of migration and invasion in breast cancer.
Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway.
Overexpression of KCNJ4 correlates with cancer progression and unfavorable prognosis in lung adenocarcinoma.
Overexpression of KIAA0101 Promotes the Progression of Non-small Cell Lung Cancer.
Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Overexpression of KLF5 is associated with poor survival and G1/S progression in pancreatic cancer.
Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis.
Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway.
Overexpression of LncRNA HOTAIR is Associated with Poor Prognosis in Thyroid Carcinoma: A Study Based on TCGA and GEO Data.
Overexpression of lncRNA SNGH3 Predicts Unfavorable Prognosis and Clinical Outcomes in Human Cancers: Evidence from a Meta-Analysis.
Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis.
Overexpression of long non-coding RNA KCNQ1OT1 is related to good prognosis via inhibiting cell proliferation in non-small cell lung cancer.
Overexpression of long noncoding RNA LINC01419 in esophageal squamous cell carcinoma and its relation to the sensitivity to 5-fluorouracil by mediating GSTP1 methylation.
Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma.
Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma.
Overexpression of malignant brain tumor domain containing protein 1 predicts a poor prognosis of prostate cancer.
Overexpression of MAX dimerization protein 3 (MXD3) predicts poor prognosis in clear cell renal cell carcinoma.
Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer.
Overexpression of METTL3 associated with the metabolic status on 18F-FDG PET/CT in patients with Esophageal Carcinoma.
Overexpression of MiR-452-5p in hepatocellular carcinoma tissues and its prospective signaling pathways.
Overexpression of MMP14 predicts the poor prognosis in gastric cancer: Meta-analysis and database validation.
Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response.
Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer.
Overexpression of Nicotinamide N-methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA.
Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis.
Overexpression of novel long intergenic non?coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.
Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma.
Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/?-catenin/EMT signalling axis.
Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.
Overexpression of P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma.
Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia.
Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma.
Overexpression of PLXDC2 in Stromal Cell-Associated M2 Macrophages Is Related to EMT and the Progression of Gastric Cancer.
Overexpression of PSAT1 Gene is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients with IDH1 Mutations and Chromosome 1p19q Codeletion.
Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity.
Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma.
Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer.
Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma.
Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.
Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer.
Overexpression of stathmin/oncoprotein 18 correlates with poorer prognosis and interacts with p53 in oral squamous cell carcinoma.
Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients.
Overexpression of TC2N is associated with poor prognosis in gastric cancer.
Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.
Overexpression of the Kininogen-1 inhibits proliferation and induces apoptosis of glioma cells.
Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia.
Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer.
Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.
Overexpression of TMEM158 contributes to ovarian carcinogenesis.
Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients.
Overexpression of transposable elements is associated with immune evasion and poor outcome in colorectal cancer.
Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.
Overexpression of trophoblast cell surface antigen 2 is associated with BRAF V600E mutation and aggressive behavior in papillary thyroid cancer.
Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway.
Overexpression of ULK1 Represents a Potential Diagnostic Marker for Clear Cell Renal Carcinoma and the Antitumor Effects of SBI-0206965.
Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma.
Overlap of the cancer genome atlas and the immune epitope database.
Overlapping clustering of gene expression data using penalized weighted normalized cut.
Overproduction of IGF-2 drives a subset of colorectal cancer cells, which specifically respond to an anti-IGF therapeutic antibody and combination therapies.
Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options.
Overview upon miR-21 in lung cancer: focus on NSCLC.
OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis.
Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches.
Oxidative Stress-Part of the Solution or Part of the Problem in the Hypoxic Environment of a Brain Tumor.
Oxidized low-density lipoprotein is associated with advanced-stage prostate cancer.
Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer.
Oxytocin receptor genetic alterations in hepatocellular carcinoma.
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma.
p120 catenin is a key effector of a Ras-PKC? oncogenic signaling axis.
p120-Catenin Downregulation and PIK3CA Mutations Cooperate to Induce Invasion through MMP1 in HNSCC.
p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer.
p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation.
P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment.
P38 pathway as a key downstream signal of connective tissue growth factor to regulate metastatic potential in non-small-cell lung cancer.
P3H4 is correlated with clinicopathological features and prognosis in bladder cancer.
P4HA1/HIF1? feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer.
P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma.
p52 expression enhances lung cancer progression.
p53 affects epigenetic signature on SOCS1 promoter in response to TLR4 inhibition.
p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics.
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
p53/PGC?1??mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis.
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification.
PABPC1 relevant bioinformatic profiling and prognostic value in gliomas.
PABPC1L depletion inhibits proliferation and migration via blockage of AKT pathway in human colorectal cancer cells.
PADI1 contributes to EMT in PAAD by activating the ERK1/2-p38 signaling pathway.
PAFAH1B3 Expression Is Correlated With Gastric Cancer Cell Proliferation and Immune Infiltration.
PAGE-Net: Interpretable and Integrative Deep Learning for Survival Analysis Using Histopathological Images and Genomic Data.
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patients.
PALB2 as a potential prognostic biomarker for colorectal cancer.
Pan cancer patterns of allelic imbalance from chromosomal alterations in 33 tumor types.
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA).
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
Pan-cancer analyses of human nuclear receptors reveal transcriptome diversity and prognostic value across cancer types.
Pan-cancer analyses of the nuclear receptor superfamily.
Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer.
Pan-cancer analyses reveal genomics and clinical characteristics of the melatonergic regulators in cancer.
Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis.
Pan-Cancer Analyses Reveal Prognostic Value of Osteomimicry Across 20 Solid Cancer Types.
Pan-cancer analyses reveal regulation and clinical outcome association of the shelterin complex in cancer.
Pan-Cancer Analysis Identified C1ORF112 as a Potential Biomarker for Multiple Tumor Types.
Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer.
Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes.
Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity.
Pan-Cancer Analysis of Atrial-Fibrillation-Related Innate Immunity Gene ANXA4.
Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes.
Pan-cancer analysis of clinical significance and associated molecular features of glycolysis.
Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.
Pan-cancer analysis of differential DNA methylation patterns.
Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators.
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs.
Pan-Cancer Analysis of Genomic Sequencing Among the Elderly.
Pan-Cancer Analysis of Head-to-Head Gene Pairs in Terms of Transcriptional Activity, Co-expression and Regulation.
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Pan-cancer analysis of intratumor heterogeneity associated with patient prognosis using multidimensional measures.
Pan-cancer analysis of iron metabolic landscape across the Cancer Genome Atlas.
Pan-cancer analysis of long non-coding RNA NEAT1 in various cancers.
Pan-cancer analysis of m5C regulator genes reveals consistent epigenetic landscape changes in multiple cancers.
Pan-Cancer Analysis of Mitochondria Chaperone-Client Co-Expression Reveals Chaperone Functional Partitioning.
Pan-cancer Analysis of NEDD4L and Its Tumor Suppressor Effects in Clear Cell Renal Cell Carcinoma.
Pan-cancer analysis of non-coding recurrent mutations and their possible involvement in cancer pathogenesis.
Pan-Cancer Analysis of NOS3 Identifies Its Expression and Clinical Relevance in Gastric Cancer.
Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy.
Pan-cancer analysis of systematic batch effects on somatic sequence variations.
Pan-Cancer Analysis of TCGA Data Revealed Promising Reference Genes for qPCR Normalization.
Pan-cancer analysis of TCGA data reveals notable signaling pathways.
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.
Pan-Cancer Analysis of the Genomic Alterations and Mutations of the Matrisome.
Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas.
Pan-cancer analysis of transcripts encoding novel open-reading frames (nORFs) and their potential biological functions.
Pan-cancer analysis of whole genomes.
Pan-cancer analysis on microRNA-associated gene activation.
Pan-Cancer Analysis Pinpoints Targets in PI3K Pathway.
Pan-cancer analysis reveals an immunological role and prognostic potential of PXN in human cancer.
Pan-Cancer Analysis Reveals Distinct Metabolic Reprogramming in Different Epithelial-Mesenchymal Transition Activity States.
Pan-cancer analysis reveals presence of pronounced DNA methylation drift in CpG island methylator phenotype clusters.
Pan-cancer analysis reveals technical artifacts in TCGA germline variant calls.
Pan-Cancer Analysis Shows TP53 Mutations Modulate the Association of NOX4 with Genetic Programs of Cancer Progression and Clinical Outcome.
Pan-cancer association of a centrosome amplification gene expression signature with genomic alterations and clinical outcome.
Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors.
Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets.
Pan-cancer chromatin analysis of the human vtRNA genes uncovers their association with cancer biology.
Pan-cancer diagnostic consensus through searching archival histopathology images using artificial intelligence.
Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
Pan-Cancer Genome-Wide DNA Methylation Analyses Revealed That Hypermethylation Influences 3D Architecture and Gene Expression Dysregulation in HOXA Locus During Carcinogenesis of Cancers.
Pan-cancer genomic analyses reveal prognostic and immunogenic features of the tumor melatonergic microenvironment across 14 solid cancer types.
Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering.
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.
Pan-cancer immunogenomic perspective on the tumor microenvironment based on PD-L1 and CD8 T cell infiltration.
Pan-cancer mapping of differential protein-protein interactions.
Pan-Cancer Metastasis Prediction Based on Graph Deep Learning Method.
Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy.
Pan-cancer methylation and expression profiling of adenocarcinomas revealed epigenetic silencing in the WNT signaling pathway.
Pan-Cancer Molecular Characterization of m6A Regulators and Immunogenomic Perspective on the Tumor Microenvironment.
Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers.
Pan-Cancer Mutational and Transcriptional Analysis of the Integrator Complex.
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
Pan-cancer Network Disorders Revealed by Overall and Local Signaling Entropy.
Pan-cancer patterns of somatic copy number alteration.
Pan-cancer pharmacogenetics: targeted sequencing panels or exome sequencing?
Pan-cancer repository of validated natural and cryptic mRNA splicing mutations.
Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas.
Pan-Cancer Survey of Tumor Mass Dormancy and Underlying Mutational Processes.
Pan-Cancer Survival Classification With Clinicopathological and Targeted Gene Expression Features.
Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism.
Pan-organ transcriptome variation across 21 cancer types.
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy.
Pancan-meQTL: a database to systematically evaluate the effects of genetic variants on methylation in human cancer.
Pancancer analysis identifies prognostic high-APOBEC1 expression level implicated in cancer in-frame insertions and deletions.
PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective.
PancanQTL: systematic identification of cis-eQTLs and trans-eQTLs in 33 cancer types.
Pancreatic adenocarcinomas with mature blood vessels have better overall survival.
Pancreatic cancer as a sentinel for hereditary cancer predisposition.
Pancreatic Cancer Cell Fraction Estimation in a DNA Sample.
Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
Pancreatic cancer survival analysis defines a signature that predicts outcome.
Pancreatic stellate cells regulate branched-chain amino acid metabolism in pancreatic cancer.
Pannexin1 Is Associated with Enhanced Epithelial-To-Mesenchymal Transition in Human Patient Breast Cancer Tissues and in Breast Cancer Cell Lines.
Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib.
PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.
Papillary renal cell carcinoma-derived chemerin, IL-8, and CXCL16 promote monocyte recruitment and differentiation into foam-cell macrophages.
Papillary Renal Cell Carcinomas Rewire Glutathione Metabolism and Are Deficient in Both Anabolic Glucose Synthesis and Oxidative Phosphorylation.
Papillary thyroid carcinoma behavior: clues in the tumor microenvironment.
Papillary Thyroid Carcinoma Variants are Characterized by Co-dysregulation of Immune and Cancer Associated Genes.
Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis.
Paradoxical effects of cellular senescence-inhibited gene involved in hepatocellular carcinoma migration and proliferation by ERK pathway and mesenchymal-like markers.
Parallel evolution of tumour subclones mimics diversity between tumours.
Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.
PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.
Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
Past and future impact of next-generation sequencing in head and neck cancer.
Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer.
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients.
Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample.
Pathologic evolution-related Gene Analysis based on both single-cell and bulk transcriptomics in Colorectal Cancer.
Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).
Pathological significance of MAD2L1 in breast cancer: an immunohistochemical study and meta analysis.
Pathology of Endometrial Carcinoma.
Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis.
Pathomorphologic atlas for differential diagnosis of skin diseases, with particular regard to tumors. Part II. Neoplasms and pseudo-neoplastic proliferations.
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs.
Pathway index models for construction of patient-specific risk profiles.
Pathway Instability Is an Effective New Mutation-Based Type of Cancer Biomarkers.
Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer.
Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.
PathwayMapper: a collaborative visual web editor for cancer pathways and genomic data.
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.
Patient-Specific Cell Communication Networks Associate With Disease Progression in Cancer.
Patients with integrated HPV16 in head and neck cancer show poor survival.
Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC).
Pattern discovery and cancer gene identification in integrated cancer genomic data.
Pattern fusion analysis by adaptive alignment of multiple heterogeneous omics data.
Patterns and functional implications of rare germline variants across 12 cancer types.
Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer.
Patterns of somatic structural variation in human cancer genomes.
Patterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer.
Patterns of Transposable Element Expression and Insertion in Cancer.
PBK/TOPK promotes chemoresistance to oxaliplatin in hepatocellular carcinoma cells by regulating PTEN.
PCBP2 Posttranscriptional Modifications Induce Breast Cancer Progression via Upregulation of UFD1 and NT5E.
PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations.
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer.
PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer.
PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential.
PD-L1 and prognosis in patients with malignant pleural mesothelioma: a meta-analysis and bioinformatics study.
PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer.
PD-L1 expression and prognostic impact in glioblastoma.
PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells: Differences Across Histologic and TCGA-based Molecular Subgroups.
PD-L1 expression in triple-negative breast cancer.
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.
PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC.
PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms.
PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy.
PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor.
PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression.
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.
PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance.
PDGF family function and prognostic value in tumor biology.
PDGFR? Is a Novel Marker of Stromal Activation in Oral Squamous Cell Carcinomas.
PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation.
PDL1 Regulation by p53 via miR-34.
Pediatric giant cell tumor of the tendon sheath of the craniocervical junction involving the occipital condyle.
PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer.
Penalized integrative semiparametric interaction analysis for multiple genetic datasets.
Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
Performance Comparison of Deep Learning Autoencoders for Cancer Subtype Detection Using Multi-Omics Data.
Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest.
Perioperative chemotherapy for resectable gastric cancer - what is the evidence?
PERK-Phosphorylated eIF2? Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer.
Permutation-based identification of important biomarkers for complex diseases via machine learning models.
Peroxiredoxin-5 is a negative survival predictor in ovarian cancer.
Peroxiredoxins and Immune Infiltrations in Colon Adenocarcinoma: Their Negative Correlations and Clinical Significances, an In Silico Analysis.
Peroxiredoxins in Cancer and Response to Radiation Therapies.
Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients.
Personal Health Information Inference Using Machine Learning on RNA Expression Data from Patients With Cancer: Algorithm Validation Study.
Personalised Treatment in Gastric Cancer: Myth or Reality?
Personalized characterization of diseases using sample-specific networks.
Personalized Integrated Network Modeling of the Cancer Proteome Atlas.
Personalized medicine in gastric cancer: Where are we and where are we going?
Personalized Network Modeling of the Pan-Cancer Patient and Cell Line Interactome.
Personalized Prediction of Proliferation Rates and Metabolic Liabilities in Cancer Biopsies.
Personalizing therapy for colorectal cancer.
Perspective of mesenchymal transformation in glioblastoma.
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma.
PF4V1, an miRNA-875-3p target, suppresses cell proliferation, migration, and invasion in prostate cancer and serves as a potential prognostic biomarker.
PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.
PFKP is highly expressed in lung cancer and regulates glucose metabolism.
PGC1? downregulation and glycolytic phenotype in thyroid cancer.
PGM5: a novel diagnostic and prognostic biomarker for liver cancer.
Phaeochromocytomas overexpress insulin transcript and produce insulin.
Pharmacologic IL-6R? inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency.
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.
Phenethyl Isothiocyanate Suppresses Stemness in the Chemo- and Radio-Resistant Triple-Negative Breast Cancer Cell Line MDA-MB-231/IR Via Downregulation of Metadherin.
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology.
Phenotypic and Functional Analyses of B7S1 in Ovarian Cancer.
PHENOTYPIC CHARACTERIZATION OF BREAST INVASIVE CARCINOMA VIA TRANSFERABLE TISSUE MORPHOMETRIC PATTERNS LEARNED FROM GLIOBLASTOMA MULTIFORME.
Phenotypically Dormant and Immature Leukaemia Cells Display Increased Ribosomal Protein S6 Phosphorylation.
Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells.
PHLPP2 as a novel metastatic and prognostic biomarker in non-small cell lung cancer patients.
PHLPP2 is a novel biomarker and epigenetic target for the treatment of vitamin C in pancreatic cancer.
Phosphatase and Tensin Homolog Is a Potential Target for Ovarian Cancer Sensitization to Cytotoxic Agents.
Phosphatase and Tensin Homolog Mutation in Immune Cell Infiltration and Clinicopathological Features of Low-Grade Gliomas.
Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck.
Phospho?STAT1 expression as a potential biomarker for anti?PD?1/anti?PD?L1 immunotherapy for breast cancer.
Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25+ /CD54+ NK cells.
Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer.
Phosphoinositide specific phospholipase C?1 inhibition-driven autophagy caused cell death in human lung adenocarcinoma A549 cells in vivo and in vitro.
Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.
Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathway.
Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer.
Phosphotyrosine signaling analysis in human tumors is confounded by systemic Ischemia-driven artifacts and intra-specimen heterogeneity.
Phytanoyl-CoA 2-Hydroxylase-Interacting Protein-Like Gene Is a Therapeutic Target Gene for Glioblastoma Multiforme.
PI3KCA Mutations in Uterine Cervix Carcinoma.
PIAS3 expression in squamous cell lung cancer is low and predicts overall survival.
PICOT binding to chromatin-associated EED negatively regulates cyclin D2 expression by increasing H3K27me3 at the CCND2 gene promoter.
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma.
PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma.
PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing.
Pilot studies for personalized cancer medicine: focusing on the patient for treatment selection.
Pilot Study to Establish a Novel Five-Gene Biomarker Panel for Predicting Lymph Node Metastasis in Patients With Early Stage Endometrial Cancer.
PINCAGE: Probabilistic integration of cancer genomics data for perturbed gene identification and sample classification.
Pinin acts as a poor prognostic indicator for renal cell carcinoma by reducing apoptosis and promoting cell migration and invasion.
Pinpointing Cell Identity in Time and Space.
PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.
PIPKI? Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling.
Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.
PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.
PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy.
PIWI-interacting RNAs piR-13643 and piR-21238 are promising diagnostic biomarkers of papillary thyroid carcinoma.
PKMYT1 is associated with prostate cancer malignancy and may serve as a therapeutic target.
PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Plakophilin-2 Promotes Lung Adenocarcinoma Development via Enhancing Focal Adhesion and Epithelial-Mesenchymal Transition.
Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients.
Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC.
Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression.
Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression.
Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer.
Plasmin(ogen) serves as a favorable biomarker for prediction of survival in advanced high-grade serous ovarian cancer.
Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.
Plasminogen Receptors in Human Malignancies: Effects on Prognosis and Feasibility as Targets for Drug Development.
Platform-Independent Classification System to Predict Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.
Platform-integrated mRNA Isoform Quantification.
Platinum Sensitivity-Related Germline Polymorphism Discovered via a Cell-Based Approach and Analysis of Its Association with Outcome in Ovarian Cancer Patients.
PLC? regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.
PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma.
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.
PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma.
Pleotropic role of RNA binding protein CELF2 in autophagy induction.
PLK1 and NOTCH Positively Correlate in Melanoma and Their Combined Inhibition Results in Synergistic Modulations of Key Melanoma Pathways.
Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.
PLOD3 is Upregulated in Gastric Cancer and Correlated with Clinicopathologic Characteristics.
PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43.
PMEPA1 induces EMT via a non-canonical TGF-? signalling in colorectal cancer.
Point mutation screening of tumor neoantigens and peptide-induced specific cytotoxic T lymphocytes using The Cancer Genome Atlas database.
Pokemon Inhibits Transforming Growth Factor ?-Smad4-Related Cell Proliferation Arrest in Breast Cancer through Specificity Protein 1.
POLE Mutation Characteristics in a Chinese Cohort with Endometrial Carcinoma.
POLE, MMR, and MSI Testing in Endometrial Cancer: Proceedings of the ISGyP Companion Society Session at the USCAP 2020 Annual Meeting.
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.
Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer.
POLQ Overexpression Is Associated with an Increased Somatic Mutation Load and PLK4 Overexpression in Lung Adenocarcinoma.
Polycomb-like 2 regulates PRC2 components to affect proliferation in glioma cells.
Polymerase ? (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing.
Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma.
Polymeric immunoglobulin receptor (PIGR) exerts oncogenic functions via activating ribosome pathway in hepatocellular carcinoma.
Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancer.
Polymorphisms involving gain or loss of CpG sites are significantly enriched in trait-associated SNPs.
Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese.
Polyphyllin I promotes cell death via suppressing UPR-mediated CHOP ubiquitination and degradation in non-small cell lung cancer.
PON1 hypermethylation is associated with progression of renal cell carcinoma.
Pooling analysis reveals that galectin-1 is a reliable prognostic biomarker in various cancers.
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancer.
Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients.
Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
POPDC3 is a potential biomarker for prognosis and radioresistance in patients with head and neck squamous cell carcinoma.
PopInf: An Approach for Reproducibly Visualizing and Assigning Population Affiliation in Genomic Samples of Uncertain Origin.
Population analysis of microsatellite genotypes reveals a signature associated with ovarian cancer.
Population Based Cancer Registry of India – the Challenges and Opportunities
Population Substructure Has Implications in Validating Next-Generation Cancer Genomics Studies with TCGA.
Population-based structural variation discovery with Hydra-Multi.
Population-dependent Intron Retention and DNA Methylation in Breast Cancer.
Population-level distribution and putative immunogenicity of cancer neoepitopes.
Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer.
Positive expression of PAX7 indicates poor prognosis of pediatric and adolescent AML patients.
Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
Positron emission tomography/computed tomography imaging of head and neck tumors: an atlas.
Possible Human Papillomavirus 38 Contamination of Endometrial Cancer RNA Sequencing Samples in The Cancer Genome Atlas Database.
Posterior fixation and fusion with atlas pedicle screw system for upper cervical diseases.
Posterior interhemispheric transtentorial approach for resection of a meningioma at the posteromedial tentorial incisura.
Posterolateral approach to the atlas and the axis.
Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrence.
Potassium voltage-gated channel subfamily D member 2 induces an aggressive phenotype in lung adenocarcinoma.
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation.
Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.
Potential Drug Prediction of Glioblastoma Based on Drug Perturbation-Induced Gene Expression Signatures.
Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis.
Potential five-mRNA signature model for the prediction of prognosis in patients with papillary thyroid carcinoma.
Potential four?miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co?expression analysis.
Potential functional variants of KIAA genes are associated with breast cancer risk in a case control study.
Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis.
Potential of the cell-free blood-based biomarker uroplakin 2 RNA to detect recurrence after surgical resection of lung adenocarcinoma.
Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition.
Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy.
Potential prognostic impact of EBV RNA-seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort.
Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis.
Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma.
Potential role for targeted therapy in muscle-invasive bladder cancer: lessons from the cancer genome atlas and beyond.
Potential role of cyclin F mRNA expression in the survival of skin melanoma patients: Comprehensive analysis of the pathways altered due to cyclin F upregulation.
Potential role of LINC00996 in colorectal cancer: a study based on data mining and bioinformatics.
Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma.
Potential role of microRNA?223?3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
Potential Targets and Clinical Value of MiR-224-5p in Cancers of the Digestive Tract.
Potential targets and clinical value of miR-490-5p in hepatocellular carcinoma: a study based on TCGA, qRT-PCR and bioinformatics analyses.
Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis.
Potential therapeutic targets of TP53 gene in the context of its classically canonical functions and its latest non-canonical functions in human cancer.
Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis.
Potentially Curable Cancers of the Esophagus and Stomach.
Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
PP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer.
PP2A Deficiency Enhances Carcinogenesis of Lgr5+ Intestinal Stem Cells Both in Organoids and In Vivo.
PPAR-Responsive Elements Enriched with Alu Repeats May Contribute to Distinctive PPAR?-DNMT1 Interactions in the Genome.
PPFIA4 Promotes Colon Cancer Cell Proliferation and Migration by Enhancing Tumor Glycolysis.
PR/SET Domain Family and Cancer: Novel Insights from the Cancer Genome Atlas.
PRADA: Pipeline for RNA sequencing Data Analysis.
PRDX2 removal inhibits the cell cycle and autophagy in colorectal cancer cells.
Pre-treatment neutrophils count as a prognostic marker to predict chemotherapeutic response and survival outcomes in glioma: a single-center analysis of 288 cases.
Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance system.
Precision medicine in gastric cancer.
Precision medicine: Uses and challenges.
Precision oncology for acute myeloid leukemia using a knowledge bank approach.
Preclinical analysis of novel prognostic transcription factors and immune-related gene signatures for bladder cancer via TCGA-based bioinformatic analysis.
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes.
Predicted CD4+ T cell infiltration levels could indicate better overall survival in sarcoma patients.
Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
Predicting Cancer Cell Line Dependencies From the Protein Expression Data of Reverse-Phase Protein Arrays.
Predicting cancer origins with a DNA methylation-based deep neural network model.
Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes.
Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data.
Predicting DNA methylation from genetic data lacking racial diversity using shared classified random effects.
Predicting drug response of tumors from integrated genomic profiles by deep neural networks.
Predicting drug sensitivity of cancer cells based on DNA methylation levels.
Predicting Functional Modules of Liver Cancer Based on Differential Network Analysis.
Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.
Predicting lung adenocarcinoma disease progression using methylation-correlated blocks and ensemble machine learning classifiers.
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features.
Predicting prognosis and IDH mutation status for patients with lower-grade gliomas using whole slide images.
Predicting prognosis of endometrioid endometrial adenocarcinoma on the basis of gene expression and clinical features using Random Forest.
Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature.
Predicting responses to platin chemotherapy agents with biochemically-inspired machine learning.
Predicting STAT1 as a prognostic marker in patients with solid cancer.
Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study.
Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein.
Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Predicting the effect of 5-fluorouracil-based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles.
Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA.
Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
Predicting the radiosensitivity of HPV-negative oropharyngeal squamous cell carcinoma using miR-130b.
Predicting the Risk of Melanoma Metastasis Using an Immune Risk Score in the Melanoma Cohort.
Predicting the survival of patients with lung adenocarcinoma using a four-gene prognosis risk model.
Predicting tumor purity from methylation microarray data.
Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines.
Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis.
Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data.
Prediction of a competing endogenous RNA co-expression network as a prognostic marker in glioblastoma.
Prediction of ATPase cation transporting 13A2 molecule in Petromyzon marinus and pan-cancer analysis into human tumors from an evolutionary perspective.
Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
Prediction of chemo-response in serous ovarian cancer.
Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature.
Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data.
Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.
Prediction of clinically actionable genetic alterations from colorectal cancer histopathology images using deep learning.
Prediction of Driver Modules via Balancing Exclusive Coverages of Mutations in Cancer Samples.
Prediction of genome-wide DNA methylation in repetitive elements.
Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs.
Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set.
Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles.
Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.
Prediction of MiR-21-5p in Promoting the Development of Lung Adenocarcinoma via PDZD2 Regulation.
Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma.
Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Prediction of Overall Survival in Gastric Cancer Using a Nine-lncRNA.
Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy Model.
Prediction of Poor Prognosis of HCC by Early Warning Model for Co-Expression of miRNA and mRNA Based on Bioinformatics Analysis.
Prediction of prognosis of patients with lung cancer in combination with the immune score.
Prediction of Prognostic Biomarkers and Construction of an Autophagy Prognostic Model for Colorectal Cancer Using Bioinformatics.
Prediction of radiosensitive patients with gastric cancer by developing gene signature.
Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data.
Prediction of radiotherapy response with a 5-microRNA signature-based nomogram in head and neck squamous cell carcinoma.
Prediction of response to anti-cancer drugs becomes robust via network integration of molecular data.
Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data.
Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
Prediction of Target-Drug Therapy by Identifying Gene Mutations in Lung Cancer With Histopathological Stained Image and Deep Learning Techniques.
Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles.
Prediction of the Outcome for Patients with Glioblastoma with lncRNA Expression Profiles.
Prediction of the Prognosis Based on Chromosomal Instability-Related DNA Methylation Patterns of ELOVL2 and UBAC2 in PTCs.
Prediction of transcription factors binding events based on epigenetic modifications in different human cells.
Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging.
Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy.
Predictive modeling using a somatic mutational profile in ovarian high grade serous carcinoma.
Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma.
Predictive value of protease-activated receptor-2 (PAR2 ) in cervical cancer metastasis.
Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma.
Predictive values of Notch signalling in renal carcinoma.
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis.
Predictors of disease aggressiveness influence outcome from immunotherapy treatment in renal clear cell carcinoma.
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
Preferential tumor localization in relation to 18F-FDOPA uptake for lower-grade gliomas.
Preliminary investigation of five novel long non-coding RNAs in hepatocellular carcinoma cell lines.
PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.
Presence of viral DNA in whole-genome sequencing of brain tumor tissues from the cancer genome atlas.
Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
PretiMeth: precise prediction models for DNA methylation based on single methylation mark.
Prevalence and clinical relevance of tumor-associated tissue eosinophilia (TATE) in breast cancer.
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma.
Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel.
Prevalence of comprehensive DNA damage repair gene germline mutations in Chinese prostate cancer patients.
Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach.
PREVALENCE OF MISMATCH REPAIR GENE MUTATIONS IN UVEAL MELANOMA.
Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors.
Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance.
PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma.
PRIM1 promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo.
Primary Cilia Blockage Promotes the Malignant Behaviors of Hepatocellular Carcinoma via Induction of Autophagy.
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.
PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas.
Prion protein is associated with a worse prognosis of head and neck squamous cell carcinoma.
Prioritization of cancer marker candidates based on the immunohistochemistry staining images deposited in the human protein atlas.
Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data.
PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway.
PRKCA Overexpression Is Frequent in Young Oral Tongue Squamous Cell Carcinoma Patients and Is Associated with Poor Prognosis.
PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy.
PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition.
PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
PRMT8 demonstrates variant-specific expression in cancer cells and correlates with patient survival in breast, ovarian and gastric cancer.
Probing Biological Sex Differences in Cancer.
ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
Processing and Analysis of RNA-seq Data from Public Resources.
Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma.
Production of tissue microarrays, immunohistochemistry staining and digitalization within the human protein atlas.
Profile of sphingolipid-related genes and its association with prognosis highlights sphingolipid metabolism in oral cancer.
Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs.
Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.
Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
Profiles of immune infiltration in the tumor microenvironment of hepatocellular carcinoma.
Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
Profiles of m6A RNA methylation regulators for the prognosis of hepatocellular carcinoma.
Profiles of miRNA Isoforms and tRNA Fragments in Prostate Cancer.
Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
Profiles of prognostic alternative splicing signature in hepatocellular carcinoma.
Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer.
Profiles of tumor-infiltrating immune cells in renal cell carcinoma and their clinical implications.
Profiling age-related epigenetic markers of stomach adenocarcinoma in young and old subjects.
Profiling cancer testis antigens in non-small-cell lung cancer.
Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients.
Profiling cytochrome P450 family 4 gene expression in human hepatocellular carcinoma.
Profiling of differential gene expression in Wilms tumor by cDNA expression array.
Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array.
Profiling of differentially expressed genes in LRRC4 overexpressed glioblastoma cells by cDNA array.
Profiling of gastric cancer cell-surface markers to achieve tumour-normal discrimination.
Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma.
Profiling of prognostic alternative splicing in melanoma.
Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma.
Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer Patients.
Progesterone Receptor Is a Haploinsufficient Tumor-Suppressor Gene in Cervical Cancer.
Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
Prognosis and modulation mechanisms of COMMD6 in human tumours based on expression profiling and comprehensive bioinformatics analysis.
Prognosis model of colorectal cancer patients based on NOTCH3, KMT2C, and CREBBP mutations.
Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
Prognosis of Non-small-cell Lung Cancer Patients With Lipid Metabolism Pathway Alternations to Immunotherapy.
Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.
Prognosis-Predictive Signature and Nomogram Based on Autophagy-Related Long Non-coding RNAs for Hepatocellular Carcinoma.
Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors.
Prognostic 4-lncRNA-based risk model predicts survival time of patients with head and neck squamous cell carcinoma.
Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma.
Prognostic Alternative mRNA Splicing Signature and a Novel Biomarker in Triple-Negative Breast Cancer.
Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma.
Prognostic alternative splicing regulatory network of splicing events in acute myeloid leukemia patients based on SpliceSeq data from 136 cases.
Prognostic alternative splicing signature in cervical squamous cell carcinoma.
Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.
Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Prognostic and Clinicopathological Significance of Long Non-Coding RNA BLACAT1 in Cancer: An Updated Meta-Analysis and TCGA Data Review.
Prognostic and clinicopathological significance of long noncoding RNA CTD-2510F5.4 in gastric cancer.
Prognostic and diagnostic roles of prolyl 4-hydroxylase subunit ? members in breast cancer.
Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.
Prognostic and immune regulating roles of YIF1B in Pan-Cancer: a potential target for both survival and therapy response evaluation.
Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma.
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Prognostic and Predictive Value of a 15 Transcription Factors (TFs) Panel for Hepatocellular Carcinoma.
Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients.
Prognostic and predictive value of immune/stromal-related gene biomarkers in renal cell carcinoma.
Prognostic and Predictive Value of O
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma.
Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma.
Prognostic autophagy model based on CASP4 and BIRC5 expression in patients with renal cancer: independent datasets-based study.
Prognostic biomarker identification and tumor classification in breast cancer patients by methylation and transcriptome analysis.
Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC).
Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma.
Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
Prognostic Biomarker-Based Identification of Drugs for Managing the Treatment of Endometrial Cancer.
Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis.
Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset.
Prognostic classification of endometrial cancer using a molecular approach based on a twelve-gene NGS panel.
Prognostic classifier based on genome-wide DNA methylation profiling in well-differentiated thyroid tumors.
Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.
Prognostic Correlation of Glycolysis-Related Gene Signature in Patients with Laryngeal Cancer.
Prognostic Effect of Comorbid Disease and Immune Gene Expression on Mortality in Kidney Cancer-A Population Based Study.
Prognostic Effect of Inflammatory Genes on Stage I-III Colorectal Cancer-Integrative Analysis of TCGA Data.
Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study.
Prognostic factors modifying the treatment-free interval in recurrent ovarian cancer.
Prognostic Factors of Malignant Pheochromocytoma and Paraganglioma: A Combined SEER and TCGA Databases Review.
Prognostic Gene Discovery in Glioblastoma Patients using Deep Learning.
Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.
Prognostic gene signature identification using causal structure learning: applications in kidney cancer.
Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis.
Prognostic genes of melanoma identified by weighted gene co-expression network analysis and drug repositioning using a network-based method.
Prognostic genes of triple-negative breast cancer identified by weighted gene co-expression network analysis.
Prognostic Immunity and Therapeutic Sensitivity Analyses Based on Differential Genomic Instability-Associated LncRNAs in Left- and Right-Sided Colon Adenocarcinoma.
Prognostic impact of cancer stem cell markers ABCB1, NEO1 and HIST1H2AE in colorectal cancer.
Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.
Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer.
Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers.
Prognostic Impact of IGF2BP3 Expression in Patients with Surgically Resected Lung Adenocarcinoma.
Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
Prognostic impact of p53 and/or NY-ESO-1 autoantibody induction in patients with gastroenterological cancers.
Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer.
Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.
Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
Prognostic implication and functional annotations of APOBEC3G expression in patients with Melanoma.
Prognostic implication and functional annotations of Rad50 expression in patients with prostate cancer.
Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma.
Prognostic implication of glycolysis related gene signature in non-small cell lung cancer.
Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma.
Prognostic implication of proteomic profiles in head and neck squamous cell carcinoma.
Prognostic Implication of SOX2 Expression Associated with p16 in Oropharyngeal Cancer: A Study of Consecutive Tissue Microarrays and TCGA.
Prognostic Implication of the Expression Level of PECAM-1 in Non-small Cell Lung Cancer.
Prognostic Implication of the m6A RNA Methylation Regulators in Rectal Cancer.
Prognostic implications of aberrantly expressed methylation?driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma.
Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Prognostic Implications of CD10 and CD15 Expression in Papillary Thyroid Carcinoma.
Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma.
Prognostic implications of metabolism-associated gene signatures in colorectal cancer.
Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment.
Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment.
Prognostic implications of programmed death ligand 1 expression in resected lung adenocarcinoma: a systematic review and meta-analysis.
Prognostic implications of the BRAF-V600E mutation in papillary thyroid carcinoma based on a new cut-off age stratification.
Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database.
Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.
Prognostic Inflammasome-Related Signature Construction in Kidney Renal Clear Cell Carcinoma Based on a Pan-Cancer Landscape.
PROGNOSTIC INTEGRATED IMAGE-BASED IMMUNE AND MOLECULAR PROFILING IN EARLY-STAGE ENDOMETRIAL CANCER.
Prognostic landscape of tumor-infiltrating immune cells and immune-related genes in the tumor microenvironment of gastric cancer.
Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma.
Prognostic lncRNAs, miRNAs, and mRNAs Form a Competing Endogenous RNA Network in Colon Cancer.
Prognostic Markers Identification in Glioma by Gene Expression Profile Analysis.
Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.
Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation.
Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation.
Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes.
Prognostic model of invasive ductal carcinoma of the breast based on differentially expressed glycolysis-related genes.
Prognostic model of patients with liver cancer based on tumor stem cell content and immune process.
Prognostic nomogram for previously untreated adult patients with acute myeloid leukemia.
Prognostic nomogram of hypoxia-related genes predicting overall survival of colorectal cancer-Analysis of TCGA database.
Prognostic Nomogram of Prognosis-Related Genes and Clinicopathological Characteristics to Predict the 5-Year Survival Rate of Colon Cancer Patients.
Prognostic nomograms based on immune scores for head-neck squamous cell carcinoma patients.
Prognostic Power of a Chaperonin Containing TCP-1 Subunit Genes Panel for Hepatocellular Carcinoma.
Prognostic power of a lipid metabolism gene panel for diffuse gliomas.
Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas.
Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation.
Prognostic prediction of a 12-methylation gene-based risk score system on pancreatic adenocarcinoma.
Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis.
Prognostic relevance of acquired uniparental disomy in serous ovarian cancer.
Prognostic relevance of CSF and peri-tumoral edema volumes in glioblastoma.
Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
Prognostic relevance of miR-137 and its liver microenvironment regulatory target gene AFM in hepatocellular carcinoma.
Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma.
Prognostic role of ACTL10 in Cytogenetic Normal Acute Myeloid Leukemia.
Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion.
Prognostic role of DOK family adapters in acute myeloid leukemia.
Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process.
Prognostic role of Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified primary and recurrent glioblastomas.
Prognostic Role of EYA4 in Lower Grade Glioma with IDH1 Mutation and 1p19q Co-Deletion.
Prognostic Role of KRAS mRNA Expression in Breast Cancer.
Prognostic role of long non-coding RNA HNF1A-AS1 in Chinese cancer patients: a meta-analysis.
Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC).
Prognostic Role of Receptor Tyrosine Kinase-Like Orphan Receptors in Intestinal-Type Gastric Cancer.
Prognostic role of SCAMP family in acute myeloid leukemia.
Prognostic role of the beta-2 adrenergic receptor in clear cell renal cell carcinoma.
Prognostic Role of TMED3 in Clear Cell Renal Cell Carcinoma: A Retrospective Multi-Cohort Analysis.
Prognostic role of TPD52 in acute myeloid leukemia: A retrospective multicohort analysis.
Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer.
Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis.
Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia.
Prognostic Role of Zinc Finger Homeobox 4 in Ovarian Serous Cystadenocarcinoma.
Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma.
Prognostic Roles of N6-Methyladenosine METTL3 in Different Cancers: A System Review and Meta-Analysis.
Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma.
Prognostic Score Model Based on Ten Differentially Methylated Genes for Predicting Clinical Outcomes in Patients with Adenocarcinoma of the Colon.
Prognostic score model-based signature genes for predicting the prognosis of metastatic skin cutaneous melanoma.
Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients.
Prognostic Score-based Clinical Factors and Metabolism-related Biomarkers for Predicting the Progression of Hepatocellular Carcinoma.
Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients.
Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes.
Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
Prognostic signature of ovarian cancer based on 14 tumor microenvironment-related genes.
Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer.
Prognostic significance and function of the vacuolar H+-ATPase subunit V1E1 in esophageal squamous cell carcinoma.
Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
Prognostic significance and oncogene function of cathepsin A in hepatocellular carcinoma.
Prognostic Significance and Related Mechanisms of Hexokinase 1 in Ovarian Cancer.
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer.
Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
Prognostic significance of age related genes in patients with lower grade glioma.
Prognostic significance of an autophagy-related long non-coding RNA signature in patients with oral and oropharyngeal squamous cell carcinoma.
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
Prognostic significance of ANLN in lung adenocarcinoma.
Prognostic significance of autophagy-related genes within esophageal carcinoma.
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.
Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.
Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data.
Prognostic significance of chemokines CCL11 and CCL5 modulated by low-density lipoprotein cholesterol in colon cancer patients with normal body mass index.
Prognostic significance of contactin 3 expression and associated genes in glioblastoma multiforme.
Prognostic Significance of COVID-19 Receptor ACE2 and Recommendation for Antihypertensive Drug in Renal Cell Carcinoma.
Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma.
Prognostic significance of FAM83D gene expression across human cancer types.
Prognostic Significance of FKBP14 in Gastric Cancer.
Prognostic significance of heat shock protein 90AA1 (HSP90?) in invasive breast cancer.
Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer.
Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.
Prognostic Significance of LncRNA GHET1 Expression in Various Cancers: A Systematic Review and Meta-analysis.
Prognostic Significance of LncRNA PVT1 and Its Potential Target Gene Network in Human Cancers: a Comprehensive Inquiry Based Upon 21 Cancer Types and 9972 Cases.
Prognostic significance of MEOX2 in gliomas.
Prognostic significance of microRNA-135 in patients with digestive system cancers: a systematic review and meta-analysis.
Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
Prognostic significance of microsatellite instability?associated pathways and genes in gastric cancer.
Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma.
Prognostic Significance of Nucleolar Assessment in Invasive Breast Cancer.
Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma.
Prognostic significance of PAK family kinases in acute myeloid leukemia.
Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma.
Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Prognostic significance of Spinster homolog gene family in acute myeloid leukemia.
Prognostic Significance of the Hsp70 Gene Family in Colorectal Cancer.
Prognostic significance of the PANK family expression in acute myeloid leukemia.
Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas.
Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
Prognostic SLC family genes promote cell proliferation, migration, and invasion in hepatocellular carcinoma.
Prognostic stromal gene signatures in breast cancer.
Prognostic targets recognition of rectal adenocarcinoma based on transcriptomics.
Prognostic thirteen-long non-coding RNAs (IncRNAs) could improve the survival prediction of gastric cancer.
Prognostic value and functional bioinformatic analysis of spindle- and kinetochore-associated protein 1 in stage IIA esophageal squamous cell carcinoma.
Prognostic value and immune cell infiltration of hypoxic phenotype-related gene signatures in glioblastoma microenvironment.
Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Prognostic value and immunological characteristics of a novel autophagy-related signature in pancreatic cancer.
Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma.
Prognostic Value and Molecular Regulatory Mechanism of MSTO2P in Hepatocellular Carcinoma: A Comprehensive Study Based on Bioinformatics, Clinical Analysis and in vitro Validation.
Prognostic Value and Potential Biological Functions of CLDN8 in Patients with Clear Cell Renal Cell Carcinoma.
Prognostic value and potential function of splicing events in prostate adenocarcinoma.
Prognostic Value and Potential Immunoregulatory Role of SCARF1 in Hepatocellular Carcinoma.
Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer.
Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer.
Prognostic value and prospective molecular mechanism of miR-100-5p in hepatocellular carcinoma: A comprehensive study based on 1,258 samples.
Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer.
Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
Prognostic Value of a Novel Signature With Nine Hepatitis C Virus-Induced Genes in Hepatic Cancer by Mining GEO and TCGA Databases.
Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma.
Prognostic value of a two-microRNA signature for papillary thyroid cancer and a bioinformatic analysis of their possible functions.
Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients.
Prognostic value of an autophagy-related gene expression signature for endometrial cancer patients.
Prognostic Value of an m5C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell Carcinoma.
Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma.
Prognostic Value of ANXA8 in Gastric Carcinoma.
Prognostic value of ATAD3 gene cluster expression in hepatocellular carcinoma.
Prognostic value of B cells in cutaneous melanoma.
Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
Prognostic value of carbonic anhydrase XII (CA XII) overexpression in hepatocellular carcinoma.
Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
Prognostic value of chloride channel accessory mRNA expression in colon cancer.
Prognostic value of CLIC3 mRNA overexpression in bladder cancer.
Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma.
Prognostic value of differentially methylated gene profiles in bladder cancer.
Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer.
Prognostic Value of DNA Methylation-Driven Genes in Clear Cell Renal Cell Carcinoma: A Study Based on Methylation and Transcriptome Analyses.
Prognostic value of DNA repair based stratification of hepatocellular carcinoma.
Prognostic Value of Dynactin mRNA Expression in Cutaneous Melanoma.
Prognostic Value of Enolase Gene Family in Colon Cancer.
Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Prognostic value of estrogen receptor ? and estrogen receptor ? in gastric cancer based on a meta-analysis and The Cancer Genome Atlas (TCGA) datasets.
Prognostic value of estrogen receptor-? and progesterone receptor in curatively resected colorectal cancer: a retrospective analysis with independent validations.
Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Prognostic value of fatty acid metabolism-related genes in patients with hepatocellular carcinoma.
Prognostic value of ferroptosis-related genes in patients with lung adenocarcinoma.
Prognostic Value of Genes and Immune Infiltration in Prostate Tumor Microenvironment.
Prognostic value of genome-wide DNA methylation patterns in noncoding miRNAs and lncRNAs in uveal melanomas.
Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.
Prognostic Value of HMGA2 in Human Cancers: A Meta-Analysis Based on Literatures and TCGA Datasets.
Prognostic value of IL-34 in colorectal cancer patients.
Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma.
Prognostic value of immune scores in the microenvironment of colorectal cancer.
Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
Prognostic value of immune-related genes in clear cell renal cell carcinoma.
Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer.
Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma.
Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.
Prognostic value of increased expression of RBM8A in gastric cancer.
Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma.
Prognostic value of key genes of the JAK-STAT signaling pathway in patients with cutaneous melanoma.
Prognostic value of lipid metabolism-related genes in head and neck squamous cell carcinoma.
Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Prognostic value of long noncoding RNA urothelial carcinoma-associated 1 in esophageal carcinoma: A protocol for meta-analysis, TCGA data and bioinformatics analysis.
Prognostic Value of microRNA-133a Expression and Its Clinicopathologic Significance in Non-Small Cell Lung Cancer: A Comprehensive Study Based on Meta-Analysis and the TCGA Database.
Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy.
Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.
Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
Prognostic value of monocarboxylate transporter 4 in patients with esophageal squamous cell carcinoma.
Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Prognostic Value of Phosphotyrosine Phosphatases in Hepatocellular Carcinoma.
Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.
Prognostic Value of RNASEH2A-, CDK1-, and CD151-Related Pathway Gene Profiling for Kidney Cancers.
Prognostic Value of SLC4A4 and its Correlation with Immune Infiltration in Colon Adenocarcinoma.
Prognostic value of small nuclear RNAs (snRNAs) for digestive tract pan- adenocarcinomas identified by RNA sequencing data.
Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis.
Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer.
Prognostic value of the expression of chemokines and their receptors in regional lymph nodes of melanoma patients.
Prognostic value of the FUT family in acute myeloid leukemia.
Prognostic value of the PDLIM family in acute myeloid leukemia.
Prognostic value of the SPOP mutant genomic subclass in prostate cancer.
Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer.
Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma.
Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
Prognostic values and clinical relationship of TYK2 in laryngeal squamous cell cancer.
Prognostic values of a novel multi-mRNA signature for predicting relapse of cholangiocarcinoma.
Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis.
Prognostic values of EDNRB in triple-negative breast cancer.
Prognostic values of GMPS, PR, CD40, and p21 in ovarian cancer.
Prognostic Values of Radiosensitivity Genes and CD19 Status in Gastric Cancer: A Retrospective Study Using TCGA Database.
Prognostic values of SNAI family members in breast cancer patients.
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.
Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
Prognostic Value of MicroRNA-20b in Acute Myeloid Leukemia.
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival.
Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer.
Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior.
Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma.
Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma.
Programmed Death-Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC.
Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma.
Progressive and Prognostic Performance of an Extracellular Matrix-Receptor Interaction Signature in Gastric Cancer.
Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Proliferative and Invasive Colorectal Tumors in Pet Dogs Provide Unique Insights into Human Colorectal Cancer.
Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma.
Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma.
Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma.
Promoter CpG Island Methylation of Genes in Key Cancer Pathways Associates with Clinical Outcome in High-Grade Serous Ovarian Cancer.
Promoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer.
Promoter Hypermethylation of CHODL Contributes to Carcinogenesis and Indicates Poor Survival in Patients with Early-stage Colorectal Cancer.
Promoter hypermethylation of PIEZO2 is a risk factor and potential clinical biomarker for laryngeal squamous cell carcinoma.
Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome.
Promoter Methylation of DNA Repair Genes Predicts Disease-free Survival of Gastric Adenocarcinoma after Adjuvant Radiotherapy.
Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence.
Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival.
Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.
Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia.
Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy.
Promoting cell proliferation, cell cycle progression, and glycolysis: Glycometabolism-related genes act as prognostic signatures for prostate cancer.
Proper Use of Allele-Specific Expression Improves Statistical Power for cis-eQTL Mapping with RNA-Seq Data.
Proportional Upregulation of CD97 Isoforms in Glioblastoma and Glioblastoma-Derived Brain Tumor Initiating Cells.
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer.
Prospective Clinical Sequencing of Adult Glioma.
Prospective lncRNA-miRNA-mRNA regulatory network of long non-coding RNA LINC00968 in non-small cell lung cancer A549 cells: A miRNA microarray and bioinformatics investigation.
Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry.
Prospective Randomized Double-Blind Pilot Study of Site-Specific Consensus Atlas Implementation for Rectal Cancer Target Volume Delineation in the Cooperative Group Setting.
Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
Prostasin regulates PD-L1 expression in human lung cancer cells.
Prostate Cancer Gene Regulatory Network Inferred from RNA-Seq Data.
Prostate Cancer Genomic Subtypes.
Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype.
Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma.
Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging.
Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate Cancer.
Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice.
Protective potential of miR-146a-5p and its underlying molecular mechanism in diverse cancers: a comprehensive meta-analysis and bioinformatics analysis.
Protein anabolism is key to long-term survival in high-grade serous ovarian cancer.
Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.
Protein citrullination as a source of cancer neoantigens.
Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.
Protein dynamics analysis identifies candidate cancer driver genes and mutations in TCGA data.
Protein Expression of Cyclin B1, Transferrin Receptor, and Fibronectin Is Correlated with the Prognosis of Adrenal Cortical Carcinoma.
Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray.
Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients.
Protein Kinase D3 Promotes the Reconstruction of OSCC Immune Escape Niche Via Regulating MHC-I and Immune Inhibit Molecules Expression.
Protein kinases that phosphorylate splicing factors: Roles in cancer development, progression and possible therapeutic options.
Protein tyrosine phosphatase, receptor type B is a potential biomarker and facilitates cervical cancer metastasis via epithelial-mesenchymal transition.
Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: Results from a proteomic study integrated with bioinformatics analysis.
Proteins with Evolutionarily Hypervariable Domains are Associated with Immune Response and Better Survival of Basal-like Breast Cancer Patients.
Proteogenomic analysis of melanoma brain metastases from distinct anatomical sites identifies pathways of metastatic progression.
Proteogenomic analysis of pancreatic cancer subtypes.
Proteogenomic characterization of human colon and rectal cancer.
Proteoglycans and their roles in brain cancer.
Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.
Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction.
Proteomic analyses identify differentially expressed proteins and pathways between low-risk and high-risk subtypes of early-stage lung adenocarcinoma and their prognostic impacts.
Proteomic analysis of colon and rectal carcinoma using standard and customized databases.
Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival.
Proteomic analysis of malignant and benign endometrium according to obesity and insulin-resistance status using Reverse Phase Protein Array.
Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination.
Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer.
Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.
Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins.
Proteomic characterization of peroxisome proliferator-activated receptor-? (PPAR?) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
Proteomic profiling identifies PTK2/FAK as a driver of radioresistance in HPV negative head and neck cancer.
Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.
Proteomic profiling reveals a signature for optimizing prognostic prediction in Colon Cancer.
Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review.
Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer.
Proteomics of Colorectal Cancer in a Genomic Context: First Large-Scale Mass Spectrometry-Based Analysis from the Cancer Genome Atlas.
Proto-oncogene RTL4 promotes tumorigenesis and invasiveness of papillary thyroid cancer.
Protocadherin ?-A7 is down-regulated in colorectal cancer and associated with the prognosis in patients with wild-type KRAS.
Protocadherin alpha 3 inhibits lung squamous cell carcinoma metastasis and epithelial-mesenchymal transition.
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Proximity Ligation Assay as a Tool for Antibody Validation in Human Tissues.
PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis.
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer.
PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1.
PRSS contributes to cetuximab resistance in colorectal cancer.
PRSS1 Upregulation Predicts Platinum Resistance in Ovarian Cancer Patients.
PSD3 is an oncogene that promotes proliferation, migration, invasion, and G1/S transition while inhibits apoptotic in papillary thyroid cancer.
PseudoFuN: Deriving functional potentials of pseudogenes from integrative relationships with genes and microRNAs across 32 cancers.
Pseudogene CHIAP2 inhibits proliferation and invasion of lung adenocarcinoma cells by means of the WNT pathway.
Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma.
Pseudogene DUXAP10 can be used as a diagnostic and prognostic biomarker in human cancers.
Pseudogene Transcripts in Head and Neck Cancer: Literature Review and In Silico Analysis.
Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma.
Pseudouridylate Synthase 7 Promotes Cell Proliferation and Invasion in Colon Cancer Through Activating PI3K/AKT/mTOR Signaling Pathway.
psichomics: graphical application for alternative splicing quantification and analysis.
PSMC2, ORC5 and KRTDAP are specific biomarkers for HPV-negative head and neck squamous cell carcinoma.
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation.
PTBP3 promotes migration of non-small cell lung cancer through regulating E-cadherin in EMT signaling pathway.
PTEN and NEDD4 in Human Breast Carcinoma.
PTEN loss correlates with T cell exclusion across human cancers.
PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma.
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.
PTGS2 Over-Expression: A Colorectal Carcinoma Initiator not an Invasive Factor.
PTHrP, A Biomarker for CNS Metastasis in Triple-Negative Breast Cancer and Selection for Adjuvant Chemotherapy in Node-Negative Disease.
PTK7 regulates Id1 expression in CD44-high glioma cells.
PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
PTPN11 hypomethylation is associated with gastric cancer progression.
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.
PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC.
PTTG3P promotes gastric tumour cell proliferation and invasion and is an indicator of poor prognosis.
pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma.
Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression.
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents.
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course.
Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.
Putatively cancer-specific exon-exon junctions are shared across patients and present in developmental and other non-cancer cells.
pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing.
Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Q&A: Anna Barker on the cancer genome atlas.
QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
QMachine: commodity supercomputing in web browsers.
Quality and concordance of genotyping array data of 12,064 samples from 5840 cancer patients.
Quality Assurance of Cancer Study Common Data Elements Using A Post-Coordination Approach.
Quality control of single amino acid variations detected by tandem mass spectrometry.
Quality of leadership in multidisciplinary cancer tumor boards: development and evaluation of a leadership assessment instrument (ATLAS).
Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression.
Quantification of glioblastoma mass effect by lateral ventricle displacement.
Quantification of read species behavior within whole genome sequencing of cancer genomes for the stratification and visualization of genomic variation.
Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy.
Quantitative Analysis of Differential Expression of HOX Genes in Multiple Cancers.
Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation.
Quantitative analysis of the mitochondrial proteome in human ovarian carcinomas.
Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer.
Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
Quantitative assessment of aberrant P16INK4a methylation in ovarian cancer: a meta-analysis based on literature and TCGA datasets.
Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates.
Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challenge.
Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA).
Quantitative characterization of metastatic disease in the spine. Part I. Semiautomated segmentation using atlas-based deformable registration and the level set method.
Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome.
Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer.
Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology.
Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma.
Quantum processor-inspired machine learning in the biomedical sciences.
Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis.
Quiescin Sulfhydryl Oxidase 1 Regulates the Proliferation, Migration and Invasion of Human Glioblastoma Cells via PI3K/Akt Pathway.
R.JIVE for exploration of multi-source molecular data.
RAB18 promotes proliferation and metastasis in hepatocellular carcinoma.
Rab18 Regulates Proliferation, Invasion and Cisplatin Sensitivity Through STAT3 Signaling in Head and Neck Squamous Cell Carcinoma.
RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis.
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition.
Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.
Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
Race disparities in the contribution of miRNA isoforms and tRNA-derived fragments to triple-negative breast cancer.
Race influences survival in glioblastoma patients with KPS ??80 and associates with genetic markers of retinoic acid metabolism.
Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas.
Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas.
Racial disparities in molecular subtypes of endometrial cancer.
Racial disparities in patient survival and tumor mutation burden, and the association between tumor mutation burden and cancer incidence rate.
Racial Representation Disparity of Population-Level Genomic Sequencing Efforts.
Racial/Ethnic Disparities in Genomic Sequencing.
RACK1 Acts as a Potential Tumor Promoter in Colorectal Cancer.
Rad18 mediates specific mutational signatures and shapes the genomic landscape of carcinogen-induced tumors in vivo.
RADIA: RNA and DNA integrated analysis for somatic mutation detection.
RADIO-IBAG: RADIOMICS-BASED INTEGRATIVE BAYESIAN ANALYSIS OF MULTIPLATFORM GENOMIC DATA.
Radiogenomic Analysis of Breast Cancer: Luminal B Molecular Subtype Is Associated with Enhancement Dynamics at MR Imaging.
Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.
Radiogenomics correlation between MR imaging features and mRNA-based subtypes in lower-grade glioma.
Radiogenomics model for overall survival prediction of glioblastoma.
Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.
Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.
Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
Radiomics Features Predict CIC Mutation Status in Lower Grade Glioma.
Radiomics in gliomas: A promising assistance ?for glioma clinical research.
Radiomics MRI Phenotyping with Machine Learning to Predict the Grade of Lower-Grade Gliomas: A Study Focused on Nonenhancing Tumors.
Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy.
RAI14 Regulated by circNFATC3/miR-23b-3p axis Facilitates Cell Growth and Invasion in Gastric Cancer.
RAI14 silencing suppresses progression of esophageal cancer via the STAT3 pathway.
Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma.
RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-?B activation and EGFR signaling.
Ranking novel cancer driving synthetic lethal gene pairs using TCGA data.
Rap2B promotes the proliferation and migration of human glioma cells via activation of the ERK pathway.
Rapidly and Slowly Growing Lineages in Chromosomal Instability-Type Gland-Forming Gastric Carcinomas as Revealed by Multisampling Analysis of DNA Copy-Number Profile.
Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma.
Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma.
Rare variant phasing using paired tumor:normal sequence data.
Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.
RARRES1 is a novel immune-related biomarker in GBM.
Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Ras related GTP binding D promotes aerobic glycolysis of hepatocellular carcinoma.
RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis.
Rational design and identification of immuno-oncology drug combinations.
Rationale for targeting the Ras/MAPK pathway in triple-negative breast cancer.
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
RBAK is upregulated in non-small cell lung cancer and promotes cell migration and invasion.
RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma.
RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma.
RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer.
RDGN-based predictive model for the prognosis of breast cancer.
Re-Clustering and Profiling of Digestive System Tumors According to Microenvironment Components.
Re-emerging role of macroscopic appearance in treatment strategy for gastric cancer.
Re-Evaluate Fusion Genes in Prostate Cancer.
Re-Evaluating E-Cadherin and ?-Catenin: A Pan-Cancer Proteomic Approach with an Emphasis on Breast Cancer.
Re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway.
ReactomeGSA - Efficient Multi-Omics Comparative Pathway Analysis.
Reading between the lines; understanding drug response in the post genomic era.
Reannotation and Analysis of Clinical and Chemotherapy Outcomes in the Ovarian Data Set From The Cancer Genome Atlas.
REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Recent advancements in esophageal cancer treatment in Japan.
Recent advances in genitourinary tumors: A review focused on biology and systemic treatment.
Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults.
Recent Cancer Atlas of the Federal Republic of Germany.
Recent Developments in Surgical Pathology of the Uterine Corpus.
Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients.
Recent therapeutic advances in the treatment of colorectal cancer.
Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder Cancer.
Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy.
Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.
Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
Reciprocal loop of hypoxia-inducible factor-1? (HIF-1?) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.
Reciprocal regulation of HIF-1? and Uroplakin 1A promotes glycolysis and proliferation in Hepatocellular Carcinoma.
RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival.
Reclassifying endometrial carcinomas with a combined morphological and molecular approach.
Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma.
Reconstruction and analysis of circRNA?miRNA?mRNA network in the pathology of cervical cancer.
Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
Reconstruction and Analysis of the Immune-Related LINC00987/A2M Axis in Lung Adenocarcinoma.
Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival.
Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.
Recurrence-associated genes in papillary thyroid cancer: An analysis of data from The Cancer Genome Atlas.
Recurrence-Associated Multi-RNA Signature to Predict Disease-Free Survival for Ovarian Cancer Patients.
Recurrent Amplification of the Osmotic Stress Transcription Factor NFAT5 in Adrenocortical Carcinoma.
Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.
Recurrent human papillomavirus-related head and neck cancer undergoes metabolic re-programming and is driven by oxidative phosphorylation.
Recurrent somatic mutations in regulatory regions of human cancer genomes.
Recurrent tumor-specific regulation of alternative polyadenylation of cancer-related genes.
Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylation.
Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas.
Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma.
Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.
Reduced expression of microRNA-139-5p in hepatocellular carcinoma results in a poor outcome: An exploration the roles of microRNA-139-5p in tumorigenesis, advancement and prognosis at the molecular biological level using an integrated meta-analysis and bioinformatic investigation.
Reduced expression of the DNA glycosylase gene MUTYH is associated with an increased number of somatic mutations via a reduction in the DNA repair capacity in prostate adenocarcinoma.
Reduced GRAMD1C expression correlates to poor prognosis and immune infiltrates in kidney renal clear cell carcinoma.
Reduced levels of actin gamma 1 predict poor prognosis in ovarian cancer patients.
Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.
Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
Reduced rate of copy number aberrations in mucinous colorectal carcinoma.
Reduced Smad4 expression and DNA topoisomerase inhibitor chemosensitivity in non-small cell lung cancer.
Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer.
Reference genome and annotation updates lead to contradictory prognostic predictions in gene expression signatures: a case study of resected stage I lung adenocarcinoma.
Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz.
Reference-free transcriptome exploration reveals novel RNAs for prostate cancer diagnosis.
Reformed smokers have survival benefits after head and neck cancer.
Regional specificity of matrix metalloproteinase-9 expression in the brain: voxel-level mapping in primary glioblastomas.
Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma.
regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors.
Regression analysis of combined gene expression regulation in acute myeloid leukemia.
Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma.
Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer.
Regulation of AURKC expression by CpG island methylation in human cancer cells.
Regulation of breast tumorigenesis through acid sensors.
Regulation of gliomagenesis and stemness through acid sensor ASIC1a.
Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.
Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
Regulation of mRNA expression in breast cancer - a cis-tematic trans-action.
Regulation of periostin expression by Notch signaling in hepatocytes and liver cancer cell lines.
Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
Regulation of Pharmacogene Expression by microRNA in The Cancer Genome Atlas (TCGA) Research Network.
Regulation of prognosis-related Siglecs in the glioma microenvironment.
Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer.
Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.
Regulation of UDP-Glucuronosyltransferases UGT2B4 and UGT2B7 by MicroRNAs in Liver Cancer Cells.
Regulation of Wnt receptor activity: Implications for therapeutic development in colon cancer.
Regulation rewiring analysis reveals mutual regulation between STAT1 and miR-155-5p in tumor immunosurveillance in seven major cancers.
Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancer.
Regulatory effects of noncoding RNAs on the interplay of oxidative stress and autophagy in cancer malignancy and therapy.
Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
Regulatory interactions between long noncoding RNA LINC00968 and miR-9-3p in non-small cell lung cancer: A bioinformatic analysis based on miRNA microarray, GEO and TCGA.
Regulatory network of PD1 signaling is associated with prognosis in glioblastoma multiforme.
Regulatory network reconstruction of five essential microRNAs for survival analysis in breast cancer by integrating miRNA and mRNA expression datasets.
RelA-Induced Interferon Response Negatively Regulates Proliferation.
Relapse-related molecular signature in early-stage lung adenocarcinomas based on base excision repair, stimulator of interferon genes pathway and tumor-infiltrating lymphocytes.
Relating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational research.
Relating pancreatic ductal adenocarcinoma tumor samples and cell lines using gene expression data in translational research.
Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
Relation-aware Shared Representation Learning for Cancer Prognosis Analysis with Auxiliary Clinical Variables and Incomplete Multi-modality Data.
Relationship between a 7-mRNA signature of the pancreatic adenocarcinoma microenvironment and patient prognosis (a STROBE-compliant article).
Relationship between Glioblastoma Heterogeneity and Survival Time: An MR Imaging Texture Analysis.
Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.
Relationships Between Human-Extracted MRI Tumor Phenotypes of Breast Cancer and Clinical Prognostic Indicators Including Receptor Status and Molecular Subtype.
Relevance of STK11 Mutations Regarding Immune Cell Infiltration, Drug Sensitivity, and Cellular Processes in Lung Adenocarcinoma.
RELL1, a novel oncogene, accelerates tumor progression and regulates immune infiltrates in glioma.
Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections.
Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis?
Renal Cell Carcinoma-Infiltrating CD3low V?9V?1 T Cells Represent Potentially Novel Anti-Tumor Immune Players.
Renal cell carcinoma: molecular characterization and evolving treatment paradigms.
Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
Replisome genes regulation by antitumor miR-101-5p in clear cell renal cell carcinoma.
Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment.
Repression of GCN5 expression or activity attenuates c-MYC expression in non-small cell lung cancer.
Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor ?-Positive Breast Cancer.
Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts.
Reproducibility of SNV-calling in multiple sequencing runs from single tumors.
Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system.
Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
REPURPOSING GERMLINE EXOMES OF THE CANCER GENOME ATLAS DEMANDS A CAUTIOUS APPROACH AND SAMPLE-SPECIFIC VARIANT FILTERING.
Repurposing Methotrexate in Dampening SARS-CoV2-S1-Mediated IL6 Expression: Lessons Learnt from Lung Cancer.
Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
Requirement for ssbp2 in hematopoietic stem cell maintenance and stress response.
Research on circadian clock genes in common abdominal malignant tumors.
Research on circadian clock genes in non-small-cell lung carcinoma.
Research on the circadian clock gene HNF4a in different malignant tumors.
Research Resource: Global Identification of Estrogen Receptor ? Target Genes in Triple Negative Breast Cancer Cells.
Researches on the Correlation Between Estrogen and Progesterone Receptors Expression and Disease-Free Survival of Endometrial Cancer.
Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells.
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes.
Response to Anti-PD-1 in Uveal Melanoma Without High-Volume Liver Metastasis.
Response to Comment on "DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification".
Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.
REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress.
Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma.
Retinoblastoma binding protein 4 up-regulation is correlated with hepatic metastasis and poor prognosis in colon cancer patients.
Retrospective clinical trial experimentally validates glioblastoma genome-wide pattern of DNA copy-number alterations predictor of survival.
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Retrospective Review of a Mobile Mammography Screening Program in an Underserved Population within a Large Metropolitan Area.
Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO.
Retrospective Validation of a 168-Gene Expression Signature for Glioma Classification on a Single Molecule Counting Platform.
Retrotransposition of gene transcripts leads to structural variation in mammalian genomes.
Reusability and composability in process description maps: RAS-RAF-MEK-ERK signalling.
Reveal the Regulation Patterns of Prognosis-Related miRNAs and lncRNAs Across Solid Tumors in the Cancer Genome Atlas.
Revealing Biological Pathways Implicated in Lung Cancer from TCGA Gene Expression Data Using Gene Set Enrichment Analysis.
Revealing Prognosis-Related Pathways at the Individual Level by a Comprehensive Analysis of Different Cancer Transcription Data.
Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer.
Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma.
RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells.
RGS16 promotes glioma progression and serves as a prognostic factor.
Rho GTPases in cancer: friend or foe?
Rho guanine nucleotide exchange factor 39 increases the viability, migration and invasion of clear cell renal cell carcinoma cells via the activation of the AKT/ERK signaling pathway.
Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition.
Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
Ribosome Assembly Factor URB1 Contributes to Colorectal Cancer Proliferation via Transcriptional Activation of ATF4.
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors.
RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/?-catenin signaling.
RIP-seq reveals LINE-1 ORF1p association with p-body enriched mRNAs.
RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma.
Risk characteristics with seven epithelial-mesenchymal transition-related genes are used to predict the prognosis of patients with hepatocellular carcinoma.
Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives.
Risk of cognition alteration and emotional frailty via circulating transcriptome in treatment naïve head and neck squamous cell cancer patients.
Risk score based on expression of five novel genes predicts survival in soft tissue sarcoma.
Risk score based on three mRNA expression predicts the survival of bladder cancer.
Risk Score Based on Two microRNAs as a Prognostic Marker of Hepatocellular Carcinoma and the Corresponding Competitive Endogenous RNA Network.
Risk scoring based on expression of long non?coding RNAs can effectively predict survival in hepatocellular carcinoma patients with or without fibrosis.
Risk Scoring System based on lncRNA Expression for Predicting Survival in Hepatocellular Carcinoma with Cirrhosis.
Risk stratification of cutaneous melanoma reveals carcinogen metabolism enrichment and immune inhibition in high-risk patients.
Rlip Depletion Suppresses Growth of Breast Cancer.
RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.
RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.
RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy.
RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers.
RNA m6A Methylation Regulators Subclassify Luminal Subtype in Breast Cancer.
RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
RNA sequencing analysis reveals protective role of kruppel-like factor 3 in colorectal cancer.
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes.
RNA sequencing-based cell proliferation analysis across 19 cancers identifies a subset of proliferation-informative cancers with a common survival signature.
RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestry.
RNA-Associated Co-expression Network Identifies Novel Biomarkers for Digestive System Cancer.
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer.
RNA-Binding Proteins Play an Important Role in the Prognosis of Patients With Testicular Germ Cell Tumor.
RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer.
RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis.
RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma.
RNA-seq Identification of RACGAP1 as a Metastatic Driver in Uterine Carcinosarcoma.
RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.
RNA-seq Reveals the Overexpression of IGSF9 in Endometrial Cancer.
RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective.
RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
RNA-sequencing investigation identifies an effective risk score generated by three novel lncRNAs for the survival of papillary thyroid cancer patients.
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers.
RnaSeqSampleSize: real data based sample size estimation for RNA sequencing.
RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
Robust analysis of novel mRNA-lncRNA cross talk based on ceRNA hypothesis uncovers carcinogenic mechanism and promotes diagnostic accuracy in esophageal cancer.
Robust and Efficient Biomolecular Clustering of Tumor Based on ${p}$ -Norm Singular Value Decomposition.
Robust biomarker discovery for hepatocellular carcinoma from high-throughput data by multiple feature selection methods.
Robust clustering of noisy high-dimensional gene expression data for patients subtyping.
Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
Robust genomic copy number predictor of pan cancer metastasis.
Robust Histopathology Image Analysis: to Label or to Synthesize?
Robust identification of target genes and outliers in triple-negative breast cancer data.
Robust Principal Component Analysis Regularized by Truncated Nuclear Norm for Identifying Differentially Expressed Genes.
Robust semiparametric gene-environment interaction analysis using sparse boosting.
Roentgen anatomy. III. A cross section atlas for the radiation therapy of the cancer of cervix uteri.
Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis.
Role of alternative splicing events in endometrial cancer prognosis.
Role of alternative splicing signatures in the prognosis of glioblastoma.
Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival.
Role of B7-H4 siRNA in Proliferation, Migration, and Invasion of LOVO Colorectal Carcinoma Cell Line.
Role of Bclaf1 in Promoting Adrenocortical Carcinoma Proliferation: A Study Combining the Use of Bioinformatics and Molecular Events.
Role of BRAF and RAS Mutations in Extrathyroidal Extension in Papillary Thyroid Cancer.
Role of cancer stem-cell marker doublecortin-like kinase 1 in head and neck squamous cell carcinoma.
Role of chromosome 1q copy number variation in hepatocellular carcinoma.
Role of CYP4F2 as a novel biomarker regulating malignant phenotypes of liver cancer cells via the Nrf2 signaling axis.
Role of DNA methylation regulation of miR-130b expression in human lung cancer using bioinformatics analysis.
Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.
Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma.
Role of endothelin receptor type B (EDNRB) in lung adenocarcinoma.
Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.
Role of exchange protein directly activated by cAMP (EPAC1) in breast cancer cell migration and apoptosis.
Role of host-microRNA Hsa-miR-139-3p in HPV-16 induced carcinomas.
Role of HOX Genes in Stem Cell Differentiation and Cancer.
Role of Immune Cell-Specific Hypermethylation Signatures in Classification and Risk Stratification of Breast Cancer.
Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression.
Role of Increased n-acetylaspartate Levels in Cancer.
Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.
Role of Krüppel-like Factor 4-p21CIP1 Axis in Breast Cancer Stem-like Cell Inhibition by Benzyl Isothiocyanate.
Role of m5C-related regulatory genes in the diagnosis and prognosis of hepatocellular carcinoma.
Role of miR-1 expression in clear cell renal cell carcinoma (ccRCC): A bioinformatics study based on GEO, ArrayExpress microarrays and TCGA database.
Role of miR-182-5p overexpression in trichloroethylene-induced abnormal cell cycle functions in human HepG2 cells.
Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma.
Role of oncogene PIM-1 in the development and progression of papillary thyroid carcinoma: Involvement of oxidative stress.
Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis.
Role of PLZF in melanoma progression.
Role of PRDM1 in Tumor Immunity and Drug Response: A Pan-Cancer Analysis.
Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma.
Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value.
Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy.
Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis.
Roles of MYC-targeting long non-coding RNA MINCR in cell cycle regulation and apoptosis in non-small cell lung Cancer.
Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.
Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis.
ROR2 Is Epigenetically Regulated in Endometrial Cancer.
RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma.
RSPO3 is a marker candidate for predicting tumor aggressiveness in ovarian cancer.
RTCGAToolbox: a new tool for exporting TCGA Firehose data.
RTOG Sarcoma Radiation Oncologists Reach Consensus on Gross Tumor Volume and Clinical Target Volume on Computed Tomographic Images for Preoperative Radiotherapy of Primary Soft Tissue Sarcoma of Extremity in Radiation Therapy Oncology Group Studies.
RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
RUNX1 and REXO2 are associated with the heterogeneity and prognosis of IDH wild type lower grade glioma.
RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGF? pathway-dependent manner.
RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.
S-score: a scoring system for the identification and prioritization of predicted cancer genes.
S100 Calcium Binding Protein A10, A Novel Oncogene, Promotes the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma.
S100A10 Accelerates Aerobic Glycolysis and Malignant Growth by Activating mTOR-Signaling Pathway in Gastric Cancer.
S100A11 is a potential prognostic marker for clear cell renal cell carcinoma.
S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine.
S100A16 regulated by Snail promotes the chemoresistance of nonmuscle invasive bladder cancer through the AKT/Bcl-2 pathway.
S100A9 as a novel diagnostic and prognostic biomarker in human gastric cancer.
S100P acts as a target of miR-495 in pancreatic cancer through bioinformatics analysis and experimental verification.
Salt-inducible kinase 2 functions as a tumor suppressor in hepatocellular carcinoma.
SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy.
Sample type bias in the analysis of cancer genomes.
Sampling Based Tumor Recognition in Whole-slide Histology Image with Deep Learning Approaches.
SAMQA: error classification and validation of high-throughput sequenced read data.
Sanguinarine inhibits the tumorigenesis of gastric cancer by regulating the TOX/DNA-PKcs/ KU70/80 pathway.
SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer.
SATB2 is a novel biomarker and therapeutic target for cancer.
Scalable Nonparametric Prescreening Method for Searching Higher-Order Genetic Interactions Underlying Quantitative Traits.
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.
scan_tcga tools for integrated epigenomic and transcriptomic analysis of tumor subgroups.
Scavenger Receptor A1 Prevents Metastasis of Non-Small Cell Lung Cancer via Suppression of Macrophage Serum Amyloid A1.
Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
SCDb: an integrated database of stomach cancer.
SCG3 Protein Expression in Glioma Associates With less Malignancy and Favorable Clinical Outcomes.
Scottish Cancer Incidence Atlas 1985.
Screening a Prognosis-Related Target Gene in Patients with HER-2-Positive Breast Cancer by Bioinformatics Analysis.
Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan-cancer.
Screening and discrimination of optimal prognostic genes for pancreatic cancer based on a prognostic prediction model.
Screening and Identification of an Immune-Associated lncRNA Prognostic Signature in Ovarian Carcinoma: Evidence from Bioinformatic Analysis.
Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis.
Screening and identification of biomarkers associated with clinicopathological parameters and prognosis in oral squamous cell carcinoma.
Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma.
Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Screening and Identification of Potential Biomarkers for Hepatocellular Carcinoma: An Analysis of TCGA Database and Clinical Validation.
Screening and Identification of Potential Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
Screening and Identification of Prognostic Tumor-Infiltrating Immune Cells and Genes of Endometrioid Endometrial Adenocarcinoma: Based on The Cancer Genome Atlas Database and Bioinformatics.
Screening and Identifying Cisplatin-Related Gene Mutations in Lung Squamous Cell Carcinoma.
Screening and Identifying Immune-Related Cells and Genes in the Tumor Microenvironment of Bladder Urothelial Carcinoma: Based on TCGA Database and Bioinformatics.
Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database.
Screening and Interaction Analysis of Key Genes in miR-542-3p Over- Expressed Osteosarcoma Cells by Bioinformatics.
Screening and prognostic value of potential biomarkers for ovarian cancer.
Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
Screening and Validation of the Hypoxia-Related Signature of Evaluating Tumor Immune Microenvironment and Predicting Prognosis in Gastric Cancer.
Screening and verification of long noncoding RNA promoter methylation sites in hepatocellular carcinoma.
Screening and verification of microRNA promoter methylation sites in hepatocellular carcinoma.
Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.
Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing.
Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
Screening key long non-coding RNAs in early-stage colon adenocarcinoma by RNA-sequencing.
Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis.
Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer.
Screening of differentially methylated genes in breast cancer and risk model construction based on TCGA database.
Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.
Screening of gene markers related to the prognosis of metastatic skin cutaneous melanoma based on Logit regression and survival analysis.
Screening of genes related to survival prognosis of cervical squamous cell carcinoma and construction of prognosis prediction model.
Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers.
Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.
Screening of key genes and prediction of therapeutic agents in Arsenic-induced lung carcinoma.
Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Screening of MicroRNA Biomarkers Related to the Progression of Bladder Cancer.
Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis.
Screening of Prognosis-Related Genes in Primary Breast Carcinoma Using Genomic Expression Data.
Screening of Prognostic Factors in Early-Onset Breast Cancer.
Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
Screening of tumor grade-related mRNAs and lncRNAs for Esophagus Squamous Cell Carcinoma.
Screening potential microRNAs associated with pancreatic cancer: Data mining based on RNA sequencing and microarrays.
Screening potential prognostic biomarkers for portal vein emboli in patients with hepatocellular carcinoma.
Screening prognosis-related genes in glioblastoma by microarray analysis.
Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Screening responsive or resistant biomarkers of immune checkpoint inhibitors based on online databases.
Screening TCGA database for prognostic genes in lower grade glioma microenvironment.
Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia.
Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation.
Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma.
SCRIB Promotes Proliferation and Metastasis by Targeting Hippo/YAP Signalling in Colorectal Cancer.
SCTR hypermethylation is a diagnostic biomarker in colorectal cancer.
SEaCorAl: Identifying and contrasting the regulation-correlation bias in RNA-Seq paired expression data of patient groups.
Searching for a signature involving 10 genes to predict the survival of patients with acute myelocytic leukemia through a combined multi-omics analysis.
Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.
SEC61G is upregulated and required for tumor progression in human kidney cancer.
SEC61G promotes breast cancer development and metastasis via modulating glycolysis and is transcriptionally regulated by E2F1.
Second edition of 'The Bethesda System for reporting cervical cytology' - atlas, website, and Bethesda interobserver reproducibility project.
Secondary chronic respiratory acidosis in a dog following the cervical cord compression by an intradural glioma.
Segmentation of brain structures in presence of a space-occupying lesion.
SEGreg: a database for human specifically expressed genes and their regulations in cancer and normal tissue.
SELE gene as a characteristic prognostic biomarker of colorectal cancer.
Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue.
Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia.
Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature.
Selective expression of long non-coding RNAs in a breast cancer cell progression model.
Selective inhibition of TGF?1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape.
Selective inhibition of the lactate transporter MCT4 reduces growth of invasive bladder cancer.
Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.
SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis.
SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
SEMA3F Promotes Liver Hepatocellular Carcinoma Metastasis by Activating Focal Adhesion Pathway.
Sema4D correlates with tumour immune infiltration and is a prognostic biomarker in bladder cancer, renal clear cell carcinoma, melanoma and thymoma.
SEMA6D Expression and Patient Survival in Breast Invasive Carcinoma.
Semi-automated cancer genome analysis using high-performance computing.
Semi-supervised identification of cancer subgroups using survival outcomes and overlapping grouping information.
Semiparametric integrative interaction analysis for non-small-cell lung cancer.
Sensitivity to differential NRF1 gene signatures contributes to breast cancer disparities.
Sensitization of human erythroleukemia K562 cells resistant to methotrexate by inhibiting IMPDH.
Separated Siamese Twins: Intronic Small Nucleolar RNAs and Matched Host Genes May be Altered in Conjunction or Separately in Multiple Cancer Types.
Sequencing Errors Rife in Genome Databases.
Sequencing the head and neck cancer genome: implications for therapy.
Sequencing the next generation of glioblastomas.
Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers.
Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression.
Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2.
Serological response to Epstein-Barr virus early antigen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: a case-control study.
Serous BMP8A has clinical significance in ultrasonic diagnosis of thyroid cancer and promotes thyroid cancer cell progression.
Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.
SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target.
Serum deprivation response functions as a tumor suppressor gene in papillary thyroid cancer.
Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways.
Serum exosomal miR-1269a serves as a diagnostic marker and plays an oncogenic role in non-small cell lung cancer.
Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma.
Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Serum long non-coding RNA LOC553103 as non-specific diagnostic and prognostic biomarker for common types of human cancer.
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
Serum proteome profiling reveals SOX3 as a candidate prognostic marker for gastric cancer.
Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
Serum Type XIX Collagen is Significantly Elevated in Non-Small Cell Lung Cancer: A Preliminary Study on Biomarker Potential.
Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules.
Set-Wise Differential Interaction Between Copy Number Alterations and Gene Expressions of Lower-Grade Glioma Reveals Prognosis-Associated Pathways.
SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis.
Seven genes for the prognostic prediction in patients with glioma.
Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
Seven-Gene Signature Based on Glycolysis Is Closely Related to the Prognosis and Tumor Immune Infiltration of Patients With Gastric Cancer.
Seven-gene signature on tumor microenvironment for predicting the prognosis of patients with pancreatic cancer.
Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma.
Several microRNAs could predict survival in patients with hepatitis B-related liver cancer.
Sex difference of mutation clonality in diffuse glioma evolution.
Sex Differences in Colon Cancer Metabolism Reveal A Novel Subphenotype.
Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma.
Sex-Associated Gene Expression Alterations Correlate With Esophageal Cancer Survival.
Sex-associated molecular differences for cancer immunotherapy.
Sex-biased differences in the correlation between epithelial-to-mesenchymal transition-associated genes in cancer cell lines.
Sexual dimorphism in glioma glycolysis underlies sex differences in survival.
SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma.
SGI: Automatic clinical subgroup identification in omics datasets.
SGK2 promotes renal cancer progression via enhancing ERK 1/2 and AKT phosphorylation.
SHARPIN regulates the development of clear cell renal cell carcinoma by promoting von Hippel-Lindau protein ubiquitination and degradation.
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway.
shinyMethyl: interactive quality control of Illumina 450k DNA methylation arrays in R.
SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer.
Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells.
Short-term RANKL exposure initiates a neoplastic transcriptional program in the basal epithelium of the murine salivary gland.
SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Shp1 in Solid Cancers and Their Therapy.
Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.
shRNA knockdown of DNA helicase ERCC6L expression inhibits human breast cancer growth.
Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas.
SIFORM: shared informative factor models for integration of multi-platform bioinformatic data.
SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples.
Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.
Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.
Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine.
Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics.
Signalling maps in cancer research: construction and data analysis.
Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer.
Signature Gene Identification of Cancer Occurrence and Pattern Recognition.
Signature identification of relapse-related overall survival of early lung adenocarcinoma after radical surgery.
Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
Signature of prognostic epithelial-mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma.
Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients.
Signatures of gene expression, DNA methylation and microRNAs of hepatocellular carcinoma with vascular invasion.
Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas.
Significance of aquaporins' expression in the prognosis of gastric cancer.
Significance of BMI1 and FSCN1 expression in colorectal cancer.
Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto's Thyroiditis.
Significance of KDM6A mutation in bladder cancer immune escape.
Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer.
Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis.
Significance of positive and inhibitory regulators in the TGF-? signaling pathway in colorectal cancers.
Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.
Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.
Significance of TP53 mutation in bladder cancer disease progression and drug selection.
Significance of TP53 Mutation in Cellular Process and Disease Progression in Lung Adenocarcinoma.
Significance of TP53 mutation in treatment and prognosis in head and neck squamous cell carcinoma.
Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors.
Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer.
Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Significant association of DIRC1 overexpression with tumor progression and poor prognosis in gastric cancer.
Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients.
Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers.
Significant Prognostic Value of the Autophagy-Related Gene P4HB in Bladder Urothelial Carcinoma.
Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
Silence of Hippo Pathway Associates with Pro-Tumoral Immunosuppression: Potential Therapeutic Target of Glioblastomas.
Silenced PITX1 promotes chemotherapeutic resistance to 5-fluorocytosine and cisplatin in gastric cancer cells.
Silencing DSCAM-AS1 suppresses the growth and invasion of ER-positive breast cancer cells by downregulating both DCTPP1 and QPRT.
Silencing KIF18B enhances radiosensitivity: identification of a promising therapeutic target in sarcoma.
Silencing of ARL14 Gene Induces Lung Adenocarcinoma Cells to a Dormant State.
Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1.
Silencing of Growth Differentiation Factor-15 Promotes Breast Cancer Cell Invasion by Down-regulating Focal Adhesion Genes.
Silencing of HAS2-AS1 mediates PI3K/AKT signaling pathway to inhibit cell proliferation, migration, and invasion in glioma.
Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK/STAT3 signaling pathway.
Silencing of LINC00461 enhances radiosensitivity of lung adenocarcinoma cells by down-regulating HOXA10 via microRNA-195.
Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-?/Smad Signaling.
Silencing of long non-coding RNA LINC00520 promotes radiosensitivity of head and neck squamous cell carcinoma cells.
Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
Silencing of SmgGDS, a Novel mTORC1 Inducer That Binds to RHEBs, Inhibits Malignant Mesothelioma Cell Proliferation.
Silencing of the long non-coding RNA RHPN1-AS1 suppresses the epithelial-to-mesenchymal transition and inhibits breast cancer progression.
Silencing of WWP2 inhibits adhesion, invasion, and migration in liver cancer cells.
Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial?mesenchymal transition.
Silencing the long noncoding RNA NORAD inhibits gastric cancer cell proliferation and invasion by the RhoA/ROCK1 pathway.
Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin-related modifier 1 modification of glucose 6-phosphate dehydrogenase.
Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancer.
Similar Squamous Cell Carcinoma Epithelium microRNA Expression in Never Smokers and Ever Smokers.
Similarities and Differences in Gene Expression Networks Between the Breast Cancer Cell Line Michigan Cancer Foundation-7 and Invasive Human Breast Cancer Tissues.
Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme.
Simultaneous Expression of Long Non-Coding RNA FAL1 and Extracellular Matrix Protein 1 Defines Tumour Behaviour in Young Patients with Papillary Thyroid Cancer.
Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.
Simultaneous targeting PI3K and PERK pathways promotes cell death and improves the clinical prognosis in esophageal squamous carcinoma.
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.
Single Nucleotide Polymorphism rs6942067 Is a Risk Factor in Young and in Non-Smoking Patients with HPV Negative Head and Neck Squamous Cell Carcinoma.
Single sample scoring of hepatocellular carcinoma: A study based on data mining.
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.
Single-cell analyses reveal mechanisms of cancer stem cell maintenance and epithelial-mesenchymal transition in recurrent bladder cancer.
Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Single-Cell Deconvolution of Head and Neck Squamous Cell Carcinoma.
Single-cell genomic profile-based analysis of tissue differentiation in colorectal cancer.
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages.
Single-Cell RNA Sequencing of a Postmenopausal Normal Breast Tissue Identifies Multiple Cell Types That Contribute to Breast Cancer.
Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient.
Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.
Single-cell RNA-seq reveals invasive trajectory and determines cancer stem cell-related prognostic genes in pancreatic cancer.
Single-Cell Sequencing to Identify Six Heat Shock Protein (HSP) Genes-Mediated Progression Subtypes of Clear Cell Renal Cell Carcinoma.
Single-Cell Spatial Analysis of Tumor and Immune Microenvironment on Whole-Slide Image Reveals Hepatocellular Carcinoma Subtypes.
Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer.
Single-Cell Transcriptome Analysis Reveals Intratumoral Heterogeneity in ccRCC, which Results in Different Clinical Outcomes.
Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4.
Single-sample expression-based chemo-sensitivity score improves survival associations independently from genomic mutations for ovarian cancer Patients.
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic-smoking interaction analysis.
siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth.
SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia.
SIRT6 is upregulated and associated with cancer aggressiveness in papillary thyroid cancer via BRAF/ERK/Mcl?1 pathway.
SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells.
Six genes as potential diagnosis and prognosis biomarkers for hepatocellular carcinoma through data mining.
Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma.
Six long noncoding RNAs as potentially biomarkers involved in competitive endogenous RNA of hepatocellular carcinoma.
Six Metabolism Related mRNAs Predict the Prognosis of Patients With Hepatocellular Carcinoma.
Six Novel Biomarkers for Diagnosis and Prognosis of Esophageal squamous cell carcinoma: validated by scRNA-seq and qPCR.
Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and it is associated with immune infiltration.
Six-lncRNA Immune Prognostic Signature for Cervical Cancer.
Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Six-mRNA risk score system and nomogram constructed for patients with ovarian cancer.
SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer.
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.
Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.
SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment.
SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.
SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer.
SLC25A11 serves as a novel prognostic biomarker in liver cancer.
SLC25A18 has prognostic value in colorectal cancer and represses Warburg effect and cell proliferation via Wnt signaling.
SLC34A2 Up-regulation And SLC4A4 Down-regulation Correlates With Invasion, Metastasis, And The MAPK Signaling Pathway In Papillary Thyroid Carcinomas.
SLC39A4 as a Novel Prognosis Marker Promotes Tumor Progression in Esophageal Squamous Cell Carcinoma.
SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway.
SLC7A5 serves as a prognostic factor of breast cancer and promotes cell proliferation through activating AKT/mTORC1 signaling pathway.
SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.
Sleeping Beauty transposon insertional mutagenesis based mouse models for cancer gene discovery.
SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival.
SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
SMAD3 Hypomethylation as a Biomarker for Early Prediction of Colorectal Cancer.
SMAD4 mutation correlates with poor prognosis in non-small cell lung cancer.
Small interfering RNA-mediated knockdown of KRT80 suppresses colorectal cancer proliferation.
Small Nucleolar RNA Host Gene 1 (SNHG1) and Chromosome 2 Open Reading Frame 48 (C2orf48) as Potential Prognostic Signatures for Liver Cancer by Constructing Regulatory Networks.
Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer.
Small RNA sequencing reveals a comprehensive miRNA signature of BRCA1-associated high-grade serous ovarian cancer.
Small-molecule binding sites to explore protein-protein interactions in the cancer proteome.
Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysis.
SMARCD1 is a transcriptional target of specific non-hotspot mutant p53 forms.
SMARCD3 is a potential prognostic marker and therapeutic target in CAFs.
SMG9 Serves as an Oncogene to Promote the Tumor Progression via EMT and Wnt/?-Catenin Signaling Pathway in Hepatocellular Carcinoma.
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlas.
Smoking is Associated with Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Progression through Inducing Distinguishing lncRNA Alterations in Different Genders.
Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma.
Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project.
Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility.
SmulTCan: A Shiny application for multivariate survival analysis of TCGA data with gene sets.
SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis.
SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis.
SnapShot: TCGA-Analyzed Tumors.
SnapShot: TP53 status and macrophages infiltration in TCGA-analyzed tumors.
SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a.
SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection.
SNORA71A Promotes Colorectal Cancer Cell Proliferation, Migration, and Invasion.
Snowball: resampling combined with distance-based regression to discover transcriptional consequences of a driver mutation.
SNP2APA: a database for evaluating effects of genetic variants on alternative polyadenylation in human cancers.
SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transition.
Social attention of the top 50 scientific articles on gastric cancer: Bibliometric and altmetric analysis.
SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer.
SOD3 induces a HIF-2?-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells.
Software for the Integration of Multiomics Experiments in Bioconductor.
Solar ultraviolet irradiance and cancer incidence and mortality.
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy.
Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients.
Somatic Copy Number Alterations in Human Cancers: An Analysis of Publicly Available Data From The Cancer Genome Atlas.
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer.
Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma.
Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells.
Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma.
Somatic Functional Deletions of Upstream Open Reading Frame-Associated Initiation and Termination Codons in Human Cancer.
Somatic genome alterations in relation to age in lung adenocarcinoma.
Somatic genome alterations in relation to age in lung squamous cell carcinoma.
Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.
Somatic microsatellite variability as a predictive marker for colorectal cancer and liver cancer progression.
Somatic mutaome profile in human cancer tissues.
Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An Accurate Method for Assessment of Preferential Allelic Imbalance in Tumor DNA.
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients.
Somatic mutation profiling of liver and biliary cancer by targeted next generation sequencing.
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non-Small Cell Lung Cancer.
Somatic mutations favorable to patient survival are predominant in ovarian carcinomas.
Somatic mutations in arachidonic acid metabolism pathway genes enhance oral cancer post-treatment disease-free survival.
Somatic Mutations in LRRK2 Identify a Subset of Invasive Mammary Carcinomas Associated with High Mutation Burden.
Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants.
Somatic mutations of PIK3R1 promote gliomagenesis.
Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing.
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome.
Sonographic features of invasive ductal breast carcinomas predictive of malignancy grade.
Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1.
Sorting Five Human Tumor Types Reveals Specific Biomarkers and Background Classification Genes.
Sorting Nexin 5 Controls Head and Neck Squamous Cell Carcinoma Progression by Modulating FBW7.
Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer.
Sources of abnormal EEG activity in the presence of brain lesions.
SOX14 hypermethylation as a tumour biomarker in cervical cancer.
SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.
Sox2 Gene Amplification Significantly Impacts Overall Survival in Serous Epithelial Ovarian Cancer.
SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.
SOX7 blocks vasculogenic mimicry in oral squamous cell carcinoma.
SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to promote tumor progression through HGF/c-Met-FRA1 signaling.
SP3 is associated with migration, invasion, and Akt/PKB signalling in MDA-MB-231 breast cancer cells.
Space-time visualization and analysis in the Cancer Atlas Viewer.
SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma.
sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses.
SPARC promotes pancreatic cancer cell proliferation and migration through autocrine secretion into the extracellular milieu.
Sparse data embedding and prediction by tropical matrix factorization.
Sparse Graph Regularization Non-Negative Matrix Factorization Based on Huber Loss Model for Cancer Data Analysis.
Sparse overlapping group lasso for integrative multi-omics analysis.
Sparse robust graph-regularized non-negative matrix factorization based on correntropy.
Spatial EGFR Dynamics and Metastatic Phenotypes Modulated by Upregulated EphB2 and Src Pathways in Advanced Prostate Cancer.
Spatial habitats from multiparametric MR imaging are associated with signaling pathway activities and survival in glioblastoma.
Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients.
Spatial statistical analysis of Chinese cancer mortality: a comparison study of the D statistic.
Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma.
Spatiotemporal trends in oral cancer mortality and potential risks associated with heavy metal content in Taiwan soil.
SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Specific clinical and immune features of CD68 in glioma via 1,024 samples.
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer.
Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes.
Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns.
Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns.
Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival.
Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis.
Spectrum of gastric malignancy on (18)F-FDG PET/CT: a pictorial essay.
Spectrum of malignant renal and urinary bladder tumors on 18F-FDG PET/CT: a pictorial essay.
Spectrum of Mesenchymal-Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis.
Spectrum of somatic mitochondrial mutations in five cancers.
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon ? production.
Sphingosine Kinase 1 is Associated With Immune Cell-Related Gene Expressions in Human Breast Cancer.
SpidermiR: An R/Bioconductor Package for Integrative Analysis with miRNA Data.
Spindle pole body component 25 homolog expressed by ECM stiffening is required for lung cancer cell proliferation.
Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma.
Splicing mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer.
SPONGEdb: a pan-cancer resource for competing endogenous RNA interactions.
SPOP suppresses testicular germ cell tumors progression through ubiquitination and degradation of DPPA2.
Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma.
SPTAN1 Expression Predicts Treatment and Survival Outcomes in Colorectal Cancer.
Squamous Cell Carcinoma Antigen-encoding Genes
SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer.
SRSF2 Mutations in Uveal Melanoma: A Preference for In-Frame Deletions?
SRSF5 regulates alternative splicing of DMTF1 pre-mRNA through modulating SF1 binding.
SRSF6 regulates alternative splicing of genes involved in DNA damage response and DNA repair in HeLa cells.
SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
SRY-related high-mobility-group box 6 suppresses cell proliferation and is downregulated in breast cancer.
ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.
ssGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications.
SSRP1 influences colorectal cancer cell growth and apoptosis via the AKT pathway.
SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
SSTR5?AS1 functions as a ceRNA to regulate CA2 by sponging miR?15b?5p for the development and prognosis of HBV?related hepatocellular carcinoma.
ST8SIA1 inhibits the proliferation, migration and invasion of bladder cancer cells by blocking the JAK/STAT signaling pathway.
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Stacked Predictive Sparse Coding for Classification of Distinct Regions of Tumor Histopathology.
STAG Mutations in Cancer.
Stalled developmental programs at the root of pediatric brain tumors.
STAM Prolongs Clear Cell Renal Cell Carcinoma Patients' Survival via Inhibiting Cell Growth and Invasion.
sTAM: An Online Tool for the Discovery of miRNA-Set Level Disease Biomarkers.
Stanniocalcin 1 is a prognostic biomarker in glioma.
STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA.
STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas.
STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
STAT gene family mRNA expression and prognostic value in hepatocellular carcinoma.
STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability.
STAT1 expression and HPV16 viral load predict cervical lesion progression.
STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
STAT1-induced upregulation of lncRNA RHPN1-AS1 predicts a poor prognosis of hepatocellular carcinoma and contributes to tumor progression via the miR-485/CDCA5 axis.
STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
STAT3-induced upregulation of lncRNA CASC11 promotes the cell migration, invasion and epithelial-mesenchymal transition in hepatocellular carcinoma by epigenetically silencing PTEN and activating PI3K/AKT signaling pathway.
STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells.
STATegra: Multi-Omics Data Integration - A Conceptual Scheme With a Bioinformatics Pipeline.
Statin use, HMGCR expression, and breast cancer survival - The Malmö Diet and Cancer Study.
Statistical 3D Prostate Imaging Atlas Construction via Anatomically Constrained Registration.
STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer.
Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored.
Steroid receptor RNA activator gene footprint in the progression and drug resistance of colorectal cancer through oxidative phosphorylation pathway.
STIL is upregulated in nasopharyngeal carcinoma tissues and promotes nasopharyngeal carcinoma proliferation, migration and invasion.
Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma.
STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV
STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype.
STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/?-catenin pathway in cervical carcinoma cells.
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma.
STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway.
Strand Orientation Bias Detector to determine the probability of FFPE sequencing artifacts.
Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression.
Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.
Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
Stratifying melanoma and breast cancer TCGA datasets on the basis of the CNV of transcription factor binding sites common to proliferation- and apoptosis-effector genes.
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
STRIP2, a member of the striatin-interacting phosphatase and kinase complex, is implicated in lung adenocarcinoma cell growth and migration.
Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.
Stromal iodothyronine deiodinase 2 (DIO2) promotes the growth of intestinal tumors in Apc?716 mutant mice.
Stromal LAG-3+ cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture.
Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma.
Stromal-associated cytokines bias the interplay between gene expression and DNA methylation in human breast cancers.
Stromal-Based Signatures for the Classification of Gastric Cancer.
Structural learning and integrative decomposition of multi-view data.
Structure-based predictions broadly link transcription factor mutations to gene expression changes in cancers.
Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts.
Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis.
Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing.
Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma.
Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.
Study on the Selection of the Targets of Esophageal Carcinoma and Interventions of Ginsenosides Based on Network Pharmacology and Bioinformatics.
Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome.
STYK1 promotes autophagy through enhancing the assembly of autophagy-specific class III phosphatidylinositol 3-kinase complex I.
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.
Subgroup analysis reveals molecular heterogeneity and provides potential precise treatment for pancreatic cancers.
Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.
Subset testing and analysis of multiple phenotypes.
Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
Subtype identification from heterogeneous TCGA datasets on a genomic scale by multi-view clustering with enhanced consensus.
Subtyping glioblastoma by combining miRNA and mRNA expression data using compressed sensing-based approach.
Subtyping of microsatellite instability-high colorectal cancer.
SUCO as a Promising Diagnostic Biomarker of Hepatocellular Carcinoma: Integrated Analysis and Experimental Validation.
Sulfatase 2-Induced Cancer-Associated Fibroblasts Promote Hepatocellular Carcinoma Progression via Inhibition of Apoptosis and Induction of Epithelial-to-Mesenchymal Transition.
SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
SUMOylated MAFB promotes colorectal cancer tumorigenesis.
SUMOylation Regulator-Related Molecules Can Be Used as Prognostic Biomarkers for Glioblastoma.
SUN-MKL1 Crosstalk Regulates Nuclear Deformation and Fast Motility of Breast Carcinoma Cells in Fibrillar ECM Microenvironment.
Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data.
SuperFreq: Integrated mutation detection and clonal tracking in cancer.
Superhighway or blind alley? The cancer genome atlas releases first results.
Superpixel-Based Conditional Random Fields (SuperCRF): Incorporating Global and Local Context for Enhanced Deep Learning in Melanoma Histopathology.
Support vector machine classifier for prediction of the metastasis of colorectal cancer.
Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer.
Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
Surgical approaches: postoperative care and complications "posterolateral-far lateral transcondylar approach to the ventral foramen magnum and upper cervical spinal canal".
Surgical treatment for recurrent solitary fibrous tumor invading atlas.
Surgical treatment of craniovertebral junction instability : clinical outcomes and effectiveness in personal experience.
Surrogate Markers: Lessons from the Next Gen?
SurvBoost: An R Package for High-Dimensional Variable Selection in the Stratified Proportional Hazards Model via Gradient Boosting.
Survival analysis and functional annotation of long non-coding RNAs in lung adenocarcinoma.
Survival analysis for long noncoding RNAs identifies TP53TG1 as an antioncogenic target for the breast cancer.
Survival analysis of genome-wide profiles coupled with Connectivity Map database mining to identify potential therapeutic targets for cholangiocarcinoma.
Survival correlation of immune response in human cancers.
Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.
Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
Survival kinase genes present prognostic significance in glioblastoma.
Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort.
Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data.
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase.
Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers.
Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer.
Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma.
Survival prediction in patients with colon adenocarcinoma via multi-omics data integration using a deep learning algorithm.
Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron.
Survival prediction of kidney renal papillary cell carcinoma by comprehensive LncRNA characterization.
Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q.
Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
Survival-associated alternative splicing signatures in esophageal carcinoma.
Survival-associated alternative splicing signatures in non-small cell lung cancer.
Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers.
Survival-related risk score of lung adenocarcinoma identified by weight gene co-expression network analysis.
SVD identifies transcript length distribution functions from DNA microarray data and reveals evolutionary forces globally affecting GBM metabolism.
SVExpress: identifying gene features altered recurrently in expression with nearby structural variant breakpoints.
SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents.
SWIM: a computational tool to unveiling crucial nodes in complex biological networks.
SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.
Synaptopodin-2 promotes hepatocellular carcinoma metastasis via calcineurin-induced nuclear-cytoplasmic translocation.
Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Syndecan Family Gene and Protein Expression and Their Prognostic Values for Prostate Cancer.
Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway.
SYNE1 mutation may enhance the response to immune checkpoint blockade therapy in clear cell renal cell carcinoma patients.
Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models.
Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers.
Synergy of Sex Differences in Visceral Fat Measured with CT and Tumor Metabolism Helps Predict Overall Survival in Patients with Renal Cell Carcinoma.
Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer.
Syntaxin 6: A novel predictive and prognostic biomarker in papillary renal cell carcinoma.
Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.
Synthesis of diagnostic quality cancer pathology images by generative adversarial networks.
Synthetic Evaluation of MicroRNA-1-3p Expression in Head and Neck Squamous Cell Carcinoma Based on Microarray Chips and MicroRNA Sequencing.
System-scale network modeling of cancer using EPoC.
Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma.
Systematic Analyses of the Role of the Reader Protein of N 6-Methyladenosine RNA Methylation, YTH Domain Family 2, in Liver Hepatocellular Carcinoma.
Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy.
Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response.
Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins.
Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
Systematic analysis of differentially methylated expressed genes and site-speci?c methylation as potential prognostic markers in head and neck cancer.
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Systematic analysis of somatic mutations impacting gene expression in 12 tumour types.
Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
Systematic analysis of survival-associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer.
Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer.
Systematic analysis of the function and prognostic value of RNA binding protein in head and neck squamous cell carcinoma.
Systematic analysis of the function and prognostic value of RNA binding proteins in Colon Adenocarcinoma.
Systematic analysis of the intersection of disease mutations with protein modifications.
Systematic analysis reveals a functional role for STAMBPL1 in the epithelial-mesenchymal transition process across multiple carcinomas.
Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
Systematic analysis using a bioinformatics strategy identifies SFTA1P and LINC00519 as potential prognostic biomarkers for lung squamous cell carcinoma.
Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma.
Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data.
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population.
Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma.
Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
Systematic construction and validation of an immune prognostic model for lung adenocarcinoma.
Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma.
Systematic discovery of the functional impact of somatic genome alterations in individual tumors through tumor-specific causal inference.
Systematic dissection of dysregulated transcription factor-miRNA feed-forward loops across tumor types.
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer.
Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts.
Systematic evaluation of the effects of genetic variants on PIWI-interacting RNA expression across 33 cancer types.
Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell Carcinoma.
Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma.
Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma.
Systematic functional interrogation of human pseudogenes using CRISPRi.
Systematic genetic analysis identifies Cis-eQTL target genes associated with glioblastoma patient survival.
Systematic Identification and Assessment of Therapeutic Targets for Breast Cancer Based on Genome-Wide RNA Interference Transcriptomes.
Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma.
Systematic identification of dysregulated lncRNAs associated with platinum-based chemotherapy response across 11 cancer types.
Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
Systematic Identification of Survival-Associated Alternative Splicing Events in Kidney Renal Clear Cell Carcinoma.
Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer.
Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers.
Systematic mutation analysis in rare colorectal cancer presenting ovarian metastases.
Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Systematic pan-cancer analysis of somatic allele frequency.
Systematic pan-cancer analysis of tumour purity.
Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment.
Systematic prediction of key genes for ovarian cancer by co-expression network analysis.
Systematic prediction of the biological functions of TAS2R10 using positive co-expression analysis.
Systematic Prioritization of Druggable Mutations in ?5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach.
Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
Systematic profiling identifies PDLIM2 as a novel prognostic predictor for oesophageal squamous cell carcinoma (ESCC).
Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significance.
Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
Systematic profiling of diagnostic and prognostic value of autophagy-related genes for sarcoma patients.
Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma.
Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Systematic profiling of invasion-related gene signature predicts prognostic features of lung adenocarcinoma.
Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.
Systematic screening identifies a TEAD4-S100A13 axis modulating cisplatin sensitivity of oral squamous cell carcinoma cells.
Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells.
Systematical Analysis of the Cancer Genome Atlas Database Reveals EMCN/MUC15 Combination as a Prognostic Signature for Gastric Cancer.
Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.
Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Systematically Characterizing A-to-I RNA Editing Neoantigens in Cancer.
Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma.
Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity.
Systemic Analysis of the Prognosis-Associated Alternative Polyadenylation Events in Breast Cancer.
Systemic Analysis of the Prognosis-Related RNA Alternative Splicing Signals in Melanoma.
Systemic Expression Analysis Reveals Prognostic Significance of WIPI3 in Hepatocellular Carcinoma.
Systemic screening identifies GABRD, a subunit gene of GABAA receptor as a prognostic marker in adult IDH wild-type diffuse low-grade glioma.
Systems analysis of barrier molecule and ARNT-related gene expression regulation in melanoma.
Systems biology analysis reveals new insights into invasive lung cancer.
T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme.
T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-? VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
T-Cell Deletion of MyD88 Connects IL17 and I?B? to RAS Oncogenesis.
T-Cell Exhaustion Status Under High and Low Levels of Hypoxia-Inducible Factor 1? Expression in Glioma.
T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma.
T-cell receptors provide potential prognostic signatures for breast cancer.
TAFA5 promotes proliferation and migration in gastric cancer.
TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Taking pan-cancer analysis global.
Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival.
Tamoxifen therapy benefit predictive signature combining with prognostic signature in surgical-only ER-positive breast cancer.
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors.
Tandem histone methyltransferase upregulation defines a unique aggressive prostate cancer phenotype.
Tankyrases/?-catenin Signaling Pathway as an Anti-proliferation and Anti-metastatic Target in Hepatocarcinoma Cell Lines.
TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer.
TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes.
Tapping microRNA regulation networks through integrated analysis of microRNA-mRNA high-throughput profiles.
Target definition in prostate, head, and neck.
Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
Target identification reveals lanosterol synthase as a vulnerability in glioma.
Targetable alterations in invasive pleomorphic lobular carcinoma of the breast.
Targetable T-type Calcium Channels Drive Glioblastoma.
Targeted assessment of G0S2 methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma.
Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Targeted cancer therapy--are the days of systemic chemotherapy numbered?
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer.
Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer.
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.
Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.
Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification.
Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies are Uncommon.
Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade.
Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population.
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.
Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer.
Targeted Proteomics-Based Quantitative Protein Atlas of Pannexin and Connexin Subtypes in Mouse and Human Tissues and Cancer Cell Lines.
Targeted Therapies in Melanoma.
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
Targeted therapies in the treatment of urothelial cancers.
Targeted therapy for upper gastrointestinal tract cancer: current and future prospects.
Targeted therapy: its status and promise in selected solid tumors. Part II: Impact on selected tumor subsets, and areas of evolving integration.
Targeted variant detection using unaligned RNA-Seq reads.
Targeting 14-3-3? Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling.
Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma.
Targeting c-MYC in Platinum-Resistant Ovarian Cancer.
Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas.
Targeting cholangiocarcinoma.
Targeting CMTM6 Suppresses Stem Cell-Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma.
Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer.
Targeting deubiquitinating enzyme USP26 by microRNA-203 regulates Snail1's pro-metastatic functions in esophageal cancer.
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer.
Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/?-catenin pathway in pancreatic cancer cells.
Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis.
Targeting molecular aberrations in urothelial carcinoma.
Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma.
Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy.
Targeting of TGF? signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma.
Targeting of TLE3 by miR-3677 in human breast cancer promotes cell proliferation, migration and invasion.
Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1.
Targeting Protein Kinase CK2 Suppresses Pro-survival Signaling Pathways and Growth of Glioblastoma.
Targeting RGS4 Ablates Glioblastoma Proliferation.
Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma.
Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in PIK3CA-Mutant Lung Squamous Cell Carcinoma.
Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744.
Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy.
Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
Targeting triglyceride metabolism for colorectal cancer prevention and therapy.
Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro.
Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2.
TBX5-AS1, an enhancer RNA, is a potential novel prognostic biomarker for lung adenocarcinoma.
TC3A: The Cancer 3' UTR Atlas.
TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1.
TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression.
TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer.
TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients.
TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma.
TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.
TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis.
TCGA dataset screening for genes implicated in endometrial cancer using RNA-seq profiling.
TCGA dataset?based construction and integrated analysis of aberrantly expressed long non?coding RNA mediated competing endogenous RNA network in gastric cancer.
TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics.
TCGA Expedition: A Data Acquisition and Management System for TCGA Data.
TCGA Findings Spotlight Drivers for Colorectal Cancer.
TCGA finds thyroid cancer drivers, subtypes.
TCGA molecular groups of endometrial cancer: Pooled data about prognosis.
TCGA molecular subgroups and FIGO grade in endometrial endometrioid carcinoma.
TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.
TCGA Pan-Cancer Genomic Analysis of Alternative Lengthening of Telomeres (ALT) Related Genes.
TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages.
TCGA-Assembler 2: Software Pipeline for Retrieval and Processing of TCGA/CPTAC Data.
TCGA-TCIA Impact on Radiogenomics Cancer Research: A Systematic Review.
TCGA-TCIA-Based CT Radiomics Study for Noninvasively Predicting Epstein-Barr Virus Status in Gastric Cancer.
TCGA2BED: extracting, extending, integrating, and querying The Cancer Genome Atlas.
TCGA2STAT: simple TCGA data access for integrated statistical analysis in R.
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data.
TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data.
TDO2 knockdown inhibits colorectal cancer progression via TDO2-KYNU-AhR pathway.
TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer.
TEAD2 as a novel prognostic factor for hepatocellular carcinoma.
TEAD4 is a novel independent predictor of prognosis in LGG patients with IDH mutation.
TEK is a novel prognostic marker for clear cell renal cell carcinoma.
Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors.
Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Telomere Length Variation in Tumor cells and Cancer-Associated Fibroblasts: Potential Biomarker for Hepatocellular Carcinoma.
Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).
Telomeric zinc-finger associated protein (TZAP) in cancer biology: friend or foe?
Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43.
Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma.
Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases.
Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas.
TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma.
TESC Promotes TGF-?/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma.
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients.
Testing equality of means in partially paired data with incompleteness in single response.
Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.
TET1 promotes malignant progression of cholangiocarcinoma with IDH1 wild-type.
TET2 binds the androgen receptor and loss is associated with prostate cancer.
Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma.
TFAP2A is a novel regulator that modulates ferroptosis in gallbladder carcinoma cells via the Nrf2 signalling axis.
TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.
TFF2-CXCR4 Axis Is Associated with BRAF V600E Colon Cancer.
TFPI2 Promotes Perivascular Migration in an Angiotropism Model of Melanoma.
TGF-? receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-?/SMAD4 signaling pathway.
TGF-? signaling in liver and gastrointestinal cancers.
TGF? isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications.
TGF?1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma.
TGF?1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.
TGF?1: An Indicator for Tumor Immune Microenvironment of Colon Cancer From a Comprehensive Analysis of TCGA.
TGF?2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer.
TGF?2-mediated epithelial-mesenchymal transition and NF-?B pathway activation contribute to osimertinib resistance.
TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
TGM4: an immunogenic prostate-restricted antigen.
Th2 cell infiltrations predict neoadjuvant chemotherapy response of estrogen receptor-positive breast cancer.
THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.
The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers.
The 2nd Conference and Workshop of The Cancer Genome Atlas (TCGA) in India: Towards Team Science for Multi-omics Cancer Research in South Asia.
The ?-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis.
The ability of human nuclear DNA to cause false positive low-abundance heteroplasmy calls varies across the mitochondrial genome.
The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance.
The ADRB1 (Adrenoceptor Beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer.
The Aged Microenvironment Influences the Tumorigenic Potential of Malignant Prostate Epithelial Cells.
The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro.
The Analysis of Gene Expression Data Incorporating Tumor Purity Information.
The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
The analysis of surgical prognostic factors and molecular typing of locally advanced lung squamous cell carcinomas.
The androgen receptor expression and association with patient's survival in different cancers.
The androgen receptor expression and its activity have different relationships with prognosis in hepatocellular carcinoma.
The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinoma.
The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma.
The Art and Science of Thyroid Surgery in the Age of Genomics: 100 years after Theodor Kocher.
The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.
The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets.
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma.
The Association between TIF1 Family Members and Cancer Stemness in Solid Tumors.
The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer.
The Association of Long Non-Coding RNA SNHG6 Expression with Clinicopathological Features and Prognosis in Cancer.
The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network.
The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma.
The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma.
The Association of Serum IL-33 and sST2 with Breast Cancer.
The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity.
The Atlas of Tumor Pathology.
The Australian experience with the Bethesda classification system for thyroid fine needle aspiration biopsies.
The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach.
The basic pathology of human breast cancer.
The Beneficial Role of Sunitinib in Tumor Immune Surveillance by Regulating Tumor PD-L1.
The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi-omics data.
The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer.
The biobank of barretos cancer hospital: 14 years of experience in cancer research.
The Biological Function Delineated Across Pan-Cancer Levels Through lncRNA-Based Prognostic Risk Assessment Factors for Pancreatic Cancer.
The biological functions of target genes in pan-cancers and cell lines were predicted by miR-375 microarray data from GEO database and bioinformatics.
The Biological Role of Sponge Circular RNAs in Gastric Cancer: Main Players or Coadjuvants?
The BIRC Family Genes Expression in Patients with Triple Negative Breast Cancer.
The brave new world of endometrial cancer : Future implications for adjuvant treatment decisions.
The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool.
The Burden of Post-Translational Modification (PTM)-Disrupting Mutations in the Tumor Matrisome.
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
The Cancer Editome Atlas: A Resource for Exploratory Analysis of the Adenosine-to-Inosine RNA Editome in Cancer.
The Cancer Genome Atlas (TCGA) based m6A methylation-related genes predict prognosis in hepatocellular carcinoma.
The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.
The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma.
The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical-genomic driver associations.
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: focusing on T cells.
The Cancer Genome Atlas expression profiles of low-grade gliomas.
The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability.
The Cancer Genome Atlas findings in head and neck cancer: a renewed hope.
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
The Cancer Genome Atlas Pan-Cancer analysis project.
The Cancer Genome Atlas Project in Bladder Cancer.
The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer.
The Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma.
The cancer genome atlas research network: a sight to behold.
The Cancer Genome Atlas: clinical applications for breast cancer.
The Cancer Genome Atlas: Creating Lasting Value beyond Its Data.
The cancer genome atlas: new weapon in old war?
The Cancer Genomics Cloud: Collaborative, Reproducible, and Democratized-A New Paradigm in Large-Scale Computational Research.
The Cancer Genomics Hub (CGHub): overcoming cancer through the power of torrential data.
The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants.
The Cancer Omics Atlas: an integrative resource for cancer omics annotations.
The cancer-testis gene, MEIOB, sensitizes triple-negative breast cancer to PARP1 inhibitors by inducing homologous recombination deficiency.
The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells.
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination.
The chromatin accessibility landscape of primary human cancers.
The chromosome 19 microRNA cluster, regulated by promoter hypomethylation, is associated with tumour burden and poor prognosis in patients with hepatocellular carcinoma.
The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma.
The clinical and biological significance of MICA in clear cell renal cell carcinoma patients.
The Clinical and Molecular Characterization of Gastric Cancer Patients in Qinghai-Tibetan Plateau.
The clinical and prognostic significance of paraoxonase-2 in gastric cancer patients: immunohistochemical analysis.
The clinical applications of The Cancer Genome Atlas project for bladder cancer.
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine.
The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer.
The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma.
The clinical significance of CCBE1 expression in human colorectal cancer.
The clinical significance of collagen family gene expression in esophageal squamous cell carcinoma.
The clinical significance of endothelin receptor type B in hepatocellular carcinoma and its potential molecular mechanism.
The clinical significance of glutathione peroxidase 2 in glioblastoma multiforme.
The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.
The clinical significance of Interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.
The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
The clinical significance of PYCR1 expression in renal cell carcinoma.
The clinical value of Fibulin-1 for prognosis and its prospective mechanism in intrahepatic cholangiocarcinoma.
The clinical value of miR-193a-3p in non-small cell lung cancer and its potential molecular mechanism explored
The clinicomolecular landscape of de novo versus relapsed stage IV metastatic breast cancer.
The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data.
The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study.
The Clinicopathological Significance and Correlative Signaling Pathways of an Autophagy-Related Gene, Ambra1, in Breast Cancer: a Study of 25 Microarray RNA-Seq Datasets and in-House Gene Silencing.
The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer.
The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data.
The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3? pathway in non-small cell lung cancer.
The Combination of Low Skeletal Muscle Mass and High Tumor Interleukin-6 Associates with Decreased Survival in Clear Cell Renal Cell Carcinoma.
The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer.
The construction and analysis of a ferroptosis-related gene prognostic signature for pancreatic cancer.
The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas.
The construction and analysis of competitive endogenous RNA (ceRNA) networks in metastatic renal cell carcinoma: a study based on The Cancer Genome Atlas.
The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer.
The Construction and Analysis of Tumor-Infiltrating Immune Cells and ceRNA Networks in Bladder Cancer.
The Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Bone Metastatic Melanoma.
The Construction and Comprehensive Prognostic Analysis of the LncRNA-Associated Competitive Endogenous RNAs Network in Colorectal Cancer.
The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
The contribution of molecular pathology to the classification of thyroid tumors.
The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas.
The converging roles of Batten disease proteins in neurodegeneration and cancer.
The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101.
The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer.
The cox-filter method identifies respective subtype-specific lncRNA prognostic signatures for two human cancers.
The CPTAC Data Portal: A Resource for Cancer Proteomics Research.
The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.
The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death.
The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
The Development of Three-DNA Methylation Signature as a Novel Prognostic Biomarker in Patients with Colorectal Cancer.
The diagnosis and prognosis values of WNT mRNA expression in colon adenocarcinoma.
The diagnosis of neoplasm in Matthew Baillie's atlas of anatomy (1812).
The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma.
The diagnostic and prognostic significance of long non-coding RNA CRNDE in pan-cancer based on TCGA, GEO and comprehensive meta-analysis.
The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates Colorectal Carcinogenesis and Prognosis.
The discovery of a novel eight-mRNA-lncRNA signature predicting survival of hepatocellular carcinoma patients.
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
The dJ/dS Ratio Test Reveals Hundreds of Novel Putative Cancer Drivers.
The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
The Doppelgänger Effect: Hidden Duplicates in Databases of Transcriptome Profiles.
The downregulated long noncoding RNA DHRS4-AS1 is protumoral and associated with the prognosis of clear cell renal cell carcinoma.
The Downregulation of eIF3a Contributes to Vemurafenib Resistance in Melanoma by Activating ERK via PPP2R1B.
The Dysregulated Expression of KCNQ1OT1 and Its Interaction with Downstream Factors miR-145/CCNE2 in Breast Cancer Cells.
The Early Diagnostic and Prognostic Value of BIRC5 in Clear-Cell Renal Cell Carcinoma Based on the Cancer Genome Atlas Data.
The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
The Ecology and Evolution of Cancer: The Ultra-Microevolutionary Process.
The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer.
The effect of glioblastoma heterogeneity on survival stratification: a multimodal MR imaging texture analysis.
The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds.
The effects of alternative splicing on miRNA binding sites in bladder cancer.
The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.
The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer-The Impact in Intratumoral Heterogeneity.
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancer.
The Emergence of Pan-Cancer CIMP and Its Elusive Interpretation.
The Emerging Role of Cytoskeletal Proteins as Reliable Biomarkers.
The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer.
The ERR?-VDR axis promotes calcitriol degradation and estrogen signaling in breast cancer cells, while VDR-CYP24A1-ERR? overexpression correlates with poor prognosis in patients with basal-like breast cancer.
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
The essential role of MTDH in the progression of HCC: a study with immunohistochemistry, TCGA, meta-analysis and in vitro investigation.
The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia.
The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future.
The evolutionary history of 2,658 cancers.
The evolving genomic landscape in urothelial cancer.
The evolving genomic landscape of urothelial carcinoma.
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response.
The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer.
The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC).
The exploration of new therapeutic targets for HPV-negative head and neck squamous cell cancer through the construction of a ceRNA network and immune microenvironment analysis.
The expression and biological information analysis of miR-375-3p in head and neck squamous cell carcinoma based on 1825 samples from GEO, TCGA, and peer-reviewed publications.
The Expression and Effection of MicroRNA-499a in High-Tobacco Exposed Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
The Expression and Prognostic Impact of Immune Cytolytic Activity-Related Markers in Human Malignancies: A Comprehensive Meta-analysis.
The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma.
The Expression and Prognostic Roles of MCMs in Pancreatic Cancer.
The Expression and Prognostic Significance of Claudin-8 and Androgen Receptor in Breast Cancer.
The expression and prognostic significance of Drp1 in lung cancer: A bioinformatics analysis and immunohistochemistry.
The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study.
The Expression and Therapeutic Potential of Checkpoint Kinase 2 in Laryngeal Squamous Cell Carcinoma.
The expression change of OTUD3-PTEN signaling axis in glioma cells.
The expression characteristics and prognostic roles of autophagy-related genes in gastric cancer.
The expression landscape of cachexia-inducing factors in human cancers.
The Expression Level of PD-L1 (CD274) mRNA in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
The expression level of small non-coding RNAs derived from the first exon of protein-coding genes is predictive of cancer status.
The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction.
The expression of long noncoding RNA CRCAL-3 in colorectal cancer and its impacts on cell proliferation and migration.
The expression of miR-375 in prostate cancer: A study based on GEO, TCGA data and bioinformatics analysis.
The Expression of PD-L1 and B7-H4 in Thymic Epithelial Tumor and Its Relationship With Tumor Immune-Infiltrating Cells.
The expression of SALL4 in patients with gliomas: high level of SALL4 expression is correlated with poor outcome.
The Expression of the SLIT-ROBO Family in Adult Patients with Acute Myeloid Leukemia.
The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathway.
The Expression of Tripartite Motif Protein 36 and ?-Catenin Correlates with the Prognosis of Esophageal Cancer.
The expression patterns and the diagnostic/prognostic roles of PTPN family members in digestive tract cancers.
The Expression Profiles of ADME Genes in Human Cancers and Their Associations with Clinical Outcomes.
The expression signature of cancer-associated KRAB-ZNF factors identified in TCGA pan-cancer transcriptomic data.
The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p.
The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
The extracellular matrix: Tools and insights for the "omics" era.
The Forgotten YY2 in Reported YY1 Expression Levels in Human Cancers.
The FOXC1/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect.
The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness.
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis.
The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer.
The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy.
The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor.
The future of the Atlas of Tumor Pathology.
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
The GALNT6?LGALS3BP axis promotes breast cancer cell growth.
The Gasdermin E Gene Has Potential as a Pan-Cancer Biomarker, While Discriminating between Different Tumor Types.
The genetic and pharmacogenomic landscape of snoRNAs in human cancer.
The genetic landscape of endometrial clear cell carcinomas.
The genetic landscape of programmed death ligand-1 (PD-L1) alterations in head and neck cancer.
The genetic landscapes of urological cancers and their clinical implications in the era of high-throughput genome analysis.
The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer.
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.
The genomic landscape of cutaneous melanoma.
The Genomic Landscape of Lobular Breast Cancer.
The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma.
The genomic map of breast cancer: which roads lead to better targeted therapies?
The Germline Variants rs61757955 and rs34988193 Are Predictive of Survival in Lower Grade Glioma Patients.
The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.
The GNAQ T96S Mutation Affects Cell Signaling and Enhances the Oncogenic Properties of Hepatocellular Carcinoma.
The head and neck cancer immune landscape and its immunotherapeutic implications.
The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma.
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.
The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
The histologic features of musculoskeletal tumors.
The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 in and Promotes Tumorigenesis in Mice.
The Human Cancer Pathology Atlas: An open-access source for more than 900,000 Kaplan-Meier plots and 5 million cancer tissue images.
The human genome project: big science transforms biology and medicine.
The human intermediate prolactin receptor is a mammary proto-oncogene.
The human nucleophosmin 1 mutation A inhibits myeloid differentiation of leukemia cells by modulating miR-10b.
The Human Protein Atlas as a proteomic resource for biomarker discovery.
The Human Protein Atlas-Spatial localization of the human proteome in health and disease.
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
The identification of autophagy-related genes in the prognosis of oral squamous cell carcinoma.
The Identification of Critical m6A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma.
The Identification of Differentially Expressed Genes Showing Aberrant Methylation Patterns in Pheochromocytoma by Integrated Bioinformatics Analysis.
The Identification of Key Gene Expression Signature in Prostate Cancer.
The Identification of Stemness-Related Genes in the Risk of Head and Neck Squamous Cell Carcinoma.
The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma.
The IL1?-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma.
The Immune Heterogeneity Between Pulmonary Adenocarcinoma and Squamous Cell Carcinoma: A Comprehensive Analysis Based on lncRNA Model.
The Immune Landscape and Prognostic Immune Key Genes Potentially Involved in Modulating Synaptic Functions in Prostate Cancer.
The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade.
The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.
The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
The Immune Subtypes and Landscape of Squamous Cell Carcinoma.
The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers.
The immune-related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation.
The immune-related gene CD52 is a favorable biomarker for breast cancer prognosis.
The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
The Impact of Age and Sex in DLBCL: Systems Biology Analyses Identify Distinct Molecular Changes and Signaling Networks.
The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples.
The impact of HER2 overexpression on the miRNA and circRNA transcriptomes in two breast cell lines and their vesicles.
The impact of high co-expression of Sp1 and HIF1? on prognosis of patients with hepatocellular cancer.
The impact of MCM6 on hepatocellular carcinoma in a Southern Chinese Zhuang population.
The Impact of MicroRNA-133a on Prognosis and Clinicopathological Parameters for Digestive System Cancers: a Comprehensive Study Based on Meta-Analysis and TCGA Database.
The Impact of Normalization Approaches to Automatically Detect Radiogenomic Phenotypes Characterizing Breast Cancer Receptors Status.
The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC.
The impact of pharmacokinetic gene profiles across human cancers.
The impact of site-specific digital histology signatures on deep learning model accuracy and bias.
The impact of the Cancer Genome Atlas on lung cancer.
The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis.
The Importance of Sex in the Discovery of Colorectal Cancer Prognostic Biomarkers.
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer.
The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
The integration of differentially expressed genes based on multiple microarray datasets for prediction of the prognosis in oral squamous cell carcinoma.
The Integrative Analysis Identifies Three Cancer Subtypes and Stemness Features in Cutaneous Melanoma.
The integrative epigenomic-transcriptomic landscape of ER positive breast cancer.
The integrative knowledge base for miRNA-mRNA expression in colorectal cancer.
The interactive Web-based histology atlas system.
The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma.
The ISB Cancer Genomics Cloud: A Flexible Cloud-Based Platform for Cancer Genomics Research.
The journey of personalizing gastric cancer treatment.
The Landscape and Implications of Chimeric RNAs in Cervical Cancer.
The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer.
The landscape and prognostic value of tumor-infiltrating immune cells in gastric cancer.
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas.
The Landscape of Chromosome Instability in Breast Cancers and Associations with the Tumor Mutation Burden: An Analysis of Data from TCGA.
The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma.
The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
The landscape of kinase fusions in cancer.
The Landscape of Long Non-Coding RNA Dysregulation and Clinical Relevance in Muscle Invasive Bladder Urothelial Carcinoma.
The landscape of miRNA-related ceRNA networks for marking different renal cell carcinoma subtypes.
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.
The landscape of the mesenchymal signature in brain tumours.
The landscape of viral expression and host gene fusion and adaptation in human cancer.
The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas.
The level of zinc finger of the cerebellum 2 is predictive of overall survival in clear cell renal cell carcinoma.
The LIM Protein Ajuba Augments Tumor Metastasis in Colon Cancer.
The lipid peroxidation product EKODE exacerbates colonic inflammation and colon tumorigenesis.
The Liver Microbiome Is Implicated in Cancer Prognosis and Modulated by Alcohol and Hepatitis B.
The LncRNA AL161431.1 targets miR-1252-5p and facilitates cellular proliferation and migration via MAPK signaling in endometrial carcinoma.
The lncRNA myocardial infarction associated transcript-centric competing endogenous RNA network in non-small-cell lung cancer.
The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2.
The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
The lncRNAs LINC00261 and LINC00665 are upregulated in long-term prostate cancer adaptation after radiotherapy.
The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.
The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer.
The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway.
The long non-coding RNA SNHG12 promotes gastric cancer by activating the phosphatidylinositol 3-kinase/AKT pathway.
The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma.
The Long Noncoding RNA ZFAS1 Potentiates the Development of Hepatocellular Carcinoma via the microRNA-624/MDK/ERK/JNK/P38 Signaling Pathway.
The Long Noncoding RNA, LINC01555, Promotes Invasion and Metastasis of Colorectal Cancer by Activating the Neuropeptide, Neuromedin U.
The Long-To-Short-Axis Ratio and Multifocality are Associated With TP53 Mutation Status in Surgically Resected Hepatocellular Carcinomas.
The loss of nuclear expression of single-stranded DNA binding protein 2 of gastric adenocarcinoma and its prognostic role: Analysis of molecular subtype.
The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma.
The Lung Cancer Associated MicroRNAs and Single Nucleotides Polymorphisms: a Mendelian Randomization Analysis.
The LZIP: A Bayesian latent factor model for correlated zero-inflated counts.
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients.
The m6A-related gene signature for predicting the prognosis of breast cancer.
The m6A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients.
The magnitude of cancer breast in India: a summary.
The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA Export.
The management of localized esophageal squamous cell carcinoma: Western approach.
The Matrisome Genes From Hepatitis B-Related Hepatocellular Carcinoma Unveiled.
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer.
The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
The microcosmos of intratumor heterogeneity: the space-time of cancer evolution.
The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
The miR-106b/NR2F2-AS1/PLEKHO2 Axis Regulates Migration and Invasion of Colorectal Cancer through the MAPK Pathway.
The miR-183/182/96 cluster functions as a potential carcinogenic factor and prognostic factor in kidney renal clear cell carcinoma.
The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
The miR-503 cluster is coordinately under-expressed in endometrial endometrioid adenocarcinoma and targets many oncogenes, cell cycle genes, DNA repair genes and chemotherapy response genes.
The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.
The mir-767-105 cluster: a crucial factor related to the poor prognosis of hepatocellular carcinoma.
The miRNA, miR-125b, Inhibited Invasion and Metastasis of Gastric-Cancer Cells by Triggering the STAT3 Signaling Pathway.
The mitochondrial fission factor FIS1 promotes stemness of human lung cancer stem cells via mitophagy.
The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
The modulation relationship of genomic pattern of intratumor heterogeneity and immunity microenvironment heterogeneity in hepatocellular carcinoma.
The modulatory properties of Astragalus membranaceus treatment on endometrial cancer: an integrated pharmacological method.
The molecular basis of breast cancer pathological phenotypes.
The Molecular Biologic Basis of Esophageal and Gastric Cancers.
The Molecular Context of Vulnerability for CDK9 Suppression in Triple Wild-Type Melanoma.
The Molecular Effects of a High Fat Diet on Endometrial Tumour Biology.
The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment.
The molecular landscape of head and neck cancer.
The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.
The molecular profile of luminal B breast cancer.
The Molecular Taxonomy of Primary Prostate Cancer.
The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis.
The MS-lincRNA landscape reveals a novel lincRNA BCLIN25 that contributes to tumorigenesis by upregulating ERBB2 expression via epigenetic modification and RNA-RNA interactions in breast cancer.
The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.
The mutational landscape of endometrial cancer.
The mutational landscape of phosphorylation signaling in cancer.
The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role.
The mutational spectrum of squamous-cell carcinoma of the head and neck: Targetable genetic events and clinical impact.
The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.
The NANOTUMOR consortium - Towards the Tumor Cell Atlas.
The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2.
The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.
The Neurogenic Compound P7C3 Regulates the Aerobic Glycolysis by Targeting Phosphoglycerate Kinase 1 in Glioma.
The New Paradigm of Network Medicine to Analyze Breast Cancer Phenotypes.
The new United States Cancer Atlas.
The new world of poly-(ADP)-ribose polymerase inhibitors (PARPi) used in the treatment of gynecological cancers.
The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment.
The NF-?B signalling pathway regulates GLUT6 expression in endometrial cancer.
The nine ADAMs family members serve as potential biomarkers for immune infiltration in pancreatic adenocarcinoma.
The non-coding landscape of head and neck squamous cell carcinoma.
The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma.
The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.
The Nuclear Receptor Signaling Atlas: development of a functional atlas of nuclear receptors.
The nucleolar-related protein Dyskerin pseudouridine synthase 1 (DKC1) predicts poor prognosis in breast cancer.
The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.
The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis.
The Opposing Roles of PIK3R1/p85? and PIK3R2/p85? in Cancer.
The Outer Retinal Membrane Protein 1 Could Inhibit Lung Cancer Progression as a Tumor Suppressor.
The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma.
The overexpression of GRASP might inhibit cell proliferation and invasion in hepatocellular carcinoma.
The Overexpression of NMHC IIA Promoted Invasion and Metastasis of Nasopharyngeal Carcinoma Cells.
The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance.
The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes.
The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
The Pan-Cancer Atlas: a New Chapter in Cancer Molecular Targeting Therapy.
The pan-cancer landscape of prognostic germline variants in 10,582 patients.
The Pancancer DNA Methylation Trackhub: A Window to The Cancer Genome Atlas Epigenomics Data.
The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers.
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
The PD-L1 metabolic interactome intersects with choline metabolism and inflammation.
The PeptideAtlas of the Domestic Laying Hen.
The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma.
The Pharmacological Effects of Spatholobi Caulis Tannin in Cervical Cancer and Its Precise Therapeutic Effect on Related circRNA.
The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma.
The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells.
The polyoma virus large T binding protein p150 is a transcriptional repressor of c-MYC.
The possible roles of B-cell novel protein-1 (BCNP1) in cellular signalling pathways and in cancer.
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
The Potential of Five Immune-Related Prognostic Genes to Predict Survival and Response to Immune Checkpoint Inhibitors for Soft Tissue Sarcomas Based on Multi-Omic Study.
The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.
The PreCancer Atlas (PCA).
The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer.
The prediction of survival in Gastric Cancer based on a Robust 13-Gene Signature.
The Prediction of Survival in Hepatocellular Carcinoma Based on A Four Long Non-coding RNAs Expression Signature.
The predictive value of RNA binding proteins in colon adenocarcinoma.
The presence of TIM-3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status.
The presence of tumour-infiltrating neutrophils is an independent adverse prognostic feature in clear cell renal cell carcinoma.
The prevalence of DICER1 pathogenic variation in population databases.
The prevalence of germline DICER1 pathogenic variation in cancer populations.
The prognosis of glioblastoma: a large, multifactorial study.
The prognostic and diagnostic value of tissue inhibitor of metalloproteinases gene family and potential function in gastric cancer.
The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?
The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma.
The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer.
The prognostic landscape of tumor-infiltrating immune cells in lung squamous cell carcinoma.
The prognostic potential of alpha-1 type I collagen expression in papillary thyroid cancer.
The prognostic potential of alternative transcript isoforms across human tumors.
The prognostic role of FZD6 in esophageal squamous cell carcinoma patients.
The Prognostic Role of Glutathione Peroxidase 1 and Immune Infiltrates in Glioma Investigated Using Public Datasets.
The prognostic role of the Transducin-like Enhancer of split protein family in lung adenocarcinoma.
The Prognostic Signature and Potential Target Genes of Six Long Non-coding RNA in Laryngeal Squamous Cell Carcinoma.
The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
The prognostic significance of fibroblast activation protein-? in human lung adenocarcinoma.
The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer genome atlas.
The Prognostic Significance of Immune-Related Metabolic Enzyme MTHFD2 in Head and Neck Squamous Cell Carcinoma.
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.
The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia.
The Prognostic Value and Function of HOXB5 in Acute Myeloid Leukemia.
The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
The prognostic value of ADRA1 subfamily genes in gastric carcinoma.
The prognostic value of circular RNA regulatory genes in competitive endogenous RNA network in gastric cancer.
The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma.
The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma.
The Prognostic Value of EMT in Glioma and its Role in the Glioma Immune Microenvironment.
The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma.
The prognostic value of LINC01296 in pan-cancers and the molecular regulatory mechanism in hepatocellular carcinoma: a comprehensive study based on data mining, bioinformatics, and in vitro validation.
The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer.
The prognostic value of lncRNA SNHG6 in cancer patients.
The prognostic value of long non-coding RNA H19 in various cancers: A meta-analysis based on 15 studies with 1584 patients and the Cancer Genome Atlas data.
The prognostic value of long noncoding RNA SNHG16 on clinical outcomes in human cancers: a systematic review and meta-analysis.
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
The prognostic value of matrix metalloproteinase-7 and matrix metalloproteinase-15 in acute myeloid leukemia.
The prognostic value of Piezo1 in breast cancer patients with various clinicopathological features.
The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma.
The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma.
The Prognostic Value of the Expression of SMC4 mRNA in Breast Cancer.
The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base.
The Prognostic Value of Tumor Mutation Burden and Immune Cell Infiltration in Thymic Epithelial Tumors.
The prognostic value of tumor mutation burden in EGFR-mutant advanced lung adenocarcinoma, an analysis based on cBioPortal data base.
The prognostic values of matrix metalloproteinases in ovarian cancer.
The prognostic values of the peroxiredoxins family in ovarian cancer.
The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas.
The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-?/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer.
The protective value of miR-204-5p for prognosis and its potential gene network in various malignancies: a comprehensive exploration based on RNA-seq high-throughput data and bioinformatics.
The Proteomic Landscape of Growth Factor Signaling Networks Associated with FAT1 Mutations in Head and Neck Cancers.
The pseudogene PRELID1P6 promotes glioma progression via the hnHNPH1-Akt/mTOR axis.
The pseudogene-derived long noncoding RNA SFTA1P is down-regulated and suppresses cell migration and invasion in lung adenocarcinoma.
The PVT1/miR-612/CENP-H/CDK1 axis promotes malignant progression of advanced endometrial cancer.
The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas.
The radiosensitivity index predicts for overall survival in glioblastoma.
The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinoma.
The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer.
The relationship among Girdin DNA methylation, its high expression, and immune infiltration in hepatocellular carcinoma: Clues from in silico analysis.
The relationship between autophagy-related genes and the staging and prognosis of thyroid cancer: a bioinformatics analysis.
The Relationship Between Mismatch Repair Deficiency and PD-L1 Expression in Breast Carcinoma.
The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.
The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA).
The repertoire of mutational signatures in human cancer.
The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression.
The RNA-Binding Protein DDX18 Promotes Gastric Cancer by Affecting the Maturation of MicroRNA-21.
The role of an immune signature for prognosis and immunotherapy response in endometrial cancer.
The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia.
The role of bile acid subtypes in the diagnosis of cholangiocarcinoma.
The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling.
The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer.
The Role of Cholesterol in Cancer.
The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors.
The Role of Early Growth Response Family Members 1-4 in Prognostic Value of Breast Cancer.
The Role of ERO1? in Modulating Cancer Progression and Immune Escape.
The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer.
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
The Role of Fibroblast Growth Factor 19 in Hepatocellular Carcinoma.
The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
The role of Glial cell derived neurotrophic factor in head and neck cancer.
The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
The Role of Interleukin-33 in Head and Neck Squamous Cell Carcinoma Is Determined by Its Cellular Sources in the Tumor Microenvironment.
The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy.
The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics.
The Role of Lysosome-associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane.
The Role of MDM2 Amplification and Overexpression in Tumorigenesis.
The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism.
The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.
The role of miR-485-5p/NUDT1 axis in gastric cancer.
The role of miR-92b in cholangiocarcinoma patients.
The role of mitogen-activated protein targeting in melanoma beyond BRAFV600.
The Role of N6-Methyladenosine Methylation in the Progression of Endometrial Cancer.
The Role of Nrf2 Activity in Cancer Development and Progression.
The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer.
The Role of Upregulated DDX11 as A Potential Prognostic and Diagnostic Biomarker in Lung Adenocarcinoma.
The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study.
The role of visfatin in cancer proliferation, angiogenesis, metastasis, drug resistance and clinical prognosis.
The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer.
The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients.
The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
The shape of gene expression distributions matter: how incorporating distribution shape improves the interpretation of cancer transcriptomic data.
The shortest path is not the one you know: application of biological network resources in precision oncology research.
The signature lncRNAs associated with the lung adenocarcinoma patients prognosis.
The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers.
The silencing of FNDC1 inhibits the tumorigenesis of breast cancer cells via modulation of the PI3K/Akt signaling pathway.
The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization.
The Solute Carrier Family 2 Genes Are Potential Prognostic Biomarkers in Acute Myeloid Leukemia.
The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma.
The somatic mutation landscape of premalignant colorectal adenoma.
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
The Superior Ability of Human BDCA3+ (CD141+) Dendritic Cells (DCs) to Cross-Present Antigens Derived From Necrotic Lung Cancer Cells.
The TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma.
The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer.
The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer.
The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer.
The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
The transcription factor PPAR? is overexpressed and is associated with a favourable prognosis in IDH-wildtype primary glioblastoma.
The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1.
The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.
The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer.
The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia.
The transcriptomic and proteomic landscapes of bone marrow and secondary lymphoid tissues.
The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy.
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.
The tumor suppressive effect of long non-coding RNA FRMD6-AS2 in uteri corpus endometrial carcinoma.
The Tumor Suppressive Roles and Prognostic Values of STEAP Family Members in Breast Cancer.
The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.
The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
The ubiquitin-associated (UBA) domain of SCCRO/DCUN1D1 protein serves as a feedback regulator of biochemical and oncogenic activity.
The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth.
The UCSC Cancer Genomics Browser: update 2011.
The underlying pathophysiology association between the Type 2-diabetic and hepatocellular carcinoma.
The up-regulation of Myb may help mediate EGCG inhibition effect on mouse lung adenocarcinoma.
The Updated AJCC/TNM Staging System for Papillary Thyroid Cancer (8th Edition): From the Perspective of Genomic Analysis.
The upregulation of hypoxia-related miRNA 210 in primary tumor of lymphogenic metastatic prostate cancer.
The upregulation of PYCR2 is associated with aggressive colon cancer progression and a poor prognosis.
The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
The use of global profiling in biomarker development for gliomas.
The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53.
The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.
The utility of regional cancer mortality data for identifying occupations at high risk.
The value of Angipoietin-2 as a biomarker for the prognosis of osteosarcoma: A protocol for systematic review and meta-analysis.
The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors.
The X-linked tumor suppressor TSPX downregulates cancer-drivers/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner.
The Y-linked proto-oncogene TSPY contributes to poor prognosis of the male hepatocellular carcinoma patients by promoting the pro-oncogenic and suppressing the anti-oncogenic gene expression.
The YAP1-NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target.
The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
The ZNF304-integrin axis protects against anoikis in cancer.
Theoretical and in silico Analyses Reveal MYC as a Dynamic Network Biomarker in Colon and Rectal Cancer.
Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer.
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.
Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.
Therapeutic potential of the human endogenous retroviral envelope protein HEMO: a pan-cancer analysis.
Therapeutic relevance of SOX9 stem cell factor in gastric cancer.
Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways.
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models.
Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma.
The DNA methylation landscape of PD-1 (PDCD1) and adjacent lncRNA AC131097.3 in head and neck squamous cell carcinoma.
Thirteenth AACR Special Conference on Cancer Epigenetics.
Thirty biologically interpretable clusters of transcription factors distinguish cancer type.
Three Biomarkers Predict Gastric Cancer Patients' Susceptibility To Fluorouracil-based Chemotherapy.
Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma.
Three differentially expressed miRNAs as potential biomarkers for lung adenocarcinoma prognosis.
Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis.
Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression.
Three-dimensional atlas of lymph node topography based on the visible human data set.
Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma.
Three-microRNA expression signature predicts survival in triple-negative breast cancer.
Threonine Tyrosine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy.
Thrombospondin 2 promotes tumor metastasis by inducing matrix metalloproteinase-13 production in lung cancer cells.
Thrombospondin 2/Toll-Like Receptor 4 Axis Contributes to HIF-1?-Derived Glycolysis in Colorectal Cancer.
Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
Thymosin ? 4 gene silencing decreases stemness and invasiveness in glioblastoma.
Thymosin beta 10 is overexpressed and associated with unfavorable prognosis in hepatocellular carcinoma.
Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.
Tight Junction Protein 1 Dysfunction Contributes to Cell Motility in Bladder Cancer.
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma.
TIGIT-related transcriptome profile and its association with tumor immune microenvironment in breast cancer.
TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation.
Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-?B/STAT3 signalling pathway in breast cancer cells.
Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.
Time-Varying Differential Network Analysis for Revealing Network Rewiring over Cancer Progression.
TIMER2.0 for analysis of tumor-infiltrating immune cells.
TIMP-1-Mediated Chemoresistance via Induction of IL-6 in NSCLC.
TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment.
TissGDB: tissue-specific gene database in cancer.
Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer.
Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma.
Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.
Tissue-specific signaling networks rewired by major somatic mutations in human cancer revealed by proteome-wide discovery.
TLE2 is associated with favorable prognosis and regulates cell growth and gemcitabine sensitivity in pancreatic cancer.
TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways.
TLR2 promotes development and progression of human glioma via enhancing autophagy.
TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth.
TM4SF1 promotes EMT and cancer stemness via the Wnt/?-catenin/SOX2 pathway in colorectal cancer.
TMEM100 induces cell death in non?small cell lung cancer via the activation of autophagy and apoptosis.
TMEM18: A Novel Prognostic Marker in Acute Myeloid Leukemia.
TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.
TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma.
TMEM213 as a novel prognostic and predictive biomarker for patients with lung adenocarcinoma after curative resection: a study based on bioinformatics analysis.
TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.
TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity.
TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma.
TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
TNF-? modulates genome-wide redistribution of ?Np63?/TAp73 and NF-?B cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
TNF-like ligand 1A is associated with progression and prognosis of human gastric cancer.
TNF? signalling predicts poor prognosis of patients with endometrial cancer.
TNFAIP3 inhibits migration and invasion in nasopharyngeal carcinoma by suppressing epithelial mesenchymal transition.
TNFRSF10C copy number variation is associated with metastatic colorectal cancer.
TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma.
TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues.
TNNT1, negatively regulated by miR-873, promotes the progression of colorectal cancer.
TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
To Develop and Validate the Combination of RNA Methylation Regulators for the Prognosis of Patients with Gastric Cancer.
To infinium, and beyond!
Tobacco Smoke and Electronic Cigarette Vapor Alter Enhancer RNA Expression That Can Regulate the Pathogenesis of Lung Squamous Cell Carcinoma.
Tobacco smoking induces metabolic reprogramming of renal cell carcinoma.
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas.
TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
Toll-like receptor 2 (TLR2) is a candidate prognostic factor in testicular germ cell tumors as well as an indicator of immune function in the tumor microenvironment.
Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis.
Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma.
Tools for translational epigenetic studies involving formalin-fixed paraffin-embedded human tissue: applying the Infinium HumanMethyation450 Beadchip assay to large population-based studies.
TOOme: A Novel Computational Framework to Infer Cancer Tissue-of-Origin by Integrating Both Gene Mutation and Expression.
TopFed: TCGA tailored federated query processing and linking to LOD.
Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas.
Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway.
Topological integration of RPPA proteomic data with multi-omics data for survival prediction in breast cancer via pathway activity inference.
Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology.
Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis.
Total copy number variation as a prognostic factor in adult astrocytoma subtypes.
Toward atlas-assisted automatic interpretation of MRI morphological brain scans in the presence of tumor.
Toward predicting metastatic progression of melanoma based on gene expression data.
Toward Recovering Allele-specific Cancer Genome Graphs.
Toward Signaling-Driven Biomarkers Immune to Normal Tissue Contamination.
Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
Towards clinically more relevant dissection of patient heterogeneity via survival-based Bayesian clustering.
Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes.
Toxicogenomic outcomes predictive of forestomach carcinogenesis following exposure to benzo(a)pyrene: Relevance to human cancer risk.
TP53 and CDKN2A mutations in patients with early-stage lung squamous cell carcinoma: an analysis of the correlations and prognostic outcomes.
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.
TP53 isoform junction reads based analysis in malignant and normal contexts.
TP53 loss creates therapeutic vulnerability in colorectal cancer.
TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment.
TP53 Mutation and Extraneural Metastasis of Glioblastoma: Insights From an Institutional Experience and Comprehensive Literature Review.
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma.
TP53 Mutation Related and Directly Regulated lncRNA Prognosis Markers in Hepatocellular Carcinoma.
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.
TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer.
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database.
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial.
TP53 mutations, expression and interaction networks in human cancers.
TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer.
TP53 oncomorphic mutations predict resistance to platinum? and taxane?based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.
TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases.
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors.
TP63 isoform expression is linked with distinct clinical outcomes in cancer.
TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis.
TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer.
TRAF3/CYLD mutations identify a distinct subset of human papilloma virus-associated head and neck squamous cell carcinoma.
Transcript Isoform Variation Associated with Cytosine Modification in Human Lymphoblastoid Cell Lines.
Transcription factor AP-4 (TFAP4)-upstream ORF coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the TFAP4/long noncoding RNA 00520/microRNA-520f-3p feedback loop.
Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma.
Transcription factor networks of oligodendrogliomas treated with adjuvant radiotherapy or observation inform prognosis.
Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas.
Transcription factor profiling reveals molecular choreography and key regulators of human retrotransposon expression.
Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management.
Transcription factor RUNX3 promotes CD8+ T cell recruitment by CCL3 and CCL20 in lung adenocarcinoma immune microenvironment.
Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial-Mesenchymal Transition.
Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort.
Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Transcription profiles of non-immortalized breast cancer cell lines.
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target.
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression.
Transcriptional Biomarkers in Oral Cancer: An Integrative Analysis and the Cancer Genome Atlas Validation.
Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival.
Transcriptional Characterization Of The Tumor Immune Microenvironment And Its Prognostic Value For Locally Advanced Lung Adenocarcinoma In A Chinese Population.
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members.
Transcriptional information underlying the generation of CSCs and the construction of a nine-mRNA signature to improve prognosis prediction in colorectal cancer.
Transcriptional landscape of human cancers.
Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival--Evidence from TCGA Pan-Cancer Data.
Transcriptional Profiling of Advanced Urothelial Cancer Predicts Prognosis and Response to Immunotherapy.
Transcriptional profiling revealed the anti-proliferative effect of MFN2 deficiency and identified risk factors in lung adenocarcinoma.
Transcriptional regulation of Bcl-2 gene by the PR/SET domain family member PRDM10.
Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival.
Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.
Transcriptome Analyses Identify an RNA Binding Protein Related Prognostic Model for Clear Cell Renal Cell Carcinoma.
Transcriptome analyses of tumor-adjacent somatic tissues reveal genes co-expressed with transposable elements.
Transcriptome analysis and prognosis of ALDH isoforms in human cancer.
Transcriptome analysis and prognostic model construction based on splicing profiling in glioblastoma.
Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma.
Transcriptome analysis of copper homeostasis genes reveals coordinated upregulation of SLC31A1,SCO1, and COX11 in colorectal cancer.
Transcriptome analysis of distinct long non-coding RNA transcriptional fingerprints in lung adenocarcinoma and squamous cell carcinoma.
Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation.
Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers.
Transcriptome analysis reveals gender-specific differences in overall metabolic response of male and female patients in lung adenocarcinoma.
Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer.
Transcriptome Analysis Reveals Significant Differences in Gene Expression of Malignant Pheochromocytoma or Paraganglioma.
Transcriptome analysis reveals the effect of oral contraceptive use on cervical cancer.
Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer.
Transcriptome Based System Biology Exploration Reveals Homogeneous Tumorigenicity of Alimentary Tract Malignancy.
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes.
Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4+ T Cells Associated with Poor Disease-Specific Survival.
Transcriptome profiling and pathway analysis in squamous cell carcinoma of buccal mucosa.
Transcriptome profiling by combined machine learning and statistical R analysis identifies TMEM236 as a potential novel diagnostic biomarker for colorectal cancer.
Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma.
Transcriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma.
Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival.
Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CA (H1047R) in HER2/ER-positive breast cancer.
Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia.
Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer.
Transcriptome-based stemness indices analysis reveals platinum-based chemo-theraputic response indicators in advanced-stage serous ovarian cancer.
Transcriptome-wide analysis and modelling of prognostic alternative splicing signatures in invasive breast cancer: a prospective clinical study.
Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.
Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.
Transcriptomic analysis links hepatocellular carcinoma (HCC) in HZE ion irradiated mice to a human HCC subtype with favorable outcomes.
Transcriptomic Analysis of Glycolysis-Related Genes Reveals an Independent Signature of Bladder Carcinoma.
Transcriptomic analysis of the aquaporin gene family and associated interactors in rectal cancer.
Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Transcriptomic analysis reveals that heat shock protein 90? is a potential diagnostic and prognostic biomarker for cancer.
Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer.
Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications.
Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data.
Transcriptomic and Proteomic Analysis of Steatohepatitic Hepatocellular Carcinoma Reveals Novel Distinct Biologic Features.
Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population.
Transcriptomic heterogeneity of driver gene mutations reveals novel mutual exclusivity and improves exploration of functional associations.
Transcriptomic model-based lncRNAs and mRNAs serve as independent prognostic indicators in head and neck squamous cell carcinoma.
Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis.
Transcriptomic profiling identifies a DNA repair-related signature as a novel prognostic marker in lower-grade gliomas.
Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme.
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
Transcriptomics-based validation of the relatedness of heterogeneous nuclear ribonucleoproteins to chronic lymphocytic leukemia as potential biomarkers of the disease aggressiveness.
Transfer-RNA-Derived Fragments Are Potential Prognostic Factors in Patients with Squamous Cell Carcinoma of the Head and Neck.
Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.
Transforming Growth Factor Beta Promotes Liver Tumorigenesis in Mice via Upregulation of Snail.
Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome.
Translating cancer genomes and transcriptomes for precision oncology.
Translating ceRNA Susceptibilities into Correlation Functions.
Translating insights from the cancer genome into clinical practice.
Translational adaptation of human viruses to the tissues they infect.
Translational Bioinformatics and Clinical Research (Biomedical) Informatics.
Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset.
Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma.
Transmembrane Channel-Like 5 (TMC5) promotes prostate cancer cell proliferation through cell cycle regulation.
Transmembrane protein 92 performs a tumor-promoting function in breast carcinoma by contributing to the cell growth, invasion, migration and epithelial-mesenchymal transition.
Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells.
Transmembrane protein GRINA modulates aerobic glycolysis and promotes tumor progression in gastric cancer.
Transnasal Endoscopic Biopsy Approach to Atlas Tumor with X-ray Assisted and Related Radiographic Measure.
Transoral approach for percutaneous vertebroplasty in the treatment of osteolytic tumor lesions of the lateral mass of the atlas: feasibility and initial experience in 2 patients.
Transposable Element Expression in Acute Myeloid Leukemia Transcriptome and Prognosis.
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity.
Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene.
Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFN? secretion.
TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
Treating Cancer as an Invasive Species.
Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective Study.
Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
Trends in Cancer Mortality Among Adolescents and Young Adults in Brazil.
Trends in cancer mortality rates, Bergen County, New Jersey, 1962-75.
TRGAted: A web tool for survival analysis using protein data in the Cancer Genome Atlas.
Tribbles pseudokinase 3 (TRIB3) contributes to the progression of hepatocellular carcinoma by activating the mitogen-activated protein kinase pathway.
Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating ?-Catenin Expression.
tRic: a user-friendly data portal to explore the expression landscape of tRNAs in human cancers.
TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients' survival.
TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-? signaling.
TRIM27 interacts with I?b? to promote the growth of human renal cancer cells through regulating the NF-?B pathway.
TRIM28 is a distinct prognostic biomarker that worsens the tumor immune microenvironment in lung adenocarcinoma.
TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
Trim47 overexpression correlates with poor prognosis in gastric cancer.
TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
TRIM59: A potential diagnostic and prognostic biomarker in human tumors.
TRIM65 negatively regulates p53 through ubiquitination.
TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation.
TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.
TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signaling.
Tripartite motif-containing 15 overexpression in non-small cell lung cancer is associated with poor patient prognoses.
Triple-high expression of phosphatase and tensin homolog (PTEN), estrogen receptor (ER) and progesterone receptor (PR) may predict favorable prognosis for patients with Type I endometrial carcinoma.
Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.
Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F.
tRNA Fragments Show Intertwining with mRNAs of Specific Repeat Content and Have Links to Disparities.
Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.
Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases.
Trophinin-associated protein expression is an independent prognostic biomarker in lung adenocarcinoma.
TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets.
TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs.
Truncation- and motif-based pan-cancer analysis reveals tumor-suppressing kinases.
Tryptophan 2, 3?dioxygenase promotes proliferation, migration and invasion of ovarian cancer cells.
Tryptophanyl-tRNA synthetase (WARS) expression in uveal melanoma - possible contributor during uveal melanoma progression.
TSDLPP: A Novel Two-stage Deep Learning Framework for Prognosis Prediction Based on Whole Slide Histopathological Images.
TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.
TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis.
TSP50 promotes hepatocyte proliferation and tumour formation by activating glucose-6-phosphate dehydrogenase (G6PD).
TSPAN12 Precedes Tumor Proliferation by Cell Cycle Control in Ovarian Cancer.
Tsukushi is a novel prognostic biomarker and correlates with tumor-infiltrating B cells in non-small cell lung cancer.
TSVdb: a web-tool for TCGA splicing variants analysis.
TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/?-Catenin Signaling.
Tumor Atlas of the Gastrointestinal Tract.
Tumor Atlas of the Gastrointestinal Tract: The Duodenum, Small Intestine and Colon.
Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance.
Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages.
Tumor cells in light-chain amyloidosis and myeloma show different transcriptional rewiring of normal plasma cell development.
Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer.
Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients.
Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma.
Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors.
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
Tumor Habitat-derived Radiomic Features at Pretreatment MRI That Are Prognostic for Progression-free Survival in Glioblastoma Are Associated with Key Morphologic Attributes at Histopathologic Examination: A Feasibility Study.
Tumor hepatitis B virus RNA identifies a clinically and molecularly distinct subset of hepatocellular carcinoma.
Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients.
Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma.
Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes.
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy.
Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma.
Tumor immunity landscape in non-small cell lung cancer.
Tumor immunogenomic signatures improve a prognostic model of melanoma survival.
Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications.
Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer.
Tumor infiltrating lymphocytes associated competitive endogenous RNA networks as predictors of outcome in hepatic carcinoma based on WGCNA analysis.
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy.
Tumor infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T cell responses, and superior prognosis in ovarian cancer.
Tumor IsomiR Encyclopedia (TIE): a pancancer database of miRNA isoforms.
Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures.
Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
Tumor microenvironment characterization in stage IV gastric cancer.
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer.
Tumor microenvironment immune-related lncRNA signature for patients with melanoma.
Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survival.
Tumor Microenvironment Properties are Associated With Low CD68-positive Cell Infiltration and Favorable Disease-free Survival in EGFR-mutant Lung Adenocarcinoma.
Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast Cancer.
Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma.
Tumor Microenvironmental Competitive Endogenous RNA Network and Immune Cells Act as Robust Prognostic Predictor of Acute Myeloid Leukemia.
Tumor Molecular Features Predict Endometrial Cancer Patients' Survival After Open or Minimally Invasive Surgeries.
Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.
Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis.
Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
Tumor Mutation Burden Computation in Two Pan-Cancer Precision Medicine Next-Generation Sequencing Panels.
Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma.
Tumor mutation burden in Chinese cancer patients and the underlying driving pathways of high tumor mutation burden across different cancer types.
Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers.
Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens.
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
Tumor mutational burden is associated with poor outcomes in diffuse glioma.
Tumor mutational burden is polygenic and genetically associated with complex traits and diseases.
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1.
Tumor mutational load and immune parameters across metastatic Renal Cell Carcinoma (mRCC) risk groups.
Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment.
Tumor Progression Locus 2 (Tpl2) Kinase Contributes Tumor Growth and Metastasis of Clear Cell Renal Cell Carcinoma.
Tumor promoting effects of glucagon receptor: a promising biomarker of papillary thyroid carcinoma via regulating EMT and P38/ERK pathways.
Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer.
Tumor RAS Gene Expression Levels Are Influenced by the Mutational Status of RAS Genes and Both Upstream and Downstream RAS Pathway Genes.
Tumor resident stromal cells promote breast cancer invasion through regulation of the basal phenotype.
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
Tumor Signature Analysis Implicates Hereditary Cancer Genes in Endometrial Cancer Development.
Tumor size and genomic risk in localized prostate cancer.
Tumor specific methylome in Chinese high-grade serous ovarian cancer characterized by gene expression profile and tumor genotype.
Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer.
Tumor stratification by a novel graph-regularized bi-clique finding algorithm.
Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers.
Tumor suppressive autophagy in intestinal stem cells controls gut homeostasis.
Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/?-Catenin Signaling.
Tumor Suppressor Effect of RBMS3 in Breast Cancer.
Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
Tumor suppressor miR-33b-5p regulates cellular function and acts a prognostic biomarker in RCC.
Tumor suppressor properties of the small C-terminal domain phosphatases in non-small cell lung cancer.
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.
Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance.
Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.
Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas.
Tumor-associated macrophages based signaling pathway analysis and hub genes identification in glioma.
Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis.
Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics.
Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer.
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss.
Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors.
Tumor-Infiltrating Neutrophils and Non-Classical Monocytes May Be Potential Therapeutic Targets for HER2negative Gastric Cancer.
Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contexture.
Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma.
Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
Tumor-suppressor NF?B2 p100 interacts with ERK2 and stabilizes PTEN mRNA via inhibition of miR-494.
Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile.
Tumor?suppressive microRNA?223 targets WDR62 directly in bladder cancer.
TumorFusions: an integrative resource for cancer-associated transcript fusions.
Tumorigenesis-related key genes in adolescents and young adults with HR(+)/HER2(-) breast cancer.
TumorMap: Exploring the Molecular Similarities of Cancer Samples in an Interactive Portal.
Tumors masquerading as type 2 papillary renal cell carcinoma: pathologists' ever-expanding differential diagnosis for a heterogeneous group of entities.
Tumors of the atlas. 3 incidental cases of osteochondroma, benign osteoblastoma, and atypical Ewing's sarcoma.
Tumors of the Central Nervous System (AFIP Atlas of Tumor Pathology, Series 4. Fascicle 7).
Tumors of the eye and ocular adnexa AFIP atlas of tumor pathology, series 4, fascicle 5.
Tumors of the Major Salivary Glands. (Fascicle 10, Second Series, Atlas of Tumor Pathology.).
Tumors of the Thymus. Atlas of Tumor Pathology. 2nd series. Fascicle 13.
Tumors: An Atlas of Differential Diagnosis.
Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
Tumour immunology: Immune atlas sheds light on anticancer responses.
Tumour-Agnostic Therapy for Pancreatic Cancer and Biliary Tract Cancer.
Tumour-derived exosomes: Tiny envelopes for big stories.
Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tumour-specific Causal Inference Discovers Distinct Disease Mechanisms Underlying Cancer Subtypes.
Tumours of the atlas and axis: a 37-year experience with diagnosis and management.
Tumours of the Nervous System. An Ultrastructural Atlas.
Tuning Parameter Selection in Cox Proportional Hazards Model with a Diverging Number of Parameters.
Twenty Metabolic Genes Based Signature Predicts Survival of Glioma Patients.
Twenty-gene-based prognostic model predicts lung adenocarcinoma survival.
Twist1 and AP-1 cooperatively upregulate integrin ?5 expression to induce invasion and the epithelial-mesenchymal transition.
Twist1 induces chromosomal instability (CIN) in colorectal cancer cells.
TWIST1 transcriptionally regulates glycolytic genes to promote the Warburg metabolism in pancreatic cancer.
Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
Two critical positions in zinc finger domains are heavily mutated in three human cancer types.
Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.
Two immune-enhanced molecular subtypes differ in inflammation, immune checkpoints, mutations, and prognostic outcome in stage I-II colonic carcinoma.
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.
Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes.
Two microRNA signatures for malignancy and immune infiltration predict overall survival in advanced epithelial ovarian cancer.
Two predicted models based on ceRNAs and immune cells in lung adenocarcinoma.
Two protein-coding genes act as a novel clinical signature to predict prognosis in patients with ovarian serous cystadenocarcinoma.
Two Unique Glioma Subtypes Revealed.
TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer.
Type 1 Insulin-Like Growth Factor Receptor/Insulin Receptor Substrate 1 Signaling Confers Pathogenic Activity on Breast Tumor Cells Lacking REST.
TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma.
Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
UBASH3B promotes tamoxifen resistance and could be negatively regulated by ESR1.
UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells.
UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma.
UBE2C overexpression in melanoma and its essential role in G2/M transition.
UBE2C promotes the progression of head and neck squamous cell carcinoma.
UBE2D1 RNA Expression Was an Independent Unfavorable Prognostic Indicator in Lung Adenocarcinoma, but Not in Lung Squamous Cell Carcinoma.
UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma.
UBE2O Promotes Progression and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.
UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma.
UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.
UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
UBE2V2 Positively Correlates With PD-L1 Expression and Confers Poor Patient Survival in Lung Adenocarcinoma.
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.
Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
Ubiquitin-Like Modifier Activating Enzyme 1 as a Novel Diagnostic and Prognostic Indicator That Correlates With Ferroptosis and the Malignant Phenotypes of Liver Cancer Cells.
Ubiquitin-like modifier-activating enzyme 7 as a marker for the diagnosis and prognosis of breast cancer.
Ubiquitin-specific protease-44 inhibits the proliferation and migration of cells via inhibition of JNK pathway in clear cell renal cell carcinoma.
Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.
UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer.
UCK2 upregulation might serve as an indicator of unfavorable prognosis of hepatocellular carcinoma.
UCSC Genome Browser enters 20th year.
UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer.
Ultra-mutated colorectal cancer patients with POLE driver mutations exhibit distinct clinical patterns.
Ultrasensitive immunoprofiling of plasma extracellular vesicles identifies syndecan-1 as a potential tool for minimally invasive diagnosis of glioma.
Ultrastructural Appearances of Tumours: A Diagnostic Atlas.
Ultraviolet-A radiation induces changes in cyclin G gene expression in mouse melanoma B16-F1 cells.
Unbalanced YAP-SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma.
UNC5B-AS1 promoted ovarian cancer progression by regulating the H3K27me on NDRG2 via EZH2.
Uncoordinated expression of DNA methylation-related enzymes in human cancer.
Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancers.
Uncovering biomarker genes with enriched classification potential from Hallmark gene sets.
Uncovering genetic mechanisms of kidney aging through transcriptomics, genomics, and epigenomics.
Uncovering Prognosis-Related Genes and Pathways by Multi-Omics Analysis in Lung Cancer.
Uncovering robust patterns of microRNA co-expression across cancers using Bayesian Relevance Networks.
Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinoma.
Uncovering the Pharmacological Mechanism of 2-Dodecyl-6-Methoxycyclohexa-2,5 -Diene-1,4-Dione Against Lung Cancer Based on Network Pharmacology and Experimental Evaluation.
Uncovering the potential differentially expressed miRNAs as diagnostic biomarkers for hepatocellular carcinoma based on machine learning in The Cancer Genome Atlas database.
Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity.
Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma.
Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma.
Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans.
Unifying cancer and normal RNA sequencing data from different sources.
Unifying gene expression measures from multiple platforms using factor analysis.
Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas.
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.
Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancer.
Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1.
Unraveling Immune-Related lncRNAs in Breast Cancer Molecular Subtypes.
Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer.
Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection.
Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
Unravelling the Role of LncRNA WT1-AS/miR-206/NAMPT Axis as Prognostic Biomarkers in Lung Adenocarcinoma.
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis.
Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes.
Unsupervised Feature Selection Using an Integrated Strategy of Hierarchical Clustering with Singular Value Decomposition: An Integrative Biomarker Discovery Method with Application to Acute Myeloid Leukemia.
Unsupervised Hierarchical Clustering of Pancreatic Adenocarcinoma Dataset from TCGA Defines a Mucin Expression Profile that Impacts Overall Survival.
Unsupervised multiple kernel learning for heterogeneous data integration.
Unsupervised Resolution of Histomorphologic Heterogeneity in Renal Cell Carcinoma Using a Brain Tumor-Educated Neural Network.
Unveiling new interdependencies between significant DNA methylation sites, gene expression profiles and glioma patients survival.
Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.
Up-Regulated AKR1C2 is correlated with favorable prognosis in thyroid carcinoma.
Up-regulated long non-coding RNA DUXAP8 promotes cell growth through repressing Krüppel-like factor 2 expression in human hepatocellular carcinoma.
Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Up-regulation of ANKDR49, a poor prognostic factor, regulates cell proliferation of gliomas.
Up-regulation of CKAP2L expression promotes lung adenocarcinoma invasion and is associated with poor prognosis.
Up-regulation of CTD-2547G23.4 in hepatocellular carcinoma tissues and its prospective molecular regulatory mechanism: a novel qRT-PCR and bioinformatics analysis study.
Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia.
Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway.
Up-regulation of L Antigen Family Member 3 Associates With Aggressive Progression of Breast Cancer.
Up-regulation of long non-coding RNA SPRY4-IT1 promotes tumor cell migration and invasion in lung adenocarcinoma.
Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.
Up-Regulation of miR-26a-5p Inhibits E2F7 to Regulate the Progression of Renal Carcinoma Cells.
Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.
Update on The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer.
Upgrading the Repertoire of miRNAs in Gastric Adenocarcinoma to Provide a New Resource for Biomarker Discovery.
Upregulated delta-like protein 3 expression is a diagnostic and prognostic marker in endometrial cancer: A retrospective study.
Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial?mesenchymal transition.
Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle.
Upregulated forkhead-box A3 elevates the expression of forkhead-box A1 and forkhead-box A2 to promote metastasis in esophageal cancer.
Upregulated GAPLINC predicts a poor prognosis in bladder cancer patients and promotes tumor proliferation and invasion.
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway.
Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types.
Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.
Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer.
Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC.
Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer.
Upregulated long-non-coding RNA DLEU2 exon 9 expression was an independent indicator of unfavorable overall survival in patients with esophageal adenocarcinoma.
Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma.
Upregulated miR?203a?3p and its potential molecular mechanism in breast cancer: A study based on bioinformatics analyses and a comprehensive meta?analysis.
Upregulated NLGN1 predicts poor survival in colorectal cancer.
Upregulated Seizure-Related 6 Homolog-Like 2 Is a Prognostic Predictor of Hepatocellular Carcinoma.
Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter.
Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma.
Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms.
Upregulation of centromere protein K is crucial for lung adenocarcinoma cell viability and invasion.
Upregulation of centromere protein M promotes tumorigenesis: A potential predictive target for cancer in humans.
Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer.
Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients.
Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods.
Upregulation of DLEU1 expression by epigenetic modification promotes tumorigenesis in human cancer.
Upregulation of DLX2 Confers a Poor Prognosis in Glioblastoma Patients by Inducing a Proliferative Phenotype.
Upregulation of ERCC6L is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma.
Upregulation of Excision Repair Cross-Complementation Group 6-Like (ERCC6L) Promotes Tumor Growth in Hepatocellular Carcinoma.
Upregulation of exosomal microRNA?21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity.
Upregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycle.
Upregulation of FGD6 Predicts Poor Prognosis in Gastric Cancer.
Upregulation of glucosamine-phosphate N-acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma.
Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia.
Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma.
Upregulation of GPNCA is associated with poor prognosis through enhancement of tumor growth via regulating GSK3B.
Upregulation of HOXA1 promotes tumorigenesis and development of non?small cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis.
Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches.
Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics.
Upregulation of HSF1 in estrogen receptor positive breast cancer.
Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome.
Upregulation of LAGE3 correlates with prognosis and immune infiltrates in colorectal cancer: A bioinformatic analysis.
Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma.
Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/?-catenin pathway.
Upregulation of lncRNA DARS-AS1 accelerates tumor malignancy in cervical cancer by activating cGMP-PKG pathway.
Upregulation of Long Non-Coding RNA DRAIC Correlates with Adverse Features of Breast Cancer.
Upregulation of MIAT Regulates LOXL2 Expression by Competitively Binding MiR-29c in Clear Cell Renal Cell Carcinoma.
Upregulation of microfibrillar-associated protein 2 is closely associated with tumor angiogenesis and poor prognosis in hepatocellular carcinoma.
Upregulation of microRNA-31 is associated with poor prognosis in patients with advanced colorectal cancer.
Upregulation of miR-183-5p predicts worse survival in patients with renal cell cancer after surgery.
Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein.
Upregulation of miR?132?3p in cholangiocarcinoma tissues: A study based on RT?qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses.
Upregulation of miR?598 promotes cell proliferation and cell cycle progression in human colorectal carcinoma by suppressing INPP5E expression.
Upregulation of MYBL2 independently predicts a poorer prognosis in patients with clear cell renal cell carcinoma.
Upregulation of nectin-4 is associated with ITGB1 and vasculogenic mimicry and may serve as a predictor of poor prognosis in colorectal cancer.
Upregulation of oncogene Activin A receptor type I by Helicobacter pylori infection promotes gastric intestinal metaplasia via regulating CDX2.
Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma.
Upregulation of proline rich 11 is an independent unfavorable prognostic factor for survival of tongue squamous cell carcinoma patients.
Upregulation Of Protein Tyrosine Phosphatase Receptor Type C Associates To The Combination Of Hashimoto's Thyroiditis And Papillary Thyroid Carcinoma And Is Predictive Of A Poor Prognosis.
Upregulation of RAC3 in bladder cancer predicts adverse clinical outcome and increased tumor immune response.
Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas.
Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data.
Upregulation of SPP1 Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance.
Upregulation of STC2 in colorectal cancer and its clinicopathological significance.
Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer.
Upregulation of the ESR1 Gene and ESR Ratio (ESR1/ESR2) is Associated with a Worse Prognosis in Papillary Thyroid Carcinoma: The Impact of the Estrogen Receptor ?/? Expression on Clinical Outcomes in Papillary Thyroid Carcinoma Patients.
Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients.
Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma.
Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma.
Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway.
Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
Upregulation of ubiquitin-conjugating enzyme E2Z is associated with human hepatocellular carcinoma.
Upregulation of ZBTB7A exhibits a tumor suppressive role in gastric cancer cells.
Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.
UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells.
Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.
Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage.
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.
Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinoma.
Uronic acid metabolic process-related gene expression-based signature predicts overall survival of glioma.
Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile.
Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications.
Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.
Ursolic Acid Regulates Cell Cycle and Proliferation in Colon Adenocarcinoma by Suppressing Cyclin B1.
Use of bioinformatic database analysis and specimen verification to identify novel biomarkers predicting gastric cancer metastasis.
Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma.
Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
Using association signal annotations to boost similarity network fusion.
Using bioinformatics approaches to investigate driver genes and identify BCL7A as a prognostic gene in colorectal cancer.
Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images.
Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancer.
Using Frankenstein's creature paradigm to build a patient specific atlas.
Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma.
Using knowledge-driven genomic interactions for multi-omics data analysis: metadimensional models for predicting clinical outcomes in ovarian carcinoma.
Using machine learning method to identify MYLK as a novel marker to predict biochemical recurrence in prostate cancer.
Using Semantic Web Technologies to Enable Cancer Genomics Discovery at Petabyte Scale.
Using the "Hidden" genome to improve classification of cancer types.
Using The Cancer Genome Atlas as a Tool to Improve Undergraduate Student Understanding of Cancer Genetics and the Hallmarks of Cancer Progression.
Using The Cancer Genome Atlas as an Inquiry Tool in the Undergraduate Classroom.
Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma.
Using the Seven Bridges Cancer Genomics Cloud to Access and Analyze Petabytes of Cancer Data.
USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway.
USP19 and RPL23 as Candidate Prognostic Markers for Advanced-Stage High-Grade Serous Ovarian Carcinoma.
USP19 Enhances MMP2/MMP9-Mediated Tumorigenesis in Gastric Cancer.
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1?/USP22 positive feedback loop upon TP53 inactivation.
USP4 expression independently predicts favorable survival in lung adenocarcinoma.
USP5 Promotes Uterine Corpus Endometrial Carcinoma Cell Growth and Migration via mTOR/4EBP1 Activation.
Uterine serous carcinoma.
Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.
Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta-analysis.
Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types.
Utility of miR?133a?3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta?analysis and bioinformatics.
Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer.
Utilizing somatic mutation data from numerous studies for cancer research: proof of concept and applications.
Uveal melanoma: laboratory advances and new frontiers in patient care.
UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy.
V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.
Validating a Predictive Atlas of Tumor Shrinkage for Adaptive Radiotherapy of Locally Advanced Lung Cancer.
Validating HMMR Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods.
Validating the RTOG-endorsed brachial plexus contouring atlas: an evaluation of reproducibility among patients treated by intensity-modulated radiotherapy for head-and-neck cancer.
Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas.
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.
Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma.
Validation of Gene Profiles for Analysis of Regional Lymphatic Metastases in Head and Neck Squamous Cell Carcinoma.
Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.
Value of Collaboration among Multi-Domain Experts in Analysis of High-Throughput Genomics Data.
Value of Ferritin Heavy Chain (FTH1) Expression in Diagnosis and Prognosis of Renal Cell Carcinoma.
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research.
Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.
Variable expression of CXCR4 in molecular subtypes of infiltrating gliomas.
Variable maternal methylation overlapping the nc886/vtRNA2-1 locus is locked between hypermethylated repeats and is frequently altered in cancer.
Variance component tests of multivariate mediation effects under composite null hypotheses.
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
Varied clinical significance of ATP-binding cassette C sub-family members for lung adenocarcinoma.
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing.
Vascular endothelial growth factor receptor 1 in glioblastoma?associated microglia/macrophages.
Vascular endothelial growth factor receptor-2 and its association with tumor immune regulatory gene expression in hepatocellular carcinoma.
VASN promotes YAP/TAZ and EMT pathway in thyroid carcinogenesis in vitro.
VDR mRNA overexpression is associated with worse prognostic factors in papillary thyroid carcinoma.
VECTOR: An Integrated Correlation Network Database for the Identification of CeRNA Axes in Uveal Melanoma.
VegaMC: A R/Bioconductor Package for Fast Downstream Analysis of Large Array Comparative Genomic Hybridization Datasets.
Verification of expressions of lncRNA FOXCUT in gastric adenocarcinoma patients and its effects on cell biological function based on TCGA database.
Verrucous carcinoma of the oesophagus is a genetically distinct subtype of oesophageal squamous cell carcinoma.
Verrucous esophageal carcinoma is a unique indolent subtype of squamous cell carcinoma: a systematic review and individual patient regression analysis.
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer.
Vimentin acetylation is involved in SIRT5-mediated hepatocellular carcinoma migration.
Viral sequences in human cancer.
Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma.
Virus expression detection reveals RNA-sequencing contamination in TCGA.
VirusSeq: software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue.
VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer.
Visual Display of 5p-arm and 3p-arm miRNA Expression with a Mobile Application.
Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study.
Visualization and Analysis in the Field of Pan-Cancer Studies and Its Application in Breast Cancer Treatment.
Visualizing molecular profiles of glioblastoma with GBM-BioDP.
Visualizing multidimensional cancer genomics data.
Visually Meaningful Histopathological Features for Automatic Grading of Prostate Cancer.
Vitamin D-VDR Signaling Inhibits Wnt/?-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
VNN3 is a potential novel biomarker for predicting prognosis in clear cell renal cell carcinoma.
Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.
von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53.
VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients.
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.
Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer.
WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-?B activation.
WDR5 Promotes Proliferation and Correlates with Poor Prognosis in Oesophageal Squamous Cell Carcinoma.
WDR62 overexpression is associated with a poor prognosis in patients with lung adenocarcinoma.
Weakly Supervised Deep Learning for Whole Slide Lung Cancer Image Analysis.
Weakly Supervised Deep Ordinal Cox Model for Survival Prediction from Whole-slide Pathological Images.
Web-TCGA: an online platform for integrated analysis of molecular cancer data sets.
WebMeV: A Cloud Platform for Analyzing and Visualizing Cancer Genomic Data.
Weighted correlation network analysis of triple-negative breast cancer progression: Identifying specific modules and hub genes based on the GEO and TCGA database.
Weighted dimensionality reduction and robust Gaussian mixture model based cancer patient subtyping from gene expression data.
Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.
Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the Cancer Genome Atlas database.
Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.
Weighted gene co-expression network analysis of hub genes in lung adenocarcinoma.
Weighted gene co-expression network analysis of the association between upregulated AMD1, EN1 and VGLL1 and the progression and poor prognosis of breast cancer.
Weighted gene co?expression network analysis for identifying hub genes in association with prognosis in Wilms tumor.
Weighted Gene Coexpression Network Analysis Identifies Cysteine-Rich Intestinal Protein 1 (CRIP1) as a Prognostic Gene Associated with Relapse in Patients with Acute Myeloid Leukemia.
Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
Weighted Gene Coexpression Network Analysis of Features That Control Cancer Stem Cells Reveals Prognostic Biomarkers in Lung Adenocarcinoma.
Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis.
Weighted Gene Coexpression Network Analysis Reveals the Dynamic Transcriptome Regulation and Prognostic Biomarkers of Hepatocellular Carcinoma.
Weighted Gene Coexpression Network Analysis to Construct Competitive Endogenous RNA Network in Chromogenic Renal Cell Carcinoma.
Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma.
What "The Cancer Genome Atlas" database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs.
What Mediates Fibrosis in the Tumor Microenvironment of Clear Renal Cell Carcinoma.
What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
What's New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives.
What's new in the AFIP fascicle on salivary gland tumors: a few highlights from the 4th Series Atlas.
Where cancer genomics should go next: a clinician's perspective.
Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers.
Where you live = how you die: 'Geography is destiny' for end-of-life care, which often is costly, aggressive.
Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma.
Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer.
Whole Exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma.
Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.
Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival.
Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma.
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas.
Whole-exome and RNA sequencing reveal novel insights into the pathogenesis of HPV associated cervical cancer.
Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma.
Whole-exome sequencing capture kit biases yield false negative mutation calls in TCGA cohorts.
Whole-Exome Sequencing Characterized the Landscape of Somatic Mutations and Pathways in Colorectal Cancer Liver Metastasis.
Whole-exome sequencing identifies somatic mutations associated with lung cancer metastasis to the brain.
Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma.
Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.
Whole-exome sequencing of ovarian cancer families uncovers putative predisposition genes.
Whole-exome Sequencing of Prostate Cancer in Sardinian Identify Recurrent UDP-glucuronosyltransferase Amplifications.
Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
Whole-genome and transcriptome profiling of a metastatic thyroid-like follicular renal cell carcinoma.
Whole-genome characterization of lung adenocarcinomas lacking the RTK/RAS/RAF pathway.
Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme.
Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme.
Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme.
Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
Whole-Slide Mitosis Detection in H&E Breast Histology Using PHH3 as a Reference to Train Distilled Stain-Invariant Convolutional Networks.
Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCC.
Whole-transcriptome sequencing identified gene expression signatures associated with aggressive clear cell renal cell carcinoma.
Whole-Transcriptome Sequencing Identifies Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs Associated with CHOL.
WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling.
WHSC1/NSD2 regulates immune infiltration in prostate cancer.
Why MUC16 mutations lead to a better prognosis: A study based on The Cancer Genome Atlas gastric cancer cohort.
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma.
Widespread expression of Sonic hedgehog (Shh) and Nrf2 in patients treated with cisplatin predicts outcome in resected tumors and are potential therapeutic targets for HPV-negative head and neck cancer.
Widespread inference of weighted microRNA-mediated gene regulation in cancer transcriptome analysis.
Wild-type p53 regulates OTOP2 transcription through DNA loop alteration of the promoter in colorectal cancer.
Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?
WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p/Snail Axis.
WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis.
With me or against me: Tumor suppressor and drug resistance activities of SAMHD1.
Wnt Signaling and Survival of Women With High-Grade Serous Ovarian Cancer: A Brief Report.
WNT signaling pathway regulator-FRAT2 affects oncogenesis and prognosis of basal-like breast cancer.
Wnt signalling in gynaecological cancers: A future target for personalised medicine?
Wnt/?-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice.
WNT/?-catenin pathway activation correlates with immune exclusion across human cancers.
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.
X-CAL: Explicit Calibration for Survival Analysis.
Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.
XRCC1 promotes replication restart, nascent fork degradation and mutagenic DNA repair in BRCA2-deficient cells.
Y-box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma.
Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells.
YAP Activity is Not Associated with Survival of Uveal Melanoma Patients and Cell Lines.
YAP Promotes VEGFA Expression and Tumor Angiogenesis Though Gli2 in Human Renal Cell Carcinoma.
YAP1 is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Pancreatic Cancer.
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
Yes-associated protein (YAP) binds to HIF-1? and sustains HIF-1? protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Yottixel - An Image Search Engine for Large Archives of Histopathology Whole Slide Images.
Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?
YRDC is upregulated in non-small cell lung cancer and promotes cell proliferation by decreasing cell apoptosis.
YTHDF2 correlates with tumor immune infiltrates in lower-grade glioma.
YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells.
ZBTB7A acts as a tumor suppressor through the transcriptional repression of glycolysis.
ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.
ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance.
Zebrafish Discoveries in Cancer Epigenetics.
ZFAS1 functions as an oncogenic long non-coding RNA in bladder cancer.
ZGRF1 Is Associated with Poor Prognosis in Triple-Negative Breast Cancer and Promotes Cancer Stemness Based on Bioinformatics.
ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21.
Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-Cancer.
ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
Zinc finger and BTB domain-containing protein 46 is essential for survival and proliferation of acute myeloid leukemia cell line but dispensable for normal hematopoiesis.
Zinc finger C3H1 domain-containing protein (ZFC3H1) evaluates the prognosis and treatment of prostate adenocarcinoma (PRAD): A study based on TCGA data.
Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.
ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
ZNF277 regulates ovarian cancer cell proliferation and invasion through inhibition of PTEN.
ZNF492 and GPR149 methylation patterns as prognostic markers for clear cell renal cell carcinoma: Array?based DNA methylation profiling.
ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer.
ZNF677 downregulation by promoter hypermethylation as a driver event through gastric tumorigenesis.
ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma.
Zodiac: A Comprehensive Depiction of Genetic Interactions in Cancer by Integrating TCGA Data.
Zooming-in on cancer metabolic rewiring with tissue specific constraint-based models.
ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.
[2 Cases of sudden death caused by spontaneous dislocation of the atlas; metastatic cancer & Grisel's disease.]
[2 Cases of sudden death caused by spontaneous dislocation of the atlas; metastatic cancer and Grisel's disease.]
[A cancer mortality atlas on a small geographic scale: procedure, validity and possibilities for its use]
[A case of giant cell tumor in atlas]
[A new bioinformatics approach for prediction of potential tumor neoantigens based on the cancer genome atlas dataset].
[Aggressive angiomyxoma - case report].
[Analysis of characteristics of gene expression in pericancerous stromal cells of nasopharyngeal carcinoma by cDNA array]
[Analysis of key genes and signal pathways of human papilloma virus-related head and neck squamous cell carcinoma].
[Application of atlas pedicle screw system fixation and fusion for treatment of upper cervical disease]
[Application of posterior arch of the atlasrch resection for high-level cervical dumbbell schwannoma surgery].
[Association of gene FN1 with pulmonary metastasis of human fibrosarcoma]
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially neoplasms. Part II. Neoplasms and pseudo-neoplastic proliferations]
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially tumors. Part I. Non-neoplastic diseases]
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially tumors. Part II. Neoplasms and pseudo-neoplastic proliferations]
[Atlas of intracranial tumors. 12. Congenital tumors]
[Atlas of intracranial tumors. 7. Neurinoma]
[Atlas of intracranial tumors. 9. Pinealoma and teratoma]
[Bioinformatics analysis of genes related to poor prognosis of human hepatocellular carcinoma and its clinical significance].
[Cancer atlas of Lower Saxony--possibilities and limitations]
[Cancer Genome Atlas Pan-cancer Analysis Project].
[Cartography as an instrument in epidemiology: methodologic considerations for the new Swiss cancer atlas]
[Cathepsin S (CTSS) is highly expressed in temozolomide-resistant glioblastoma T98G cells and associated with poor prognosis].
[cDNA expression array in the differential expression profiles of p53 regulated genes in nasopharyngeal carcinoma and the human normal nasopharynx]
[Cervical vertebral tuberculosis simulating a peritonsillar abscess.]
[Checkpoint Inhibitors in the Treatment of Upper Gastrointestinal Tract Tumors].
[China: an atlas of malignant tumors]
[Circulating tumor DNA assessment for gynaecological cancers management].
[Citron Rho-interacting serine/threonine kinase knockdown suppresses prostate cancer cell proliferation and metastasis by blocking Hippo-YAP pathway].
[Clinical application of TCGA molecular classification in endometrial endometrioid carcinoma].
[Clinical aspects and therapy of lid tumors; a clinical and pathological study of 300 cases: a textbook and atlas, 116 illustrations, 4 color charts, 7 tables]
[Clinical significance of ?1 receptor over-expression in cervical cancer and the effect of its synthetic ligands on the growth of cervical cancer cells].
[Clinicopathological and molecular characteristics of Epstein-Barr virus associated gastric cancer: a single center large sample case investigation].
[Common cancer genetic analysis methods and application study based on TCGA database].
[Comprehensive analysis of the aberrantly expressed profiles of lncRNAs, miRNAs and the regulation network of the associated ceRNAs in clear cell renal cell carcinoma].
[Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
[Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
[Correlation studies of distinct mutational signatures with common cancer pathological subtyping].
[Crohn's disease-associated colorectal carcinogenesis : TP53 mutations and copy number gains of chromosome arm 5p as (early) markers of tumor progression].
[Current status and research progress of perioperative chemotherapy in advanced gastric cancer].
[Data mining of esophageal squamous cell carcinoma from The Cancer Genome Atlas database].
[Developing a small-area cancer atlas: process, validity and possible applications]
[Difference in gene expression profile of human polymeric immunoglobulin receptor-transfected mouse nasopharyngeal epithelial cells before and after EBV infection]
[Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
[DNA damage associated genetic variants contribute to lung cancer susceptibility in a Han Chinese population].
[Downregulation of OGDHL expression is associated with promoter hypermethylation in colorectal cancer].
[Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients].
[Endoscopic transnasal approach for surgical treatment of skull base clival area chordomas (Report of 2 cases)].
[Establishment and validation of prognostic risk score model for esophageal squamous cell carcinoma based on immune related genes].
[Evaluation of Gene Expression of Hexokinases in Colorectal Cancer with the Use of Bioinformatics Methods].
[Exploratory screening of potential pan-cancer biomarkers based on The Cancer Genome Atlas database].
[Exploring of a prognostic long non-coding RNA signature of hepatocellular carcinoma by using public database].
[Expression and clinical significance of chemokine CXCL10 and its receptor CXCR3 in hepatocellular carcinoma].
[Expression and clinical significance of SETD2 in maligant pleural mesothelioma].
[Expression of microRNA-107 in hepatocellular carcinoma and its clinical significance].
[Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect ?on Immune Microenvironment].
[Expression of Toll-like receptors in human hepatocellular carcinoma and its correlation with inflammasome-associated cytokines].
[Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
[FOXC1 Knockdown Reverses Gefitinib Resistance in Non-small Cell Lung Cancer].
[Functional Hypermethylation of ALDH1L1, PLCL2, and PPP2R3A in Colon Cancer].
[Gene apoptosis expression profiles in liver cancer and their comparison to normal peri-cancerous liver tissues]
[Gene expression profiles in squamous esophageal cancer tissues and adjacent almost normal tissues]
[Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
[Glioblastomas: Gliomagenesis, genetics, angiogenesis, and microenvironment.]
[High expression of activated CD4+ memory T cells and CD8+ T cells and low expression of M0 macrophage are associated with better clinical prognosis in bladder cancer patients].
[High-throughput molecular analysis of urothelial carcinoma: potential clinical applications].
[Histological and molecular classification of endometrial carcinoma and therapeutical implications].
[HPV-associated head and neck cancer : mutational signature and genomic aberrations].
[Identifying Molecular Subtypes of Whole-Slide Image in Colorectal Cancer via Deep Learning].
[Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
[Implications of TCGA Network Data on 2nd Generation Immunotherapy Concepts Based on PD-L1 and PD-1 Target Structures].
[In Process Citation].
[Increased TRIM5 is associated with a poor prognosis and immune infiltration in glioma patients].
[Inframunicipality distribution of lung cancer in the urban area of Grenoble]
[Integrated analysis of DNA methylation and gene expression profiles of hepatocellular carcinoma to construct miR-1180-3p relevant ceRNA regulatory network].
[Inter-individual variability of gene expression detected by biochips]
[MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
[Molecular Subtypes of Gastric Cancer].
[Mutation signatures in head and neck squamous cell carcinoma : Pathogenesis and therapeutic potential].
[Mutational tumor profiles beyond organ and tissue specificity: implications for diagnostics and clinical study design].
[Nomenclature and classification of cancers based on an atlas.]
[Oncology at the Hotel-Dieu in Montreal]
[Overexpression of histone deacetylase 11 suppresses basal-like breast cancer cell invasion and metastasis].
[Plerosis of cDNA array of normal human nasopharyngeal tissue and nasopharyngeal carcinoma]
[Preliminary analysis on the gene expression profiles of medulloblastomas by use of cDNA array]
[Preliminary study on the gene expression profiles of ependymomas with cDNA array]
[Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
[Regional distribution of stomach and colon cancer mortality in the Dithmarschen and Nordfriesland districts--cartographic presentation]
[Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].
[Small atlas for the diagnosis of retroperitoneal tumors]
[Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].
[Study on the development of a choropleth atlas on cancer mortality using the inverse distance weight interpolation in the 1990's]
[Study on the Difference of Gene Expression between Central and Peripheral Lung Squamous Cell Carcinoma Based on TCGA Database].
[The cartographic depiction of regional variation in morbidity : Data analysis options using the example of the small-scale cancer atlas for Schleswig-Holstein].
[The general rules for clinical and pathological management of ovarian tumors part 1: histological classification and color atlas of ovarian tumors].
[Update on molecular classifications and new histological classification of bladder cancer].
Neoplasms, Germ Cell and Embryonal
SPOP suppresses testicular germ cell tumors progression through ubiquitination and degradation of DPPA2.
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
Neoplasms, Glandular and Epithelial
Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
Neoplasms, Second Primary
[Breast cancer mortality in women in the Schleswig-Holstein district 1981 to 1995]
Neoplasms, Squamous Cell
Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
Threonine Tyrosine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy.
Nephritis, Hereditary
AJKD Atlas of Renal Pathology: Alport Syndrome.
Nephritis, Interstitial
AJKD Atlas of Renal Pathology: Acute Interstitial Nephritis.
AJKD Atlas of Renal Pathology: Chronic Interstitial Nephritis.
AJKD Atlas of Renal Pathology: Tubulointerstitial Nephritis With Uveitis.
Nephrocalcinosis
AJKD Atlas of Renal Pathology: Nephrocalcinosis and Acute Phosphate Nephropathy.
Nephrosis
AJKD Atlas of Renal Pathology: Bile Nephrosis.
Nephrosis, Lipoid
AJKD Atlas of Renal Pathology: Minimal Change Disease.
Histopathological atlas of renal diseases: Minimal Change disease and focal glomerulosclerosis.
Nephrotic Syndrome
AJKD Atlas of Renal Pathology: Congenital Nephrotic Syndrome of Finnish Type.
Nervous System Diseases
A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders.
A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders.
Bridging neuroanatomy, neuroradiology and neurology: three-dimensional interactive atlas of neurological disorders.
Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders.
Joint functional brain network atlas estimation and feature selection for neurological disorder diagnosis with application to autism.
Multi-contrast human neonatal brain atlas: Application to normal neonate development analysis.
NSDNA: a manually curated database of experimentally supported ncRNAs associated with nervous system diseases.
Three-dimensional interactive atlas of cranial nerve-related disorders.
Ultra-high spatial resolution basal and evoked cerebral blood flow MRI of the rat brain.
WHO/WFN Survey of neurological services: a worldwide perspective.
[Atlas of nervous system diseases. 10. Giant aneurysm of the cranial base]
[Atlas of nervous system diseases. 11. A case of hemorrhage of the cerebellar hemisphere]
[Atlas of nervous system diseases. 12. Subclavian steal syndrome]
[Atlas of nervous system diseases. 4. Autopsy case of progressive spinal muscular atrophy]
[Atlas of nervous system diseases. 5. Myasthenia gravis]
[Atlas of nervous system diseases. 6. Autopsy case of subacute necrotic encephalitis]
[Atlas of nervous system diseases. 7. Autopsy case of obstruction of vertibrobasilar artery]
[Atlas of nervous system diseases. 8. Diabetic ophthalmoplegia]
[Atlas of nervous system diseases. 9. Hypoplasia of the internal carotid artery with recurrent cerebral ischemic syndrome]
Nervous System Malformations
Exencephaly and axial skeletal dysmorphogenesis induced by maternal exposure to cadmium in the mouse.
Nervous System Neoplasms
Tumours of the Nervous System. An Ultrastructural Atlas.
Neural Tube Defects
Craniovertebral junction neoplasms in the pediatric population.
Neuralgia
Comparison of gene expression profiles in neuropathic and inflammatory pain.
Occipital neuralgia secondary to hypermobile posterior arch of atlas. Case report.
Occipital neuralgia: anatomic considerations.
[Surgical decompression for the C-1 and C-2 sensory roots and upper cervical cord in a case with cervical myelopathy and occipital neuralgia due to bilateral fenestration of vertebral artery: a case report]
Neurilemmoma
Craniovertebral junction neoplasms in the pediatric population.
Expanded endoscopic endonasal transcribriform approach for resection of anterior skull base olfactory schwannoma.
Posterior fixation and fusion with atlas pedicle screw system for upper cervical diseases.
[Application of atlas pedicle screw system fixation and fusion for treatment of upper cervical disease]
[Application of posterior arch of the atlasrch resection for high-level cervical dumbbell schwannoma surgery].
[Minimally invasive treatment of cervical1-2 epidural neurilemmoma].
Neuroblastoma
Single-cell atlas of developing murine adrenal gland reveals relation of Schwann cell precursor signature to neuroblastoma phenotype.
Neurodegenerative Diseases
Atlas-based anatomic labeling in neurodegenerative disease via structure-driven atlas warping.
Construction of a neuroanatomical shape complex atlas from 3D MRI brain structures.
High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlas.
In vivo normative atlas of the hippocampal subfields using multi-echo susceptibility imaging at 7 Tesla.
Use of brain MRI atlases to determine boundaries of age-related pathology: the importance of statistical method.
Neuroendocrine Tumors
[Scintigraphy atlas of somatostatin receptors in neuroendocrine tumors of the pancreas and carcinoid tumors]
Neurofibroma
[Posterior arch of the atlas bone on x-ray; a study on spinal neurofibroma on C2.]
Neurofibroma, Plexiform
Craniovertebral junction neoplasms in the pediatric population.
Neurofibromatoses
Gigantic neurofibromatosis of the orbit.
Intermittent atlantoaxial subluxation caused by a prolapsing neurofibroma. Case report.
Neurofibromatosis 1
Intermittent atlantoaxial subluxation caused by a prolapsing neurofibroma. Case report.
Neuroinflammatory Diseases
A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation.
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation.
Neurologic Manifestations
3- to 11-year followup of occipitocervical fusion for rheumatoid arthritis.
Cervical spinal stenosis and myelopathy due to atlas hypoplasia.
Neurologic dysfunction in patients with rheumatoid arthritis of the cervical spine. Predictive value of clinical, radiographic and MR imaging parameters.
Occipital-cervical instability.
Pyogenic osteomyelitis of the atlas: a case report.
[Comparative study on indirect decompression versus open decompression to vertebral canal in treating thoracolumbar burst fractures without neurologic deficit]
[The neurologic manifestations of malformations of the occipito-atloid joint; a case of occipitalization of the atlas accompanied by cystic arachnoiditis, and treated surgically.]
Neuroma, Acoustic
Retractorless translabyrinthine approach for resection of a large acoustic neuroma: operative video and technical nuances.
Retrosigmoid Transmeatal Approach for Resection of Acoustic Neuroma: Operative Video and Technical Nuances of Subperineural Dissection for Facial Nerve Preservation.
Translabyrinthine Approach for Resection of Large Cystic Acoustic Neuroma: Operative Video and Technical Nuances of Subperineural Dissection for Facial Nerve Preservation.
Neuromuscular Diseases
An Atlas of Muscle Pathology in Neuromuscular Diseases.
AN ATLAS OF MUSCLE PATHOLOGY IN NEUROMUSCULAR DISEASES.
An Atlas of Muscle Pathology in Neuromuscular Diseases.
Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI.
Neurosyphilis
Occipital neuralgia: anatomic considerations.
Nevi and Melanomas
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
Nevus
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
Nevus sebaceus is associated with unusual neoplasms. An atlas.
Nevus, Pigmented
Clinical features of dysplastic nevi.
Non-alcoholic Fatty Liver Disease
Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD.
The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients.
Noonan Syndrome
Imaging of lymphatic dysplasia in Noonan syndrome: Case studies and historical atlas.
Nutrition Disorders
A Colour Atlas of Nutritional Disorders.
Obesity
Assessing the sustained impact of a school-based obesity prevention program for adolescent boys: the ATLAS cluster randomized controlled trial.
Association of cancer mortality with postdiagnosis overweight and obesity using body mass index.
Association of Processed Meats and Alcohol Consumption with Renal Cell Carcinoma: A Worldwide Population-Based Study.
Dead adipocytes and metabolic dysfunction: recent progress.
Diabetes Interactive Atlas.
Examining Associations among Obesity and Per Capita Farmers' Markets, Grocery Stores/Supermarkets, and Supercenters in US Counties.
Food Swamps Predict Obesity Rates Better Than Food Deserts in the United States.
Mediators of change in screen-time in a school-based intervention for adolescent boys: findings from the ATLAS cluster randomized controlled trial.
Obesity atlas and methodbox: towards an open framework for sharing public health intelligence workflows.
Obesity gene atlas in mammals.
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies studies and correlation with flt3 mutations and polyunsaturated fatty acid metabolism.
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity.
Obesity, overweight and body-weight perception in a High Atlas Moroccan population.
Small area estimation and childhood obesity surveillance using electronic health records.
Smart-phone obesity prevention trial for adolescent boys in low-income communities: the ATLAS RCT.
Obesity, Morbid
NASH-related increases in plasma bile acid levels depend on insulin resistance.
Oligodendroglioma
Comparative analysis of histologically classified oligodendrogliomas reveals characteristic molecular differences between subgroups.
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.
Transcription factor networks of oligodendrogliomas treated with adjuvant radiotherapy or observation inform prognosis.
[Preliminary analysis on the gene expression profiles of different types of gliomas with cDNA array]
[Preliminary study on the gene expression profiles of oligodendrogliom as with cDNA array]
Onchocerciasis
Complex emergencies and the control and elimination of neglected tropical diseases in Africa: developing a practical approach for implementing safe and effective mapping and intervention strategies.
Onychomycosis
[Mycological atlas: 34. Typical agents of onychomycosis]
Open Bite
[Head position, atlas position and breathing in open bite]
Ophthalmoplegia
[Atlas of nervous system diseases. 8. Diabetic ophthalmoplegia]
Oral Manifestations
An atlas of oral manifestations of diseases of the skin.
Oropharyngeal Neoplasms
Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.
Optimising volumetric arc radiotherapy for dental rehabilitation in oropharynx cancer - A retrospective dosimetry review and feasibility planning study.
Osteitis
[Tuberculous osteitis of the atlas. Apropos of a case]
Osteoarthritis
A radiological survey of the hips and knees in female specialist teachers of physical education.
A Standardized, Pragmatic Approach to Knee Ultrasound for Clinical Research in Osteoarthritis: The Johnston County Osteoarthritis Project.
Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial.
Assessing progression of patellofemoral osteoarthritis: a comparison between two radiographic methods.
Assessing the prevalence of hand osteoarthritis in epidemiological studies. The reliability of a radiological hand scale.
Association between Dietary Magnesium Intake and Radiographic Knee Osteoarthritis.
Association Between Infrapatellar Fat Pad Volume and Knee Structural Changes in Patients with Knee Osteoarthritis.
Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis.
Association between MRI-detected osteophytes and changes in knee structures and pain in older adults: a cohort study.
Association Between Preoperative Radiographic Severity of Osteoarthritis and Patient-Reported Outcomes of Total Knee Replacement.
Association of varus thrust with prevalent patellofemoral osteoarthritis: A cross-sectional study.
Associations between serum ghrelin and knee symptoms, joint structures and cartilage or bone biomarkers in patients with knee osteoarthritis.
Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS).
Atlas of individual radiographic features in osteoarthritis, revised.
Atlas of individual radiographic features in osteoarthritis.
Atlas of radiographic features of osteoarthritis of the ankle and hindfoot.
Automatic Grading of Individual Knee Osteoarthritis Features in Plain Radiographs Using Deep Convolutional Neural Networks.
Case definitions of knee osteoarthritis in 4,151 unselected subjects: relevance for epidemiological studies : The Copenhagen Osteoarthritis Study.
Changes in outcome measures for impairment, activity limitation, and participation restriction over two years in osteoarthritis of the lower extremities.
Classification of four distinct osteoarthritis subtypes with a knee joint tissue transcriptome atlas.
Clinical and radiographic disease course of hand osteoarthritis and determinants of outcome after 6 years.
Clinical Significance of Medial Versus Lateral Compartment Patellofemoral Osteoarthritis: Cross-Sectional Analyses in an Adult Population With Knee Pain.
Clustering of hand osteoarthritis progression and its relationship to progression of osteoarthritis at the knee.
Coexisting lateral tibiofemoral osteoarthritis is associated with worse knee pain in patients with mild medial osteoarthritis.
Comparison of radiographic and MRI osteoarthritis definitions and their combination for prediction of tibial cartilage loss, knee symptoms and total knee replacement: a longitudinal study.
Correction: Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS--).
Defining the presence of radiographic knee osteoarthritis: a comparison between the Kellgren and Lawrence system and OARSI atlas criteria.
Degeneration of the scaphoid-trapezium joint: a useful finding to differentiate calcium pyrophosphate deposition disease from osteoarthritis.
Development and reproducibility of a first metatarsophalangeal joint osteoarthritis magnetic resonance imaging scoring system.
Development and Validation of a Multitask Deep Learning Model for Severity Grading of Hip Osteoarthritis Features on Radiographs.
Development of a logically devised line drawing atlas for grading of knee osteoarthritis.
Differences in the radiological characteristics between post-traumatic and non-traumatic knee osteoarthritis.
Differential Contribution of the Medial and the Lateral Side of the Joint to Symptoms in Knee Osteoarthritis: A Radiographic and Laboratory Analysis in the Nagahama Study.
Do MRI features at baseline predict radiographic joint space narrowing in the medial compartment of the osteoarthritic knee 2 years later?
Does Patellofemoral Disease Affect Outcomes in Contemporary Medial Fixed-Bearing Unicompartmental Knee Arthroplasty?
Effect of medial tibial plateau alignment on serial radiographs on the capacity to predict progression of knee osteoarthritis.
Effect of vitamin D levels on radiographic knee osteoarthritis and functional status.
Factors influencing osteological changes in the hands and fingers of rock climbers.
Fully automatic analysis of the knee articular cartilage T1? relaxation time using voxel-based relaxometry.
Future of Chondroprotectors in the Treatment of Degenerative Processes of Connective Tissue.
Genome-wide analysis of aberrant methylation of enhancer DNA in human osteoarthritis.
High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury.
Hypointense signals in the infrapatellar fat pad assessed by magnetic resonance imaging are associated with knee symptoms and structure in older adults: a cohort study.
Identification of Radiographic Foot Osteoarthritis: Sensitivity of Views and Features Using The La Trobe Radiographic Atlas.
Initial results on development and application of statistical atlas of femoral cartilage in osteoarthritis to determine sex differences in structure: Data from the osteoarthritis initiative.
Interleukin-6 and tumor necrosis factor alpha in synovial fluid are associated with progression of radiographic knee osteoarthritis in subjects with previous meniscectomy.
Is loss in femorotibial cartilage thickness related to severity of contra-lateral radiographic knee osteoarthritis?--longitudinal data from the Osteoarthritis Initiative.
Knee Osteoarthritis in Type 2 Diabetes Mellitus: Does Insulin Therapy Retard Osteophyte Formation?
Lateral-compartment Osteophytes are not Associated With Lateral-compartment Cartilage Degeneration in Arthritic Varus Knees.
Myelopathy due to hypoplasia of the atlas. A case report.
Occipital neuralgia: anatomic considerations.
Osteophytes, juxta-articular radiolucencies and cancellous bone changes in the proximal tibia of patients with knee osteoarthritis.
Patella malalignment, pain and patellofemoral progression: the Health ABC Study.
Patellofemoral osteoarthritis 15 years after anterior cruciate ligament injury - a prospective cohort study.
Predictors of Radiographic Osteoarthritis 2 to 3 Years After Anterior Cruciate Ligament Reconstruction: Data From the MOON On-site Nested Cohort.
Quadriceps Weakness in Individuals with Coexisting Medial and Lateral Osteoarthritis.
Radiographic assessment of the femorotibial joint of the CCLT rabbit experimental model of osteoarthritis.
Radiographic classification of osteoarthritis in commonly affected joints of the foot.
Radiographic evaluation of foot osteoarthritis: sensitivity of radiographic variables and relationship to symptoms.
Reconstruction of the health status in a past human population: the Iron Age necropolis of Monte Bibele (Bologna, Italy).
Relationship between soy milk intake and radiographic knee joint space narrowing and osteophytes.
Reliability of Assessing Hand Osteoarthritis on Digital Photographs and Associations With Radiographic and Clinical Findings.
Reliability of grading scales for individual radiographic features of osteoarthritis of the knee. The Baltimore longitudinal study of aging atlas of knee osteoarthritis.
Sensitivity-to-change and validity of semi-automatic joint space width measurements in hand osteoarthritis: a follow-up study.
Should return to pivoting sport be avoided for the secondary prevention of osteoarthritis after anterior cruciate ligament reconstruction? A prospective cohort study with MRI, radiographic and symptomatic outcomes.
Synovial cyst of the transverse ligament of the atlas causing tetraparesia in a context of generalized osteoarthritis.
The association between changes in synovial fluid levels of ARGS-aggrecan fragments, progression of radiographic osteoarthritis and self-reported outcomes: a cohort study.
The association between radiographic severity and pre-operative function in patients undergoing primary knee replacement for osteoarthritis.
The associations of serum uric acid level and hyperuricemia with knee osteoarthritis.
The effect of variation in interpretation of the La Trobe radiographic foot atlas on the prevalence of foot osteoarthritis in older women: the Chingford general population cohort.
The third occipital condyle, a constituent part of a median occipito-atlanto-odontoid joint: a case report.
TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.
Treatment with TNF-? inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis.
Two-Year Results of the PHANTOM High Flex Trial: A Single-Arm Study on the Atlas Unicompartmental Knee System Load Absorber in Patients With Medial Compartment Osteoarthritis of the Knee.
Updated osteoarthritis reference standard.
Validating a new computed tomography atlas for grading ankle osteoarthritis.
Variations in the pre-operative status of patients coming to primary hip replacement for osteoarthritis in European orthopaedic centres.
Osteoarthritis, Hip
Scoring hip osteoarthritis with MRI (SHOMRI): A whole joint osteoarthritis evaluation system.
Osteoarthritis, Knee
A Standardized, Pragmatic Approach to Knee Ultrasound for Clinical Research in Osteoarthritis: The Johnston County Osteoarthritis Project.
Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial.
Defining the presence of radiographic knee osteoarthritis: a comparison between the Kellgren and Lawrence system and OARSI atlas criteria.
Development of a logically devised line drawing atlas for grading of knee osteoarthritis.
Does increasing the grades of the knee osteoarthritis line drawing atlas alter its clinimetric properties?
Reliability of grading scales for individual radiographic features of osteoarthritis of the knee. The Baltimore longitudinal study of aging atlas of knee osteoarthritis.
Two-Year Results of the PHANTOM High Flex Trial: A Single-Arm Study on the Atlas Unicompartmental Knee System Load Absorber in Patients With Medial Compartment Osteoarthritis of the Knee.
Osteoblastoma
Benign osteoblastoma of the atlas. A case report.
Benign osteoblastoma of the atlas: a case report.
Bilateral C-1 lateral mass reconstruction following radical resection of a giant osteoblastoma of the atlas: case report.
Craniovertebral junction neoplasms in the pediatric population.
Massive benign osteoblastoma of the clivus and atlas.
Osteoblastoma of the atlas.
Recurrent burner syndrome due to presumed cervical spine osteoblastoma in a collision sport athlete - a case report.
Transoral-transpharyngeal approach to the anterior craniocervical junction. Ten-year experience with 72 patients.
Tumors of the atlas. 3 incidental cases of osteochondroma, benign osteoblastoma, and atypical Ewing's sarcoma.
Tumours of the atlas and axis: a 37-year experience with diagnosis and management.
[Benign osteoblastoma of the atlas. Case report]
Osteochondroma
A case of osteochondroma of the atlas causing obstructive sleep apnea syndrome.
Cervical cord compression by solitary osteochondroma of the atlas.
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
Compressive Myelopathy due to Osteochondroma of the Atlas and Review of the Literature.
Mandibular pain as a consequence of atlas osteochondroma.
Myelopathy and Quadriparesis due to Spinal Cord Compression of C1 Laminar Osteochondroma.
Osteochondroma of the atlas: a case report.
Solitary osteochondroma of the atlas causing spinal cord compression: a case report and literature review.
Tumors of the atlas. 3 incidental cases of osteochondroma, benign osteoblastoma, and atypical Ewing's sarcoma.
[Case of the month. Chiari I deformity and osteochondroma of the atlas]
Osteolysis
Sinonasal Extramedullary Plasmacytoma With Rare Osteolytic Lesions.
Osteoma
"Dynamic" Rotational Canal Stenosis Caused by Osteoma of the Atlas: A Case Report and Review of Literature.
Osteoma, Osteoid
Occipital pain in osteoid osteoma of the atlas. A report of two cases.
Osteoid Osteoma of the Atlas in a Boy: Clinical and Imaging Features-A Case Report and Review of the Literature.
Osteoid osteoma of the atlas.
Radiofrequency ablation of osteoid osteoma in the atlas: A case report.
Osteomyelitis
Actinomycotic osteomyelitis of the skull and atlas with late dissemination. A case of transient neurosurgical syndrome.
Acute Osteomyelitis of Atlas and Axis, with Recovery.
Candida albicans osteomyelitis of the cervical spine.
Multiple Abscesses With Osteomyelitis and Destruction of Both the Atlas and the Axis in a 4-week-old Infant.
Neonatal retropharyngeal abscess with complications: Apnea and cervical osteomyelitis.
Osteomyelitis of the atlanto-occipital region as a sequela to a pharyngeal stick injury.
Osteomyelitis of the atlas in an infant.
Pyogenic osteomyelitis of the atlas: a case report.
Pyogenic osteomyelitis of the occiput, the atlas, and the axis. A report of five cases.
Severe Fusobacteria infections (Lemierre syndrome) in two boys.
[Osteomyelitis of the atlas.]
[Primary, chronic, hematogenic osteomyelitis of the posterior tubercle of the atlas.]
Osteonecrosis
Imaging atlas for eligibility and on-study safety of potential shoulder adverse events in anti-NGF studies (Part 3).
Osteophyte
A comparison of the semiflexed (MTP) view with the standing extended view (SEV) in the radiographic assessment of knee osteoarthritis in a busy routine X-ray department.
A cross sectional study of the association between sex, smoking, and other lifestyle factors and osteoarthritis of the hand.
A cross-sectional study of the association between Heberden's nodes, radiographic osteoarthritis of the hands, grip strength, disability and pain.
A randomised controlled trial of intra-articular corticosteroid injection of the carpometacarpal joint of the thumb in osteoarthritis.
Abnormal spicules on the inferior aspect of anterior arch of atlas vertebra.
Accessory joints between basiocciput and atlas/axis in the median plane.
Age and sex differences in hip joint space among asymptomatic subjects without structural change: implications for epidemiologic studies.
Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial.
Association Between Infrapatellar Fat Pad Volume and Knee Structural Changes in Patients with Knee Osteoarthritis.
Association between KLOTHO gene and hand osteoarthritis in a female Caucasian population.
Association between metabolic syndrome and knee structural change on MRI.
Association of pain with radiological changes in different compartments and views of the knee joint.
Associations between obesity and the radiographic phenotype in knee osteoarthritis.
Associations between serum ghrelin and knee symptoms, joint structures and cartilage or bone biomarkers in patients with knee osteoarthritis.
Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS).
Atlas-based knee osteophyte assessment with ultrasonography and radiography: relationship to arthroscopic degeneration of articular cartilage.
Automatic Grading of Individual Knee Osteoarthritis Features in Plain Radiographs Using Deep Convolutional Neural Networks.
Beauty parlor stroke syndrome due to a bone fragment from an osteophyte of the atlas: case report.
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
Cervical myelopathy caused by pseudoarthrosis between posterior arch of the atlas and lamina of the axis in Klippel-Feil syndrome: a case report.
Characterisation of first metatarsophalangeal joint osteoarthritis using magnetic resonance imaging.
Characterisation of size and direction of osteophyte in knee osteoarthritis: a radiographic study.
Choosing the best method for radiological assessment of patellofemoral osteoarthritis.
Clinical and radiographic disease course of hand osteoarthritis and determinants of outcome after 6 years.
Clinical Significance of Medial Versus Lateral Compartment Patellofemoral Osteoarthritis: Cross-Sectional Analyses in an Adult Population With Knee Pain.
Clustering of hand osteoarthritis progression and its relationship to progression of osteoarthritis at the knee.
Complex cervical spondylotic myelopathy: a report of two cases and literature review.
Defining the presence of radiographic knee osteoarthritis: a comparison between the Kellgren and Lawrence system and OARSI atlas criteria.
Definition of osteoarthritis of the knee for epidemiological studies.
Development and reproducibility of a first metatarsophalangeal joint osteoarthritis magnetic resonance imaging scoring system.
Development and Validation of a Multitask Deep Learning Model for Severity Grading of Hip Osteoarthritis Features on Radiographs.
Development of a logically devised line drawing atlas for grading of knee osteoarthritis.
Development of osteoarthritis in patients with degenerative meniscal tears treated with exercise therapy or surgery. A randomized controlled trial.
Differences in the radiological characteristics between post-traumatic and non-traumatic knee osteoarthritis.
Effect of medial tibial plateau alignment on serial radiographs on the capacity to predict progression of knee osteoarthritis.
Foot osteoarthritis frequency and associated factors in a community-based cross-sectional study of White and African American adults.
Genetic influence on the progression of radiographic knee osteoarthritis: a longitudinal twin study.
High Bone Mass is associated with bone-forming features of osteoarthritis in non-weight bearing joints independent of body mass index.
High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury.
Identification of Radiographic Foot Osteoarthritis: Sensitivity of Views and Features Using The La Trobe Radiographic Atlas.
Individuals with high bone mass have an increased prevalence of radiographic knee osteoarthritis.
Knee and Hip Radiographic Osteoarthritis Predict Total Hip Bone Loss in Older Adults: A Prospective Study.
Lateral-compartment Osteophytes are not Associated With Lateral-compartment Cartilage Degeneration in Arthritic Varus Knees.
Natural history of radiographic features of hand osteoarthritis over 10 years.
Osteophytes and progression of knee osteoarthritis.
Osteophytes, juxta-articular radiolucencies and cancellous bone changes in the proximal tibia of patients with knee osteoarthritis.
Patella malalignment, pain and patellofemoral progression: the Health ABC Study.
Quantification of hip effusion-synovitis and its cross-sectional and longitudinal associations with hip pain, MRI findings and early radiographic hip OA.
Radiographic classification of osteoarthritis in commonly affected joints of the foot.
Radiographic osteoarthritis and pain are independent predictors of knee cartilage loss: a prospective study.
Reduction of leucocyte telomere length in radiographic hand osteoarthritis: a population-based study.
Relation between Heberden's nodes and distal interphalangeal joint osteophytes and their role as markers of generalised disease.
Relation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: the Chingford study.
Relationship between Heberden's nodes and underlying radiographic changes of osteoarthritis.
Reversal of longstanding musculoskeletal changes in basilar invagination after surgical decompression and stabilization.
Risk factors for osteoarthritis in the tibiofemoral and patellofemoral joints of the knee.
Risk factors for progression of lumbar spine disc degeneration: the Chingford Study.
The association between hormonal and reproductive factors and hand osteoarthritis.
The median atlanto-occipital joint in advanced age.
The natural history of radiographic first metatarsophalangeal joint osteoarthritis: a nineteen-year population based cohort study.
TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.
Trabecular morphometry by fractal signature analysis is a novel marker of osteoarthritis progression.
Treatment with TNF-? inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis.
Ultrasonographic assessment of osteophytes in 127 patients with hand osteoarthritis: exploring reliability and associations with MRI, radiographs and clinical joint findings.
Vertebral spinal osteophytes.
["Crowned" odontoid process and osteoarthrosis of the anterior atlantoaxial joint (author's transl)]
Osteoporosis
An atlas of genetic influences on osteoporosis in humans and mice.
Author Correction: An atlas of genetic influences on osteoporosis in humans and mice.
Odontoid fractures complicated by fractures of the posterior arch of the atlas in the elderly over 85 years with severe thoracic kyphosis secondary to osteoporosis.
Osteosarcoma
A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
A DNA methylation-associated nomogram predicts the overall survival of osteosarcoma.
Analyzing the disease module associated with osteosarcoma via a network- and pathway-based approach.
Comprehensive Analysis of Aerobic Exercise-Related Genes Identifies CDCA4 That Promotes the Progression of Osteosarcoma.
DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas.
Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
Homeodomain-containing gene 10 inhibits cell apoptosis and promotes cell invasion and migration in osteosarcoma cell lines.
Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma.
Long noncoding RNA MEG3 play an important role in osteosarcoma development through sponging microRNAs.
Long term survival of an atlas osteosarcoma treated by surgery, chemotherapy and robotic stereotactic radiotherapy: a case report.
m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
Occipito-cervical Reconstruction Through Direct Lateral and Posterior Approach or the Treatment of Primary Osteosarcoma in the Atlas: A Case Report.
Osteosarcoma of the atlas in a dog.
Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma.
The value of Angipoietin-2 as a biomarker for the prognosis of osteosarcoma: A protocol for systematic review and meta-analysis.
Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases.
Otitis Media
Severe Fusobacteria infections (Lemierre syndrome) in two boys.
Unusual presentations of craniovertebral junction tuberculosis: a report of 2 cases and literature review.
Otorhinolaryngologic Diseases
[Otorhinolaryngological diseases in radiography. A clinical and practical atlas]
Ovarian Neoplasms
'BRCAness' and its implications for platinum action in gynecologic cancer.
A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.
A FXYD5/TGF??/SMAD positive feedback loop drives epithelial?to?mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.
A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors.
A graph-based multi-sample test for identifying pathways associated with cancer progression.
A mixture copula Bayesian network model for multimodal genomic data.
A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.
A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population.
A non-negative matrix factorization method for detecting modules in heterogeneous omics multi-modal data.
A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
Adverse Drug Events-based Tumor Stratification for Ovarian Cancer Patients Receiving Platinum Therapy.
Age-related copy number variations and expression levels of F-box protein FBXL20 predict ovarian cancer prognosis.
An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients.
An integrated analysis reveals the oncogenic function of lncRNA LINC00511 in human ovarian cancer.
An integrated network of microRNA and gene expression in ovarian cancer.
Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.
ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.
Association analysis of a chemo-response signature identified within The Cancer Genome Atlas aimed at predicting genetic risk for chemo-response in ovarian cancer.
Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer.
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer.
Bayesian graphical models for computational network biology.
Beyond genomics: critical evaluation of cell line utility for ovarian cancer research.
Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer.
BNIP3 contributes to cisplatin-induced apoptosis in ovarian cancer cells.
BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different.
Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.
CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
Clinical and prognostic effects of CDKN2A, CDKN2B and CDH13 promoter methylation in ovarian cancer: a study using meta-analysis and TCGA data.
Clinically Relevant microRNAs in Ovarian Cancer.
Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma.
Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis.
Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer.
Cooperative driver pathway discovery via fusion of multi-relational data of genes, miRNAs and pathways.
Correlation between gene expression and mutator phenotype predicts homologous recombination deficiency and outcome in ovarian cancer.
Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/?-Catenin-Mediated EMT and Tumour Metastasis.
Data integration to prioritize drugs using genomics and curated data.
Death receptor 6 promotes ovarian cancer cell migration through KIF11.
Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1.
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.
Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis.
Development of a multi-gene-based immune prognostic signature in ovarian Cancer.
DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis.
Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells.
Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile.
Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer.
Discovery of multi-dimensional modules by integrative analysis of cancer genomic data.
Discovery of mutated subnetworks associated with clinical data in cancer.
DNA methylation subtypes for ovarian cancer prognosis.
Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review.
Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer.
ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition.
Enhancing the sensitivity of ovarian cancer cells to olaparib via microRNA-20b-mediated cyclin D1 targeting.
Epigenetic regulation of IQGAP2 promotes ovarian cancer progression via activating Wnt/?-catenin signaling.
Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment.
Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes.
Estimation of Heterogeneous Restricted Mean Survival Time Using Random Forest.
Estrogen-related receptor alpha copy number variation is associated with ovarian cancer histological grade.
Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.
Exploration of Genomic, Proteomic, and Histopathological Image Data Integration Methods for Clinical Prediction.
Exploring prognostic genes in ovarian cancer stage-related coexpression network modules.
Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
Expression profile and prognostic value of SFN in human ovarian cancer.
Expression profiles and prognostic values of BolA family members in ovarian cancer.
FGMD: A novel approach for functional gene module detection in cancer.
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
GEMINI: a computationally-efficient search engine for large gene expression datasets.
Gene-Gene Interaction Analysis for the Survival Phenotype Based on the Kaplan-Meier Median Estimate.
Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens.
Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer.
Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer.
Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene.
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer.
Glutamine-fructose-6-phosphate transaminase 2 (GFPT2) promotes the EMT of serous ovarian cancer by activating the hexosamine biosynthetic pathway to increase the nuclear location of ?-catenin.
Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/?-catenin signaling and is regulated by miR-133a-3p.
Graph-based semi-supervised learning with genomic data integration using condition-responsive genes applied to phenotype classification.
HDAC10 as a potential therapeutic target in ovarian cancer.
High expression of miR-532-5p, a tumor suppressor, leads to better prognosis in ovarian cancer both in vivo and in vitro.
HMGA2 and high-grade serous ovarian carcinoma.
Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian Cancer.
Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer.
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.
Identification of influential observations in high-dimensional cancer survival data through the rank product test.
Identification of key genes and pathways associated with topotecan treatment using multiple bioinformatics tools.
Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Identification of rare germline copy number variations over-represented in five human cancer types.
Identification of the miRNA signature associated with survival in patients with ovarian cancer.
Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Identification of two molecular subtypes of dysregulated immune lncRNAs in ovarian cancer.
Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Identifying candidate drivers of drug response in heterogeneous cancer by mining high throughput genomics data.
Identifying Functional Modules in Co-Regulatory Networks Through Overlapping Spectral Clustering.
Identifying Gene Network Rewiring by Integrating Gene Expression and Gene Network Data.
Identifying microRNA/mRNA dysregulations in ovarian cancer.
Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer.
Immunoregulatory gene expression and response to bevacizumab in ovarian cancer - An analysis of the cancer genome atlas.
In North America, Some Ovarian Cancers Express the Oncogenes of Preventable Human Papillomavirus HPV-18.
Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis.
Inferring active and prognostic ligand-receptor pairs with interactions in survival regression models.
Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells.
Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer.
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma.
Integrated multiomic predictors for ovarian cancer survival.
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.
Integrative network analysis for survival-associated gene-gene interactions across multiple genomic profiles in ovarian cancer.
Integrative network analysis of TCGA data for ovarian cancer.
Interactions between tumor mutation burden and immune infiltration in ovarian cancer.
Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis.
Kelch-like protein 14 promotes proliferation and migration of ovarian cancer cells.
Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer.
Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells.
Knowledge-driven genomic interactions: an application in ovarian cancer.
KRT7 promotes epithelial?mesenchymal transition in ovarian cancer via the TGF??/Smad2/3 signaling pathway.
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women.
Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition.
Low EIF2B5 expression predicts poor prognosis in ovarian cancer.
Low-dose mono(2-ethylhexyl) phthalate promotes ovarian cancer development through PPAR?-dependent PI3K/Akt/NF-?B pathway.
MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma.
miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression.
miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
Molecular insights into the transcriptional regulatory role of thyroid hormones in ovarian cancer.
Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Multi-omics Data Integration by Generative Adversarial Network.
Network-Based Isoform Quantification with RNA-Seq Data for Cancer Transcriptome Analysis.
Network-based machine learning and graph theory algorithms for precision oncology.
On the reproducibility of TCGA ovarian cancer microRNA profiles.
Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity.
Overexpression of TMEM158 contributes to ovarian carcinogenesis.
Pathway index models for construction of patient-specific risk profiles.
Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.
Peroxiredoxin-5 is a negative survival predictor in ovarian cancer.
Platinum Sensitivity-Related Germline Polymorphism Discovered via a Cell-Based Approach and Analysis of Its Association with Outcome in Ovarian Cancer Patients.
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.
PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43.
ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
Prognostic relevance of acquired uniparental disomy in serous ovarian cancer.
Prognostic signature of ovarian cancer based on 14 tumor microenvironment-related genes.
Prognostic values of GMPS, PR, CD40, and p21 in ovarian cancer.
Protein anabolism is key to long-term survival in high-grade serous ovarian cancer.
Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer.
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.
Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Reannotation and Analysis of Clinical and Chemotherapy Outcomes in the Ovarian Data Set From The Cancer Genome Atlas.
Reduced levels of actin gamma 1 predict poor prognosis in ovarian cancer patients.
Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer.
RSPO3 is a marker candidate for predicting tumor aggressiveness in ovarian cancer.
S-score: a scoring system for the identification and prioritization of predicted cancer genes.
Semi-supervised identification of cancer subgroups using survival outcomes and overlapping grouping information.
Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression.
Single gold-bridged nanoprobes for identification of single point DNA mutations.
Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma.
Single-sample expression-based chemo-sensitivity score improves survival associations independently from genomic mutations for ovarian cancer Patients.
Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival.
Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer.
Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers.
Targeting c-MYC in Platinum-Resistant Ovarian Cancer.
The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis.
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer.
The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment.
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
The prognostic values of matrix metalloproteinases in ovarian cancer.
The prognostic values of the peroxiredoxins family in ovarian cancer.
The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-?/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer.
The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression.
Toward Recovering Allele-specific Cancer Genome Graphs.
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.
TP53 oncomorphic mutations predict resistance to platinum? and taxane?based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.
Tryptophan 2, 3?dioxygenase promotes proliferation, migration and invasion of ovarian cancer cells.
Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications.
Tumor infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T cell responses, and superior prognosis in ovarian cancer.
Tumor specific methylome in Chinese high-grade serous ovarian cancer characterized by gene expression profile and tumor genotype.
Using knowledge-driven genomic interactions for multi-omics data analysis: metadimensional models for predicting clinical outcomes in ovarian carcinoma.
Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?
Wnt Signaling and Survival of Women With High-Grade Serous Ovarian Cancer: A Brief Report.
ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer.
Overweight
Association of cancer mortality with postdiagnosis overweight and obesity using body mass index.
Main Therapeutic Uses of Some Moroccan Hot Springs' Waters.
Obesity, overweight and body-weight perception in a High Atlas Moroccan population.
Sci-Fri AM: Imaging - 06: The role of body mass and gender in atlas construction for attenuation correction in PET/MRI.
Pancreatic Diseases
Radiological Atlas of Biliary and Pancreatic Disease.
Single-Nucleus and In Situ RNA-Sequencing Reveal Cell Topographies in the Human Pancreas.
The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1aCre/+;LSL-KrasG12D/+ transgenic mouse model of pancreatic cancer.
Pancreatic Neoplasms
??elemene inhibits the generation of peritoneum effusion in pancreatic cancer via suppression of the HIF1A?VEGFA pathway based on network pharmacology.
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer.
A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.
A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients.
A two-gene-based prognostic signature for pancreatic cancer.
Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
An overactive neddylation pathway serves as a therapeutic target and MLN4924 enhances the anticancer activity of cisplatin in pancreatic cancer.
ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer.
B3GNT3: A prognostic biomarker associated with immune cell infiltration in pancreatic adenocarcinoma.
Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features.
CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway.
Deep learning-based gene selection in comprehensive gene analysis in pancreatic cancer.
Development and validation of a ferroptosis-related prognostic model in pancreatic cancer.
Development and validation of a four-lipid metabolism gene signature for diagnosis of pancreatic cancer.
Development and Validation of a Novel Metabolic-Related Signature Predicting Overall Survival for Pancreatic Cancer.
Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins.
Expression and prognostic analyses of the insulin-like growth factor 2 mRNA binding protein family in human pancreatic cancer.
Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.
Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data mining.
Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer.
Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment.
Genomic analysis of pancreatic cancer reveals 3 molecular subtypes with different clinical outcomes.
GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.
HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer.
High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer.
Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer.
HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
Human ALKBH6 Is Required for Maintenance of Genomic Stability and Promoting Cell Survival During Exposure of Alkylating Agents in Pancreatic Cancer.
Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients With Pancreatic Cancer.
Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer.
Identification of Key mRNAs as Prediction Models for Early Metastasis of Pancreatic Cancer Based on LASSO.
Imaging and Pathology of Pancreatic Neoplasms: A Pictorial Atlas Edited by Mirko D'Onofrio , Paola Capelli , and Paolo Pederzoli New York, NY , Springer Science & Business Media , 2015 . ISBN: 978-88-470-5677-0 . Hardcover, $109.00; pp 432 .
IMIX: a multivariate mixture model approach to association analysis through multi-omics data integration.
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels.
Integrating high-throughput microRNA and mRNA expression data to identify risk mRNA signature for pancreatic cancer prognosis.
Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Integrin ?6?4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer.
Knockdown of ISOC1 suppresses cell proliferation in pancreatic cancer in vitro.
LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p.
Long non-coding RNA LINC00460 predicts poor survival and promotes cell viability in pancreatic cancer.
MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.
MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value.
MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer.
Mind Bomb 1 Promotes Pancreatic Cancer Proliferation by Activating ?-Catenin Signaling.
Mirko D'Onofrio, Paola Capelli and Paolo Pederzoli (Eds) Imaging and Pathology of Pancreatic Neoplasms. A Pictorial Atlas : Springer-Verlag Italia, 2015 ISBN 978-88-470-5677-0.
Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
Mutations of p53 associated with pancreatic cancer and therapeutic implications.
NCEH1 may be a prognostic biomarker for pancreatic cancer.
Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma.
Novel three?lncRNA signature predicts survival in patients with pancreatic cancer.
Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.
Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma.
Overexpression and biological function of IQGAP3 in human pancreatic cancer.
Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer.
Pancreatic adenocarcinomas with mature blood vessels have better overall survival.
Pancreatic cancer as a sentinel for hereditary cancer predisposition.
Pancreatic Cancer Cell Fraction Estimation in a DNA Sample.
PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer.
PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.
Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation.
Prognostic value and immunological characteristics of a novel autophagy-related signature in pancreatic cancer.
Proteogenomic analysis of pancreatic cancer subtypes.
Relating pancreatic ductal adenocarcinoma tumor samples and cell lines using gene expression data in translational research.
Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis.
Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database.
Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transition.
Structural impact due to PPQEE deletion in multiple cancer associated protein - Integrin ?V: An In silico exploration.
SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents.
Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/?-catenin pathway in pancreatic cancer cells.
The Biological Function Delineated Across Pan-Cancer Levels Through lncRNA-Based Prognostic Risk Assessment Factors for Pancreatic Cancer.
The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells.
The construction and analysis of a ferroptosis-related gene prognostic signature for pancreatic cancer.
The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study.
The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.
The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1aCre/+;LSL-KrasG12D/+ transgenic mouse model of pancreatic cancer.
The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer.
TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer.
YAP1 is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Pancreatic Cancer.
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
Papilloma
Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5'-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients.
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.
Papillomavirus Infections
Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes.
Paraganglioma
A long noncoding RNA-microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas.
Phaeochromocytomas overexpress insulin transcript and produce insulin.
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Paralysis
An unusual aetiology of unilateral vagal palsy: A case report.
Bone Age in Children With Obstetrical Brachial Plexus Palsy: Effect of Peripheral Nerve Injury on Skeletal Maturation.
Bony exostosis of the atlas with resultant cranial nerve palsy.
Cruciate paralysis and hemiplegia cruciata: report of three cases.
Occipital condyle fractures: clinical presentation and radiologic detection.
Plasmacytoma of the atlas presenting as hoarseness: a rare cause of unilateral vocal fold palsy.
Selective paralysis of the upper extremities after odontoid fracture: acute central cord syndrome or cruciate paralysis?
[Atlas fractures with paralysis of the caudal cranial nerves. A case report]
[Hypoglossal nerve palsy caused by hypoplasia of the atlas and ossification of the posterior longitudinal ligament]
Paraplegia
[Classification of upper cervical fractures: a review].
Paraproteinemias
Exploration of the personalized immune checkpoint atlas of plasma cell dyscrasias patients using high?dimensional single?cell analysis.
Parasitic Diseases
An Atlas of Infectious and Parasitic Diseases of the Central Nervous System. A Cooperative Study of SILAN (Sociedad Iberolatinoamericana de Neurorradiologia).
Global mapping of lymphatic filariasis.
Human Parasitic Diseases: A Diagnostic Atlas.
Parathyroid Diseases
Parathyroid subtraction imaging--pitfalls in diagnosis.
Paresthesia
Clinical Paresthesia Atlas Illustrates Likelihood of Coverage Based on Spinal Cord Stimulator Electrode Location.
New advancements in spinal cord stimulation for chronic pain management.
Parkinson Disease
3D Textural, Morphological and Statistical Analysis of Voxel of Interests in 3T MRI Scans for the Detection of Parkinson's Disease Using Artificial Neural Networks.
A probabilistic functional atlas of the human subthalamic nucleus.
A Probabilistic Functional Atlas of the VIM Nucleus Constructed from Pre-, Intra- and Postoperative Electrophysiological and Neuroimaging Data Acquired during the Surgical Treatment of Parkinson's Disease Patients.
A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease.
Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
Computed three-dimensional atlas of subthalamic nucleus and its adjacent structures for deep brain stimulation in Parkinson's disease.
Correlated regions of cerebral blood flow with clinical parameters in Parkinson's disease; comparison using 'Anatomy' and 'Talairach Daemon' software.
Creation of Computerized 3D MRI-Integrated Atlases of the Human Basal Ganglia and Thalamus.
Development and Implementation of a Corriedale Ovine Brain Atlas for Use in Atlas-Based Segmentation.
Dynamic Atlas-based segmentation and quantification of Neuromelanin-rich brainstem structures in Parkinson disease.
Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine.
HybraPD atlas: Towards precise subcortical nuclei segmentation using multimodality medical images in patients with Parkinson disease.
In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data.
Longitudinal Connectomes as a Candidate Progression Marker for Prodromal Parkinson's Disease.
Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study.
Modeling of Electric Fields in Individual Imaging Atlas for Capsular Threshold Prediction of Deep Brain Stimulation in Parkinson's Disease: A Pilot Study.
Multi-contrast unbiased MRI atlas of a Parkinson's disease population.
Multi-parametric analysis assists in STN localization in Parkinson's patients.
Optimal location of thalamotomy lesions for tremor associated with Parkinson disease: a probabilistic analysis based on postoperative magnetic resonance imaging and an integrated digital atlas.
Regional transcriptional architecture of Parkinson's disease pathogenesis and network spread.
Single-cell brain atlas of Parkinson's disease mouse model.
Subthalamic nucleus stimulation for advanced Parkinson's disease: how to find a far medial STN.
Parkinsonian Disorders
[Atlas of cranial and spinal MRI--magnetic resonance imaging in carbon monoxide poisoning and Parkinsonian syndrome]
Pelvic Infection
Pouchitis atlas for objective endoscopic diagnosis.
Penile Induration
Surgical Atlas. Correction of Peyronie's disease: plaque incision and grafting.
Periodontal Diseases
An Atlas of the Surgical Management of Periodontal Disease.
Periodontitis
Human oral mucosa cell atlas reveals a stromal-neutrophil axis regulating tissue immunity.
Identification of the Bacterial Biosynthetic Gene Clusters of the Oral Microbiome Illuminates the Unexplored Social Language of Bacteria during Health and Disease.
Immune landscape of periodontitis unveils alterations of infiltrating immunocytes and molecular networks-aggregating into an interactive web-tool for periodontitis related immune analysis and visualization.
Peripheral Nerve Injuries
ATLAS OF PERIPHERAL NERVE INJURIES.
Peripheral Vascular Diseases
A Colour Atlas of Peripheral Vascular Diseases.
Peroxisomal Disorders
Atlas of common lysosomal and peroxisomal disorders - manual of metabolic diseases
Persistent Infection
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing.
Pheochromocytoma
A long noncoding RNA-microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas.
Integrative analysis of ceRNA network and DNA methylation associated with gene expression in malignant pheochromocytomas: a study based on The Cancer Genome Atlas.
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
[Tomodensitometry in pheochromocytomas]
Pierre Robin Syndrome
Combined occipitoatlantoaxial hypermobility with anterior and posterior arch defects of the atlas in Pierre-Robin syndrome.
Pinealoma
[Atlas of intracranial tumors. 9. Pinealoma and teratoma]
Plagiocephaly
Palpatory diagnosis of plagiocephaly.
Plague
Atlas occipitalisation associated with other anomalies in a 16th century skeleton from Sardinia (Italy).
The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities.
[Towards <>: idea, principle and methodology of design and research results]
Plasmacytoma
Comprehensive investigation of the clinical significance and molecular mechanisms of plasmacytoma variant translocation 1 in sarcoma using genome-wide RNA sequencing data.
Pathological fracture of the atlas secondary to plasmacytoma.
Plasmacytoma of the atlas presenting as hoarseness: a rare cause of unilateral vocal fold palsy.
Surgical Resection of Solitary Bone Plasmacytoma of Atlas and Reconstruction with 3-Dimensional-Printed Titanium Patient-Specific Implant.
[Halo-fixator vest--indications and complications]
[Plasmacytoma involving the atlas and axis]
Platybasia
Assimilation of the atlas and basilar impression: a review of 1,500 skull and cervical spine radiographs.
Cerebellar infarctions secondary to cranio-cervical anomalies: a case report.
Congenital basilar impression: correlated neurological syndromes.
Successful treatment of adult Arnold-Chiari malformation associated with basilar impression and syringomyelia by the transoral anterior approach.
[2 cases of bone deformity at the cranio-vertebral junction, accompanying occipitalization of atlas and basilar impression]
[A case of hypoplasia and unilateral assimilation of the atlas with platybasia, basilar impression and Arnold-Chiari deformity.]
[A case with complicated disorder of the occipito-cervical junction]
[An alternative dorsal fusion technique after transoral dens resection in basilar impression with atlas assimilation]
[Atlas assimilation and basilar impression.]
[Biomechanism of intracranial and spinal trauma of child born in occipitoanterior presentation as used in forensic examination]
[Clinical picture of congenital atlas assimilation with basilar impression; with a contribution on the theme, neural pathology of spine.]
[Early diagnosis of basilar impression and atlas assimilation from clinical manifestations.]
[Occipitalization of the atlas (Wackenheim III), basilar impression, chiari malformation (I) and paracondyloid process]
[Sudden deafness and the craniocervical transition]
[Sudden hearing loss and the cranio-cervical junction]
[X-ray diagnosis of cranio-vertebral anomalies]
Pleural Effusion
A panel of novel detection and prognostic methylated DNA markers in primary non-small cell lung cancer and serum DNA.
Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Pneumoconiosis
[Radiographic atlas of pneumoconiosis]
Pneumocystis Infections
Signatures of B Cell Receptor Repertoire Following Pneumocystis Infection.
Pneumonia
Association of hospice utilization and publicly reported outcomes following hospitalization for pneumonia or heart failure: a retrospective cohort study.
Gene expression profiling in inflammatory airway disease associated with elevated adenosine.
Impact of hospitals' Referral Region racial and ethnic diversity on 30-day readmission rates of older adults.
Pneumonia, Ventilator-Associated
First year of mandatory reporting of healthcare-associated infections, pennsylvania: an infection control-chart abstractor collaboration.
Pneumoperitoneum
[Pneumoperitoneum: diagnostic value. II. Exploration of the abdomen. Atlas de radiologie clinique.]
Polymicrogyria
Neuroimaging findings in Pallister-Killian syndrome.
Porokeratosis
Mibelli revisited: A case of type 2 segmental porokeratosis from 1893.
Post-Traumatic Headache
Can atlas spina bifida-occulta be a cause of cervicogenic headaches?
Incidence of ponticulus posterior of the atlas in migraine and cervicogenic headache.
Pouchitis
Pouchitis atlas for objective endoscopic diagnosis.
Pre-Eclampsia
Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Identification of Potential Signatures and Their Functions for Acute Lymphoblastic Leukemia: A Study Based on the Cancer Genome Atlas.
Pregnancy Complications
Visualizing Dynamic Changes at the Maternal-Fetal Interface Throughout Human Pregnancy by Mass Cytometry.
Pregnancy, Tubal
[Radiological diagnosis of tubal pregnancies. Atlas de radiologie clinique.]
Premature Birth
Multi-contrast human neonatal brain atlas: Application to normal neonate development analysis.
Priapism
Mythology and Neurosurgery.
Primary Myelofibrosis
Images from the Haematologica Atlas of Hematologic Cytology: primary myelofibrosis, micromegakaryocytic transformation.
Prognathism
Upper spine morphology in hypophosphatemic rickets and healthy controls: a radiographic study.
[Relation between atlas position, prognathism and prognathous jaw anomalies]
Prolactinoma
MicroRNA?29?3p regulates the ??catenin pathway by targeting IGF1 to inhibit the proliferation of prolactinoma cells.
Prosopagnosia
Looking beyond the face area: lesion network mapping of prosopagnosia.
Prostatic Hyperplasia
Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs.
Prostatic Neoplasms
A genomic and epigenomic atlas of prostate cancer in Asian populations.
A geographic analysis of prostate cancer mortality in the United States, 1970-89.
A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expression.
A Multiphase Validation of Atlas-Based Automatic and Semiautomatic Segmentation Strategies for Prostate MRI.
A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer.
Accurate diagnosis of prostate cancer using logistic regression.
Adaptation of a 3D prostate cancer atlas for transrectal ultrasound guided target-specific biopsy.
ALDH1A3 correlates with luminal phenotype in prostate cancer.
Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patients.
Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
Analysis of interactions between the epigenome and structural mutability of the genome using Genboree Workbench tools.
Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk.
Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity.
Androgen metabolism genes in prostate cancer health disparities.
ANKRD22 is involved in the progression of prostate cancer.
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation.
Autophagy-related genes are potential diagnostic and prognostic biomarkers in prostate cancer.
BAP1 functions as a tumor promoter in prostate cancer cells through EMT regulation.
C-MYC, HIF-1?, ERG, TKT, and GSTP1: an Axis in Prostate Cancer?
Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer.
Cholesterol uptake and regulation in high-grade and lethal prostate cancers.
Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
Clinical significance of EPHX2 deregulation in prostate cancer.
Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer.
Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
Comprehensive Analysis of the Relationship Between Metabolic Reprogramming and Immune Function in Prostate Cancer.
Comprehensive investigation of alternative splicing and development of a prognostic risk score for prostate cancer based on six-gene signatures.
Comprehensive microRNA profiling of prostate cancer cells after ionizing radiation treatment.
Computational Methods and Correlation of Exon-skipping Events with Splicing, Transcription, and Epigenetic Factors.
Computer-Assisted, Atlas-Based Segmentation for Target Volume Delineation in Whole Pelvic IMRT for Prostate Cancer.
Computerized Classification of Prostate Cancer Gleason Scores from Whole Slide Images.
CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.
Creation of RTOG compliant patient CT-atlases for automated atlas based contouring of local regional breast and high-risk prostate cancers.
Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients.
Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.
Differentially Expressed Genes Associated With Prognosis in Locally Advanced Lymph Node-Negative Prostate Cancer.
Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment.
Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells.
Downregulation of Collagen COL4A6 Is Associated with Prostate Cancer Progression and Metastasis.
Dysregulation of cystathionine ?-lyase promotes prostate cancer progression and metastasis.
Early growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancer.
Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression.
Epithelial Splicing Regulatory Protein (ESPR1) Expression in an Unfavorable Prognostic Factor in Prostate Cancer Patients.
Expression array analysis of the hepatocyte growth factor invasive program.
Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.
Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling.
Gene expression profiling to identify the toxicities and potentially relevant disease outcomes due to endosulfan exposure.
Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort.
Genetics and biology of prostate cancer.
Genome and transcriptome profiling of FBXW family in human prostate cancer.
Genome atlas analysis based profiling of Akt pathway genes in the early and advanced human prostate cancer.
Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis.
Geographic variation in prostate cancer mortality rates among white males in the united states.
High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer.
High risk human papilloma viruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer.
hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
Human Prostate Cancer Hallmarks Map.
Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.
Identification of core genes associated with prostate cancer progression and outcome via bioinformatics analysis in multiple databases.
Identification of miRNA-Mediated Subpathways as Prostate Cancer Biomarkers Based on Topological Inference in a Machine Learning Process Using Integrated Gene and miRNA Expression Data.
Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis.
Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells.
Identification of potential autophagy-associated lncRNA in prostate cancer.
Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis.
Identification of RNA-binding protein SNRPA1 for prognosis in prostate cancer.
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy.
Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-?/? Recombinations.
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer.
Improvement in prediction of prostate cancer prognosis with somatic mutational signatures.
Indel detection from DNA and RNA sequencing data with transIndel.
ING3 promotes prostate cancer growth by activating the androgen receptor.
Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.
Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.
Integrative Analysis of MicroRNA and Gene Interactions for Revealing Candidate Signatures in Prostate Cancer.
Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer.
Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition.
KAT5 Negatively regulates the proliferation of prostate cancer LNCaP cells via the caspase 3-dependent apoptosis pathway.
Knockdown of TNF receptor-associated factor 2 (TRAF2) modulates in vitro growth of TRAIL-treated prostate cancer cells.
LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer.
Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination.
Low expression of the androgen-induced tumor suppressor gene PLZF and lethal prostate cancer.
Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes.
Microarray-based data mining reveals key genes and potential therapeutic drugs for Cadmium-induced prostate cell malignant transformation.
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
miR-210 is induced by hypoxia and regulates neural cell adhesion molecule in prostate cells.
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
miR-484 is associated with disease recurrence and promotes migration in prostate cancer.
miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation.
Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation.
Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer.
Molecular subtyping of prostate cancer.
Multiatlas-based segmentation with preregistration atlas selection.
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
Network-based multi-task learning models for biomarker selection and cancer outcome prediction.
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Post-Operative Prostate Cancer.
Oncogenic Properties of NEAT1 in Prostate Cancer Cells Depend on the CDC5L-AGRN Transcriptional Regulation Circuit.
Optimized prostate biopsy via a statistical atlas of cancer spatial distribution.
Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer.
p53/PGC?1??mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis.
PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance.
Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements.
Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy Model.
Profiles of miRNA Isoforms and tRNA Fragments in Prostate Cancer.
Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer.
Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence.
Prostate Cancer Gene Regulatory Network Inferred from RNA-Seq Data.
Prostate Cancer Genomic Subtypes.
Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins.
PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy.
regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors.
Revisiting Prostate Cancer Recurrence with PSMA PET: Atlas of Typical and Atypical Patterns of Spread.
Robust genomic copy number predictor of pan cancer metastasis.
SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy.
Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer.
Spatial EGFR Dynamics and Metastatic Phenotypes Modulated by Upregulated EphB2 and Src Pathways in Advanced Prostate Cancer.
Statistical 3D Prostate Imaging Atlas Construction via Anatomically Constrained Registration.
Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
Targeted prostate biopsy using statistical image analysis.
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
The lncRNAs LINC00261 and LINC00665 are upregulated in long-term prostate cancer adaptation after radiotherapy.
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.
The Role of Lysosome-associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane.
The X-linked tumor suppressor TSPX downregulates cancer-drivers/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner.
TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer.
Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications.
Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
Tumor size and genomic risk in localized prostate cancer.
Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1.
Whole-exome Sequencing of Prostate Cancer in Sardinian Identify Recurrent UDP-glucuronosyltransferase Amplifications.
[Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
Prostatitis
Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs.
Proteinuria
Diagnostic accuracy study of urine dipstick in relation to 24-hour measurement as a screening tool for proteinuria in lupus nephritis.
Pseudarthrosis
A paracondylar process and early onset cervical osteoarthritis in a California Amerind adult.
Bony observations of some morphological variations and anomalies of the craniovertebral region.
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
Cervical myelopathy caused by pseudoarthrosis between posterior arch of the atlas and lamina of the axis in Klippel-Feil syndrome: a case report.
Cervical myelopathy caused by pseudoarthrosis between the atlas and axis associated with diffuse idiopathic skeletal hyperostosis.
Cervical vertebral malformations in 9 dogs: radiological findings, treatment options and outcomes.
Fracture of the odontoid process in a male individual from the medieval necropolis of Maro (Málaga, Spain).
Paleopathological features of the cervical spine in the early middle ages: natural history of degenerative diseases.
Regeneration of the skeleton by recombinant human bone morphogenetic proteins.
[Pseudarthrosis of the atlas after Jefferson's fracture]
[Treatment of pseudarthrosis of the odontoid process of the axis and complicated transodontoid posterior subluxation of the atlas]
Psoriasis
Main Therapeutic Uses of Some Moroccan Hot Springs' Waters.
PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.
Patient-dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real-world multinational survey.
The global state of psoriasis disease epidemiology: a workshop report.
Upward subluxation of the axis in ankylosing spondylitis. A clinical pathologic report.
Puberty, Precocious
Letter to the Editor From Gabby Atlas et al: "Long-term Outcomes of Treatments for Central Precocious Puberty or Early and Fast Puberty in Chinese Girls".
Pulmonary Disease, Chronic Obstructive
A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients.
A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Autophagy-related genes contribute to malignant progression and have a clinical prognostic impact in colon adenocarcinoma.
Bioinformatics analysis of RNA-seq data revealed critical genes in colon adenocarcinoma.
Chaperonin-Containing TCP1 Subunit 6A Is a Prognostic Potential Biomarker That Correlates With the Presence of Immune Infiltrates in Colorectal Cancer.
Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis.
Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma.
Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
Development and Characterization of a Chest CT Atlas.
Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.
Diagnostic and prognostic values of integrin ? subfamily mRNA expression in colon adenocarcinoma.
Disparities in access to food and chronic obstructive pulmonary disease (COPD)-related outcomes: a cross-sectional analysis.
Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma.
Establishment of a 12-gene expression signature to predict colon cancer prognosis.
Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
Extracellular vesicles from human umbilical cord mesenchymal stem cells treated with siRNA against ELFN1-AS1 suppress colon adenocarcinoma proliferation and migration.
Gene Expression Along with Genomic Copy Number Variation and Mutational Analysis Were Used to Develop a 9-Gene Signature for Estimating Prognosis of COAD.
High expression of CDH3 predicts a good prognosis for colon adenocarcinoma patients.
HOXC11 Expression Is Associated with the Progression of Colon Adenocarcinoma and Is a Prognostic Biomarker.
HTR1D, TIMP1, SERPINE1, MMP3 and CNR2 affect the survival of patients with colon adenocarcinoma.
Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma.
Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment.
Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma.
Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Identification prognosis-associated immune genes in colon adenocarcinoma.
Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
Key Candidate Genes - VSIG2 of Colon Cancer Identified by Weighted Gene Co-Expression Network Analysis.
LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
MicroRNA-1249 targets four-jointed box kinase 1 and reduces cell proliferation, migration and invasion of colon adenocarcinoma.
MicroRNAs Associated With Colon Cancer: New Potential Prognostic Markers and Targets for Therapy.
Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer.
MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method.
Peroxiredoxins and Immune Infiltrations in Colon Adenocarcinoma: Their Negative Correlations and Clinical Significances, an In Silico Analysis.
Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis.
SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis.
SOD3 induces a HIF-2?-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells.
Survival prediction in patients with colon adenocarcinoma via multi-omics data integration using a deep learning algorithm.
The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma.
The diagnosis and prognosis values of WNT mRNA expression in colon adenocarcinoma.
The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma.
The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma.
Ursolic Acid Regulates Cell Cycle and Proliferation in Colon Adenocarcinoma by Suppressing Cyclin B1.
Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.
Pulmonary Fibrosis
New reference atlas for pulmonary fibrosis severity score in systemic sclerosis.
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis.
Purpura, Thrombotic Thrombocytopenic
Transfusion medicine illustrated: a microscopic atlas of thrombotic thrombocytopenic purpura.
Pyelonephritis
AJKD Atlas of Renal Pathology: Acute Pyelonephritis.
AJKD Atlas of Renal Pathology: Chronic Pyelonephritis.
Atlas on acute pyelonephritis in children.
Pyloric Stenosis, Hypertrophic
A lost piece of melanoma history.
Pyoderma
[Presentation of pyoderma gangraenosum in a dermatologic atlas of the early 19th century]
Pyoderma Gangrenosum
[Presentation of pyoderma gangraenosum in a dermatologic atlas of the early 19th century]
Quadriplegia
Bipartite atlas with os odontoideum and synovial cyst: case report and review literature.
Cervical neurofibromatosis with quadriparesis: Management by fibular strut graft.
Congenital deformation of the posterior arch of the atlas: Subluxation of the atlanto-axial joint with temporary quadriplegia.
Incomplete ossification of the atlas in dogs with cervical signs.
Intermittent quadriparesis associated with a congenital anomaly of the posterior arch of the atlas. Case report.
Recurrent transient quadriparesis after minor cervical trauma associated with bilateral partial agenesis of the posterior arch of the atlas. Case report.
Spinal canal stenosis at the level of Atlas.
Spinal cord compression caused by ossification of the transverse ligament of the atlas.
Unilateral atlantal mass hypertrophy in acromegaly. Case report.
[Classification of upper cervical fractures: a review].
[Non-reducible anterior luxation of the atlas; quadriplegia; cure by C1 and C2 laminectomy.]
Rabies
A whole-brain map of long-range inputs to GABAergic interneurons in the mouse medial prefrontal cortex.
Mapping and Analysis of the Connectome of Sympathetic Premotor Neurons in the Rostral Ventrolateral Medulla of the Rat Using a Volumetric Brain Atlas.
Sex-Related Differential Whole-Brain Input Atlas of Locus Coeruleus Noradrenaline Neurons.
Radiation Pneumonitis
Using Generalized Equivalent Uniform Dose Atlases to Combine and Analyze Prospective Dosimetric and Radiation Pneumonitis Data From 2 Non-Small Cell Lung Cancer Dose Escalation Protocols.
Radiculopathy
Mineralization of the transverse ligament of the atlas causing compressive radiculopathy. Resolution following odontoidectomy and atlantoaxial arthrodesis.
Occipital neuralgia secondary to hypermobile posterior arch of atlas. Case report.
Rectal Neoplasms
A prognostic five long-noncoding RNA signature for patients with rectal cancer.
Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer.
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study.
Characterizing the cancer-associated microbiome with small RNA sequencing data.
Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis.
Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data.
Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: An Radiation Therapy Oncology Group Consensus Panel Contouring Atlas.
Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer.
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
Loss of PTPN4 activates STAT3 to promote the tumor growth in rectal cancer.
miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1.
Pan-cancer methylation and expression profiling of adenocarcinomas revealed epigenetic silencing in the WNT signaling pathway.
Prognostic Implication of the m6A RNA Methylation Regulators in Rectal Cancer.
Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Prospective Randomized Double-Blind Pilot Study of Site-Specific Consensus Atlas Implementation for Rectal Cancer Target Volume Delineation in the Cooperative Group Setting.
Proteogenomic characterization of human colon and rectal cancer.
Rectal MRI after neoadjuvant chemoradiation therapy: a pictorial guide to interpretation.
Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression.
The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer-The Impact in Intratumoral Heterogeneity.
[A misleading mistake in the classification of colonic and rectal cancers, in the 4th edition of the TNM Atlas, published in French by Springer]
[Preoperative radiotherapy for rectal cancer: Target volumes].
Relative Energy Deficiency in Sport
Atlas of rat fetal skeleton double stained for bone and cartilage.
Renal Insufficiency
Ethnicity and socioeconomic status influence use of primary angioplasty in patients presenting with acute myocardial infarction.
International Society of Nephrology Global Kidney Health Atlas: structures, organization and services for the management of kidney failure in North and East Asia.
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Africa.
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Eastern and Central Europe.
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin America.
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Newly Independent States and Russia.
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in North America and the Caribbean.
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Oceania and South East Asia.
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in South Asia.
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in the Middle East.
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe.
Renal Insufficiency, Chronic
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.
Respiratory Tract Infections
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum ?-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
Retinal Diseases
INFECTIOUS RETINITIS AND RETINAL DISEASE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS: A Photographic Atlas.
Retinitis
INFECTIOUS RETINITIS AND RETINAL DISEASE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS: A Photographic Atlas.
Retinitis Pigmentosa
A high-resolution RNA expression atlas of retinitis pigmentosa genes in human and mouse retinas.
Retinoblastoma
Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK).
MR Imaging Features of Retinoblastoma: Association with Gene Expression Profiles.
Retinopathy of Prematurity
Atlas of Fluorescein Angiographic Findings in Eyes Undergoing Laser for Retinopathy of Prematurity.
Retropharyngeal Abscess
Severe Fusobacteria infections (Lemierre syndrome) in two boys.
Rhabdomyolysis
Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management.
Quantitative Structure-Activity Relationship (QSAR) Model for the Severity Prediction of Drug-Induced Rhabdomyolysis by Using Random Forest.
Rheumatic Diseases
Anterior subluxation of the atlas in rheumatic diseases.
Atlas of rheumatic diseases: Differential Diagnosis in Rheumatology.
Main Therapeutic Uses of Some Moroccan Hot Springs' Waters.
Rheumatic Fever
Radiological Atlas of Chronic Rheumatic Arthritis (The Hand).
Treatment of nontraumatic atlantoaxial dislocation and fibrous fusion. Case report.
Rift Valley Fever
A Rift Valley fever atlas for Africa.
Sacroiliitis
Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part I: Active lesions.
Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part II: Structural damage lesions.
Salivary Gland Neoplasms
Guidelines for Clinical Target Volume Definition for Perineural Spread of Major Salivary Gland Cancers.
Salmonella Infections
An atlas of human kinase regulation.
Sarcoidosis
A cooperative study of sarcoidosis in Asia and Africa: analytic epidemiology.
AJKD Atlas of Renal Pathology: Sarcoidosis.
Sarcoma
A 3-DNA methylation signature as a novel prognostic biomarker in patients with sarcoma by bioinformatics analysis.
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.
A Global and Integrated Analysis of CINSARC-Associated Genetic Defects.
A Prognostic Molecular Signature of N?-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database.
A Rapid and Cost-Effective Gene Expression Assay for the Diagnosis of Well-Differentiated and Dedifferentiated Liposarcomas.
A rare case of sarcoma involving atlas.
Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas.
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.
BCL7B is a potential novel diagnosis and prognosis biomarker for sarcomas using bioinformatics analysis.
Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer.
Case Report: Exome sequencing reveals recurrent RETSAT mutations and a loss-of-function POLDIP2 mutation in a rare undifferentiated tongue sarcoma.
CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
Colorectal Cancer Prognosis is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study.
Comprehensive investigation of the clinical significance and molecular mechanisms of plasmacytoma variant translocation 1 in sarcoma using genome-wide RNA sequencing data.
Deformable Imaging Capability for the Radiation Therapy Oncology Group (RTOG) Consensus Atlas of Musculoskeletal Anatomy (CAMAS) for Soft Tissue Sarcoma of the Lower Extremities.
Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma.
Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas.
Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types.
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma.
FXR silencing in human colon cancer by DNA methylation and KRAS signaling.
Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature.
Identification of potential prognostic small nucleolar RNA biomarkers for predicting overall survival in patients with sarcoma.
Identification of prognostic alternative splicing events in sarcoma.
Identification of Tumor Microenvironment-Related Prognostic Genes in Sarcoma.
Integrated Analysis of the Transcriptome Profile Reveals the Potential Roles Played by Long Noncoding RNAs in Immunotherapy for Sarcoma.
Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8+ T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.
Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care.
Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.
miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma.
Molecular phenotyping using networks, diffusion, and topology: soft tissue sarcoma.
Neoplastic Transformation of Human Mesenchymal Stromal Cells Mediated via LIN28B.
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.
Predicted CD4+ T cell infiltration levels could indicate better overall survival in sarcoma patients.
Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature.
Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature.
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Risk score based on expression of five novel genes predicts survival in soft tissue sarcoma.
RTOG Sarcoma Radiation Oncologists Reach Consensus on Gross Tumor Volume and Clinical Target Volume on Computed Tomographic Images for Preoperative Radiotherapy of Primary Soft Tissue Sarcoma of Extremity in Radiation Therapy Oncology Group Studies.
Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Tumors of the atlas. 3 incidental cases of osteochondroma, benign osteoblastoma, and atypical Ewing's sarcoma.
[Sarcoma of the proximal end of the humerus; metastasis to the atlas, localized by tomography.]
Sarcoma, Ewing
Craniovertebral junction neoplasms in the pediatric population.
DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas.
Tumors of the atlas. 3 incidental cases of osteochondroma, benign osteoblastoma, and atypical Ewing's sarcoma.
[Clinical manifestation of Ewing's sarcoma as a retrotonsillar pharyngeal tumor]
Sarcoma, Synovial
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas.
Scabies
[Ferdinand von Hebra: the man and his work (author's transl)]
Schistosomiasis
Complex emergencies and the control and elimination of neglected tropical diseases in Africa: developing a practical approach for implementing safe and effective mapping and intervention strategies.
Global distribution of schistosomiasis: CEGET/WHO atlas.
Temperature-suitability maps for schistosomiasis in South Africa.
The colposcopic atlas of schistosomiasis in the lower female genital tract based on studies in Malawi,Zimbabwe, Madagascar and South Africa.
The Three Gorges Dam: Does the Flooding Time Determine the Distribution of Schistosome-Transmitting Snails in the Middle and Lower Reaches of the Yangtze River, China?
Sciatica
Inflammatory biomarkers do not distinguish between patients with sciatica and referred leg pain within a primary care population: results from a nested study within the ATLAS cohort.
Prognosis of sciatica and back-related leg pain in primary care: the ATLAS cohort.
Scleroderma, Systemic
AJKD Atlas of Renal Pathology: Systemic Sclerosis.
New reference atlas for pulmonary fibrosis severity score in systemic sclerosis.
Scoliosis
Another "new" form, the palagonia type of acrofacial dysostosis in a Sicilian family.
Clinical application of three-dimensional printing in the personalized treatment of complex spinal disorders.
Complex Chiari Malformation Presenting with Bulbar Symptoms in an Adult: Single-stage Posterior Fusion and Foramen Magnum Decompression: A Rare Case Report.
Congenital occipitoatlantoaxial malformations in the horse.
Is Cervical Stabilization for All Cases of Chiari-I Malformation an Overkill? Evidence Speaks Louder Than Words!
Obex position is associated with syringomyelia and use of posterior fossa decompression among patients with Chiari I malformation.
Occipitoatlantoaxial malformation in an adult goat.
The complex Chiari: issues and management strategies.
[Goldenhar syndrome: a polymalformation syndrome with conductive hearing loss]
Sea-Blue Histiocyte Syndrome
Images from the Haematologica Atlas of Hematologic Cytology: sea-blue histiocytosis.
Seizures
Anterior temporal lobe white matter abnormal signal (ATLAS) as an indicator of seizure focus laterality in temporal lobe epilepsy: comparison of double inversion recovery, FLAIR and T2W MR imaging.
Assessment of Acute Hospital Use and Transfers for Management of Pediatric Seizures.
Clinical validation of automated hippocampal segmentation in temporal lobe epilepsy.
Imaging the seizure onset zone with stereo-electroencephalography.
Partial epileptic seizure with versive movements examined by [99m Tc] HM-PAO brain single photon emission computed tomography: an early post study analyzed by computerized brain atlas methods.
Predicting the likelihood of postoperative seizure status based on mRNA sequencing in low-grade gliomas.
Quantitative analysis of double inversion recovery and FLAIR signals in temporal lobe epilepsy.
Semiologic subgroups of insulo-opercular seizures based on connectional architecture atlas.
Through diffusion tensor magnetic resonance imaging to evaluate the original properties of neural pathways of patients with partial seizures and secondary generalization by individual anatomic reference atlas.
Video atlas of lateralising and localising seizure phenomena.
Seminoma
Distinct Metabolic Features of Seminoma and Embryonal Carcinoma Revealed by Combined Transcriptome and Metabolome Analyses.
HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas.
Hypermethylation of genes in testicular embryonal carcinomas.
Methylation gene KCNC1 is associated with overall survival in patients with seminoma.
Nuclear Localization of PTTG1 Promotes Migration and Invasion of Seminoma Tumor through Activation of MMP-2.
Sepsis
Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.
Proteomic atlas of organ vasculopathies triggered by Staphylococcus aureus sepsis.
Sexually Transmitted Diseases
A Complete Practical Treatise on Venereal Diseases, and their immediate and remote Consequences; including Observations on certain Affections of the Uterus, attended with Discharges. With an Atlas of Plates.
Atlas of Skin and Venereal Diseases.
Atlas of Syphilis and the Venereal Diseases.
Atlas of Venereal Diseases.
Data harmonization process for creating the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Atlas.
Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Côte d'Ivoire, Mali and Senegal.
Performance of the Atlas Genetics Rapid Test for Chlamydia trachomatis and Women's Attitudes Toward Point-Of-Care Testing.
Shoulder Dislocation
An atlas of shoulder dislocations.
An atlas of shoulder dislocations. Part two.
Silicosis
An X-Ray Atlas of Silicosis.
Situs Inversus
Hypoplasia of the atlas causing cervical myelopathy with situs inversus totalis.
Skin Diseases
A Pictorial Atlas of Skin Diseases and Syphilitic Affections in Photo-Lithochromes, from Models in the Museum of the St Louis Hospital, Paris.
A Pictorial Atlas of Skin Diseases and Syphilitic Affections, from Models in the Museum of the Saint Louis Hospital, Paris, with Explanatory Woodcuts and Text.
A Pictorial Atlas of Skin Diseases and Syphilitic Affections, in Photo-Lithochromes.
A Pictorial Atlas of Skin Diseases and Syphilitic Affections.
Ackerman AB, Kerl H, Sanchez J, editors. A Clinical Atlas of 101 Common Skin Diseases. Ardor Scribendi Ltd., New York, 2000, 662 pages.
AN ATLAS of common skin diseases.
An Atlas of Skin Diseases in the Tropics.
An Atlas of the Commoner Skin Diseases.
AN ATLAS OF THE COMMONER SKIN DISEASES.
An Atlas of the Commoner Skin Diseases.
AN ATLAS OF THE COMMONER SKIN DISEASES: 4th Edition.
AN ATLAS OF THE COMMONER SKIN DISEASES: Fifth Edition.
Atlas of Canine and Feline Dermatoses.
Atlas of Skin Diseases of the Horse: Diagnosis and Treatment in Equine Dermatology.
Atlas of Skin Diseases.
Atlas of Skin Diseases. Part VII.
Atlas of the Commoner Skin Diseases.
ATLAS OF THE COMMONER SKIN DISEASES. Second Edition.
Book and new media reviews: An atlas of histopathology of skin diseases: An illustrated textbook and reference for clinicians
Dynamic Optical Coherence Tomography in Dermatology.
Finding Dr. Olavide Inside The Atlas of Clinical Images of the Skin and Skin Diseases.
Main Therapeutic Uses of Some Moroccan Hot Springs' Waters.
Mibelli revisited: A case of type 2 segmental porokeratosis from 1893.
Pathomorphologic atlas for differential diagnosis of skin diseases, with particular regard to tumors. Part II. Neoplasms and pseudo-neoplastic proliferations.
Robert Willan: Pioneer in morphology.
Teledermatology.
Valentin Barrecheguren (1853-1893) - Painter of the Granada Illustrations in Olavide's Atlas of Clinical Images of the Skin and Skin Diseases.
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially neoplasms. Part II. Neoplasms and pseudo-neoplastic proliferations]
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially tumors. Part I. Non-neoplastic diseases]
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially tumors. Part II. Neoplasms and pseudo-neoplastic proliferations]
[Neisser and the clap].
[Use of www.dermatoweb.net to support undergraduate teaching of dermatology]
Skin Neoplasms
Dynamic Optical Coherence Tomography in Dermatology.
Gene Coexpression Analyses Differentiate Networks Associated with Diverse Cancers Harboring TP53 Missense or Null Mutations.
Lymphoscintigraphy for sentinel lymph node mapping in Japanese patients with malignant skin neoplasms of the lower extremities: comparison with previously investigated Japanese lymphatic anatomy.
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Skin cancer: a review and atlas for the medical provider.
Somatic Functional Deletions of Upstream Open Reading Frame-Associated Initiation and Termination Codons in Human Cancer.
Sleep Apnea, Obstructive
A case of osteochondroma of the atlas causing obstructive sleep apnea syndrome.
Evaluation of cerebral microstructural changes in adult patients with obstructive sleep apnea by MR diffusion kurtosis imaging using a whole-brain atlas.
Sleep Wake Disorders
EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association.
Sleep and wakefulness in somnambulism: a spectral analysis study.
Sleep atlas and multimedia database.
Soft Tissue Infections
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum ?-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
Solitary Fibrous Tumors
Surgical treatment for recurrent solitary fibrous tumor invading atlas.
Spasm
Chiropractic correction of congenital muscular torticollis.
Spina Bifida Occulta
A cervical myelopathy caused by invaginated anomaly of laminae of the axis in spina bifida occulta with hypoplasia of the atlas: case report.
Another "new" form, the palagonia type of acrofacial dysostosis in a Sicilian family.
Problem in diagnostic radiology.
Spinal Cord Compression
Accidental or linked: separated odontoid process fused to the enlarged anterior arch of the atlas associated with atlantoaxial subluxation in a Kashin-Beck disease patient.
An unusual form of occipitocervical assimilation presenting with spastic tetraparesis in a child.
Anomalous Cervical Spinous Process Leading to Myelopathy.
Anteroposterior spondyloschisis of atlas with incurving of the posterior arch causing compressive myelopathy.
Atlanto-axial approach for cervical myelography in a Thoroughbred horse with complete fusion of the atlanto-occipital bones.
C1-2 Pedicle Screw Fixation for Ponticulus Posticus and Duplication of Vertebral Artery: 2-Dimensional Operative Video.
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
Compressive Myelopathy due to Osteochondroma of the Atlas and Review of the Literature.
Concurrent Ossification of the Posterior Atlantoaxial Interlaminar Membrane and Atlas Hypoplasia: A Case Report.
Congenital anterior midline cleft of the atlas and posterior atlanto-occipital fusion associated with symptomatic anterior atlantoaxial subluxation.
Elongated Clivus with Deficient Anterior Atlantal Arch and Congenital Posterior Atlantooccipital Dislocation: Pathoembryology and Management Nuances of a Rare Form of Proatlas Segmentation Anomaly.
Evaluation of clinical outcomes of one-stage anterior and posterior surgical treatment for atlantoaxial tuberculosis complicated with neurological damage.
Laminectomy for relief of atlantoaxial subluxation in four horses.
Myelopathy due to hypoplasia of the atlas. A case report.
Solitary osteochondroma of the atlas causing spinal cord compression: a case report and literature review.
Spinal accessory nerve cavernous malformation.
Spinal compression due to atlantal vertebral malformation in two African lions (Panthera leo).
Spinal cord compression caused by ossification of the transverse ligament of the atlas.
Spinolaminar Line Test as a Screening Tool for C1 Stenosis.
Subluxation of the atlas causing spinal cord compression in a case of Down's syndrome with a "manifestation of an occipital vertebra".
Upper cervical spine surgery in rheumatoid arthritis: retrospective study of 30 patients followed for two years or more after Cotrel-Dubousset instrumentation.
[Effects of decompression combined with electro-acupuncture on rat with acute severe upper cervical spinal cord compression injury].
Spinal Cord Diseases
3- to 11-year followup of occipitocervical fusion for rheumatoid arthritis.
A case of cervical myelopathy with developmental canal stenosis at the level of the atlas. A case report.
A case of progressive myelopathy with atlas hypoplasia in an infant: controversy in the surgical strategy.
A cervical myelopathy caused by invaginated anomaly of laminae of the axis in spina bifida occulta with hypoplasia of the atlas: case report.
A rare cause of cervical spinal stenosis: posterior arch hypoplasia in a bipartite atlas.
A surgical case of C1 arch stenosis: A case report and review of literature.
Acute Spinal Cord Contusion in a Patient with Multiple Upper Cervical Fractures, Parkinson's Disease, and Torticollis: Surgical Management.
Atlantoaxial subluxation-induced myelopathy in cleidocranial dysplasia. Case report.
Atlantodental osteoarthritis as a cause of upper cervical myelopathy: a case report.
Atlas hypoplasia and ossification of the transverse atlantal ligament: a rare cause of cervical myelopathy.
Atlas hypoplasia as a cause of high cervical myelopathy. Case report.
Atlas hypoplasia associated with non-traumatic retro-odontoid mass.
Atlas hypoplasia manifesting as myelopathy in a child--case report.
Atlas shrugged: cervical myelopathy caused by congenital atlantoaxial dislocation aggravated by child labor.
C1-2 Pedicle Screw Fixation for Ponticulus Posticus and Duplication of Vertebral Artery: 2-Dimensional Operative Video.
Calcium pyrophosphate dihydrate deposition in the transverse ligament of the atlas: an unusual cause of cervical myelopathy.
Cervical myelopathy accompanied with hypoplasia of the posterior arch of the atlas: case report.
Cervical myelopathy and congenital stenosis from hypoplasia of the atlas: report of three cases and literature review.
Cervical myelopathy associated with congenital C2/3 canal stenosis and deficiencies of the posterior arch of the atlas and laminae of the axis: case report and review of the literature.
Cervical myelopathy caused by anomalies at the level of atlas.
Cervical myelopathy caused by atlantoaxial instability in a patient with an os odontoideum and total aplasia of the posterior arch of the atlas: a case report.
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
Cervical myelopathy caused by hypoplasia of the atlas and ossification of the transverse ligament--case report.
Cervical myelopathy caused by hypoplasia of the atlas: two case reports and review of the literature.
Cervical myelopathy caused by invaginated laminae of the axis associated with occipitalizaion of the atlas: Case report and literature review.
Cervical myelopathy caused by pseudoarthrosis between posterior arch of the atlas and lamina of the axis in Klippel-Feil syndrome: a case report.
Cervical myelopathy caused by pseudoarthrosis between the atlas and axis associated with diffuse idiopathic skeletal hyperostosis.
Cervical Myelopathy Secondary to Atlanto-occipital Assimilation: The Usefulness of the Simple Decompressive Surgery.
Cervical myelopathy secondary to atlas hypoplasia - reports of 3 adult cases -.
Cervical spinal stenosis and myelopathy due to atlas hypoplasia.
Complete Atlantooccipital Assimilation with Basilar Invagination and Atlantoaxial Subluxation Treated Non-Surgically: A Case Report.
Concurrent Ossification of the Posterior Atlantoaxial Interlaminar Membrane and Atlas Hypoplasia: A Case Report.
Congenital malformed posterior arch of atlas with fusion defect: a case of developmental canal stenosis causing cervical myelopathy.
Congenital Malrotation of the Atlas with Unilateral Hypertrophy of the Atlanto-occipital Joint-A Rare Anomaly of the Craniovertebral Junction and Its Management.
Congenital partial aplasia of the posterior arch of the atlas causing myelopathy: case report and review of the literature.
Development of bilateral collateral circulation after fracture of the axis.
Enlarging retro-odontoid pseudotumor after expanding cervical laminoplasty in the presence of kyphosis.
Hypertrophic dens resulting in cervical myelopathy: histologic features of the hypertrophic dens.
Hypertrophic posterior arch of atlas causing cervical myelopathy.
Hypoplasia of the atlas causing cervical myelopathy with situs inversus totalis.
Imaging diagnosis--traumatic myelopathy in a dog with incomplete ossification of the dorsal lamina of the atlas.
Isolated cervical spinal canal stenosis at C-1 in the pediatric population and in Williams syndrome.
Isolated enchondroma of atlas.
Malformed vertebrae: a clinical and imaging review.
Myelopathy due to hypoplasia of the atlas. A case report.
Myelopathy resulting from the atlantodental hypertrophic osteoarthritis accompanying the dens hypertrophy. Two case reports.
Os odontoideum with posterior atlantoaxial instability.
Ossification of the Cruciform Ligament of Atlas; a Rare Cause of Cervical Myelopathy: Case Report and Review of Literature.
Ossification of the posterior atlantoaxial membrane associated with atlas hypoplasia: A case report.
Ossification of transverse ligament of atlas causing cervical myelopathy: a case report and review of the literature.
Spinal canal stenosis at the level of the atlas: case report.
Surgical treatment for atlantoaxial subluxation with myelopathy in spondyloepiphyseal dysplasia congenita.
Symptomatic Atlas Hypoplasia in a Latin-American Patient: Case Report and Literature Review.
The relationship between atlas hypoplasia and os odontoideum in children with Down syndrome: a preliminary case report.
Transoral Approach to the Craniovertebral Junction: A Neuronavigated Cadaver Study.
Unilateral lateral mass hypertrophy: An extremely rare congenital anomaly of atlas.
Unusual cause of high cervical myelopathy-C1 arch stenosis.
Ventral cervicomedullary junction compression secondary to condylus occipitalis (median occipital condyle), a rare entity.
[Delayed myelopathy secondary to dislocation of the atlas on the epistropheus of the odontoid apophysis. Presentation of a case.]
[Mucopolysaccharidosis 6-A (Maroteaux-Lamy disease): comparison of clinical and pathologico-anatomic findings in a 27-year-old patient]
[Post-traumatic delayed cervical myelopathy, as sequela of an unrecognized old fracture of the dens epistrophei with luxation of the atlas.]
[Spinal stenosis at the level of atlas in a boy with Down syndrome. A case report and literature review.]
[Surgical decompression for the C-1 and C-2 sensory roots and upper cervical cord in a case with cervical myelopathy and occipital neuralgia due to bilateral fenestration of vertebral artery: a case report]
Spinal Cord Injuries
Airway compromise secondary to upper cervical spine injury.
Atlantal stenosis: a rare cause of quadriparesis in a child. Case report.
Injury volume extracted from MRI predicts neurologic outcome in acute spinal cord injury: A prospective TRACK-SCI pilot study.
[Assessment of the risk of occipitocervical dislocation in inflammatory rheumatic diseases]
[Clinical diagnosis and treatment of multiple-level injuries of the cervical spine.]
Spinal Diseases
Eosinophilic granuloma of the spine involving C1 and pulmonary infiltration in young children - Presentation of two cases with a follow-up over 10 years including review of the literature.
Spinal Dysraphism
"Split atlas" in a trauma and nontrauma patient: two different case reports for a rare congenital malformation.
Clinical management of cranio-vertebral instability after whiplash, when guidelines should be adapted: A case report.
Congenital posterior atlas defect associated with anterior rachischisis and early cervical degenerative disc disease: a case study and review of the literature.
Craniovertebral junction: normal anatomy, craniometry, and congenital anomalies.
Dislocation and/or congenital malformation of the shoulder joint. Observations on a Mediaeval skeleton from Denmark.
Odontoid fracture with spina bifida posterior of the atlas. A case report.
Persistent torticollis, facial asymmetry, grooved tongue, and dolicho-odontoid process in connection with atlas malformation complex in three family subjects.
Reconstruction of the health status in a past human population: the Iron Age necropolis of Monte Bibele (Bologna, Italy).
[Spina bifida of the atlas in routine neuroradiologic diagnosis]
[Spina bifida of the atlas]
Spinal Stenosis
A rare cause of cervical spinal stenosis: posterior arch hypoplasia in a bipartite atlas.
Atlantoaxial dislocation with congenital "sandwich fusion" in the craniovertebral junction: a retrospective case series of 70 patients.
Cervical myelopathy caused by hypoplasia of the atlas: two case reports and review of the literature.
Cervical spinal stenosis and myelopathy due to atlas hypoplasia.
[Spinal stenosis at the level of atlas in a boy with Down syndrome. A case report and literature review.]
Spinocerebellar Degenerations
[Atlas of mental pathology. 15. Changes in the central nervous system. Spinocerebellar degeneration]
Spondylarthritis
Similarities and differences between non-radiographic and radiographic axial spondyloarthritis: The patient perspective from the Spanish atlas.
Spondylitis
Spondylitis of Upper Cervical Vertebræ including Atlas and Axis, with Cord Compression. Typhoid Origin.
[Crowned dens syndrome: three new cases]
[Ventral decompression techniques in patients with traumatic and non-traumatic atlanto-axial dislocations].
Spondylitis, Ankylosing
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.
Cervical spine involvement in longstanding ankylosing spondylitis.
Paleopathological features of the cervical spine in the early middle ages: natural history of degenerative diseases.
Upward subluxation of the axis in ankylosing spondylitis. A clinical pathologic report.
[Operative strategy of atlantoaxial instability]
Spondylolisthesis
Combined injuries in the upper cervical spine: clinical and epidemiological data over a 14-year period.
Congenital Spondylolytic Spondylolisthesis of C2 Vertebra Associated With Atlanto-Axial Dislocation, Chiari Type I Malformation, and Anomalous Vertebral Artery: Case Report With Review Literature.
Multiple unstable cervical fractures with cord compromise treated nonoperatively: a case report.
Posterior arthrodesis of C1-C3 for the stabilization of multiple unstable upper cervical fractures with spinal cord compromise: A case report and literature review.
Prognosis of neurological deficits associated with upper cervical spine injuries.
Spectrum of imaging findings in hyperextension injuries of the neck.
Upper cervical spine injuries.
Spondylosis
Unilateral atlantal mass hypertrophy in acromegaly. Case report.
[Sudden deafness and the craniocervical transition]
[Sudden hearing loss and the cranio-cervical junction]
[Syringomyelic syndrome secondary to cervical canal stenosis and cervical spondylosis]
Squamous Cell Carcinoma of Head and Neck
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
?Np63?/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers.
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients.
A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
A comprehensive investigation using meta-analysis and bioinformatics on miR-34a-5p expression and its potential role in head and neck squamous cell carcinoma.
A gene expression profile associated with perineural invasion identifies a subset of HNSCC at risk of post-surgical recurrence.
A HPV16-related prognostic indicator for head and neck squamous cell carcinoma.
A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates.
A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
A Novel Prognostic Index Based on the Analysis of Glycolysis-Related Genes in Head and Neck Squamous Cell Carcinomas.
A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
A novel seven?miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
A Novel Three-lncRNA Signature Predicts the Overall Survival of HNSCC Patients.
A panel of Transcription factors identified by data mining can predict the prognosis of head and neck squamous cell carcinoma.
A prognostic long non-coding RNA-associated competing endogenous RNA network in head and neck squamous cell carcinoma.
A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma.
A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma.
A three-gene expression signature associated with positive surgical margins in tongue squamous cell carcinomas: Predicting surgical resectability from tumour biology?
A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications.
Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing.
Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker.
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma.
An 11-lncRNA expression could be potential prognostic biomarkers in head and neck squamous cell carcinoma.
An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.
An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases.
An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.
Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.
Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
Analysis of methylation-driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma.
Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma.
APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma.
Association of LINC00673 Genetic Variants with Progression of Oral Cancer.
Association of lnc-IL17RA-11 with increased radiation sensitivity and improved prognosis of HPV-positive HNSCC.
Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
Biological information and functional analysis reveal the role of discoidin domain receptor 1 in oral squamous cell carcinoma.
Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Cannabinoids promote progression of HPV positive head and neck squamous cell carcinoma via p38 MAPK activation.
Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
CDK6 inhibits lymphoid cell infiltration and represents a prognostic marker in HPV+ squamous cell carcinoma of head and neck.
CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma.
Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.
Characteristics of B lymphocyte infiltration in HPV+ head and neck squamous cell carcinoma.
Characterization of a prognostic four?gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma.
Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
Chromosome 3p loss in the progression and prognosis of head and neck cancer.
Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma.
Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.
Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma.
Clinicopathological Significance of FOXO4 Expression and Correlation with Prx1 in Head and Neck Squamous Cell Carcinoma.
Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates.
Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Comprehensive analysis of competitive endogenous RNAs network associated with head and neck squamous cell carcinoma.
Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma.
Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer.
Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer.
Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Copy number alterations identify a smoking-associated expression signature predictive of poor outcome in head and neck squamous cell carcinoma.
Critical genes in head and neck squamous cell carcinoma revealed by bioinformatic analysis of gene expression data.
CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.
CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.
Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer.
Development and validation of a m6A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma.
Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.
Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
Development of a five-protein signature for predicting the prognosis of head and neck squamous cell carcinoma.
Development of a Prognostic Signature Based on Autophagy-related Genes for Head and Neck Squamous Cell Carcinoma.
Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma.
Differential Effect of Smoking on Gene Expression in Head and Neck Cancer Patients.
Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer.
Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms is associated with poor prognosis in head and neck cancer.
Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.
Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients.
DNA Methylation Markers from Negative Surgical Margins Can Predict Recurrence of Oral Squamous Cell Carcinoma.
DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon ? signature.
DNA methylation-mediated Klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma.
Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.
Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.
Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck Cancers.
EGOT lncRNA in head and neck squamous cell carcinomas.
Elevated DKK1 expression is an independent unfavorable prognostic indicator of survival in head and neck squamous cell carcinoma.
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.
Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
Establishment and Validation of a Comprehensive Prognostic Model for Patients With HNSCC Metastasis.
Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases.
Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.
Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.
Fewer tumour-specific PD-1+CD8+ TILs in high-risk "Infiltrating" HPV- HNSCC.
Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.
Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma.
Five extracellular matrix-associated genes upregulated in oral tongue squamous cell carcinoma: An integrated bioinformatics analysis.
FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma.
Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.
G3BP1 may serve as a potential biomarker of proliferation, apoptosis, and prognosis in oral squamous cell carcinoma.
Gene expression profile in oral squamous cell carcinoma: a pilot study.
Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway.
Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?
Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Gene signatures of m5C regulators may predict prognoses of patients with head and neck squamous cell carcinoma.
Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma.
Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas.
Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer.
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.
Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma.
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Genomic insights into head and neck cancer.
Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-?B Pathways.
Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
High Abundance of Intratumoral ?? T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells.
High SEC61G expression predicts poor prognosis in patients with Head and Neck Squamous Cell Carcinomas.
Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma.
HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/?-catenin signaling axis.
HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity.
HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.
Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.
Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
Identification and validation of potential long non-coding RNA biomarkers in predicting survival of patients with head and neck squamous cell carcinoma.
Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma.
Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck.
Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Identification of a Human Papillomavirus-Associated Oncogenic miRNA Panel in Human Oropharyngeal Squamous Cell Carcinoma Validated by Bioinformatics Analysis of The Cancer Genome Atlas.
Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC.
Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype.
Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma.
Identification of ESM1 overexpressed in head and neck squamous cell carcinoma.
Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.
Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis.
Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.
Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma.
Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
Identification of Three Autophagy-Related Long Non-Coding RNAs as a Novel Head and Neck Squamous Cell Carcinoma Prognostic Signature.
IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer.
Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.
Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
Immunohistochemical Expression of Five Protein Combinations Revealed as Prognostic Markers in Asian Oral Cancer.
Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Integrated analysis of lncRNA CTD-2357A8.3 expression and its potential roles in head and neck squamous cell carcinoma.
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals distinct cancer-associated fibroblasts in head and neck squamous cell carcinoma.
Integrated analysis of the prognostic values of RNA-binding proteins in head and neck squamous cell carcinoma.
Integrating Clinical and Genetic Analysis of Perineural Invasion in Head and Neck Squamous Cell Carcinoma.
Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma.
Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas.
Integrative Models of Histopathological Image Features and Omics Data Predict Survival in Head and Neck Squamous Cell Carcinoma.
Integrin ?-5 as a potential biomarker of head and neck squamous cell carcinoma.
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma.
Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated 188Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor.
JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4.
Jumonji domain-containing protein 6 functions as a marker of head and neck squamous cell carcinoma at advanced stage with no effect on prognosis.
LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
Liprin-?1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton.
LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.
Long Non-coding RNA LINC02195 as a Regulator of MHC I Molecules and Favorable Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Long noncoding RNA, LINC00460, as a prognostic biomarker in head and neck squamous cell carcinoma (HNSCC).
Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC.
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.
Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.
Low Mast Cell Density Predicts Poor Prognosis in Oral Squamous Cell Carcinoma and Reduces Survival in Head and Neck Squamous Cell Carcinoma.
Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).
Lymphotoxin-? receptor-NIK signaling induces alternative RELB/NF-?B2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer.
Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.
miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.
miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension.
Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma.
Models for Predicting Stage in Head and Neck Squamous Cell Carcinoma using Proteomic and Transcriptomic Data.
Molecular homology between canine spontaneous oral squamous cell carcinomas and human head-and-neck squamous cell carcinomas reveals disease drivers and therapeutic vulnerabilities.
Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma.
Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status.
Mutational load and mutational patterns in relation to age in head and neck cancer.
Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.
MYCT1 Inhibits the Adhesion and Migration of Laryngeal Cancer Cells Potentially Through Repressing Collagen VI.
NGFI-A Binding Protein 2 Promotes EGF-Dependent HNSCC Cell Invasion.
Non-coding RNAs profiling in head and neck cancers.
Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents.
Overexpression of hsa-miR-125a-5p enhances proliferation, migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7.
Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
p120-Catenin Downregulation and PIK3CA Mutations Cooperate to Induce Invasion through MMP1 in HNSCC.
Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
Patterns of Transposable Element Expression and Insertion in Cancer.
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.
PDGFR? Is a Novel Marker of Stromal Activation in Oral Squamous Cell Carcinomas.
PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.
Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC.
Predicting the radiosensitivity of HPV-negative oropharyngeal squamous cell carcinoma using miR-130b.
Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs.
Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data.
PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma.
Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
Prognostic implication of proteomic profiles in head and neck squamous cell carcinoma.
Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas.
Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
Prognostic value of lipid metabolism-related genes in head and neck squamous cell carcinoma.
Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.
PSMC2, ORC5 and KRTDAP are specific biomarkers for HPV-negative head and neck squamous cell carcinoma.
QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome.
Rab18 Regulates Proliferation, Invasion and Cisplatin Sensitivity Through STAT3 Signaling in Head and Neck Squamous Cell Carcinoma.
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma.
Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
Recurrent human papillomavirus-related head and neck cancer undergoes metabolic re-programming and is driven by oxidative phosphorylation.
Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells.
Risk of cognition alteration and emotional frailty via circulating transcriptome in treatment naïve head and neck squamous cell cancer patients.
Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.
Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma.
Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma.
Short-term RANKL exposure initiates a neoplastic transcriptional program in the basal epithelium of the murine salivary gland.
SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples.
Silencing of long non-coding RNA LINC00520 promotes radiosensitivity of head and neck squamous cell carcinoma cells.
Single Nucleotide Polymorphism rs6942067 Is a Risk Factor in Young and in Non-Smoking Patients with HPV Negative Head and Neck Squamous Cell Carcinoma.
Single-Cell Deconvolution of Head and Neck Squamous Cell Carcinoma.
Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival.
SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
Sorting Nexin 5 Controls Head and Neck Squamous Cell Carcinoma Progression by Modulating FBW7.
Squamous Cell Carcinoma Antigen-encoding Genes
Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma.
STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers.
Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.
Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer.
Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.
The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma.
The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.
The cox-filter method identifies respective subtype-specific lncRNA prognostic signatures for two human cancers.
The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.
The exploration of new therapeutic targets for HPV-negative head and neck squamous cell cancer through the construction of a ceRNA network and immune microenvironment analysis.
The Expression and Effection of MicroRNA-499a in High-Tobacco Exposed Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
The head and neck cancer immune landscape and its immunotherapeutic implications.
The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma.
The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas.
The management of localized esophageal squamous cell carcinoma: Western approach.
The molecular landscape of head and neck cancer.
The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.
The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.
The non-coding landscape of head and neck squamous cell carcinoma.
The Overexpression of NMHC IIA Promoted Invasion and Metastasis of Nasopharyngeal Carcinoma Cells.
The Prognostic Significance of Immune-Related Metabolic Enzyme MTHFD2 in Head and Neck Squamous Cell Carcinoma.
The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma.
The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
The Proteomic Landscape of Growth Factor Signaling Networks Associated with FAT1 Mutations in Head and Neck Cancers.
The role of Glial cell derived neurotrophic factor in head and neck cancer.
The Role of Interleukin-33 in Head and Neck Squamous Cell Carcinoma Is Determined by Its Cellular Sources in the Tumor Microenvironment.
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
TRAF3/CYLD mutations identify a distinct subset of human papilloma virus-associated head and neck squamous cell carcinoma.
Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort.
Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.
Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
UBE2C promotes the progression of head and neck squamous cell carcinoma.
UBE2O Promotes Progression and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.
Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection.
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
Widespread expression of Sonic hedgehog (Shh) and Nrf2 in patients treated with cisplatin predicts outcome in resected tumors and are potential therapeutic targets for HPV-negative head and neck cancer.
[Mutation signatures in head and neck squamous cell carcinoma : Pathogenesis and therapeutic potential].
ST Elevation Myocardial Infarction
Mortality in the TRACER and ATLAS ACS 2 Trials: Two More Reasons to Audit Vital Records in PLATO.
Rivaroxaban in Patients Stabilized after a ST-Elevation Myocardial Infarction: Results from the ATLAS ACS 2-TIMI 51 Trial.
Starvation
Can Aluminum Tolerant Wheat Cultivar Perform Better under Phosphate Deficient Conditions?
Endocytosis-mediated siderophore uptake as a strategy for Fe acquisition in diatoms.
Status Epilepticus
Ex vivo characterization of neuroinflammatory and neuroreceptor changes during epileptogenesis using candidate positron emission tomography biomarkers.
steroid 11beta-monooxygenase deficiency
High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco.
Stomach Diseases
Spectrum of gastric malignancy on (18)F-FDG PET/CT: a pictorial essay.
Stomach Neoplasms
"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy.
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
?-Actinin1 promotes tumorigenesis and epithelial-mesenchymal transition of gastric cancer via the AKT/GSK3?/?-Catenin pathway.
A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration.
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits.
A DNA methylation signature to improve survival prediction of gastric cancer.
A functional network of gastric-cancer-associated splicing events controlled by dysregulated splicing factors.
A novel assessing system for predicting the prognosis of gastric cancer.
A Novel RNA-Binding Protein-Based Nomogram for Predicting Survival of Patients with Gastric Cancer.
A Pipeline to Call Multilevel Expression Changes between Cancer and Normal Tissues and Its Applications in Repurposing Drugs Effective for Gastric Cancer.
A protein and mRNA expression-based classification of gastric cancer.
ACBD3 is up-regulated in gastric cancer and promotes cell cycle G1-to-S transition in an AKT-dependent manner.
Acute Tumor Transition Angle on Computed Tomography Predicts Chromosomal Instability Status of Primary Gastric Cancer: Radiogenomics Analysis from TCGA and Independent Validation.
Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
An atlas of gastric PIWI-interacting RNA transcriptomes and their utility for identifying signatures of gastric cancer recurrence.
An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups.
Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.
Analysis of key genes and signaling pathways involved in Helicobacter pylori-associated gastric cancer based on The Cancer Genome Atlas database and RNA sequencing data.
Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer.
Bayesian semi-nonnegative matrix tri-factorization to identify pathways associated with cancer phenotypes.
Biased Influences of Low Tumor Purity on Mutation Detection in Cancer.
BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Bioinformatics analysis for the identification of differentially expressed genes and related signaling pathways in H. pylori-CagA transfected gastric cancer cells.
Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-? Correlates with Gastric Cancer Progression and Poor Prognosis.
Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments.
CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses.
CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer.
Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety.
Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.
Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.
Common polymorphic inversions at 17q21.31 and 8p23.1 associate with cancer prognosis.
Comparison between two amplicon-based sequencing panels of different scales in the detection of somatic mutations associated with gastric cancer.
Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Comprehensive analysis of expression profiles of long non?coding RNAs with associated ceRNA network involved in gastric cancer progression.
Comprehensive Analysis of Survival-Related lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Gastric Cancer.
Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer.
Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis.
Correlation Between Infection Status of Epstein-Barr Virus and (18)F-Fluorodeoxyglucose Uptake in Patients with Advanced Gastric Cancer.
Depletion of FOXM1 via MET targeting underlies establishment of a DNA damage-induced senescence program in gastric cancer.
Development of a novel gene signature in patients without Helicobacter pylori infection gastric cancer.
Development of RNA binding proteins expression signature for prognosis prediction in gastric cancer patients.
Diagnostic and therapeutic potencies of miR-18a-5p in mixed-type gastric adenocarcinoma.
Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved.
Discovering the mechanism and involvement of the methylation of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and its special locus region in gastric cancer.
Dissecting the Single-Cell Transcriptome Network Underlying Gastric Premalignant Lesions and Early Gastric Cancer.
Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer.
Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies.
Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features.
Elevated FAM3C promotes cell epithelial- mesenchymal transition and cell migration in gastric cancer.
Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer.
Emerging Therapies in the Management of Advanced-Stage Gastric Cancer.
Establishment of an immune microenvironment-based prognostic predictive model for gastric cancer.
Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types.
Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study.
Expression profiling of gastric adenocarcinoma using cDNA array.
FARP1 boosts CDC42 activity from integrin ?v?5 signaling and correlates with poor prognosis of advanced gastric cancer.
From molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancer.
GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer.
Gastric cancer: The times they are a-changin'.
Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features.
Gastric lymph node contouring atlas: A tool to aid in clinical target volume definition in 3-dimensional treatment planning for gastric cancer.
Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
Gene regulatory network analysis with drug sensitivity reveals synergistic effects of combinatory chemotherapy in gastric cancer.
Genome-wide analysis to identify a novel distant metastasis-related gene signature predicting survival in patients with gastric cancer.
Genomic Alterations and Targeted Therapy in Gastric and Esophageal Adenocarcinoma.
Genomic Characterization of Non-Invasive Differentiated-Type Gastric Cancer in the Japanese Population.
GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond.
GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on co?expression network analysis.
Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data.
Glycerophospholipids pathways and chromosomal instability in gastric cancer: Global lipidomics analysis.
GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
High Expression of ABRACL Is Associated with Tumorigenesis and Affects Clinical Outcome in Gastric Cancer.
High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer.
Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.
Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients.
Identification and Validation of SNP-Containing Genes With Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis.
Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer.
Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
Identification of DNA methylation-regulated differentially-expressed genes and related pathways using Illumina 450K BeadChip and bioinformatic analysis in gastric cancer.
Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways.
Identification of genes associated with gastric cancer survival and construction of a nomogram to improve risk stratification for patients with gastric cancer.
Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Identification of subtype-specific genes signature by WGCNA for prognostic prediction in diffuse type gastric cancer.
Identification of the angiogenesis related genes for predicting prognosis of patients with gastric cancer.
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer.
Indoleamine 2,3-dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and is Associated with Type II Hypersensitivity/Autoimmunity.
Integrated analysis of long non-coding RNAs in human gastric cancer: An in silico study.
Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A.
Interobserver Variation of Clinical Target Volume Delineation in Gastric Cancer.
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer.
Landscape of EBV-positive gastric cancer.
Latency-associated Peptide Identifies Immunoevasive Subtype Gastric Cancer With Poor Prognosis and Inferior Chemotherapeutic Responsiveness.
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer.
LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway.
LINC00675 Suppresses Cell Proliferation and Migration via Downregulating the H3K4me2 Level at the SPRY4 Promoter in Gastric Cancer.
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1.
LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a.
LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis.
Long noncoding RNA H19 participates in metformin-mediated inhibition of gastric cancer cell invasion.
Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance.
Low CBS expression can identify patients who benefit from adjuvant chemotherapy in gastric cancer.
LUM Expression and Its Prognostic Significance in Gastric Cancer.
MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
Medical management of gastric cancer: a 2017 update.
MicroRNA profiles in five pairs of early gastric cancer tissues and adjacent non-cancerous tissues.
MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer.
MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis.
MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer.
MIR-1265 regulates cellular proliferation and apoptosis by targeting calcium binding protein 39 in gastric cancer and, thereby, impairing oncogenic autophagy.
MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
miR-588 is a prognostic marker in gastric cancer.
MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer.
miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7 in vitro.
Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.
Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE.
Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives.
Morphologic and molecular analysis of early-onset gastric cancer.
MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy.
Mucin 17 inhibits the progression of human gastric cancer by limiting inflammatory responses through a MYH9-p53-RhoA regulatory feedback loop.
Next generation sequencing in gastric or gastroesophageal adenocarcinoma.
Norepinephrine Enhances Aerobic Glycolysis and May Act as a Predictive Factor for Immunotherapy in Gastric Cancer.
Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Novel CpG-SNPs in the gastric acid secretion pathway GNAI3 and susceptibility to gastric cancer.
Novel targets in the treatment of advanced gastric cancer: a perspective review.
OncoBinder facilitates interpretation of proteomic interaction data by capturing coactivation pairs in cancer.
Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer.
Over-expression of vitronectin correlates with impaired survival in gastric cancers.
Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.
Overexpression of PLXDC2 in Stromal Cell-Associated M2 Macrophages Is Related to EMT and the Progression of Gastric Cancer.
P4HA3 is Epigenetically Activated by Slug in Gastric Cancer and its Deregulation is Associated With Enhanced Metastasis and Poor Survival.
Perioperative chemotherapy for resectable gastric cancer - what is the evidence?
Personalised Treatment in Gastric Cancer: Myth or Reality?
Personalized medicine in gastric cancer: Where are we and where are we going?
Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients.
Potential prognostic impact of EBV RNA-seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort.
Prediction of radiosensitive patients with gastric cancer by developing gene signature.
Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients.
Prognostic and clinicopathological significance of long noncoding RNA CTD-2510F5.4 in gastric cancer.
Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment.
Prognostic landscape of tumor-infiltrating immune cells and immune-related genes in the tumor microenvironment of gastric cancer.
Prognostic Significance of FKBP14 in Gastric Cancer.
Prognostic value of estrogen receptor ? and estrogen receptor ? in gastric cancer based on a meta-analysis and The Cancer Genome Atlas (TCGA) datasets.
Prognostic Values of Radiosensitivity Genes and CD19 Status in Gastric Cancer: A Retrospective Study Using TCGA Database.
Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray.
Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer.
Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer.
Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
Social attention of the top 50 scientific articles on gastric cancer: Bibliometric and altmetric analysis.
Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients.
Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients.
Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes.
STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells.
Stromal-Based Signatures for the Classification of Gastric Cancer.
Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase.
Systematical Analysis of the Cancer Genome Atlas Database Reveals EMCN/MUC15 Combination as a Prognostic Signature for Gastric Cancer.
T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-? VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics.
TCGA-TCIA-Based CT Radiomics Study for Noninvasively Predicting Epstein-Barr Virus Status in Gastric Cancer.
TGF?2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer.
The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity.
The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study.
The journey of personalizing gastric cancer treatment.
The management of localized esophageal squamous cell carcinoma: Western approach.
The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.
The Molecular Biologic Basis of Esophageal and Gastric Cancers.
Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contexture.
Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas.
What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.
Why MUC16 mutations lead to a better prognosis: A study based on The Cancer Genome Atlas gastric cancer cohort.
[Current status and research progress of perioperative chemotherapy in advanced gastric cancer].
[Identification of characteristic methylation sites in gastric cancer using genomics-based machine learning].
[KDM6A mutation and expression in gastric cancer are associated with prognosis].
[Molecular Subtypes of Gastric Cancer].
[Regional distribution of stomach and colon cancer mortality in the Dithmarschen and Nordfriesland districts--cartographic presentation]
Stomach Ulcer
A lost piece of melanoma history.
Stomatitis
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
Strabismus
Atlas of Strabismus Surgery.
Atlas of Strabismus.
ATLAS OF STRABISMUS.
Color Atlas of Strabismus Surgery: Strategies and Techniques Third Edition: Kenneth W. Wright, M.D. Sonal Farzavandi, Editor, Springer, New York, NY, 2006, 233 pages, 255 illustrations (80 color), $199.00.
Practical Atlas of the Surgery of Strabismus. Operative Indications, Surgical Technique.
Von Noorden—Maumenee's Atlas of Strabismus.
Stroke
'Whose atlas I use, his song I sing?' - The impact of anatomical atlases on fiber tract contributions to cognitive deficits after stroke.
A Colour Atlas of Stroke: Cerebrovascular Disease and its Management.
A comparison of automated segmentation and manual tracing in estimating hippocampal volume in ischemic stroke and healthy control participants.
A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study.
Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study.
Atlas registration for edema-corrected MRI lesion volume in mouse stroke models.
Beauty parlor stroke syndrome due to a bone fragment from an osteophyte of the atlas: case report.
Better Diffusion Segmentation in Acute Ischemic Stroke Through Automatic Tree Learning Anomaly Segmentation.
Blink reflex R2 changes and localisation of lesions in the lower brainstem (Wallenberg's syndrome): an electrophysiological and MRI study.
Bow hunter's stroke due to instability at the uncovertebral C3/4 joint.
Clinically accessible neuroimaging predictors of post-stroke neurocognitive disorder: a prospective observational study.
Community and Hospital Factors Associated With Stroke Center Certification in the United States, 2009 to 2017.
Congenital anomaly of the posterior arch of the atlas: a rare risk factor for posterior circulation stroke.
Grey and white matter network disruption is associated with sensory deficits after stroke.
Healthcare Resource Availability, Quality of Care, and Acute Ischemic Stroke Outcomes.
Human Brain Atlases in Stroke Management.
Isolated right temporal lobe stroke patients present with Geschwind Gastaut syndrome, frontal network syndrome and delusional misidentification syndromes.
Multimodal MRI segmentation of ischemic stroke lesions.
Normative ascent with local gaussians for unsupervised lesion detection.
Of fractal and Fourier: A measure for local shape complexity for neurological applications.
Population-based Stroke Atlas for outcome prediction: method and preliminary results for ischemic stroke from CT.
Poverty, a risk factor overlooked: a cross-sectional cohort study comparing poverty rate and cardiovascular disease outcomes in the state of Florida.
Regional cerebral blood flow changes in stroke imaged by Tc-99m HMPAO SPECT with corresponding anatomic image comparison.
Regional implementation of the stroke systems of care model: recommendations of the northeast cerebrovascular consortium.
Right insular infarction and mortality after ischaemic stroke.
Rivaroxaban: a review of its use in acute coronary syndromes.
Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial.
Spatiotemporal Protein Atlas of Cell Death-Related Molecules in the Rat MCAO Stroke Model.
Statistical atlas of acute stroke from magnetic resonance diffusion-weighted-images of the brain.
Stroke atlas of the brain: Voxel-wise density-based clustering of infarct lesions topographic distribution.
Stroke atlas: a 3D interactive tool correlating cerebrovascular pathology with underlying neuroanatomy and resulting neurological deficits.
Structural and Social Determinants of Health Factors Associated with County-Level Variation in Non-Adherence to Antihypertensive Medication Treatment.
The "Dual-Pathway" Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2-TIMI 51 Trial.
The ATLAS ACS 2-TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects With Acute Coronary Syndrome ACS 2-Thrombolysis In Myocardial Infarction 51).
The cerefy brain atlases: continuous enhancement of the electronic talairach-tournoux brain atlas.
The extreme capsule and aphasia: proof-of-concept of a new way relating structure to neurological symptoms.
The pupillary light reflex pathway: cytoarchitectonic probabilistic maps in hemianopic patients.
The real estate factor: quantifying the impact of infarct location on stroke severity.
The treatment of missing data in a large cardiovascular clinical outcomes study.
WHO publishes definitive atlas on global heart disease and stroke epidemic.
[A Dangerous Combination for Stroke in Young Patient: Assimilation of the Atlas and Anti beta2-Glycoprotein I Antibodies.]
[Contribution of the new oral anticoagulants to the treatment of acute coronary syndrome].
Stroke, Lacunar
Cortical degeneration detected by neurite orientation dispersion and density imaging in chronic lacunar infarcts.
Stuttering
Neurofilament-lysosomal genetic intersections in the cortical network of stuttering.
Subarachnoid Hemorrhage
Associated injuries and mechanism of atlanto-occipital dislocation caused by trauma.
Massive subarachnoid hemorrhage due to laceration of the vertebral artery associated with fracture of the transverse process of the atlas.
[Biomechanism of intracranial and spinal trauma of child born in occipitoanterior presentation as used in forensic examination]
Subclavian Steal Syndrome
[Atlas of nervous system diseases. 12. Subclavian steal syndrome]
Surgical Wound Infection
First year of mandatory reporting of healthcare-associated infections, pennsylvania: an infection control-chart abstractor collaboration.
Syndactyly
Another "new" form, the palagonia type of acrofacial dysostosis in a Sicilian family.
Synkinesis
Rotational synkineses of occiput and atlas on lateral inclination.
Synostosis
A case study of occipital outgrowth: a rare suboccipital abnormality.
An osteological study of occipitocervical synostosis: its embryological and clinical significance.
Atlantooccipital Fusion: Prevalence and its Developmental and Clinical Correlation.
Complete occipitalization of the atlas with bilateral external auditory canal atresia.
[Atloido-occipital synostosis; narrowing of occipital foramen and bulbo-medullary compression by an osseous prominence, vestige of the lateral masses of the atlas.]
Synovial Cyst
Bipartite atlas with os odontoideum and synovial cyst: case report and review literature.
Synovial cyst of the transverse ligament of the atlas causing tetraparesia in a context of generalized osteoarthritis.
Synovial cyst of the transverse ligament of the atlas in a patient with os odontoideum and atlantoaxial instability.
Synovitis
An introduction to the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas.
Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis.
Examination of intra and interrater reliability with a new ultrasonographic reference atlas for scoring of synovitis in patients with rheumatoid arthritis.
Role of ultrasound in managing rheumatoid arthritis.
The very early inflammatory triquetral lesion by MRI - is this the first sign in Rheumatoid Arthritis?
Syphilis
An atlas of syphilis in a single case.
Atlas of Syphilis and the Veneral Diseases.
Atlas of Syphilis and the Venereal Diseases.
Atlas of Syphilis, &c.
[Atlas: clinical traps of syphilis]
Syringomyelia
Assimilation of the atlas with associated syringomyelia and Chiari 1 malformation (Klippel-Feil type 2).
Atlantoaxial dislocation with congenital "sandwich fusion" in the craniovertebral junction: a retrospective case series of 70 patients.
Chiari I malformation accompanied by assimilation of the atlas, Klippel-Feil syndrome, and syringomyelia: case report.
Complex Chiari Malformation Presenting with Bulbar Symptoms in an Adult: Single-stage Posterior Fusion and Foramen Magnum Decompression: A Rare Case Report.
Magnetic resonance imaging-based measures of atlas position: Relationship to canine atlantooccipital overlapping, syringomyelia and clinical signs.
Obex position is associated with syringomyelia and use of posterior fossa decompression among patients with Chiari I malformation.
SPONTANEOUS DISLOCATION OF THE ATLAS. REPORT OF A CASE SIMULATING SYRINGOMYELIA WITH A DISCUSSION OF ETIOLOGY AND METHODS OF TREATMENT.
Successful treatment of adult Arnold-Chiari malformation associated with basilar impression and syringomyelia by the transoral anterior approach.
The complex Chiari: issues and management strategies.
[Chiari type I malformation in a patient with Poland's syndrome].
Systemic Vasculitis
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.
Tachycardia
Body surface mapping of atrial arrhythmias: atlas of paced P wave integral maps to localize the focal origin of right atrial tachycardia.
Localization of abnormal conduction pathways for tachyarrhythmia treatment using tagged MRI.
Tachycardia, Ventricular
Atlas of paced body surface QRS integral maps for localization of the site of origin of postinfarction ventricular tachycardia.
Ventricular arrhythmias. A guide to their localisation.
Temporomandibular Joint Disorders
Chiropractic care of a patient with temporomandibular disorder and atlas subluxation.
The role of soft tissue mobilization in reducing orofacial and general complaints in a patient with Kimmerle anomaly and temporomandibular joint disorder: A case report.
Tendinopathy
Calcific retropharyngeal tendinitis.
Retropharyngeal calcific tendinitis: report of five cases and review of the literature.
Single-cell Transcriptomic Analyses Identifies Extensive Heterogeneity in the Cellular Composition of Mouse Achilles Tendons.
Teratoma
Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas.
[Atlas of intracranial tumors. 9. Pinealoma and teratoma]
Testicular Neoplasms
ASH2L drives proliferation and sensitivity to bleomycin and other genotoxins in Hodgkin's lymphoma and testicular cancer cells.
Identification of novel genes in testicular cancer microenvironment based on ESTIMATE algorithm-derived immune scores.
Nuclear Localization of PTTG1 Promotes Migration and Invasion of Seminoma Tumor through Activation of MMP-2.
Thoracic Diseases
Nerves of the thorax: atlas of normal and pathologic findings.
Thoracic Outlet Syndrome
Thermal asymmetry of the upper extremity in scalenus anticus syndrome, leg-length inequality and response to chiropractic adjustment.
Thromboembolism
Preliminary experience of stent salvage using Neuroform Atlas stent for procedure-related complication during coil embolization of intracranial aneurysms.
Thrombosis
Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association.
Neck manipulation causing stroke. Case reports.
Preliminary experience of stent salvage using Neuroform Atlas stent for procedure-related complication during coil embolization of intracranial aneurysms.
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.
Safety of the Atlas Gold Balloon in Treating Iliofemoral Veins: Experience From a Single Center.
Severe Fusobacteria infections (Lemierre syndrome) in two boys.
The "Dual-Pathway" Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2-TIMI 51 Trial.
[Multiple fractures of the atlas with delayed fatal thrombosis of vertebral artery following "whiplash" injury of the neck (author's transl)]
[Vertebrobasilar arterial thrombosis secondary to aneurysmatic cysts of the atlas and the epistropheus]
Thrombotic Microangiopathies
AJKD Atlas of Renal Pathology: Thrombotic Microangiopathy.
Thymoma
A novel prognostic signature of seven genes for the prediction in patients with thymoma.
High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma.
Identification of Long Non-Coding RNAs for Predicting Prognosis Among Patients with Thymoma.
Identification of prognostic and subtype-specific potential miRNAs in thymoma.
The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: focusing on T cells.
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
Thymus Neoplasms
Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challenge.
Thyroid Cancer, Papillary
A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer.
Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study.
Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma.
Distinctive Desmoplastic 3D Morphology Associated With BRAFV600E in Papillary Thyroid Cancers.
Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
E26 transformation (ETS)?specific related transcription factor?3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas.
Exploration of DNA Methylation-Driven Genes in Papillary Thyroid Carcinoma Based on the Cancer Genome Atlas.
Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.
Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells.
Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.
FMO1 gene expression independently predicts favorable recurrence-free survival of classical papillary thyroid cancer.
Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network.
Genetics: The Cancer Genome Atlas maps papillary thyroid cancer.
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence.
Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background.
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Genomic Characterization of Differentiated Thyroid Carcinoma.
Identification of an Autophagy-Related Signature Predicting Overall Survival for Papillary Thyroid Carcinoma.
Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis.
Immune Landscape of Thyroid Cancers: New Insights.
Is papillary thyroid microcarcinoma a biologically different disease? A propensity score-matched analysis.
Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database.
Loss of Integrase Interactor 1 (INI1) Expression in a Subset of Differentiated Thyroid Cancer.
LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110?.
miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2.
mRNA Expression of SLC5A5 and SLC2A Family Genes in Papillary Thyroid Cancer: An Analysis of The Cancer Genome Atlas.
New and Emerging Biomarkers in Endocrine Pathology.
Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas.
Recurrence-associated genes in papillary thyroid cancer: An analysis of data from The Cancer Genome Atlas.
Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.
The contribution of molecular pathology to the classification of thyroid tumors.
The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation.
Up-Regulated AKR1C2 is correlated with favorable prognosis in thyroid carcinoma.
Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas.
Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma.
VDR mRNA overexpression is associated with worse prognostic factors in papillary thyroid carcinoma.
Thyroid Neoplasms
HABP2 gene mutations do not cause familial or sporadic non-medullary thyroid cancer in a highly inbred Middle Eastern population.
A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.
A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.
A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
A Positive Feedback Loop Between DICER1 and Differentiation Transcription Factors Is Important for Thyroid Tumorigenesis.
Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence.
BRAFV600E-induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT.
Brn3a/Pou4f1 Functions as a Tumor Suppressor by Targeting c-MET/STAT3 Signaling in Thyroid Cancer.
Cancer-Associated Fibroblasts Positively Correlate with Dedifferentiation and Aggressiveness of Thyroid Cancer.
Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study.
Combining DNA methylation and RNA sequencing data of cancer for supervised knowledge extraction.
Correction to: Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants.
Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
Epithelial-to-mesenchymal transition and its association with PD-L1 and CD8 in thyroid cancer.
Evaluation of immune infiltrating of thyroid cancer based on the intrinsic correlation between pair-wise immune genes.
Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma.
Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.
Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis.
G Protein-coupled Receptors in Radioiodine-refractory Thyroid Cancer in the Era of Precision Medicine.
Gene Expression Patterns Unveil New Insights in Papillary Thyroid Cancer.
Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas.
Genomic Characterization of Differentiated Thyroid Carcinoma.
Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer.
Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer.
GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer.
Growth Differentiation Factor 15 is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for Invasiveness.
Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
HOPX homeobox methylation in differentiated thyroid cancer and its clinical relevance.
Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Identification of differential expressed lncRNAs in human thyroid cancer by a genome-wide analyses.
Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Identification of Key Genes in Thyroid Cancer Microenvironment.
Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database.
Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer.
Identification of TNIK as a novel potential drug target in thyroid cancer based on protein druggability prediction.
Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array.
Identifying M1 Macrophage-Related Genes Through a Co-expression Network to Construct a Four-Gene Risk-Scoring Model for Predicting Thyroid Cancer Prognosis.
Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes.
Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness.
Integrating omics data and protein interaction networks to prioritize driver genes in cancer.
Linc00941 Is a Novel Transforming Growth Factor ? Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6.
LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer.
Long noncoding RNA LINC00284 facilitates cell proliferation in papillary thyroid cancer via impairing miR-3127-5p targeted E2F7 suppression.
Low expression of ryanodine receptor 2 is associated with poor prognosis in thyroid carcinoma.
LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110?.
MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma.
MicroRNA-3690 promotes cell proliferation and cell cycle progression by altering DKK3 expression in human thyroid cancer.
Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.
miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo Signaling in Thyroid Cancer.
Molecular Network-Based Drug Prediction in Thyroid Cancer.
Molecular Network-Based Identification of Competing Endogenous RNAs in Thyroid Carcinoma.
nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer.
Overexpression of novel long intergenic non?coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.
Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer.
Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese.
Serous BMP8A has clinical significance in ultrasonic diagnosis of thyroid cancer and promotes thyroid cancer cell progression.
Sirt1 induction confers resistance to etoposide-induced genotoxic apoptosis in thyroid cancers.
TCGA finds thyroid cancer drivers, subtypes.
The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision-making from a fine-needle aspiration sample.
The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA).
Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.
Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.
Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma.
VASN promotes YAP/TAZ and EMT pathway in thyroid carcinogenesis in vitro.
Thyroid Nodule
Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules.
Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples.
The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision-making from a fine-needle aspiration sample.
Tics
IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.
Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma.
TGF?1: An Indicator for Tumor Immune Microenvironment of Colon Cancer From a Comprehensive Analysis of TCGA.
Tinea
Prevalence and distribution of ringworm by Trichophyton verrucosum in sheep in the high atlas of Morocco.
Tinnitus
Differences in resting state regional cerebral blood flow assessed with 99mTc-HMPAO SPECT and brain atlas matching between depressed patients with and without tinnitus.
The Influence of Atlas Therapy on Tinnitus.
Tongue Neoplasms
Actin-Associated Gene Expression is Associated with Early Regional Metastasis of Tongue Cancer.
Expression profile analysis identifies IER3 to predict overall survival and promote lymph node metastasis in tongue cancer.
SMARCD1 is a transcriptional target of specific non-hotspot mutant p53 forms.
The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
Toxic Optic Neuropathy
Design and evaluation of a novel series of 2,3-oxidosqualene cyclase inhibitors with low systemic exposure, relationship between pharmacokinetic properties and ocular toxicity.
Trachoma
Complex emergencies and the control and elimination of neglected tropical diseases in Africa: developing a practical approach for implementing safe and effective mapping and intervention strategies.
Mapping the global distribution of trachoma: why an updated atlas is needed.
Progress Towards Elimination of Trachoma as a Public Health Problem in Eritrea: Results of a Systematic Review and Nine Population-based Prevalence Surveys Conducted in 2014.
The geographical distribution and burden of trachoma in Africa.
[Trachoma manual and atlas.]
Trauma, Nervous System
Atlas fractures.
Tremor
136?Field-Steering Rescue Lead Therapy for Patients With Essential Tremor Refractory to Ventralis Intermedius Deep Brain Stimulation.
Characteristics of Tremor Induced by Lesions of the Cerebellum.
Deep Brain Stimulation for Tremor: Is There a Common Structure?
Individual fiber anatomy of the subthalamic region revealed with DTI - A concept to identify the DBS target for tremor suppression.
Network Fingerprint of Stimulation-Induced Speech Impairment in Essential Tremor.
Optimal location of thalamotomy lesions for tremor associated with Parkinson disease: a probabilistic analysis based on postoperative magnetic resonance imaging and an integrated digital atlas.
Stereotactic gamma-thalamotomy with a computerized brain atlas: technical case report.
Triple Negative Breast Neoplasms
Accurate Segmentation of Nuclear Regions with Multi-Organ Histopathology Images Using Artificial Intelligence for Cancer Diagnosis in Personalized Medicine.
Associations of two-pore domain potassium channels and triple negative breast cancer subtype in The Cancer Genome Atlas: systematic evaluation of gene expression and methylation.
Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling.
Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer.
Crumbs protein homolog 3 (CRB3) expression is associated with oestrogen and progesterone receptor positivity in breast cancer.
Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo.
Elevated expression of protein arginine methyltransferase 5 predicts the poor prognosis of breast cancer.
Enhanced expression of histone chaperone APLF associate with breast cancer.
Ensemble outlier detection and gene selection in triple-negative breast cancer data.
Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.
Identification of candidate RNA signatures in triple-negative breast cancer by the construction of a competing endogenous RNA network with integrative analyses of Gene Expression Omnibus and The Cancer Genome Atlas data.
Insulin-Induced Gene 2 Expression Is Associated with Breast Cancer Metastasis.
Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
MEK1 Inhibitor Combined with Irradiation Reduces Migration of Breast Cancer Cells Including miR-221 and ZEB1 EMT Marker Expression.
ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer.
p120 catenin is a key effector of a Ras-PKC? oncogenic signaling axis.
Robust genomic copy number predictor of pan cancer metastasis.
The human intermediate prolactin receptor is a mammary proto-oncogene.
The IL1?-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer.
Trypanosomiasis, African
An atlas of tsetse and animal African trypanosomiasis in Zimbabwe.
Mapping sleeping sickness in Western Africa in a context of demographic transition and climate change.
The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases.
Towards the Atlas of human African trypanosomiasis.
Tuberculosis
Abasy Atlas v2.2: The most comprehensive and up-to-date inventory of meta-curated, historical, bacterial regulatory networks, their completeness and system-level characterization.
An atlas overview of characteristic features of tuberculosis that may be encountered at autopsy.
Cervical tuberculous vertebral osteomyelitis: case report and discussion of the literature.
Craniovertebral junction tuberculosis: a review of 29 cases.
Data harmonization process for creating the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Atlas.
Evaluation of clinical outcomes of one-stage anterior and posterior surgical treatment for atlantoaxial tuberculosis complicated with neurological damage.
Mycobacterial species as case-study of comparative genome analysis.
Parkinson's: another look.
Tuberculosis of the arch of the atlas. Case report.
Tuberculosis of the craniocervical junction: two case reports.
[Tuberculosis of the atlas and axis.]
Tuberculosis, Meningeal
[Atlas series in neuropathology. (14). Pathology of encephalomyelitis. (2). Tuberculous meningitis]
Tuberculosis, Spinal
Head-supporting sign during reclining: an indication of craniovertebral junction involvement.
Typhoid Fever
Spondylitis of Upper Cervical Vertebræ including Atlas and Axis, with Cord Compression. Typhoid Origin.
Unilateral Breast Neoplasms
Radiotherapy dose distribution prediction for breast cancer using deformable image registration.
Urinary Bladder Diseases
Atlas of Bladder Disease.
Urinary Bladder Neoplasms
A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify MYO16-AS1 as an Oncogenic lncRNA in Bladder Cancer.
A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer.
A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
A Novel Ferroptosis-Related Gene Model for Overall Survival Predictions of Bladder Urothelial Carcinoma Patients.
A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer.
A novel strategy based on histological protein profiling in-silico for identifying potential biomarkers in urinary bladder cancer.
A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients.
A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts.
A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.
Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts.
ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data.
APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.
Artificial Intelligence-based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?
Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer.
ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment.
Autophagy-related long noncoding RNAs can predict prognosis in patients with bladder cancer.
Biased Expression of the FOXP3?3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance.
Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer.
Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer.
Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer.
Biological and Clinical Significance of GATA3 Detected from TCGA Database and FFPE Sample in Bladder Cancer Patients.
Bladder cancer.
BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell.
Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.
Characterization of Tumor Blood Vasculature Expression of Human Invasive Bladder Cancer by Laser Capture Microdissection and Transcriptional Profiling.
Checkpoint Genes at the Cancer Side of the Immunological Synapse in Bladder Cancer.
Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
Clinical value and potential pathways of miR-183-5p in bladder cancer: A study based on miRNA-seq data and bioinformatics analysis.
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.
Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.
Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer.
Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.
Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.
Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients.
Enrichment of FGFR3-TACC3 Fusions in Patients With Bladder Cancer Who Are Young, Asian, or Have Never Smoked.
EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients.
Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer.
Evaluation of the Cancer of Bladder Risk Assessment (COBRA) Score in the Cancer Genome Atlas (TCGA) Bladder Cancer Cohort.
Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis.
Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
FADS1 is a Prognostic Biomarker in Bladder Cancer: A Study Based on TCGA Data.
FOXA1, GATA3 and PPAR? Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature.
Genetic alteration in phosphofructokinase family promotes growth of muscle-invasive bladder cancer.
Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.
Genetic variations in Hippo pathway genes influence bladder cancer risk in a Chinese population.
Heterogeneity of PTEN and PPAR-? in cancer and their prognostic application to bladder cancer.
Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer.
Identification of Cancer-Specific Methylation of Gene Combination for the Diagnosis of Bladder Cancer.
Identification of deregulation mechanisms specific to cancer subtypes.
Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.
Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR.
Identification of Mutated Peptides in Bladder Cancer From Exomic Sequencing Data Reveals Negative Correlation Between Mutation-Specific Immunoreactivity and Inflammation.
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis.
Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.
Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.
IMIX: a multivariate mixture model approach to association analysis through multi-omics data integration.
Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder.
Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis.
Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer.
Integrative Analysis of Genomic and Clinical Data Reveals Intrinsic Characteristics of Bladder Urothelial Carcinoma Progression.
Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer?
Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells.
Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis.
Long Non-Coding RNA Expression Profiles for the Characterization of Different Bladder Cancer Grade.
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis.
MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response.
MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1.
MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.
MOGSA: Integrative Single Sample Gene-set Analysis of Multiple Omics Data.
Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
Multi-omics Perspective on the Tumor Microenvironment based on PD-L1 and CD8 T-Cell Infiltration in Urothelial Cancer.
Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer.
Occupation and cancer in London: an investigation into nasal and bladder cancer using the Cancer Atlas.
Optimal treatment for metastatic bladder cancer.
Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.
P3H4 is correlated with clinicopathological features and prognosis in bladder cancer.
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.
Potential role for targeted therapy in muscle-invasive bladder cancer: lessons from the cancer genome atlas and beyond.
Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
Prognostic value of differentially methylated gene profiles in bladder cancer.
Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer.
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
Robotic-assisted laparoscopic pelvic lymphadenectomy for bladder cancer: a surgical atlas.
Screening of MicroRNA Biomarkers Related to the Progression of Bladder Cancer.
Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.
Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project.
Surgical atlas: Orthotopic bladder substitution in women after cystectomy for bladder cancer.
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.
The Cancer Genome Atlas Project in Bladder Cancer.
The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer.
The clinical applications of The Cancer Genome Atlas project for bladder cancer.
The effects of alternative splicing on miRNA binding sites in bladder cancer.
The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor.
Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.
To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis.
Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
Update on The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer.
Upregulated GAPLINC predicts a poor prognosis in bladder cancer patients and promotes tumor proliferation and invasion.
Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway.
Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage.
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.
Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images.
ZFAS1 functions as an oncogenic long non-coding RNA in bladder cancer.
[Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
[High expression of activated CD4+ memory T cells and CD8+ T cells and low expression of M0 macrophage are associated with better clinical prognosis in bladder cancer patients].
[Update on molecular classifications and new histological classification of bladder cancer].
Urinary Calculi
[Analysis of urinary calculi in adults from the Moroccan Medium Atlas by Fourier transform infrared spectrophotometry]
Urinary Incontinence
Isolated atlantal stenosis in a patient with idiopathic growth hormone deficiency, and Klippel-Feil and Duane's syndromes.
Urinary Tract Infections
Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.
First year of mandatory reporting of healthcare-associated infections, pennsylvania: an infection control-chart abstractor collaboration.
Urogenital Neoplasms
In Silico Inference of Synthetic Cytotoxic Interactions from Paclitaxel Responses.
Urolithiasis
Atlas of Practical Diagnosis in Urolithiasis.
Urologic Neoplasms
Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Uterine Cervical Neoplasms
A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer.
A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction.
An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.
An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.
An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer.
Analysis of the Role and Regulatory Mechanism of hsa-miR-504 in Cervical Cancer Based on The Cancer Genome Atlas Database.
APLN: A potential novel biomarker for cervical cancer.
Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma.
Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women.
Characterization of DNA hydroxymethylation profile in cervical cancer.
Chromosomal instability as a prognostic marker in cervical cancer.
Comparison of normalization approaches for gene expression studies completed with high-throughput sequencing.
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.
Construction of Gene Modules and Analysis of Prognostic Biomarkers for Cervical Cancer by Weighted Gene Co-Expression Network Analysis.
Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer.
DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
DNA repair gene expression is associated with differential prognosis between HPV16 and HPV18 positive cervical cancer patients following radiation therapy.
Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
Dual oxidase 1 and NADPH oxidase 2 exert favorable effects in cervical cancer patients by activating immune response.
Effects of ABT-737 combined with irradiation treatment on uterine cervical cancer cells.
Elastic Net-Based Identification of a Multigene Combination Predicting the Survival of Patients with Cervical Cancer.
Elevated MYO10 Predicts Poor Prognosis and its Deletion Hampers Proliferation and Migration Potentials of Cells Through Rewiring PI3K/Akt Signaling in Cervical Cancer.
Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
Exogenous regucalcin negatively regulates the progression of cervical adenocarcinoma.
FEZF1 is an Independent Predictive Factor for Recurrence and Promotes Cell Proliferation and Migration in Cervical Cancer.
GJA1 Expression and Its Prognostic Value in Cervical Cancer.
Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment.
Identification and characterization of HPV-independent cervical cancers.
Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.
Identification and validation of a prognostic proteomic signature for cervical cancer.
Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.
Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Identification of a six lncRNAs signature as novel diagnostic biomarkers for cervical cancer.
Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets.
Identification of driver genes regulating immune cell infiltration in cervical cancer by multiple omics integration.
Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis.
Identification of Potential Driver Genes Based on Multi-Genomic Data in Cervical Cancer.
Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study.
Integrated Analysis of a Competing Endogenous RNA Network Revealing a Prognostic Signature for Cervical Cancer.
Integrated analysis of HPV-mediated immune alterations in cervical cancer.
Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.
Integrative Bioinformatics Approaches to Screen Potential Prognostic Immune-Related Genes and Drugs in the Cervical Cancer Microenvironment.
Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer.
LGR6 activates the Wnt/?-catenin signaling pathway and forms a ?-catenin/TCF7L2/LGR6 feedback loop in LGR6high cervical cancer stem cells.
LINC00294 induced by GRP78 promotes cervical cancer development by promoting cell cycle transition.
Long Intergenic Non-Coding RNA LINC00885 Promotes Tumorigenesis of Cervical Cancer by Upregulating MACC1 Expression Through Serving as a Competitive Endogenous RNA for microRNA-432-5p.
Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
Long non-coding RNA USP30-AS1 aggravates the malignant progression of cervical cancer by sequestering microRNA-299-3p and thereby overexpressing PTP4A1.
Long noncoding RNA ALOX12-AS1 inhibits cervical cancer cells proliferation via targeting miR-3171.
Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer.
Machine learning-based prediction of survival prognosis in cervical cancer.
Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in Immune-Related Gene Expression.
MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.
Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
NRG Oncology /RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer- An Update.
Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer.
Overlapping clustering of gene expression data using penalized weighted normalized cut.
Polo like kinase 1 expression in cervical cancer tissues generated from multiple detection methods.
Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer.
Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
Predicting DNA methylation from genetic data lacking racial diversity using shared classified random effects.
Roentgen anatomy. III. A cross section atlas for the radiation therapy of the cancer of cervix uteri.
Role of host-microRNA Hsa-miR-139-3p in HPV-16 induced carcinomas.
Six-lncRNA Immune Prognostic Signature for Cervical Cancer.
SOX14 hypermethylation as a tumour biomarker in cervical cancer.
The Landscape and Implications of Chimeric RNAs in Cervical Cancer.
The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism.
The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.
Updating and Optimizing Anatomic Atlases for Elective Radiation of Para-Aortic Lymph Nodes in Cervical Cancer.
Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.
Whole-exome and RNA sequencing reveal novel insights into the pathogenesis of HPV associated cervical cancer.
[Knockdown of YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) inhibits cell proliferation and promotes apoptosis in cervical cancer cells].
Uterine Neoplasms
Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer.
Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival rates.
DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
HTLV-1-associated genes as potential biomarkers for endometrial cancer.
Uveitis
A Colour Atlas of Uveitis Diagnosis.
Diagnosis and Management of Uveitis: An Atlas Approach.
Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease.
Varicocele
Surgical atlas varicocele: Antegrade scrotal sclerotherapy.
Varicose Veins
A Colour Atlas of Surgery for Varicose Veins: Single Surgical Procedures, vol 8.
Vascular Diseases
Three-dimensional stereotactic atlas of the extracranial vasculature correlated with the intracranial vasculature, cranial nerves, skull and muscles.
[Kimmerle's anomaly and stroke]
Vascular Headaches
[Radiography of the transverse foramen of the atlas; contribution to the study of occipital vascular headaches.]
Vascular Ring
AN ATLAS OF VASCULAR RINGS AND RELATED MALFORMATIONS OF THE AORTIC ARCH SYSTEM.
Vasculitis
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.
Vertebral Artery Dissection
Congenital anomaly of the posterior arch of the atlas: a rare risk factor for posterior circulation stroke.
Evaluation of Rotational Vertebral Artery Occlusion Using Ultrasound Facilitates the Detection of Arterial Dissection in the Atlas Loop.
Occipital to Vertebral Artery Bypass to Stop Transient Ischemic Attacks Caused by Traumatic Vertebral Artery Dissection: A Case Report.
Tethering of the vertebral artery in the congenital arcuate foramen of the atlas vertebra: a possible cause of vertebral artery dissection in children.
Vesico-Ureteral Reflux
Surgery Illustrated - Surgical Atlas Endoscopic treatment of vesicoureteral reflux.
Viremia
Characterization of HIV-induced remodeling reveals differences in infection susceptibility of memory CD4+ T cell subsets in vivo.
Virus Diseases
Atlas of brain proton magnetic resonance spectra. Part III: Viral infections.
Charting a shared epigenetic pathway to CD8+ T cell dysfunction in infection and cancer.
Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs.
Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).
Interpretation of T cell states from single-cell transcriptomics data using reference atlases.
[Stomatological atlas. Viral infection]
Vision Disorders
Brain imaging in a patient with hemimicropsia.
Vitamin D Deficiency
Vitamin D-VDR Signaling Inhibits Wnt/?-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
Vitiligo
Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference.
Vocal Cord Paralysis
Plasmacytoma of the atlas presenting as hoarseness: a rare cause of unilateral vocal fold palsy.
Williams Syndrome
Effect of nonrigid registration algorithms on deformation-based morphometry: a comparative study with control and Williams syndrome subjects.
Isolated cervical spinal canal stenosis at C-1 in the pediatric population and in Williams syndrome.
Wilms Tumor
Profiling of differential gene expression in Wilms tumor by cDNA expression array.
Yellow Fever
An updated antennal lobe atlas for the yellow fever mosquito Aedes aegypti.
Zoonoses
[Actual problems of creation of informational-analytical system for rapid control of epidemics of infectious diseases].